activity_comment	activity_id	assay_chembl_id	assay_description	assay_type	canonical_smiles	data_validity_comment	molecule_chembl_id	relation	standard_type	standard_units	standard_value	target_chembl_id	target_organism	type	units	value
	177450	CHEMBL798940	Inhibition of Serine/threonine-protein kinase Chk2	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1ncc(C(F)(F)F)cc1Cl		CHEMBL111620	=	Activity	%	92.0	CHEMBL2527	Homo sapiens	Activity	%	92.0
	177450	CHEMBL798940	Inhibition of Serine/threonine-protein kinase Chk2	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1ncc(C(F)(F)F)cc1Cl		CHEMBL111620	=	Activity	%	92.0	CHEMBL2527	Homo sapiens	Activity	%	92.0
	178763	CHEMBL798940	Inhibition of Serine/threonine-protein kinase Chk2	B	COCCCn1cc(C2=C(c3ccccc3O)C(=O)NC2=O)c2cccnc21		CHEMBL109944	=	Activity	%	75.0	CHEMBL2527	Homo sapiens	Activity	%	75.0
	182510	CHEMBL798940	Inhibition of Serine/threonine-protein kinase Chk2	B	COc1ccccc1C1=C(c2cn(CCCNC(=O)OC(C)(C)C)c3ncccc23)C(=O)NC1=O		CHEMBL109981	=	Activity	%	49.0	CHEMBL2527	Homo sapiens	Activity	%	49.0
	616541	CHEMBL798942	Inhibition of Serine/threonine-protein kinase Chk2 at 100 nM	B	Cn1ccc2ccc3c4[nH]c5c(CCCN[C@H]6CC[C@H](O)CC6)cccc5c4c4c(c3c21)C(=O)NC4=O		CHEMBL307152	=	Control	%	84.0	CHEMBL2527	Homo sapiens	Control	%	84.0
	616580	CHEMBL799113	Inhibition of Serine/threonine-protein kinase Chk2 at 500 nM	B	Cn1ccc2ccc3c4[nH]c5c(CCCN[C@H]6CC[C@H](O)CC6)cccc5c4c4c(c3c21)C(=O)NC4=O		CHEMBL307152	=	Control	%	53.0	CHEMBL2527	Homo sapiens	Control	%	53.0
	1038874	CHEMBL798941	Inhibition of Serine/threonine-protein kinase Chk2 (CDS1 receptor)	B	CC(C)OCc1ccc2c(c1)c1c3c(c4c(c1n2CCCO)Cc1ccccc1-4)C(=O)NC3		CHEMBL150894	>	IC50	nM	3000.0	CHEMBL2527	Homo sapiens	IC50	nM	3000.0
	1405011	CHEMBL874429	Inhibition of recombinant human Chk2 kinase	B	Nc1ccc2[nH]c(-c3ccc(Oc4ccccc4)cc3)nc2c1		CHEMBL179383	=	IC50	nM	2400.0	CHEMBL2527	Homo sapiens	IC50	nM	2400.0
	1405012	CHEMBL874429	Inhibition of recombinant human Chk2 kinase	B	NS(=O)(=O)c1ccc2[nH]c(-c3ccc(Oc4ccccc4)cc3)nc2c1		CHEMBL176015	=	IC50	nM	290.0	CHEMBL2527	Homo sapiens	IC50	nM	290.0
	1405013	CHEMBL874429	Inhibition of recombinant human Chk2 kinase	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccccc4)cc3)nc2c1		CHEMBL178971	=	IC50	nM	55.0	CHEMBL2527	Homo sapiens	IC50	nM	55.0
	1405014	CHEMBL874429	Inhibition of recombinant human Chk2 kinase	B	CNC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccccc4)cc3)nc2c1		CHEMBL179636	=	IC50	nM	1400.0	CHEMBL2527	Homo sapiens	IC50	nM	1400.0
	1405015	CHEMBL874429	Inhibition of recombinant human Chk2 kinase	B	CN(C)C(=O)c1ccc2[nH]c(-c3ccc(Oc4ccccc4)cc3)nc2c1		CHEMBL175878	>	IC50	nM	10000.0	CHEMBL2527	Homo sapiens	IC50	nM	10000.0
	1405019	CHEMBL874429	Inhibition of recombinant human Chk2 kinase	B	NC(=O)c1cccc2[nH]c(-c3ccc(Oc4ccccc4)cc3)nc12		CHEMBL176276	=	IC50	nM	6000.0	CHEMBL2527	Homo sapiens	IC50	nM	6000.0
	1405020	CHEMBL874429	Inhibition of recombinant human Chk2 kinase	B	NC(=O)c1ccc2[nH]c(-c3ccccc3)nc2c1		CHEMBL176041	=	IC50	nM	1200.0	CHEMBL2527	Homo sapiens	IC50	nM	1200.0
	1405021	CHEMBL874429	Inhibition of recombinant human Chk2 kinase	B	CCOc1ccc(-c2nc3cc(C(N)=O)ccc3[nH]2)cc1		CHEMBL175780	=	IC50	nM	200.0	CHEMBL2527	Homo sapiens	IC50	nM	200.0
	1405022	CHEMBL874429	Inhibition of recombinant human Chk2 kinase	B	O=C(O)c1ccc2[nH]c(-c3ccc(Oc4ccccc4)cc3)nc2c1		CHEMBL367390	=	IC50	nM	640.0	CHEMBL2527	Homo sapiens	IC50	nM	640.0
	1405023	CHEMBL874429	Inhibition of recombinant human Chk2 kinase	B	N#Cc1ccc2[nH]c(-c3ccc(Oc4ccccc4)cc3)nc2c1		CHEMBL176554	=	IC50	nM	1900.0	CHEMBL2527	Homo sapiens	IC50	nM	1900.0
	1405024	CHEMBL874429	Inhibition of recombinant human Chk2 kinase	B	O=[N+]([O-])c1ccc2[nH]c(-c3ccc(Oc4ccccc4)cc3)nc2c1		CHEMBL175481	=	IC50	nM	1500.0	CHEMBL2527	Homo sapiens	IC50	nM	1500.0
	1405025	CHEMBL874429	Inhibition of recombinant human Chk2 kinase	B	NC(=O)c1ccc2[nH]c(-c3cccc(Oc4ccccc4)c3)nc2c1		CHEMBL176235	=	IC50	nM	930.0	CHEMBL2527	Homo sapiens	IC50	nM	930.0
	1405132	CHEMBL874429	Inhibition of recombinant human Chk2 kinase	B	Cc1ccc(-c2nc3cc(C(N)=O)ccc3[nH]2)cc1		CHEMBL176115	=	IC50	nM	1100.0	CHEMBL2527	Homo sapiens	IC50	nM	1100.0
	1405133	CHEMBL874429	Inhibition of recombinant human Chk2 kinase	B	NC(=O)c1ccc2[nH]c(-c3ccc4ccccc4c3)nc2c1		CHEMBL176326	=	IC50	nM	200.0	CHEMBL2527	Homo sapiens	IC50	nM	200.0
	1405134	CHEMBL874429	Inhibition of recombinant human Chk2 kinase	B	NC(=O)c1ccc2[nH]c(-c3cccc(Oc4ccc(Cl)c(Cl)c4)c3)nc2c1		CHEMBL175676	=	IC50	nM	530.0	CHEMBL2527	Homo sapiens	IC50	nM	530.0
	1405141	CHEMBL874429	Inhibition of recombinant human Chk2 kinase	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	IC50	nM	15.0	CHEMBL2527	Homo sapiens	IC50	nM	15.0
	1405142	CHEMBL874429	Inhibition of recombinant human Chk2 kinase	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	IC50	nM	16.0	CHEMBL2527	Homo sapiens	IC50	nM	16.0
	1405143	CHEMBL874429	Inhibition of recombinant human Chk2 kinase	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)c(Cl)c4)cc3)nc2c1		CHEMBL175553	=	IC50	nM	5.5	CHEMBL2527	Homo sapiens	IC50	nM	5.5
	1405144	CHEMBL874429	Inhibition of recombinant human Chk2 kinase	B	Cc1ccc(Oc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)cc1Cl		CHEMBL359881	=	IC50	nM	4.4	CHEMBL2527	Homo sapiens	IC50	nM	4.4
	1405145	CHEMBL874429	Inhibition of recombinant human Chk2 kinase	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)c(C(F)(F)F)c4)cc3)nc2c1		CHEMBL179717	=	IC50	nM	4.5	CHEMBL2527	Homo sapiens	IC50	nM	4.5
	1405146	CHEMBL874429	Inhibition of recombinant human Chk2 kinase	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4cc(C(F)(F)F)ccc4F)cc3)nc2c1		CHEMBL361378	=	IC50	nM	12.0	CHEMBL2527	Homo sapiens	IC50	nM	12.0
	1405147	CHEMBL874429	Inhibition of recombinant human Chk2 kinase	B	Cc1ccc(Oc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)cc1C		CHEMBL362255	=	IC50	nM	12.0	CHEMBL2527	Homo sapiens	IC50	nM	12.0
	1405148	CHEMBL874429	Inhibition of recombinant human Chk2 kinase	B	NC(=O)c1ccc(Oc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)cc1		CHEMBL362677	=	IC50	nM	47.0	CHEMBL2527	Homo sapiens	IC50	nM	47.0
	1405149	CHEMBL874429	Inhibition of recombinant human Chk2 kinase	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4cccc(O)c4)cc3)nc2c1		CHEMBL367263	=	IC50	nM	61.0	CHEMBL2527	Homo sapiens	IC50	nM	61.0
	1405150	CHEMBL874429	Inhibition of recombinant human Chk2 kinase	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)c(O)c4)cc3)nc2c1		CHEMBL175472	=	IC50	nM	9.8	CHEMBL2527	Homo sapiens	IC50	nM	9.8
	1405151	CHEMBL874429	Inhibition of recombinant human Chk2 kinase	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc5ccccc5c4)cc3)nc2c1		CHEMBL369254	=	IC50	nM	12.0	CHEMBL2527	Homo sapiens	IC50	nM	12.0
	1405156	CHEMBL874429	Inhibition of recombinant human Chk2 kinase	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4cccc(Cl)c4)cc3)nc2c1		CHEMBL178972	=	IC50	nM	17.0	CHEMBL2527	Homo sapiens	IC50	nM	17.0
	1405157	CHEMBL874429	Inhibition of recombinant human Chk2 kinase	B	COc1ccc(Oc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)cc1		CHEMBL176164	=	IC50	nM	23.0	CHEMBL2527	Homo sapiens	IC50	nM	23.0
	1405158	CHEMBL874429	Inhibition of recombinant human Chk2 kinase	B	Cc1ccc(Oc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)cc1		CHEMBL175879	=	IC50	nM	24.0	CHEMBL2527	Homo sapiens	IC50	nM	24.0
	1405159	CHEMBL874429	Inhibition of recombinant human Chk2 kinase	B	COc1ccc(Oc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)cc1OC		CHEMBL179267	=	IC50	nM	31.0	CHEMBL2527	Homo sapiens	IC50	nM	31.0
	1442939	CHEMBL833022	In vitro inhibitory concentration against checkpoint kinase 2 (Chk2) by using [gamma-33P]-ATP] as radioligand	B	Nc1nc(C2=C3C(=Nc4ccccc43)C(=O)NCC2)c(O)[nH]1		CHEMBL332551	=	IC50	nM	8.0	CHEMBL2527	Homo sapiens	IC50	nM	8.0
	1443238	CHEMBL833022	In vitro inhibitory concentration against checkpoint kinase 2 (Chk2) by using [gamma-33P]-ATP] as radioligand	B	NC1=NC(=O)/C(=C2\CCNC(=O)c3[nH]c(Br)cc32)N1		CHEMBL361708	=	IC50	nM	42.0	CHEMBL2527	Homo sapiens	IC50	nM	42.0
	1443245	CHEMBL833022	In vitro inhibitory concentration against checkpoint kinase 2 (Chk2) by using [gamma-33P]-ATP] as radioligand	B	NC1=N/C(=C2/CCNC(=O)c3[nH]ccc32)C(=O)N1		CHEMBL255465	=	IC50	nM	183.0	CHEMBL2527	Homo sapiens	IC50	nM	183.0
	1507332	CHEMBL831645	Inhibition of Serine/threonine-protein kinase Chk2	B	CC(CN(C)C)Oc1ccc(Cl)cc1NC(=O)Nc1cnc(C#N)cn1		CHEMBL425904	=	IC50	nM	2800.0	CHEMBL2527	Homo sapiens	IC50	nM	2800.0
	1507349	CHEMBL831645	Inhibition of Serine/threonine-protein kinase Chk2	B	CC1(COc2ccc(Cl)cc2NC(=O)Nc2cnc(C#N)cn2)COC1		CHEMBL192161	=	IC50	nM	7.0	CHEMBL2527	Homo sapiens	IC50	nM	7.0
	1519007	CHEMBL874429	Inhibition of recombinant human Chk2 kinase	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc([N+](=O)[O-])cc4)cc3)nc2c1		CHEMBL193397	=	IC50	nM	81.0	CHEMBL2527	Homo sapiens	IC50	nM	81.0
	1519008	CHEMBL874429	Inhibition of recombinant human Chk2 kinase	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4cccc(C(=O)O)c4)cc3)nc2c1		CHEMBL381436	=	IC50	nM	715.0	CHEMBL2527	Homo sapiens	IC50	nM	715.0
	1519009	CHEMBL874429	Inhibition of recombinant human Chk2 kinase	B	CCN(CC)C(=O)c1cccc(Oc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)c1		CHEMBL195678	=	IC50	nM	820.0	CHEMBL2527	Homo sapiens	IC50	nM	820.0
	1519010	CHEMBL874429	Inhibition of recombinant human Chk2 kinase	B	CS(=O)(=O)Nc1ccc(Oc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)cc1		CHEMBL363339	=	IC50	nM	41.0	CHEMBL2527	Homo sapiens	IC50	nM	41.0
	1519011	CHEMBL874429	Inhibition of recombinant human Chk2 kinase	B	NC(=O)c1ccc2[nH]c(-c3ccc(S(=O)(=O)Nc4ccccc4)cc3)nc2c1		CHEMBL195320	=	IC50	nM	18.0	CHEMBL2527	Homo sapiens	IC50	nM	18.0
	1519012	CHEMBL874429	Inhibition of recombinant human Chk2 kinase	B	NC(=O)c1ccc2[nH]c(-c3ccc(C(=O)Nc4ccccc4)cc3)nc2c1		CHEMBL193394	=	IC50	nM	410.0	CHEMBL2527	Homo sapiens	IC50	nM	410.0
	1519013	CHEMBL874429	Inhibition of recombinant human Chk2 kinase	B	NC(=O)c1ccc2[nH]c(-c3ccc(-c4ccccc4)cc3)nc2c1		CHEMBL193476	=	IC50	nM	100.0	CHEMBL2527	Homo sapiens	IC50	nM	100.0
	1519014	CHEMBL874429	Inhibition of recombinant human Chk2 kinase	B	NC(=O)c1ccc2[nH]c(-c3ccc(S(=O)(=O)Nc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL195846	=	IC50	nM	14.0	CHEMBL2527	Homo sapiens	IC50	nM	14.0
	1519018	CHEMBL874429	Inhibition of recombinant human Chk2 kinase	B	NC(=O)c1ccc2[nH]c(-c3ccc(C(=O)Nc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL195598	=	IC50	nM	680.0	CHEMBL2527	Homo sapiens	IC50	nM	680.0
	1519019	CHEMBL874429	Inhibition of recombinant human Chk2 kinase	B	NC(=O)c1ccc2[nH]c(-c3ccc(-c4ccc(Cl)cc4)cc3)nc2c1		CHEMBL195599	=	IC50	nM	250.0	CHEMBL2527	Homo sapiens	IC50	nM	250.0
	1519020	CHEMBL874429	Inhibition of recombinant human Chk2 kinase	B	NC(=O)c1ccc2[nH]c(-c3ccc(S(=O)(=O)Nc4ccc(Cl)c(Cl)c4)cc3)nc2c1		CHEMBL195177	=	IC50	nM	3.4	CHEMBL2527	Homo sapiens	IC50	nM	3.4
	1519021	CHEMBL874429	Inhibition of recombinant human Chk2 kinase	B	NC(=O)c1ccc2[nH]c(-c3ccc(C(=O)Nc4ccc(Cl)c(Cl)c4)cc3)nc2c1		CHEMBL192156	>	IC50	nM	10000.0	CHEMBL2527	Homo sapiens	IC50	nM	10000.0
	1519022	CHEMBL874429	Inhibition of recombinant human Chk2 kinase	B	NC(=O)c1ccc2[nH]c(-c3ccc(Sc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL191969	=	IC50	nM	8.2	CHEMBL2527	Homo sapiens	IC50	nM	8.2
	1519023	CHEMBL874429	Inhibition of recombinant human Chk2 kinase	B	NC(=O)c1ccc2[nH]c(-c3ccc([S+]([O-])c4ccc(Cl)cc4)cc3)nc2c1		CHEMBL364978	=	IC50	nM	13.0	CHEMBL2527	Homo sapiens	IC50	nM	13.0
	1519024	CHEMBL874429	Inhibition of recombinant human Chk2 kinase	B	NC(=O)c1ccc2[nH]c(-c3ccc(S(=O)(=O)c4ccc(Cl)cc4)cc3)nc2c1		CHEMBL193990	=	IC50	nM	6.6	CHEMBL2527	Homo sapiens	IC50	nM	6.6
	1519025	CHEMBL874429	Inhibition of recombinant human Chk2 kinase	B	NC(=O)c1ccc2[nH]c(-c3ccc(OCc4ccccc4)cc3)nc2c1		CHEMBL192022	=	IC50	nM	32.0	CHEMBL2527	Homo sapiens	IC50	nM	32.0
	1519026	CHEMBL874429	Inhibition of recombinant human Chk2 kinase	B	NC(=O)c1ccc2[nH]c(-c3ccc(Sc4ccc(O)cc4)cc3)nc2c1		CHEMBL195041	=	IC50	nM	2.3	CHEMBL2527	Homo sapiens	IC50	nM	2.3
	1519263	CHEMBL874429	Inhibition of recombinant human Chk2 kinase	B	NC(=O)c1ccc2[nH]c(-c3ccc4oc5ccccc5c4c3)nc2c1		CHEMBL195648	=	IC50	nM	500.0	CHEMBL2527	Homo sapiens	IC50	nM	500.0
	1666753	CHEMBL865809	Inhibitory activity against Chk2	B	COc1cc(-c2ccc3c(c2)NC(=O)/C3=C\c2ccc[nH]2)ccc1O		CHEMBL202930	=	IC50	nM	21730.0	CHEMBL2527	Homo sapiens	IC50	nM	21730.0
	1666764	CHEMBL865809	Inhibitory activity against Chk2	B	COc1cc(-c2ccc3c(c2)NC(=O)/C3=C\c2c[nH]c3ncccc23)ccc1O		CHEMBL383316	=	IC50	nM	22679.0	CHEMBL2527	Homo sapiens	IC50	nM	22679.0
	1666776	CHEMBL865809	Inhibitory activity against Chk2	B	COc1cc(-c2ccc3c(c2)NC(=O)/C3=C\c2ncc[nH]2)ccc1O		CHEMBL199299	=	IC50	nM	14649.0	CHEMBL2527	Homo sapiens	IC50	nM	14649.0
	1705399	CHEMBL862313	Inhibition of chk2 kinase	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccccc4)cc3)nc2c1		CHEMBL178971	=	IC50	nM	55.0	CHEMBL2527	Homo sapiens	IC50	nM	55.0
	1705400	CHEMBL862313	Inhibition of chk2 kinase	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2n1		CHEMBL206609	=	IC50	nM	77.0	CHEMBL2527	Homo sapiens	IC50	nM	77.0
	1705401	CHEMBL862313	Inhibition of chk2 kinase	B	NC(=O)c1c[nH]c2nc(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc-2c1		CHEMBL377597	=	IC50	nM	2000.0	CHEMBL2527	Homo sapiens	IC50	nM	2000.0
	1705402	CHEMBL862313	Inhibition of chk2 kinase	B	O=C(O)c1ccc2cc(-c3ccc(Oc4ccc(Cl)cc4)cc3)[nH]c2c1		CHEMBL204930	=	IC50	nM	5800.0	CHEMBL2527	Homo sapiens	IC50	nM	5800.0
	1705403	CHEMBL862313	Inhibition of chk2 kinase	B	Cn1c(-c2ccc(Oc3ccccc3)cc2)nc2ccc(C(N)=O)cc21		CHEMBL205906	=	IC50	nM	1540.0	CHEMBL2527	Homo sapiens	IC50	nM	1540.0
	1705404	CHEMBL862313	Inhibition of chk2 kinase	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	IC50	nM	16.0	CHEMBL2527	Homo sapiens	IC50	nM	16.0
	1705405	CHEMBL862313	Inhibition of chk2 kinase	B	O=C(O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL208463	=	IC50	nM	133.0	CHEMBL2527	Homo sapiens	IC50	nM	133.0
	1705406	CHEMBL862313	Inhibition of chk2 kinase	B	O=C(O)c1ccc2[nH]c(-c3ccc(Oc4ccccc4)cc3)nc2c1		CHEMBL367390	=	IC50	nM	640.0	CHEMBL2527	Homo sapiens	IC50	nM	640.0
	1705407	CHEMBL862313	Inhibition of chk2 kinase	B	Cn1c(-c2ccc(Oc3ccccc3)cc2)nc2cc(C(N)=O)ccc21		CHEMBL205905	>	IC50	nM	10000.0	CHEMBL2527	Homo sapiens	IC50	nM	10000.0
	1705408	CHEMBL862313	Inhibition of chk2 kinase	B	NC(=O)c1cnc2cc(-c3ccc(Oc4ccccc4)cc3)nn2c1		CHEMBL382588	>	IC50	nM	10000.0	CHEMBL2527	Homo sapiens	IC50	nM	10000.0
	1705409	CHEMBL862313	Inhibition of chk2 kinase	B	NC(=O)c1ccc2nc(-c3ccc(Oc4ccccc4)cc3)oc2c1		CHEMBL204929	>	IC50	nM	10000.0	CHEMBL2527	Homo sapiens	IC50	nM	10000.0
	1705410	CHEMBL862313	Inhibition of chk2 kinase	B	NC(=O)c1ccc2oc(-c3ccc(Oc4ccccc4)cc3)nc2c1		CHEMBL202669	>	IC50	nM	10000.0	CHEMBL2527	Homo sapiens	IC50	nM	10000.0
	1723104	CHEMBL860199	Inhibition of CHK2	B	CCOc1nc(NC(C)=O)cc(N)c1C#N		CHEMBL208637	>	Ki	nM	9500.0	CHEMBL2527	Homo sapiens	Ki	nM	9500.0
	1723105	CHEMBL860199	Inhibition of CHK2	B	CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1Cl		CHEMBL210928	>	Ki	nM	9500.0	CHEMBL2527	Homo sapiens	Ki	nM	9500.0
	1723106	CHEMBL860199	Inhibition of CHK2	B	CC(=O)Nc1cc(N)c(C#N)c(-c2ccccc2)n1		CHEMBL210032	>	Ki	nM	9500.0	CHEMBL2527	Homo sapiens	Ki	nM	9500.0
	1723107	CHEMBL860199	Inhibition of CHK2	B	COc1cc(S(C)(=O)=O)c(OC)cc1CC(=O)Nc1cc(N)c(C#N)c(OC(C)C)n1		CHEMBL378627	>	Ki	nM	9500.0	CHEMBL2527	Homo sapiens	Ki	nM	9500.0
	1723108	CHEMBL860199	Inhibition of CHK2	B	CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1C#N		CHEMBL210963	>	Ki	nM	9500.0	CHEMBL2527	Homo sapiens	Ki	nM	9500.0
	1723109	CHEMBL860199	Inhibition of CHK2	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	>	Ki	nM	9500.0	CHEMBL2527	Homo sapiens	Ki	nM	9500.0
	1734204	CHEMBL862467	Residual activity at human Chk2 at 10 uM in presence of 10 uM ATP relative to control	B	O=C1NC(=O)/C(=C/c2ccc(-c3ccc(F)cc3O)o2)S1		CHEMBL379156	=	Activity	%	82.0	CHEMBL2527	Homo sapiens	Activity	%	82.0
	1744351	CHEMBL867404	Inhibition of CHK2	B	CCOc1nc(C(=O)NCc2ccc(S(C)(=O)=O)cc2)cc(N)c1Cl		CHEMBL377383	>	Ki	nM	9500.0	CHEMBL2527	Homo sapiens	Ki	uM	9.5
	1769384	CHEMBL910904	Inhibition of Chk1	B	C[C@@H]1C[C@H]2CN1CCn1nc3c(cccc3c1O)-c1nc3c(cccc3nc1O)O2		CHEMBL215803	>	IC50	nM	1000.0	CHEMBL2527	Homo sapiens	IC50	uM	1.0
	1790009	CHEMBL853556	Percentage activity of human CHK2 in the presence of 10 uM of compound and 10 uM of ATP in comparison with control	B	O=C(NCc1ccc(S(=O)(=O)N2CCC(n3nnc4ccccc43)CC2)s1)c1ccc(Cl)cc1		CHEMBL383955	=	Activity	%	75.0	CHEMBL2527	Homo sapiens	Activity	%	75.0
	1790111	CHEMBL873741	Inhibition of CHK2	B	CC(CO)NC(=N)c1c(O)nsc1Nc1ccc(Nc2ccccc2)cc1		CHEMBL253116	=	IC50	nM	13.0	CHEMBL2527	Homo sapiens	IC50	nM	13.0
	1790281	CHEMBL873741	Inhibition of CHK2	B	CC(CO)/N=C(\N)c1c(O)nsc1Nc1ccc(Oc2ccccc2)cc1		CHEMBL437331	=	IC50	nM	142.0	CHEMBL2527	Homo sapiens	IC50	nM	142.0
	1790327	CHEMBL873767	Percent residual activity, relative to control, of CHK2 at 1uM concentration of inhibitor in presence of 20uM ATP	B	N=C(N)NCCC[C@@H](NC(=O)CCCCCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)NC(=O)CCCCCNCCNS(=O)(=O)c1cccc2cnccc12		CHEMBL413460	=	Activity	%	22.0	CHEMBL2527	Homo sapiens	Activity	%	22.0
	1790381	CHEMBL873767	Percent residual activity, relative to control, of CHK2 at 1uM concentration of inhibitor in presence of 20uM ATP	B	N=C(N)NCCC[C@@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)CCCCCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)C(N)=O		CHEMBL279185	=	Activity	%	14.0	CHEMBL2527	Homo sapiens	Activity	%	14.0
	1824517	CHEMBL913844	Inhibition of Chk2	B	CS(=O)(=O)Nc1cc2c(cc1Cl)NC(=O)Nc1cnc(C#N)c(n1)OCCCCCO2		CHEMBL223460	>	Ki	nM	10000.0	CHEMBL2527	Homo sapiens	Ki	uM	10.0
	1824701	CHEMBL913844	Inhibition of Chk2	B	N#Cc1ncc2nc1OCCCCCOc1cc(OCCCO)c(Cl)cc1NC(=O)N2		CHEMBL373598	=	Ki	nM	5670.0	CHEMBL2527	Homo sapiens	Ki	uM	5.67
	1824776	CHEMBL913844	Inhibition of Chk2	B	N#Cc1ncc2nc1OCCCCCOc1cc(CCCO)c(Cl)cc1NC(=O)N2		CHEMBL223367	>	Ki	nM	10000.0	CHEMBL2527	Homo sapiens	Ki	uM	10.0
	1916296	CHEMBL894157	Inhibition of recombinant Chk2 by radiometric assay	B	COc1cc(-c2ccc3c(c2)Nc2ccc(CC(=O)Nc4ccc(N5CCOCC5)cc4)cc2NC3=O)ccc1N		CHEMBL395080	=	IC50	nM	13450.0	CHEMBL2527	Homo sapiens	IC50	uM	13.45
	1916349	CHEMBL894157	Inhibition of recombinant Chk2 by radiometric assay	B	COc1cc(-c2ccc3c(c2)Nc2ccc(C(C)(C)C(=O)Nc4ccc(N5CCOCC5)cc4)cc2NC3=O)ccc1N		CHEMBL389745	>	IC50	nM	50000.0	CHEMBL2527	Homo sapiens	IC50	uM	50.0
	1944444	CHEMBL891241	Inhibition of CHK2 by radiometric assay	B	O=C(N[C@H]1CC[C@H](O)CC1)c1ccc2c(c1)Cc1c(-c3ccc(-c4ccc(O)cc4)cc3)n[nH]c1-2		CHEMBL438485	>	IC50	nM	50000.0	CHEMBL2527	Homo sapiens	IC50	nM	50000.0
	1944447	CHEMBL891241	Inhibition of CHK2 by radiometric assay	B	O=C(NCc1ccncc1)c1ccc2c(c1)Cc1c(-c3ccc(-c4ccc(O)cc4)cc3)n[nH]c1-2		CHEMBL242753	=	IC50	nM	10300.0	CHEMBL2527	Homo sapiens	IC50	nM	10300.0
	1989374	CHEMBL898056	Inhibition of human CHK2 expressed in Escherichia coli at 1 uM	B	CC(C)NCc1ccc(Nc2cc(-c3ccc(-c4ccc(O)cc4O)cc3)[nH]n2)cc1		CHEMBL398606	=	Inhibition	%	27.5	CHEMBL2527	Homo sapiens	Inhibition	%	27.5
	2015687	CHEMBL885493	Inhibition of Chk2 at 10 uM	B	NC[C@H]1CC[C@H](c2nc(-c3cccc(OCc4ccccc4)c3)c3c(N)nccn32)CC1		CHEMBL392284	<	Inhibition	%	50.0	CHEMBL2527	Homo sapiens	Inhibition	%	50.0
	2025130	CHEMBL886957	Inhibition of human CHK2 at 1 uM relative to control	B	CN(C)c1cc2cc(n1)CCCn1cc(c3ccccc31)C1=C(C(=O)NC1=O)c1cn(c3ccccc13)CCC2		CHEMBL247067	=	Inhibition	%	94.0	CHEMBL2527	Homo sapiens	Inhibition	%	94.0
	2025282	CHEMBL886957	Inhibition of human CHK2 at 1 uM relative to control	B	CN(C)c1nc2ccc1CCCn1cc(c3ccccc31)C1=C(C(=O)NC1=O)c1cn(c3ccccc13)CC2		CHEMBL1162963	=	Inhibition	%	91.0	CHEMBL2527	Homo sapiens	Inhibition	%	91.0
	2025283	CHEMBL886957	Inhibition of human CHK2 at 1 uM relative to control	B	O=C1NC(=O)C2=C1c1cn(c3ccccc13)CCCc1ccc(c(N3CCCC3)n1)CCCn1cc2c2ccccc21		CHEMBL396327	=	Inhibition	%	91.0	CHEMBL2527	Homo sapiens	Inhibition	%	91.0
	2025284	CHEMBL886957	Inhibition of human CHK2 at 1 uM relative to control	B	O=C1NC(=O)C2=C1c1cn(c3ccccc13)CCCc1cc(nc(N3CCCC3)c1)CCCn1cc2c2ccccc21		CHEMBL397771	=	Inhibition	%	84.0	CHEMBL2527	Homo sapiens	Inhibition	%	84.0
	2051603	CHEMBL942744	Inhibition of CHK2	B	N#Cc1ncc2nc1OCCCCOc1cc(NCc3cncs3)c(Cl)cc1NC(=O)N2		CHEMBL248757	>	Ki	nM	5578.0	CHEMBL2527	Homo sapiens	Ki	uM	5.578
	2051804	CHEMBL942788	Inhibition of human recombinant Chk2	B	NC(=O)c1ccc2[nH]c(-c3ccc(OCCO)cc3)nc2c1		CHEMBL251585	=	IC50	nM	52.0	CHEMBL2527	Homo sapiens	IC50	nM	52.0
	2051805	CHEMBL942788	Inhibition of human recombinant Chk2	B	NC(=O)c1ccc2[nH]c(-c3ccc(O[C@H]4CC[C@H](CO)CC4)cc3)nc2c1		CHEMBL429480	=	IC50	nM	400.0	CHEMBL2527	Homo sapiens	IC50	nM	400.0
	2051806	CHEMBL942788	Inhibition of human recombinant Chk2	B	NC(=O)c1ccc2[nH]c(-c3ccc(O[C@H]4CC[C@@H](CO)CC4)cc3)nc2c1		CHEMBL249570	=	IC50	nM	35.0	CHEMBL2527	Homo sapiens	IC50	nM	35.0
	2051807	CHEMBL942788	Inhibition of human recombinant Chk2	B	NC(=O)c1ccc2[nH]c(-c3ccc(OC4CCC(O)CC4)cc3)nc2c1		CHEMBL249569	=	IC50	nM	80.0	CHEMBL2527	Homo sapiens	IC50	nM	80.0
	2051808	CHEMBL942788	Inhibition of human recombinant Chk2	B	NC(=O)c1ccc2[nH]c(-c3ccc(OC4CCC(O)C4)cc3)nc2c1		CHEMBL250992	=	IC50	nM	72.0	CHEMBL2527	Homo sapiens	IC50	nM	72.0
	2051809	CHEMBL942788	Inhibition of human recombinant Chk2	B	NC(=O)c1ccc2[nH]c(-c3ccc(OCCCO)cc3)nc2c1		CHEMBL250796	=	IC50	nM	73.0	CHEMBL2527	Homo sapiens	IC50	nM	73.0
	2051821	CHEMBL942788	Inhibition of human recombinant Chk2	B	NC(=O)c1ccc2[nH]c(-c3ccc(OCCCN4CCCCC4)cc3)nc2c1		CHEMBL249750	=	IC50	nM	110.0	CHEMBL2527	Homo sapiens	IC50	nM	110.0
	2051822	CHEMBL942788	Inhibition of human recombinant Chk2	B	CN(C)CCCOc1ccc(-c2nc3cc(C(N)=O)ccc3[nH]2)cc1		CHEMBL249546	=	IC50	nM	176.0	CHEMBL2527	Homo sapiens	IC50	nM	176.0
	2051823	CHEMBL942788	Inhibition of human recombinant Chk2	B	NC(=O)c1ccc2[nH]c(-c3ccc(OC4CCCNC4)cc3)nc2c1		CHEMBL400287	=	IC50	nM	180.0	CHEMBL2527	Homo sapiens	IC50	nM	180.0
	2051824	CHEMBL942788	Inhibition of human recombinant Chk2	B	NC(=O)c1ccc2[nH]c(-c3ccc(OCCN4CCCCC4)cc3)nc2c1		CHEMBL249350	=	IC50	nM	174.0	CHEMBL2527	Homo sapiens	IC50	nM	174.0
	2051825	CHEMBL942788	Inhibition of human recombinant Chk2	B	NC(=O)c1ccc2[nH]c(-c3ccc(OC4CCN(Cc5ccccc5)C4)cc3)nc2c1		CHEMBL248934	=	IC50	nM	109.0	CHEMBL2527	Homo sapiens	IC50	nM	109.0
	2051826	CHEMBL942788	Inhibition of human recombinant Chk2	B	CN1CCC(Oc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)C1		CHEMBL400936	=	IC50	nM	710.0	CHEMBL2527	Homo sapiens	IC50	nM	710.0
	2051827	CHEMBL942788	Inhibition of human recombinant Chk2	B	NC(=O)c1ccc2[nH]c(-c3ccc(OCC4CCNCC4)cc3)nc2c1		CHEMBL249777	=	IC50	nM	231.0	CHEMBL2527	Homo sapiens	IC50	nM	231.0
	2051828	CHEMBL942788	Inhibition of human recombinant Chk2	B	NC(=O)c1ccc2[nH]c(-c3ccc(OCC4CCCNC4)cc3)nc2c1		CHEMBL249776	=	IC50	nM	158.0	CHEMBL2527	Homo sapiens	IC50	nM	158.0
	2051829	CHEMBL942788	Inhibition of human recombinant Chk2	B	CN1CCC(Oc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)CC1		CHEMBL442282	=	IC50	nM	233.0	CHEMBL2527	Homo sapiens	IC50	nM	233.0
	2051830	CHEMBL942788	Inhibition of human recombinant Chk2	B	NC(=O)c1ccc2[nH]c(-c3ccc(OC4CCNCC4)cc3)nc2c1		CHEMBL251368	=	IC50	nM	710.0	CHEMBL2527	Homo sapiens	IC50	nM	710.0
	2051851	CHEMBL942788	Inhibition of human recombinant Chk2	B	COc1ccc(CN2CCC(COc3ccc(-c4nc5cc(C(N)=O)ccc5[nH]4)cc3)CC2)cc1		CHEMBL250159	=	IC50	nM	67.0	CHEMBL2527	Homo sapiens	IC50	nM	67.0
	2051852	CHEMBL942788	Inhibition of human recombinant Chk2	B	Cc1ccc(CN2CCC(COc3ccc(-c4nc5cc(C(N)=O)ccc5[nH]4)cc3)CC2)cc1		CHEMBL398467	=	IC50	nM	70.0	CHEMBL2527	Homo sapiens	IC50	nM	70.0
	2051853	CHEMBL942788	Inhibition of human recombinant Chk2	B	NC(=O)c1ccc2[nH]c(-c3ccc(OCC4CCN(Cc5ccccc5)CC4)cc3)nc2c1		CHEMBL249959	=	IC50	nM	70.0	CHEMBL2527	Homo sapiens	IC50	nM	70.0
	2051854	CHEMBL942788	Inhibition of human recombinant Chk2	B	NC(=O)c1ccc2[nH]c(-c3ccc(OCC4CCCN(Cc5ccc(Cl)c(Cl)c5)C4)cc3)nc2c1		CHEMBL399933	=	IC50	nM	180.0	CHEMBL2527	Homo sapiens	IC50	nM	180.0
	2051855	CHEMBL942788	Inhibition of human recombinant Chk2	B	NC(=O)c1ccc2[nH]c(-c3ccc(OCC4CCCN(Cc5ccc(Cl)cc5)C4)cc3)nc2c1		CHEMBL248935	=	IC50	nM	14.0	CHEMBL2527	Homo sapiens	IC50	nM	14.0
	2051856	CHEMBL942788	Inhibition of human recombinant Chk2	B	COc1ccc(CN2CCCC(COc3ccc(-c4nc5cc(C(N)=O)ccc5[nH]4)cc3)C2)cc1		CHEMBL427879	=	IC50	nM	55.0	CHEMBL2527	Homo sapiens	IC50	nM	55.0
	2051857	CHEMBL942788	Inhibition of human recombinant Chk2	B	Cc1ccc(CN2CCCC(COc3ccc(-c4nc5cc(C(N)=O)ccc5[nH]4)cc3)C2)cc1		CHEMBL250963	=	IC50	nM	57.0	CHEMBL2527	Homo sapiens	IC50	nM	57.0
	2051858	CHEMBL942788	Inhibition of human recombinant Chk2	B	NC(=O)c1ccc2[nH]c(-c3ccc(OCC4CCCN(Cc5ccccc5)C4)cc3)nc2c1		CHEMBL250765	=	IC50	nM	37.0	CHEMBL2527	Homo sapiens	IC50	nM	37.0
	2051859	CHEMBL942788	Inhibition of human recombinant Chk2	B	NC(=O)c1ccc2[nH]c(-c3ccc(OCCC4CCN(Cc5ccc(Cl)c(Cl)c5)CC4)cc3)nc2c1		CHEMBL249541	=	IC50	nM	157.0	CHEMBL2527	Homo sapiens	IC50	nM	157.0
	2051860	CHEMBL942788	Inhibition of human recombinant Chk2	B	NC(=O)c1ccc2[nH]c(-c3ccc(OCCC4CCN(Cc5ccc(Cl)cc5)CC4)cc3)nc2c1		CHEMBL438868	=	IC50	nM	82.0	CHEMBL2527	Homo sapiens	IC50	nM	82.0
	2051861	CHEMBL942788	Inhibition of human recombinant Chk2	B	COc1ccc(CN2CCC(CCOc3ccc(-c4nc5cc(C(N)=O)ccc5[nH]4)cc3)CC2)cc1		CHEMBL249347	=	IC50	nM	95.0	CHEMBL2527	Homo sapiens	IC50	nM	95.0
	2051862	CHEMBL942788	Inhibition of human recombinant Chk2	B	Cc1ccc(CN2CCC(CCOc3ccc(-c4nc5cc(C(N)=O)ccc5[nH]4)cc3)CC2)cc1		CHEMBL249345	=	IC50	nM	90.0	CHEMBL2527	Homo sapiens	IC50	nM	90.0
	2051863	CHEMBL942788	Inhibition of human recombinant Chk2	B	NC(=O)c1ccc2[nH]c(-c3ccc(OCCC4CCN(Cc5ccccc5)CC4)cc3)nc2c1		CHEMBL399146	=	IC50	nM	90.0	CHEMBL2527	Homo sapiens	IC50	nM	90.0
	2051864	CHEMBL942788	Inhibition of human recombinant Chk2	B	NC(=O)c1ccc2[nH]c(-c3ccc(OCCC4CCCCN4Cc4ccc(Cl)c(Cl)c4)cc3)nc2c1		CHEMBL251155	=	IC50	nM	114.0	CHEMBL2527	Homo sapiens	IC50	nM	114.0
	2051865	CHEMBL942788	Inhibition of human recombinant Chk2	B	NC(=O)c1ccc2[nH]c(-c3ccc(OCCC4CCCCN4Cc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL398529	=	IC50	nM	53.0	CHEMBL2527	Homo sapiens	IC50	nM	53.0
	2051866	CHEMBL942788	Inhibition of human recombinant Chk2	B	COc1ccc(CN2CCCCC2CCOc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)cc1		CHEMBL250957	=	IC50	nM	74.0	CHEMBL2527	Homo sapiens	IC50	nM	74.0
	2051867	CHEMBL942788	Inhibition of human recombinant Chk2	B	Cc1ccc(CN2CCCCC2CCOc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)cc1		CHEMBL250759	=	IC50	nM	61.0	CHEMBL2527	Homo sapiens	IC50	nM	61.0
	2051868	CHEMBL942788	Inhibition of human recombinant Chk2	B	NC(=O)c1ccc2[nH]c(-c3ccc(OCCC4CCCCN4Cc4ccccc4)cc3)nc2c1		CHEMBL250555	=	IC50	nM	45.0	CHEMBL2527	Homo sapiens	IC50	nM	45.0
	2051869	CHEMBL942788	Inhibition of human recombinant Chk2	B	NC(=O)c1ccc2[nH]c(-c3ccc(OCC4CCN(Cc5ccc(Cl)c(Cl)c5)CC4)cc3)nc2c1		CHEMBL251364	=	IC50	nM	176.0	CHEMBL2527	Homo sapiens	IC50	nM	176.0
	2051870	CHEMBL942788	Inhibition of human recombinant Chk2	B	NC(=O)c1ccc2[nH]c(-c3ccc(OCC4CCN(Cc5ccc(Cl)cc5)CC4)cc3)nc2c1		CHEMBL251170	=	IC50	nM	60.0	CHEMBL2527	Homo sapiens	IC50	nM	60.0
	2051911	CHEMBL942788	Inhibition of human recombinant Chk2	B	CC(=O)N1CCC(CCOc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)CC1		CHEMBL249566	=	IC50	nM	86.0	CHEMBL2527	Homo sapiens	IC50	nM	86.0
	2051912	CHEMBL942788	Inhibition of human recombinant Chk2	B	CC(=O)N1CCCCC1CCOc1ccc(-c2nc3cc(C(N)=O)ccc3[nH]2)cc1		CHEMBL400980	=	IC50	nM	292.0	CHEMBL2527	Homo sapiens	IC50	nM	292.0
	2051913	CHEMBL942788	Inhibition of human recombinant Chk2	B	CC(=O)N1CCC(COc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)CC1		CHEMBL400755	=	IC50	nM	78.0	CHEMBL2527	Homo sapiens	IC50	nM	78.0
	2051914	CHEMBL942788	Inhibition of human recombinant Chk2	B	CC(=O)N1CCCC(COc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)C1		CHEMBL250566	=	IC50	nM	140.0	CHEMBL2527	Homo sapiens	IC50	nM	140.0
	2051915	CHEMBL942788	Inhibition of human recombinant Chk2	B	CC(=O)N1CCCC(Oc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)C1		CHEMBL250361	=	IC50	nM	100.0	CHEMBL2527	Homo sapiens	IC50	nM	100.0
	2051916	CHEMBL942788	Inhibition of human recombinant Chk2	B	NC(=O)c1ccc2[nH]c(-c3ccc(OCCC4CCN(C(=O)c5ccccc5)CC4)cc3)nc2c1		CHEMBL250360	=	IC50	nM	23.0	CHEMBL2527	Homo sapiens	IC50	nM	23.0
	2051917	CHEMBL942788	Inhibition of human recombinant Chk2	B	NC(=O)c1ccc2[nH]c(-c3ccc(OCCC4CCCCN4C(=O)c4ccccc4)cc3)nc2c1		CHEMBL250359	=	IC50	nM	52.0	CHEMBL2527	Homo sapiens	IC50	nM	52.0
	2051918	CHEMBL942788	Inhibition of human recombinant Chk2	B	NC(=O)c1ccc2[nH]c(-c3ccc(OCC4CCN(C(=O)c5ccccc5)CC4)cc3)nc2c1		CHEMBL250158	=	IC50	nM	39.0	CHEMBL2527	Homo sapiens	IC50	nM	39.0
	2051935	CHEMBL942788	Inhibition of human recombinant Chk2	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	IC50	nM	15.0	CHEMBL2527	Homo sapiens	IC50	nM	15.0
	2051936	CHEMBL942788	Inhibition of human recombinant Chk2	B	NC(=O)c1ccc2[nH]c(-c3ccc(Sc4ccc(O)cc4)cc3)nc2c1		CHEMBL195041	=	IC50	nM	2.0	CHEMBL2527	Homo sapiens	IC50	nM	2.0
	2053726	CHEMBL942096	Inhibition of Chk2 kinase	B	CC(C)NC(=N)c1c(O)nsc1Nc1ccc(Nc2ccc(Br)cc2)cc1		CHEMBL250230	=	IC50	nM	87.0	CHEMBL2527	Homo sapiens	IC50	uM	0.087
	2053727	CHEMBL942096	Inhibition of Chk2 kinase	B	N=C(NCC(O)CO)c1c(O)nsc1Nc1ccc(Nc2ccccc2)cc1		CHEMBL401105	=	IC50	nM	900.0	CHEMBL2527	Homo sapiens	IC50	uM	0.9
	2053728	CHEMBL942096	Inhibition of Chk2 kinase	B	N=C(NCCCCO)c1c(O)nsc1Nc1ccc(Nc2ccccc2)cc1		CHEMBL253542	=	IC50	nM	1200.0	CHEMBL2527	Homo sapiens	IC50	uM	1.2
	2053729	CHEMBL942096	Inhibition of Chk2 kinase	B	N=C(NCC1CCCCC1)c1c(O)nsc1Nc1ccc(Nc2ccccc2)cc1		CHEMBL253541	=	IC50	nM	1800.0	CHEMBL2527	Homo sapiens	IC50	uM	1.8
	2053730	CHEMBL942096	Inhibition of Chk2 kinase	B	N=C(NCCO)c1c(O)nsc1Nc1ccc(Nc2ccccc2)cc1		CHEMBL253324	=	IC50	nM	1000.0	CHEMBL2527	Homo sapiens	IC50	uM	1.0
	2053731	CHEMBL942096	Inhibition of Chk2 kinase	B	CC(CO)NC(=N)c1c(O)nsc1Nc1ccc(Nc2ccccc2)cc1		CHEMBL253116	=	IC50	nM	460.0	CHEMBL2527	Homo sapiens	IC50	uM	0.46
	2053732	CHEMBL942096	Inhibition of Chk2 kinase	B	CC(C)NC(=N)c1c(O)nsc1Nc1ccc(Nc2ccccc2)cc1		CHEMBL253115	=	IC50	nM	420.0	CHEMBL2527	Homo sapiens	IC50	uM	0.42
	2053733	CHEMBL942096	Inhibition of Chk2 kinase	B	CCC[C@H]1CC[C@H](c2ccc(Nc3snc(O)c3C(=N)NCC(O)CO)cc2)CC1		CHEMBL438150	=	IC50	nM	17000.0	CHEMBL2527	Homo sapiens	IC50	uM	17.0
	2053734	CHEMBL942096	Inhibition of Chk2 kinase	B	CC(CO)NC(=N)c1c(O)nsc1Nc1ccc(-n2cccn2)cc1		CHEMBL251473	>	IC50	nM	40000.0	CHEMBL2527	Homo sapiens	IC50	uM	40.0
	2053735	CHEMBL942096	Inhibition of Chk2 kinase	B	N=C(NCC1CCCCC1)c1c(O)nsc1Nc1ccc(-n2cccn2)cc1		CHEMBL251471	=	IC50	nM	40000.0	CHEMBL2527	Homo sapiens	IC50	uM	40.0
	2053736	CHEMBL942096	Inhibition of Chk2 kinase	B	CC(C)NC(=N)c1c(O)nsc1Nc1ccc(C2CCCCC2)cc1		CHEMBL249255	=	IC50	nM	19000.0	CHEMBL2527	Homo sapiens	IC50	uM	19.0
	2053737	CHEMBL942096	Inhibition of Chk2 kinase	B	N=C(NCC1CCCCC1)c1c(O)nsc1Nc1ccc(C(=O)c2ccccc2)cc1		CHEMBL249253	=	IC50	nM	5000.0	CHEMBL2527	Homo sapiens	IC50	uM	5.0
	2053738	CHEMBL942096	Inhibition of Chk2 kinase	B	N=C(NCC1CCCCC1)c1c(O)nsc1Nc1ccc(Sc2ccccc2)cc1		CHEMBL251629	=	IC50	nM	19000.0	CHEMBL2527	Homo sapiens	IC50	uM	19.0
	2053739	CHEMBL942096	Inhibition of Chk2 kinase	B	N=C(NCC1CCCCC1)c1c(O)nsc1Nc1ccc(/N=N/c2ccccc2)cc1		CHEMBL399151	=	IC50	nM	11000.0	CHEMBL2527	Homo sapiens	IC50	uM	11.0
	2053740	CHEMBL942096	Inhibition of Chk2 kinase	B	N=C(NCC1CCCCC1)c1c(O)nsc1Nc1ccc(Cc2ccccc2)cc1		CHEMBL251628	=	IC50	nM	37000.0	CHEMBL2527	Homo sapiens	IC50	uM	37.0
	2053741	CHEMBL942096	Inhibition of Chk2 kinase	B	CC(C)NC(=N)c1c(O)nsc1Nc1ccc(S(=O)(=O)c2ccccc2)cc1		CHEMBL398760	>	IC50	nM	40000.0	CHEMBL2527	Homo sapiens	IC50	uM	40.0
	2053742	CHEMBL942096	Inhibition of Chk2 kinase	B	CC(C)NC(=N)c1c(O)nsc1Nc1ccc(Oc2ccccc2)cc1		CHEMBL398759	=	IC50	nM	2300.0	CHEMBL2527	Homo sapiens	IC50	uM	2.3
	2053743	CHEMBL942096	Inhibition of Chk2 kinase	B	CC(C)NC(=N)c1c(O)nsc1Nc1ccc(/N=N/c2ccccc2)cc1		CHEMBL398758	=	IC50	nM	11000.0	CHEMBL2527	Homo sapiens	IC50	uM	11.0
	2053744	CHEMBL942096	Inhibition of Chk2 kinase	B	CC(C)NC(=N)c1c(O)nsc1Nc1ccc(Cc2ccccc2)cc1		CHEMBL249252	=	IC50	nM	8000.0	CHEMBL2527	Homo sapiens	IC50	uM	8.0
	2053745	CHEMBL942096	Inhibition of Chk2 kinase	B	N=C(NCc1cccc2ccccc12)c1c(O)nsc1Nc1ccc(Nc2ccc(Br)cc2)cc1		CHEMBL249251	=	IC50	nM	460.0	CHEMBL2527	Homo sapiens	IC50	uM	0.46
	2053746	CHEMBL942096	Inhibition of Chk2 kinase	B	N=C(NCC(O)CO)c1c(O)nsc1Nc1ccc(Nc2ccc(Br)cc2)cc1		CHEMBL400772	=	IC50	nM	470.0	CHEMBL2527	Homo sapiens	IC50	uM	0.47
	2053747	CHEMBL942096	Inhibition of Chk2 kinase	B	N=C(NCCCCO)c1c(O)nsc1Nc1ccc(Nc2ccc(Br)cc2)cc1		CHEMBL251284	=	IC50	nM	310.0	CHEMBL2527	Homo sapiens	IC50	uM	0.31
	2053748	CHEMBL942096	Inhibition of Chk2 kinase	B	N=C(NCC1CCCCC1)c1c(O)nsc1Nc1ccc(Nc2ccc(Br)cc2)cc1		CHEMBL399237	=	IC50	nM	300.0	CHEMBL2527	Homo sapiens	IC50	uM	0.3
	2053749	CHEMBL942096	Inhibition of Chk2 kinase	B	N=C(NCCO)c1c(O)nsc1Nc1ccc(Nc2ccc(Br)cc2)cc1		CHEMBL398561	=	IC50	nM	220.0	CHEMBL2527	Homo sapiens	IC50	uM	0.22
	2053750	CHEMBL942096	Inhibition of Chk2 kinase	B	CC(CO)NC(=N)c1c(O)nsc1Nc1ccc(Nc2ccc(Br)cc2)cc1		CHEMBL251256	=	IC50	nM	140.0	CHEMBL2527	Homo sapiens	IC50	uM	0.14
	2081717	CHEMBL928803	Inhibition of CHK2 at 10 uM	B	CC[C@@H](C)Nc1nc2ccc(-c3c(-c4ccccc4F)n[nH]c3N)cc2s1		CHEMBL404115	<=	Inhibition	%	20.0	CHEMBL2527	Homo sapiens	Inhibition	%	20.0
	2101324	CHEMBL949023	Inhibition of CHK2 at 10 uM	B	CC(C)(C)CN1CCC(NC(=O)c2csc(NC(=O)c3ccc4cc5n(c4c3)C3(CCC3)CNC5=O)n2)CC1		CHEMBL257834	=	Inhibition	%	84.0	CHEMBL2527	Homo sapiens	Inhibition	%	84.0
	2136818	CHEMBL939334	Inhibition of Chk2	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	IC50	nM	15.0	CHEMBL2527	Homo sapiens	IC50	nM	15.0
	2136819	CHEMBL939334	Inhibition of Chk2	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Ki	nM	37.0	CHEMBL2527	Homo sapiens	Ki	nM	37.0
	2136924	CHEMBL939334	Inhibition of Chk2	B	NC1=N/C(=C2/CCNC(=O)c3[nH]ccc32)C(=O)N1		CHEMBL255465	=	IC50	nM	3500.0	CHEMBL2527	Homo sapiens	IC50	nM	3500.0
	2137088	CHEMBL939334	Inhibition of Chk2	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	IC50	nM	3000.0	CHEMBL2527	Homo sapiens	IC50	nM	3000.0
	2147100	CHEMBL934732	Inhibition of CHK2 by radioactive flashplate assay	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	IC50	nM	28000.0	CHEMBL2527	Homo sapiens	IC50	uM	28.0
	2147218	CHEMBL929097	Activity of human CHK2 kinase at 1 uM	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Activity	%	83.0	CHEMBL2527	Homo sapiens	Activity	%	83.0
	2153721	CHEMBL928288	Inhibition of Chk2 at 20 uM	B	CN(C)CCOc1ccc2c(-c3c(-c4ccccn4)nn4c3CCC4)ccnc2c1		CHEMBL409525	<	Inhibition	%	50.0	CHEMBL2527	Homo sapiens	Inhibition	%	50.0
	2153756	CHEMBL928288	Inhibition of Chk2 at 20 uM	B	c1ccc(-c2nn3c(c2-c2ccnc4cc(OCCN5CCOCC5)ccc24)CCC3)nc1		CHEMBL260015	<	Inhibition	%	50.0	CHEMBL2527	Homo sapiens	Inhibition	%	50.0
	2157690	CHEMBL932645	Inhibition of CHK2 at 1 uM	B	NCC1(c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL406863	>	Inhibition	%	60.0	CHEMBL2527	Homo sapiens	Inhibition	%	60.0
Not Evaluated	2188818	CHEMBL991462	Effect on Chk2-Thr-68 phosphorylation in ataxia telangiectasia mutated and Rad3 related-deficient human HCT116 cells at 1 nM after 1 hr by Western blotting	B	C=C1Oc2cc(OC)cc(C(=O)O[C@H]3COC(=O)C[C@H](N)c4cc(O)c(c(Cl)c4)O[C@@H]4C#C/C=C/3C#CC3=CC=C[C@@]34O[C@@H]3OC(C)(C)[C@@H](N(C)C)[C@@H](O)[C@H]3O)c2NC1=O		CHEMBL506048		Activity			CHEMBL2527	Homo sapiens	Activity		
Not Evaluated	2188842	CHEMBL991463	Effect on Chk2-Thr-68 phosphorylation in ataxia telangiectasia mutated and Rad3 related-deficient human HCT116 cells at 3 nM after 1 hr by Western blotting	B	C=C1Oc2cc(OC)cc(C(=O)O[C@H]3COC(=O)C[C@H](N)c4ccc(c(O)c4)O[C@@H]4C#C/C=C/3C#CC3=CC=C[C@@]34O[C@@H]3OC(C)(C)[C@@H](N(C)C)[C@@H](O)[C@H]3O)c2NC1=O		CHEMBL506842		Activity			CHEMBL2527	Homo sapiens	Activity		
	2248194	CHEMBL1012677	Inhibition of CHK2 at 5 uM	B	O=C1NC(=O)/C(=C/c2cccc(C(F)(F)F)c2)S1		CHEMBL183906	=	Inhibition	%	1.0	CHEMBL2527	Homo sapiens	INH	%	1.0
	2248224	CHEMBL1012677	Inhibition of CHK2 at 5 uM	B	CCCOc1ccc(/C=C2\SC(=O)NC2=O)cc1		CHEMBL84558	=	Inhibition	%	4.0	CHEMBL2527	Homo sapiens	INH	%	4.0
	2251038	CHEMBL1011062	Inhibition of CHK2 at 100 nM relative to control	B	N=C(N)NCCC[C@@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)CCCCCNC(=O)[C@@H](CCCCN)NC(=O)CCCCCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)C(N)=O		CHEMBL525385	=	Inhibition	%	62.0	CHEMBL2527	Homo sapiens	INH	%	62.0
Not Active	2302190	CHEMBL950859	Inhibition of CHK2 at 10 uM	B	Nc1ncnc2ncn(CC(=O)c3c[nH]c4ccccc34)c12		CHEMBL485246		Inhibition	%		CHEMBL2527	Homo sapiens	INH		
	2341421	CHEMBL953381	Inhibition of CHK2 at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(N3CCN(C(=O)Cc4c[nH]c5ccccc45)CC3)ncn2)c1		CHEMBL524898	=	Inhibition	%	0.0	CHEMBL2527	Homo sapiens	INH	%	0.0
	2341461	CHEMBL953381	Inhibition of CHK2 at 10 uM by HTRF assay relative to control	B	CN(C)CC(C)(C)CNC(=O)c1cccc(Nc2nccc(Nc3ccc4ncsc4c3)n2)c1		CHEMBL501459	=	Inhibition	%	27.0	CHEMBL2527	Homo sapiens	INH	%	27.0
	2341502	CHEMBL953381	Inhibition of CHK2 at 10 uM by HTRF assay relative to control	B	Nc1nc(N2CCOCC2)cc(N2CCC(C(=O)NCCc3ccc(O)cc3)CC2)n1		CHEMBL501728	=	Inhibition	%	0.0	CHEMBL2527	Homo sapiens	INH	%	0.0
	2341543	CHEMBL953381	Inhibition of CHK2 at 10 uM by HTRF assay relative to control	B	O=C(NCCc1ccc(O)cc1)c1cccc(Nc2nccc(Nc3ccc4ncsc4c3)n2)c1		CHEMBL499617	=	Inhibition	%	0.0	CHEMBL2527	Homo sapiens	INH	%	0.0
	2341584	CHEMBL953381	Inhibition of CHK2 at 10 uM by HTRF assay relative to control	B	O=C(c1nc(SCc2ccc(Cl)cc2)n2ccccc12)N1CCN(c2cc(Nc3cccc(Br)c3)ncn2)CC1		CHEMBL501200	=	Inhibition	%	6.0	CHEMBL2527	Homo sapiens	INH	%	6.0
	2341625	CHEMBL953381	Inhibition of CHK2 at 10 uM by HTRF assay relative to control	B	Nc1nc(Nc2ccc3ncsc3c2)cc(N2CCC[C@H]2C(=O)N[C@@H](CO)c2ccccc2)n1		CHEMBL525070	=	Inhibition	%	2.0	CHEMBL2527	Homo sapiens	INH	%	2.0
	2341666	CHEMBL953381	Inhibition of CHK2 at 10 uM by HTRF assay relative to control	B	Nc1nc(Nc2ccc3ncsc3c2)cc(N2CCC[C@H]2C(=O)NCCc2cccc(I)c2)n1		CHEMBL501463	=	Inhibition	%	1.0	CHEMBL2527	Homo sapiens	INH	%	1.0
	2341707	CHEMBL953381	Inhibition of CHK2 at 10 uM by HTRF assay relative to control	B	O=C(NC1Cc2ccccc2C1)c1cccc(Nc2ccnc(N3CCN(c4ccccc4)CC3)n2)c1		CHEMBL499624	=	Inhibition	%	1.0	CHEMBL2527	Homo sapiens	INH	%	1.0
	2341748	CHEMBL953381	Inhibition of CHK2 at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(Nc3cccc(C(=O)NCc4ccc(N(C)C)cc4)c3)ncn2)c1		CHEMBL502826	=	Inhibition	%	0.0	CHEMBL2527	Homo sapiens	INH	%	0.0
	2341789	CHEMBL953381	Inhibition of CHK2 at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(Nc3ccc(CC(=O)Nc4ccc5ncsc5c4)cc3)ncn2)c1		CHEMBL502827	=	Inhibition	%	0.0	CHEMBL2527	Homo sapiens	INH	%	0.0
	2341830	CHEMBL953381	Inhibition of CHK2 at 10 uM by HTRF assay relative to control	B	COc1ccc(NC(=O)Cc2ccc(Nc3cc(N(C)c4cccc(C)c4)ncn3)cc2)cn1		CHEMBL526914	=	Inhibition	%	1.0	CHEMBL2527	Homo sapiens	INH	%	1.0
	2341871	CHEMBL953381	Inhibition of CHK2 at 10 uM by HTRF assay relative to control	B	Cc1cccc(Nc2nccc(Nc3cccc(C(=O)NCc4ccc(N(C)C)cc4)c3)n2)c1		CHEMBL501471	=	Inhibition	%	0.0	CHEMBL2527	Homo sapiens	INH	%	0.0
	2341912	CHEMBL953381	Inhibition of CHK2 at 10 uM by HTRF assay relative to control	B	O=C(NCc1cccnc1)c1cccc(-c2ccc(Nc3ccc4ncsc4c3)nn2)c1		CHEMBL501182	=	Inhibition	%	28.0	CHEMBL2527	Homo sapiens	INH	%	28.0
	2341953	CHEMBL953381	Inhibition of CHK2 at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(Nc3cccc(C(=O)N4CCCC5CCCCC54)c3)ncn2)c1		CHEMBL499606	=	Inhibition	%	2.0	CHEMBL2527	Homo sapiens	INH	%	2.0
	2341994	CHEMBL953381	Inhibition of CHK2 at 10 uM by HTRF assay relative to control	B	COc1cccc(Nc2cc(Nc3cccc(C(=O)N(C)CCc4ccccn4)c3)nc(N)n2)c1		CHEMBL499865	=	Inhibition	%	4.0	CHEMBL2527	Homo sapiens	INH	%	4.0
	2342035	CHEMBL953381	Inhibition of CHK2 at 10 uM by HTRF assay relative to control	B	Cc1cccc(Nc2nccc(Nc3cccc(C(=O)N(C)CCc4ccccn4)c3)n2)c1		CHEMBL499866	=	Inhibition	%	0.0	CHEMBL2527	Homo sapiens	INH	%	0.0
	2342076	CHEMBL953381	Inhibition of CHK2 at 10 uM by HTRF assay relative to control	B	O=C(CN1CCN(c2ncnc3c2CN(Cc2ccccc2)CC3)CC1)Nc1cc(F)ccc1F		CHEMBL520451	=	Inhibition	%	5.0	CHEMBL2527	Homo sapiens	INH	%	5.0
	2342117	CHEMBL953381	Inhibition of CHK2 at 10 uM by HTRF assay relative to control	B	O=C(NCc1ccncc1)c1cccc(Nc2cc(Nc3cccc(Br)c3)ncn2)c1		CHEMBL482513	=	Inhibition	%	0.0	CHEMBL2527	Homo sapiens	INH	%	0.0
	2342158	CHEMBL953381	Inhibition of CHK2 at 10 uM by HTRF assay relative to control	B	Cc1cccc(Nc2cc(Nc3cccc(C(=O)N(CC(C)O)CC(C)O)c3)ncn2)c1		CHEMBL483318	=	Inhibition	%	1.0	CHEMBL2527	Homo sapiens	INH	%	1.0
	2342199	CHEMBL953381	Inhibition of CHK2 at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(Nc3cccc(C(=O)NCCCn4ccnc4)c3)ncn2)c1		CHEMBL520971	=	Inhibition	%	0.0	CHEMBL2527	Homo sapiens	INH	%	0.0
	2342240	CHEMBL953381	Inhibition of CHK2 at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(Nc3cccc(C(=O)N(C)CCc4ccccn4)c3)ncn2)c1		CHEMBL521469	=	Inhibition	%	0.0	CHEMBL2527	Homo sapiens	INH	%	0.0
	2342281	CHEMBL953381	Inhibition of CHK2 at 10 uM by HTRF assay relative to control	B	CC(=O)N1CCN(C(=O)c2cccc(Nc3cc(N(C)c4cccc(C)c4)ncn3)c2)CC1		CHEMBL521478	=	Inhibition	%	0.0	CHEMBL2527	Homo sapiens	INH	%	0.0
	2342322	CHEMBL953381	Inhibition of CHK2 at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(Nc3cccc(C(=O)NCc4ccncc4)c3)ncn2)c1		CHEMBL483506	=	Inhibition	%	5.0	CHEMBL2527	Homo sapiens	INH	%	5.0
	2342363	CHEMBL953381	Inhibition of CHK2 at 10 uM by HTRF assay relative to control	B	CN(CCc1ccccn1)C(=O)c1cccc(Nc2nccc(Nc3ccc4ncsc4c3)n2)c1		CHEMBL483507	=	Inhibition	%	7.0	CHEMBL2527	Homo sapiens	INH	%	7.0
	2342404	CHEMBL953381	Inhibition of CHK2 at 10 uM by HTRF assay relative to control	B	COc1cccc(Nc2cc(Nc3cccc(C(=O)NCCCn4ccnc4)c3)nc(N)n2)c1		CHEMBL520980	=	Inhibition	%	3.0	CHEMBL2527	Homo sapiens	INH	%	3.0
	2342445	CHEMBL953381	Inhibition of CHK2 at 10 uM by HTRF assay relative to control	B	COC[C@@H]1CCCN1C(=O)[C@@H]1CCCN1c1cc(Nc2cccc(OC)c2)nc(N)n1		CHEMBL519962	=	Inhibition	%	0.0	CHEMBL2527	Homo sapiens	INH	%	0.0
	2342486	CHEMBL953381	Inhibition of CHK2 at 10 uM by HTRF assay relative to control	B	COc1cccc(Nc2cc(N3CCC[C@H]3C(=O)NCCN3CCCCC3)nc(N)n2)c1		CHEMBL526526	=	Inhibition	%	0.0	CHEMBL2527	Homo sapiens	INH	%	0.0
	2342527	CHEMBL953381	Inhibition of CHK2 at 10 uM by HTRF assay relative to control	B	O=C(COc1ccccc1)N1CCN(c2nccc(Nc3ccc4ncsc4c3)n2)CC1		CHEMBL482488	=	Inhibition	%	6.0	CHEMBL2527	Homo sapiens	INH	%	6.0
	2342800	CHEMBL953381	Inhibition of CHK2 at 10 uM by HTRF assay relative to control	B	O=C(NC[C@@H]1CCCO1)c1cccc(Nc2nccc(Nc3ccc4ncsc4c3)n2)c1		CHEMBL500661	=	Inhibition	%	13.0	CHEMBL2527	Homo sapiens	INH	%	13.0
	2342833	CHEMBL953381	Inhibition of CHK2 at 10 uM by HTRF assay relative to control	B	Clc1ccc2sc(CN3CCN(c4ncnc5c4CN(Cc4ccccc4)CC5)CC3)cc2c1		CHEMBL483710	=	Inhibition	%	0.0	CHEMBL2527	Homo sapiens	INH	%	0.0
	2343108	CHEMBL953381	Inhibition of CHK2 at 10 uM by HTRF assay relative to control	B	Nc1nc(Nc2ccccc2)cc(N2CCC(C(=O)NCCc3ccccn3)CC2)n1		CHEMBL521002	=	Inhibition	%	0.0	CHEMBL2527	Homo sapiens	INH	%	0.0
	2343132	CHEMBL953381	Inhibition of CHK2 at 10 uM by HTRF assay relative to control	B	CC(=O)CCCCC(=O)N1CCN(c2nccc(Oc3cccc(C)c3)n2)CC1		CHEMBL484713	=	Inhibition	%	0.0	CHEMBL2527	Homo sapiens	INH	%	0.0
	2343154	CHEMBL953381	Inhibition of CHK2 at 10 uM by HTRF assay relative to control	B	COc1ccc(-c2noc(CN3CCN(c4cc(Nc5cccc(O)c5)ncn4)CC3)n2)cc1		CHEMBL483715	=	Inhibition	%	0.0	CHEMBL2527	Homo sapiens	INH	%	0.0
	2343178	CHEMBL953381	Inhibition of CHK2 at 10 uM by HTRF assay relative to control	B	Cc1cccc(Oc2ccnc(N3CCN(CC(=O)Nc4cccc5c4CCCC5)CC3)n2)c1		CHEMBL520512	=	Inhibition	%	3.0	CHEMBL2527	Homo sapiens	INH	%	3.0
	2343202	CHEMBL953381	Inhibition of CHK2 at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(N3CCN(CC(=O)Nc4nc(-c5ccccc5)cs4)CC3)ncn2)c1		CHEMBL519534	=	Inhibition	%	0.0	CHEMBL2527	Homo sapiens	INH	%	0.0
	2343226	CHEMBL953381	Inhibition of CHK2 at 10 uM by HTRF assay relative to control	B	Nc1nc(Nc2ccc(C(=O)NCCc3ccncc3)cc2)cc(N2CCOCC2)n1		CHEMBL485524	=	Inhibition	%	0.0	CHEMBL2527	Homo sapiens	INH	%	0.0
	2343250	CHEMBL953381	Inhibition of CHK2 at 10 uM by HTRF assay relative to control	B	Cc1cccc(Nc2nccc3c2CN(C(=O)c2cc(C)n(C)c2C)CC3)c1		CHEMBL519146	=	Inhibition	%	0.0	CHEMBL2527	Homo sapiens	INH	%	0.0
	2343274	CHEMBL953381	Inhibition of CHK2 at 10 uM by HTRF assay relative to control	B	Cc1cc(C(=O)N2CCN(c3ncnc4c3CN(Cc3ccccc3)CC4)CC2)c(C)n1C		CHEMBL482710	=	Inhibition	%	2.0	CHEMBL2527	Homo sapiens	INH	%	2.0
	2343635	CHEMBL953381	Inhibition of CHK2 at 10 uM by HTRF assay relative to control	B	Nc1nc(N2CCOCC2)cc(N2CCC(C(=O)NCc3cccs3)CC2)n1		CHEMBL482910	=	Inhibition	%	0.0	CHEMBL2527	Homo sapiens	INH	%	0.0
	2343696	CHEMBL953381	Inhibition of CHK2 at 10 uM by HTRF assay relative to control	B	COc1cccc(Nc2cc(N3CCC[C@H]3C(=O)NCCc3ccc(O)cc3)nc(N)n2)c1		CHEMBL483518	=	Inhibition	%	0.0	CHEMBL2527	Homo sapiens	INH	%	0.0
	2343717	CHEMBL953381	Inhibition of CHK2 at 10 uM by HTRF assay relative to control	B	Cc1cccc(Oc2ccnc(N3CCC[C@H]3C(=O)NCc3cccnc3)n2)c1		CHEMBL482717	=	Inhibition	%	4.0	CHEMBL2527	Homo sapiens	INH	%	4.0
	2343739	CHEMBL953381	Inhibition of CHK2 at 10 uM by HTRF assay relative to control	B	COC(=O)C(CO)NC(=O)[C@@H]1CCCN1c1nccc(Oc2cccc(C)c2)n1		CHEMBL519310	=	Inhibition	%	3.0	CHEMBL2527	Homo sapiens	INH	%	3.0
	2343761	CHEMBL953381	Inhibition of CHK2 at 10 uM by HTRF assay relative to control	B	Cc1cccc(Oc2ccnc(N3CCN(C(=O)c4c(C)noc4C)CC3)n2)c1		CHEMBL482721	=	Inhibition	%	3.0	CHEMBL2527	Homo sapiens	INH	%	3.0
	2343783	CHEMBL953381	Inhibition of CHK2 at 10 uM by HTRF assay relative to control	B	CN(C)CC(C)(C)CNC(=O)C1CCN(c2cc(N3CCOCC3)nc(N)n2)CC1		CHEMBL519311	=	Inhibition	%	2.0	CHEMBL2527	Homo sapiens	INH	%	2.0
	2343805	CHEMBL953381	Inhibition of CHK2 at 10 uM by HTRF assay relative to control	B	Cc1cccc(Oc2ccnc(N3CCC[C@H]3C(=O)NCCCn3ccnc3)n2)c1		CHEMBL482722	=	Inhibition	%	0.0	CHEMBL2527	Homo sapiens	INH	%	0.0
	2343826	CHEMBL953381	Inhibition of CHK2 at 10 uM by HTRF assay relative to control	B	O=C(c1nc(SCc2ccc(Cl)cc2)n2ccccc12)N1CCN(c2ncnc3c2CN(Cc2ccccc2)CC3)CC1		CHEMBL446637	=	Inhibition	%	0.0	CHEMBL2527	Homo sapiens	INH	%	0.0
	2343848	CHEMBL953381	Inhibition of CHK2 at 10 uM by HTRF assay relative to control	B	CN(C)c1ccc(C(=O)N2CCN(c3ncnc4c3CN(Cc3ccccc3)CC4)CC2)c2ccccc12		CHEMBL520331	=	Inhibition	%	6.0	CHEMBL2527	Homo sapiens	INH	%	6.0
	2343870	CHEMBL953381	Inhibition of CHK2 at 10 uM by HTRF assay relative to control	B	Cc1cccc(Nc2ncnc3c2CN(C(=O)c2ccc(N(C)C)c4ccccc24)CC3)c1		CHEMBL484324	=	Inhibition	%	2.0	CHEMBL2527	Homo sapiens	INH	%	2.0
	2343892	CHEMBL953381	Inhibition of CHK2 at 10 uM by HTRF assay relative to control	B	COC[C@@H]1CCCN1C(=O)C1CCCN1c1cc(Nc2cccc(Br)c2)ncn1		CHEMBL484521	=	Inhibition	%	3.0	CHEMBL2527	Homo sapiens	INH	%	3.0
	2343914	CHEMBL953381	Inhibition of CHK2 at 10 uM by HTRF assay relative to control	B	COC[C@@H]1CCCN1C(=O)[C@@H]1CCCN1c1nccc(Nc2ccccc2)n1		CHEMBL519349	=	Inhibition	%	3.0	CHEMBL2527	Homo sapiens	INH	%	3.0
	2343936	CHEMBL953381	Inhibition of CHK2 at 10 uM by HTRF assay relative to control	B	CN(C)CC(C)(C)CNC(=O)[C@@H]1CCCN1c1nccc(Nc2ccccc2)n1		CHEMBL521000	=	Inhibition	%	0.0	CHEMBL2527	Homo sapiens	INH	%	0.0
	2343957	CHEMBL953381	Inhibition of CHK2 at 10 uM by HTRF assay relative to control	B	O=C(C1CCN(c2nccc(Nc3ccccc3)n2)CC1)N1CC[C@@H](O)C1		CHEMBL484706	=	Inhibition	%	0.0	CHEMBL2527	Homo sapiens	INH	%	0.0
	2343979	CHEMBL953381	Inhibition of CHK2 at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(Nc3cccc(C(=O)N(CC(C)C)CC(C)C)c3)ncn2)c1		CHEMBL484707	=	Inhibition	%	0.0	CHEMBL2527	Homo sapiens	INH	%	0.0
	2344001	CHEMBL953381	Inhibition of CHK2 at 10 uM by HTRF assay relative to control	B	CN(CCc1ccccn1)C(=O)[C@@H]1CCCN1c1nccc(Nc2ccccc2)n1		CHEMBL521479	=	Inhibition	%	3.0	CHEMBL2527	Homo sapiens	INH	%	3.0
	2344024	CHEMBL953381	Inhibition of CHK2 at 10 uM by HTRF assay relative to control	B	CN(CCCn1ccnc1)C(=O)[C@@H]1CCCN1c1nccc(Nc2ccccc2)n1		CHEMBL519658	=	Inhibition	%	5.0	CHEMBL2527	Homo sapiens	INH	%	5.0
	2344730	CHEMBL953381	Inhibition of CHK2 at 10 uM by HTRF assay relative to control	B	Cc1cccc(CN2CCN(c3cc(N(C)c4cccc(C)c4)ncn3)CC2)c1		CHEMBL446087	=	Inhibition	%	2.0	CHEMBL2527	Homo sapiens	INH	%	2.0
	2344754	CHEMBL953381	Inhibition of CHK2 at 10 uM by HTRF assay relative to control	B	Cc1ccc(CN2CCN(c3nccc(C(C#N)c4ccccn4)n3)CC2)cc1		CHEMBL521145	=	Inhibition	%	0.0	CHEMBL2527	Homo sapiens	INH	%	0.0
	2356964	CHEMBL958261	Inhibition of CHK2 at 1 uM relative to control	B	Cc1ccn(-c2cccc(C(F)(F)F)c2)c(=O)c1-c1ccc2nc(N)ncc2c1		CHEMBL504805	>	Inhibition	%	50.0	CHEMBL2527	Homo sapiens	INH	%	50.0
	2357007	CHEMBL958261	Inhibition of CHK2 at 1 uM relative to control	B	Cc1ccn(-c2ccc(-c3ncco3)cc2)c(=O)c1-c1ccc2nc(N)ncc2c1		CHEMBL525893	>	Inhibition	%	50.0	CHEMBL2527	Homo sapiens	INH	%	50.0
	2470128	CHEMBL1032271	Inhibition of CHEK2 at 3 uM	B	CN(C)CCOc1cc(-c2cn[nH]c2)ccc1NC(=O)C1COc2ccccc2O1		CHEMBL521179	<	Inhibition	%	10.0	CHEMBL2527	Homo sapiens	INH	%	10.0
	2486595	CHEMBL994201	Inhibition of Chk2	B	CCn1c2cc(Cl)c(O)cc2c(=O)c2c(=O)o[nH]c21		CHEMBL523823	>	Ki	nM	9520.0	CHEMBL2527	Homo sapiens	Ki	uM	9.52
	2511570	CHEMBL972529	Inhibition of CHK2	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	6.7	CHEMBL2527	Homo sapiens	IC50	uM	0.0067
	2512018	CHEMBL970577	Inhibition of CHK2 at 1 uM	B	CC(=O)N1CCN(C(=O)Cc2ccc(Nc3ncc(F)c(Nc4ccc(C(=O)Nc5ccccc5Cl)cc4)n3)cc2)CC1		CHEMBL508307	=	Inhibition	%	12.0	CHEMBL2527	Homo sapiens	INH	%	12.0
	2562271	CHEMBL984677	Inhibition of human Chk1 expressed in Escherichia coli at 10 uM	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1		CHEMBL477989	=	Inhibition	%	9.0	CHEMBL2527	Homo sapiens	INH	%	9.0
	2562293	CHEMBL984677	Inhibition of human Chk1 expressed in Escherichia coli at 10 uM	B	O/N=C1\CCc2cc(-c3cc(CN4CCOCC4)oc3-c3ccncc3)ccc21		CHEMBL476732	=	Inhibition	%	7.0	CHEMBL2527	Homo sapiens	INH	%	7.0
	2635195	CHEMBL1000634	Inhibition of CHK2 at 1 uM relative to control	B	CSc1cc(Oc2ccnc3[nH]c(=O)[nH]c23)ccc1NC(=O)Nc1cccc(C(F)(F)F)c1		CHEMBL496009	=	Residual_activity	%	100.0	CHEMBL2527	Homo sapiens	Residual_activity	%	100.0
	2635938	CHEMBL1000634	Inhibition of CHK2 at 1 uM relative to control	B	O=C(Nc1cc(C(F)(F)F)ccc1F)Nc1ccc(Oc2ccnc3[nH]c(=O)[nH]c23)c2ccccc12		CHEMBL498112	=	Residual_activity	%	100.0	CHEMBL2527	Homo sapiens	Residual_activity	%	100.0
	2636006	CHEMBL1000634	Inhibition of CHK2 at 1 uM relative to control	B	CC(C)(C)c1cccc(NC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)[nH]c34)c3ccccc23)c1		CHEMBL496073	=	Residual_activity	%	75.0	CHEMBL2527	Homo sapiens	Residual_activity	%	75.0
	2696654	CHEMBL1051603	Inhibition of CHK2 assessed as CDC25C peptide phosphorylation by DELFIA assay	B	CCOC(=O)c1cnc2[nH]ncc2c1N1CCOC(CN)C1		CHEMBL560056	=	IC50	nM	74000.0	CHEMBL2527	Homo sapiens	IC50	uM	74.0
	2696655	CHEMBL1051603	Inhibition of CHK2 assessed as CDC25C peptide phosphorylation by DELFIA assay	B	NCC1CN(c2c(Br)cnc3[nH]ncc23)CCO1		CHEMBL559781	=	IC50	nM	7400.0	CHEMBL2527	Homo sapiens	IC50	uM	7.4
	2696656	CHEMBL1051603	Inhibition of CHK2 assessed as CDC25C peptide phosphorylation by DELFIA assay	B	NCC1CN(c2c(-c3ccsc3)cnc3[nH]ncc23)CCO1		CHEMBL562715	=	IC50	nM	4600.0	CHEMBL2527	Homo sapiens	IC50	uM	4.6
	2696657	CHEMBL1051603	Inhibition of CHK2 assessed as CDC25C peptide phosphorylation by DELFIA assay	B	NC[C@@H]1CN(c2c(-c3ccccc3)cnc3[nH]ncc23)CCO1		CHEMBL554900	=	IC50	nM	5900.0	CHEMBL2527	Homo sapiens	IC50	uM	5.9
	2696658	CHEMBL1051603	Inhibition of CHK2 assessed as CDC25C peptide phosphorylation by DELFIA assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	27.0	CHEMBL2527	Homo sapiens	IC50	nM	27.0
	2721574	CHEMBL1060982	Inhibition of CHK2 at 1 uM	B	C[C@@H](Oc1cc(-c2cnc3ccccn23)sc1C(N)=O)c1ccc(CNC(C)(C)C)cc1OC(F)F		CHEMBL551079	<	Inhibition	%	50.0	CHEMBL2527	Homo sapiens	INH	%	50.0
	2899710	CHEMBL1062899	Percentage CHK2 activity remaining in the presence of 0.01uM inhibitor	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784	=	Activity	%	91.0	CHEMBL2527	Homo sapiens	Activity	%	91.0
	2899711	CHEMBL1062899	Percentage CHK2 activity remaining in the presence of 0.01uM inhibitor	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL379300	=	Activity	%	94.0	CHEMBL2527	Homo sapiens	Activity	%	94.0
	2899712	CHEMBL1062899	Percentage CHK2 activity remaining in the presence of 0.01uM inhibitor	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL574737	=	Activity	%	96.0	CHEMBL2527	Homo sapiens	Activity	%	96.0
	2899713	CHEMBL1061201	Percentage CHK2 activity remaining in the presence of 0.1uM inhibitor	B	CC(C)CCN1c2nc(Nc3cc(F)c(O)c(F)c3)ncc2N(C)C(=O)C1C		CHEMBL573107	=	Activity	%	96.0	CHEMBL2527	Homo sapiens	Activity	%	96.0
Antagonist	2899714	CHEMBL1061201	Percentage CHK2 activity remaining in the presence of 0.1uM inhibitor	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784	=	Activity	%	46.0	CHEMBL2527	Homo sapiens	Activity	%	46.0
	2899715	CHEMBL1061201	Percentage CHK2 activity remaining in the presence of 0.1uM inhibitor	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL379300	=	Activity	%	95.0	CHEMBL2527	Homo sapiens	Activity	%	95.0
	2899716	CHEMBL1061201	Percentage CHK2 activity remaining in the presence of 0.1uM inhibitor	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Activity	%	94.0	CHEMBL2527	Homo sapiens	Activity	%	94.0
	2899717	CHEMBL1061201	Percentage CHK2 activity remaining in the presence of 0.1uM inhibitor	B	Cn1cc(C2=C(c3cn(CCCSC(=N)N)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL6291	=	Activity	%	99.0	CHEMBL2527	Homo sapiens	Activity	%	99.0
Antagonist	2899718	CHEMBL1061201	Percentage CHK2 activity remaining in the presence of 0.1uM inhibitor	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Activity	%	43.0	CHEMBL2527	Homo sapiens	Activity	%	43.0
	2899719	CHEMBL1061201	Percentage CHK2 activity remaining in the presence of 0.1uM inhibitor	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	=	Activity	%	92.0	CHEMBL2527	Homo sapiens	Activity	%	92.0
	2899720	CHEMBL1052082	Percentage CHK2 activity remaining in the presence of 10uM inhibitor	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	=	Activity	%	95.0	CHEMBL2527	Homo sapiens	Activity	%	95.0
	2899721	CHEMBL1052082	Percentage CHK2 activity remaining in the presence of 10uM inhibitor	B	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL507361	=	Activity	%	102.0	CHEMBL2527	Homo sapiens	Activity	%	102.0
	2899722	CHEMBL1052082	Percentage CHK2 activity remaining in the presence of 10uM inhibitor	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Activity	%	93.0	CHEMBL2527	Homo sapiens	Activity	%	93.0
Antagonist	2899723	CHEMBL1052082	Percentage CHK2 activity remaining in the presence of 10uM inhibitor	B	CC(C)(C(N)=O)C(=O)NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1Br		CHEMBL573108	=	Activity	%	45.0	CHEMBL2527	Homo sapiens	Activity	%	45.0
	2899724	CHEMBL1052082	Percentage CHK2 activity remaining in the presence of 10uM inhibitor	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Activity	%	92.0	CHEMBL2527	Homo sapiens	Activity	%	92.0
	2899725	CHEMBL1052082	Percentage CHK2 activity remaining in the presence of 10uM inhibitor	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	=	Activity	%	86.0	CHEMBL2527	Homo sapiens	Activity	%	86.0
	2899726	CHEMBL1052082	Percentage CHK2 activity remaining in the presence of 10uM inhibitor	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Activity	%	84.0	CHEMBL2527	Homo sapiens	Activity	%	84.0
	2899727	CHEMBL1052082	Percentage CHK2 activity remaining in the presence of 10uM inhibitor	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Activity	%	64.0	CHEMBL2527	Homo sapiens	Activity	%	64.0
Antagonist	2899728	CHEMBL1052082	Percentage CHK2 activity remaining in the presence of 10uM inhibitor	B	CC(=O)c1c(O)c(C)c(O)c(Cc2c(O)c3c(c(C(=O)/C=C/c4ccccc4)c2O)OC(C)(C)C=C3)c1O		CHEMBL34241	=	Activity	%	12.0	CHEMBL2527	Homo sapiens	Activity	%	12.0
	2899729	CHEMBL1052082	Percentage CHK2 activity remaining in the presence of 10uM inhibitor	B	C[C@H]1CNCCN1S(=O)(=O)c1cccc2cnccc12		CHEMBL1233654	=	Activity	%	90.0	CHEMBL2527	Homo sapiens	Activity	%	90.0
	2899730	CHEMBL1052082	Percentage CHK2 activity remaining in the presence of 10uM inhibitor	B	O=C1NC(=O)C(c2ccccc2[N+](=O)[O-])=C1Nc1ccc(O)c(Cl)c1		CHEMBL322970	=	Activity	%	69.0	CHEMBL2527	Homo sapiens	Activity	%	69.0
	2899731	CHEMBL1052082	Percentage CHK2 activity remaining in the presence of 10uM inhibitor	B	CNCCNS(=O)(=O)c1cccc2cnccc12		CHEMBL148333	=	Activity	%	92.0	CHEMBL2527	Homo sapiens	Activity	%	92.0
	2899732	CHEMBL1052082	Percentage CHK2 activity remaining in the presence of 10uM inhibitor	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Activity	%	66.0	CHEMBL2527	Homo sapiens	Activity	%	66.0
	2899733	CHEMBL1052082	Percentage CHK2 activity remaining in the presence of 10uM inhibitor	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Activity	%	100.0	CHEMBL2527	Homo sapiens	Activity	%	100.0
	2899734	CHEMBL1052082	Percentage CHK2 activity remaining in the presence of 10uM inhibitor	B	NC(=O)c1sc(-c2ccsc2)cc1N		CHEMBL193093	=	Activity	%	93.0	CHEMBL2527	Homo sapiens	Activity	%	93.0
Antagonist	2899735	CHEMBL1052082	Percentage CHK2 activity remaining in the presence of 10uM inhibitor	B	CC(C)(C)n1nc(-c2cccc3ccccc23)c2c(N)ncnc21		CHEMBL264406	=	Activity	%	32.0	CHEMBL2527	Homo sapiens	Activity	%	32.0
Antagonist	2899736	CHEMBL1052082	Percentage CHK2 activity remaining in the presence of 10uM inhibitor	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Activity	%	44.0	CHEMBL2527	Homo sapiens	Activity	%	44.0
	2899737	CHEMBL1052082	Percentage CHK2 activity remaining in the presence of 10uM inhibitor	B	Cc1ccc(NC(=O)c2cccc(N(C)C)c2)cc1NC(=O)c1ccc(O)cc1		CHEMBL186526	=	Activity	%	80.0	CHEMBL2527	Homo sapiens	Activity	%	80.0
	2899738	CHEMBL1052082	Percentage CHK2 activity remaining in the presence of 10uM inhibitor	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Activity	%	99.0	CHEMBL2527	Homo sapiens	Activity	%	99.0
	2899739	CHEMBL1052082	Percentage CHK2 activity remaining in the presence of 10uM inhibitor	B	CC(=O)O[C@H]1[C@H](C)O[C@@H](Oc2c(-c3ccc(O)cc3)oc3cc(O)cc(O)c3c2=O)[C@H](O)[C@@H]1OC(C)=O		CHEMBL240954	=	Activity	%	99.0	CHEMBL2527	Homo sapiens	Activity	%	99.0
	2899740	CHEMBL1052082	Percentage CHK2 activity remaining in the presence of 10uM inhibitor	B	O=C(Nc1cc(Cl)cc2c1[nH]c1cnccc12)c1cccnc1		CHEMBL79004	=	Activity	%	102.0	CHEMBL2527	Homo sapiens	Activity	%	102.0
	2899741	CHEMBL1052082	Percentage CHK2 activity remaining in the presence of 10uM inhibitor	B	O=C(NOC[C@@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl.O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL540501	=	Activity	%	87.0	CHEMBL2527	Homo sapiens	Activity	%	87.0
	2899742	CHEMBL1052082	Percentage CHK2 activity remaining in the presence of 10uM inhibitor	B	N#CC(=C(/N)Sc1ccccc1N)/C(C#N)=C(\N)Sc1ccccc1N		CHEMBL34704	=	Activity	%	98.0	CHEMBL2527	Homo sapiens	Activity	%	98.0
	2899743	CHEMBL1052082	Percentage CHK2 activity remaining in the presence of 10uM inhibitor	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Activity	%	83.0	CHEMBL2527	Homo sapiens	Activity	%	83.0
	2899744	CHEMBL1062000	Percentage CHK2 activity remaining in the presence of 1uM inhibitor	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Activity	%	117.0	CHEMBL2527	Homo sapiens	Activity	%	117.0
	2899745	CHEMBL1062000	Percentage CHK2 activity remaining in the presence of 1uM inhibitor	B	Cc1c[nH]c(-c2cnc(NCCNc3ccc(C#N)cn3)nc2-c2ccc(Cl)cc2Cl)n1		CHEMBL412142	=	Activity	%	93.0	CHEMBL2527	Homo sapiens	Activity	%	93.0
	2899746	CHEMBL1062000	Percentage CHK2 activity remaining in the presence of 1uM inhibitor	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Activity	%	79.0	CHEMBL2527	Homo sapiens	Activity	%	79.0
	2899747	CHEMBL1062000	Percentage CHK2 activity remaining in the presence of 1uM inhibitor	B	CC(C)(C(N)=O)C(=O)NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1Br		CHEMBL573108	=	Activity	%	100.0	CHEMBL2527	Homo sapiens	Activity	%	100.0
	2899748	CHEMBL1062000	Percentage CHK2 activity remaining in the presence of 1uM inhibitor	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Activity	%	93.0	CHEMBL2527	Homo sapiens	Activity	%	93.0
Antagonist	2899749	CHEMBL1062000	Percentage CHK2 activity remaining in the presence of 1uM inhibitor	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL274654	=	Activity	%	16.0	CHEMBL2527	Homo sapiens	Activity	%	16.0
	2899750	CHEMBL1062000	Percentage CHK2 activity remaining in the presence of 1uM inhibitor	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Activity	%	95.0	CHEMBL2527	Homo sapiens	Activity	%	95.0
	2899751	CHEMBL1062000	Percentage CHK2 activity remaining in the presence of 1uM inhibitor	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Activity	%	92.0	CHEMBL2527	Homo sapiens	Activity	%	92.0
	2899752	CHEMBL1062000	Percentage CHK2 activity remaining in the presence of 1uM inhibitor	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Activity	%	99.0	CHEMBL2527	Homo sapiens	Activity	%	99.0
	2899753	CHEMBL1062000	Percentage CHK2 activity remaining in the presence of 1uM inhibitor	B	COC[C@H]1OC(=O)c2coc3c2[C@@]1(C)C1=C(C3=O)[C@@H]2CCC(=O)[C@@]2(C)C[C@H]1OC(C)=O		CHEMBL428496	=	Activity	%	90.0	CHEMBL2527	Homo sapiens	Activity	%	90.0
	2899754	CHEMBL1062000	Percentage CHK2 activity remaining in the presence of 1uM inhibitor	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	=	Activity	%	93.0	CHEMBL2527	Homo sapiens	Activity	%	93.0
Antagonist	2899755	CHEMBL1062000	Percentage CHK2 activity remaining in the presence of 1uM inhibitor	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Activity	%	13.0	CHEMBL2527	Homo sapiens	Activity	%	13.0
Antagonist	2899756	CHEMBL1062000	Percentage CHK2 activity remaining in the presence of 1uM inhibitor	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Activity	%	28.0	CHEMBL2527	Homo sapiens	Activity	%	28.0
	2899757	CHEMBL1062000	Percentage CHK2 activity remaining in the presence of 1uM inhibitor	B	CC(=O)O.O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL265470	=	Activity	%	90.0	CHEMBL2527	Homo sapiens	Activity	%	90.0
Antagonist	2899758	CHEMBL1062000	Percentage CHK2 activity remaining in the presence of 1uM inhibitor	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Activity	%	44.0	CHEMBL2527	Homo sapiens	Activity	%	44.0
	2899759	CHEMBL1062000	Percentage CHK2 activity remaining in the presence of 1uM inhibitor	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Activity	%	95.0	CHEMBL2527	Homo sapiens	Activity	%	95.0
	2899760	CHEMBL1062000	Percentage CHK2 activity remaining in the presence of 1uM inhibitor	B	COc1ccc2c(c1)[nH]c1c(C)nccc12		CHEMBL269538	=	Activity	%	100.0	CHEMBL2527	Homo sapiens	Activity	%	100.0
	2899761	CHEMBL1062000	Percentage CHK2 activity remaining in the presence of 1uM inhibitor	B	CC1=NCCc2c1[nH]c1cc(O)ccc21		CHEMBL129177	=	Activity	%	122.0	CHEMBL2527	Homo sapiens	Activity	%	122.0
	2899762	CHEMBL1062000	Percentage CHK2 activity remaining in the presence of 1uM inhibitor	B	Cc1nccc2c1[nH]c1ccccc12		CHEMBL12014	=	Activity	%	92.0	CHEMBL2527	Homo sapiens	Activity	%	92.0
	2899763	CHEMBL1062000	Percentage CHK2 activity remaining in the presence of 1uM inhibitor	B	COc1ccc2c3c([nH]c2c1)C(C)=NCC3		CHEMBL340807	=	Activity	%	117.0	CHEMBL2527	Homo sapiens	Activity	%	117.0
	2899764	CHEMBL1062000	Percentage CHK2 activity remaining in the presence of 1uM inhibitor	B	Oc1c(Br)cc(C=C2c3cc(I)ccc3NC2O)cc1Br		CHEMBL1794051	=	Activity	%	75.0	CHEMBL2527	Homo sapiens	Activity	%	75.0
	2899765	CHEMBL1062000	Percentage CHK2 activity remaining in the presence of 1uM inhibitor	B	CNCCNS(=O)(=O)c1cccc2cnccc12		CHEMBL148333	=	Activity	%	69.0	CHEMBL2527	Homo sapiens	Activity	%	69.0
	2899766	CHEMBL1062000	Percentage CHK2 activity remaining in the presence of 1uM inhibitor	B	Cc1cncc2cccc(S(=O)(=O)N3CCCNC[C@@H]3C)c12		CHEMBL406821	=	Activity	%	82.0	CHEMBL2527	Homo sapiens	Activity	%	82.0
	2899767	CHEMBL1062000	Percentage CHK2 activity remaining in the presence of 1uM inhibitor	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Activity	%	95.0	CHEMBL2527	Homo sapiens	Activity	%	95.0
	2899768	CHEMBL1062000	Percentage CHK2 activity remaining in the presence of 1uM inhibitor	B	CC(C)(C)n1nc(-c2cccc3ccccc23)c2c(N)ncnc21		CHEMBL264406	=	Activity	%	75.0	CHEMBL2527	Homo sapiens	Activity	%	75.0
	2899769	CHEMBL1062000	Percentage CHK2 activity remaining in the presence of 1uM inhibitor	B	CC(C)(C)n1nc(-c2ccc(Cl)cc2)c2c(N)ncnc21		CHEMBL406845	=	Activity	%	103.0	CHEMBL2527	Homo sapiens	Activity	%	103.0
	2899770	CHEMBL1062000	Percentage CHK2 activity remaining in the presence of 1uM inhibitor	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Activity	%	83.0	CHEMBL2527	Homo sapiens	Activity	%	83.0
	2899771	CHEMBL1062000	Percentage CHK2 activity remaining in the presence of 1uM inhibitor	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Activity	%	92.0	CHEMBL2527	Homo sapiens	Activity	%	92.0
Antagonist	2899772	CHEMBL1062000	Percentage CHK2 activity remaining in the presence of 1uM inhibitor	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Activity	%	29.0	CHEMBL2527	Homo sapiens	Activity	%	29.0
Antagonist	2899773	CHEMBL1062000	Percentage CHK2 activity remaining in the presence of 1uM inhibitor	B	CCCCCCOC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608532	=	Activity	%	47.0	CHEMBL2527	Homo sapiens	Activity	%	47.0
Antagonist	2899774	CHEMBL1062000	Percentage CHK2 activity remaining in the presence of 1uM inhibitor	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Activity	%	11.0	CHEMBL2527	Homo sapiens	Activity	%	11.0
	2899775	CHEMBL1062000	Percentage CHK2 activity remaining in the presence of 1uM inhibitor	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Activity	%	91.0	CHEMBL2527	Homo sapiens	Activity	%	91.0
	2899776	CHEMBL1062000	Percentage CHK2 activity remaining in the presence of 1uM inhibitor	B	Cc1ccc(-c2nn(C(C)(C)C)c3ncnc(N)c23)cc1		CHEMBL306380	=	Activity	%	101.0	CHEMBL2527	Homo sapiens	Activity	%	101.0
	2899777	CHEMBL1062900	Percentage CHK2 activity remaining in the presence of 25uM inhibitor	B	COc1cc(OC)c(C=C2C(=O)Nc3ccccc32)c(OC)c1		CHEMBL576349	=	Activity	%	76.0	CHEMBL2527	Homo sapiens	Activity	%	76.0
	2899778	CHEMBL1062900	Percentage CHK2 activity remaining in the presence of 25uM inhibitor	B	NCCNS(=O)(=O)c1ccc(Cl)c2ccncc12		CHEMBL489157	=	Activity	%	64.0	CHEMBL2527	Homo sapiens	Activity	%	64.0
	2899779	CHEMBL1061952	Percentage CHK2 activity remaining in the presence of 2uM inhibitor	B	Cn1cc(C2=C(c3ccc(Cl)cc3Cl)C(=O)NC2=O)c2ccccc21		CHEMBL102714	=	Activity	%	93.0	CHEMBL2527	Homo sapiens	Activity	%	93.0
	2899780	CHEMBL1061202	Percentage CHK2 activity remaining in the presence of 3uM inhibitor	B	Cc1ccc(-c2c(C(=O)CF)n(CCCO)c3ncnc(N)c23)cc1		CHEMBL515414	=	Activity	%	81.0	CHEMBL2527	Homo sapiens	Activity	%	81.0
	2921400	CHEMBL1052892	Inhibition of CHEK2 assessed as enzyme activity at 1 uM relative to untreated control	B	Cc1ccc2c(Nc3ccc(Cl)cc3)nccc2c1Nc1ncccc1-c1ncnc2[nH]cnc12.Cl.Cl.Cl		CHEMBL3215582	=	Activity	%	100.0	CHEMBL2527	Homo sapiens	Activity	%	100.0
	2924805	CHEMBL1056874	Inhibition of CHK2 assessed as residual enzyme activity at 10 uM relative to untreated control	B	c1ccc2c(c1)[nH]c1c3cc[nH]c3ccc21		CHEMBL567173	=	Activity	%	73.0	CHEMBL2527	Homo sapiens	Activity	%	73.0
	2924806	CHEMBL1056874	Inhibition of CHK2 assessed as residual enzyme activity at 10 uM relative to untreated control	B	c1ccc2c(c1)[nH]c1c2ccc2cc[nH]c21		CHEMBL584980	=	Activity	%	58.0	CHEMBL2527	Homo sapiens	Activity	%	58.0
	2924807	CHEMBL1056874	Inhibition of CHK2 assessed as residual enzyme activity at 10 uM relative to untreated control	B	O=Cc1c[nH]c2ccc3c4ccccc4[nH]c3c12		CHEMBL575754	=	Activity	%	89.0	CHEMBL2527	Homo sapiens	Activity	%	89.0
	2924808	CHEMBL1056874	Inhibition of CHK2 assessed as residual enzyme activity at 10 uM relative to untreated control	B	O=Cc1c[nH]c2c1ccc1c3ccccc3[nH]c12		CHEMBL583972	=	Activity	%	38.0	CHEMBL2527	Homo sapiens	Activity	%	38.0
	2926220	CHEMBL1050232	Inhibition of CHK2 assessed as remaining enzyme activity at 3 uM relative to DMSO	B	COc1ccccc1-n1c(-c2ccccc2C)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL574236	=	Activity	%	99.0	CHEMBL2527	Homo sapiens	Activity	%	99.0
	2926713	CHEMBL1052142	Inhibition of recombinant CHK2 by [gamma-33P]ATP based assay	B	CC(Oc1nc(-c2ccc(C(=O)NCC3CCCNC3)cc2)cnc1N)c1c(Cl)cccc1Cl.Cl		CHEMBL567391	=	IC50	nM	1130.0	CHEMBL2527	Homo sapiens	IC50	uM	1.13
	2926718	CHEMBL1052147	Inhibition of recombinant CHK2 at 20 uM by [gamma-33P]ATP based assay	B	CC(Oc1nc(-c2ccc(C(=O)NCC3CCCNC3)cc2)cnc1N)c1c(Cl)cccc1Cl.Cl		CHEMBL567391	=	Inhibition	%	60.0	CHEMBL2527	Homo sapiens	INH	%	60.0
	2926721	CHEMBL1052142	Inhibition of recombinant CHK2 by [gamma-33P]ATP based assay	B	Cl.Nc1ncc(-c2ccc(C(=O)NCC3CCNC3)cc2)nc1Oc1ccc2cc[nH]c2c1		CHEMBL573177	=	IC50	nM	580.0	CHEMBL2527	Homo sapiens	IC50	uM	0.58
	2926726	CHEMBL1052147	Inhibition of recombinant CHK2 at 20 uM by [gamma-33P]ATP based assay	B	Cl.Nc1ncc(-c2ccc(C(=O)NCC3CCNC3)cc2)nc1Oc1ccc2cc[nH]c2c1		CHEMBL573177	=	Inhibition	%	98.0	CHEMBL2527	Homo sapiens	INH	%	98.0
	2926729	CHEMBL1052142	Inhibition of recombinant CHK2 by [gamma-33P]ATP based assay	B	Cl.Nc1ncc(-c2ccc(C(=O)N[C@@H]3CCNC3)cc2)nc1Oc1ccc2cc[nH]c2c1		CHEMBL572910	=	IC50	nM	610.0	CHEMBL2527	Homo sapiens	IC50	uM	0.61
	2926734	CHEMBL1052147	Inhibition of recombinant CHK2 at 20 uM by [gamma-33P]ATP based assay	B	Cl.Nc1ncc(-c2ccc(C(=O)N[C@@H]3CCNC3)cc2)nc1Oc1ccc2cc[nH]c2c1		CHEMBL572910	=	Inhibition	%	96.0	CHEMBL2527	Homo sapiens	INH	%	96.0
	2926737	CHEMBL1052142	Inhibition of recombinant CHK2 by [gamma-33P]ATP based assay	B	Cl.Nc1ncc(-c2ccc(C(=O)NC3CCNCC3)cc2)nc1Oc1ccc2cc[nH]c2c1		CHEMBL566083	=	IC50	nM	800.0	CHEMBL2527	Homo sapiens	IC50	uM	0.8
	2926742	CHEMBL1052147	Inhibition of recombinant CHK2 at 20 uM by [gamma-33P]ATP based assay	B	Cl.Nc1ncc(-c2ccc(C(=O)NC3CCNCC3)cc2)nc1Oc1ccc2cc[nH]c2c1		CHEMBL566083	=	Inhibition	%	98.0	CHEMBL2527	Homo sapiens	INH	%	98.0
	2926745	CHEMBL1052142	Inhibition of recombinant CHK2 by [gamma-33P]ATP based assay	B	Cl.Nc1ncc(-c2ccc(C(=O)NCC3CCCNC3)cc2)nc1Oc1ccc2cc[nH]c2c1		CHEMBL567174	=	IC50	nM	890.0	CHEMBL2527	Homo sapiens	IC50	uM	0.89
	2926750	CHEMBL1052147	Inhibition of recombinant CHK2 at 20 uM by [gamma-33P]ATP based assay	B	Cl.Nc1ncc(-c2ccc(C(=O)NCC3CCCNC3)cc2)nc1Oc1ccc2cc[nH]c2c1		CHEMBL567174	=	Inhibition	%	98.0	CHEMBL2527	Homo sapiens	INH	%	98.0
	2926753	CHEMBL1052142	Inhibition of recombinant CHK2 by [gamma-33P]ATP based assay	B	Cl.Nc1ncc(-c2ccc(C(=O)NCC3CCCN3)cc2)nc1Oc1ccc2cc[nH]c2c1		CHEMBL575565	=	IC50	nM	960.0	CHEMBL2527	Homo sapiens	IC50	uM	0.96
	2926758	CHEMBL1052147	Inhibition of recombinant CHK2 at 20 uM by [gamma-33P]ATP based assay	B	Cl.Nc1ncc(-c2ccc(C(=O)NCC3CCCN3)cc2)nc1Oc1ccc2cc[nH]c2c1		CHEMBL575565	=	Inhibition	%	98.0	CHEMBL2527	Homo sapiens	INH	%	98.0
	2926761	CHEMBL1052142	Inhibition of recombinant CHK2 by [gamma-33P]ATP based assay	B	Cl.Nc1ncc(-c2ccc(C(=O)NCC3CCNCC3)cc2)nc1Oc1ccc2cc[nH]c2c1		CHEMBL575566	=	IC50	nM	1120.0	CHEMBL2527	Homo sapiens	IC50	uM	1.12
	2926766	CHEMBL1052147	Inhibition of recombinant CHK2 at 20 uM by [gamma-33P]ATP based assay	B	Cl.Nc1ncc(-c2ccc(C(=O)NCC3CCNCC3)cc2)nc1Oc1ccc2cc[nH]c2c1		CHEMBL575566	=	Inhibition	%	97.0	CHEMBL2527	Homo sapiens	INH	%	97.0
	2928406	CHEMBL1060304	Inhibition of CHK2 assessed as remaining enzyme activity at 1 uM relative to DMSO	B	COc1ccccc1-n1c(-c2cc(O)ccc2C)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL566515	=	Activity	%	90.0	CHEMBL2527	Homo sapiens	Activity	%	90.0
Not Active	2938623	CHEMBL1041493	Inhibition of CHK2 at 10 uM	B	O=C1OC(/C=C/c2ccccc2)=N/C1=C\c1cccnc1		CHEMBL565286		Inhibition	%		CHEMBL2527	Homo sapiens	INH		
	2947577	CHEMBL1047350	Inhibition of CHK2 at 100 uM	B	COc1cc2nccc(Oc3ccc(NC(=O)N4CCN(c5ccccc5)C4=O)cc3F)c2cc1OC		CHEMBL573761	=	Inhibition	%	1.0	CHEMBL2527	Homo sapiens	INH	%	1.0
	2999014	CHEMBL1043717	Inhibition of CHK2 assessed as residual activity at 10 uM by Cherenkov counting relative to control in presence of 20 uM ATP	B	CC(C)c1onc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL220227	=	Activity	%	104.0	CHEMBL2527	Homo sapiens	Activity	%	104.0
	2999804	CHEMBL1043717	Inhibition of CHK2 assessed as residual activity at 10 uM by Cherenkov counting relative to control in presence of 20 uM ATP	B	CC(C)c1noc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL375428	=	Activity	%	109.0	CHEMBL2527	Homo sapiens	Activity	%	109.0
	2999879	CHEMBL1049881	Inhibition of CHK2 assessed as residual activity at 0.1 uM by Cherenkov counting relative to control in presence of 20 uM ATP	B	COc1ccc(/C=C/C(=O)Nc2cc(-c3[nH]c(SC)nc3-c3ccc(F)cc3)ccn2)c(OC)c1		CHEMBL569114	=	Activity	%	79.0	CHEMBL2527	Homo sapiens	Activity	%	79.0
	2999955	CHEMBL1049881	Inhibition of CHK2 assessed as residual activity at 0.1 uM by Cherenkov counting relative to control in presence of 20 uM ATP	B	COc1ccc(/C=C/C(=O)Nc2cc(-c3[nH]c([S+](C)[O-])nc3-c3ccc(F)cc3)ccn2)c(OC)c1		CHEMBL572006	=	Activity	%	85.0	CHEMBL2527	Homo sapiens	Activity	%	85.0
	3052563	CHEMBL1037104	Residual activity of CHK2 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	51.0	CHEMBL2527	Homo sapiens	Residual activity	%	51.0
	3052815	CHEMBL1044272	Residual activity of CHK2 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	9.0	CHEMBL2527	Homo sapiens	Residual activity	%	9.0
	3054124	CHEMBL1066642	Residual activity of CHK2 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	91.0	CHEMBL2527	Homo sapiens	Residual activity	%	91.0
	3055411	CHEMBL1037104	Residual activity of CHK2 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	54.0	CHEMBL2527	Homo sapiens	Residual activity	%	54.0
	3055663	CHEMBL1044272	Residual activity of CHK2 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	11.0	CHEMBL2527	Homo sapiens	Residual activity	%	11.0
	3056968	CHEMBL1066642	Residual activity of CHK2 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	88.0	CHEMBL2527	Homo sapiens	Residual activity	%	88.0
	3058288	CHEMBL1037104	Residual activity of CHK2 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	75.0	CHEMBL2527	Homo sapiens	Residual activity	%	75.0
	3058540	CHEMBL1044272	Residual activity of CHK2 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	17.0	CHEMBL2527	Homo sapiens	Residual activity	%	17.0
	3072886	CHEMBL1066642	Residual activity of CHK2 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	92.0	CHEMBL2527	Homo sapiens	Residual activity	%	92.0
	3084376	CHEMBL1072655	Inhibition of CHK2	B	NCCn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL590109	=	IC50	nM	44.0	CHEMBL2527	Homo sapiens	IC50	uM	0.044
	3094831	CHEMBL1069042	Inhibition of CHK2 at 1 uM by microfluidic substrate phosphorylation assay	B	NC(=O)c1ccc(-c2cc(-c3cccc4c3OCO4)cnc2N)cc1		CHEMBL590335	=	Inhibition	%	72.0	CHEMBL2527	Homo sapiens	INH	%	72.0
	3094832	CHEMBL1069042	Inhibition of CHK2 at 1 uM by microfluidic substrate phosphorylation assay	B	NC(=O)c1ccc(-c2cc(-c3scc4c3OCCO4)cnc2N)cc1		CHEMBL602931	=	Inhibition	%	89.0	CHEMBL2527	Homo sapiens	INH	%	89.0
	3094833	CHEMBL1069042	Inhibition of CHK2 at 1 uM by microfluidic substrate phosphorylation assay	B	NCCNC(=O)c1cc(-c2ccsc2)cnc1N		CHEMBL610226	=	Inhibition	%	91.0	CHEMBL2527	Homo sapiens	INH	%	91.0
	3094834	CHEMBL1069042	Inhibition of CHK2 at 1 uM by microfluidic substrate phosphorylation assay	B	NCCNC(=O)c1cc(-c2scc3c2OCCO3)cnc1N		CHEMBL599171	=	Inhibition	%	94.0	CHEMBL2527	Homo sapiens	INH	%	94.0
	3094839	CHEMBL1069054	Inhibition of CHK2 in human HT29 cells assessed as blockade of etoposide-induced DNA damage-activated enzyme phosphorylation by Western bloting	B	NC(=O)c1ccc(-c2cc(-c3cccc4c3OCO4)cnc2N)cc1		CHEMBL590335	=	EC50	nM	10000.0	CHEMBL2527	Homo sapiens	EC50	uM	10.0
	3094840	CHEMBL1069054	Inhibition of CHK2 in human HT29 cells assessed as blockade of etoposide-induced DNA damage-activated enzyme phosphorylation by Western bloting	B	NC(=O)c1ccc(-c2cc(-c3scc4c3OCCO4)cnc2N)cc1		CHEMBL602931	=	EC50	nM	5000.0	CHEMBL2527	Homo sapiens	EC50	uM	5.0
	3094842	CHEMBL1069055	Inhibition of CHK2 in human HT29 cells	B	NCCNC(=O)c1cc(-c2scc3c2OCCO3)cnc1N		CHEMBL599171	=	EC50	nM	5000.0	CHEMBL2527	Homo sapiens	EC50	uM	5.0
	3094845	CHEMBL1068399	Inhibition of CHK2 by DELFIA assay	B	NC(=O)c1ccc(-c2cc(-c3ccsc3)cnc2N)cc1		CHEMBL590637	=	IC50	nM	610.0	CHEMBL2527	Homo sapiens	IC50	uM	0.61
	3094847	CHEMBL1068399	Inhibition of CHK2 by DELFIA assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	27000.0	CHEMBL2527	Homo sapiens	IC50	uM	27.0
	3094861	CHEMBL1068399	Inhibition of CHK2 by DELFIA assay	B	NC(=O)c1cccc(-c2cc(-c3ccsc3)cnc2N)c1		CHEMBL590774	>	IC50	nM	100000.0	CHEMBL2527	Homo sapiens	IC50	uM	100.0
	3094862	CHEMBL1068399	Inhibition of CHK2 by DELFIA assay	B	Nc1ncc(-c2ccccc2)cc1-c1ccc(C(=O)NCCO)cc1		CHEMBL590792	>	IC50	nM	100000.0	CHEMBL2527	Homo sapiens	IC50	uM	100.0
	3094863	CHEMBL1068399	Inhibition of CHK2 by DELFIA assay	B	Nc1ncc(-c2ccccc2)cc1-c1ccc(CO)cc1		CHEMBL589501	>	IC50	nM	100000.0	CHEMBL2527	Homo sapiens	IC50	uM	100.0
	3094864	CHEMBL1068399	Inhibition of CHK2 by DELFIA assay	B	NC(=O)c1ccc(-c2cc(-c3csc4ccccc34)cnc2N)cc1		CHEMBL590817	>	IC50	nM	100000.0	CHEMBL2527	Homo sapiens	IC50	uM	100.0
	3094865	CHEMBL1068399	Inhibition of CHK2 by DELFIA assay	B	CNc1ncc(-c2ccsc2)cc1-c1ccc(C(N)=O)cc1		CHEMBL602232	=	IC50	nM	85000.0	CHEMBL2527	Homo sapiens	IC50	uM	85.0
	3094866	CHEMBL1068399	Inhibition of CHK2 by DELFIA assay	B	NC(=O)c1ccc(-c2cnc(N)c(-c3ccsc3)c2)cc1		CHEMBL589986	=	IC50	nM	22000.0	CHEMBL2527	Homo sapiens	IC50	uM	22.0
	3094867	CHEMBL1068399	Inhibition of CHK2 by DELFIA assay	B	CCOC(=O)c1cc(-c2ccsc2)cnc1N		CHEMBL602729	=	IC50	nM	17000.0	CHEMBL2527	Homo sapiens	IC50	uM	17.0
	3094868	CHEMBL1068399	Inhibition of CHK2 by DELFIA assay	B	NC(=O)c1ccc(-c2cc(-c3cc4ccccc4s3)cnc2N)cc1		CHEMBL590581	>	IC50	nM	10000.0	CHEMBL2527	Homo sapiens	IC50	uM	10.0
	3094869	CHEMBL1068399	Inhibition of CHK2 by DELFIA assay	B	Nc1ncc(-c2ccsc2)cc1-c1ccc(C(=O)O)cc1		CHEMBL589089	=	IC50	nM	9800.0	CHEMBL2527	Homo sapiens	IC50	uM	9.8
	3094872	CHEMBL1068399	Inhibition of CHK2 by DELFIA assay	B	CNC(=O)c1ccc(-c2cc(-c3ccsc3)cnc2N)cc1		CHEMBL589090	=	IC50	nM	6700.0	CHEMBL2527	Homo sapiens	IC50	uM	6.7
	3094873	CHEMBL1068399	Inhibition of CHK2 by DELFIA assay	B	CN(C)C(=O)c1ccc(-c2cc(-c3ccsc3)cnc2N)cc1		CHEMBL589091	=	IC50	nM	6100.0	CHEMBL2527	Homo sapiens	IC50	uM	6.1
	3094874	CHEMBL1068399	Inhibition of CHK2 by DELFIA assay	B	NC(=O)c1ccc(-c2cncc(-c3ccsc3)c2)cc1		CHEMBL587506	=	IC50	nM	5200.0	CHEMBL2527	Homo sapiens	IC50	uM	5.2
	3094876	CHEMBL1068399	Inhibition of CHK2 by DELFIA assay	B	COc1cc(-c2cc(-c3cc(OC)c(C)c(OC)c3)cnc2N)ccc1O		CHEMBL600865	=	IC50	nM	4400.0	CHEMBL2527	Homo sapiens	IC50	uM	4.4
	3094878	CHEMBL1068399	Inhibition of CHK2 by DELFIA assay	B	CN(C)CCNC(=O)c1cc(-c2ccsc2)cnc1N		CHEMBL599582	=	IC50	nM	3600.0	CHEMBL2527	Homo sapiens	IC50	uM	3.6
	3094881	CHEMBL1068399	Inhibition of CHK2 by DELFIA assay	B	COc1cc(-c2cc(-c3cc(OC)c(OC)c(OC)c3)cnc2N)ccc1O		CHEMBL590793	=	IC50	nM	3000.0	CHEMBL2527	Homo sapiens	IC50	uM	3.0
	3094882	CHEMBL1068399	Inhibition of CHK2 by DELFIA assay	B	NC(=O)c1ccc(-c2cc(-c3ccccc3)cnc2N)cc1		CHEMBL604251	=	IC50	nM	2700.0	CHEMBL2527	Homo sapiens	IC50	uM	2.7
	3094885	CHEMBL1068399	Inhibition of CHK2 by DELFIA assay	B	CC(=O)Nc1cccc(-c2cnc(N)c(-c3ccc(C(N)=O)cc3)c2)c1		CHEMBL592489	=	IC50	nM	2400.0	CHEMBL2527	Homo sapiens	IC50	uM	2.4
	3094886	CHEMBL1068399	Inhibition of CHK2 by DELFIA assay	B	COc1cc(-c2cnc(N)c(-c3ccc(O)cc3)c2)cc(OC)c1OC		CHEMBL604459	=	IC50	nM	2300.0	CHEMBL2527	Homo sapiens	IC50	uM	2.3
	3094888	CHEMBL1068399	Inhibition of CHK2 by DELFIA assay	B	NC(=O)c1ccc(-c2cc(-c3ccccn3)cnc2N)cc1		CHEMBL590807	=	IC50	nM	2200.0	CHEMBL2527	Homo sapiens	IC50	uM	2.2
	3094889	CHEMBL1068399	Inhibition of CHK2 by DELFIA assay	B	NC(=O)c1ccc(-c2cc(-c3cccnc3)cnc2N)cc1		CHEMBL600868	=	IC50	nM	2200.0	CHEMBL2527	Homo sapiens	IC50	uM	2.2
	3094890	CHEMBL1068399	Inhibition of CHK2 by DELFIA assay	B	NC(=O)c1ccc(-c2cc(-c3cccc4c3OCCO4)cnc2N)cc1		CHEMBL590336	=	IC50	nM	2200.0	CHEMBL2527	Homo sapiens	IC50	uM	2.2
	3094891	CHEMBL1068399	Inhibition of CHK2 by DELFIA assay	B	NC(=O)c1ccc(-c2cc(-c3cccc(F)c3)cnc2N)cc1		CHEMBL592488	=	IC50	nM	2100.0	CHEMBL2527	Homo sapiens	IC50	uM	2.1
	3094893	CHEMBL1068399	Inhibition of CHK2 by DELFIA assay	B	CN(C)CCCOc1ccc(-c2cnc(N)c(-c3ccc(C(N)=O)cc3)c2)cn1		CHEMBL592490	=	IC50	nM	1800.0	CHEMBL2527	Homo sapiens	IC50	uM	1.8
	3094894	CHEMBL1068399	Inhibition of CHK2 by DELFIA assay	B	NC(=O)c1ccc(-c2cc(-c3ccncc3)cnc2N)cc1		CHEMBL590808	=	IC50	nM	1600.0	CHEMBL2527	Homo sapiens	IC50	uM	1.6
	3094895	CHEMBL1068399	Inhibition of CHK2 by DELFIA assay	B	COc1ccc(-c2cnc(N)c(-c3ccc(C(N)=O)cc3)c2)cc1		CHEMBL605083	=	IC50	nM	1400.0	CHEMBL2527	Homo sapiens	IC50	uM	1.4
	3094896	CHEMBL1068399	Inhibition of CHK2 by DELFIA assay	B	NC(=O)c1ccc(-c2cc(-c3ccc4c(c3)OCO4)cnc2N)cc1		CHEMBL590079	=	IC50	nM	1350.0	CHEMBL2527	Homo sapiens	IC50	uM	1.35
	3094897	CHEMBL1068399	Inhibition of CHK2 by DELFIA assay	B	NC(=O)c1ccc(-c2cc(-c3cscn3)cnc2N)cc1		CHEMBL604784	=	IC50	nM	1100.0	CHEMBL2527	Homo sapiens	IC50	uM	1.1
	3094898	CHEMBL1068399	Inhibition of CHK2 by DELFIA assay	B	COCCOc1ccc(-c2cnc(N)c(-c3ccc(C(N)=O)cc3)c2)cc1		CHEMBL589347	=	IC50	nM	1100.0	CHEMBL2527	Homo sapiens	IC50	uM	1.1
	3094900	CHEMBL1068399	Inhibition of CHK2 by DELFIA assay	B	NC(=O)c1ccc(-c2cc(-c3nccs3)cnc2N)cc1		CHEMBL591284	=	IC50	nM	990.0	CHEMBL2527	Homo sapiens	IC50	uM	0.99
	3094901	CHEMBL1068399	Inhibition of CHK2 by DELFIA assay	B	NC(=O)c1ccc(-c2cc(-c3ccc4c(c3)OCCO4)cnc2N)cc1		CHEMBL608262	=	IC50	nM	830.0	CHEMBL2527	Homo sapiens	IC50	uM	0.83
	3094903	CHEMBL1068399	Inhibition of CHK2 by DELFIA assay	B	CN(C)CCNC(=O)c1cc(-c2scc3c2OCCO3)cnc1N		CHEMBL598973	=	IC50	nM	700.0	CHEMBL2527	Homo sapiens	IC50	uM	0.7
	3094904	CHEMBL1068399	Inhibition of CHK2 by DELFIA assay	B	NC(=O)c1ccc(-c2cc(-c3cncs3)cnc2N)cc1		CHEMBL591518	=	IC50	nM	680.0	CHEMBL2527	Homo sapiens	IC50	uM	0.68
	3094905	CHEMBL1068399	Inhibition of CHK2 by DELFIA assay	B	COc1cccc(-c2cnc(N)c(-c3ccc(C(N)=O)cc3)c2)c1		CHEMBL590809	=	IC50	nM	600.0	CHEMBL2527	Homo sapiens	IC50	uM	0.6
	3094906	CHEMBL1068399	Inhibition of CHK2 by DELFIA assay	B	COCCOc1cccc(-c2cnc(N)c(-c3ccc(C(N)=O)cc3)c2)c1		CHEMBL592784	=	IC50	nM	420.0	CHEMBL2527	Homo sapiens	IC50	uM	0.42
	3094907	CHEMBL1068399	Inhibition of CHK2 by DELFIA assay	B	NC(=O)CCNC(=O)c1cc(-c2ccsc2)cnc1N		CHEMBL599581	=	IC50	nM	410.0	CHEMBL2527	Homo sapiens	IC50	uM	0.41
	3094908	CHEMBL1068399	Inhibition of CHK2 by DELFIA assay	B	NC(=O)c1ccc(-c2cc(-c3cccs3)cnc2N)cc1		CHEMBL591283	=	IC50	nM	350.0	CHEMBL2527	Homo sapiens	IC50	uM	0.35
	3094909	CHEMBL1068399	Inhibition of CHK2 by DELFIA assay	B	COc1cc(-c2cnc(N)c(-c3ccc(C(N)=O)cc3)c2)ccc1O		CHEMBL600441	=	IC50	nM	310.0	CHEMBL2527	Homo sapiens	IC50	uM	0.31
	3094910	CHEMBL1068400	Inhibition of CHK2 at 100 uM by DELFIA assay	B	N#Cc1ccc(-c2cc(-c3ccsc3)cnc2N)cc1		CHEMBL589816	=	Inhibition	%	30.0	CHEMBL2527	Homo sapiens	INH	%	30.0
	3094911	CHEMBL1068400	Inhibition of CHK2 at 100 uM by DELFIA assay	B	COC(=O)c1ccc(-c2cc(-c3ccsc3)cnc2N)cc1		CHEMBL590062	=	Inhibition	%	27.0	CHEMBL2527	Homo sapiens	INH	%	27.0
	3094912	CHEMBL1068399	Inhibition of CHK2 by DELFIA assay	B	COc1ccc(-c2cnc(N)c(-c3ccc(C(N)=O)cc3)c2)cc1OC		CHEMBL588536	=	IC50	nM	270.0	CHEMBL2527	Homo sapiens	IC50	uM	0.27
	3094913	CHEMBL1068399	Inhibition of CHK2 by DELFIA assay	B	NC(=O)c1ccc(-c2cc(-c3cccc4c3OCO4)cnc2N)cc1		CHEMBL590335	=	IC50	nM	210.0	CHEMBL2527	Homo sapiens	IC50	uM	0.21
	3094914	CHEMBL1068400	Inhibition of CHK2 at 100 uM by DELFIA assay	B	CN(C)c1ncc(-c2ccsc2)cc1-c1ccc(C(N)=O)cc1		CHEMBL603404	=	Inhibition	%	16.0	CHEMBL2527	Homo sapiens	INH	%	16.0
	3094915	CHEMBL1068399	Inhibition of CHK2 by DELFIA assay	B	NC(=O)c1ccc(-c2cc(-c3scc4c3OCCO4)cnc2N)cc1		CHEMBL602931	=	IC50	nM	92.0	CHEMBL2527	Homo sapiens	IC50	uM	0.092
	3094916	CHEMBL1068399	Inhibition of CHK2 by DELFIA assay	B	NCCNC(=O)c1cc(-c2ccsc2)cnc1N		CHEMBL610226	=	IC50	nM	39.0	CHEMBL2527	Homo sapiens	IC50	uM	0.039
	3094917	CHEMBL1068399	Inhibition of CHK2 by DELFIA assay	B	NCCNC(=O)c1cc(-c2scc3c2OCCO3)cnc1N		CHEMBL599171	=	IC50	nM	28.0	CHEMBL2527	Homo sapiens	IC50	uM	0.028
	3127290	CHEMBL1074368	Inhibition of CHK2 at 1 uM	B	NC1(Cc2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL263664	=	Inhibition	%	45.0	CHEMBL2527	Homo sapiens	INH	%	45.0
	3127309	CHEMBL1074368	Inhibition of CHK2 at 1 uM	B	CC(C)(C)c1ccc(CC2(N)CCN(c3ncnc4[nH]ccc34)CC2)cc1		CHEMBL597211	=	Inhibition	%	7.0	CHEMBL2527	Homo sapiens	INH	%	7.0
	3127328	CHEMBL1074368	Inhibition of CHK2 at 1 uM	B	NC1(C(=O)NCc2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL598194	=	Inhibition	%	-10.0	CHEMBL2527	Homo sapiens	INH	%	-10.0
	3130828	CHEMBL1066175	Inhibition of CHK2 at 3 to 6 uM relative to control	B	COc1ccc(C(=O)NCc2cccc(C(=O)Nc3ccc4c(c3)CNCC4)c2)cc1OC		CHEMBL604087	>	Inhibition	%	50.0	CHEMBL2527	Homo sapiens	INH	%	50.0
	3131747	CHEMBL1065752	Inhibition of CHK2 at 3 uM relative to control	B	NC(=O)c1ccc(NC(=O)NCc2cccc(C(=O)Nc3ccc4c(c3)CNCC4)c2)cc1		CHEMBL600852	>	Inhibition	%	50.0	CHEMBL2527	Homo sapiens	INH	%	50.0
	3213900	CHEMBL1114048	Inhibition of CHK2 at 5 uM	B	O=C(Nc1ccccc1Cl)c1cnc2ccc(C3CCNCC3)cn12.O=C(O)C(=O)O		CHEMBL1077739	=	Inhibition	%	2.0	CHEMBL2527	Homo sapiens	INH	%	2.0
	3219670	CHEMBL1110421	Inhibition of CHK2 at 100 nM relative to control	B	N=C(N)NCCC[C@@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)CCCCCNC(=O)[C@@H](CCCCN)NC(=O)CCCCCNC(=O)c1ccc(-c2ccnc(N)n2)s1)C(N)=O		CHEMBL1077375	=	Inhibition	%	33.0	CHEMBL2527	Homo sapiens	INH	%	33.0
	3224780	CHEMBL1102774	Inhibition of CHK2 at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1-c1cnc(CO)cn1		CHEMBL1081678	<	Inhibition	%	50.0	CHEMBL2527	Homo sapiens	INH	%	50.0
	3225030	CHEMBL1102774	Inhibition of CHK2 at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1Cc1ccc(CN(C)C)cc1		CHEMBL1078665	<	Inhibition	%	50.0	CHEMBL2527	Homo sapiens	INH	%	50.0
	3240796	CHEMBL1109659	Inhibition of CHK2	B	O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCOCC4)c3)n2)c1		CHEMBL1090360	>	IC50	nM	1000.0	CHEMBL2527	Homo sapiens	IC50	uM	1.0
	3260101	CHEMBL1108067	Inhibition of CHK2 at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control	B	CN(C)CCCC(=O)Nc1ccc2nccc(Nc3cccc(Br)c3)c2c1		CHEMBL1089524	=	Activity	%	27.0	CHEMBL2527	Homo sapiens	Activity	%	27.0
	3261212	CHEMBL1113453	Inhibition of CHK2 at 10 uM	B	O=C1OC(c2ccccc2)=N/C1=C\c1cccnc1		CHEMBL579387	=	Inhibition	%	4.0	CHEMBL2527	Homo sapiens	INH	%	4.0
Not Determined	3261213	CHEMBL1113453	Inhibition of CHK2 at 10 uM	B	Cc1cccc(C2=N/C(=C\c3cccnc3)C(=O)O2)c1		CHEMBL1091786		Inhibition	%		CHEMBL2527	Homo sapiens	INH		
	3261214	CHEMBL1113453	Inhibition of CHK2 at 10 uM	B	O=C1OC(c2ccc(Cl)cc2)=N/C1=C\c1cccnc1		CHEMBL1091787	=	Inhibition	%	24.0	CHEMBL2527	Homo sapiens	INH	%	24.0
	3261215	CHEMBL1113453	Inhibition of CHK2 at 10 uM	B	O=C1OC(/C=C/c2ccccc2)=N/C1=C\c1cccnc1		CHEMBL565286	=	Inhibition	%	17.0	CHEMBL2527	Homo sapiens	INH	%	17.0
	3261216	CHEMBL1113453	Inhibition of CHK2 at 10 uM	B	O=C1OC(c2ccc(F)c(F)c2)=N/C1=C\c1cccnc1		CHEMBL1091764	=	Inhibition	%	7.0	CHEMBL2527	Homo sapiens	INH	%	7.0
	3261217	CHEMBL1113453	Inhibition of CHK2 at 10 uM	B	Cc1cc(C2=N/C(=C\c3cccnc3)C(=O)O2)ccc1Br		CHEMBL1091766	=	Inhibition	%	19.0	CHEMBL2527	Homo sapiens	INH	%	19.0
	3261372	CHEMBL1108067	Inhibition of CHK2 at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control	B	CN(C)CCCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL1088901	=	Activity	%	38.0	CHEMBL2527	Homo sapiens	Activity	%	38.0
Not Active	3271820	CHEMBL1112905	Inhibition of CHK2	B	COc1cc(OC)c(C=C2C(=O)Nc3ccccc32)c(OC)c1		CHEMBL576349		Inhibition	%		CHEMBL2527	Homo sapiens	INH		
Not Active	3271821	CHEMBL1112905	Inhibition of CHK2	B	COc1ccccc1/C=C1/C(=O)Nc2ccccc21		CHEMBL444673		Inhibition	%		CHEMBL2527	Homo sapiens	INH		
Not Active	3271822	CHEMBL1112905	Inhibition of CHK2	B	O=C1Nc2ccc(Cl)cc2/C1=C\c1ccccc1F		CHEMBL1088391		Inhibition	%		CHEMBL2527	Homo sapiens	INH		
Not Active	3271823	CHEMBL1112905	Inhibition of CHK2	B	O=C1Nc2ccc(Cl)cc2/C1=C\c1ccccc1[N+](=O)[O-]		CHEMBL1088392		Inhibition	%		CHEMBL2527	Homo sapiens	INH		
Not Active	3271824	CHEMBL1112905	Inhibition of CHK2	B	O=C1Nc2ccc(Cl)cc2/C1=C\c1ccccc1S(=O)(=O)O		CHEMBL1088529		Inhibition	%		CHEMBL2527	Homo sapiens	INH		
Not Active	3271825	CHEMBL1112905	Inhibition of CHK2	B	O=C1Nc2ccc(Cl)cc2/C1=C\c1ccc2c(c1)OCO2		CHEMBL1086669		Inhibition	%		CHEMBL2527	Homo sapiens	INH		
Not Active	3271826	CHEMBL1112905	Inhibition of CHK2	B	O=C1Nc2ccc(Cl)cc2/C1=C\c1cc(F)cc(F)c1		CHEMBL1086670		Inhibition	%		CHEMBL2527	Homo sapiens	INH		
Not Active	3271827	CHEMBL1112905	Inhibition of CHK2	B	NC(=O)Cc1ccc(/C=C2/C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL1086795		Inhibition	%		CHEMBL2527	Homo sapiens	INH		
Not Active	3271828	CHEMBL1112905	Inhibition of CHK2	B	COc1ccc(/C=C2/C(=O)Nc3ccc(Cl)cc32)c(OC)c1OC		CHEMBL1086796		Inhibition	%		CHEMBL2527	Homo sapiens	INH		
Not Active	3271829	CHEMBL1112905	Inhibition of CHK2	B	COc1cc(/C=C2/C(=O)Nc3ccc(Cl)cc32)cc(OC)c1OC		CHEMBL383871		Inhibition	%		CHEMBL2527	Homo sapiens	INH		
	3271830	CHEMBL1112905	Inhibition of CHK2	B	COc1cc(OC)c(/C=C2/C(=O)Nc3ccc(Cl)cc32)c(OC)c1		CHEMBL1086939	<	Inhibition	%	20.0	CHEMBL2527	Homo sapiens	INH	%	20.0
Not Active	3271831	CHEMBL1112905	Inhibition of CHK2	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535		Inhibition	%		CHEMBL2527	Homo sapiens	INH		
	3306924	CHEMBL1117949	Inhibition of CHK2 at 3 uM	B	O=C(Nc1cc2cc[nH]c(=O)c2cc1Cl)C(NC1CC1)c1ccccc1		CHEMBL1084106	=	Inhibition	%	76.0	CHEMBL2527	Homo sapiens	INH	%	76.0
	3331871	CHEMBL1168830	Inhibition of CHEK2 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(F)ccc3F)CCN4)cn2)CC1		CHEMBL1165499	<	Inhibition	%	50.0	CHEMBL2527	Homo sapiens	INH	%	50.0
	3333286	CHEMBL1168830	Inhibition of CHEK2 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	<	Inhibition	%	50.0	CHEMBL2527	Homo sapiens	INH	%	50.0
	3334691	CHEMBL1168830	Inhibition of CHEK2 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3Cl)CCN4)cn2)CC1		CHEMBL1164181	<	Inhibition	%	50.0	CHEMBL2527	Homo sapiens	INH	%	50.0
	3336111	CHEMBL1168830	Inhibition of CHEK2 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1		CHEMBL1164265	<	Inhibition	%	50.0	CHEMBL2527	Homo sapiens	INH	%	50.0
	3340639	CHEMBL1168830	Inhibition of CHEK2 at 1 uM	B	FC(F)(F)c1ccc(Cl)cc1CN1CCNc2ncc(-c3ccnc(N4CCNCC4)c3)cc21		CHEMBL1163566	<	Inhibition	%	50.0	CHEMBL2527	Homo sapiens	INH	%	50.0
	3342055	CHEMBL1168830	Inhibition of CHEK2 at 1 uM	B	CC(=O)N1CCN(c2cc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)ccn2)CC1		CHEMBL1163565	<	Inhibition	%	50.0	CHEMBL2527	Homo sapiens	INH	%	50.0
	3344677	CHEMBL1168098	Inhibition of CHK2 assessed as residual activity at 10 uM after 80 mins by microplate scintillation counting	B	CN1CCN(c2ccc(NC(=O)c3ccc4c(c3)/C(=C3/Nc5ccccc5C3=O)C(=O)N4)cc2)CC1		CHEMBL1164526	=	Activity	%	69.0	CHEMBL2527	Homo sapiens	Activity	%	69.0
	3344678	CHEMBL1168099	Inhibition of CHK2 assessed as residual activity at 1 uM after 80 mins by microplate scintillation counting	B	CN1CCN(c2ccc(NC(=O)c3ccc4c(c3)/C(=C3/Nc5ccccc5C3=O)C(=O)N4)cc2)CC1		CHEMBL1164526	=	Activity	%	90.0	CHEMBL2527	Homo sapiens	Activity	%	90.0
	3354387	CHEMBL1173988	Inhibition of CHK2 at 10 uM by DELFIA assay	B	c1ccc(-c2cnc3cnc(-c4cc[nH]n4)cn23)cc1		CHEMBL1170750	=	Inhibition	%	10.0	CHEMBL2527	Homo sapiens	INH	%	10.0
	3354388	CHEMBL1173988	Inhibition of CHK2 at 10 uM by DELFIA assay	B	c1ccc(-c2cnc3cnc(-c4cn[nH]c4)cn23)cc1		CHEMBL1172464	=	Inhibition	%	50.0	CHEMBL2527	Homo sapiens	INH	%	50.0
	3354389	CHEMBL1173988	Inhibition of CHK2 at 10 uM by DELFIA assay	B	c1ccc(-c2cnc3cnc(-c4ccncc4)cn23)cc1		CHEMBL1170317	=	Inhibition	%	18.0	CHEMBL2527	Homo sapiens	INH	%	18.0
	3354390	CHEMBL1173988	Inhibition of CHK2 at 10 uM by DELFIA assay	B	c1n[nH]cc1-c1cnc2ncc(-c3cn[nH]c3)n2c1		CHEMBL1171532	=	Inhibition	%	67.0	CHEMBL2527	Homo sapiens	INH	%	67.0
	3354391	CHEMBL1173988	Inhibition of CHK2 at 10 uM by DELFIA assay	B	Cn1cc(-c2cnc3ncc(-c4cn[nH]c4)cn23)cn1		CHEMBL1171533	=	Inhibition	%	57.0	CHEMBL2527	Homo sapiens	INH	%	57.0
	3354392	CHEMBL1173988	Inhibition of CHK2 at 10 uM by DELFIA assay	B	c1cc(-c2cnc3ncc(-c4cn[nH]c4)cn23)n[nH]1		CHEMBL1171534	=	Inhibition	%	95.0	CHEMBL2527	Homo sapiens	INH	%	95.0
	3354393	CHEMBL1173988	Inhibition of CHK2 at 10 uM by DELFIA assay	B	OCc1cccc(-c2cnc3ncc(-c4cn[nH]c4)cn23)c1		CHEMBL1171699	=	Inhibition	%	34.0	CHEMBL2527	Homo sapiens	INH	%	34.0
	3354394	CHEMBL1173988	Inhibition of CHK2 at 10 uM by DELFIA assay	B	c1ccc2c(-c3cnc4cnc(-c5cn[nH]c5)cn34)c[nH]c2c1		CHEMBL1170126	=	Inhibition	%	82.0	CHEMBL2527	Homo sapiens	INH	%	82.0
	3354395	CHEMBL1173988	Inhibition of CHK2 at 10 uM by DELFIA assay	B	NCc1ccc(-c2cn3c(-c4cn[nH]c4)cnc3cn2)cc1		CHEMBL1170747	=	Inhibition	%	95.0	CHEMBL2527	Homo sapiens	INH	%	95.0
	3354396	CHEMBL1173988	Inhibition of CHK2 at 10 uM by DELFIA assay	B	OCc1cccc(-c2cn3c(-c4cn[nH]c4)cnc3cn2)c1		CHEMBL1170748	=	Inhibition	%	79.0	CHEMBL2527	Homo sapiens	INH	%	79.0
	3354397	CHEMBL1173988	Inhibition of CHK2 at 10 uM by DELFIA assay	B	OCc1ccc(-c2cn3c(-c4cn[nH]c4)cnc3cn2)cc1		CHEMBL1170749	=	Inhibition	%	57.0	CHEMBL2527	Homo sapiens	INH	%	57.0
	3354398	CHEMBL1173989	Inhibition of CHK2 by DELFIA assay	B	c1ccc(-c2cnc3cnc(-c4cn[nH]c4)cn23)cc1		CHEMBL1172464	=	IC50	nM	6000.0	CHEMBL2527	Homo sapiens	IC50	uM	6.0
	3354399	CHEMBL1173989	Inhibition of CHK2 by DELFIA assay	B	c1n[nH]cc1-c1cnc2ncc(-c3cn[nH]c3)n2c1		CHEMBL1171532	=	IC50	nM	6800.0	CHEMBL2527	Homo sapiens	IC50	uM	6.8
	3354400	CHEMBL1173989	Inhibition of CHK2 by DELFIA assay	B	Cn1cc(-c2cnc3ncc(-c4cn[nH]c4)cn23)cn1		CHEMBL1171533	=	IC50	nM	15000.0	CHEMBL2527	Homo sapiens	IC50	uM	15.0
	3354401	CHEMBL1173989	Inhibition of CHK2 by DELFIA assay	B	c1cc(-c2cnc3ncc(-c4cn[nH]c4)cn23)n[nH]1		CHEMBL1171534	=	IC50	nM	480.0	CHEMBL2527	Homo sapiens	IC50	uM	0.48
	3354402	CHEMBL1173989	Inhibition of CHK2 by DELFIA assay	B	c1ccc2c(-c3cnc4cnc(-c5cn[nH]c5)cn34)c[nH]c2c1		CHEMBL1170126	=	IC50	nM	1300.0	CHEMBL2527	Homo sapiens	IC50	uM	1.3
	3354403	CHEMBL1173989	Inhibition of CHK2 by DELFIA assay	B	NCc1ccc(-c2cn3c(-c4cn[nH]c4)cnc3cn2)cc1		CHEMBL1170747	=	IC50	nM	120.0	CHEMBL2527	Homo sapiens	IC50	uM	0.12
	3354404	CHEMBL1173989	Inhibition of CHK2 by DELFIA assay	B	OCc1cccc(-c2cn3c(-c4cn[nH]c4)cnc3cn2)c1		CHEMBL1170748	=	IC50	nM	1700.0	CHEMBL2527	Homo sapiens	IC50	uM	1.7
	3354405	CHEMBL1173989	Inhibition of CHK2 by DELFIA assay	B	OCc1ccc(-c2cn3c(-c4cn[nH]c4)cnc3cn2)cc1		CHEMBL1170749	=	IC50	nM	2200.0	CHEMBL2527	Homo sapiens	IC50	uM	2.2
	3354931	CHEMBL1173988	Inhibition of CHK2 at 10 uM by DELFIA assay	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Inhibition	%	81.0	CHEMBL2527	Homo sapiens	INH	%	81.0
	3358503	CHEMBL1174175	Inhibition of CHEK2 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cccnc4)c3)cc2C(F)(F)F)CC1		CHEMBL1171523	=	Inhibition	%	40.0	CHEMBL2527	Homo sapiens	INH	%	40.0
	3358945	CHEMBL1174175	Inhibition of CHEK2 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cnc5[nH]ccc5c4)c3)cc2C(F)(F)F)CC1		CHEMBL1170139	=	Inhibition	%	22.0	CHEMBL2527	Homo sapiens	INH	%	22.0
	3400012	CHEMBL1217209	Inhibition of human CHK2 at 10 uM	B	Cc1ccc(Nc2ncc3c(n2)N(C)C(=O)N(c2cc(NC(=O)c4cccc(C(F)(F)F)c4)ccc2C)C3)cn1		CHEMBL1214141	=	Inhibition	%	12.0	CHEMBL2527	Homo sapiens	INH	%	12.0
	3419120	CHEMBL1228788	Inhibition of Chk2 at 100 uM relative to control	B	NC(=O)c1sc2c([N+](=O)[O-])cc(C(F)(F)F)cc2[n+]1[O-]		CHEMBL476124	=	Inhibition	%	97.0	CHEMBL2527	Homo sapiens	INH	%	97.0
Not Active	3420083	CHEMBL1225110	Inhibition of Chk2 phosphorylation at thr68 in human HeLa cells at 5 uM after 3 hrs	B	O=C1NCCc2[nH]c(-c3ccncc3)cc21		CHEMBL225519		Inhibition	%		CHEMBL2527	Homo sapiens	INH		
Not Active	3420084	CHEMBL1225111	Inhibition of Chk2 phosphorylation at thr68 in human HeLa cells at 5 uM after 6 hrs	B	O=C1NCCc2[nH]c(-c3ccncc3)cc21		CHEMBL225519		Inhibition	%		CHEMBL2527	Homo sapiens	INH		
Not Active	3420085	CHEMBL1225112	Inhibition of Chk2 phosphorylation at thr68 in human HeLa cells at 5 uM after 9 hrs	B	O=C1NCCc2[nH]c(-c3ccncc3)cc21		CHEMBL225519		Inhibition	%		CHEMBL2527	Homo sapiens	INH		
Not Active	3420086	CHEMBL1225113	Inhibition of Chk2 phosphorylation at thr68 in human HeLa cells at 5 uM after 24 hrs	B	O=C1NCCc2[nH]c(-c3ccncc3)cc21		CHEMBL225519		Inhibition	%		CHEMBL2527	Homo sapiens	INH		
Not Active	3420087	CHEMBL1225114	Inhibition of Chk2 phosphorylation in human HeLa cells at 5 uM after 3 hrs	B	O=C1NCCc2[nH]c(-c3ccncc3)cc21		CHEMBL225519		Inhibition	%		CHEMBL2527	Homo sapiens	INH		
Not Active	3420088	CHEMBL1225115	Inhibition of Chk2 phosphorylation in human HeLa cells at 5 uM after 6 hrs	B	O=C1NCCc2[nH]c(-c3ccncc3)cc21		CHEMBL225519		Inhibition	%		CHEMBL2527	Homo sapiens	INH		
Not Active	3420089	CHEMBL1225116	Inhibition of Chk2 phosphorylation in human HeLa cells at 5 uM after 9 hrs	B	O=C1NCCc2[nH]c(-c3ccncc3)cc21		CHEMBL225519		Inhibition	%		CHEMBL2527	Homo sapiens	INH		
	3420224	CHEMBL1226918	Inhibition of chk2	B	O=C1NCCc2[nH]c(-c3ccncc3)cc21		CHEMBL225519	=	IC50	nM	1100.0	CHEMBL2527	Homo sapiens	IC50	nM	1100.0
	3425384	CHEMBL1228398	Inhibition of CHK2	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL574737	=	IC50	nM	10.0	CHEMBL2527	Homo sapiens	IC50	nM	10.0
	3445066	CHEMBL1244768	Binding affinity to CHEK2	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	210.0	CHEMBL2527	Homo sapiens	Kd	nM	210.0
	3446150	CHEMBL1244312	Inhibition of CHK2 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cccc(O)c2)c2c(N)ncnc21		CHEMBL1230790	=	Inhibition	%	0.0	CHEMBL2527	Homo sapiens	INH	%	0.0
	3446151	CHEMBL1244312	Inhibition of CHK2 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	Cn1nc(-c2ccc3ccccc3c2)c2c(N)ncnc21		CHEMBL1234815	=	Inhibition	%	7.0	CHEMBL2527	Homo sapiens	INH	%	7.0
	3447537	CHEMBL1249817	Inhibition of His-tagged human CHK2 expressed in Escherichia coli at 1 uM	B	CC[C@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@@H]4O		CHEMBL1242366	=	Inhibition	%	69.0	CHEMBL2527	Homo sapiens	INH	%	69.0
	3448020	CHEMBL1249705	Inhibition of human CHK2 activity at 10 uM by radiometric assay	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Inhibition	%	0.0	CHEMBL2527	Homo sapiens	INH	%	0.0
	3448096	CHEMBL1249705	Inhibition of human CHK2 activity at 10 uM by radiometric assay	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	=	Inhibition	%	17.0	CHEMBL2527	Homo sapiens	INH	%	17.0
	3448379	CHEMBL1244768	Binding affinity to CHEK2	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL2527	Homo sapiens	Kd	uM	10.0
	3448716	CHEMBL1244768	Binding affinity to CHEK2	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL2527	Homo sapiens	Kd	uM	10.0
	3449132	CHEMBL1244768	Binding affinity to CHEK2	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	7.1	CHEMBL2527	Homo sapiens	Kd	nM	7.1
	3449604	CHEMBL1244768	Binding affinity to CHEK2	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL2527	Homo sapiens	Kd	uM	10.0
	3450028	CHEMBL1244768	Binding affinity to CHEK2	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL2527	Homo sapiens	Kd	uM	10.0
	3450945	CHEMBL1244768	Binding affinity to CHEK2	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL1240703	>	Kd	nM	10000.0	CHEMBL2527	Homo sapiens	Kd	uM	10.0
	3502348	CHEMBL1260608	Inhibition of CHK2 at 1 uM	B	Cc1c[nH]c2ncnc(N3CCN(C(=O)[C@H](N)C4Cc5ccccc5C4)CC3)c12		CHEMBL1257283	>	Inhibition	%	90.0	CHEMBL2527	Homo sapiens	INH	%	90.0
	3556540	CHEMBL1285577	Inhibition of CHEK2 at 1 uM	B	CN1C[C@@H]2C[C@H]1CN2c1cc(F)c(-c2ccnc3c(-c4cccc5[nH]ncc45)c(-c4ccncc4)nn23)c(F)c1		CHEMBL1276179	=	Inhibition	%	7.0	CHEMBL2527	Homo sapiens	INH	%	7.0
Active	3564122	CHEMBL1285292	Inhibition of Chk2 at 0.1 uM	B	NC(=O)c1cccc(CNC(=O)c2cc3c(c4c2[nH]c2ccccc24)C(=O)NC3=O)c1		CHEMBL1278026		Inhibition	%		CHEMBL2527	Homo sapiens	INH		
	5120396	CHEMBL1648364	Inhibition of human CHK2 I157T mutant at 10 uM after 60 mins by TR-FRET assay	B	S=c1[nH]nc(-c2ccncc2)n1-c1ccc2ccccc2c1		CHEMBL1644616	=	Inhibition	%	108.0	CHEMBL2527	Homo sapiens	INH	%	108.0
	5120397	CHEMBL1648365	Inhibition of human CHK2 R145W mutant at 10 uM after 60 mins by TR-FRET assay	B	S=c1[nH]nc(-c2ccncc2)n1-c1ccc2ccccc2c1		CHEMBL1644616	=	Inhibition	%	108.0	CHEMBL2527	Homo sapiens	INH	%	108.0
	5120858	CHEMBL1646944	Inhibition of CHEK2 at 10 uM	B	CC(C)(C)c1cc(C(=O)O)c(NC(=O)Nc2ccc3[nH]ncc3c2)s1		CHEMBL1641799	=	Inhibition	%	20.0	CHEMBL2527	Homo sapiens	INH	%	20.0
	5121151	CHEMBL1648203	Inhibition of human CHK2 at 10 uM after 60 mins by TR-FRET assay	B	S=c1[nH]nc(-c2ccncc2)n1-c1ccc2ccccc2c1		CHEMBL1644616	=	Inhibition	%	116.0	CHEMBL2527	Homo sapiens	INH	%	116.0
	5132499	CHEMBL1648519	Inhibition of CHK2 assessed as residual activity at 10 uM	B	CN1CCN(CCC(=O)Nc2ccc3c(C#N)cnc(Nc4cccc(Br)c4)c3c2)CC1		CHEMBL1641992	=	Activity	%	53.0	CHEMBL2527	Homo sapiens	Activity	%	53.0
	5133723	CHEMBL1648519	Inhibition of CHK2 assessed as residual activity at 10 uM	B	CN(C)C/C=C/C(=O)Nc1ccc2c(C#N)cnc(Nc3cccc(Br)c3)c2c1		CHEMBL1641990	=	Activity	%	51.0	CHEMBL2527	Homo sapiens	Activity	%	51.0
	5133818	CHEMBL1648519	Inhibition of CHK2 assessed as residual activity at 10 uM	B	CN(C)CCCC(=O)Nc1ccc2c(C#N)cnc(Nc3cccc(Br)c3)c2c1		CHEMBL1641989	=	Activity	%	56.0	CHEMBL2527	Homo sapiens	Activity	%	56.0
	5140488	CHEMBL1646799	Inhibition of CHEK2 at 1 uM	B	CC(C)(C)c1cc(C(=O)O)c(NC(=O)Nc2ccc3[nH]ncc3c2)s1		CHEMBL1641799	=	Inhibition	%	20.0	CHEMBL2527	Homo sapiens	INH	%	20.0
	5191163	CHEMBL1663817	Inhibition of CHK2 by DELFIA assay	B	CN(C)[C@@H]1CCN(c2nc(-c3ccccc3O)nc3ccccc23)C1		CHEMBL1650094	=	IC50	nM	1500.0	CHEMBL2527	Homo sapiens	IC50	uM	1.5
	5191164	CHEMBL1663817	Inhibition of CHK2 by DELFIA assay	B	CN(C)[C@@H]1CCN(c2nc(-c3cccc(F)c3O)nc3ccccc23)C1		CHEMBL1650095	>	IC50	nM	100000.0	CHEMBL2527	Homo sapiens	IC50	uM	100.0
	5191165	CHEMBL1663817	Inhibition of CHK2 by DELFIA assay	B	CN(C)[C@@H]1CCN(c2nc(-c3ccc(F)cc3O)nc3ccccc23)C1		CHEMBL1650096	=	IC50	nM	1690.0	CHEMBL2527	Homo sapiens	IC50	uM	1.69
	5191166	CHEMBL1663817	Inhibition of CHK2 by DELFIA assay	B	CN(C)[C@@H]1CCN(c2nc(-c3cc(F)ccc3O)nc3ccccc23)C1		CHEMBL1650097	=	IC50	nM	860.0	CHEMBL2527	Homo sapiens	IC50	uM	0.86
	5191167	CHEMBL1663817	Inhibition of CHK2 by DELFIA assay	B	CN(C)[C@@H]1CCN(c2nc(-c3c(O)cccc3F)nc3ccccc23)C1		CHEMBL1650098	=	IC50	nM	5400.0	CHEMBL2527	Homo sapiens	IC50	uM	5.4
	5191168	CHEMBL1663817	Inhibition of CHK2 by DELFIA assay	B	Oc1ccccc1-c1nc(N[C@H]2CCNC2)c2ccccc2n1		CHEMBL1231179	=	IC50	nM	160.0	CHEMBL2527	Homo sapiens	IC50	uM	0.16
	5191169	CHEMBL1663817	Inhibition of CHK2 by DELFIA assay	B	Oc1ccccc1-c1nc(N[C@@H]2CCNC2)c2ccccc2n1		CHEMBL1650099	=	IC50	nM	5100.0	CHEMBL2527	Homo sapiens	IC50	uM	5.1
	5191170	CHEMBL1663817	Inhibition of CHK2 by DELFIA assay	B	Oc1ccccc1-c1nc(N[C@H]2CCCNC2)c2ccccc2n1		CHEMBL1649589	=	IC50	nM	1300.0	CHEMBL2527	Homo sapiens	IC50	uM	1.3
	5191171	CHEMBL1663817	Inhibition of CHK2 by DELFIA assay	B	Oc1ccccc1-c1nc(N[C@@H]2CCCNC2)c2ccccc2n1		CHEMBL1650100	=	IC50	nM	180.0	CHEMBL2527	Homo sapiens	IC50	uM	0.18
	5191172	CHEMBL1663817	Inhibition of CHK2 by DELFIA assay	B	CN1CC[C@H](Nc2nc(-c3ccccc3O)nc3ccccc23)C1		CHEMBL1650101	=	IC50	nM	920.0	CHEMBL2527	Homo sapiens	IC50	uM	0.92
	5191173	CHEMBL1663817	Inhibition of CHK2 by DELFIA assay	B	CN(c1nc(-c2ccccc2O)nc2ccccc12)[C@H]1CCNC1		CHEMBL1650102	=	IC50	nM	500.0	CHEMBL2527	Homo sapiens	IC50	uM	0.5
	5191174	CHEMBL1663817	Inhibition of CHK2 by DELFIA assay	B	Oc1ccccc1-c1nc(NC2CCCCNC2)c2ccccc2n1		CHEMBL1650103	=	IC50	nM	250.0	CHEMBL2527	Homo sapiens	IC50	uM	0.25
	5191175	CHEMBL1663817	Inhibition of CHK2 by DELFIA assay	B	Oc1ccccc1-c1nc(NC2CCCNCC2)c2ccccc2n1		CHEMBL1650104	=	IC50	nM	510.0	CHEMBL2527	Homo sapiens	IC50	uM	0.51
	5191176	CHEMBL1663817	Inhibition of CHK2 by DELFIA assay	B	Oc1ccc(F)cc1-c1nc(N[C@H]2CCNC2)c2ccccc2n1		CHEMBL1650105	=	IC50	nM	60.0	CHEMBL2527	Homo sapiens	IC50	uM	0.06
	5191177	CHEMBL1663817	Inhibition of CHK2 by DELFIA assay	B	Oc1ccc(Cl)cc1-c1nc(N[C@H]2CCNC2)c2ccccc2n1		CHEMBL1650106	=	IC50	nM	70.0	CHEMBL2527	Homo sapiens	IC50	uM	0.07
	5191178	CHEMBL1663817	Inhibition of CHK2 by DELFIA assay	B	Cc1ccc(O)c(-c2nc(N[C@H]3CCNC3)c3ccccc3n2)c1		CHEMBL1650107	=	IC50	nM	92.0	CHEMBL2527	Homo sapiens	IC50	uM	0.092
	5191179	CHEMBL1663817	Inhibition of CHK2 by DELFIA assay	B	CC(C)c1ccc(O)c(-c2nc(N[C@H]3CCNC3)c3ccccc3n2)c1		CHEMBL1650108	=	IC50	nM	1700.0	CHEMBL2527	Homo sapiens	IC50	uM	1.7
	5191180	CHEMBL1663817	Inhibition of CHK2 by DELFIA assay	B	Oc1ccc(C(F)(F)F)cc1-c1nc(N[C@H]2CCNC2)c2ccccc2n1		CHEMBL1650109	=	IC50	nM	201.0	CHEMBL2527	Homo sapiens	IC50	uM	0.201
	5191181	CHEMBL1663817	Inhibition of CHK2 by DELFIA assay	B	Oc1ccc(-c2cn[nH]c2)cc1-c1nc(N[C@H]2CCNC2)c2ccccc2n1		CHEMBL1650110	=	IC50	nM	65.0	CHEMBL2527	Homo sapiens	IC50	uM	0.065
	5191182	CHEMBL1663817	Inhibition of CHK2 by DELFIA assay	B	Oc1ccc(-c2ccn[nH]2)cc1-c1nc(N[C@H]2CCNC2)c2ccccc2n1		CHEMBL1234108	=	IC50	nM	9.0	CHEMBL2527	Homo sapiens	IC50	uM	0.009
	5191183	CHEMBL1663817	Inhibition of CHK2 by DELFIA assay	B	COC(=O)[C@@H]1C[C@H](Nc2nc(-c3ccccc3O)nc3ccccc23)CN1		CHEMBL1650111	=	IC50	nM	4600.0	CHEMBL2527	Homo sapiens	IC50	uM	4.6
	5191184	CHEMBL1663817	Inhibition of CHK2 by DELFIA assay	B	COC(=O)[C@H]1C[C@H](Nc2nc(-c3ccccc3C)nc3ccccc23)CN1		CHEMBL1650112	=	IC50	nM	1050.0	CHEMBL2527	Homo sapiens	IC50	uM	1.05
	5191185	CHEMBL1663817	Inhibition of CHK2 by DELFIA assay	B	CN(C)C(=O)[C@H]1C[C@H](Nc2nc(-c3ccccc3O)nc3ccccc23)CN1		CHEMBL1650113	=	IC50	nM	181.0	CHEMBL2527	Homo sapiens	IC50	uM	0.181
	5191186	CHEMBL1663817	Inhibition of CHK2 by DELFIA assay	B	CC(C)(O)[C@H]1C[C@H](Nc2nc(-c3cc(F)ccc3O)nc3ccccc23)CN1		CHEMBL1650114	=	IC50	nM	460.0	CHEMBL2527	Homo sapiens	IC50	uM	0.46
	5191187	CHEMBL1663817	Inhibition of CHK2 by DELFIA assay	B	OC[C@H]1C[C@H](Nc2nc(-c3cc(F)ccc3O)nc3ccccc23)CN1		CHEMBL1650115	=	IC50	nM	81.0	CHEMBL2527	Homo sapiens	IC50	uM	0.081
	5191188	CHEMBL1663817	Inhibition of CHK2 by DELFIA assay	B	CCOC(=O)[C@H]1CNC[C@@H]1Nc1nc(-c2cc(F)ccc2O)nc2ccccc12		CHEMBL1650116	=	IC50	nM	2850.0	CHEMBL2527	Homo sapiens	IC50	uM	2.85
	5191189	CHEMBL1663817	Inhibition of CHK2 by DELFIA assay	B	CCOC(=O)[C@@H]1CNC[C@H]1Nc1nc(-c2cc(F)ccc2O)nc2ccccc12		CHEMBL1650055	=	IC50	nM	154.0	CHEMBL2527	Homo sapiens	IC50	uM	0.154
	5191190	CHEMBL1663817	Inhibition of CHK2 by DELFIA assay	B	OC[C@@H]1CNC[C@H]1Nc1nc(-c2cc(F)ccc2O)nc2ccccc12		CHEMBL1650056	=	IC50	nM	37.0	CHEMBL2527	Homo sapiens	IC50	uM	0.037
	5191191	CHEMBL1663817	Inhibition of CHK2 by DELFIA assay	B	CC(C)(O)[C@@H]1CNC[C@H]1Nc1nc(-c2cc(F)ccc2O)nc2ccccc12		CHEMBL1650117	=	IC50	nM	21.0	CHEMBL2527	Homo sapiens	IC50	uM	0.021
	5191192	CHEMBL1663817	Inhibition of CHK2 by DELFIA assay	B	COc1ccc2nc(-c3ccccc3O)nc(N[C@H]3CCNC3)c2c1		CHEMBL1650118	=	IC50	nM	200.0	CHEMBL2527	Homo sapiens	IC50	uM	0.2
	5191193	CHEMBL1663817	Inhibition of CHK2 by DELFIA assay	B	COc1ccc2c(N[C@H]3CCNC3)nc(-c3ccccc3O)nc2c1		CHEMBL1650119	=	IC50	nM	29.0	CHEMBL2527	Homo sapiens	IC50	uM	0.029
	5191194	CHEMBL1663817	Inhibition of CHK2 by DELFIA assay	B	COCCOc1ccc2nc(-c3ccccc3O)nc(N[C@H]3CCNC3)c2c1		CHEMBL1650120	=	IC50	nM	280.0	CHEMBL2527	Homo sapiens	IC50	uM	0.28
	5191195	CHEMBL1663817	Inhibition of CHK2 by DELFIA assay	B	COCCOc1ccc2c(N[C@H]3CCNC3)nc(-c3ccccc3O)nc2c1		CHEMBL1650121	=	IC50	nM	70.0	CHEMBL2527	Homo sapiens	IC50	uM	0.07
	5191196	CHEMBL1663817	Inhibition of CHK2 by DELFIA assay	B	OCCCc1ccc2nc(-c3ccccc3O)nc(N[C@H]3CCNC3)c2c1		CHEMBL1650093	=	IC50	nM	600.0	CHEMBL2527	Homo sapiens	IC50	uM	0.6
	5191197	CHEMBL1663817	Inhibition of CHK2 by DELFIA assay	B	OCCCc1ccc2c(N[C@H]3CCNC3)nc(-c3ccccc3O)nc2c1		CHEMBL1650122	=	IC50	nM	78.0	CHEMBL2527	Homo sapiens	IC50	uM	0.078
	5191198	CHEMBL1663817	Inhibition of CHK2 by DELFIA assay	B	COc1cc2nc(-c3ccccc3O)nc(N[C@H]3CCNC3)c2cc1OC		CHEMBL1650123	=	IC50	nM	28.0	CHEMBL2527	Homo sapiens	IC50	uM	0.028
	5191199	CHEMBL1663817	Inhibition of CHK2 by DELFIA assay	B	COCCOc1cc2nc(-c3ccccc3O)nc(N[C@H]3CCNC3)c2cc1OC		CHEMBL1650124	=	IC50	nM	120.0	CHEMBL2527	Homo sapiens	IC50	uM	0.12
	5191200	CHEMBL1663817	Inhibition of CHK2 by DELFIA assay	B	COc1cc2nc(-c3cc(F)ccc3O)nc(N[C@H]3CCNC3)c2cc1OC		CHEMBL1650125	=	IC50	nM	12.0	CHEMBL2527	Homo sapiens	IC50	uM	0.012
	5191201	CHEMBL1663817	Inhibition of CHK2 by DELFIA assay	B	COCCOc1ccc2c(N[C@H]3CCNC3)nc(-c3cc(F)ccc3O)nc2c1		CHEMBL1650126	=	IC50	nM	11.0	CHEMBL2527	Homo sapiens	IC50	uM	0.011
	5191202	CHEMBL1663817	Inhibition of CHK2 by DELFIA assay	B	COCCOc1cc2nc(-c3cc(F)ccc3O)nc(N[C@H]3CCNC3)c2cc1OC		CHEMBL1650127	=	IC50	nM	30.0	CHEMBL2527	Homo sapiens	IC50	uM	0.03
	5191203	CHEMBL1663817	Inhibition of CHK2 by DELFIA assay	B	COCCOc1cc2nc(-c3cc(F)ccc3O)nc(N[C@@H]3CNC[C@H]3C(C)(C)O)c2cc1OC		CHEMBL1650128	=	IC50	nM	5.0	CHEMBL2527	Homo sapiens	IC50	uM	0.005
	5191204	CHEMBL1663817	Inhibition of CHK2 by DELFIA assay	B	COc1cc2nc(-c3cc(F)ccc3O)nc(N[C@@H]3CNC[C@H]3C(C)(C)O)c2cc1OC		CHEMBL1236782	=	IC50	nM	3.0	CHEMBL2527	Homo sapiens	IC50	uM	0.003
	5191205	CHEMBL1663817	Inhibition of CHK2 by DELFIA assay	B	COc1cc2nc(-c3cc(F)ccc3O)nc(N[C@@H]3CNC[C@H]3CO)c2cc1OC		CHEMBL1650129	=	IC50	nM	11.0	CHEMBL2527	Homo sapiens	IC50	uM	0.011
	5191206	CHEMBL1663817	Inhibition of CHK2 by DELFIA assay	B	CC(C)(O)[C@@H]1CNC[C@H]1Nc1nc(-c2cc(-c3cn[nH]c3)ccc2O)nc2ccccc12		CHEMBL1650130	=	IC50	nM	14.0	CHEMBL2527	Homo sapiens	IC50	uM	0.014
	5191207	CHEMBL1663817	Inhibition of CHK2 by DELFIA assay	B	CC(C)(O)[C@@H]1CNC[C@H]1Nc1nc(-c2cc(-c3cc[nH]n3)ccc2O)nc2ccccc12		CHEMBL1650131	=	IC50	nM	8.0	CHEMBL2527	Homo sapiens	IC50	uM	0.008
Active	5191307	CHEMBL1663815	Inhibition of CHK2 phosphorylation at Thr68 in human HT-29 cells at 1 uM by gel electrophoresis	B	COc1cc2nc(-c3cc(F)ccc3O)nc(N[C@@H]3CNC[C@H]3C(C)(C)O)c2cc1OC		CHEMBL1236782		Activity			CHEMBL2527	Homo sapiens	Activity		
Active	5191308	CHEMBL1663816	Inhibition of CHK2 phosphorylation at Ser516 in human HT-29 cells at 1 uM by gel electrophoresis	B	COc1cc2nc(-c3cc(F)ccc3O)nc(N[C@@H]3CNC[C@H]3C(C)(C)O)c2cc1OC		CHEMBL1236782		Activity			CHEMBL2527	Homo sapiens	Activity		
Not Determined	5191309	CHEMBL1663814	Inhibition of etoposide-induced CHK2 bandshift in human HT-29 cells by gel electrophoresis	B	Oc1ccccc1-c1nc(N[C@H]2CCNC2)c2ccccc2n1		CHEMBL1231179		MEC			CHEMBL2527	Homo sapiens	MEC		
	5191310	CHEMBL1663814	Inhibition of etoposide-induced CHK2 bandshift in human HT-29 cells by gel electrophoresis	B	Oc1ccc(F)cc1-c1nc(N[C@H]2CCNC2)c2ccccc2n1		CHEMBL1650105	=	MEC	uM	10.0	CHEMBL2527	Homo sapiens	MEC	uM	10.0
	5191311	CHEMBL1663814	Inhibition of etoposide-induced CHK2 bandshift in human HT-29 cells by gel electrophoresis	B	Oc1ccc(-c2ccn[nH]2)cc1-c1nc(N[C@H]2CCNC2)c2ccccc2n1		CHEMBL1234108	=	MEC	uM	1.0	CHEMBL2527	Homo sapiens	MEC	uM	1.0
	5191312	CHEMBL1663814	Inhibition of etoposide-induced CHK2 bandshift in human HT-29 cells by gel electrophoresis	B	COCCOc1ccc2c(N[C@H]3CCNC3)nc(-c3cc(F)ccc3O)nc2c1		CHEMBL1650126	=	MEC	uM	5.0	CHEMBL2527	Homo sapiens	MEC	uM	5.0
	5191313	CHEMBL1663814	Inhibition of etoposide-induced CHK2 bandshift in human HT-29 cells by gel electrophoresis	B	COc1cc2nc(-c3cc(F)ccc3O)nc(N[C@@H]3CNC[C@H]3C(C)(C)O)c2cc1OC		CHEMBL1236782	=	MEC	uM	1.0	CHEMBL2527	Homo sapiens	MEC	uM	1.0
	5191314	CHEMBL1663814	Inhibition of etoposide-induced CHK2 bandshift in human HT-29 cells by gel electrophoresis	B	CC(C)(O)[C@@H]1CNC[C@H]1Nc1nc(-c2cc(-c3cc[nH]n3)ccc2O)nc2ccccc12		CHEMBL1650131	=	MEC	uM	10.0	CHEMBL2527	Homo sapiens	MEC	uM	10.0
	5191393	CHEMBL1664053	Inhibition of CHK2 at 1 uM	B	COc1cc2nc(-c3cc(F)ccc3O)nc(N[C@@H]3CNC[C@H]3C(C)(C)O)c2cc1OC		CHEMBL1236782	=	Inhibition	%	96.0	CHEMBL2527	Homo sapiens	INH	%	96.0
	5191394	CHEMBL1664053	Inhibition of CHK2 at 1 uM	B	CC(C)(O)[C@@H]1CNC[C@H]1Nc1nc(-c2cc(-c3cc[nH]n3)ccc2O)nc2ccccc12		CHEMBL1650131	=	Inhibition	%	97.0	CHEMBL2527	Homo sapiens	INH	%	97.0
	6161282	CHEMBL1764344	Inhibition of human CHK2 kinase expressed in insect Sf21 cells using phospho-CREBtide as substrate at 30 uM	B	O=C(N/N=C/c1ccc([N+](=O)[O-])cc1)c1ccc2ccccc2c1		CHEMBL1760505	=	Inhibition	%	0.0	CHEMBL2527	Homo sapiens	INH	%	0.0
	6161283	CHEMBL1764344	Inhibition of human CHK2 kinase expressed in insect Sf21 cells using phospho-CREBtide as substrate at 30 uM	B	O=C(O)c1ccc(/C=N/NC(=O)c2ccc3ccccc3c2)cc1		CHEMBL1760506	=	Inhibition	%	0.0	CHEMBL2527	Homo sapiens	INH	%	0.0
	6161284	CHEMBL1764344	Inhibition of human CHK2 kinase expressed in insect Sf21 cells using phospho-CREBtide as substrate at 30 uM	B	COC(=O)c1ccc(/C=N/NC(=O)c2ccc3ccccc3c2)cc1		CHEMBL1760507	=	Inhibition	%	0.0	CHEMBL2527	Homo sapiens	INH	%	0.0
	6161285	CHEMBL1764344	Inhibition of human CHK2 kinase expressed in insect Sf21 cells using phospho-CREBtide as substrate at 30 uM	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	27.0	CHEMBL2527	Homo sapiens	IC50	uM	0.027
	6169200	CHEMBL1768978	Inhibition of human CHK2 assessed as residual activity at 10 uM	B	CNc1nc(-c2ccc3c(N)n[nH]c3c2)cc(N2C[C@@H](C(=O)NC3CCCCC3)CC[C@H]2C)n1		CHEMBL1765740	=	Activity	%	29.0	CHEMBL2527	Homo sapiens	Activity	%	29.0
	6202281	CHEMBL1780661	Inhibition of CHK2 at 1 uM	B	O=C1NCCc2[nH]c(-c3ccnc(-c4ccccc4F)c3)cc21		CHEMBL226471	>=	Inhibition	%	80.0	CHEMBL2527	Homo sapiens	INH	%	80.0
	6202282	CHEMBL1780661	Inhibition of CHK2 at 1 uM	B	O=C1NCC2(CCNCC2)c2[nH]c(-c3ccnc(-c4ccc5c(c4)OCO5)n3)cc21		CHEMBL1738702	>=	Inhibition	%	80.0	CHEMBL2527	Homo sapiens	INH	%	80.0
	6202283	CHEMBL1780661	Inhibition of CHK2 at 1 uM	B	O=C1NCC2(CCOCC2)c2[nH]c(-c3ccnc(-c4ccc5c(c4)OCO5)n3)cc21		CHEMBL1779351	>=	Inhibition	%	80.0	CHEMBL2527	Homo sapiens	INH	%	80.0
	6202284	CHEMBL1780661	Inhibition of CHK2 at 1 uM	B	O=C1NCC2(CCNCC2)c2[nH]c(-c3ccnc(-c4cc5ccccc5o4)n3)cc21		CHEMBL1779352	>=	Inhibition	%	80.0	CHEMBL2527	Homo sapiens	INH	%	80.0
	6202285	CHEMBL1780661	Inhibition of CHK2 at 1 uM	B	CN1CCC2(CC1)CNC(=O)c1cc(-c3ccnc(-c4cc5ccccc5o4)n3)[nH]c12		CHEMBL1779353	>=	Inhibition	%	80.0	CHEMBL2527	Homo sapiens	INH	%	80.0
	6202286	CHEMBL1780661	Inhibition of CHK2 at 1 uM	B	CCN1CCC2(CC1)CNC(=O)c1cc(-c3ccnc(-c4cc5ccccc5o4)n3)[nH]c12		CHEMBL1779354	>=	Inhibition	%	80.0	CHEMBL2527	Homo sapiens	INH	%	80.0
	6202287	CHEMBL1780661	Inhibition of CHK2 at 1 uM	B	CC(=O)c1cccc(-c2nccc(-c3cc4c([nH]3)C3(CCNCC3)CNC4=O)n2)c1		CHEMBL1779355	>=	Inhibition	%	80.0	CHEMBL2527	Homo sapiens	INH	%	80.0
	6202288	CHEMBL1780661	Inhibition of CHK2 at 1 uM	B	CC(=O)c1ccc(-c2nccc(-c3cc4c([nH]3)C3(CCNCC3)CNC4=O)n2)cc1		CHEMBL1779346	>=	Inhibition	%	80.0	CHEMBL2527	Homo sapiens	INH	%	80.0
	6202289	CHEMBL1780661	Inhibition of CHK2 at 1 uM	B	O=C1NCC2(CCNCC2)c2[nH]c(-c3ccnc(-c4ccc5c(c4)OCCCO5)n3)cc21		CHEMBL1779347	>=	Inhibition	%	80.0	CHEMBL2527	Homo sapiens	INH	%	80.0
	6202290	CHEMBL1780661	Inhibition of CHK2 at 1 uM	B	CC(C)c1cccc(-c2nccc(-c3cc4c([nH]3)C3(CCNCC3)CNC4=O)n2)c1		CHEMBL1779348	>=	Inhibition	%	80.0	CHEMBL2527	Homo sapiens	INH	%	80.0
	6202291	CHEMBL1780661	Inhibition of CHK2 at 1 uM	B	O=C1NCC2(CCNCC2)c2[nH]c(-c3ccnc(-c4ccccc4F)n3)cc21		CHEMBL1779349	>=	Inhibition	%	80.0	CHEMBL2527	Homo sapiens	INH	%	80.0
	6202292	CHEMBL1780661	Inhibition of CHK2 at 1 uM	B	O=C1NCC2(CCNCC2)c2[nH]c(-c3ccnc(-c4cccc(F)c4)n3)cc21		CHEMBL1779350	>=	Inhibition	%	80.0	CHEMBL2527	Homo sapiens	INH	%	80.0
	6202293	CHEMBL1780661	Inhibition of CHK2 at 1 uM	B	O=C1NCC2(CCNCC2)c2[nH]c(-c3ccnc(-c4cccc(C(F)(F)F)c4)n3)cc21		CHEMBL1779356	>=	Inhibition	%	80.0	CHEMBL2527	Homo sapiens	INH	%	80.0
	6202294	CHEMBL1780661	Inhibition of CHK2 at 1 uM	B	O=C1NCC2(CCNCC2)c2[nH]c(-c3ccnc(-c4ccc(C(F)(F)F)cc4)n3)cc21		CHEMBL1779357	>=	Inhibition	%	80.0	CHEMBL2527	Homo sapiens	INH	%	80.0
	6202295	CHEMBL1780661	Inhibition of CHK2 at 1 uM	B	CC(C)(C)c1ccc(-c2nccc(-c3cc4c([nH]3)C3(CCNCC3)CNC4=O)n2)cc1		CHEMBL1779358	>=	Inhibition	%	80.0	CHEMBL2527	Homo sapiens	INH	%	80.0
	6202296	CHEMBL1780661	Inhibition of CHK2 at 1 uM	B	O=C1NCC2(CCNCC2)c2[nH]c(-c3ccnc(-c4ccc5ccccc5c4)n3)cc21		CHEMBL1779359	>=	Inhibition	%	80.0	CHEMBL2527	Homo sapiens	INH	%	80.0
	6202297	CHEMBL1780661	Inhibition of CHK2 at 1 uM	B	O=C1NCC2(CCNCC2)c2[nH]c(-c3ccnc(-c4cc(Cl)cc(Cl)c4)n3)cc21		CHEMBL1779360	>=	Inhibition	%	80.0	CHEMBL2527	Homo sapiens	INH	%	80.0
	6202298	CHEMBL1780661	Inhibition of CHK2 at 1 uM	B	O=C1NCC2(CCNCC2)c2[nH]c(-c3ccnc(-c4cnc5ccccc5c4)n3)cc21		CHEMBL1779361	>=	Inhibition	%	80.0	CHEMBL2527	Homo sapiens	INH	%	80.0
	6202299	CHEMBL1780661	Inhibition of CHK2 at 1 uM	B	O=C1NCC2(CCNCC2)c2[nH]c(-c3ccnc(-c4cccnc4)n3)cc21		CHEMBL1779362	>=	Inhibition	%	80.0	CHEMBL2527	Homo sapiens	INH	%	80.0
	6202300	CHEMBL1780661	Inhibition of CHK2 at 1 uM	B	COc1cncc(-c2nccc(-c3cc4c([nH]3)C3(CCNCC3)CNC4=O)n2)c1		CHEMBL1779363	>=	Inhibition	%	80.0	CHEMBL2527	Homo sapiens	INH	%	80.0
	6202301	CHEMBL1780661	Inhibition of CHK2 at 1 uM	B	Nc1ccc(-c2nccc(-c3cc4c([nH]3)C3(CCNCC3)CNC4=O)n2)cn1		CHEMBL1779364	>=	Inhibition	%	80.0	CHEMBL2527	Homo sapiens	INH	%	80.0
	6202302	CHEMBL1780661	Inhibition of CHK2 at 1 uM	B	CCC(=O)Nc1ccc(-c2nccc(-c3cc4c([nH]3)C3(CCNCC3)CNC4=O)n2)cn1		CHEMBL1779365	>=	Inhibition	%	80.0	CHEMBL2527	Homo sapiens	INH	%	80.0
	6202303	CHEMBL1780661	Inhibition of CHK2 at 1 uM	B	Nc1ncc(-c2nccc(-c3cc4c([nH]3)C3(CCNCC3)CNC4=O)n2)cn1		CHEMBL1779366	>=	Inhibition	%	80.0	CHEMBL2527	Homo sapiens	INH	%	80.0
	6202304	CHEMBL1780661	Inhibition of CHK2 at 1 uM	B	O=C1NCC2(CCNCC2)c2[nH]c(-c3ccnc(-c4cnc(NC5CCCC5)nc4)n3)cc21		CHEMBL1779367	>=	Inhibition	%	80.0	CHEMBL2527	Homo sapiens	INH	%	80.0
	6202305	CHEMBL1780661	Inhibition of CHK2 at 1 uM	B	O=C1NCC2(CCCNC2)c2[nH]c(-c3ccnc(-c4cc5ccccc5o4)n3)cc21		CHEMBL1779368	>=	Inhibition	%	80.0	CHEMBL2527	Homo sapiens	INH	%	80.0
	6202306	CHEMBL1780661	Inhibition of CHK2 at 1 uM	B	O=C1NCC2(CCCNC2)c2[nH]c(-c3ccnc(-c4ccc5c(c4)OCO5)n3)cc21		CHEMBL1779369	>=	Inhibition	%	80.0	CHEMBL2527	Homo sapiens	INH	%	80.0
	6202307	CHEMBL1780661	Inhibition of CHK2 at 1 uM	B	COc1cncc(-c2nccc(-c3cc4c([nH]3)C3(CCCNC3)CNC4=O)n2)c1		CHEMBL1779370	>=	Inhibition	%	80.0	CHEMBL2527	Homo sapiens	INH	%	80.0
	6202308	CHEMBL1780661	Inhibition of CHK2 at 1 uM	B	COCCCOc1ccc(-c2nccc(-c3cc4c([nH]3)C3(CCCNC3)CNC4=O)n2)cn1		CHEMBL1779371	>=	Inhibition	%	80.0	CHEMBL2527	Homo sapiens	INH	%	80.0
	6202309	CHEMBL1780661	Inhibition of CHK2 at 1 uM	B	O=C1NC[C@@]2(CCCNC2)c2[nH]c(-c3ccnc(-c4ccc5c(c4)OCO5)n3)cc21		CHEMBL1779372	>=	Inhibition	%	80.0	CHEMBL2527	Homo sapiens	INH	%	80.0
	6202310	CHEMBL1780661	Inhibition of CHK2 at 1 uM	B	O=C1NC[C@]2(CCCNC2)c2[nH]c(-c3ccnc(-c4ccc5c(c4)OCO5)n3)cc21		CHEMBL1779373	>=	Inhibition	%	80.0	CHEMBL2527	Homo sapiens	INH	%	80.0
	6202311	CHEMBL1780661	Inhibition of CHK2 at 1 uM	B	COc1cncc(-c2nccc(-c3cc4c([nH]3)[C@]3(CCCNC3)CNC4=O)n2)c1		CHEMBL1779374	>=	Inhibition	%	80.0	CHEMBL2527	Homo sapiens	INH	%	80.0
	6202312	CHEMBL1780661	Inhibition of CHK2 at 1 uM	B	COc1cncc(-c2nccc(-c3cc4c([nH]3)[C@@]3(CCCNC3)CNC4=O)n2)c1		CHEMBL1779375	>=	Inhibition	%	80.0	CHEMBL2527	Homo sapiens	INH	%	80.0
	6202313	CHEMBL1780661	Inhibition of CHK2 at 1 uM	B	COCCCOc1ccc(-c2nccc(-c3cc4c([nH]3)[C@]3(CCCNC3)CNC4=O)n2)cn1		CHEMBL1779485	>=	Inhibition	%	80.0	CHEMBL2527	Homo sapiens	INH	%	80.0
	6202314	CHEMBL1780661	Inhibition of CHK2 at 1 uM	B	COCCCOc1ccc(-c2nccc(-c3cc4c([nH]3)[C@@]3(CCCNC3)CNC4=O)n2)cn1		CHEMBL1779486	>=	Inhibition	%	80.0	CHEMBL2527	Homo sapiens	INH	%	80.0
	6202315	CHEMBL1780661	Inhibition of CHK2 at 1 uM	B	O=C1NCC2(CCCNC2)c2[nH]c(-c3ccnc(-c4cccnc4)n3)cc21		CHEMBL1779487	>=	Inhibition	%	80.0	CHEMBL2527	Homo sapiens	INH	%	80.0
	6202316	CHEMBL1780661	Inhibition of CHK2 at 1 uM	B	O=C1NC[C@@]2(CCCNC2)c2[nH]c(-c3ccnc(-c4cccnc4)n3)cc21		CHEMBL1779488	>=	Inhibition	%	80.0	CHEMBL2527	Homo sapiens	INH	%	80.0
	6202317	CHEMBL1780661	Inhibition of CHK2 at 1 uM	B	O=C1NC[C@]2(CCCNC2)c2[nH]c(-c3ccnc(-c4cccnc4)n3)cc21		CHEMBL1779489	>=	Inhibition	%	80.0	CHEMBL2527	Homo sapiens	INH	%	80.0
	6231474	CHEMBL1787308	Inhibition of Chk2	B	O=C(c1ccco1)N1N=C(c2cccnc2)CC1c1ccccc1O		CHEMBL1779593	>	IC50	nM	10000.0	CHEMBL2527	Homo sapiens	IC50	uM	10.0
	6262759	CHEMBL1798631	Inhibition of CHK2	B	Cc1ccc(C(=O)NCCO)cc1-n1cnc(OCc2ccc(F)cc2F)c(Cl)c1=O		CHEMBL1738710	>	IC50	nM	10000.0	CHEMBL2527	Homo sapiens	IC50	uM	10.0
	6273841	CHEMBL1806154	Inhibition of CHK2 assessed as residual enzyme activity at 10 uM	B	CC(C)c1cnn2c(NCc3ccccc3)cc(N[C@@H](CO)[C@H](O)CO)nc12		CHEMBL1234833	=	Activity	%	61.0	CHEMBL2527	Homo sapiens	Activity	%	61.0
	6316376	CHEMBL1815729	Inhibition of CHK2 at 30 uM by microfluidic mobility shift assay	B	Cc1cc2[nH]nc(N)c2c(=O)[nH]1		CHEMBL1813604	=	Inhibition	%	27.0	CHEMBL2527	Homo sapiens	INH	%	27.0
	6316377	CHEMBL1815729	Inhibition of CHK2 at 30 uM by microfluidic mobility shift assay	B	Nc1n[nH]c2cc(-c3cccnc3)[nH]c(=O)c12		CHEMBL1813606	=	Inhibition	%	27.0	CHEMBL2527	Homo sapiens	INH	%	27.0
	6316378	CHEMBL1815729	Inhibition of CHK2 at 30 uM by microfluidic mobility shift assay	B	Nc1n[nH]c2cc(-c3ccccn3)[nH]c(=O)c12		CHEMBL1813607	=	Inhibition	%	47.0	CHEMBL2527	Homo sapiens	INH	%	47.0
	6316379	CHEMBL1815729	Inhibition of CHK2 at 30 uM by microfluidic mobility shift assay	B	Nc1n[nH]c2cc(-c3ccncc3)[nH]c(=O)c12		CHEMBL1813608	=	Inhibition	%	34.0	CHEMBL2527	Homo sapiens	INH	%	34.0
	6316380	CHEMBL1815729	Inhibition of CHK2 at 30 uM by microfluidic mobility shift assay	B	COc1cccc(-c2cc3[nH]nc(N)c3c(=O)[nH]2)c1		CHEMBL1813609	=	Inhibition	%	52.0	CHEMBL2527	Homo sapiens	INH	%	52.0
	6316381	CHEMBL1815729	Inhibition of CHK2 at 30 uM by microfluidic mobility shift assay	B	COc1ccc(-c2cc3[nH]nc(N)c3c(=O)[nH]2)cc1		CHEMBL1813610	=	Inhibition	%	43.0	CHEMBL2527	Homo sapiens	INH	%	43.0
	6316382	CHEMBL1815729	Inhibition of CHK2 at 30 uM by microfluidic mobility shift assay	B	CN1CCN(c2ccc(-c3cc4[nH]nc(N)c4c(=O)[nH]3)cc2)CC1		CHEMBL1813611	=	Inhibition	%	68.0	CHEMBL2527	Homo sapiens	INH	%	68.0
	6316383	CHEMBL1815729	Inhibition of CHK2 at 30 uM by microfluidic mobility shift assay	B	Nc1n[nH]c2cc(-c3cccs3)[nH]c(=O)c12		CHEMBL1813612	=	Inhibition	%	59.0	CHEMBL2527	Homo sapiens	INH	%	59.0
	6316384	CHEMBL1815729	Inhibition of CHK2 at 30 uM by microfluidic mobility shift assay	B	CC(C)(C)c1cc2[nH]nc(N)c2c(=O)[nH]1		CHEMBL1813613	=	Inhibition	%	21.0	CHEMBL2527	Homo sapiens	INH	%	21.0
	6316385	CHEMBL1815729	Inhibition of CHK2 at 30 uM by microfluidic mobility shift assay	B	Nc1n[nH]c2cc(-c3ccc(N4CCOCC4)cc3)[nH]c(=O)c12		CHEMBL1813614	=	Inhibition	%	38.0	CHEMBL2527	Homo sapiens	INH	%	38.0
	6316386	CHEMBL1815729	Inhibition of CHK2 at 30 uM by microfluidic mobility shift assay	B	Nc1n[nH]c2cc(CC3CCNCC3)[nH]c(=O)c12		CHEMBL1813615	=	Inhibition	%	7.0	CHEMBL2527	Homo sapiens	INH	%	7.0
	6316387	CHEMBL1815729	Inhibition of CHK2 at 30 uM by microfluidic mobility shift assay	B	Nc1n[nH]c2c3c([nH]c(=O)c12)CCCC3		CHEMBL1813617	=	Inhibition	%	7.0	CHEMBL2527	Homo sapiens	INH	%	7.0
	6316388	CHEMBL1815729	Inhibition of CHK2 at 30 uM by microfluidic mobility shift assay	B	Cc1cc2[nH]nc(N)c2c(N2CCCCC2)n1		CHEMBL1813618	=	Inhibition	%	33.0	CHEMBL2527	Homo sapiens	INH	%	33.0
	6316389	CHEMBL1815729	Inhibition of CHK2 at 30 uM by microfluidic mobility shift assay	B	Cc1cc2[nH]nc(N)c2c(N2CCOCC2)n1		CHEMBL1813619	=	Inhibition	%	23.0	CHEMBL2527	Homo sapiens	INH	%	23.0
	6316390	CHEMBL1815729	Inhibition of CHK2 at 30 uM by microfluidic mobility shift assay	B	Cc1cc2c(c(N)nn2C)c(=O)[nH]1		CHEMBL1813620	=	Inhibition	%	3.0	CHEMBL2527	Homo sapiens	INH	%	3.0
	6316391	CHEMBL1815729	Inhibition of CHK2 at 30 uM by microfluidic mobility shift assay	B	Cn1nc(N)c2c(=O)[nH]c(-c3ccccc3)cc21		CHEMBL1813621	=	Inhibition	%	16.0	CHEMBL2527	Homo sapiens	INH	%	16.0
	6316392	CHEMBL1815729	Inhibition of CHK2 at 30 uM by microfluidic mobility shift assay	B	Cn1nc(N)c2c(=O)[nH]c(-c3ccccn3)cc21		CHEMBL1813622	=	Inhibition	%	25.0	CHEMBL2527	Homo sapiens	INH	%	25.0
	6316393	CHEMBL1815729	Inhibition of CHK2 at 30 uM by microfluidic mobility shift assay	B	COc1ccc(-c2cc3c(c(N)nn3C)c(=O)[nH]2)cc1		CHEMBL1813623	=	Inhibition	%	16.0	CHEMBL2527	Homo sapiens	INH	%	16.0
	6316394	CHEMBL1815729	Inhibition of CHK2 at 30 uM by microfluidic mobility shift assay	B	COc1cccc(-c2cc3c(c(N)nn3C)c(=O)[nH]2)c1		CHEMBL1813624	=	Inhibition	%	31.0	CHEMBL2527	Homo sapiens	INH	%	31.0
	6316395	CHEMBL1815729	Inhibition of CHK2 at 30 uM by microfluidic mobility shift assay	B	CN1CCN(c2ccc(-c3cc4c(c(N)nn4C)c(=O)[nH]3)cc2)CC1		CHEMBL1813625	=	Inhibition	%	53.0	CHEMBL2527	Homo sapiens	INH	%	53.0
	6316396	CHEMBL1815729	Inhibition of CHK2 at 30 uM by microfluidic mobility shift assay	B	COC(=O)CCc1c(C)[nH]c(=O)c2c(N)nn(C)c12		CHEMBL1813627	=	Inhibition	%	-1.0	CHEMBL2527	Homo sapiens	INH	%	-1.0
	6316397	CHEMBL1815729	Inhibition of CHK2 at 30 uM by microfluidic mobility shift assay	B	COc1ccc(-c2c(C)[nH]c(=O)c3c(N)nn(C)c23)cc1		CHEMBL1813628	=	Inhibition	%	18.0	CHEMBL2527	Homo sapiens	INH	%	18.0
	6316398	CHEMBL1815729	Inhibition of CHK2 at 30 uM by microfluidic mobility shift assay	B	Cc1cc2c(c(NC(=O)Nc3ccccc3)nn2C)c(=O)[nH]1		CHEMBL1813630	=	Inhibition	%	2.0	CHEMBL2527	Homo sapiens	INH	%	2.0
	6316399	CHEMBL1815729	Inhibition of CHK2 at 30 uM by microfluidic mobility shift assay	B	CC(=O)Nc1nn(C)c2cc(-c3ccccc3)[nH]c(=O)c12		CHEMBL1813777	=	Inhibition	%	4.0	CHEMBL2527	Homo sapiens	INH	%	4.0
	6316400	CHEMBL1815729	Inhibition of CHK2 at 30 uM by microfluidic mobility shift assay	B	Cc1cc2c(c(NS(C)(=O)=O)nn2C)c(=O)[nH]1		CHEMBL1813778	=	Inhibition	%	-1.0	CHEMBL2527	Homo sapiens	INH	%	-1.0
	6316401	CHEMBL1815729	Inhibition of CHK2 at 30 uM by microfluidic mobility shift assay	B	COc1ccc(S(=O)(=O)Nc2nn(C)c3cc(C)[nH]c(=O)c23)c(OC)c1		CHEMBL1813779	=	Inhibition	%	6.0	CHEMBL2527	Homo sapiens	INH	%	6.0
	6316402	CHEMBL1815729	Inhibition of CHK2 at 30 uM by microfluidic mobility shift assay	B	CC(=O)Nc1nn(C)c2cc(-c3ccc(N4CCN(C)CC4)cc3)[nH]c(=O)c12		CHEMBL1813780	=	Inhibition	%	3.0	CHEMBL2527	Homo sapiens	INH	%	3.0
	6316403	CHEMBL1815729	Inhibition of CHK2 at 30 uM by microfluidic mobility shift assay	B	Cc1cc2c(c(N)nn2C)c(N2CCCCC2)n1		CHEMBL1813781	=	Inhibition	%	4.0	CHEMBL2527	Homo sapiens	INH	%	4.0
	6316404	CHEMBL1815729	Inhibition of CHK2 at 30 uM by microfluidic mobility shift assay	B	Cc1cc2c(c(N)nn2C)c(N2CCOCC2)n1		CHEMBL1813782	=	Inhibition	%	3.0	CHEMBL2527	Homo sapiens	INH	%	3.0
	6316405	CHEMBL1815729	Inhibition of CHK2 at 30 uM by microfluidic mobility shift assay	B	Cc1cc2c(c(N)nn2C)c(N2CC[C@H](O)C2)n1		CHEMBL1813784	=	Inhibition	%	-2.0	CHEMBL2527	Homo sapiens	INH	%	-2.0
	6316406	CHEMBL1815729	Inhibition of CHK2 at 30 uM by microfluidic mobility shift assay	B	COCCNc1nc(C)cc2c1c(N)nn2C		CHEMBL1813785	=	Inhibition	%	-2.0	CHEMBL2527	Homo sapiens	INH	%	-2.0
	6316407	CHEMBL1815729	Inhibition of CHK2 at 30 uM by microfluidic mobility shift assay	B	COCCNc1nc(-c2ccccc2)cc2c1c(N)nn2C		CHEMBL1813786	=	Inhibition	%	8.0	CHEMBL2527	Homo sapiens	INH	%	8.0
	6316408	CHEMBL1815729	Inhibition of CHK2 at 30 uM by microfluidic mobility shift assay	B	COCCNc1nc(C)cc2nn(-c3ccccc3)c(N)c12		CHEMBL1813787	=	Inhibition	%	4.0	CHEMBL2527	Homo sapiens	INH	%	4.0
	6316409	CHEMBL1815729	Inhibition of CHK2 at 30 uM by microfluidic mobility shift assay	B	Cc1cc2nn(-c3ccccc3)c(N)c2c(=O)[nH]1		CHEMBL1813788	=	Inhibition	%	-4.0	CHEMBL2527	Homo sapiens	INH	%	-4.0
	6316410	CHEMBL1815729	Inhibition of CHK2 at 30 uM by microfluidic mobility shift assay	B	CC(C)(C)c1cc2nn(-c3ccccc3)c(N)c2c(=O)[nH]1		CHEMBL1813789	=	Inhibition	%	5.0	CHEMBL2527	Homo sapiens	INH	%	5.0
	6316411	CHEMBL1815729	Inhibition of CHK2 at 30 uM by microfluidic mobility shift assay	B	Nc1c2c(=O)[nH]c(-c3ccccc3)cc2nn1-c1ccccc1		CHEMBL1813790	=	Inhibition	%	-8.0	CHEMBL2527	Homo sapiens	INH	%	-8.0
	6316412	CHEMBL1815729	Inhibition of CHK2 at 30 uM by microfluidic mobility shift assay	B	Nc1c2c(=O)[nH]c(-c3ccccn3)cc2nn1-c1ccccc1		CHEMBL1813791	=	Inhibition	%	3.0	CHEMBL2527	Homo sapiens	INH	%	3.0
	6316413	CHEMBL1815729	Inhibition of CHK2 at 30 uM by microfluidic mobility shift assay	B	COc1ccccc1-c1cc2nn(-c3ccccc3)c(N)c2c(=O)[nH]1		CHEMBL1813792	=	Inhibition	%	16.0	CHEMBL2527	Homo sapiens	INH	%	16.0
	6316414	CHEMBL1815729	Inhibition of CHK2 at 30 uM by microfluidic mobility shift assay	B	COc1ccc(-c2cc3nn(-c4ccccc4)c(N)c3c(=O)[nH]2)cc1		CHEMBL1813793	=	Inhibition	%	-3.0	CHEMBL2527	Homo sapiens	INH	%	-3.0
	6316415	CHEMBL1815729	Inhibition of CHK2 at 30 uM by microfluidic mobility shift assay	B	CN1CCN(c2ccc(-c3cc4nn(-c5ccccc5)c(N)c4c(=O)[nH]3)cc2)CC1		CHEMBL1813795	=	Inhibition	%	18.0	CHEMBL2527	Homo sapiens	INH	%	18.0
	6316416	CHEMBL1815729	Inhibition of CHK2 at 30 uM by microfluidic mobility shift assay	B	Nc1c2c(=O)[nH]c(-c3ccccc3)cc2nn1-c1ccccn1		CHEMBL1813796	=	Inhibition	%	18.0	CHEMBL2527	Homo sapiens	INH	%	18.0
	6316417	CHEMBL1815729	Inhibition of CHK2 at 30 uM by microfluidic mobility shift assay	B	Cc1cc2nn(-c3ccccc3)c(N)c2c(N2CCCCC2)n1		CHEMBL1813797	=	Inhibition	%	4.0	CHEMBL2527	Homo sapiens	INH	%	4.0
	6316418	CHEMBL1815729	Inhibition of CHK2 at 30 uM by microfluidic mobility shift assay	B	Cc1[nH]c(=O)c2c(N)n(-c3ccccc3)nc2c1-c1ccccc1		CHEMBL1813798	=	Inhibition	%	-1.0	CHEMBL2527	Homo sapiens	INH	%	-1.0
	6316419	CHEMBL1815729	Inhibition of CHK2 at 30 uM by microfluidic mobility shift assay	B	Cn1nc2c3c(nc(-c4ccccc4)cc31)NCC(=O)N2		CHEMBL1813799	=	Inhibition	%	5.0	CHEMBL2527	Homo sapiens	INH	%	5.0
	6316420	CHEMBL1815729	Inhibition of CHK2 at 30 uM by microfluidic mobility shift assay	B	Cn1nc(N)c2cnc(-c3ccccc3)cc21		CHEMBL1813800	=	Inhibition	%	5.0	CHEMBL2527	Homo sapiens	INH	%	5.0
	6316421	CHEMBL1815729	Inhibition of CHK2 at 30 uM by microfluidic mobility shift assay	B	Cc1cc2c(cn1)c(N)nn2C		CHEMBL1813801	=	Inhibition	%	3.0	CHEMBL2527	Homo sapiens	INH	%	3.0
	6316422	CHEMBL1815729	Inhibition of CHK2 at 30 uM by microfluidic mobility shift assay	B	Nc1c2cnc(-c3ccccc3)cc2nn1-c1ccccc1		CHEMBL1813802	=	Inhibition	%	7.0	CHEMBL2527	Homo sapiens	INH	%	7.0
	6316423	CHEMBL1815729	Inhibition of CHK2 at 30 uM by microfluidic mobility shift assay	B	Cc1cc2[nH]nc(N)c2cn1		CHEMBL1813803	=	Inhibition	%	7.0	CHEMBL2527	Homo sapiens	INH	%	7.0
	6316424	CHEMBL1815729	Inhibition of CHK2 at 30 uM by microfluidic mobility shift assay	B	Cc1cc2[nH]ncc2c(=O)[nH]1		CHEMBL1813804	=	Inhibition	%	12.0	CHEMBL2527	Homo sapiens	INH	%	12.0
	6316425	CHEMBL1815729	Inhibition of CHK2 at 30 uM by microfluidic mobility shift assay	B	Cc1cc2nc(N)nc(N)c2c(=O)[nH]1		CHEMBL1813805	=	Inhibition	%	16.0	CHEMBL2527	Homo sapiens	INH	%	16.0
	6316426	CHEMBL1815729	Inhibition of CHK2 at 30 uM by microfluidic mobility shift assay	B	Cc1cc2nc(-c3ccccc3)nc(N)c2c(=O)[nH]1		CHEMBL1813806	=	Inhibition	%	4.0	CHEMBL2527	Homo sapiens	INH	%	4.0
	6316427	CHEMBL1815729	Inhibition of CHK2 at 30 uM by microfluidic mobility shift assay	B	Cc1nc(N)c2c(=O)[nH]c(C)cc2n1		CHEMBL1813807	=	Inhibition	%	5.0	CHEMBL2527	Homo sapiens	INH	%	5.0
	6316428	CHEMBL1815729	Inhibition of CHK2 at 30 uM by microfluidic mobility shift assay	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Inhibition	%	81.0	CHEMBL2527	Homo sapiens	INH	%	81.0
	6318853	CHEMBL1815748	Inhibition of CHK2 by microfluidic mobility shift assay	B	CN1CCN(c2ccc(-c3cc4c(c(N)nn4C)c(=O)[nH]3)cc2)CC1		CHEMBL1813625	=	IC50	nM	34000.0	CHEMBL2527	Homo sapiens	IC50	uM	34.0
	6340913	CHEMBL1826937	Activity of CHEK2 kinase at 1 uM	B	CC(=O)Nc1cn2nc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1		CHEMBL1822054	=	Activity	%	90.0	CHEMBL2527	Homo sapiens	Activity	%	90.0
	6352217	CHEMBL1825754	Inhibition of CHK2 assessed as residual activity at 10 uM by radioactivity assay in presence of 20 uM ATP	B	Nc1n[nH]c(N)c1/N=N/c1ccc(O)cc1		CHEMBL215205	=	Activity	%	57.0	CHEMBL2527	Homo sapiens	Activity	%	57.0
	6375132	CHEMBL1838154	Inhibition of CHK2 at 1 uM	B	CC(=O)Nc1ccc(-c2cc3ncnc(SCC(=O)O)c3s2)cc1		CHEMBL1836724	=	Inhibition	%	10.8	CHEMBL2527	Homo sapiens	INH	%	10.8
	6376041	CHEMBL1838154	Inhibition of CHK2 at 1 uM	B	O=C(O)COc1ncnc2cc(-c3ccc4[nH]ncc4c3)sc12		CHEMBL1836641	=	Inhibition	%	-2.3	CHEMBL2527	Homo sapiens	INH	%	-2.3
	7567197	CHEMBL1908500	Binding constant for CHEK2 kinase domain	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	10000.0	CHEMBL2527	Homo sapiens	Kd	nM	10000.0
	7567656	CHEMBL1908500	Binding constant for CHEK2 kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL2527	Homo sapiens	Kd	nM	10000.0
	7568127	CHEMBL1908500	Binding constant for CHEK2 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL2527	Homo sapiens	Kd	nM	10000.0
	7568595	CHEMBL1908500	Binding constant for CHEK2 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1		CHEMBL450786	>	Kd	nM	10000.0	CHEMBL2527	Homo sapiens	Kd	nM	10000.0
	7569170	CHEMBL1908500	Binding constant for CHEK2 kinase domain	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	10000.0	CHEMBL2527	Homo sapiens	Kd	nM	10000.0
	7569630	CHEMBL1908500	Binding constant for CHEK2 kinase domain	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	10000.0	CHEMBL2527	Homo sapiens	Kd	nM	10000.0
	7570102	CHEMBL1908500	Binding constant for CHEK2 kinase domain	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	10000.0	CHEMBL2527	Homo sapiens	Kd	nM	10000.0
	7570550	CHEMBL1908500	Binding constant for CHEK2 kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	10.0	CHEMBL2527	Homo sapiens	Kd	nM	10.0
	7571146	CHEMBL1908500	Binding constant for CHEK2 kinase domain	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	=	Kd	nM	7700.0	CHEMBL2527	Homo sapiens	Kd	nM	7700.0
	7571603	CHEMBL1908500	Binding constant for CHEK2 kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	10000.0	CHEMBL2527	Homo sapiens	Kd	nM	10000.0
	7572100	CHEMBL1908500	Binding constant for CHEK2 kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL2527	Homo sapiens	Kd	nM	10000.0
	7572516	CHEMBL1908500	Binding constant for CHEK2 kinase domain	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Kd	nM	72.0	CHEMBL2527	Homo sapiens	Kd	nM	72.0
	7573127	CHEMBL1908500	Binding constant for CHEK2 kinase domain	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	>	Kd	nM	10000.0	CHEMBL2527	Homo sapiens	Kd	nM	10000.0
	7573584	CHEMBL1908500	Binding constant for CHEK2 kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL2527	Homo sapiens	Kd	nM	10000.0
	7573618	CHEMBL1908500	Binding constant for CHEK2 kinase domain	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1.Cl		CHEMBL1908395	>	Kd	nM	10000.0	CHEMBL2527	Homo sapiens	Kd	nM	10000.0
	7574087	CHEMBL1908500	Binding constant for CHEK2 kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL2527	Homo sapiens	Kd	nM	10000.0
	7574495	CHEMBL1908500	Binding constant for CHEK2 kinase domain	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	10000.0	CHEMBL2527	Homo sapiens	Kd	nM	10000.0
	7575105	CHEMBL1908500	Binding constant for CHEK2 kinase domain	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	10000.0	CHEMBL2527	Homo sapiens	Kd	nM	10000.0
	7575595	CHEMBL1908500	Binding constant for CHEK2 kinase domain	B	COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1		CHEMBL1908396	>	Kd	nM	10000.0	CHEMBL2527	Homo sapiens	Kd	nM	10000.0
	7576060	CHEMBL1908500	Binding constant for CHEK2 kinase domain	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F		CHEMBL1230020	>	Kd	nM	10000.0	CHEMBL2527	Homo sapiens	Kd	nM	10000.0
	7576468	CHEMBL1908500	Binding constant for CHEK2 kinase domain	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	>	Kd	nM	10000.0	CHEMBL2527	Homo sapiens	Kd	nM	10000.0
	7577096	CHEMBL1908500	Binding constant for CHEK2 kinase domain	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	=	Kd	nM	57.0	CHEMBL2527	Homo sapiens	Kd	nM	57.0
	7577574	CHEMBL1908500	Binding constant for CHEK2 kinase domain	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	=	Kd	nM	95.0	CHEMBL2527	Homo sapiens	Kd	nM	95.0
	7578044	CHEMBL1908500	Binding constant for CHEK2 kinase domain	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Kd	nM	2900.0	CHEMBL2527	Homo sapiens	Kd	nM	2900.0
	7578449	CHEMBL1908500	Binding constant for CHEK2 kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	10000.0	CHEMBL2527	Homo sapiens	Kd	nM	10000.0
	7578645	CHEMBL1908500	Binding constant for CHEK2 kinase domain	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12		CHEMBL379218	=	Kd	nM	9800.0	CHEMBL2527	Homo sapiens	Kd	nM	9800.0
	7579019	CHEMBL1908500	Binding constant for CHEK2 kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL2527	Homo sapiens	Kd	nM	10000.0
	7579469	CHEMBL1908500	Binding constant for CHEK2 kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL2527	Homo sapiens	Kd	nM	10000.0
	7579943	CHEMBL1908500	Binding constant for CHEK2 kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL2527	Homo sapiens	Kd	nM	10000.0
	7580412	CHEMBL1908500	Binding constant for CHEK2 kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL2527	Homo sapiens	Kd	nM	10000.0
	7580815	CHEMBL1908500	Binding constant for CHEK2 kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	10000.0	CHEMBL2527	Homo sapiens	Kd	nM	10000.0
	7581003	CHEMBL1908500	Binding constant for CHEK2 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	10000.0	CHEMBL2527	Homo sapiens	Kd	nM	10000.0
	7581388	CHEMBL1908500	Binding constant for CHEK2 kinase domain	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	>	Kd	nM	10000.0	CHEMBL2527	Homo sapiens	Kd	nM	10000.0
	7581833	CHEMBL1908500	Binding constant for CHEK2 kinase domain	B	OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1		CHEMBL525191	>	Kd	nM	10000.0	CHEMBL2527	Homo sapiens	Kd	nM	10000.0
	7582304	CHEMBL1908500	Binding constant for CHEK2 kinase domain	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	10000.0	CHEMBL2527	Homo sapiens	Kd	nM	10000.0
	7582768	CHEMBL1908500	Binding constant for CHEK2 kinase domain	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	>	Kd	nM	10000.0	CHEMBL2527	Homo sapiens	Kd	nM	10000.0
	7583168	CHEMBL1908500	Binding constant for CHEK2 kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL2527	Homo sapiens	Kd	nM	10000.0
	7583349	CHEMBL1908500	Binding constant for CHEK2 kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL2527	Homo sapiens	Kd	nM	10000.0
	7583746	CHEMBL1908500	Binding constant for CHEK2 kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL2527	Homo sapiens	Kd	nM	10000.0
	7584191	CHEMBL1908500	Binding constant for CHEK2 kinase domain	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	10000.0	CHEMBL2527	Homo sapiens	Kd	nM	10000.0
	7584662	CHEMBL1908500	Binding constant for CHEK2 kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	=	Kd	nM	3700.0	CHEMBL2527	Homo sapiens	Kd	nM	3700.0
	7585124	CHEMBL1908500	Binding constant for CHEK2 kinase domain	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	10000.0	CHEMBL2527	Homo sapiens	Kd	nM	10000.0
	7585679	CHEMBL1908500	Binding constant for CHEK2 kinase domain	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL2527	Homo sapiens	Kd	nM	10000.0
	7586087	CHEMBL1908500	Binding constant for CHEK2 kinase domain	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	10000.0	CHEMBL2527	Homo sapiens	Kd	nM	10000.0
	7586533	CHEMBL1908500	Binding constant for CHEK2 kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	=	Kd	nM	800.0	CHEMBL2527	Homo sapiens	Kd	nM	800.0
	7587004	CHEMBL1908500	Binding constant for CHEK2 kinase domain	B	COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C		CHEMBL608154	>	Kd	nM	10000.0	CHEMBL2527	Homo sapiens	Kd	nM	10000.0
	7587640	CHEMBL1908500	Binding constant for CHEK2 kinase domain	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	10000.0	CHEMBL2527	Homo sapiens	Kd	nM	10000.0
	7588059	CHEMBL1908500	Binding constant for CHEK2 kinase domain	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	210.0	CHEMBL2527	Homo sapiens	Kd	nM	210.0
	7588512	CHEMBL1908500	Binding constant for CHEK2 kinase domain	B	CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL464552	=	Kd	nM	280.0	CHEMBL2527	Homo sapiens	Kd	nM	280.0
	7588992	CHEMBL1908500	Binding constant for CHEK2 kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL2527	Homo sapiens	Kd	nM	10000.0
	7589605	CHEMBL1908500	Binding constant for CHEK2 kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL2527	Homo sapiens	Kd	nM	10000.0
	7590029	CHEMBL1908500	Binding constant for CHEK2 kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	10000.0	CHEMBL2527	Homo sapiens	Kd	nM	10000.0
	7590528	CHEMBL1908500	Binding constant for CHEK2 kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL2527	Homo sapiens	Kd	nM	10000.0
	7590979	CHEMBL1908500	Binding constant for CHEK2 kinase domain	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	10000.0	CHEMBL2527	Homo sapiens	Kd	nM	10000.0
	7591578	CHEMBL1908500	Binding constant for CHEK2 kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Kd	nM	360.0	CHEMBL2527	Homo sapiens	Kd	nM	360.0
	7592000	CHEMBL1908500	Binding constant for CHEK2 kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL2527	Homo sapiens	Kd	nM	10000.0
	7592030	CHEMBL1908500	Binding constant for CHEK2 kinase domain	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	10000.0	CHEMBL2527	Homo sapiens	Kd	nM	10000.0
	7592503	CHEMBL1908500	Binding constant for CHEK2 kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL2527	Homo sapiens	Kd	nM	10000.0
	7592956	CHEMBL1908500	Binding constant for CHEK2 kinase domain	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	Kd	nM	120.0	CHEMBL2527	Homo sapiens	Kd	nM	120.0
	7593545	CHEMBL1908500	Binding constant for CHEK2 kinase domain	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	10000.0	CHEMBL2527	Homo sapiens	Kd	nM	10000.0
	7594010	CHEMBL1908500	Binding constant for CHEK2 kinase domain	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	=	Kd	nM	5300.0	CHEMBL2527	Homo sapiens	Kd	nM	5300.0
	7594483	CHEMBL1908500	Binding constant for CHEK2 kinase domain	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	10000.0	CHEMBL2527	Homo sapiens	Kd	nM	10000.0
	7594935	CHEMBL1908500	Binding constant for CHEK2 kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL2527	Homo sapiens	Kd	nM	10000.0
	7595515	CHEMBL1908500	Binding constant for CHEK2 kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL2527	Homo sapiens	Kd	nM	10000.0
	7595989	CHEMBL1908500	Binding constant for CHEK2 kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL2527	Homo sapiens	Kd	nM	10000.0
	7596460	CHEMBL1908500	Binding constant for CHEK2 kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL2527	Homo sapiens	Kd	nM	10000.0
	7596907	CHEMBL1908500	Binding constant for CHEK2 kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	74.0	CHEMBL2527	Homo sapiens	Kd	nM	74.0
	7597043	CHEMBL1908500	Binding constant for CHEK2 kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	=	Kd	nM	1400.0	CHEMBL2527	Homo sapiens	Kd	nM	1400.0
	7597496	CHEMBL1908500	Binding constant for CHEK2 kinase domain	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	>	Kd	nM	10000.0	CHEMBL2527	Homo sapiens	Kd	nM	10000.0
	7597969	CHEMBL1908500	Binding constant for CHEK2 kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	=	Kd	nM	850.0	CHEMBL2527	Homo sapiens	Kd	nM	850.0
	7598439	CHEMBL1908500	Binding constant for CHEK2 kinase domain	B	CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1		CHEMBL386051	>	Kd	nM	10000.0	CHEMBL2527	Homo sapiens	Kd	nM	10000.0
	7598881	CHEMBL1908500	Binding constant for CHEK2 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	40.0	CHEMBL2527	Homo sapiens	Kd	nM	40.0
	7841900	CHEMBL1913731	Inhibition of CHK2 using biotinylated substrate preincubated for 15 mins before substrate addition measured after 30 mins by fluorescence microplate analysis	B	Cl.N=C(N)N/N=C\c1c(-c2ccc([N+](=O)[O-])cc2)nc2sc(Br)cn12		CHEMBL1910608	=	IC50	nM	1960.0	CHEMBL2527	Homo sapiens	IC50	nM	1960.0
	7841906	CHEMBL1913731	Inhibition of CHK2 using biotinylated substrate preincubated for 15 mins before substrate addition measured after 30 mins by fluorescence microplate analysis	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	IC50	nM	16.84	CHEMBL2527	Homo sapiens	IC50	nM	16.84
	7841920	CHEMBL1913731	Inhibition of CHK2 using biotinylated substrate preincubated for 15 mins before substrate addition measured after 30 mins by fluorescence microplate analysis	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	3.34	CHEMBL2527	Homo sapiens	IC50	nM	3.34
	7841982	CHEMBL1913740	Inhibition of CHK2 assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate by microplate reader assay	B	Cl.N=C(N)N/N=C/c1c(-c2cc(Cl)sc2Cl)nc2sc(Cl)cn12		CHEMBL1910371	>	IC50	nM	100000.0	CHEMBL2527	Homo sapiens	IC50	uM	100.0
	7841983	CHEMBL1913740	Inhibition of CHK2 assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate by microplate reader assay	B	Cl.N#Cc1ccc(-c2nc3sc(Cl)cn3c2/C=N/NC(=N)N)cc1		CHEMBL1910375	=	IC50	nM	93500.0	CHEMBL2527	Homo sapiens	IC50	uM	93.5
	7841984	CHEMBL1913740	Inhibition of CHK2 assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate by microplate reader assay	B	Cl.N=C(N)N/N=C\c1c(-c2ccc([N+](=O)[O-])cc2)nc2sc(F)cn12		CHEMBL1910607	=	IC50	nM	56500.0	CHEMBL2527	Homo sapiens	IC50	uM	56.5
	7841985	CHEMBL1913740	Inhibition of CHK2 assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate by microplate reader assay	B	Cl.N=C(N)N/N=C\c1c(-c2ccc([N+](=O)[O-])cc2)nc2sc(Br)cn12		CHEMBL1910608	=	IC50	nM	88500.0	CHEMBL2527	Homo sapiens	IC50	uM	88.5
	7841986	CHEMBL1913740	Inhibition of CHK2 assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate by microplate reader assay	B	Cl.N=C(N)N/N=C/c1c(-c2cc(Cl)sc2Cl)nc2sc3ccccc3n12		CHEMBL1910616	>	IC50	nM	100000.0	CHEMBL2527	Homo sapiens	IC50	uM	100.0
	7841987	CHEMBL1913740	Inhibition of CHK2 assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate by microplate reader assay	B	COc1cc([N+](=O)[O-])c(OC)cc1-c1nc2sc3ccccc3n2c1/C=N/NC(=N)N.Cl		CHEMBL1910614	>	IC50	nM	100000.0	CHEMBL2527	Homo sapiens	IC50	uM	100.0
	7841988	CHEMBL1913740	Inhibition of CHK2 assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate by microplate reader assay	B	COc1cc([N+](=O)[O-])c(OC)cc1-c1nc2ccccn2c1/C=N/NC(=N)N.Cl		CHEMBL1910623	>	IC50	nM	100000.0	CHEMBL2527	Homo sapiens	IC50	uM	100.0
	7841989	CHEMBL1913740	Inhibition of CHK2 assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate by microplate reader assay	B	Cl.N=C(N)N/N=C/c1c(-c2ccc([N+](=O)[O-])cc2)nc2sc(Cl)cn12		CHEMBL1910625	=	IC50	nM	78750.0	CHEMBL2527	Homo sapiens	IC50	uM	78.75
	7841990	CHEMBL1913740	Inhibition of CHK2 assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate by microplate reader assay	B	Cc1cn2c(/C=N/NC(=N)N)c(-c3ccc([N+](=O)[O-])cc3)nc2s1.Cl		CHEMBL1910626	=	IC50	nM	83000.0	CHEMBL2527	Homo sapiens	IC50	uM	83.0
	7841991	CHEMBL1913740	Inhibition of CHK2 assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate by microplate reader assay	B	Cl.N=C(N)N/N=C/c1c(-c2ccc(Cl)c([N+](=O)[O-])c2)nc2ccccn12		CHEMBL1910627	=	IC50	nM	79000.0	CHEMBL2527	Homo sapiens	IC50	uM	79.0
	7841992	CHEMBL1913740	Inhibition of CHK2 assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate by microplate reader assay	B	Cl.N=C(N)N/N=C/c1c(-c2ccc(N)cc2)nc2sccn12		CHEMBL1910628	=	IC50	nM	67500.0	CHEMBL2527	Homo sapiens	IC50	uM	67.5
	7841993	CHEMBL1913740	Inhibition of CHK2 assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate by microplate reader assay	B	Cl.N=C(N)N/N=C/c1c(-c2ccc(Cl)c([N+](=O)[O-])c2)nc2sccn12		CHEMBL1910629	=	IC50	nM	81000.0	CHEMBL2527	Homo sapiens	IC50	uM	81.0
	7841994	CHEMBL1913740	Inhibition of CHK2 assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate by microplate reader assay	B	COc1cc([N+](=O)[O-])c(OC)cc1-c1nc2sccn2c1/C=N/NC(=N)N.Cl		CHEMBL1910630	=	IC50	nM	96000.0	CHEMBL2527	Homo sapiens	IC50	uM	96.0
	7841995	CHEMBL1913740	Inhibition of CHK2 assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate by microplate reader assay	B	Cc1cn2c(/C=N/NC(=N)N)c(-c3ccc(Cl)c([N+](=O)[O-])c3)nc2s1.Cl		CHEMBL1910631	=	IC50	nM	64800.0	CHEMBL2527	Homo sapiens	IC50	uM	64.8
	7841996	CHEMBL1913740	Inhibition of CHK2 assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate by microplate reader assay	B	Cc1cn2c(/C=N/NC(=N)N)c(-c3cc([N+](=O)[O-])c(Cl)cc3Cl)nc2s1.Cl		CHEMBL1910632	>	IC50	nM	100000.0	CHEMBL2527	Homo sapiens	IC50	uM	100.0
	7841997	CHEMBL1913740	Inhibition of CHK2 assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate by microplate reader assay	B	Cl.N=C(N)N/N=C/c1c(-c2ccc([N+](=O)[O-])cc2)nc2sccn12		CHEMBL1910633	>	IC50	nM	100000.0	CHEMBL2527	Homo sapiens	IC50	uM	100.0
	7841998	CHEMBL1913740	Inhibition of CHK2 assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate by microplate reader assay	B	Cl.N=C(N)N/N=C/c1c(-c2ccc(Cl)c([N+](=O)[O-])c2)nc2sc(Cl)cn12		CHEMBL1910634	=	IC50	nM	90000.0	CHEMBL2527	Homo sapiens	IC50	uM	90.0
	7841999	CHEMBL1913740	Inhibition of CHK2 assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate by microplate reader assay	B	Cl.N=C(N)N/N=C/c1c(-c2cc([N+](=O)[O-])c(Cl)cc2Cl)nc2sccn12		CHEMBL1910635	>	IC50	nM	100000.0	CHEMBL2527	Homo sapiens	IC50	uM	100.0
	7842000	CHEMBL1913740	Inhibition of CHK2 assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate by microplate reader assay	B	CCCc1cn2c(/C=N/NC(=N)N)c(-c3cc([N+](=O)[O-])c(Cl)cc3Cl)nc2s1.Cl		CHEMBL1910636	>	IC50	nM	100000.0	CHEMBL2527	Homo sapiens	IC50	uM	100.0
	7842001	CHEMBL1913740	Inhibition of CHK2 assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate by microplate reader assay	B	Cl.N=C(N)N/N=C/c1c(-c2cccc([N+](=O)[O-])c2)nc2sc(Cl)cn12		CHEMBL1910637	>	IC50	nM	100000.0	CHEMBL2527	Homo sapiens	IC50	uM	100.0
	7842002	CHEMBL1913740	Inhibition of CHK2 assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate by microplate reader assay	B	CCCc1cn2c(/C=N/NC(=N)N)c(-c3ccc(Cl)c([N+](=O)[O-])c3)nc2s1.Cl		CHEMBL1910744	=	IC50	nM	90500.0	CHEMBL2527	Homo sapiens	IC50	uM	90.5
	7842003	CHEMBL1913740	Inhibition of CHK2 assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate by microplate reader assay	B	Cl.N=C(N)N/N=C/c1c(-c2ccc(Cl)c([N+](=O)[O-])c2)nc2sc3ccccc3n12		CHEMBL1910745	>	IC50	nM	100000.0	CHEMBL2527	Homo sapiens	IC50	uM	100.0
	7842004	CHEMBL1913740	Inhibition of CHK2 assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate by microplate reader assay	B	COc1cc([N+](=O)[O-])c(OC)cc1-c1nc2sc(Cl)cn2c1/C=N/NC(=N)N/N=C/c1c(-c2cc(OC)c([N+](=O)[O-])cc2OC)nc2sc(Cl)cn12.Cl		CHEMBL1910746	>	IC50	nM	100000.0	CHEMBL2527	Homo sapiens	IC50	uM	100.0
	7842005	CHEMBL1913740	Inhibition of CHK2 assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate by microplate reader assay	B	CCCc1cn2c(/C=N/NC(=N)N)c(-c3cccc([N+](=O)[O-])c3)nc2s1.Cl		CHEMBL1910747	=	IC50	nM	69500.0	CHEMBL2527	Homo sapiens	IC50	uM	69.5
	7842006	CHEMBL1913740	Inhibition of CHK2 assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate by microplate reader assay	B	Cc1sc2nc(-c3ccc(Cl)c([N+](=O)[O-])c3)c(/C=N/NC(=N)N)n2c1C.Cl		CHEMBL1910748	=	IC50	nM	48500.0	CHEMBL2527	Homo sapiens	IC50	uM	48.5
	7842007	CHEMBL1913740	Inhibition of CHK2 assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate by microplate reader assay	B	Cl.N=C(N)N/N=C/c1c(-c2ccc(Cl)cc2)nc2sc(Cl)cn12		CHEMBL1910749	=	IC50	nM	49320.0	CHEMBL2527	Homo sapiens	IC50	uM	49.32
	7842008	CHEMBL1913740	Inhibition of CHK2 assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate by microplate reader assay	B	Cc1cn2c(/C=N/NC(=N)N)c(-c3cccc([N+](=O)[O-])c3)nc2s1.Cl		CHEMBL1910750	=	IC50	nM	59000.0	CHEMBL2527	Homo sapiens	IC50	uM	59.0
	7842011	CHEMBL1913740	Inhibition of CHK2 assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate by microplate reader assay	B	Cl.N=C(N)N/N=C/c1c(-c2ccc(F)c([N+](=O)[O-])c2)nc2sc(Cl)cn12		CHEMBL1910374	=	IC50	nM	41300.0	CHEMBL2527	Homo sapiens	IC50	uM	41.3
	7842076	CHEMBL1913740	Inhibition of CHK2 assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate by microplate reader assay	B	Cl.N=C(N)N/N=C/c1c(-c2ccccc2)nc2sc(Cl)cn12		CHEMBL1910372	>	IC50	nM	100000.0	CHEMBL2527	Homo sapiens	IC50	uM	100.0
	7842077	CHEMBL1913740	Inhibition of CHK2 assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate by microplate reader assay	B	Cl.N=C(N)N/N=C/c1c(-c2ccc(F)cc2)nc2sc(Cl)cn12		CHEMBL1910373	=	IC50	nM	90000.0	CHEMBL2527	Homo sapiens	IC50	uM	90.0
	7842078	CHEMBL1913740	Inhibition of CHK2 assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate by microplate reader assay	B	Cc1nn2c(/C=N/NC(=N)N)c(-c3cc(Cl)sc3Cl)nc2s1.Cl		CHEMBL1910376	>	IC50	nM	20000.0	CHEMBL2527	Homo sapiens	IC50	uM	20.0
	7842079	CHEMBL1913740	Inhibition of CHK2 assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate by microplate reader assay	B	COc1cc([N+](=O)[O-])c(OC)cc1-c1nc2sc(C)nn2c1/C=N\NC(=N)N.Cl		CHEMBL1910595	>	IC50	nM	20000.0	CHEMBL2527	Homo sapiens	IC50	uM	20.0
	7842080	CHEMBL1913740	Inhibition of CHK2 assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate by microplate reader assay	B	Cl.N=C(N)N/N=C\c1c(-c2ccc(F)cc2)nc2sccn12		CHEMBL1910597	>	IC50	nM	100000.0	CHEMBL2527	Homo sapiens	IC50	uM	100.0
	7842081	CHEMBL1913740	Inhibition of CHK2 assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate by microplate reader assay	B	Cl.N=C(N)N/N=C\c1c(-c2ccccc2F)nc2sccn12		CHEMBL1910598	>	IC50	nM	100000.0	CHEMBL2527	Homo sapiens	IC50	uM	100.0
	7842082	CHEMBL1913740	Inhibition of CHK2 assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate by microplate reader assay	B	Cl.N=C(N)N/N=C\c1c(-c2c(F)cccc2F)nc2sccn12		CHEMBL1910599	>	IC50	nM	100000.0	CHEMBL2527	Homo sapiens	IC50	uM	100.0
	7842083	CHEMBL1913740	Inhibition of CHK2 assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate by microplate reader assay	B	Cl.N=C(N)N/N=C\c1c(-c2ccc(F)c(F)c2)nc2sccn12		CHEMBL1910600	>	IC50	nM	100000.0	CHEMBL2527	Homo sapiens	IC50	uM	100.0
	7842084	CHEMBL1913740	Inhibition of CHK2 assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate by microplate reader assay	B	Cl.N=C(N)N/N=C\c1c(-c2cc(F)c(F)cc2F)nc2sccn12		CHEMBL1910601	>	IC50	nM	100000.0	CHEMBL2527	Homo sapiens	IC50	uM	100.0
	7842085	CHEMBL1913740	Inhibition of CHK2 assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate by microplate reader assay	B	Cl.N=C(N)N/N=C\c1c(-c2ccc(F)c([N+](=O)[O-])c2)nc2sccn12		CHEMBL1910602	=	IC50	nM	77500.0	CHEMBL2527	Homo sapiens	IC50	uM	77.5
	7842086	CHEMBL1913740	Inhibition of CHK2 assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate by microplate reader assay	B	Cl.N=C(N)N/N=C\c1c(-c2cccc([N+](=O)[O-])c2F)nc2sccn12		CHEMBL1910603	>	IC50	nM	100000.0	CHEMBL2527	Homo sapiens	IC50	uM	100.0
	7842087	CHEMBL1913740	Inhibition of CHK2 assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate by microplate reader assay	B	Cl.N=C(N)N/N=C\c1c(-c2cccc(C(F)(F)F)c2)nc2sccn12		CHEMBL1910604	>	IC50	nM	100000.0	CHEMBL2527	Homo sapiens	IC50	uM	100.0
	7842088	CHEMBL1913740	Inhibition of CHK2 assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate by microplate reader assay	B	Cl.N=C(N)N/N=C\c1c(-c2ccc(Br)c([N+](=O)[O-])c2)nc2sccn12		CHEMBL1909651	>	IC50	nM	100000.0	CHEMBL2527	Homo sapiens	IC50	uM	100.0
	7842089	CHEMBL1913740	Inhibition of CHK2 assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate by microplate reader assay	B	Cc1cn2c(/C=N\NC(=N)N)c(-c3ccc(F)cc3)nc2s1.Cl		CHEMBL1910605	>	IC50	nM	50000.0	CHEMBL2527	Homo sapiens	IC50	uM	50.0
	7842090	CHEMBL1913740	Inhibition of CHK2 assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate by microplate reader assay	B	Cc1cn2c(/C=N\NC(=N)N)c(-c3ccc(F)c([N+](=O)[O-])c3)nc2s1.Cl		CHEMBL1910606	=	IC50	nM	18850.0	CHEMBL2527	Homo sapiens	IC50	uM	18.85
	7842091	CHEMBL1913740	Inhibition of CHK2 assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate by microplate reader assay	B	Br.Clc1cc(-c2nc3sc(Cl)cn3c2/C=N/NC2=NCCN2)c(Cl)s1		CHEMBL1910609	>	IC50	nM	20000.0	CHEMBL2527	Homo sapiens	IC50	uM	20.0
	7842092	CHEMBL1913740	Inhibition of CHK2 assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate by microplate reader assay	B	Br.Cc1nn2c(/C=N/NC3=NCCN3)c(-c3ccc(Cl)c([N+](=O)[O-])c3)nc2s1		CHEMBL1910610	>	IC50	nM	20000.0	CHEMBL2527	Homo sapiens	IC50	uM	20.0
	7842093	CHEMBL1913740	Inhibition of CHK2 assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate by microplate reader assay	B	Br.Clc1cc(-c2nc3sc4ccccc4n3c2/C=N/NC2=NCCN2)c(Cl)s1		CHEMBL1910617	>	IC50	nM	100000.0	CHEMBL2527	Homo sapiens	IC50	uM	100.0
	7842094	CHEMBL1913740	Inhibition of CHK2 assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate by microplate reader assay	B	Cl.N=C(N)N/N=C/c1c(-c2cc(Cl)sc2Cl)nc2ccccn12		CHEMBL1910622	>	IC50	nM	20000.0	CHEMBL2527	Homo sapiens	IC50	uM	20.0
	7842095	CHEMBL1913740	Inhibition of CHK2 assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate by microplate reader assay	B	Br.Clc1cc(-c2nc3ccccn3c2/C=N/NC2=NCCN2)c(Cl)s1		CHEMBL1910624	>	IC50	nM	20000.0	CHEMBL2527	Homo sapiens	IC50	uM	20.0
	7842096	CHEMBL1913740	Inhibition of CHK2 assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate by microplate reader assay	B	Cc1cn2c(/C=N/NC(=N)NN)c(-c3ccc(Cl)c([N+](=O)[O-])c3)nc2s1.Cl		CHEMBL1910751	>	IC50	nM	100000.0	CHEMBL2527	Homo sapiens	IC50	uM	100.0
	7842097	CHEMBL1913740	Inhibition of CHK2 assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate by microplate reader assay	B	Cl.N=C(N)N/N=C/c1c(-c2cccc([N+](=O)[O-])c2)nc2sccn12		CHEMBL1910752	>	IC50	nM	100000.0	CHEMBL2527	Homo sapiens	IC50	uM	100.0
	7842098	CHEMBL1913740	Inhibition of CHK2 assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate by microplate reader assay	B	Cc1cn2c(/C=N/NC3=NCCN3)c(-c3ccc(Cl)c([N+](=O)[O-])c3)nc2s1.Cl		CHEMBL1910753	>	IC50	nM	100000.0	CHEMBL2527	Homo sapiens	IC50	uM	100.0
	7842099	CHEMBL1913740	Inhibition of CHK2 assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate by microplate reader assay	B	CCCc1cn2c(/C=N/NC(=N)N)c(-c3ccc([N+](=O)[O-])cc3)nc2s1.Cl		CHEMBL1910754	>	IC50	nM	100000.0	CHEMBL2527	Homo sapiens	IC50	uM	100.0
	7842100	CHEMBL1913740	Inhibition of CHK2 assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate by microplate reader assay	B	Cc1cn2c(/C=N/NC(=N)N)c(-c3cc(Cl)sc3Cl)nc2s1.Cl		CHEMBL1910755	>	IC50	nM	100000.0	CHEMBL2527	Homo sapiens	IC50	uM	100.0
	7842101	CHEMBL1913740	Inhibition of CHK2 assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate by microplate reader assay	B	Cc1csc2nc(-c3ccc(Cl)c([N+](=O)[O-])c3)c(/C=N/NC(=N)N)n12.Cl		CHEMBL1910756	=	IC50	nM	84400.0	CHEMBL2527	Homo sapiens	IC50	uM	84.4
	7842102	CHEMBL1913740	Inhibition of CHK2 assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate by microplate reader assay	B	Cl.N=C(N)N/N=C/c1c(-c2cc(Cl)sc2Cl)nc2sccn12		CHEMBL1910757	=	IC50	nM	65000.0	CHEMBL2527	Homo sapiens	IC50	uM	65.0
	7842103	CHEMBL1913740	Inhibition of CHK2 assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate by microplate reader assay	B	CCc1cn2c(/C=N/NC(=N)N)c(-c3cc([N+](=O)[O-])c(Cl)cc3Cl)nc2s1.Cl		CHEMBL1910758	=	IC50	nM	59000.0	CHEMBL2527	Homo sapiens	IC50	uM	59.0
	7842104	CHEMBL1913740	Inhibition of CHK2 assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate by microplate reader assay	B	Cc1nn2c(/C=N/NC(=N)N)c(-c3ccc(Cl)c([N+](=O)[O-])c3)nc2s1.Cl		CHEMBL1910759	=	IC50	nM	78000.0	CHEMBL2527	Homo sapiens	IC50	uM	78.0
	7842105	CHEMBL1913740	Inhibition of CHK2 assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate by microplate reader assay	B	Cc1sc2nc(-c3cc([N+](=O)[O-])c(Cl)cc3Cl)c(/C=N/NC(=N)N)n2c1C.Cl		CHEMBL1910760	>	IC50	nM	100000.0	CHEMBL2527	Homo sapiens	IC50	uM	100.0
	7842106	CHEMBL1913740	Inhibition of CHK2 assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate by microplate reader assay	B	Cc1sc2nc(-c3cccnc3)c(/C=N/NC(=N)N)n2c1C.Cl		CHEMBL1910761	=	IC50	nM	6580.0	CHEMBL2527	Homo sapiens	IC50	uM	6.58
	7842107	CHEMBL1913740	Inhibition of CHK2 assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate by microplate reader assay	B	Cc1csc2nc(-c3cccnc3)c(/C=N/NC(=N)N)n12.Cl		CHEMBL1910762	=	IC50	nM	34320.0	CHEMBL2527	Homo sapiens	IC50	uM	34.32
	7931075	CHEMBL1919254	Inhibition of CHEK2 relative to control	B	Cc1ccccc1Nc1nc2cc(F)c(N(C)C(=O)/C=C/CN(C)C)cc2n2cncc12		CHEMBL1916891	=	Inhibition	%	19.0	CHEMBL2527	Homo sapiens	INH	%	19.0
	7959711	CHEMBL1932830	Inhibition of CHK2	B	CN(C)CCN1CCN(C(=O)c2cc(C(C)(C)C)sc2NC(=O)Nc2cccc(Cl)c2Cl)CCC1=O		CHEMBL1929238	>	IC50	nM	30000.0	CHEMBL2527	Homo sapiens	IC50	uM	30.0
	7959712	CHEMBL1932830	Inhibition of CHK2	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	IC50	nM	19000.0	CHEMBL2527	Homo sapiens	IC50	uM	19.0
	7969703	CHEMBL1930959	Inhibition of CHK2 assessed as residual activity at 10 uM using [33P-ATP] by radiometric filter binding assay	B	Cc1ccc(F)cc1-c1nc2[nH]nc(N)c2c2c1CCCC2		CHEMBL1927262	=	Activity	%	113.0	CHEMBL2527	Homo sapiens	Activity	%	113.0
	7970419	CHEMBL1930198	Inhibition of CHK2 at 10 uM	B	NCCN1C(=O)S/C(=C\CCC2CCCCC2)C1=O		CHEMBL1929247	=	Inhibition	%	8.0	CHEMBL2527	Homo sapiens	INH	%	8.0
	7977572	CHEMBL1930051	Competitive inhibition of human CHK2 using ATP as substrate by DELFIA	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	27.0	CHEMBL2527	Homo sapiens	IC50	nM	27.0
Not Determined	7977573	CHEMBL1930051	Competitive inhibition of human CHK2 using ATP as substrate by DELFIA	B	C[C@@H](CN(C)C)Oc1nc(Nc2cc3cccc(Cl)c3cn2)cnc1C#N		CHEMBL1928706		IC50			CHEMBL2527	Homo sapiens	IC50		
	7977574	CHEMBL1930051	Competitive inhibition of human CHK2 using ATP as substrate by DELFIA	B	C[C@H](CN(C)C)Oc1nc(Nc2cc3cccc(Cl)c3cn2)cnc1C#N		CHEMBL1928705	>	IC50	nM	100000.0	CHEMBL2527	Homo sapiens	IC50	uM	100.0
	7977575	CHEMBL1930051	Competitive inhibition of human CHK2 using ATP as substrate by DELFIA	B	CC(CN(C)C)Oc1nc(Nc2cc3cccc(Cl)c3cn2)cnc1C#N		CHEMBL1928704	=	IC50	nM	84000.0	CHEMBL2527	Homo sapiens	IC50	uM	84.0
	7977576	CHEMBL1930051	Competitive inhibition of human CHK2 using ATP as substrate by DELFIA	B	CC(CN(C)C)Oc1nc(Nc2cc3ccccc3cn2)cnc1C#N		CHEMBL1928703	=	IC50	nM	6200.0	CHEMBL2527	Homo sapiens	IC50	uM	6.2
	7977577	CHEMBL1930051	Competitive inhibition of human CHK2 using ATP as substrate by DELFIA	B	CN(C)CCOc1nc(Nc2cc3cccc(Cl)c3cn2)cnc1C#N		CHEMBL1928702	=	IC50	nM	12000.0	CHEMBL2527	Homo sapiens	IC50	uM	12.0
	7977578	CHEMBL1930051	Competitive inhibition of human CHK2 using ATP as substrate by DELFIA	B	N#Cc1ncc(Nc2cc3cccc(Cl)c3cn2)nc1OC1CCCNC1		CHEMBL1928701	=	IC50	nM	1800.0	CHEMBL2527	Homo sapiens	IC50	uM	1.8
Not Determined	7977579	CHEMBL1930051	Competitive inhibition of human CHK2 using ATP as substrate by DELFIA	B	N#Cc1ncc(Nc2cc3ccccc3cn2)nc1OC1CCCNC1		CHEMBL1928700		IC50			CHEMBL2527	Homo sapiens	IC50		
	7977580	CHEMBL1930051	Competitive inhibition of human CHK2 using ATP as substrate by DELFIA	B	N#Cc1ncc(Nc2cc3cccc(Cl)c3cn2)nc1OCC1CCNCC1		CHEMBL1928699	=	IC50	nM	17000.0	CHEMBL2527	Homo sapiens	IC50	uM	17.0
	7977581	CHEMBL1930051	Competitive inhibition of human CHK2 using ATP as substrate by DELFIA	B	N#Cc1cnc(Nc2cc3cccc(Cl)c3cn2)cn1		CHEMBL1928698	>	IC50	nM	100000.0	CHEMBL2527	Homo sapiens	IC50	uM	100.0
	7977582	CHEMBL1930051	Competitive inhibition of human CHK2 using ATP as substrate by DELFIA	B	N#Cc1ncc(Nc2cc3ccccc3cn2)nc1OCC1CCNCC1		CHEMBL1928697	=	IC50	nM	6600.0	CHEMBL2527	Homo sapiens	IC50	uM	6.6
	7977583	CHEMBL1930051	Competitive inhibition of human CHK2 using ATP as substrate by DELFIA	B	N#Cc1cnc(Nc2cc3ccccc3cn2)cn1		CHEMBL1928696	>	IC50	nM	100000.0	CHEMBL2527	Homo sapiens	IC50	uM	100.0
	7977584	CHEMBL1930051	Competitive inhibition of human CHK2 using ATP as substrate by DELFIA	B	N#Cc1ncc(Nc2cc3[nH]cnc3cn2)nc1OCC1CCNCC1		CHEMBL1928695	=	IC50	nM	44000.0	CHEMBL2527	Homo sapiens	IC50	uM	44.0
Not Determined	7977585	CHEMBL1930051	Competitive inhibition of human CHK2 using ATP as substrate by DELFIA	B	N#Cc1cnc(Nc2cc3c(cn2)ncn3CC2CCNCC2)cn1		CHEMBL1928694		IC50			CHEMBL2527	Homo sapiens	IC50		
Not Determined	7977586	CHEMBL1930051	Competitive inhibition of human CHK2 using ATP as substrate by DELFIA	B	N#Cc1cnc(Nc2cc3[nH]cnc3cn2)cn1		CHEMBL1928693		IC50			CHEMBL2527	Homo sapiens	IC50		
	7977587	CHEMBL1930051	Competitive inhibition of human CHK2 using ATP as substrate by DELFIA	B	COC(=O)c1cnc(Nc2cnc(C#N)cn2)cc1NCC1CCNCC1		CHEMBL1928692	=	IC50	nM	12000.0	CHEMBL2527	Homo sapiens	IC50	uM	12.0
Not Determined	7977588	CHEMBL1930051	Competitive inhibition of human CHK2 using ATP as substrate by DELFIA	B	N#Cc1cnc(Nc2cc(NCCCO)ncn2)cn1		CHEMBL1928690		IC50			CHEMBL2527	Homo sapiens	IC50		
	7977589	CHEMBL1930051	Competitive inhibition of human CHK2 using ATP as substrate by DELFIA	B	N#Cc1cnc(Nc2cc(NCC3CCNCC3)ncn2)cn1		CHEMBL1928689	=	IC50	nM	8600.0	CHEMBL2527	Homo sapiens	IC50	uM	8.6
Not Determined	7977590	CHEMBL1930051	Competitive inhibition of human CHK2 using ATP as substrate by DELFIA	B	N#Cc1cnc(Nc2cc(NCCCN)ncn2)cn1		CHEMBL1928688		IC50			CHEMBL2527	Homo sapiens	IC50		
Not Determined	7977591	CHEMBL1930051	Competitive inhibition of human CHK2 using ATP as substrate by DELFIA	B	N#Cc1cnc(Nc2cc(NCCN)ncn2)cn1		CHEMBL1928687		IC50			CHEMBL2527	Homo sapiens	IC50		
Not Determined	7977592	CHEMBL1930051	Competitive inhibition of human CHK2 using ATP as substrate by DELFIA	B	N#Cc1cnc(Nc2cc(N3CCC(N)CC3)ncn2)cn1		CHEMBL1928686		IC50			CHEMBL2527	Homo sapiens	IC50		
	7977593	CHEMBL1930051	Competitive inhibition of human CHK2 using ATP as substrate by DELFIA	B	N#Cc1cnc(Nc2cc(N3CCC(CN)CC3)ncn2)cn1		CHEMBL1928685	=	IC50	nM	38000.0	CHEMBL2527	Homo sapiens	IC50	uM	38.0
	7977594	CHEMBL1930051	Competitive inhibition of human CHK2 using ATP as substrate by DELFIA	B	NCC1CCN(c2cc(Nc3cnccn3)ncn2)CC1		CHEMBL1928684	=	IC50	nM	41000.0	CHEMBL2527	Homo sapiens	IC50	uM	41.0
Not Determined	7977595	CHEMBL1930051	Competitive inhibition of human CHK2 using ATP as substrate by DELFIA	B	c1cncc(Nc2cc(NCC3CCNCC3)ncn2)c1		CHEMBL1928683		IC50			CHEMBL2527	Homo sapiens	IC50		
	7978748	CHEMBL1930051	Competitive inhibition of human CHK2 using ATP as substrate by DELFIA	B	NCC1CCN(c2ncnc3[nH]c4cnccc4c23)CC1		CHEMBL1928682	=	IC50	nM	12000.0	CHEMBL2527	Homo sapiens	IC50	uM	12.0
	7978749	CHEMBL1930051	Competitive inhibition of human CHK2 using ATP as substrate by DELFIA	B	NC1CCN(c2ncnc3[nH]c4cnccc4c23)CC1		CHEMBL1928681	=	IC50	nM	16000.0	CHEMBL2527	Homo sapiens	IC50	uM	16.0
	7978750	CHEMBL1930051	Competitive inhibition of human CHK2 using ATP as substrate by DELFIA	B	NCCCNc1ncnc2[nH]c3cnccc3c12		CHEMBL1928680	=	IC50	nM	11000.0	CHEMBL2527	Homo sapiens	IC50	uM	11.0
	7978751	CHEMBL1930051	Competitive inhibition of human CHK2 using ATP as substrate by DELFIA	B	NCCNc1ncnc2[nH]c3cnccc3c12		CHEMBL1928679	=	IC50	nM	23000.0	CHEMBL2527	Homo sapiens	IC50	uM	23.0
	7978752	CHEMBL1930051	Competitive inhibition of human CHK2 using ATP as substrate by DELFIA	B	N#Cc1ccc2c(c1)[nH]c1ncnc(N3CCOC(CN)C3)c12		CHEMBL1928678	=	IC50	nM	10000.0	CHEMBL2527	Homo sapiens	IC50	uM	10.0
	7978753	CHEMBL1930051	Competitive inhibition of human CHK2 using ATP as substrate by DELFIA	B	NCC1CN(c2ncnc3[nH]c4cnccc4c23)CCO1		CHEMBL1928677	=	IC50	nM	19000.0	CHEMBL2527	Homo sapiens	IC50	uM	19.0
	7978754	CHEMBL1930051	Competitive inhibition of human CHK2 using ATP as substrate by DELFIA	B	NC[C@H]1CN(c2ncnc3[nH]c4ccccc4c23)CCO1		CHEMBL1928676	=	IC50	nM	3500.0	CHEMBL2527	Homo sapiens	IC50	uM	3.5
	7978755	CHEMBL1930051	Competitive inhibition of human CHK2 using ATP as substrate by DELFIA	B	NC[C@@H]1CN(c2ncnc3[nH]c4ccccc4c23)CCO1		CHEMBL1928675	=	IC50	nM	13000.0	CHEMBL2527	Homo sapiens	IC50	uM	13.0
	7978756	CHEMBL1930051	Competitive inhibition of human CHK2 using ATP as substrate by DELFIA	B	NCC1CN(c2ncnc3[nH]c4ccccc4c23)CCO1		CHEMBL1928674	=	IC50	nM	12000.0	CHEMBL2527	Homo sapiens	IC50	uM	12.0
	7978757	CHEMBL1930051	Competitive inhibition of human CHK2 using ATP as substrate by DELFIA	B	NCC1CN(c2ncnc3[nH]cc(-c4cccc(CO)c4)c23)CCO1		CHEMBL1928673	=	IC50	nM	3400.0	CHEMBL2527	Homo sapiens	IC50	uM	3.4
	7978758	CHEMBL1930051	Competitive inhibition of human CHK2 using ATP as substrate by DELFIA	B	N#Cc1cccc(-c2c[nH]c3ncnc(N4CCOC(CN)C4)c23)c1		CHEMBL1928672	=	IC50	nM	28000.0	CHEMBL2527	Homo sapiens	IC50	uM	28.0
Not Determined	7978759	CHEMBL1930051	Competitive inhibition of human CHK2 using ATP as substrate by DELFIA	B	CCOC(=O)c1cnc2[nH]nc(-c3cccc(C#N)c3)c2c1N1CCOC(CN)C1		CHEMBL1928671		IC50			CHEMBL2527	Homo sapiens	IC50		
	7978760	CHEMBL1930051	Competitive inhibition of human CHK2 using ATP as substrate by DELFIA	B	CCOC(=O)c1cnc2[nH]ncc2c1N1CCOC(CN)C1		CHEMBL560056	=	IC50	nM	50000.0	CHEMBL2527	Homo sapiens	IC50	uM	50.0
	7987118	CHEMBL1936071	Inhibition of Chk2	B	O=C(c1cc2cc(F)ccc2[nH]1)N1C[C@]2(CCN(C3CCCNC3)C2)c2ccccc21		CHEMBL1933538	>	IC50	nM	30000.0	CHEMBL2527	Homo sapiens	IC50	uM	30.0
	7987140	CHEMBL1936071	Inhibition of Chk2	B	O=C(c1cc2ccc(F)cc2[nH]1)N1C[C@]2(CCN(C3CCNC3)C2)c2ccccc21		CHEMBL1933550	>	IC50	nM	30000.0	CHEMBL2527	Homo sapiens	IC50	uM	30.0
	7987162	CHEMBL1936071	Inhibition of Chk2	B	C[C@@H]1CCC(N2CC[C@]3(CN(C(=O)c4cc5ccccc5[nH]4)c4ccccc43)C2)CN1		CHEMBL1933551	>	IC50	nM	30000.0	CHEMBL2527	Homo sapiens	IC50	uM	30.0
	7987194	CHEMBL1936071	Inhibition of Chk2	B	C[C@@H]1CCC(N2CC[C@]3(CN(C(=O)c4cc5ccc(F)cc5[nH]4)c4ccccc43)C2)CN1		CHEMBL1933552	>	IC50	nM	30000.0	CHEMBL2527	Homo sapiens	IC50	uM	30.0
	7989235	CHEMBL1936341	Inhibition of human CHEK2 at 3 uM	B	Cn1cc(NC(=O)c2ccc3cc4n(c3c2)C(C)(C)CNC4=O)nc1C(=O)NC1CCCC1		CHEMBL1933142	>=	Inhibition	%	80.0	CHEMBL2527	Homo sapiens	INH	%	80.0
	7989236	CHEMBL1936341	Inhibition of human CHEK2 at 3 uM	B	Cc1cc(NC(=O)c2ccc3cc4n(c3c2)CCCNC4=O)on1		CHEMBL1933143	>=	Inhibition	%	80.0	CHEMBL2527	Homo sapiens	INH	%	80.0
	7989237	CHEMBL1936341	Inhibition of human CHEK2 at 3 uM	B	Cn1cc(NC(=O)c2ccc3cc4n(c3c2)CCCNC4=O)cn1		CHEMBL1933148	>=	Inhibition	%	80.0	CHEMBL2527	Homo sapiens	INH	%	80.0
	7989238	CHEMBL1936341	Inhibition of human CHEK2 at 3 uM	B	Cn1c(NC(=O)c2ccc3cc4n(c3c2)CCCNC4=O)nc2ccccc21		CHEMBL1933279	>=	Inhibition	%	80.0	CHEMBL2527	Homo sapiens	INH	%	80.0
	8002065	CHEMBL1942171	Inhibition of CHEK2 at 1 uM	B	CC(C)n1cc(C(=O)c2cncc(N[C@@H]3CCN(C=O)[C@@H]3c3ccc(F)cc3)n2)c2c(N)ncnc21		CHEMBL1940251	=	Inhibition	%	98.0	CHEMBL2527	Homo sapiens	INH	%	98.0
	8002066	CHEMBL1942171	Inhibition of CHEK2 at 1 uM	B	CC(=O)N1CC[C@@H](Nc2cncc(C(=O)c3cn(C(C)C)c4ncnc(N)c34)n2)[C@H]1c1ccc(F)cc1		CHEMBL1940252	=	Inhibition	%	99.0	CHEMBL2527	Homo sapiens	INH	%	99.0
	8002067	CHEMBL1942171	Inhibition of CHEK2 at 1 uM	B	CC(=O)N1CC[C@@H](Nc2cncc(C(=O)c3cn(C(C)C)c4ncnc(N)c34)n2)[C@H]1c1ccccc1		CHEMBL1940253	=	Inhibition	%	94.0	CHEMBL2527	Homo sapiens	INH	%	94.0
	8023897	CHEMBL1947437	Inhibition of human Chk2 using STK1 as substrate after 10 mins by HTRF assay	B	NC1=N/C(=C2/CCNC(=O)c3[nH]ccc32)C(=O)N1		CHEMBL255465	=	IC50	nM	183.0	CHEMBL2527	Homo sapiens	IC50	nM	183.0
	8023898	CHEMBL1947437	Inhibition of human Chk2 using STK1 as substrate after 10 mins by HTRF assay	B	Nc1nc(C2=C3C(=Nc4ccccc43)C(=O)NCC2)c(O)[nH]1		CHEMBL332551	=	IC50	nM	8.0	CHEMBL2527	Homo sapiens	IC50	nM	8.0
	8023899	CHEMBL1947437	Inhibition of human Chk2 using STK1 as substrate after 10 mins by HTRF assay	B	NC1=NC(=O)/C(=C2\CCNC(=O)c3[nH]c(-c4ccccc4)cc32)N1		CHEMBL1947250	=	IC50	nM	20.0	CHEMBL2527	Homo sapiens	IC50	nM	20.0
	8023900	CHEMBL1947437	Inhibition of human Chk2 using STK1 as substrate after 10 mins by HTRF assay	B	COc1ccc(-c2cc3c([nH]2)C(=O)NCC/C3=C2/NC(N)=NC2=O)cc1		CHEMBL1947251	=	IC50	nM	14.0	CHEMBL2527	Homo sapiens	IC50	nM	14.0
	8023901	CHEMBL1947437	Inhibition of human Chk2 using STK1 as substrate after 10 mins by HTRF assay	B	COc1ccc(-c2cc3c([nH]2)C(=O)NCC/C3=C2/NC(N)=NC2=O)cc1OC		CHEMBL1947252	=	IC50	nM	14.0	CHEMBL2527	Homo sapiens	IC50	nM	14.0
	8023902	CHEMBL1947437	Inhibition of human Chk2 using STK1 as substrate after 10 mins by HTRF assay	B	O=C1N=C(NCc2ccccc2)N/C1=C1/CCNC(=O)c2[nH]c(-c3ccccc3)cc21		CHEMBL1947253	=	IC50	nM	28.0	CHEMBL2527	Homo sapiens	IC50	nM	28.0
	8023903	CHEMBL1947437	Inhibition of human Chk2 using STK1 as substrate after 10 mins by HTRF assay	B	COc1ccc(CNC2=NC(=O)/C(=C3\CCNC(=O)c4[nH]c(-c5ccccc5)cc43)N2)cc1		CHEMBL1947254	=	IC50	nM	588.0	CHEMBL2527	Homo sapiens	IC50	nM	588.0
	8023904	CHEMBL1947437	Inhibition of human Chk2 using STK1 as substrate after 10 mins by HTRF assay	B	O=C1N=C(NC2CCCCC2)N/C1=C1/CCNC(=O)c2[nH]c(-c3ccccc3)cc21		CHEMBL1947255	=	IC50	nM	1526.0	CHEMBL2527	Homo sapiens	IC50	nM	1526.0
	8023905	CHEMBL1947437	Inhibition of human Chk2 using STK1 as substrate after 10 mins by HTRF assay	B	CCOC(=O)CCNC1=NC(=O)/C(=C2\CCNC(=O)c3[nH]c(-c4ccccc4)cc32)N1		CHEMBL1944821	=	IC50	nM	277.0	CHEMBL2527	Homo sapiens	IC50	nM	277.0
	8023906	CHEMBL1947437	Inhibition of human Chk2 using STK1 as substrate after 10 mins by HTRF assay	B	CCCNC1=NC(=O)/C(=C2\CCNC(=O)c3[nH]c(-c4ccccc4)cc32)N1		CHEMBL1944822	=	IC50	nM	156.0	CHEMBL2527	Homo sapiens	IC50	nM	156.0
	8023907	CHEMBL1947437	Inhibition of human Chk2 using STK1 as substrate after 10 mins by HTRF assay	B	CNC1=NC(=O)/C(=C2\CCNC(=O)c3[nH]c(-c4ccccc4)cc32)N1		CHEMBL1944823	=	IC50	nM	171.0	CHEMBL2527	Homo sapiens	IC50	nM	171.0
	8061262	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	-0.52	CHEMBL2527	Homo sapiens	Inhibition	%	-0.52
	8061439	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	-3.47	CHEMBL2527	Homo sapiens	Inhibition	%	-3.47
	8061770	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	2.71	CHEMBL2527	Homo sapiens	Inhibition	%	2.71
	8061961	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	2.65	CHEMBL2527	Homo sapiens	Inhibition	%	2.65
	8062185	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	15.55	CHEMBL2527	Homo sapiens	Inhibition	%	15.55
	8062301	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	2.16	CHEMBL2527	Homo sapiens	Inhibition	%	2.16
	8062687	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	3.98	CHEMBL2527	Homo sapiens	Inhibition	%	3.98
	8062785	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	1.49	CHEMBL2527	Homo sapiens	Inhibition	%	1.49
	8063009	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	0.47	CHEMBL2527	Homo sapiens	Inhibition	%	0.47
	8063141	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	0.67	CHEMBL2527	Homo sapiens	Inhibition	%	0.67
	8063308	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	1.35	CHEMBL2527	Homo sapiens	Inhibition	%	1.35
	8063532	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	2.73	CHEMBL2527	Homo sapiens	Inhibition	%	2.73
	8063640	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	1.07	CHEMBL2527	Homo sapiens	Inhibition	%	1.07
	8064046	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	1.74	CHEMBL2527	Homo sapiens	Inhibition	%	1.74
	8064161	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	3.21	CHEMBL2527	Homo sapiens	Inhibition	%	3.21
	8064385	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	1.31	CHEMBL2527	Homo sapiens	Inhibition	%	1.31
	8064595	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	1.66	CHEMBL2527	Homo sapiens	Inhibition	%	1.66
	8064733	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	-0.14	CHEMBL2527	Homo sapiens	Inhibition	%	-0.14
	8065123	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	0.78	CHEMBL2527	Homo sapiens	Inhibition	%	0.78
	8065239	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	1.89	CHEMBL2527	Homo sapiens	Inhibition	%	1.89
	8065463	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	1.92	CHEMBL2527	Homo sapiens	Inhibition	%	1.92
	8065638	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	3.43	CHEMBL2527	Homo sapiens	Inhibition	%	3.43
	8065977	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	8.31	CHEMBL2527	Homo sapiens	Inhibition	%	8.31
	8066187	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	-1.09	CHEMBL2527	Homo sapiens	Inhibition	%	-1.09
	8066323	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	2.24	CHEMBL2527	Homo sapiens	Inhibition	%	2.24
	8066547	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	1.81	CHEMBL2527	Homo sapiens	Inhibition	%	1.81
	8066713	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	1.92	CHEMBL2527	Homo sapiens	Inhibition	%	1.92
	8067061	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	2.2	CHEMBL2527	Homo sapiens	Inhibition	%	2.2
	8067236	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	1.62	CHEMBL2527	Homo sapiens	Inhibition	%	1.62
	8067581	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	-0.38	CHEMBL2527	Homo sapiens	Inhibition	%	-0.38
	8067791	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	-0.94	CHEMBL2527	Homo sapiens	Inhibition	%	-0.94
	8068150	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	14.13	CHEMBL2527	Homo sapiens	Inhibition	%	14.13
	8068314	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	1.04	CHEMBL2527	Homo sapiens	Inhibition	%	1.04
	8068663	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	-0.21	CHEMBL2527	Homo sapiens	Inhibition	%	-0.21
	8068837	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	1.94	CHEMBL2527	Homo sapiens	Inhibition	%	1.94
	8069061	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	2.27	CHEMBL2527	Homo sapiens	Inhibition	%	2.27
	8069186	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	0.19	CHEMBL2527	Homo sapiens	Inhibition	%	0.19
	8069481	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	2.05	CHEMBL2527	Homo sapiens	Inhibition	%	2.05
	8069642	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	2.58	CHEMBL2527	Homo sapiens	Inhibition	%	2.58
	8069866	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	1.38	CHEMBL2527	Homo sapiens	Inhibition	%	1.38
	8069992	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	0.73	CHEMBL2527	Homo sapiens	Inhibition	%	0.73
	8070388	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	2.52	CHEMBL2527	Homo sapiens	Inhibition	%	2.52
	8070513	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	0.27	CHEMBL2527	Homo sapiens	Inhibition	%	0.27
	8070811	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	10.15	CHEMBL2527	Homo sapiens	Inhibition	%	10.15
	8071192	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	2.55	CHEMBL2527	Homo sapiens	Inhibition	%	2.55
	8071318	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	-0.67	CHEMBL2527	Homo sapiens	Inhibition	%	-0.67
	8071542	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	-0.16	CHEMBL2527	Homo sapiens	Inhibition	%	-0.16
	8071715	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	2.64	CHEMBL2527	Homo sapiens	Inhibition	%	2.64
	8071840	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	0.77	CHEMBL2527	Homo sapiens	Inhibition	%	0.77
	8072064	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	-0.62	CHEMBL2527	Homo sapiens	Inhibition	%	-0.62
	8072154	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	-0.85	CHEMBL2527	Homo sapiens	Inhibition	%	-0.85
	8072378	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	0.45	CHEMBL2527	Homo sapiens	Inhibition	%	0.45
	8072535	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	1.94	CHEMBL2527	Homo sapiens	Inhibition	%	1.94
	8072884	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	-0.7	CHEMBL2527	Homo sapiens	Inhibition	%	-0.7
	8073051	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	2.71	CHEMBL2527	Homo sapiens	Inhibition	%	2.71
	8073400	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	-0.04	CHEMBL2527	Homo sapiens	Inhibition	%	-0.04
	8073519	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	0.04	CHEMBL2527	Homo sapiens	Inhibition	%	0.04
	8073743	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	0.67	CHEMBL2527	Homo sapiens	Inhibition	%	0.67
	8073976	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	-1.49	CHEMBL2527	Homo sapiens	Inhibition	%	-1.49
	8074128	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	3.46	CHEMBL2527	Homo sapiens	Inhibition	%	3.46
	8074482	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	-0.07	CHEMBL2527	Homo sapiens	Inhibition	%	-0.07
	8074639	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	4.2	CHEMBL2527	Homo sapiens	Inhibition	%	4.2
	8074990	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	-0.49	CHEMBL2527	Homo sapiens	Inhibition	%	-0.49
	8075325	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	-0.55	CHEMBL2527	Homo sapiens	Inhibition	%	-0.55
	8075562	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	0.49	CHEMBL2527	Homo sapiens	Inhibition	%	0.49
	8075703	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	2.39	CHEMBL2527	Homo sapiens	Inhibition	%	2.39
	8075927	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	3.13	CHEMBL2527	Homo sapiens	Inhibition	%	3.13
	8076069	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	-1.28	CHEMBL2527	Homo sapiens	Inhibition	%	-1.28
	8076217	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	6.05	CHEMBL2527	Homo sapiens	Inhibition	%	6.05
	8076441	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	1.58	CHEMBL2527	Homo sapiens	Inhibition	%	1.58
	8076575	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	4.32	CHEMBL2527	Homo sapiens	Inhibition	%	4.32
	8076901	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	-1.12	CHEMBL2527	Homo sapiens	Inhibition	%	-1.12
	8077148	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	2.31	CHEMBL2527	Homo sapiens	Inhibition	%	2.31
	8077500	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	1.03	CHEMBL2527	Homo sapiens	Inhibition	%	1.03
	8077651	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	-0.25	CHEMBL2527	Homo sapiens	Inhibition	%	-0.25
	8078018	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	4.01	CHEMBL2527	Homo sapiens	Inhibition	%	4.01
	8078157	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	-1.68	CHEMBL2527	Homo sapiens	Inhibition	%	-1.68
	8078381	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	3.93	CHEMBL2527	Homo sapiens	Inhibition	%	3.93
	8078483	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	0.01	CHEMBL2527	Homo sapiens	Inhibition	%	0.01
	8078733	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	26.73	CHEMBL2527	Homo sapiens	Inhibition	%	26.73
	8079073	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	4.05	CHEMBL2527	Homo sapiens	Inhibition	%	4.05
	8079231	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	-1.68	CHEMBL2527	Homo sapiens	Inhibition	%	-1.68
	8079455	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	-1.71	CHEMBL2527	Homo sapiens	Inhibition	%	-1.71
	8079597	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	2.23	CHEMBL2527	Homo sapiens	Inhibition	%	2.23
	8079960	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	58.31	CHEMBL2527	Homo sapiens	Inhibition	%	58.31
	8080065	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	0.8	CHEMBL2527	Homo sapiens	Inhibition	%	0.8
	8080317	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	-0.46	CHEMBL2527	Homo sapiens	Inhibition	%	-0.46
	8080541	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	13.53	CHEMBL2527	Homo sapiens	Inhibition	%	13.53
	8080656	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	1.65	CHEMBL2527	Homo sapiens	Inhibition	%	1.65
	8081044	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	-2.81	CHEMBL2527	Homo sapiens	Inhibition	%	-2.81
	8081179	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	7.61	CHEMBL2527	Homo sapiens	Inhibition	%	7.61
	8081547	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	80.92	CHEMBL2527	Homo sapiens	Inhibition	%	80.92
	8081650	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	0.16	CHEMBL2527	Homo sapiens	Inhibition	%	0.16
	8081874	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	2.07	CHEMBL2527	Homo sapiens	Inhibition	%	2.07
	8082126	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	-2.0	CHEMBL2527	Homo sapiens	Inhibition	%	-2.0
	8082239	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	14.17	CHEMBL2527	Homo sapiens	Inhibition	%	14.17
	8082636	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	-2.65	CHEMBL2527	Homo sapiens	Inhibition	%	-2.65
	8082759	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	1.83	CHEMBL2527	Homo sapiens	Inhibition	%	1.83
	8082983	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	3.06	CHEMBL2527	Homo sapiens	Inhibition	%	3.06
	8083139	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	10.6	CHEMBL2527	Homo sapiens	Inhibition	%	10.6
	8083462	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	0.51	CHEMBL2527	Homo sapiens	Inhibition	%	0.51
	8083716	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	-1.47	CHEMBL2527	Homo sapiens	Inhibition	%	-1.47
	8083826	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	1.28	CHEMBL2527	Homo sapiens	Inhibition	%	1.28
	8084050	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	9.16	CHEMBL2527	Homo sapiens	Inhibition	%	9.16
	8084235	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	5.0	CHEMBL2527	Homo sapiens	Inhibition	%	5.0
	8084577	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	3.91	CHEMBL2527	Homo sapiens	Inhibition	%	3.91
	8084738	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	18.97	CHEMBL2527	Homo sapiens	Inhibition	%	18.97
	8085060	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	0.84	CHEMBL2527	Homo sapiens	Inhibition	%	0.84
	8085316	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	-3.42	CHEMBL2527	Homo sapiens	Inhibition	%	-3.42
	8085648	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	1.2	CHEMBL2527	Homo sapiens	Inhibition	%	1.2
	8085837	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	26.29	CHEMBL2527	Homo sapiens	Inhibition	%	26.29
	8086176	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	17.94	CHEMBL2527	Homo sapiens	Inhibition	%	17.94
	8086338	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	3.5	CHEMBL2527	Homo sapiens	Inhibition	%	3.5
	8086562	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	5.98	CHEMBL2527	Homo sapiens	Inhibition	%	5.98
	8086661	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	1.09	CHEMBL2527	Homo sapiens	Inhibition	%	1.09
	8086872	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	2.6	CHEMBL2527	Homo sapiens	Inhibition	%	2.6
	8087096	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	9.62	CHEMBL2527	Homo sapiens	Inhibition	%	9.62
	8087254	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	3.52	CHEMBL2527	Homo sapiens	Inhibition	%	3.52
	8087592	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	-2.63	CHEMBL2527	Homo sapiens	Inhibition	%	-2.63
	8087730	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	28.59	CHEMBL2527	Homo sapiens	Inhibition	%	28.59
	8087954	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	1.16	CHEMBL2527	Homo sapiens	Inhibition	%	1.16
	8088096	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	5.6	CHEMBL2527	Homo sapiens	Inhibition	%	5.6
	8088244	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	1.07	CHEMBL2527	Homo sapiens	Inhibition	%	1.07
	8088468	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	1.94	CHEMBL2527	Homo sapiens	Inhibition	%	1.94
	8088596	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	8.19	CHEMBL2527	Homo sapiens	Inhibition	%	8.19
	8088913	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	1.9	CHEMBL2527	Homo sapiens	Inhibition	%	1.9
	8089265	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	33.56	CHEMBL2527	Homo sapiens	Inhibition	%	33.56
	8089413	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	5.36	CHEMBL2527	Homo sapiens	Inhibition	%	5.36
	8089757	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	-1.42	CHEMBL2527	Homo sapiens	Inhibition	%	-1.42
	8089937	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	-0.27	CHEMBL2527	Homo sapiens	Inhibition	%	-0.27
	8090326	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	29.79	CHEMBL2527	Homo sapiens	Inhibition	%	29.79
	8090493	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	2.24	CHEMBL2527	Homo sapiens	Inhibition	%	2.24
	8090856	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	5.43	CHEMBL2527	Homo sapiens	Inhibition	%	5.43
	8091061	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	3.41	CHEMBL2527	Homo sapiens	Inhibition	%	3.41
	8091422	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	13.07	CHEMBL2527	Homo sapiens	Inhibition	%	13.07
	8091577	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	5.57	CHEMBL2527	Homo sapiens	Inhibition	%	5.57
	8091917	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	-3.53	CHEMBL2527	Homo sapiens	Inhibition	%	-3.53
	8092278	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	1.46	CHEMBL2527	Homo sapiens	Inhibition	%	1.46
	8092429	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	4.96	CHEMBL2527	Homo sapiens	Inhibition	%	4.96
	8092801	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	-6.31	CHEMBL2527	Homo sapiens	Inhibition	%	-6.31
	8092930	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	11.6	CHEMBL2527	Homo sapiens	Inhibition	%	11.6
	8093242	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	2.3	CHEMBL2527	Homo sapiens	Inhibition	%	2.3
	8093606	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	-5.8	CHEMBL2527	Homo sapiens	Inhibition	%	-5.8
	8093745	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	9.14	CHEMBL2527	Homo sapiens	Inhibition	%	9.14
	8094089	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	-0.76	CHEMBL2527	Homo sapiens	Inhibition	%	-0.76
	8094269	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	-0.74	CHEMBL2527	Homo sapiens	Inhibition	%	-0.74
	8094493	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	-0.4	CHEMBL2527	Homo sapiens	Inhibition	%	-0.4
	8094668	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	49.62	CHEMBL2527	Homo sapiens	Inhibition	%	49.62
	8094824	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	4.72	CHEMBL2527	Homo sapiens	Inhibition	%	4.72
	8095048	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	5.28	CHEMBL2527	Homo sapiens	Inhibition	%	5.28
	8095188	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	25.95	CHEMBL2527	Homo sapiens	Inhibition	%	25.95
	8095391	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	12.89	CHEMBL2527	Homo sapiens	Inhibition	%	12.89
	8095615	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	-0.32	CHEMBL2527	Homo sapiens	Inhibition	%	-0.32
	8095756	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	51.31	CHEMBL2527	Homo sapiens	Inhibition	%	51.31
	8095904	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	10.7	CHEMBL2527	Homo sapiens	Inhibition	%	10.7
	8096128	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	35.85	CHEMBL2527	Homo sapiens	Inhibition	%	35.85
	8096245	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	1.57	CHEMBL2527	Homo sapiens	Inhibition	%	1.57
	8096608	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	1.32	CHEMBL2527	Homo sapiens	Inhibition	%	1.32
	8096764	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	11.16	CHEMBL2527	Homo sapiens	Inhibition	%	11.16
	8097135	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	-6.27	CHEMBL2527	Homo sapiens	Inhibition	%	-6.27
	8097442	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	2.83	CHEMBL2527	Homo sapiens	Inhibition	%	2.83
	8097666	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	5.73	CHEMBL2527	Homo sapiens	Inhibition	%	5.73
	8097816	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	1.05	CHEMBL2527	Homo sapiens	Inhibition	%	1.05
	8097949	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	0.25	CHEMBL2527	Homo sapiens	Inhibition	%	0.25
	8098173	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	6.26	CHEMBL2527	Homo sapiens	Inhibition	%	6.26
	8098293	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	-0.72	CHEMBL2527	Homo sapiens	Inhibition	%	-0.72
	8098697	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	1.08	CHEMBL2527	Homo sapiens	Inhibition	%	1.08
	8098882	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	79.11	CHEMBL2527	Homo sapiens	Inhibition	%	79.11
	8099250	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	28.82	CHEMBL2527	Homo sapiens	Inhibition	%	28.82
	8099392	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	1.3	CHEMBL2527	Homo sapiens	Inhibition	%	1.3
	8099810	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	0.27	CHEMBL2527	Homo sapiens	Inhibition	%	0.27
	8099957	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	-1.83	CHEMBL2527	Homo sapiens	Inhibition	%	-1.83
	8100327	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	0.92	CHEMBL2527	Homo sapiens	Inhibition	%	0.92
	8100443	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	1.85	CHEMBL2527	Homo sapiens	Inhibition	%	1.85
	8100667	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	4.28	CHEMBL2527	Homo sapiens	Inhibition	%	4.28
	8100807	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	2.85	CHEMBL2527	Homo sapiens	Inhibition	%	2.85
	8100967	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	8.96	CHEMBL2527	Homo sapiens	Inhibition	%	8.96
	8101191	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	12.54	CHEMBL2527	Homo sapiens	Inhibition	%	12.54
	8101333	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	-3.16	CHEMBL2527	Homo sapiens	Inhibition	%	-3.16
	8101518	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	2.58	CHEMBL2527	Homo sapiens	Inhibition	%	2.58
	8101742	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	1.99	CHEMBL2527	Homo sapiens	Inhibition	%	1.99
	8101995	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	6.91	CHEMBL2527	Homo sapiens	Inhibition	%	6.91
	8102150	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	-2.95	CHEMBL2527	Homo sapiens	Inhibition	%	-2.95
	8102505	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	-0.98	CHEMBL2527	Homo sapiens	Inhibition	%	-0.98
	8102625	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	-0.59	CHEMBL2527	Homo sapiens	Inhibition	%	-0.59
	8102849	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	-0.17	CHEMBL2527	Homo sapiens	Inhibition	%	-0.17
	8103027	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	4.69	CHEMBL2527	Homo sapiens	Inhibition	%	4.69
	8103223	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	4.7	CHEMBL2527	Homo sapiens	Inhibition	%	4.7
	8103585	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	-0.9	CHEMBL2527	Homo sapiens	Inhibition	%	-0.9
	8103735	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	1.9	CHEMBL2527	Homo sapiens	Inhibition	%	1.9
	8103959	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	2.9	CHEMBL2527	Homo sapiens	Inhibition	%	2.9
	8104144	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	0.39	CHEMBL2527	Homo sapiens	Inhibition	%	0.39
	8104292	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	2.47	CHEMBL2527	Homo sapiens	Inhibition	%	2.47
	8104516	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	2.55	CHEMBL2527	Homo sapiens	Inhibition	%	2.55
	8104662	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	5.7	CHEMBL2527	Homo sapiens	Inhibition	%	5.7
	8105000	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	4.2	CHEMBL2527	Homo sapiens	Inhibition	%	4.2
	8105140	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	-5.72	CHEMBL2527	Homo sapiens	Inhibition	%	-5.72
	8105530	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	3.23	CHEMBL2527	Homo sapiens	Inhibition	%	3.23
	8105668	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	1.28	CHEMBL2527	Homo sapiens	Inhibition	%	1.28
	8105892	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	4.6	CHEMBL2527	Homo sapiens	Inhibition	%	4.6
	8105948	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	-2.67	CHEMBL2527	Homo sapiens	Inhibition	%	-2.67
	8106172	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	-1.77	CHEMBL2527	Homo sapiens	Inhibition	%	-1.77
	8106337	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	0.82	CHEMBL2527	Homo sapiens	Inhibition	%	0.82
	8106493	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	9.48	CHEMBL2527	Homo sapiens	Inhibition	%	9.48
	8106717	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	-1.17	CHEMBL2527	Homo sapiens	Inhibition	%	-1.17
	8106846	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	2.66	CHEMBL2527	Homo sapiens	Inhibition	%	2.66
	8107191	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	-0.76	CHEMBL2527	Homo sapiens	Inhibition	%	-0.76
	8107363	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	1.22	CHEMBL2527	Homo sapiens	Inhibition	%	1.22
	8107564	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	11.33	CHEMBL2527	Homo sapiens	Inhibition	%	11.33
	8107788	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	3.02	CHEMBL2527	Homo sapiens	Inhibition	%	3.02
	8107923	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	2.39	CHEMBL2527	Homo sapiens	Inhibition	%	2.39
	8108305	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	2.7	CHEMBL2527	Homo sapiens	Inhibition	%	2.7
	8108480	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	0.53	CHEMBL2527	Homo sapiens	Inhibition	%	0.53
	8108851	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	6.43	CHEMBL2527	Homo sapiens	Inhibition	%	6.43
	8108993	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	1.33	CHEMBL2527	Homo sapiens	Inhibition	%	1.33
	8109331	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	7.37	CHEMBL2527	Homo sapiens	Inhibition	%	7.37
	8109461	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	-6.53	CHEMBL2527	Homo sapiens	Inhibition	%	-6.53
	8109685	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	-3.67	CHEMBL2527	Homo sapiens	Inhibition	%	-3.67
	8109856	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	5.06	CHEMBL2527	Homo sapiens	Inhibition	%	5.06
	8110212	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	5.38	CHEMBL2527	Homo sapiens	Inhibition	%	5.38
	8110491	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	1.33	CHEMBL2527	Homo sapiens	Inhibition	%	1.33
	8110657	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	0.61	CHEMBL2527	Homo sapiens	Inhibition	%	0.61
	8111039	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	0.23	CHEMBL2527	Homo sapiens	Inhibition	%	0.23
	8111162	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	-4.84	CHEMBL2527	Homo sapiens	Inhibition	%	-4.84
	8111513	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	0.37	CHEMBL2527	Homo sapiens	Inhibition	%	0.37
	8111679	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	0.32	CHEMBL2527	Homo sapiens	Inhibition	%	0.32
	8111903	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	-0.89	CHEMBL2527	Homo sapiens	Inhibition	%	-0.89
	8112108	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	6.44	CHEMBL2527	Homo sapiens	Inhibition	%	6.44
	8112245	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	0.02	CHEMBL2527	Homo sapiens	Inhibition	%	0.02
	8112637	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	3.46	CHEMBL2527	Homo sapiens	Inhibition	%	3.46
	8112809	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	1.56	CHEMBL2527	Homo sapiens	Inhibition	%	1.56
	8113185	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	3.74	CHEMBL2527	Homo sapiens	Inhibition	%	3.74
	8113321	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	3.09	CHEMBL2527	Homo sapiens	Inhibition	%	3.09
	8113545	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	-6.13	CHEMBL2527	Homo sapiens	Inhibition	%	-6.13
	8113669	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	8.27	CHEMBL2527	Homo sapiens	Inhibition	%	8.27
	8114009	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	-2.84	CHEMBL2527	Homo sapiens	Inhibition	%	-2.84
	8114185	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	4.17	CHEMBL2527	Homo sapiens	Inhibition	%	4.17
	8114541	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	7.63	CHEMBL2527	Homo sapiens	Inhibition	%	7.63
	8114817	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	1.29	CHEMBL2527	Homo sapiens	Inhibition	%	1.29
	8114983	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	0.48	CHEMBL2527	Homo sapiens	Inhibition	%	0.48
	8115372	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	3.3	CHEMBL2527	Homo sapiens	Inhibition	%	3.3
	8115492	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	-2.63	CHEMBL2527	Homo sapiens	Inhibition	%	-2.63
	8115716	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	-0.4	CHEMBL2527	Homo sapiens	Inhibition	%	-0.4
	8115849	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	1.08	CHEMBL2527	Homo sapiens	Inhibition	%	1.08
	8116232	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	5.93	CHEMBL2527	Homo sapiens	Inhibition	%	5.93
	8116435	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	2.65	CHEMBL2527	Homo sapiens	Inhibition	%	2.65
	8116569	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	0.48	CHEMBL2527	Homo sapiens	Inhibition	%	0.48
	8116793	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	0.32	CHEMBL2527	Homo sapiens	Inhibition	%	0.32
	8116965	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	7.7	CHEMBL2527	Homo sapiens	Inhibition	%	7.7
	8117136	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	8.55	CHEMBL2527	Homo sapiens	Inhibition	%	8.55
	8117360	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	-0.6	CHEMBL2527	Homo sapiens	Inhibition	%	-0.6
	8117518	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	6.21	CHEMBL2527	Homo sapiens	Inhibition	%	6.21
	8117872	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	-4.43	CHEMBL2527	Homo sapiens	Inhibition	%	-4.43
	8118010	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	2.5	CHEMBL2527	Homo sapiens	Inhibition	%	2.5
	8118350	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	5.72	CHEMBL2527	Homo sapiens	Inhibition	%	5.72
	8118522	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	5.4	CHEMBL2527	Homo sapiens	Inhibition	%	5.4
	8118746	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	-2.09	CHEMBL2527	Homo sapiens	Inhibition	%	-2.09
	8118882	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	8.84	CHEMBL2527	Homo sapiens	Inhibition	%	8.84
	8119153	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	40.25	CHEMBL2527	Homo sapiens	Inhibition	%	40.25
	8119312	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	2.69	CHEMBL2527	Homo sapiens	Inhibition	%	2.69
	8119536	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	-3.59	CHEMBL2527	Homo sapiens	Inhibition	%	-3.59
	8119703	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	4.37	CHEMBL2527	Homo sapiens	Inhibition	%	4.37
	8120046	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	1.15	CHEMBL2527	Homo sapiens	Inhibition	%	1.15
	8120185	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	-0.69	CHEMBL2527	Homo sapiens	Inhibition	%	-0.69
	8120569	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	-1.25	CHEMBL2527	Homo sapiens	Inhibition	%	-1.25
	8120770	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	7.53	CHEMBL2527	Homo sapiens	Inhibition	%	7.53
	8121122	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	0.01	CHEMBL2527	Homo sapiens	Inhibition	%	0.01
	8121294	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	0.28	CHEMBL2527	Homo sapiens	Inhibition	%	0.28
	8121685	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	0.61	CHEMBL2527	Homo sapiens	Inhibition	%	0.61
	8121848	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	7.49	CHEMBL2527	Homo sapiens	Inhibition	%	7.49
	8122193	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	-3.48	CHEMBL2527	Homo sapiens	Inhibition	%	-3.48
	8122331	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	2.87	CHEMBL2527	Homo sapiens	Inhibition	%	2.87
	8122555	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	4.73	CHEMBL2527	Homo sapiens	Inhibition	%	4.73
	8122675	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	10.51	CHEMBL2527	Homo sapiens	Inhibition	%	10.51
	8123066	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	-2.46	CHEMBL2527	Homo sapiens	Inhibition	%	-2.46
	8123208	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	3.3	CHEMBL2527	Homo sapiens	Inhibition	%	3.3
	8123486	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	76.15	CHEMBL2527	Homo sapiens	Inhibition	%	76.15
	8123860	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	-0.98	CHEMBL2527	Homo sapiens	Inhibition	%	-0.98
	8124027	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	-0.94	CHEMBL2527	Homo sapiens	Inhibition	%	-0.94
	8124370	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	1.92	CHEMBL2527	Homo sapiens	Inhibition	%	1.92
	8124509	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	-0.6	CHEMBL2527	Homo sapiens	Inhibition	%	-0.6
	8124733	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	1.29	CHEMBL2527	Homo sapiens	Inhibition	%	1.29
	8124898	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	0.86	CHEMBL2527	Homo sapiens	Inhibition	%	0.86
	8125099	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	3.02	CHEMBL2527	Homo sapiens	Inhibition	%	3.02
	8125323	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	5.66	CHEMBL2527	Homo sapiens	Inhibition	%	5.66
	8125453	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	-1.27	CHEMBL2527	Homo sapiens	Inhibition	%	-1.27
	8125621	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	0.95	CHEMBL2527	Homo sapiens	Inhibition	%	0.95
	8125845	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	1.64	CHEMBL2527	Homo sapiens	Inhibition	%	1.64
	8126009	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	-0.57	CHEMBL2527	Homo sapiens	Inhibition	%	-0.57
	8126173	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	10.52	CHEMBL2527	Homo sapiens	Inhibition	%	10.52
	8126397	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	2.5	CHEMBL2527	Homo sapiens	Inhibition	%	2.5
	8126512	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	-1.74	CHEMBL2527	Homo sapiens	Inhibition	%	-1.74
	8126872	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	19.08	CHEMBL2527	Homo sapiens	Inhibition	%	19.08
	8126994	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	8.69	CHEMBL2527	Homo sapiens	Inhibition	%	8.69
	8127218	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	13.44	CHEMBL2527	Homo sapiens	Inhibition	%	13.44
	8127385	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	2.75	CHEMBL2527	Homo sapiens	Inhibition	%	2.75
	8127527	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	5.56	CHEMBL2527	Homo sapiens	Inhibition	%	5.56
	8127751	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	3.95	CHEMBL2527	Homo sapiens	Inhibition	%	3.95
	8127815	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	7.97	CHEMBL2527	Homo sapiens	Inhibition	%	7.97
	8128039	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	11.57	CHEMBL2527	Homo sapiens	Inhibition	%	11.57
	8128191	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	-0.15	CHEMBL2527	Homo sapiens	Inhibition	%	-0.15
	8128358	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	-0.32	CHEMBL2527	Homo sapiens	Inhibition	%	-0.32
	8128582	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	-0.6	CHEMBL2527	Homo sapiens	Inhibition	%	-0.6
	8128701	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	11.16	CHEMBL2527	Homo sapiens	Inhibition	%	11.16
	8129062	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	0.98	CHEMBL2527	Homo sapiens	Inhibition	%	0.98
	8129233	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	-1.13	CHEMBL2527	Homo sapiens	Inhibition	%	-1.13
	8129646	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	5.54	CHEMBL2527	Homo sapiens	Inhibition	%	5.54
	8129785	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	-0.14	CHEMBL2527	Homo sapiens	Inhibition	%	-0.14
	8130170	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	0.78	CHEMBL2527	Homo sapiens	Inhibition	%	0.78
	8130342	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	0.65	CHEMBL2527	Homo sapiens	Inhibition	%	0.65
	8130726	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	7.56	CHEMBL2527	Homo sapiens	Inhibition	%	7.56
	8130842	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	4.28	CHEMBL2527	Homo sapiens	Inhibition	%	4.28
	8131066	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	3.7	CHEMBL2527	Homo sapiens	Inhibition	%	3.7
	8131205	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	-2.71	CHEMBL2527	Homo sapiens	Inhibition	%	-2.71
	8131549	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	3.02	CHEMBL2527	Homo sapiens	Inhibition	%	3.02
	8131716	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	4.65	CHEMBL2527	Homo sapiens	Inhibition	%	4.65
	8132081	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	6.09	CHEMBL2527	Homo sapiens	Inhibition	%	6.09
	8132367	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	2.55	CHEMBL2527	Homo sapiens	Inhibition	%	2.55
	8132514	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	0.11	CHEMBL2527	Homo sapiens	Inhibition	%	0.11
	8132906	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	1.77	CHEMBL2527	Homo sapiens	Inhibition	%	1.77
	8133027	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	4.34	CHEMBL2527	Homo sapiens	Inhibition	%	4.34
	8133251	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	6.1	CHEMBL2527	Homo sapiens	Inhibition	%	6.1
	8133389	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	1.92	CHEMBL2527	Homo sapiens	Inhibition	%	1.92
	8133561	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	-1.56	CHEMBL2527	Homo sapiens	Inhibition	%	-1.56
	8133785	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	-0.83	CHEMBL2527	Homo sapiens	Inhibition	%	-0.83
	8133965	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	39.35	CHEMBL2527	Homo sapiens	Inhibition	%	39.35
	8134113	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	-1.09	CHEMBL2527	Homo sapiens	Inhibition	%	-1.09
	8134337	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	3.25	CHEMBL2527	Homo sapiens	Inhibition	%	3.25
	8134497	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	1.96	CHEMBL2527	Homo sapiens	Inhibition	%	1.96
	8134681	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	-1.67	CHEMBL2527	Homo sapiens	Inhibition	%	-1.67
	8135065	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	2.62	CHEMBL2527	Homo sapiens	Inhibition	%	2.62
	8135404	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	7.47	CHEMBL2527	Homo sapiens	Inhibition	%	7.47
	8135545	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	-3.24	CHEMBL2527	Homo sapiens	Inhibition	%	-3.24
	8135890	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	6.36	CHEMBL2527	Homo sapiens	Inhibition	%	6.36
	8136058	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	3.83	CHEMBL2527	Homo sapiens	Inhibition	%	3.83
	8136282	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	4.99	CHEMBL2527	Homo sapiens	Inhibition	%	4.99
	8136426	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	-2.12	CHEMBL2527	Homo sapiens	Inhibition	%	-2.12
	8136716	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	8.44	CHEMBL2527	Homo sapiens	Inhibition	%	8.44
	8136851	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	1.4	CHEMBL2527	Homo sapiens	Inhibition	%	1.4
	8137075	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	4.28	CHEMBL2527	Homo sapiens	Inhibition	%	4.28
	8137238	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	-4.06	CHEMBL2527	Homo sapiens	Inhibition	%	-4.06
	8137582	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	-0.74	CHEMBL2527	Homo sapiens	Inhibition	%	-0.74
	8137730	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	0.24	CHEMBL2527	Homo sapiens	Inhibition	%	0.24
	8138120	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	-2.63	CHEMBL2527	Homo sapiens	Inhibition	%	-2.63
	8138299	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	1.74	CHEMBL2527	Homo sapiens	Inhibition	%	1.74
	8138671	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	-3.25	CHEMBL2527	Homo sapiens	Inhibition	%	-3.25
	8138829	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	1.43	CHEMBL2527	Homo sapiens	Inhibition	%	1.43
	8139014	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	10.41	CHEMBL2527	Homo sapiens	Inhibition	%	10.41
	8139238	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	4.44	CHEMBL2527	Homo sapiens	Inhibition	%	4.44
	8139397	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	4.43	CHEMBL2527	Homo sapiens	Inhibition	%	4.43
	8139735	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	7.84	CHEMBL2527	Homo sapiens	Inhibition	%	7.84
	8139876	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	1.91	CHEMBL2527	Homo sapiens	Inhibition	%	1.91
	8140100	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	3.16	CHEMBL2527	Homo sapiens	Inhibition	%	3.16
	8140223	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	4.58	CHEMBL2527	Homo sapiens	Inhibition	%	4.58
	8140606	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	6.61	CHEMBL2527	Homo sapiens	Inhibition	%	6.61
	8140749	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	-3.43	CHEMBL2527	Homo sapiens	Inhibition	%	-3.43
	8141051	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	1.34	CHEMBL2527	Homo sapiens	Inhibition	%	1.34
	8141405	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	4.66	CHEMBL2527	Homo sapiens	Inhibition	%	4.66
	8141565	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	0.34	CHEMBL2527	Homo sapiens	Inhibition	%	0.34
	8141908	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	-0.03	CHEMBL2527	Homo sapiens	Inhibition	%	-0.03
	8142069	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	-1.05	CHEMBL2527	Homo sapiens	Inhibition	%	-1.05
	8142293	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	0.02	CHEMBL2527	Homo sapiens	Inhibition	%	0.02
	8142461	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	-2.0	CHEMBL2527	Homo sapiens	Inhibition	%	-2.0
	8142637	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	5.27	CHEMBL2527	Homo sapiens	Inhibition	%	5.27
	8143010	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	-2.4	CHEMBL2527	Homo sapiens	Inhibition	%	-2.4
	8143165	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	1.8	CHEMBL2527	Homo sapiens	Inhibition	%	1.8
	8143389	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	0.63	CHEMBL2527	Homo sapiens	Inhibition	%	0.63
	8143576	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	9.44	CHEMBL2527	Homo sapiens	Inhibition	%	9.44
	8143735	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	-3.6	CHEMBL2527	Homo sapiens	Inhibition	%	-3.6
	8144073	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	2.5	CHEMBL2527	Homo sapiens	Inhibition	%	2.5
	8144436	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	3.51	CHEMBL2527	Homo sapiens	Inhibition	%	3.51
	8144566	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	7.7	CHEMBL2527	Homo sapiens	Inhibition	%	7.7
	8144943	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	8.16	CHEMBL2527	Homo sapiens	Inhibition	%	8.16
	8145080	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	2.55	CHEMBL2527	Homo sapiens	Inhibition	%	2.55
	8145304	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	3.38	CHEMBL2527	Homo sapiens	Inhibition	%	3.38
	8145393	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	7.08	CHEMBL2527	Homo sapiens	Inhibition	%	7.08
	8145741	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	6.05	CHEMBL2527	Homo sapiens	Inhibition	%	6.05
	8145902	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	10.09	CHEMBL2527	Homo sapiens	Inhibition	%	10.09
	8146126	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	16.8	CHEMBL2527	Homo sapiens	Inhibition	%	16.8
	8146246	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	-0.98	CHEMBL2527	Homo sapiens	Inhibition	%	-0.98
	8146630	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	2.31	CHEMBL2527	Homo sapiens	Inhibition	%	2.31
	8146797	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	-1.44	CHEMBL2527	Homo sapiens	Inhibition	%	-1.44
	8146966	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	1.61	CHEMBL2527	Homo sapiens	Inhibition	%	1.61
	8147190	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	3.76	CHEMBL2527	Homo sapiens	Inhibition	%	3.76
	8147332	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	0.57	CHEMBL2527	Homo sapiens	Inhibition	%	0.57
	8147709	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	2.01	CHEMBL2527	Homo sapiens	Inhibition	%	2.01
	8147896	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	8.72	CHEMBL2527	Homo sapiens	Inhibition	%	8.72
	8148054	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	-3.73	CHEMBL2527	Homo sapiens	Inhibition	%	-3.73
	8148278	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	0.95	CHEMBL2527	Homo sapiens	Inhibition	%	0.95
	8148392	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	2.92	CHEMBL2527	Homo sapiens	Inhibition	%	2.92
	8148755	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	5.41	CHEMBL2527	Homo sapiens	Inhibition	%	5.41
	8148893	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	-1.09	CHEMBL2527	Homo sapiens	Inhibition	%	-1.09
	8149117	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	0.46	CHEMBL2527	Homo sapiens	Inhibition	%	0.46
	8149276	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	0.67	CHEMBL2527	Homo sapiens	Inhibition	%	0.67
	8149634	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	4.63	CHEMBL2527	Homo sapiens	Inhibition	%	4.63
	8149732	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	-3.08	CHEMBL2527	Homo sapiens	Inhibition	%	-3.08
	8149956	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	0.64	CHEMBL2527	Homo sapiens	Inhibition	%	0.64
	8150081	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	0.12	CHEMBL2527	Homo sapiens	Inhibition	%	0.12
	8150465	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	0.62	CHEMBL2527	Homo sapiens	Inhibition	%	0.62
	8150585	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	0.37	CHEMBL2527	Homo sapiens	Inhibition	%	0.37
	8150974	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	11.81	CHEMBL2527	Homo sapiens	Inhibition	%	11.81
	8151137	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	-4.46	CHEMBL2527	Homo sapiens	Inhibition	%	-4.46
	8151538	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	1.64	CHEMBL2527	Homo sapiens	Inhibition	%	1.64
	8151676	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	1.27	CHEMBL2527	Homo sapiens	Inhibition	%	1.27
	8152054	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	1.61	CHEMBL2527	Homo sapiens	Inhibition	%	1.61
	8152242	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	20.6	CHEMBL2527	Homo sapiens	Inhibition	%	20.6
	8152624	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	2.54	CHEMBL2527	Homo sapiens	Inhibition	%	2.54
	8152738	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	3.81	CHEMBL2527	Homo sapiens	Inhibition	%	3.81
	8152962	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	8.77	CHEMBL2527	Homo sapiens	Inhibition	%	8.77
	8153101	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	9.39	CHEMBL2527	Homo sapiens	Inhibition	%	9.39
	8153462	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	2.96	CHEMBL2527	Homo sapiens	Inhibition	%	2.96
	8153619	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	1.7	CHEMBL2527	Homo sapiens	Inhibition	%	1.7
	8153976	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	5.44	CHEMBL2527	Homo sapiens	Inhibition	%	5.44
	8154297	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	0.53	CHEMBL2527	Homo sapiens	Inhibition	%	0.53
	8154423	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	4.39	CHEMBL2527	Homo sapiens	Inhibition	%	4.39
	8154647	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	1.65	CHEMBL2527	Homo sapiens	Inhibition	%	1.65
	8154806	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	2.35	CHEMBL2527	Homo sapiens	Inhibition	%	2.35
	8154926	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	-5.6	CHEMBL2527	Homo sapiens	Inhibition	%	-5.6
	8155150	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	-4.58	CHEMBL2527	Homo sapiens	Inhibition	%	-4.58
	8155326	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	0.02	CHEMBL2527	Homo sapiens	Inhibition	%	0.02
	8155487	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	-3.82	CHEMBL2527	Homo sapiens	Inhibition	%	-3.82
	8155711	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	6.05	CHEMBL2527	Homo sapiens	Inhibition	%	6.05
	8155889	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	3.66	CHEMBL2527	Homo sapiens	Inhibition	%	3.66
	8156027	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	1.55	CHEMBL2527	Homo sapiens	Inhibition	%	1.55
	8156251	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	1.92	CHEMBL2527	Homo sapiens	Inhibition	%	1.92
	8156463	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	2.56	CHEMBL2527	Homo sapiens	Inhibition	%	2.56
	8156613	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	3.67	CHEMBL2527	Homo sapiens	Inhibition	%	3.67
	8156837	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	2.01	CHEMBL2527	Homo sapiens	Inhibition	%	2.01
	8156980	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	3.97	CHEMBL2527	Homo sapiens	Inhibition	%	3.97
	8157324	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	6.02	CHEMBL2527	Homo sapiens	Inhibition	%	6.02
	8157465	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	6.47	CHEMBL2527	Homo sapiens	Inhibition	%	6.47
	8157819	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	-3.31	CHEMBL2527	Homo sapiens	Inhibition	%	-3.31
	8157980	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	4.77	CHEMBL2527	Homo sapiens	Inhibition	%	4.77
	8158204	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	1.31	CHEMBL2527	Homo sapiens	Inhibition	%	1.31
	8158230	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	-0.36	CHEMBL2527	Homo sapiens	Inhibition	%	-0.36
	8158454	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	1.1	CHEMBL2527	Homo sapiens	Inhibition	%	1.1
	8158612	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	4.85	CHEMBL2527	Homo sapiens	Inhibition	%	4.85
	8158781	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	2.67	CHEMBL2527	Homo sapiens	Inhibition	%	2.67
	8159005	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	3.25	CHEMBL2527	Homo sapiens	Inhibition	%	3.25
	8159140	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	-1.01	CHEMBL2527	Homo sapiens	Inhibition	%	-1.01
	8159484	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	1.49	CHEMBL2527	Homo sapiens	Inhibition	%	1.49
	8159615	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	6.54	CHEMBL2527	Homo sapiens	Inhibition	%	6.54
	8159839	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	48.9	CHEMBL2527	Homo sapiens	Inhibition	%	48.9
	8159980	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	0.94	CHEMBL2527	Homo sapiens	Inhibition	%	0.94
	8160341	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	4.14	CHEMBL2527	Homo sapiens	Inhibition	%	4.14
	8160491	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	-1.95	CHEMBL2527	Homo sapiens	Inhibition	%	-1.95
	8160785	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	5.07	CHEMBL2527	Homo sapiens	Inhibition	%	5.07
	8161159	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	6.85	CHEMBL2527	Homo sapiens	Inhibition	%	6.85
	8161302	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	2.96	CHEMBL2527	Homo sapiens	Inhibition	%	2.96
	8161651	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	1.18	CHEMBL2527	Homo sapiens	Inhibition	%	1.18
	8161789	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	9.62	CHEMBL2527	Homo sapiens	Inhibition	%	9.62
	8162013	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	8.44	CHEMBL2527	Homo sapiens	Inhibition	%	8.44
	8162143	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	-1.64	CHEMBL2527	Homo sapiens	Inhibition	%	-1.64
	8162527	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	0.77	CHEMBL2527	Homo sapiens	Inhibition	%	0.77
	8162780	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	1.86	CHEMBL2527	Homo sapiens	Inhibition	%	1.86
	8162928	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	7.15	CHEMBL2527	Homo sapiens	Inhibition	%	7.15
	8163321	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	6.18	CHEMBL2527	Homo sapiens	Inhibition	%	6.18
	8163455	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	2.28	CHEMBL2527	Homo sapiens	Inhibition	%	2.28
	8163679	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	3.29	CHEMBL2527	Homo sapiens	Inhibition	%	3.29
	8163802	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	0.52	CHEMBL2527	Homo sapiens	Inhibition	%	0.52
	8164160	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	79.08	CHEMBL2527	Homo sapiens	Inhibition	%	79.08
	8164300	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	-4.96	CHEMBL2527	Homo sapiens	Inhibition	%	-4.96
	8164679	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	3.25	CHEMBL2527	Homo sapiens	Inhibition	%	3.25
	8164823	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	-1.72	CHEMBL2527	Homo sapiens	Inhibition	%	-1.72
	8165047	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	4.58	CHEMBL2527	Homo sapiens	Inhibition	%	4.58
	8165117	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	3.89	CHEMBL2527	Homo sapiens	Inhibition	%	3.89
	8165482	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	2.37	CHEMBL2527	Homo sapiens	Inhibition	%	2.37
	8165625	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	9.21	CHEMBL2527	Homo sapiens	Inhibition	%	9.21
	8165849	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	1.45	CHEMBL2527	Homo sapiens	Inhibition	%	1.45
	8165975	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	2.39	CHEMBL2527	Homo sapiens	Inhibition	%	2.39
	8166337	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	11.94	CHEMBL2527	Homo sapiens	Inhibition	%	11.94
	8166467	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	0.91	CHEMBL2527	Homo sapiens	Inhibition	%	0.91
	8166691	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	1.68	CHEMBL2527	Homo sapiens	Inhibition	%	1.68
	8166792	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	9.02	CHEMBL2527	Homo sapiens	Inhibition	%	9.02
	8167104	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	3.15	CHEMBL2527	Homo sapiens	Inhibition	%	3.15
	8167245	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	33.25	CHEMBL2527	Homo sapiens	Inhibition	%	33.25
	8167469	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	0.76	CHEMBL2527	Homo sapiens	Inhibition	%	0.76
	8167633	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	6.56	CHEMBL2527	Homo sapiens	Inhibition	%	6.56
	8167990	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	4.58	CHEMBL2527	Homo sapiens	Inhibition	%	4.58
	8168114	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	1.2	CHEMBL2527	Homo sapiens	Inhibition	%	1.2
	8168479	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	10.08	CHEMBL2527	Homo sapiens	Inhibition	%	10.08
	8168615	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	-4.4	CHEMBL2527	Homo sapiens	Inhibition	%	-4.4
	8168839	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	-2.9	CHEMBL2527	Homo sapiens	Inhibition	%	-2.9
	8169003	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	10.63	CHEMBL2527	Homo sapiens	Inhibition	%	10.63
	8169369	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	7.38	CHEMBL2527	Homo sapiens	Inhibition	%	7.38
	8169449	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	11.91	CHEMBL2527	Homo sapiens	Inhibition	%	11.91
	8169673	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	4.59	CHEMBL2527	Homo sapiens	Inhibition	%	4.59
	8169807	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	3.75	CHEMBL2527	Homo sapiens	Inhibition	%	3.75
	8170176	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	2.14	CHEMBL2527	Homo sapiens	Inhibition	%	2.14
	8170301	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	1.68	CHEMBL2527	Homo sapiens	Inhibition	%	1.68
	8170525	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	2.64	CHEMBL2527	Homo sapiens	Inhibition	%	2.64
	8170665	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	2.91	CHEMBL2527	Homo sapiens	Inhibition	%	2.91
	8171024	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	1.57	CHEMBL2527	Homo sapiens	Inhibition	%	1.57
	8171221	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	1.73	CHEMBL2527	Homo sapiens	Inhibition	%	1.73
	8171438	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	13.27	CHEMBL2527	Homo sapiens	Inhibition	%	13.27
	8171803	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	21.07	CHEMBL2527	Homo sapiens	Inhibition	%	21.07
	8171956	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	1.45	CHEMBL2527	Homo sapiens	Inhibition	%	1.45
	8172312	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	5.95	CHEMBL2527	Homo sapiens	Inhibition	%	5.95
	8172440	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	2.29	CHEMBL2527	Homo sapiens	Inhibition	%	2.29
	8172664	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	-3.83	CHEMBL2527	Homo sapiens	Inhibition	%	-3.83
	8172806	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	10.56	CHEMBL2527	Homo sapiens	Inhibition	%	10.56
	8173166	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	-2.43	CHEMBL2527	Homo sapiens	Inhibition	%	-2.43
	8173331	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	2.56	CHEMBL2527	Homo sapiens	Inhibition	%	2.56
	8173696	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	3.4	CHEMBL2527	Homo sapiens	Inhibition	%	3.4
	8174007	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	18.26	CHEMBL2527	Homo sapiens	Inhibition	%	18.26
	8174139	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	2.38	CHEMBL2527	Homo sapiens	Inhibition	%	2.38
	8174363	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	4.27	CHEMBL2527	Homo sapiens	Inhibition	%	4.27
	8174511	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	0.96	CHEMBL2527	Homo sapiens	Inhibition	%	0.96
	8174857	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	2.23	CHEMBL2527	Homo sapiens	Inhibition	%	2.23
	8175000	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	6.65	CHEMBL2527	Homo sapiens	Inhibition	%	6.65
	8175360	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	3.38	CHEMBL2527	Homo sapiens	Inhibition	%	3.38
	8175616	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	14.94	CHEMBL2527	Homo sapiens	Inhibition	%	14.94
	8175779	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	6.25	CHEMBL2527	Homo sapiens	Inhibition	%	6.25
	8176003	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	9.6	CHEMBL2527	Homo sapiens	Inhibition	%	9.6
	8176156	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	2.9	CHEMBL2527	Homo sapiens	Inhibition	%	2.9
	8176305	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	1.6	CHEMBL2527	Homo sapiens	Inhibition	%	1.6
	8176529	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	1.42	CHEMBL2527	Homo sapiens	Inhibition	%	1.42
	8176661	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	23.28	CHEMBL2527	Homo sapiens	Inhibition	%	23.28
	8177015	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	-2.77	CHEMBL2527	Homo sapiens	Inhibition	%	-2.77
	8177157	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	3.38	CHEMBL2527	Homo sapiens	Inhibition	%	3.38
	8177381	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	5.57	CHEMBL2527	Homo sapiens	Inhibition	%	5.57
	8177519	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	81.16	CHEMBL2527	Homo sapiens	Inhibition	%	81.16
	8177683	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	4.89	CHEMBL2527	Homo sapiens	Inhibition	%	4.89
	8177907	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	3.09	CHEMBL2527	Homo sapiens	Inhibition	%	3.09
	8178047	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	8.93	CHEMBL2527	Homo sapiens	Inhibition	%	8.93
	8178359	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	1.56	CHEMBL2527	Homo sapiens	Inhibition	%	1.56
	8178710	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	2.49	CHEMBL2527	Homo sapiens	Inhibition	%	2.49
	8178859	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	0.33	CHEMBL2527	Homo sapiens	Inhibition	%	0.33
	8179206	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	2.55	CHEMBL2527	Homo sapiens	Inhibition	%	2.55
	8179350	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	4.18	CHEMBL2527	Homo sapiens	Inhibition	%	4.18
	8179574	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	19.23	CHEMBL2527	Homo sapiens	Inhibition	%	19.23
	8179711	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	5.44	CHEMBL2527	Homo sapiens	Inhibition	%	5.44
	8179968	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	-1.11	CHEMBL2527	Homo sapiens	Inhibition	%	-1.11
	8180346	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	0.71	CHEMBL2527	Homo sapiens	Inhibition	%	0.71
	8180502	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	6.29	CHEMBL2527	Homo sapiens	Inhibition	%	6.29
	8180874	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	10.61	CHEMBL2527	Homo sapiens	Inhibition	%	10.61
	8181007	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	8.1	CHEMBL2527	Homo sapiens	Inhibition	%	8.1
	8181231	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	15.11	CHEMBL2527	Homo sapiens	Inhibition	%	15.11
	8181362	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	-0.44	CHEMBL2527	Homo sapiens	Inhibition	%	-0.44
	8181726	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	2.81	CHEMBL2527	Homo sapiens	Inhibition	%	2.81
	8181865	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	83.42	CHEMBL2527	Homo sapiens	Inhibition	%	83.42
	8182252	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	4.06	CHEMBL2527	Homo sapiens	Inhibition	%	4.06
	8182392	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	3.02	CHEMBL2527	Homo sapiens	Inhibition	%	3.02
	8182708	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	3.31	CHEMBL2527	Homo sapiens	Inhibition	%	3.31
	8183054	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	3.64	CHEMBL2527	Homo sapiens	Inhibition	%	3.64
	8183203	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	1.56	CHEMBL2527	Homo sapiens	Inhibition	%	1.56
	8183427	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	2.17	CHEMBL2527	Homo sapiens	Inhibition	%	2.17
	8183556	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	3.99	CHEMBL2527	Homo sapiens	Inhibition	%	3.99
	8183922	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	-2.37	CHEMBL2527	Homo sapiens	Inhibition	%	-2.37
	8184058	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	6.1	CHEMBL2527	Homo sapiens	Inhibition	%	6.1
	8184324	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	3.84	CHEMBL2527	Homo sapiens	Inhibition	%	3.84
	8184695	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	3.96	CHEMBL2527	Homo sapiens	Inhibition	%	3.96
	8184852	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	3.9	CHEMBL2527	Homo sapiens	Inhibition	%	3.9
	8185076	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	5.77	CHEMBL2527	Homo sapiens	Inhibition	%	5.77
	8185225	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	-4.58	CHEMBL2527	Homo sapiens	Inhibition	%	-4.58
	8185580	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	2.64	CHEMBL2527	Homo sapiens	Inhibition	%	2.64
	8185711	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	14.46	CHEMBL2527	Homo sapiens	Inhibition	%	14.46
	8186074	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	3.79	CHEMBL2527	Homo sapiens	Inhibition	%	3.79
	8186215	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	6.74	CHEMBL2527	Homo sapiens	Inhibition	%	6.74
	8186439	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	7.89	CHEMBL2527	Homo sapiens	Inhibition	%	7.89
	8186603	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	3.04	CHEMBL2527	Homo sapiens	Inhibition	%	3.04
	8186742	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	4.46	CHEMBL2527	Homo sapiens	Inhibition	%	4.46
	8186966	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	3.72	CHEMBL2527	Homo sapiens	Inhibition	%	3.72
	8187064	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	0.67	CHEMBL2527	Homo sapiens	Inhibition	%	0.67
	8187288	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	4.0	CHEMBL2527	Homo sapiens	Inhibition	%	4.0
	8187412	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	3.11	CHEMBL2527	Homo sapiens	Inhibition	%	3.11
	8187784	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	1.58	CHEMBL2527	Homo sapiens	Inhibition	%	1.58
	8187913	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	5.26	CHEMBL2527	Homo sapiens	Inhibition	%	5.26
	8188280	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	0.53	CHEMBL2527	Homo sapiens	Inhibition	%	0.53
	8188415	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	-0.14	CHEMBL2527	Homo sapiens	Inhibition	%	-0.14
	8188639	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	0.05	CHEMBL2527	Homo sapiens	Inhibition	%	0.05
	8188689	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	5.57	CHEMBL2527	Homo sapiens	Inhibition	%	5.57
	8188913	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	26.36	CHEMBL2527	Homo sapiens	Inhibition	%	26.36
	8189061	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	0.04	CHEMBL2527	Homo sapiens	Inhibition	%	0.04
	8189441	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	10.57	CHEMBL2527	Homo sapiens	Inhibition	%	10.57
	8189590	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	-3.41	CHEMBL2527	Homo sapiens	Inhibition	%	-3.41
	8189946	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	7.73	CHEMBL2527	Homo sapiens	Inhibition	%	7.73
	8190078	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	4.82	CHEMBL2527	Homo sapiens	Inhibition	%	4.82
	8190302	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	6.73	CHEMBL2527	Homo sapiens	Inhibition	%	6.73
	8190442	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	-1.34	CHEMBL2527	Homo sapiens	Inhibition	%	-1.34
	8190803	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	4.1	CHEMBL2527	Homo sapiens	Inhibition	%	4.1
	8190967	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	3.92	CHEMBL2527	Homo sapiens	Inhibition	%	3.92
	8191329	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	11.92	CHEMBL2527	Homo sapiens	Inhibition	%	11.92
	8191649	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	1.5	CHEMBL2527	Homo sapiens	Inhibition	%	1.5
	8191771	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	5.21	CHEMBL2527	Homo sapiens	Inhibition	%	5.21
	8192144	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	1.85	CHEMBL2527	Homo sapiens	Inhibition	%	1.85
	8192273	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	6.34	CHEMBL2527	Homo sapiens	Inhibition	%	6.34
	8192497	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	7.55	CHEMBL2527	Homo sapiens	Inhibition	%	7.55
	8192641	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	2.11	CHEMBL2527	Homo sapiens	Inhibition	%	2.11
	8193001	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	-0.97	CHEMBL2527	Homo sapiens	Inhibition	%	-0.97
	8193273	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	3.0	CHEMBL2527	Homo sapiens	Inhibition	%	3.0
	8193418	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	1.88	CHEMBL2527	Homo sapiens	Inhibition	%	1.88
	8193799	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	32.79	CHEMBL2527	Homo sapiens	Inhibition	%	32.79
	8193948	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	-2.44	CHEMBL2527	Homo sapiens	Inhibition	%	-2.44
	8194172	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	-2.51	CHEMBL2527	Homo sapiens	Inhibition	%	-2.51
	8194303	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	5.03	CHEMBL2527	Homo sapiens	Inhibition	%	5.03
	8194658	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	8.35	CHEMBL2527	Homo sapiens	Inhibition	%	8.35
	8194801	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	-0.01	CHEMBL2527	Homo sapiens	Inhibition	%	-0.01
	8195158	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	5.51	CHEMBL2527	Homo sapiens	Inhibition	%	5.51
	8195322	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	2.67	CHEMBL2527	Homo sapiens	Inhibition	%	2.67
	8195546	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	12.54	CHEMBL2527	Homo sapiens	Inhibition	%	12.54
	8195685	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	3.25	CHEMBL2527	Homo sapiens	Inhibition	%	3.25
	8196007	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	2.24	CHEMBL2527	Homo sapiens	Inhibition	%	2.24
	8196124	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	1.71	CHEMBL2527	Homo sapiens	Inhibition	%	1.71
	8196348	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	5.02	CHEMBL2527	Homo sapiens	Inhibition	%	5.02
	8196498	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	2.15	CHEMBL2527	Homo sapiens	Inhibition	%	2.15
	8196850	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	2.01	CHEMBL2527	Homo sapiens	Inhibition	%	2.01
	8196991	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	3.83	CHEMBL2527	Homo sapiens	Inhibition	%	3.83
	8197352	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	0.04	CHEMBL2527	Homo sapiens	Inhibition	%	0.04
	8197627	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	3.74	CHEMBL2527	Homo sapiens	Inhibition	%	3.74
	8197767	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	-4.95	CHEMBL2527	Homo sapiens	Inhibition	%	-4.95
	8197991	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	-0.53	CHEMBL2527	Homo sapiens	Inhibition	%	-0.53
	8198148	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	2.74	CHEMBL2527	Homo sapiens	Inhibition	%	2.74
	8198510	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	4.88	CHEMBL2527	Homo sapiens	Inhibition	%	4.88
	8198640	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	25.46	CHEMBL2527	Homo sapiens	Inhibition	%	25.46
	8198995	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	8.52	CHEMBL2527	Homo sapiens	Inhibition	%	8.52
	8199143	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	2.75	CHEMBL2527	Homo sapiens	Inhibition	%	2.75
	8199367	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	9.92	CHEMBL2527	Homo sapiens	Inhibition	%	9.92
	8199501	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	3.47	CHEMBL2527	Homo sapiens	Inhibition	%	3.47
	8199888	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	0.86	CHEMBL2527	Homo sapiens	Inhibition	%	0.86
	8200026	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	4.36	CHEMBL2527	Homo sapiens	Inhibition	%	4.36
	8200354	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	0.52	CHEMBL2527	Homo sapiens	Inhibition	%	0.52
	8200693	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	4.23	CHEMBL2527	Homo sapiens	Inhibition	%	4.23
	8200843	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	2.4	CHEMBL2527	Homo sapiens	Inhibition	%	2.4
	8201197	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	5.81	CHEMBL2527	Homo sapiens	Inhibition	%	5.81
	8201332	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	2.85	CHEMBL2527	Homo sapiens	Inhibition	%	2.85
	8201556	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	4.7	CHEMBL2527	Homo sapiens	Inhibition	%	4.7
	8201689	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	-6.42	CHEMBL2527	Homo sapiens	Inhibition	%	-6.42
	8201968	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	6.84	CHEMBL2527	Homo sapiens	Inhibition	%	6.84
	8202332	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	-2.92	CHEMBL2527	Homo sapiens	Inhibition	%	-2.92
	8202499	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	3.47	CHEMBL2527	Homo sapiens	Inhibition	%	3.47
	8202848	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	5.9	CHEMBL2527	Homo sapiens	Inhibition	%	5.9
	8202978	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	-1.56	CHEMBL2527	Homo sapiens	Inhibition	%	-1.56
	8203202	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	1.67	CHEMBL2527	Homo sapiens	Inhibition	%	1.67
	8203333	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	3.17	CHEMBL2527	Homo sapiens	Inhibition	%	3.17
	8203703	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	2.74	CHEMBL2527	Homo sapiens	Inhibition	%	2.74
	8203837	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	5.22	CHEMBL2527	Homo sapiens	Inhibition	%	5.22
	8204061	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	3.42	CHEMBL2527	Homo sapiens	Inhibition	%	3.42
	8204227	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	2.31	CHEMBL2527	Homo sapiens	Inhibition	%	2.31
	8204364	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	3.95	CHEMBL2527	Homo sapiens	Inhibition	%	3.95
	8204588	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	5.81	CHEMBL2527	Homo sapiens	Inhibition	%	5.81
	8204693	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	1.08	CHEMBL2527	Homo sapiens	Inhibition	%	1.08
	8205032	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	23.8	CHEMBL2527	Homo sapiens	Inhibition	%	23.8
	8205181	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	3.07	CHEMBL2527	Homo sapiens	Inhibition	%	3.07
	8205405	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	7.4	CHEMBL2527	Homo sapiens	Inhibition	%	7.4
	8205541	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	2.06	CHEMBL2527	Homo sapiens	Inhibition	%	2.06
	8205904	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	6.96	CHEMBL2527	Homo sapiens	Inhibition	%	6.96
	8206036	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	-5.67	CHEMBL2527	Homo sapiens	Inhibition	%	-5.67
	8206260	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	-3.64	CHEMBL2527	Homo sapiens	Inhibition	%	-3.64
	8206312	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	7.75	CHEMBL2527	Homo sapiens	Inhibition	%	7.75
	8206536	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	1.43	CHEMBL2527	Homo sapiens	Inhibition	%	1.43
	8206679	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	0.55	CHEMBL2527	Homo sapiens	Inhibition	%	0.55
	8206859	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	2.39	CHEMBL2527	Homo sapiens	Inhibition	%	2.39
	8207083	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	3.79	CHEMBL2527	Homo sapiens	Inhibition	%	3.79
	8207209	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	10.12	CHEMBL2527	Homo sapiens	Inhibition	%	10.12
	8207563	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	2.09	CHEMBL2527	Homo sapiens	Inhibition	%	2.09
	8207695	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	7.22	CHEMBL2527	Homo sapiens	Inhibition	%	7.22
	8207919	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	3.17	CHEMBL2527	Homo sapiens	Inhibition	%	3.17
	8208064	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	3.47	CHEMBL2527	Homo sapiens	Inhibition	%	3.47
	8208420	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	4.49	CHEMBL2527	Homo sapiens	Inhibition	%	4.49
	8208586	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	1.29	CHEMBL2527	Homo sapiens	Inhibition	%	1.29
	8208943	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	2.75	CHEMBL2527	Homo sapiens	Inhibition	%	2.75
	8209048	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	-0.11	CHEMBL2527	Homo sapiens	Inhibition	%	-0.11
	8209272	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	-0.35	CHEMBL2527	Homo sapiens	Inhibition	%	-0.35
	8209388	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	2.16	CHEMBL2527	Homo sapiens	Inhibition	%	2.16
	8209762	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	1.56	CHEMBL2527	Homo sapiens	Inhibition	%	1.56
	8209898	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	3.78	CHEMBL2527	Homo sapiens	Inhibition	%	3.78
	8210122	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	-2.58	CHEMBL2527	Homo sapiens	Inhibition	%	-2.58
	8210263	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	7.62	CHEMBL2527	Homo sapiens	Inhibition	%	7.62
	8210623	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	-3.75	CHEMBL2527	Homo sapiens	Inhibition	%	-3.75
	8210882	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	1.86	CHEMBL2527	Homo sapiens	Inhibition	%	1.86
	8211026	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	3.73	CHEMBL2527	Homo sapiens	Inhibition	%	3.73
	8211420	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	-0.02	CHEMBL2527	Homo sapiens	Inhibition	%	-0.02
	8211543	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	12.7	CHEMBL2527	Homo sapiens	Inhibition	%	12.7
	8211896	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	4.23	CHEMBL2527	Homo sapiens	Inhibition	%	4.23
	8212252	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	5.38	CHEMBL2527	Homo sapiens	Inhibition	%	5.38
	8212393	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	6.26	CHEMBL2527	Homo sapiens	Inhibition	%	6.26
	8212750	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	3.86	CHEMBL2527	Homo sapiens	Inhibition	%	3.86
	8212920	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	4.21	CHEMBL2527	Homo sapiens	Inhibition	%	4.21
	8213273	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	6.34	CHEMBL2527	Homo sapiens	Inhibition	%	6.34
	8213601	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	-2.0	CHEMBL2527	Homo sapiens	Inhibition	%	-2.0
	8213714	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	4.44	CHEMBL2527	Homo sapiens	Inhibition	%	4.44
	8213938	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	1.94	CHEMBL2527	Homo sapiens	Inhibition	%	1.94
	8214085	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	2.29	CHEMBL2527	Homo sapiens	Inhibition	%	2.29
	8214446	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	-0.51	CHEMBL2527	Homo sapiens	Inhibition	%	-0.51
	8214580	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	2.56	CHEMBL2527	Homo sapiens	Inhibition	%	2.56
	8214956	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	3.21	CHEMBL2527	Homo sapiens	Inhibition	%	3.21
	8215207	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	1.76	CHEMBL2527	Homo sapiens	Inhibition	%	1.76
	8215360	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	4.65	CHEMBL2527	Homo sapiens	Inhibition	%	4.65
	8215584	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	7.79	CHEMBL2527	Homo sapiens	Inhibition	%	7.79
	8215748	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	6.4	CHEMBL2527	Homo sapiens	Inhibition	%	6.4
	8215867	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	17.18	CHEMBL2527	Homo sapiens	Inhibition	%	17.18
	8216091	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	52.4	CHEMBL2527	Homo sapiens	Inhibition	%	52.4
	8216210	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	2.54	CHEMBL2527	Homo sapiens	Inhibition	%	2.54
	8216570	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	1.37	CHEMBL2527	Homo sapiens	Inhibition	%	1.37
	8216708	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	6.67	CHEMBL2527	Homo sapiens	Inhibition	%	6.67
	8216932	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	1.53	CHEMBL2527	Homo sapiens	Inhibition	%	1.53
	8217066	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	4.86	CHEMBL2527	Homo sapiens	Inhibition	%	4.86
	8217240	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	0.58	CHEMBL2527	Homo sapiens	Inhibition	%	0.58
	8217464	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	1.05	CHEMBL2527	Homo sapiens	Inhibition	%	1.05
	8217595	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	10.02	CHEMBL2527	Homo sapiens	Inhibition	%	10.02
	8217920	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	-1.93	CHEMBL2527	Homo sapiens	Inhibition	%	-1.93
	8218259	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	4.06	CHEMBL2527	Homo sapiens	Inhibition	%	4.06
	8218386	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	0.95	CHEMBL2527	Homo sapiens	Inhibition	%	0.95
	8218753	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	2.06	CHEMBL2527	Homo sapiens	Inhibition	%	2.06
	8218884	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	12.79	CHEMBL2527	Homo sapiens	Inhibition	%	12.79
	8219108	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	1.47	CHEMBL2527	Homo sapiens	Inhibition	%	1.47
	8219268	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	2.24	CHEMBL2527	Homo sapiens	Inhibition	%	2.24
	8219518	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	4.69	CHEMBL2527	Homo sapiens	Inhibition	%	4.69
	8219903	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	8.17	CHEMBL2527	Homo sapiens	Inhibition	%	8.17
	8220072	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	4.67	CHEMBL2527	Homo sapiens	Inhibition	%	4.67
	8220425	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	4.58	CHEMBL2527	Homo sapiens	Inhibition	%	4.58
	8220539	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	3.23	CHEMBL2527	Homo sapiens	Inhibition	%	3.23
	8220763	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	6.46	CHEMBL2527	Homo sapiens	Inhibition	%	6.46
	8220901	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	21.32	CHEMBL2527	Homo sapiens	Inhibition	%	21.32
	8221261	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	2.63	CHEMBL2527	Homo sapiens	Inhibition	%	2.63
	8221394	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	4.99	CHEMBL2527	Homo sapiens	Inhibition	%	4.99
	8221783	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	-0.53	CHEMBL2527	Homo sapiens	Inhibition	%	-0.53
	8221914	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	43.05	CHEMBL2527	Homo sapiens	Inhibition	%	43.05
	8222138	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	2.66	CHEMBL2527	Homo sapiens	Inhibition	%	2.66
	8222236	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	1.62	CHEMBL2527	Homo sapiens	Inhibition	%	1.62
	8222594	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	1.94	CHEMBL2527	Homo sapiens	Inhibition	%	1.94
	8222712	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	3.14	CHEMBL2527	Homo sapiens	Inhibition	%	3.14
	8222936	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	1.95	CHEMBL2527	Homo sapiens	Inhibition	%	1.95
	8223080	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	3.88	CHEMBL2527	Homo sapiens	Inhibition	%	3.88
	8223433	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	3.89	CHEMBL2527	Homo sapiens	Inhibition	%	3.89
	8223594	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	5.87	CHEMBL2527	Homo sapiens	Inhibition	%	5.87
	8223844	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	-2.23	CHEMBL2527	Homo sapiens	Inhibition	%	-2.23
	8224230	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	3.26	CHEMBL2527	Homo sapiens	Inhibition	%	3.26
	8224400	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	2.85	CHEMBL2527	Homo sapiens	Inhibition	%	2.85
	8224759	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	7.74	CHEMBL2527	Homo sapiens	Inhibition	%	7.74
	8225097	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	7.48	CHEMBL2527	Homo sapiens	Inhibition	%	7.48
	8225231	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	3.04	CHEMBL2527	Homo sapiens	Inhibition	%	3.04
	8225593	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	-0.09	CHEMBL2527	Homo sapiens	Inhibition	%	-0.09
	8225728	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	26.31	CHEMBL2527	Homo sapiens	Inhibition	%	26.31
	8225952	CHEMBL1961962	GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	1.85	CHEMBL2527	Homo sapiens	Inhibition	%	1.85
	8226110	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	-0.65	CHEMBL2527	Homo sapiens	Inhibition	%	-0.65
	8226459	CHEMBL1961963	GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	5.77	CHEMBL2527	Homo sapiens	Inhibition	%	5.77
inactive	9608508	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1cccc(-c2[nH]c(-c3ccnc(N)n3)cc2C(N)=O)c1C		CHEMBL1964290	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
active	9608509	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Nc1ncnc2onc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL213505	=	Ki	nM	1258.93	CHEMBL2527	Homo sapiens	pKi		5.9
inactive	9608510	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	COc1ccc(OC)c(Nc2ccc3nnc(-c4ccccc4)n3n2)c1		CHEMBL1982880	<	Ki	nM	10000.0	CHEMBL2527	Homo sapiens	pKi		5.0
inactive	9608511	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	<	Ki	nM	10000.0	CHEMBL2527	Homo sapiens	pKi		5.0
active	9608512	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	N#CCOc1ccc(Nc2nc(Nc3cccc(S(N)(=O)=O)c3)ncc2Br)cc1		CHEMBL1987034	=	Ki	nM	31.62	CHEMBL2527	Homo sapiens	pKi		7.5
inactive	9608513	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CCCn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1993941	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9608514	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CCOc1nc(C(=O)NCc2ccc(S(C)(=O)=O)cc2)cc(N)c1Cl		CHEMBL377383	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
active	9608515	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	c1ccc(Nc2ccnc(Nc3ccccc3)n2)cc1		CHEMBL578061	=	Ki	nM	7943.28	CHEMBL2527	Homo sapiens	pKi		5.1
active	9608516	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1cc(N2CCOCC2)cc2[nH]c(-c3c(NCC(O)c4cccc(Cl)c4)cc[nH]c3=O)nc12		CHEMBL2005886	=	Ki	nM	79.43	CHEMBL2527	Homo sapiens	pKi		7.1
inactive	9608517	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL481491	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
active	9608518	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	c1ccc(Cn2cc(-c3ccc4[nH]ncc4c3)nn2)cc1		CHEMBL1682345	=	Ki	nM	630.96	CHEMBL2527	Homo sapiens	pKi		6.2
inactive	9608519	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CC(=O)Nc1c(C(N)=O)sc2ccc(Cl)c(Cl)c12		CHEMBL1973142	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9608520	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4nc(N)nc(N)c34)cc2)c1		CHEMBL1973145	<	Ki	nM	5011.87	CHEMBL2527	Homo sapiens	pKi		5.3
inactive	9608521	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	COc1cccc(C(=O)Nc2cnc3[nH]cc(-c4ccccc4)c3c2)c1		CHEMBL1982924	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9608522	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CCCC(=O)Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccccc3)cc12		CHEMBL2005936	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9608523	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	NC1CCC(Nc2nccc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1966628	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9608524	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc(C(N)=O)c3)cc2)c1		CHEMBL1971141	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9608525	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	NC1CCCCC1Nc1nccc(-c2c[nH]c3ncccc23)n1		CHEMBL1995813	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9608526	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1c(C)n(Cc2ccccc2)c2ccc(C(=O)Nc3nc[nH]n3)cc12		CHEMBL1979718	<	Ki	nM	10000.0	CHEMBL2527	Homo sapiens	pKi		5.0
inactive	9608527	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	NC(COCc1ccccc1)COc1cncc(C=Cc2ccncc2)c1		CHEMBL1993781	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9608528	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CCn1c2cc(Cl)c(O)cc2c(=O)c2c(=O)o[nH]c21		CHEMBL523823	<	Ki	nM	10000.0	CHEMBL2527	Homo sapiens	pKi		5.0
active	9608529	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CC1(C)CC2=Nc3cc(Cl)ccc3SC2=C(O)C1		CHEMBL1562756	=	Ki	nM	7943.28	CHEMBL2527	Homo sapiens	pKi		5.1
active	9608530	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	O=C(O)c1ccccc1Nc1ccnc(Nc2ccc3cn[nH]c3c2)n1		CHEMBL244378	=	Ki	nM	316.23	CHEMBL2527	Homo sapiens	pKi		6.5
inactive	9608531	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(OCC(F)(F)F)nccn23)n1		CHEMBL2001957	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9608532	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	COCCNc1nccc(-c2c(-c3ccc(F)cc3)nc3cnccn23)n1		CHEMBL1969372	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9608533	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Nc1ncnn2ccc(C(=O)Nc3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1990583	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9608534	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	OC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1986943	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9608535	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1nc2ccc(NS(=O)(=O)c3ccc(N)cc3)cc2nc1C		CHEMBL2006263	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9608536	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	OC(COc1cncc(C=Cc2ccncc2)c1)Cc1c[nH]c2ccccc12		CHEMBL1993584	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
active	9608537	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CCn1c(C)c(-c2ccnc(Nc3cccc(OC)c3)n2)sc1=O		CHEMBL1986263	=	Ki	nM	630.96	CHEMBL2527	Homo sapiens	pKi		6.2
inactive	9608538	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CSc1c[nH]c2ncnc(NCCCO)c12		CHEMBL2000114	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9608539	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	<	Ki	nM	5011.87	CHEMBL2527	Homo sapiens	pKi		5.3
inactive	9608540	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	O=C(Nc1cnccn1)Nc1ccnc2c(F)cccc12		CHEMBL1975647	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
active	9608541	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CCC1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL1968380	=	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9608542	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	O=C(NCc1ccccc1)Nc1ncc([N+](=O)[O-])s1		CHEMBL1964644	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9608543	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	O=C(NCc1ccc(Cl)c(Cl)c1)Nc1ccc2[nH]ncc2c1		CHEMBL1981782	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
active	9608544	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CNC(=O)c1cc2c(-c3ccccc3F)n[nH]c2s1		CHEMBL1977681	=	Ki	nM	158.49	CHEMBL2527	Homo sapiens	pKi		6.8
inactive	9608545	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CNC(=O)C(C)n1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5ccc(C)cc5)cc4)csc23)cn1		CHEMBL1970142	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9608546	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	<	Ki	nM	10000.0	CHEMBL2527	Homo sapiens	pKi		5.0
inactive	9608547	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	OCCNc1cc2cc(-c3cccnc3)ccc2cn1		CHEMBL1990912	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9608548	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	<	Ki	nM	10000.0	CHEMBL2527	Homo sapiens	pKi		5.0
active	9608549	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	NS(=O)(=O)c1cccc(Nc2ncc3ccn(-c4ccccc4)c3n2)c1		CHEMBL1988163	=	Ki	nM	251.19	CHEMBL2527	Homo sapiens	pKi		6.6
inactive	9608550	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1cc(O)ccc1-n1c2cc(Cl)ccc2c(=O)c2c(N)nc(N)nc21		CHEMBL1995592	<	Ki	nM	10000.0	CHEMBL2527	Homo sapiens	pKi		5.0
inactive	9608551	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	O=C1CCCc2oc3cc(C(F)(F)F)ccc3c(=O)c21		CHEMBL2006493	<	Ki	nM	5011.87	CHEMBL2527	Homo sapiens	pKi		5.3
inactive	9608552	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	COc1ccc(OC)c(CNC(=O)c2cc(N)c(C#N)c(OC(C)C)n2)c1		CHEMBL1982541	<	Ki	nM	10000.0	CHEMBL2527	Homo sapiens	pKi		5.0
inactive	9608553	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Clc1cc2nn[nH]c2cc1Cl		CHEMBL1996923	<	Ki	nM	5011.87	CHEMBL2527	Homo sapiens	pKi		5.3
active	9608554	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1ccc(CNc2c(Nc3ccncc3)c(=O)c2=O)cc1C		CHEMBL1983449	=	Ki	nM	1000.0	CHEMBL2527	Homo sapiens	pKi		6.0
inactive	9608555	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	O=c1[nH]cnc2c1oc1ccc(Cl)cc12		CHEMBL1992323	<	Ki	nM	5011.87	CHEMBL2527	Homo sapiens	pKi		5.3
inactive	9608556	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(Cl)nccn23)n1		CHEMBL1969735	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9608557	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CCc1nc2c(c3cc(OC)c(OC)cc13)C(=O)NC2=O		CHEMBL2003524	<	Ki	nM	10000.0	CHEMBL2527	Homo sapiens	pKi		5.0
active	9608558	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	COc1ccc2c(c1)C(=Cc1c[nH]cn1)C(=O)N2		CHEMBL2002649	=	Ki	nM	794.33	CHEMBL2527	Homo sapiens	pKi		6.1
inactive	9608559	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CCCn1c(C2CCNCC2)nc(-c2ccc(Cl)c(Cl)c2)c1-c1ccnc(NC2CCCCC2)n1		CHEMBL437747	<	Ki	nM	10000.0	CHEMBL2527	Homo sapiens	pKi		5.0
active	9608560	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Brc1ccc2c(c1)-c1[nH]ncc1C2		CHEMBL1995172	=	Ki	nM	1258.93	CHEMBL2527	Homo sapiens	pKi		5.9
inactive	9608561	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3ccc4nccnc4c3N)cc2)c1		CHEMBL507936	<	Ki	nM	10000.0	CHEMBL2527	Homo sapiens	pKi		5.0
active	9608562	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	O=S(=O)(NCCNCC=Cc1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL1987756	=	Ki	nM	1995.26	CHEMBL2527	Homo sapiens	pKi		5.7
inactive	9608563	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCNS(C)(=O)=O)cnc(N)c34)cc2)c1		CHEMBL1994321	<	Ki	nM	3162.28	CHEMBL2527	Homo sapiens	pKi		5.5
active	9608564	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	O=C1NCCc2[nH]c(-c3ccnc(C=Cc4ccccc4)c3)cc21		CHEMBL1997129	=	Ki	nM	15.85	CHEMBL2527	Homo sapiens	pKi		7.8
inactive	9608565	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	FC(F)(F)c1ccc(-c2nnc3ccc(NC4CC4)nn23)cc1		CHEMBL451964	<	Ki	nM	10000.0	CHEMBL2527	Homo sapiens	pKi		5.0
active	9608566	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1cccc(NC(=O)Cc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL1964307	=	Ki	nM	7943.28	CHEMBL2527	Homo sapiens	pKi		5.1
inactive	9608567	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Fc1ccc(-c2nc3sccn3c2-c2ccncc2)cc1		CHEMBL2000508	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9608568	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CCCCNc1n[s+]([O-])nc1Nc1ccc(F)cc1		CHEMBL1971694	<	Ki	nM	2511.89	CHEMBL2527	Homo sapiens	pKi		5.6
inactive	9608569	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CCc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL2001547	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9608570	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1Cl		CHEMBL210928	<	Ki	nM	5011.87	CHEMBL2527	Homo sapiens	pKi		5.3
active	9608571	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Nc1ccc(-c2cncc(OCC(N)Cc3c[nH]c4ccccc34)c2)cc1C(=O)c1ccccc1F		CHEMBL1994361	=	Ki	nM	3162.28	CHEMBL2527	Homo sapiens	pKi		5.5
inactive	9608572	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1cc(NC(=O)CCNC(=O)Nc2nc(C)c(-c3ccc(-n4cccn4)cc3)s2)no1		CHEMBL1986603	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9608573	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	<	Ki	nM	5011.87	CHEMBL2527	Homo sapiens	pKi		5.3
active	9608574	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	NC(COc1cncc(-c2cc3cnccc3s2)c1)Cc1c[nH]c2ccccc12		CHEMBL1972840	=	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9608575	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	COc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CCO)c5)cnc(N)c34)cc2)cc1		CHEMBL1977148	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9608576	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	COc1cc(C=C2SC(=O)NC2=O)ccc1O		CHEMBL2003286	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9608577	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)ccn1		CHEMBL1992306	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
active	9608578	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CC(O)Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL2002165	=	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9608579	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	NCCOc1cncc(C=Cc2ccncc2)c1		CHEMBL1989518	<	Ki	nM	5011.87	CHEMBL2527	Homo sapiens	pKi		5.3
active	9608580	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Nc1ncnc2scc(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL1998585	=	Ki	nM	3162.28	CHEMBL2527	Homo sapiens	pKi		5.5
inactive	9608581	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cn1cncc1C(OCc1c(-c2ccc(OC(F)(F)F)cc2)cc(C#N)c(=O)n1C)c1ccc(C#N)cc1		CHEMBL127898	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
active	9608582	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CN(C(=O)C1CCCCC1)c1ccc2c(c1)nc(NC(=O)c1ccc(C#N)cc1)n2C		CHEMBL519697	=	Ki	nM	10.0	CHEMBL2527	Homo sapiens	pKi		8.0
inactive	9608583	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)c(F)c2)c1		CHEMBL2004934	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
active	9608584	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3I)cc12		CHEMBL1975128	=	Ki	nM	316.23	CHEMBL2527	Homo sapiens	pKi		6.5
inactive	9608585	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C(C)C(=O)N(C)C)c5)cnc(N)c34)cc2)cc1		CHEMBL2001485	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
active	9608586	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	=	Ki	nM	2511.89	CHEMBL2527	Homo sapiens	pKi		5.6
inactive	9608587	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1cc(C)c2c(n1)sc1c(N)ncnc12		CHEMBL504950	<	Ki	nM	10000.0	CHEMBL2527	Homo sapiens	pKi		5.0
active	9608588	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CN(C)CCCOc1cc2c(c(-c3ccc(Nc4nc5ccccc5o4)cc3)c1)CNC2=O		CHEMBL1966425	=	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9608589	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1cc(NC(=O)Cc2ccc(-c3cccc4[nH]nc(N)c34)cc2)ccc1F		CHEMBL1984363	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
active	9608590	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CNC(=O)COc1ccc(Nc2nc(Nc3ccc(C)c(S(N)(=O)=O)c3)ncc2F)cc1		CHEMBL1978099	=	Ki	nM	251.19	CHEMBL2527	Homo sapiens	pKi		6.6
active	9608591	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	COC(=O)c1c(-c2ccc(NC(=O)Nc3ccccc3)cc2)c2c(N)ncnn2c1C		CHEMBL1977041	=	Ki	nM	3981.07	CHEMBL2527	Homo sapiens	pKi		5.4
active	9608592	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	NC(=O)c1cccc2c1Nc1nnc(Cl)cc1C(=O)N2		CHEMBL1968070	=	Ki	nM	1995.26	CHEMBL2527	Homo sapiens	pKi		5.7
active	9608593	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CC(=O)Nc1cccc(CNc2c(Nc3ccc4[nH]ncc4c3)c(=O)c2=O)c1		CHEMBL1988608	=	Ki	nM	199.53	CHEMBL2527	Homo sapiens	pKi		6.7
inactive	9608594	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1ccc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)cc2)cc1C		CHEMBL184847	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
active	9608595	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CN(C)c1ccc(CNC(=O)c2cc3c(-c4ccccc4)n[nH]c3s2)cc1		CHEMBL1984367	=	Ki	nM	39.81	CHEMBL2527	Homo sapiens	pKi		7.4
active	9608596	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1n[nH]c2cnc(-c3cncc(OCC(N)Cc4cccc(C(F)(F)F)c4)c3)cc12		CHEMBL1998159	=	Ki	nM	79.43	CHEMBL2527	Homo sapiens	pKi		7.1
inactive	9608597	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	COCC(C)(C)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(C)nccn23)n1		CHEMBL1982563	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9608598	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	O=C1CCCN1Cc1ccc2c(c1)[nH]c(=O)c1cccn12		CHEMBL539474	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9608599	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	NC(COc1cncc(-c2ccc3[nH]c(=O)oc3c2)c1)Cc1c[nH]c2ccccc12		CHEMBL1987679	<	Ki	nM	3981.07	CHEMBL2527	Homo sapiens	pKi		5.4
active	9608600	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5ccc(OC(F)F)cc5)cc4)csc23)cn1		CHEMBL1988387	=	Ki	nM	1258.93	CHEMBL2527	Homo sapiens	pKi		5.9
inactive	9608601	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)O)c5)cnc(N)c34)cc2)c1		CHEMBL1989708	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9608602	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CC(Nc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1)c1ccccc1		CHEMBL1990288	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9608603	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	O=c1[nH]c2cc(Cl)cc(Cl)c2c(-c2cc(Cl)ccc2O)c1O		CHEMBL1974803	<	Ki	nM	5011.87	CHEMBL2527	Homo sapiens	pKi		5.3
inactive	9608604	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL1970074	<	Ki	nM	5011.87	CHEMBL2527	Homo sapiens	pKi		5.3
inactive	9608605	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	COCCN(C)C(=O)c1c(-c2ccc3[nH]ncc3c2)nnn1Cc1ccccc1		CHEMBL1986970	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9608606	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	O=c1cc(-c2ccncc2)nc(NC2CCCCC2)[nH]1		CHEMBL1958401	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9608607	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CCN(CC)CCOc1ccc(-c2nc3c(C(N)=O)cccc3[nH]2)cc1		CHEMBL1984044	<	Ki	nM	5011.87	CHEMBL2527	Homo sapiens	pKi		5.3
inactive	9608608	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	O=c1[nH]c2cc(-c3ccccc3)cnc2[nH]1		CHEMBL2003456	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9608609	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(F)cccc12		CHEMBL1966816	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
active	9608610	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CC(=O)N1CCN(C2CCC(n3nc(-c4ccc(NC(=O)c5cc6ccccc6n5C)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL1972584	=	Ki	nM	398.11	CHEMBL2527	Homo sapiens	pKi		6.4
inactive	9612175	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CC(N)C1CCC(C(=O)Nc2ccnc3[nH]ccc23)CC1		CHEMBL2002992	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9612176	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	N#Cc1cnc(NC(=O)Nc2ccc3cc(C(=O)O)ccc3c2)cn1		CHEMBL560813	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9612177	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CC(=NNC(=O)c1nnn(-c2nonc2N)c1-c1ccccc1)c1ccco1		CHEMBL1890036	<	Ki	nM	10000.0	CHEMBL2527	Homo sapiens	pKi		5.0
active	9612178	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1c(-c2cccc(OCc3ccccc3)c2)c2c(N)ncnc2n1C1CC(CN2CCCC2)C1		CHEMBL1968791	=	Ki	nM	1000.0	CHEMBL2527	Homo sapiens	pKi		6.0
inactive	9612179	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	O=C1CC(c2ccc(Cl)cc2Cl)Cc2nc3cc(Cl)ccc3c(O)c21		CHEMBL326282	<	Ki	nM	10000.0	CHEMBL2527	Homo sapiens	pKi		5.0
active	9612180	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1cccc(Cl)c1-c1cccc2c(CCCOc3cccc4ccccc34)c(C(=O)NCCOCCOCCN)[nH]c12		CHEMBL2002682	=	Ki	nM	1000.0	CHEMBL2527	Homo sapiens	pKi		6.0
inactive	9612181	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CCOc1ccccc1C=NNC(=O)c1nnn(-c2nonc2N)c1N1CCCC1		CHEMBL1992732	<	Ki	nM	10000.0	CHEMBL2527	Homo sapiens	pKi		5.0
inactive	9612182	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Fc1ccc(-c2nc3occn3c2-c2ccnc(NC3CCNCC3)n2)cc1		CHEMBL1971186	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9612183	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	O=C(Cc1ccc(Cl)cc1)Nc1[nH]nc2c1CCC2		CHEMBL2003482	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9612184	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN5CCCC5)cnc(N)c34)cc2)c1		CHEMBL1973211	<	Ki	nM	1995.26	CHEMBL2527	Homo sapiens	pKi		5.7
inactive	9612185	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CC(C)Oc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1984700	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9612186	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	<	Ki	nM	5011.87	CHEMBL2527	Homo sapiens	pKi		5.3
active	9612187	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1c(-c2cccc(OCc3ccccc3)c2)c2c(N)ncnc2n1C1CCC(N2CCCC2)CC1		CHEMBL2007151	=	Ki	nM	6309.57	CHEMBL2527	Homo sapiens	pKi		5.2
inactive	9612188	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Nc1ccc(-c2cncc(OCC(N)Cc3c[nH]c4ccccc34)c2)cc1C(=O)c1ccccc1		CHEMBL1972125	<	Ki	nM	1258.93	CHEMBL2527	Homo sapiens	pKi		5.9
inactive	9612189	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	<	Ki	nM	5011.87	CHEMBL2527	Homo sapiens	pKi		5.3
inactive	9612190	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	c1cc2cc(-c3ccc4cn[nH]c4c3)cnc2[nH]1		CHEMBL1976134	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9612191	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1ccc(C(=O)Nc2c(C(N)=O)sc3ccc(Cl)c(Cl)c23)cc1		CHEMBL1965131	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9612192	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	NCCOc1cccc(Nc2ccnc(N)n2)c1		CHEMBL1995448	<	Ki	nM	10000.0	CHEMBL2527	Homo sapiens	pKi		5.0
inactive	9612193	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccccc3)cc12		CHEMBL1972158	<	Ki	nM	2511.89	CHEMBL2527	Homo sapiens	pKi		5.6
active	9612194	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	O=C(O)c1cc2c(-c3cccc(F)c3)cncc2s1		CHEMBL1974457	=	Ki	nM	630.96	CHEMBL2527	Homo sapiens	pKi		6.2
active	9612195	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL482767	=	Ki	nM	125.89	CHEMBL2527	Homo sapiens	pKi		6.9
inactive	9612196	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CCOc1nc(C(=O)NCc2ccccc2S(N)(=O)=O)cc(N)c1Cl		CHEMBL2006581	<	Ki	nM	10000.0	CHEMBL2527	Homo sapiens	pKi		5.0
inactive	9612197	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc(C(=O)NCC#N)c2)n1		CHEMBL1979855	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9612198	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Nc1noc2cccc(-c3cccc(O)c3)c12		CHEMBL1970340	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9612199	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CC(C)NC(=O)COc1cccc(-c2nc(Nc3ccc4[nH]ncc4c3)c3ccccc3n2)c1		CHEMBL2005186	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9612200	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	NCC(O)C(O)Cn1cc(I)c2c(N)ncnc21		CHEMBL1975534	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9612201	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	NS(=O)(=O)c1cccc(Nc2ncc3ccn(Cc4ccccc4)c3n2)c1		CHEMBL1993424	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9612202	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1n[nH]c2c1C(c1ccccc1F)C1=C(CC(C)(C)CC1=O)N2		CHEMBL1966703	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9612203	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CC(C)N(C)C(=O)c1c(-c2ccc3[nH]ncc3c2)nnn1Cc1ccccc1		CHEMBL1969561	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9612204	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL1975121	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9612205	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CN(C)c1cc2sncc2cc1NC(=O)C(=O)O		CHEMBL1997023	<	Ki	nM	5011.87	CHEMBL2527	Homo sapiens	pKi		5.3
inactive	9612206	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1cc(C)cc(NC(=O)Nc2ccc3c(c2)CCc2sc4ncnc(N)c4c2-3)c1		CHEMBL1964687	<	Ki	nM	5011.87	CHEMBL2527	Homo sapiens	pKi		5.3
inactive	9612207	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
active	9612208	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	NC(=O)c1cc2c(-c3ccc(Br)c(F)c3F)cncc2s1		CHEMBL1999918	=	Ki	nM	398.11	CHEMBL2527	Homo sapiens	pKi		6.4
inactive	9612209	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CCOc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C)c5)cnc(N)c34)cc2)cc1		CHEMBL1974254	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9612210	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	COc1ccc(C(=O)N2c3ccccc3Sc3c(Cl)cncc32)cc1		CHEMBL1988537	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9612211	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)c(C)c2)c1		CHEMBL1969049	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9612212	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1ccc(NC(=O)Nc2ccc(-c3coc4ncnc(N)c34)cc2)cc1		CHEMBL2005828	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9612213	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CCc1nc(-c2cccc(C)c2)c(-c2ccnc(NC(=O)c3ccccc3)c2)s1		CHEMBL363648	<	Ki	nM	5011.87	CHEMBL2527	Homo sapiens	pKi		5.3
inactive	9612214	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	<	Ki	nM	5011.87	CHEMBL2527	Homo sapiens	pKi		5.3
inactive	9612215	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	NC(=O)c1sc2c(Br)ccc(Cl)c2c1N		CHEMBL1998611	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
active	9612216	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CN(C(=O)C1CCCCC1)c1ccc2c(c1)nc(NC(=O)c1ccc(C#N)cc1)n2CCC(N)=O		CHEMBL485556	=	Ki	nM	19.95	CHEMBL2527	Homo sapiens	pKi		7.7
active	9612217	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	O=c1c(NCc2ccc(Cl)c(Cl)c2)c(Nc2ccncc2)c1=O		CHEMBL1975900	=	Ki	nM	79.43	CHEMBL2527	Homo sapiens	pKi		7.1
inactive	9612218	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	COc1cc(C=C2SC(=S)NC2=O)ccc1O		CHEMBL1973098	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9612219	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(NC(=O)CC)c3c2)cc1		CHEMBL1972221	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9612220	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CNC(=O)C=Cc1cnc(N)c2c(-c3cc(F)c4[nH]c(C)cc4c3)csc12		CHEMBL2006778	<	Ki	nM	1995.26	CHEMBL2527	Homo sapiens	pKi		5.7
inactive	9612221	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	COc1cc(S(C)(=O)=O)c(OC)cc1CC(=O)Nc1cc(N)c(C#N)c(OC(C)C)n1		CHEMBL378627	<	Ki	nM	5011.87	CHEMBL2527	Homo sapiens	pKi		5.3
inactive	9612222	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	O=C(Nc1cnc2[nH]cc(-c3ccccc3)c2c1)c1c(F)cccc1F		CHEMBL1996979	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9612223	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	NC(=O)c1cccc2[nH]c(-c3ccc(C4CCCNC4)cc3F)nc12		CHEMBL1997025	<	Ki	nM	3981.07	CHEMBL2527	Homo sapiens	pKi		5.4
inactive	9612224	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CCc1cccc(NC(=O)Nc2ccc3c(c2)CCc2sc4ncnc(N)c4c2-3)c1		CHEMBL1968406	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9612225	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)csc12		CHEMBL1982476	<	Ki	nM	10000.0	CHEMBL2527	Homo sapiens	pKi		5.0
inactive	9612226	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	O=C1C(=NNc2cccc3c(=O)[nH][nH]c(=O)c23)C(c2ccccc2)=NN1c1ccccc1		CHEMBL1984274	<	Ki	nM	5011.87	CHEMBL2527	Homo sapiens	pKi		5.3
inactive	9612227	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	O=C(NC(CO)Cc1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1998545	<	Ki	nM	5011.87	CHEMBL2527	Homo sapiens	pKi		5.3
inactive	9612228	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1csc(NC(=O)c2sc3nc(-c4ccncc4)ccc3c2N)n1		CHEMBL1986869	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9612229	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Fc1ccc(-c2ncn(CCN3CCOCC3)c2-c2ccc3[nH]ncc3c2)cc1		CHEMBL1682558	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9612230	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cn1c(NCC(N)Cc2ccccc2)nc(-c2ccncc2)c(-c2ccc3ccccc3c2)c1=O		CHEMBL1990496	<	Ki	nM	5011.87	CHEMBL2527	Homo sapiens	pKi		5.3
active	9612231	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Nc1n[nH]c2cc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)ccc12		CHEMBL1997623	=	Ki	nM	6309.57	CHEMBL2527	Homo sapiens	pKi		5.2
active	9612232	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	NCCCOc1cc2c(c(-c3ccc(Nc4nc5ccc(Cl)cc5o4)cc3)c1)CNC2=O		CHEMBL2002479	=	Ki	nM	100.0	CHEMBL2527	Homo sapiens	pKi		7.0
active	9612233	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1c(NC2CCC(N)CC2)nc2ccnn2c1Nc1ccc(F)c(Cl)c1		CHEMBL1980371	=	Ki	nM	3981.07	CHEMBL2527	Homo sapiens	pKi		5.4
active	9612234	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CC(=NNC(=N)N)c1cc(NC(=O)NCCCN(C)CCCNC(=O)Nc2cc(C(C)=NNC(=N)N)cc(C(C)=NNC(=N)N)c2)cc(C(C)=NNC(=N)N)c1		CHEMBL1993166	=	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
active	9612235	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	O=C(NCc1ccc(Cl)cc1)c1cc2c(-c3ccccc3)n[nH]c2s1		CHEMBL1967094	=	Ki	nM	19.95	CHEMBL2527	Homo sapiens	pKi		7.7
active	9612236	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CC(Nc1c(Nc2ccncc2)c(=O)c1=O)c1ccccc1		CHEMBL1966035	=	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9612237	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	O=C(NC(CO)c1cc(Cl)cc(Cl)c1)c1ccc(-c2ccncc2)cc1		CHEMBL2003341	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9612238	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	c1ccc(-c2n[nH]cc2-c2ccncc2)cc1		CHEMBL1992644	<	Ki	nM	25118.86	CHEMBL2527	Homo sapiens	pKi		4.6
inactive	9612239	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	O=C(NS(=O)(=O)c1ccc(NCCSc2ccc(O)cc2)c([N+](=O)[O-])c1)c1ccc(-c2ccc(F)cc2)cc1		CHEMBL1992645	<	Ki	nM	10000.0	CHEMBL2527	Homo sapiens	pKi		5.0
inactive	9612240	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Oc1cccc(Nc2ncnc3scc(Cl)c23)c1		CHEMBL1982992	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9612241	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1cc(-c2ccccc2)n(-c2cc(NN=Cc3ccco3)ncn2)n1		CHEMBL1999590	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
active	9612242	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccc(Cl)cc1F		CHEMBL1981079	=	Ki	nM	1258.93	CHEMBL2527	Homo sapiens	pKi		5.9
active	9612243	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	O=c1c(NCc2ccc(Cl)cc2)c(Nc2ccncc2)c1=O		CHEMBL1980489	=	Ki	nM	316.23	CHEMBL2527	Homo sapiens	pKi		6.5
inactive	9612244	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C)c5)cnc(N)c34)cc2)c1		CHEMBL1967116	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
active	9612245	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	COc1cc(-c2ccc3c(c2)Nc2ccc(C(=O)NCc4cccc(F)c4)cc2NC3=O)ccc1O		CHEMBL2000832	=	Ki	nM	501.19	CHEMBL2527	Homo sapiens	pKi		6.3
inactive	9612246	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1nn(C)c2c1c(=O)c1cc(Cl)ccc1n2OCC(C)C		CHEMBL1977814	<	Ki	nM	10000.0	CHEMBL2527	Homo sapiens	pKi		5.0
inactive	9612247	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	O=C(NCc1ccc(Br)cc1)Nc1ccc2[nH]ncc2c1		CHEMBL1970709	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
active	9612248	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccc(Cl)cc1Cl		CHEMBL1965660	=	Ki	nM	1258.93	CHEMBL2527	Homo sapiens	pKi		5.9
inactive	9612249	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	COc1ccc(-c2cc3nccn3c(Nc3ccccc3C(N)=O)n2)cc1OC		CHEMBL1998112	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9612250	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CC(C)n1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)cc21		CHEMBL1969126	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9612251	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Nc1ncnc2sc(Br)c(-c3ccc(NC(=O)Cc4cccc(Cl)c4)cc3)c12		CHEMBL1980896	<	Ki	nM	5011.87	CHEMBL2527	Homo sapiens	pKi		5.3
active	9612252	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CC(C)(C)c1ccc2nc(-c3n[nH]c4ccccc34)[nH]c2c1		CHEMBL1970104	=	Ki	nM	316.23	CHEMBL2527	Homo sapiens	pKi		6.5
active	9612253	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCCC4=O)c3)n2)c1		CHEMBL1991429	=	Ki	nM	1000.0	CHEMBL2527	Homo sapiens	pKi		6.0
inactive	9612254	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)C(=O)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1971149	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9612255	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1ccc2c(c1)NC(=O)c1ccccc1N2		CHEMBL1999714	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9612256	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	O=C(Cc1ccccc1Cl)Nc1ccc2cn[nH]c2c1		CHEMBL1987533	<	Ki	nM	5011.87	CHEMBL2527	Homo sapiens	pKi		5.3
inactive	9612257	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CC(C)(O)CNc1nccc(-c2c(-c3ccc(F)cc3F)nc3c(CC4CC4)nccn23)n1		CHEMBL1994040	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
active	9612258	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CNC1CC2OC(C)(C1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL1980995	=	Ki	nM	10.0	CHEMBL2527	Homo sapiens	pKi		8.0
inactive	9612259	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	NC(COc1cncc(-c2ccc3c(c2)CC(=O)N3)c1)Cc1c[nH]c2ccccc12		CHEMBL1967302	<	Ki	nM	3162.28	CHEMBL2527	Homo sapiens	pKi		5.5
inactive	9612260	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	N#Cc1ccc(-c2n[nH]c3c2Cc2ccc(OCCCCN4CCOCC4)cc2-3)cn1		CHEMBL398951	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9612261	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	COc1cc2cnc3c(c2cc1OC)C(=O)NC3=O		CHEMBL1982506	<	Ki	nM	5011.87	CHEMBL2527	Homo sapiens	pKi		5.3
active	9612262	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CCN(CC)CCNC(=O)C=Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12		CHEMBL2004716	=	Ki	nM	501.19	CHEMBL2527	Homo sapiens	pKi		6.3
inactive	9612263	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CN(C)CC(C)(C)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1		CHEMBL1968127	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9612264	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	COc1cc(C)c(Cl)cc1NC(=O)Nc1cnc(C#N)cn1		CHEMBL1975233	<	Ki	nM	5011.87	CHEMBL2527	Homo sapiens	pKi		5.3
inactive	9612265	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CCCC(=O)Nc1n[nH]c2ccc(-c3cccc(F)c3F)cc12		CHEMBL1985406	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9612266	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cn1nc(C(F)(F)F)c2c(=O)c3cc(Cl)ccc3n(O)c21		CHEMBL207400	<	Ki	nM	5011.87	CHEMBL2527	Homo sapiens	pKi		5.3
inactive	9612267	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1cc(O)ccc1-n1cc(C(=O)NN)c(=O)c2ccc(-c3ccncc3)cc21		CHEMBL2000894	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9612268	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1ccccc1NC(=O)Nc1ccc2c(c1)CCc1sc3ncnc(N)c3c1-2		CHEMBL1982135	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
active	9612269	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Nc1ncnc2c1sc1ncnc(N)c12		CHEMBL1976090	=	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9612270	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CNC(=O)C=Cc1cnc(N)c2c(-c3ccc4c(c3)OCO4)csc12		CHEMBL1993243	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9612271	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	OCC(CO)Nc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL1992922	<	Ki	nM	1995.26	CHEMBL2527	Homo sapiens	pKi		5.7
inactive	9612272	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	O=C1NCc2c1cccc2-c1ccc(Nc2nc3ccccc3o2)cc1		CHEMBL2004771	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
active	9612273	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2C1CC(CN2CCCC2)C1		CHEMBL1988370	=	Ki	nM	1258.93	CHEMBL2527	Homo sapiens	pKi		5.9
inactive	9612274	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(N)c3c2)cc1		CHEMBL1997597	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
active	9612275	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	S=c1[nH]nc2c3c4c(sc3n3c(=S)[nH]nc3n12)CCC4		CHEMBL1969537	=	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
active	9612276	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Ki	nM	7943.28	CHEMBL2527	Homo sapiens	pKi		5.1
inactive	9612277	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CN(C)CC(C)(C)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3cnccn23)n1		CHEMBL1976093	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9612278	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CC(=O)Nc1cc(N)c(C#N)c(-c2ccccc2)n1		CHEMBL210032	<	Ki	nM	5011.87	CHEMBL2527	Homo sapiens	pKi		5.3
inactive	9612279	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	NC(COc1cncc(-c2ccc(F)cc2)c1)Cc1c[nH]c2ccccc12		CHEMBL1996543	<	Ki	nM	10000.0	CHEMBL2527	Homo sapiens	pKi		5.0
inactive	9612280	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Nc1nonc1-n1nnc(C(=O)NN=Cc2cccs2)c1-c1cccs1		CHEMBL1975256	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9612281	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3cnc4c(-c5cnn(C)c5)cnn4c3N)cc2)c1		CHEMBL508928	<	Ki	nM	5011.87	CHEMBL2527	Homo sapiens	pKi		5.3
inactive	9612282	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(N)c3c2)cc1		CHEMBL2004892	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9612283	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	NC(=O)c1cc2c(Oc3ccc(Br)cc3)cncc2s1		CHEMBL116070	<	Ki	nM	7943.28	CHEMBL2527	Homo sapiens	pKi		5.1
inactive	9612284	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	NC(=O)c1cc(-c2cccc(N)c2)cc2cccnc12		CHEMBL1970314	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9612285	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	OCCCn1cnc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL2004871	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9612286	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncn3)cc2)c1		CHEMBL2004872	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9612287	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	O=C1Nc2ccccc2Nc2ccccc21		CHEMBL1727312	<	Ki	nM	5011.87	CHEMBL2527	Homo sapiens	pKi		5.3
inactive	9612288	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CC1CCN(C(=O)CO)CC1N(C)c1ncnc2[nH]ccc12		CHEMBL1969879	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
active	9612289	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	O=C(Nc1cnccn1)Nc1ccnc2ccccc12		CHEMBL1981720	=	Ki	nM	501.19	CHEMBL2527	Homo sapiens	pKi		6.3
inactive	9612290	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CC(N)COc1cnc(Cl)c(C=Cc2ccncc2)c1		CHEMBL1993548	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9612291	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3nsc4ncnc(N)c34)cc2)c1		CHEMBL262433	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9612292	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1ccc(-c2nn(C(C)(C)C)c3ncnc(N)c23)cc1		CHEMBL306380	<	Ki	nM	2511.89	CHEMBL2527	Homo sapiens	pKi		5.6
inactive	9612293	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	O=C(NNC(=S)Nc1ccc(Cl)cc1)C(O)(c1ccccc1)c1ccccc1		CHEMBL1966722	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9612294	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4snc(N)c34)cc2)c1		CHEMBL1976328	<	Ki	nM	10000.0	CHEMBL2527	Homo sapiens	pKi		5.0
active	9612295	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	COc1cc(-c2ccc3c(c2)Nc2ccc(C(=O)NCCNC(C)=O)cc2NC3=O)ccc1O		CHEMBL1975500	=	Ki	nM	316.23	CHEMBL2527	Homo sapiens	pKi		6.5
inactive	9612296	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4ccnc(N)c34)cc2)c1		CHEMBL394619	<	Ki	nM	5011.87	CHEMBL2527	Homo sapiens	pKi		5.3
active	9612297	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	COc1ccc(Nc2nccc(Nc3c(NC(C)C(C)(C)C)c(=O)c3=O)n2)cc1OC		CHEMBL1964399	=	Ki	nM	31.62	CHEMBL2527	Homo sapiens	pKi		7.5
inactive	9612298	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	O=C(O)c1c2c(nc3ccccc13)C(=C1CCCC1)CC2		CHEMBL1996831	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
active	9612299	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Nc1ncnc2c1N=C(c1ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc1)CCN2		CHEMBL411903	=	Ki	nM	251.19	CHEMBL2527	Homo sapiens	pKi		6.6
active	9612300	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN)cnc(N)c34)cc2)c1		CHEMBL1965988	=	Ki	nM	1258.93	CHEMBL2527	Homo sapiens	pKi		5.9
inactive	9612301	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CN1CCC(c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)C(O)C1		CHEMBL422897	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9612302	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1c(-c2ccc3[nH]nc(N)c3c2)nnn1Cc1ccccc1		CHEMBL1989646	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9612303	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	c1ccc(Cc2cc(-c3ccc4[nH]ncc4c3)on2)cc1		CHEMBL1682357	<	Ki	nM	10000.0	CHEMBL2527	Homo sapiens	pKi		5.0
inactive	9612304	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	O=C1NCCc2[nH]c(-c3ccncc3)cc21		CHEMBL225519	<	Ki	nM	1000.0	CHEMBL2527	Homo sapiens	pKi		6.0
inactive	9612305	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CCOc1nc(C(=O)NCc2cccnc2)cc(N)c1C#N		CHEMBL209534	<	Ki	nM	10000.0	CHEMBL2527	Homo sapiens	pKi		5.0
inactive	9612306	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1nccn2c(-c3ccnc(NCCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1978200	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
active	9612307	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9612308	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	COc1cc(C=C2SC(=Nc3ccccc3)NC2=O)ccc1O		CHEMBL1970522	<	Ki	nM	3162.28	CHEMBL2527	Homo sapiens	pKi		5.5
inactive	9612309	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cncc4c3c(N)nn4C)cc2)c1		CHEMBL402846	<	Ki	nM	5011.87	CHEMBL2527	Homo sapiens	pKi		5.3
inactive	9612310	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	C(=Cc1cncc(OC2CCNC2)c1)c1ccncc1		CHEMBL1966087	<	Ki	nM	5011.87	CHEMBL2527	Homo sapiens	pKi		5.3
inactive	9612311	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cn1nc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)cncc21		CHEMBL1964692	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9612312	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	O=C(NC(CO)Cc1ccc(Cl)cc1)c1ccc(-c2ccncc2)cc1		CHEMBL1996931	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9612313	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	FC(F)(F)c1ccc(Cn2cc(-c3ccc4[nH]ncc4c3)nn2)c(C(F)(F)F)c1		CHEMBL1964413	<	Ki	nM	5011.87	CHEMBL2527	Homo sapiens	pKi		5.3
inactive	9612314	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2cc(C(F)(F)F)ccc12		CHEMBL1973483	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9612315	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1ccc(Cn2cc(-c3ccc4[nH]ncc4c3)nn2)c(C)c1		CHEMBL1984432	<	Ki	nM	10000.0	CHEMBL2527	Homo sapiens	pKi		5.0
active	9612316	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Nc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4ccccc4)cc3)c12		CHEMBL219722	=	Ki	nM	2511.89	CHEMBL2527	Homo sapiens	pKi		5.6
inactive	9612317	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	O=C(c1cc(-c2ccc3[nH]ncc3c2)on1)N1CCCC(O)C1		CHEMBL1997340	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9612318	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	COc1cccc(Nc2ncnc3ccccc23)c1		CHEMBL117697	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
active	9612319	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	=	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9612320	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cn1cc(-c2ccncn2)c(-c2ccc(F)cc2)n1		CHEMBL1989474	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9612321	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCOCC4)c3)n2)c1		CHEMBL1090360	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9612322	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	O=C(Nc1nc2ccccc2n1CCCO)c1cccc([N+](=O)[O-])c1		CHEMBL210887	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
active	9612323	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CNC(=O)c1ccccc1Nc1nc(Nc2ccc(N3CCOCC3)cc2OC)ncc1Cl		CHEMBL458997	=	Ki	nM	316.23	CHEMBL2527	Homo sapiens	pKi		6.5
inactive	9612324	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)c(C(F)(F)F)c2)c1		CHEMBL1971021	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
active	9612325	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4cccc(OC(F)(F)F)c4)c3)cc12		CHEMBL1965836	=	Ki	nM	1000.0	CHEMBL2527	Homo sapiens	pKi		6.0
inactive	9612326	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	O=c1[nH]cnc2c1sc1c(Cl)ccc(Cl)c12		CHEMBL583144	<	Ki	nM	5011.87	CHEMBL2527	Homo sapiens	pKi		5.3
active	9612327	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	NC(=O)c1cc2c(-c3ccc(F)cc3)cncc2s1		CHEMBL1974310	=	Ki	nM	501.19	CHEMBL2527	Homo sapiens	pKi		6.3
inactive	9612328	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	COc1ccc2c(NC(=O)Nc3cccc(C(F)(F)F)n3)ccnc2c1		CHEMBL1982660	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9612329	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Nc1ncnc2sc3c(c12)-c1ccc(NC(=O)Nc2ccccc2)cc1CC3		CHEMBL1994693	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
active	9612330	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	NC(=O)c1cccc(-c2cnc3[nH]cc(-c4ccccc4)c3c2)c1		CHEMBL1982957	=	Ki	nM	398.11	CHEMBL2527	Homo sapiens	pKi		6.4
active	9612331	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Ki	nM	501.19	CHEMBL2527	Homo sapiens	pKi		6.3
inactive	9612332	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	O=C(NNC(=S)Nc1ccc(F)cc1)C(O)(c1ccccc1)c1ccccc1		CHEMBL1975138	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9612333	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CCOc1nc(C(=O)NCc2ccc(S(C)(=O)=O)cc2)cc(N)c1C#N		CHEMBL424872	<	Ki	nM	3981.07	CHEMBL2527	Homo sapiens	pKi		5.4
inactive	9612334	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CC1=NN(c2ccc(C(=O)O)cc2)C(=O)C1=Cc1c(C)c(C#N)c2nc3ccccc3n2c1O		CHEMBL2006836	<	Ki	nM	5011.87	CHEMBL2527	Homo sapiens	pKi		5.3
inactive	9612335	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#Cc5cccnc5)cnc(N)c34)cc2)c1		CHEMBL1971947	<	Ki	nM	10000.0	CHEMBL2527	Homo sapiens	pKi		5.0
inactive	9612336	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1c[nH]c(-c2cnc(NCCNc3ccc(C#N)cn3)nc2-c2ccc(Cl)cc2Cl)n1		CHEMBL412142	<	Ki	nM	3981.07	CHEMBL2527	Homo sapiens	pKi		5.4
inactive	9612337	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	<	Ki	nM	10000.0	CHEMBL2527	Homo sapiens	pKi		5.0
inactive	9612338	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1cc2nnc(SCc3cn4ccccc4n3)n2c2ccccc12		CHEMBL1980704	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9612339	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	NC(=O)c1sc2ccc(Cl)c(Cl)c2c1NC(=O)c1ccc(Cl)cc1		CHEMBL2003271	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9612340	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	O=c1[nH]c2sc3c(c2c2nc(-c4ccncc4)nn12)CCCC3		CHEMBL1966808	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9612341	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CC(C)(C)c1n[nH]c2c1C(c1ccccc1F)C(C#N)=C(N)O2		CHEMBL2004447	<	Ki	nM	5011.87	CHEMBL2527	Homo sapiens	pKi		5.3
active	9612342	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL1983111	=	Ki	nM	50.12	CHEMBL2527	Homo sapiens	pKi		7.3
inactive	9612343	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	OCCNc1cc2cc(-c3ccsc3)ccc2cn1		CHEMBL1973860	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9612344	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Nc1n[nH]c2nnc(-c3ccccc3)c(-c3ccccc3)c12		CHEMBL260135	<	Ki	nM	5011.87	CHEMBL2527	Homo sapiens	pKi		5.3
inactive	9612345	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21		CHEMBL220241	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9612346	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	O=c1[nH]cc(I)c2nc(-c3cccc(Cl)c3)cn12		CHEMBL1982610	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
active	9612347	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CCn1c(=C(C#N)C(=O)O)sc(=CNc2ccccc2)c1=O		CHEMBL1986996	=	Ki	nM	3981.07	CHEMBL2527	Homo sapiens	pKi		5.4
inactive	9612348	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1cccc(C2(c3cccc(C)c3)CC2C(=O)Nc2ccncc2)c1		CHEMBL1999496	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
active	9612349	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CSc1cnc2c(ccc3cnccc32)c1O		CHEMBL2006933	=	Ki	nM	1000.0	CHEMBL2527	Homo sapiens	pKi		6.0
inactive	9612350	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Nc1ccc(-c2csc3c(C=Cc4nc5ccccc5[nH]4)cnc(N)c23)cc1		CHEMBL1988300	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
active	9612351	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	COc1ccc(C(=O)Nc2n[nH]c3ccc(-c4cn(Cc5ccccc5)nn4)cc23)cc1OC		CHEMBL1991078	=	Ki	nM	50.12	CHEMBL2527	Homo sapiens	pKi		7.3
active	9612352	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Ki	nM	1995.26	CHEMBL2527	Homo sapiens	pKi		5.7
inactive	9612353	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CCCCNc1ccc2c3c(cccc13)C(=O)N(CCNCCO)C2=O		CHEMBL1987359	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
active	9612354	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CC(=NNC(=N)N)c1cc(NC(=O)c2cccc(C(=O)Nc3cc(C(C)=NNC(=N)N)cc(C(C)=NNC(=N)N)c3)c2)cc(C(C)=NNC(=N)N)c1		CHEMBL2000685	=	Ki	nM	398.11	CHEMBL2527	Homo sapiens	pKi		6.4
inactive	9612355	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9612356	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Nc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4cc(CO)ccc4F)cc3)c12		CHEMBL1985311	<	Ki	nM	10000.0	CHEMBL2527	Homo sapiens	pKi		5.0
inactive	9612357	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CC1CSc2c(C(=O)O)c(=O)c3cc(F)c(N4CCC(N)C4)cc3n21		CHEMBL1989265	<	Ki	nM	5011.87	CHEMBL2527	Homo sapiens	pKi		5.3
active	9612358	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccc(Cl)cc1Cl		CHEMBL1965660	=	Ki	nM	1258.93	CHEMBL2527	Homo sapiens	pKi		5.9
active	9612359	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	O=C1NN=Cc2c[nH]c3cc(NC(=O)C4CC4c4ccccc4)cc1c23		CHEMBL1969502	=	Ki	nM	125.89	CHEMBL2527	Homo sapiens	pKi		6.9
active	9612360	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2C1CCC(N2CCCC2)CC1		CHEMBL1965910	=	Ki	nM	3162.28	CHEMBL2527	Homo sapiens	pKi		5.5
inactive	9612361	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CC(C)Nc1c(-c2ccc3[nH]ncc3c2)nc2ncccn12		CHEMBL1682553	<	Ki	nM	5011.87	CHEMBL2527	Homo sapiens	pKi		5.3
inactive	9612362	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1cccc(-c2c(-c3ccncc3)nc(NCC(N)Cc3ccccc3)n(C)c2=O)c1		CHEMBL1971430	<	Ki	nM	3981.07	CHEMBL2527	Homo sapiens	pKi		5.4
inactive	9612363	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	COc1ccc(C(=O)Nc2cnc3[nH]cc(-c4ccccc4)c3c2)cc1		CHEMBL1997764	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9612364	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3coc4ncnc(N)c34)cc2)c1		CHEMBL1983963	<	Ki	nM	2511.89	CHEMBL2527	Homo sapiens	pKi		5.6
active	9612365	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1n[nH]c2ccc(-c3cncc(OCC(CN)Cc4ccccc4)c3)cc12		CHEMBL2000271	=	Ki	nM	398.11	CHEMBL2527	Homo sapiens	pKi		6.4
inactive	9612366	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Oc1ccc(-c2n[nH]c(Nc3cccc(Cl)c3)c2-c2ccc(O)cc2)cc1		CHEMBL1985092	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9612367	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Nc1nonc1-n1nnc(C(=O)NN=Cc2cccs2)c1-c1ccccc1		CHEMBL2004692	<	Ki	nM	5011.87	CHEMBL2527	Homo sapiens	pKi		5.3
inactive	9612368	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CNc1ncnc2c1N=C(c1ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc1)CCN2		CHEMBL1981410	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9612369	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CC1(O)CC(c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn23)C1		CHEMBL1996234	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9612370	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	COc1ccc(C=C2C(=O)ON=C2c2ccc(Br)cc2)cc1OC		CHEMBL1991434	<	Ki	nM	5011.87	CHEMBL2527	Homo sapiens	pKi		5.3
active	9612371	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CN(C)c1cccc2c(S(=O)(=O)N(CCN)c3cncc(-c4ccc5cnccc5c4)c3)cccc12		CHEMBL1967544	=	Ki	nM	501.19	CHEMBL2527	Homo sapiens	pKi		6.3
inactive	9612372	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	N#Cc1ncc2nc1OCCCCCOc1cc(CCCO)c(Cl)cc1NC(=O)N2		CHEMBL223367	<	Ki	nM	5011.87	CHEMBL2527	Homo sapiens	pKi		5.3
active	9612373	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CN(C)c1ncnc2nc[nH]c12		CHEMBL407391	=	Ki	nM	3981.07	CHEMBL2527	Homo sapiens	pKi		5.4
inactive	9612374	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	NC(=O)c1cn(-c2ccc(O)cc2Cl)c2cc(-c3ccncc3)ccc2c1=O		CHEMBL340384	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9612375	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CC(C)(CO)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4n3CCC4)nn12		CHEMBL1996587	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9612376	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CS(=O)(=O)NCCOc1cncc(-c2ccc3cnccc3c2)c1		CHEMBL1964804	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9612377	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	COc1ccc(-c2cnc3c(Br)cnn3c2)cc1		CHEMBL443962	<	Ki	nM	2511.89	CHEMBL2527	Homo sapiens	pKi		5.6
inactive	9612378	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	COc1ccc(C=C2SC(=Nc3ccccc3)NC2=O)cc1O		CHEMBL2000354	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9612379	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cn1ncc2c1CCCC2=O		CHEMBL1981107	<	Ki	nM	25118.86	CHEMBL2527	Homo sapiens	pKi		4.6
inactive	9612380	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	<	Ki	nM	5011.87	CHEMBL2527	Homo sapiens	pKi		5.3
inactive	9612381	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CCCC(=O)Nc1n[nH]c2nc3ccccc3cc12		CHEMBL1967564	<	Ki	nM	5011.87	CHEMBL2527	Homo sapiens	pKi		5.3
active	9612382	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	NCCCn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL592030	=	Ki	nM	19.95	CHEMBL2527	Homo sapiens	pKi		7.7
inactive	9612383	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	OCCCNc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL2000071	<	Ki	nM	3981.07	CHEMBL2527	Homo sapiens	pKi		5.4
inactive	9612384	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	COc1ccc2c(NC(=O)Nc3cc(C(F)(F)F)ccn3)ccnc2c1		CHEMBL1979176	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
active	9612385	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1970317	=	Ki	nM	501.19	CHEMBL2527	Homo sapiens	pKi		6.3
inactive	9612386	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1cn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc2c(C)n1		CHEMBL2000408	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9612387	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	N#Cc1ncc2nc1OCCCCOc1cc(NCc3cncs3)c(Cl)cc1NC(=O)N2		CHEMBL248757	<	Ki	nM	5011.87	CHEMBL2527	Homo sapiens	pKi		5.3
inactive	9612388	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CN1CCC(C(=O)n2nc(N)c3cc(-c4cn(Cc5ccccc5)nn4)ccc32)CC1		CHEMBL1978014	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9612389	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	O=C(Nc1cnccn1)Nc1ccnc2c(C(F)(F)F)cccc12		CHEMBL1994538	<	Ki	nM	3981.07	CHEMBL2527	Homo sapiens	pKi		5.4
active	9612390	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CCN(CC)C(=O)Nc1ccc2nc(-c3ccco3)c(-c3ccco3)nc2c1		CHEMBL1983195	=	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9612391	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	NCCCOc1cc2c(c(-c3ccc(Nc4nc5ccccc5o4)cc3)c1)CNC2=O		CHEMBL1975490	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9612392	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1ccc2nccc(NC(=O)Nc3cccc(C(F)(F)F)n3)c2c1		CHEMBL1964444	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9612393	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CC(=O)Nc1cc(N)c(C#N)c(-c2ccsc2)n1		CHEMBL2006567	<	Ki	nM	10000.0	CHEMBL2527	Homo sapiens	pKi		5.0
inactive	9612394	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Clc1csc2ncnc(Nc3ccccc3)c12		CHEMBL1986139	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9612395	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	NC(Cc1cccc2ccccc12)C(=O)Nc1cncc(C=Cc2ccncc2)c1		CHEMBL1985580	<	Ki	nM	10000.0	CHEMBL2527	Homo sapiens	pKi		5.0
inactive	9612396	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(Cl)cccc12		CHEMBL1980540	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9612397	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN(C)C)cnc(N)c34)cc2)c1		CHEMBL1979883	<	Ki	nM	5011.87	CHEMBL2527	Homo sapiens	pKi		5.3
inactive	9612398	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	COCCOC1CCC(n2nc(-c3ccc(Nc4nc5cc(C)cc(C)c5o4)cc3)c3c(N)ncnc32)CC1		CHEMBL1984162	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9612399	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Fc1cnc(Nc2ccccc2)nc1Nc1ccccc1		CHEMBL491758	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
active	9612400	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CC(Nc1c(Nc2ccncc2)c(=O)c1=O)C(C)(C)C		CHEMBL1986186	=	Ki	nM	501.19	CHEMBL2527	Homo sapiens	pKi		6.3
active	9612401	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	c1cc2[nH]ncc2cc1-c1cc(CN2CCCCC2)no1		CHEMBL1682360	=	Ki	nM	1258.93	CHEMBL2527	Homo sapiens	pKi		5.9
inactive	9612402	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1n[nH]c2c1C(c1ccccc1Cl)C(C#N)=C(N)O2		CHEMBL1970189	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9612403	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Nc1ncnc2c1c(I)nn2C1CCC(O)CC1		CHEMBL1996791	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9612404	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3c(C)sc4ncnc(N)c34)cc2)c1		CHEMBL371206	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9612405	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	COc1ccc(C=NNc2ncnc3c2[nH]c2ccccc23)cc1OC		CHEMBL1974664	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
active	9612406	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CC(C)(C)c1ccc2nc(-c3n[nH]c4ccccc34)[nH]c2c1		CHEMBL1970104	=	Ki	nM	316.23	CHEMBL2527	Homo sapiens	pKi		6.5
inactive	9612407	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	O=C(NC(CO)c1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1974288	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9612408	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4ncnc(N)c34)cc2)c1		CHEMBL196363	<	Ki	nM	7943.28	CHEMBL2527	Homo sapiens	pKi		5.1
inactive	9612409	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	COc1ccc(-c2cc3nccn3c(Nc3ncccc3C(N)=O)n2)cc1OC		CHEMBL1190711	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9612410	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Nc1n[nH]c2cccc(-c3ccc(Br)cc3)c12		CHEMBL1990346	<	Ki	nM	10000.0	CHEMBL2527	Homo sapiens	pKi		5.0
active	9612411	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CCCC(=O)Nc1cccc(-c2nc(Nc3ccc4[nH]ncc4c3)c3cc(OCCN4CCCC4)ccc3n2)c1		CHEMBL1968705	=	Ki	nM	1000.0	CHEMBL2527	Homo sapiens	pKi		6.0
inactive	9612412	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3cncc4c3c(N)nn4C)cc2)c1		CHEMBL404367	<	Ki	nM	5011.87	CHEMBL2527	Homo sapiens	pKi		5.3
inactive	9615976	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CC(C)Cc1cc(-c2ccc3[nH]nc(N)c3c2)on1		CHEMBL1966343	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9615977	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1n[nH]c2ccc(-c3cncc(OCCN)c3)cc12		CHEMBL1967887	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
active	9615978	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CC(=O)c1cccc(-c2cnc3[nH]ccc3c2)c1		CHEMBL2000568	=	Ki	nM	630.96	CHEMBL2527	Homo sapiens	pKi		6.2
active	9615979	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1ccc(NC(=O)Nc2ccc(-c3csc4ncnc(N)c34)cc2)cc1C		CHEMBL2000335	=	Ki	nM	630.96	CHEMBL2527	Homo sapiens	pKi		6.2
active	9615980	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	=	Ki	nM	794.33	CHEMBL2527	Homo sapiens	pKi		6.1
inactive	9615981	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cn1cc(-c2cnn3c(N)c(-c4ccc(NC(=O)Nc5cccc(C(F)(F)F)c5)cc4)cnc23)cn1		CHEMBL1988717	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
active	9615982	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1cccc(Nc2nc(NC3CCCCC3N)cnc2C(N)=O)c1		CHEMBL1974328	=	Ki	nM	100.0	CHEMBL2527	Homo sapiens	pKi		7.0
active	9615983	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Ki	nM	1.259	CHEMBL2527	Homo sapiens	pKi		8.9
inactive	9615984	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	O=C(Nc1ccc2[nH]ncc2c1)c1ccc(Cl)cc1		CHEMBL1973808	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9615985	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CC(C)Oc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL2000429	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
active	9615986	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	NCC(NC(=O)c1ccc(-c2ccncc2)cc1)c1ccccc1		CHEMBL1990254	=	Ki	nM	501.19	CHEMBL2527	Homo sapiens	pKi		6.3
active	9615987	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Fc1ccc2c(c1)-c1n[nH]cc1CS2		CHEMBL1989069	=	Ki	nM	6309.57	CHEMBL2527	Homo sapiens	pKi		5.2
inactive	9615988	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(N)c3c2)cc1		CHEMBL1992342	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9615989	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1cc(Cl)ccc1NC(=S)NNC(=O)C(O)(c1ccccc1)c1ccccc1		CHEMBL1988173	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
active	9615990	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Ki	nM	7943.28	CHEMBL2527	Homo sapiens	pKi		5.1
inactive	9615991	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CC(C)Cn1c(N)nc2ccc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc21		CHEMBL1965423	<	Ki	nM	5011.87	CHEMBL2527	Homo sapiens	pKi		5.3
active	9615992	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CCC(N)(C#Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12)CC		CHEMBL1983025	=	Ki	nM	794.33	CHEMBL2527	Homo sapiens	pKi		6.1
inactive	9615993	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	NC(Cc1c[nH]c2ccccc12)C(=O)Nc1cncc(C=Cc2ccncc2)c1		CHEMBL1983945	<	Ki	nM	3162.28	CHEMBL2527	Homo sapiens	pKi		5.5
inactive	9615994	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	O=C(NCc1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1977135	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
active	9615995	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	O=C1NC(=S)SC1=C1C(=O)Nc2ccc(Br)cc21		CHEMBL2001920	=	Ki	nM	1258.93	CHEMBL2527	Homo sapiens	pKi		5.9
inactive	9615996	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	NC(=O)c1cc2c(-c3cc(C(F)(F)F)cc(C(F)(F)F)c3)cncc2s1		CHEMBL2002322	<	Ki	nM	10000.0	CHEMBL2527	Homo sapiens	pKi		5.0
active	9615997	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	COc1cc(Nc2ncc([N+](=O)[O-])c(Nc3ccccc3C(N)=O)n2)cc(OC)c1OC		CHEMBL1241473	=	Ki	nM	100.0	CHEMBL2527	Homo sapiens	pKi		7.0
inactive	9615998	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1ccc(F)c(-c2ccc3nnc(N)n3c2)c1		CHEMBL2002323	<	Ki	nM	10000.0	CHEMBL2527	Homo sapiens	pKi		5.0
inactive	9615999	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CS(=O)(=O)N(Cc1ccc2[nH]c(=O)c3cccn3c2c1)C1CC1		CHEMBL1978448	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9616000	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	NCCCOc1cncc(C=Cc2ccncc2)c1		CHEMBL1972258	<	Ki	nM	5011.87	CHEMBL2527	Homo sapiens	pKi		5.3
inactive	9616001	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CCN(CC)CC#Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12		CHEMBL2001257	<	Ki	nM	5011.87	CHEMBL2527	Homo sapiens	pKi		5.3
active	9616002	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CC(C)(C)OC(=O)n1ncc2cc(Nc3c(NCc4ccc(Cl)cc4Cl)c(=O)c3=O)ccc21		CHEMBL2005548	=	Ki	nM	251.19	CHEMBL2527	Homo sapiens	pKi		6.6
inactive	9616003	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	COc1ccc(CNc2c(Nc3ccc4[nH]ncc4c3)c(=O)c2=O)cc1		CHEMBL1992536	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9616004	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CCN1CCN(CCCC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1		CHEMBL1992740	<	Ki	nM	5011.87	CHEMBL2527	Homo sapiens	pKi		5.3
inactive	9616005	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Nc1ccc(-c2cncc(OCC(N)Cc3c[nH]c4ccccc34)c2)cc1C(=O)c1cccc(Cl)c1		CHEMBL1973348	<	Ki	nM	3162.28	CHEMBL2527	Homo sapiens	pKi		5.5
inactive	9616006	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2NCCCN)c1		CHEMBL2006188	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9616007	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Nc1ncnc2scc(-c3ccc(NC(=O)Nc4ccccc4)cc3)c12		CHEMBL1967531	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9616008	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CCCC(=O)Nc1nn(C(=O)CC)c2nc3ccccc3cc12		CHEMBL1970913	<	Ki	nM	5011.87	CHEMBL2527	Homo sapiens	pKi		5.3
inactive	9616009	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(NC(C)=O)c3c2)cc1		CHEMBL1973893	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9616010	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	<	Ki	nM	5011.87	CHEMBL2527	Homo sapiens	pKi		5.3
inactive	9616011	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	COc1cccc(C(C)NC(=O)c2cc(C)c(-c3ccc4[nH]nc(C)c4c3)s2)c1		CHEMBL1997534	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9616012	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1996500	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
active	9616013	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	NC(=O)Cn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL1985095	=	Ki	nM	39.81	CHEMBL2527	Homo sapiens	pKi		7.4
active	9616014	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	COCc1nnn(-c2nonc2N)c1C(=O)NN=C(C)c1ccc(O)cc1O		CHEMBL1991180	=	Ki	nM	398.11	CHEMBL2527	Homo sapiens	pKi		6.4
inactive	9616015	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)O)c5)cnc(N)c34)cc2)c1		CHEMBL1989708	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9616016	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	c1cnc2nc(-c3ccc4[nH]ncc4c3)cn2c1		CHEMBL1682540	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
active	9616017	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CCc1c(-c2ccc(C(C)(C)O)cc2)[nH]c2nccnc12		CHEMBL1976420	=	Ki	nM	398.11	CHEMBL2527	Homo sapiens	pKi		6.4
active	9616018	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1ccc(CNc2c(Nc3ccncc3)c(=O)c2=O)cc1		CHEMBL1994864	=	Ki	nM	794.33	CHEMBL2527	Homo sapiens	pKi		6.1
inactive	9616019	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	N#Cc1ncc2nc1OCCCCCOc1cc(OCCO)c(Cl)cc1NC(=O)N2		CHEMBL413779	<	Ki	nM	10000.0	CHEMBL2527	Homo sapiens	pKi		5.0
active	9616020	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CN1CCN(Cc2ccc3c(c2)Cc2c(-c4csc(C#CCOCC5CC5)c4)n[nH]c2-3)CC1		CHEMBL2002446	=	Ki	nM	1995.26	CHEMBL2527	Homo sapiens	pKi		5.7
inactive	9616021	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	O=c1nc(-c2cc3c(Oc4ccc(I)cc4)cncc3s2)[nH]o1		CHEMBL497151	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9616022	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	NCC1CCC(CNc2nc(NCc3ccccc3Cl)ncc2[N+](=O)[O-])CC1		CHEMBL246970	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9616023	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1cc(O)ccc1-n1cc(C(N)=O)c(=O)c2ccc(-c3ccncc3)cc21		CHEMBL340921	<	Ki	nM	6309.57	CHEMBL2527	Homo sapiens	pKi		5.2
active	9616024	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	N#Cc1ncc2nc1OCCCCCOc1cc(OCCCO)c(Cl)cc1NC(=O)N2		CHEMBL373598	=	Ki	nM	6309.57	CHEMBL2527	Homo sapiens	pKi		5.2
inactive	9616025	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	N#Cc1ccc(NC(=O)Nc2ccnc3cc(C(F)(F)F)ccc23)nc1		CHEMBL1999718	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
active	9616026	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	O=C1Nc2ccc3ncsc3c2C1=CNc1ccc(S(=O)(=O)Nc2ccccn2)cc1		CHEMBL1973540	=	Ki	nM	158.49	CHEMBL2527	Homo sapiens	pKi		6.8
active	9616027	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	O=C1Nc2ccccc2Nc2nnc(I)cc21		CHEMBL1977346	=	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9616028	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3ccc4nccnc4c3N)cc2)c1		CHEMBL1971649	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9616029	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CC(C)S(=O)(=O)n1c(N)nc2ccc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc21		CHEMBL2003657	<	Ki	nM	10000.0	CHEMBL2527	Homo sapiens	pKi		5.0
inactive	9616030	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	<	Ki	nM	2511.89	CHEMBL2527	Homo sapiens	pKi		5.6
inactive	9616031	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Clc1cc(-c2c[nH]c3ncccc23)nc(NC2CCCCC2)n1		CHEMBL2006439	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9616032	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CC(C)N(C(=O)Nc1ccc2nc(-c3ccco3)c(-c3ccco3)nc2c1)C(C)C		CHEMBL2006156	<	Ki	nM	5011.87	CHEMBL2527	Homo sapiens	pKi		5.3
active	9616033	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	COc1ccc(-c2ccc(NC(=O)Nc3cc(F)cc(F)c3)cc2)c2c(N)noc12		CHEMBL1969190	=	Ki	nM	316.23	CHEMBL2527	Homo sapiens	pKi		6.5
active	9616034	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1ccc(-c2ccc(NC(=O)Nc3cccc(Br)c3)cc2)c2c(N)n[nH]c12		CHEMBL1973937	=	Ki	nM	3981.07	CHEMBL2527	Homo sapiens	pKi		5.4
inactive	9616035	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
active	9616036	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	OC1CCC(Nc2cc(Cl)nc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1991674	=	Ki	nM	398.11	CHEMBL2527	Homo sapiens	pKi		6.4
inactive	9616037	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	NC(=O)c1ccc(-c2c[nH]c3nccc(Cl)c23)cc1		CHEMBL1982711	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9616038	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CC(C)COc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3)nc12		CHEMBL1984842	<	Ki	nM	10000.0	CHEMBL2527	Homo sapiens	pKi		5.0
inactive	9616039	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cn[nH]c5)cnc(N)c34)cc2)c1		CHEMBL1969102	<	Ki	nM	10000.0	CHEMBL2527	Homo sapiens	pKi		5.0
active	9616040	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12		CHEMBL1682346	=	Ki	nM	630.96	CHEMBL2527	Homo sapiens	pKi		6.2
inactive	9616041	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CCN(CC)CC#Cc1ccc2c(c1)-c1[nH]nc(-c3ccc(C#N)nc3)c1C2		CHEMBL2007044	<	Ki	nM	2511.89	CHEMBL2527	Homo sapiens	pKi		5.6
active	9616042	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CNC(=O)N1CCN(CCCOc2ccc3c(c2)-c2[nH]nc(-c4ccc(C#N)nc4)c2C3)CC1		CHEMBL2001998	=	Ki	nM	794.33	CHEMBL2527	Homo sapiens	pKi		6.1
inactive	9616043	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	COc1cc(C=C(C#N)c2nc3ccccc3[nH]2)c(Br)cc1O		CHEMBL1994241	<	Ki	nM	5011.87	CHEMBL2527	Homo sapiens	pKi		5.3
inactive	9616044	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CS(=O)(=O)Nc1cc2c(cc1Cl)NC(=O)Nc1cnc(C#N)c(n1)OCCCCCO2		CHEMBL223460	<	Ki	nM	5011.87	CHEMBL2527	Homo sapiens	pKi		5.3
inactive	9616045	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	O=C(Nc1cnc2[nH]cc(-c3ccccc3)c2c1)c1ccc(Cl)cc1		CHEMBL1998829	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
active	9616046	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Ki	nM	19.95	CHEMBL2527	Homo sapiens	pKi		7.7
active	9616047	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1cnc(Nc2cccc(S(N)(=O)=O)c2)nc1Nc1ccc(OCC(N)=O)cc1		CHEMBL1988838	=	Ki	nM	100.0	CHEMBL2527	Homo sapiens	pKi		7.0
active	9616048	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CCN1CCN(c2ccc(Nc3nccc(-c4c(-c5cccc(C(=O)Nc6ccccc6F)c5)nc5ccccn45)n3)cc2)CC1		CHEMBL1981725	=	Ki	nM	794.33	CHEMBL2527	Homo sapiens	pKi		6.1
inactive	9616049	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4[nH]ncc34)cc2)c1		CHEMBL375284	<	Ki	nM	10000.0	CHEMBL2527	Homo sapiens	pKi		5.0
inactive	9616050	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	COCCn1cc(-c2ccncn2)c(-c2ccc(Cl)cc2)n1		CHEMBL1982866	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9616051	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	COc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3)nc12		CHEMBL2005792	<	Ki	nM	10000.0	CHEMBL2527	Homo sapiens	pKi		5.0
inactive	9616052	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Nc1c(-c2ccccc2)c2cc(Cl)ccc2[nH]c1=O		CHEMBL462120	<	Ki	nM	5011.87	CHEMBL2527	Homo sapiens	pKi		5.3
inactive	9616053	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CCOc1nc(C(=O)NCc2ccncc2)cc(N)c1C#N		CHEMBL1984206	<	Ki	nM	10000.0	CHEMBL2527	Homo sapiens	pKi		5.0
active	9616054	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CC(Nc1c(Nc2ccncc2)c(=O)c1=O)C1CCCCC1		CHEMBL1991577	=	Ki	nM	10000.0	CHEMBL2527	Homo sapiens	pKi		5.0
inactive	9616055	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Nc1ncc(-c2ccoc2)c2scc(-c3ccc(NC(=O)Nc4ccccc4F)cc3)c12		CHEMBL1965570	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9616056	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	O=c1[nH]c2sc3c(c2c2nc(-c4ccccc4)nn12)CCCC3		CHEMBL2007592	<	Ki	nM	5011.87	CHEMBL2527	Homo sapiens	pKi		5.3
inactive	9616057	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1C#N		CHEMBL210963	<	Ki	nM	5011.87	CHEMBL2527	Homo sapiens	pKi		5.3
active	9616058	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1cncc2cccc(S(=O)(=O)N3CCCNCC3C)c12		CHEMBL1082440	=	Ki	nM	1000.0	CHEMBL2527	Homo sapiens	pKi		6.0
inactive	9616059	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	O=C(CO)N1CCC(c2[nH]nc(-c3ccc(Cl)cc3F)c2-c2ccncn2)CC1		CHEMBL1614705	<	Ki	nM	5011.87	CHEMBL2527	Homo sapiens	pKi		5.3
active	9616060	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CS(=O)(=O)c1ccc(-c2cncc3sc(C(N)=O)cc23)cc1		CHEMBL1972362	=	Ki	nM	398.11	CHEMBL2527	Homo sapiens	pKi		6.4
inactive	9616061	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	COc1cccc(C(C)NC(=O)c2cnc(-c3ccncc3)s2)c1		CHEMBL1984633	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
active	9616062	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	=	Ki	nM	630.96	CHEMBL2527	Homo sapiens	pKi		6.2
active	9616063	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	COc1cccc(C(C)NC(=O)N2CC=C(c3c[nH]c4ncccc34)CC2)c1		CHEMBL1965845	=	Ki	nM	501.19	CHEMBL2527	Homo sapiens	pKi		6.3
active	9616064	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	O=C(Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCCC4=O)c3)n2)c1)c1c(F)cccc1F		CHEMBL2006715	=	Ki	nM	1000.0	CHEMBL2527	Homo sapiens	pKi		6.0
inactive	9616065	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	NC(=O)c1cccc2[nH]c(-c3ccc(NC(=O)c4cccc(S(=O)(=O)N5CCOCC5)c4)cc3)nc12		CHEMBL1986597	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
active	9616066	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	NC(=O)c1cc2c(-c3cccc(F)c3)cncc2s1		CHEMBL1971017	=	Ki	nM	125.89	CHEMBL2527	Homo sapiens	pKi		6.9
active	9616067	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	NC(=O)c1cccc2[nH]c(-c3ccncc3)nc12		CHEMBL1990482	=	Ki	nM	5011.87	CHEMBL2527	Homo sapiens	pKi		5.3
inactive	9616068	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Fc1ccc(-c2nc3cnccn3c2-c2ccnc(NCC3CC3)n2)cc1		CHEMBL1990904	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
active	9616069	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	O=C(NCC1CCCCC1)c1cc2c(-c3ccccc3)n[nH]c2s1		CHEMBL2005475	=	Ki	nM	15.85	CHEMBL2527	Homo sapiens	pKi		7.8
active	9616070	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CCS(=O)(=O)c1ccc(-c2cncc3sc(C(N)=O)cc23)cc1		CHEMBL2000104	=	Ki	nM	1000.0	CHEMBL2527	Homo sapiens	pKi		6.0
inactive	9616071	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cncc4c3c(N)nn4C)cc2)c1		CHEMBL402846	<	Ki	nM	5011.87	CHEMBL2527	Homo sapiens	pKi		5.3
active	9616072	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CC1=NN(c2ccc(Cl)c(Cl)c2)C(=O)C1=Cc1c(C)c(C#N)c2nc3ccccc3n2c1O		CHEMBL1997349	=	Ki	nM	1000.0	CHEMBL2527	Homo sapiens	pKi		6.0
inactive	9616073	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)cc2C)c1		CHEMBL183844	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9616074	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL220057	<	Ki	nM	1995.26	CHEMBL2527	Homo sapiens	pKi		5.7
inactive	9616075	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	c1ccc(Nc2nc(-c3ccc4[nH]ncc4c3)cs2)cc1		CHEMBL1682545	<	Ki	nM	5011.87	CHEMBL2527	Homo sapiens	pKi		5.3
inactive	9616076	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	NC(COc1cncc(C=Cc2ccncc2)c1)Cc1c[nH]c2ccccc12		CHEMBL1974935	<	Ki	nM	5011.87	CHEMBL2527	Homo sapiens	pKi		5.3
inactive	9616077	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1cc(OC2CCCC2)c(NC(=O)Nc2cnc(C#N)cn2)cc1Cl		CHEMBL2001224	<	Ki	nM	5011.87	CHEMBL2527	Homo sapiens	pKi		5.3
inactive	9616078	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	<	Ki	nM	6309.57	CHEMBL2527	Homo sapiens	pKi		5.2
inactive	9616079	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CC(C)(O)Cc1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)nn12		CHEMBL1976732	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9616080	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CC(C)(C)OC(=O)n1ncc2cc(Nc3c(NCc4ccc(S(N)(=O)=O)cc4)c(=O)c3=O)ccc21		CHEMBL1969506	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
active	9616081	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	O=C(NC(CO)c1ccccc1)N1CC=C(c2c[nH]c3ncccc23)CC1		CHEMBL1964937	=	Ki	nM	1258.93	CHEMBL2527	Homo sapiens	pKi		5.9
active	9616082	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	c1ccc(COc2ccc(Nc3ncnc4ccccc34)cc2)cc1		CHEMBL1980163	=	Ki	nM	1258.93	CHEMBL2527	Homo sapiens	pKi		5.9
active	9616083	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	NCCn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL590109	=	Ki	nM	39.81	CHEMBL2527	Homo sapiens	pKi		7.4
active	9616084	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	COc1cc(-c2nn(C3CCC(N4CCN(C(C)=O)CC4)CC3)c3ncnc(N)c23)ccc1NC(=O)c1cc2ccccc2n1C		CHEMBL1970879	=	Ki	nM	794.33	CHEMBL2527	Homo sapiens	pKi		6.1
inactive	9616085	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1c(C=O)c(O)n2c(nc3ccccc32)c1C#N		CHEMBL1989856	<	Ki	nM	10000.0	CHEMBL2527	Homo sapiens	pKi		5.0
active	9616086	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CC(=O)N(c1ccncc1)c1c(NC(C)C(C)(C)C)c(=O)c1=O		CHEMBL2005899	=	Ki	nM	1000.0	CHEMBL2527	Homo sapiens	pKi		6.0
inactive	9616087	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	c1cnc2nc(-c3ccc4[nH]ncc4c3)c(NC3CCCCC3)n2c1		CHEMBL1682552	<	Ki	nM	6309.57	CHEMBL2527	Homo sapiens	pKi		5.2
inactive	9616088	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	<	Ki	nM	10000.0	CHEMBL2527	Homo sapiens	pKi		5.0
inactive	9616089	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CN1CCC1COc1cncc(CCc2ccncc2)c1		CHEMBL1996155	<	Ki	nM	10000.0	CHEMBL2527	Homo sapiens	pKi		5.0
active	9616090	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4cccc(Cl)c4)c3)cc12		CHEMBL1974870	=	Ki	nM	630.96	CHEMBL2527	Homo sapiens	pKi		6.2
active	9616091	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CCCc1cc(-c2ccc3[nH]ncc3c2)on1		CHEMBL1682359	=	Ki	nM	10000.0	CHEMBL2527	Homo sapiens	pKi		5.0
active	9616092	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1cc(C)c(C=C2C(=O)Nc3ccccc32)[nH]1		CHEMBL2002702	=	Ki	nM	79.43	CHEMBL2527	Homo sapiens	pKi		7.1
active	9616093	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL1970903	=	Ki	nM	501.19	CHEMBL2527	Homo sapiens	pKi		6.3
inactive	9616094	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	NC(COc1cncc(C=Cc2ccncc2)c1)Cc1ccccc1		CHEMBL1991846	<	Ki	nM	10000.0	CHEMBL2527	Homo sapiens	pKi		5.0
active	9616095	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1cccc(Nc2nccc(Nc3c(NC(C)C(C)(C)C)c(=O)c3=O)n2)c1		CHEMBL1969523	=	Ki	nM	19.95	CHEMBL2527	Homo sapiens	pKi		7.7
inactive	9616096	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	COc1cc(C=O)c(Cl)cc1NC(=O)Nc1cnc(C#N)cn1		CHEMBL207995	<	Ki	nM	10000.0	CHEMBL2527	Homo sapiens	pKi		5.0
inactive	9616097	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	O=C1Nc2cc(CCOc3ccc(N4CCOCC4)cc3)ccc2Nc2cc(-c3cn(Cc4cc(F)c(F)c(F)c4)c4cnccc34)ccc21		CHEMBL2001923	<	Ki	nM	10000.0	CHEMBL2527	Homo sapiens	pKi		5.0
inactive	9616098	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CC(=O)N1CCC(Nc2nccc(-c3c(-c4ccc(F)cc4)nc4occn34)n2)CC1		CHEMBL1986781	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9616099	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	O=c1nc(-c2ccc3[nH]ncc3c2)cc(-c2ccccc2)[nH]1		CHEMBL526133	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9616100	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NC3CCOCC3)nc21		CHEMBL1230122	<	Ki	nM	5011.87	CHEMBL2527	Homo sapiens	pKi		5.3
active	9616101	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	O=C1NCc2c1cccc2-c1ccc(Nc2nc3ccccc3[nH]2)cc1		CHEMBL1979057	=	Ki	nM	316.23	CHEMBL2527	Homo sapiens	pKi		6.5
inactive	9616102	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	COc1cc(-c2ccc3c(c2)Nc2ccc(CCOc4ccc(N5CCOCC5)cc4)cc2NC3=O)ccc1OCC(O)CO		CHEMBL1981045	<	Ki	nM	10000.0	CHEMBL2527	Homo sapiens	pKi		5.0
inactive	9616103	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	COCCOCC#Cc1cc(-c2n[nH]c3c2C(=O)c2cc(CN4CCN(C)CC4)ccc2-3)cs1		CHEMBL387971	<	Ki	nM	3162.28	CHEMBL2527	Homo sapiens	pKi		5.5
active	9616104	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	c1ccc(Cn2nnc(-c3ccc4[nH]ncc4c3)c2C2CC2)cc1		CHEMBL1975418	=	Ki	nM	1995.26	CHEMBL2527	Homo sapiens	pKi		5.7
inactive	9616105	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	O=c1[nH]c2ccc(Cl)cc2c(-c2ccccc2)c1C1=NNC(c2ccccc2)C1		CHEMBL1992796	<	Ki	nM	10000.0	CHEMBL2527	Homo sapiens	pKi		5.0
inactive	9616106	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CC(NC(=O)c1ccc(-c2ccncc2)cc1)c1ccccc1		CHEMBL1999428	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9616107	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	N#Cc1ncc2nc1OCCCCCOc1cc(OCC(O)CO)c(Cl)cc1NC(=O)N2		CHEMBL223257	<	Ki	nM	10000.0	CHEMBL2527	Homo sapiens	pKi		5.0
inactive	9616108	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CCN1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL1967560	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
active	9616109	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3noc4ncnc(N)c34)cc2)c1		CHEMBL211378	=	Ki	nM	630.96	CHEMBL2527	Homo sapiens	pKi		6.2
active	9616110	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Ki	nM	630.96	CHEMBL2527	Homo sapiens	pKi		6.2
inactive	9616111	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN5CCOCC5)cnc(N)c34)cc2)c1		CHEMBL1982465	<	Ki	nM	2511.89	CHEMBL2527	Homo sapiens	pKi		5.6
active	9616112	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	NC(COc1cncc(-c2ccc3c(c2)C(=Cc2ccco2)C(=O)N3)c1)Cc1c[nH]c2ccccc12		CHEMBL2001751	=	Ki	nM	50.12	CHEMBL2527	Homo sapiens	pKi		7.3
inactive	9616113	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	O=C(NCCCCCCNC(=O)NCc1cccnc1)NCc1cccnc1		CHEMBL2003420	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9616114	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1ccccc1NC(=O)Nc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL1984586	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9616115	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1c(Cl)c(N2CCC(CN)C2)nc2[nH]cc(C(=O)O)c(=O)c12		CHEMBL1999774	<	Ki	nM	10000.0	CHEMBL2527	Homo sapiens	pKi		5.0
inactive	9616116	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1c(O)ccc2c1CCCC2=NNC(=O)Cc1cccc2ccccc12		CHEMBL1972659	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
active	9616117	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	OC1CCN(c2ncnc3[nH]cc(-c4ccccc4)c23)CC1		CHEMBL1973395	=	Ki	nM	3981.07	CHEMBL2527	Homo sapiens	pKi		5.4
inactive	9616118	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	COc1ccc(NC(=O)Nc2ccc(-c3cccc4onc(N)c34)cc2)cc1Cl		CHEMBL272453	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9616119	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3C)cc2)c1		CHEMBL1970217	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
active	9616120	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	O=C1Nc2ccccc2Nc2nnccc21		CHEMBL1971801	=	Ki	nM	3162.28	CHEMBL2527	Homo sapiens	pKi		5.5
active	9616121	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	O=C1Nc2ccccc2Nc2nnc(Cl)cc21		CHEMBL1968850	=	Ki	nM	2511.89	CHEMBL2527	Homo sapiens	pKi		5.6
inactive	9616122	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CCOC(=O)c1ccc2[nH]c3c(c2c1)CCNC3=O		CHEMBL2005528	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9616123	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)cc2)c1		CHEMBL185569	<	Ki	nM	2511.89	CHEMBL2527	Homo sapiens	pKi		5.6
inactive	9616124	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	c1cc2[nH]ncc2cc1-c1cn(CC2CCOCC2)nn1		CHEMBL1969843	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9616125	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	COc1cc(-c2ccc3[nH]nc(C(=O)Nc4ccccc4)c3c2)ccc1O		CHEMBL2007002	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9616126	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CC(Nc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1)c1ccccc1		CHEMBL1990288	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
active	9616127	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CN1CCC(NC(=O)c2cc3c(-c4ccccc4)n[nH]c3s2)CC1		CHEMBL1987007	=	Ki	nM	79.43	CHEMBL2527	Homo sapiens	pKi		7.1
inactive	9616128	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Clc1cc(-c2c[nH]c3ncccc23)cc(NCc2ccccc2)n1		CHEMBL1969588	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
active	9616129	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1cc(Nc2ncc(F)c(NC3C4C=CC(C4)C3C(N)=O)n2)ccc1N1CCN(C)CC1		CHEMBL1967878	=	Ki	nM	2.512	CHEMBL2527	Homo sapiens	pKi		8.6
inactive	9616130	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	COc1cc(Nc2nccc(Nc3cc(C4CCCCC4)no3)n2)cc(OC)c1OC		CHEMBL1984711	<	Ki	nM	5011.87	CHEMBL2527	Homo sapiens	pKi		5.3
inactive	9616131	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	COc1cc(OC)c(Nc2ccc3nnc(-c4ccccc4)n3n2)cc1Cl		CHEMBL1990212	<	Ki	nM	10000.0	CHEMBL2527	Homo sapiens	pKi		5.0
active	9616132	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	NCC(NC(=O)c1ccc(-c2ccncc2)cc1)c1ccccc1		CHEMBL1990254	=	Ki	nM	630.96	CHEMBL2527	Homo sapiens	pKi		6.2
active	9616133	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CCCCn1c(NC(=O)c2ccc(C#N)cc2)nc2cc(N(C)C(=O)C3CCCCC3)ccc21		CHEMBL484390	=	Ki	nM	63.1	CHEMBL2527	Homo sapiens	pKi		7.2
active	9616134	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	O=c1c(NCc2cccc(C(F)(F)F)c2)c(Nc2ccncc2)c1=O		CHEMBL1979252	=	Ki	nM	630.96	CHEMBL2527	Homo sapiens	pKi		6.2
active	9616135	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	c1ccc(Cc2cn(-c3ccc4[nH]ncc4c3)nn2)cc1		CHEMBL1682341	=	Ki	nM	5011.87	CHEMBL2527	Homo sapiens	pKi		5.3
inactive	9616136	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	COc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)(C)O)c5)cnc(N)c34)cc2)cc1		CHEMBL2004290	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9616137	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccc(F)cc3)cc12		CHEMBL1986499	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9616138	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	COc1cccc(C=C2SC(=Nc3ccccc3)NC2=O)c1		CHEMBL1972937	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
active	9616139	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	C#Cc1cc2c(cc1OC)-c1[nH]nc(-c3ccc(C#N)nc3)c1C2		CHEMBL1972250	=	Ki	nM	794.33	CHEMBL2527	Homo sapiens	pKi		6.1
active	9616140	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	O=c1[nH]c2cnc(-n3cnc4ccc(F)cc43)nc2n1C1CCOc2c(F)cccc21		CHEMBL2000393	=	Ki	nM	1258.93	CHEMBL2527	Homo sapiens	pKi		5.9
inactive	9616141	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	COC(=O)c1cc2c(-c3cccc(F)c3)cncc2s1		CHEMBL2004072	<	Ki	nM	10000.0	CHEMBL2527	Homo sapiens	pKi		5.0
inactive	9616142	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)c(C)c2)c1		CHEMBL2004311	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9616143	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Brc1cnc2[nH]cc(-c3ccccc3)c2c1		CHEMBL1992634	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
active	9616144	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1cccc(NC(=O)Nc2ccc3c(c2)CCc2sc4ncnc(N)c4c2-3)c1		CHEMBL1242373	=	Ki	nM	1258.93	CHEMBL2527	Homo sapiens	pKi		5.9
inactive	9616145	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CCNNc1cc(C)c(C#N)c2nc3ccccc3n12		CHEMBL2000433	<	Ki	nM	10000.0	CHEMBL2527	Homo sapiens	pKi		5.0
inactive	9616146	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1ccc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1988075	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9616147	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Fc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL316264	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9616148	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1991678	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
active	9616149	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Nc1ncnc(Nc2cc(CNC(=O)C(F)(F)F)c(O)c(-c3ccc(Cl)cc3)c2)n1		CHEMBL2001239	=	Ki	nM	19.95	CHEMBL2527	Homo sapiens	pKi		7.7
active	9616150	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Nc1ncnc2scc(C(=O)Nc3ccc(NC(=O)Nc4ccccc4)cc3)c12		CHEMBL1988594	=	Ki	nM	0.631	CHEMBL2527	Homo sapiens	pKi		9.2
inactive	9616151	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Nc1ncnc2c1c(I)nn2C1OC(CO)C(O)C1O		CHEMBL2001288	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
active	9616152	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Nc1ncnc2c1N=C(c1ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc1)CCN2		CHEMBL260092	=	Ki	nM	251.19	CHEMBL2527	Homo sapiens	pKi		6.6
inactive	9616153	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	<	Ki	nM	5011.87	CHEMBL2527	Homo sapiens	pKi		5.3
inactive	9616154	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	O=C(NN=Cc1ccc(O)cc1O)Nc1cccc2nsnc12		CHEMBL1999811	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
active	9616155	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1n[nH]c2ncc(C#N)c(-c3ccccc3)c12		CHEMBL1965495	=	Ki	nM	7943.28	CHEMBL2527	Homo sapiens	pKi		5.1
inactive	9616156	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CSc1ccc2nc3c(c(Cl)c2c1)CCNC3=O		CHEMBL1985074	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9616157	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Nc1nc2ccc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc2n1CC1CC1		CHEMBL1982874	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9616158	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	NCCNS(=O)(=O)c1cccc(C(=O)Nc2ccc(-c3n[nH]c(=O)c4ccccc34)cc2)c1		CHEMBL2000481	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9616159	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CNCc1ccc(-c2[nH]c3cc(F)cc4c3c2CCNC4=O)cc1		CHEMBL1173055	<	Ki	nM	10000.0	CHEMBL2527	Homo sapiens	pKi		5.0
inactive	9616160	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CN(C)CC(=O)NC(COc1cncc(-c2ccc3cnccc3c2)c1)Cc1c[nH]c2ccccc12		CHEMBL1991725	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9616161	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4sncc34)cc2)c1		CHEMBL1992242	<	Ki	nM	5011.87	CHEMBL2527	Homo sapiens	pKi		5.3
inactive	9616162	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CCCOc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL2007296	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
active	9616163	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	O=C(O)c1ccccc1Nc1ccnc(Nc2ccc3[nH]ncc3c2)n1		CHEMBL396523	=	Ki	nM	251.19	CHEMBL2527	Homo sapiens	pKi		6.6
inactive	9616164	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	O=C1NC(=O)C(Nc2ccccc2)=C1Cl		CHEMBL2007138	<	Ki	nM	25118.86	CHEMBL2527	Homo sapiens	pKi		4.6
inactive	9616165	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CCOc1nc(NC(C)=O)cc(N)c1C#N		CHEMBL208637	<	Ki	nM	5011.87	CHEMBL2527	Homo sapiens	pKi		5.3
active	9616166	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1cc(C)cc(NC(=O)Nc2ccc(NC(=O)c3csc4ncnc(N)c34)cc2)c1		CHEMBL1970203	=	Ki	nM	1.585	CHEMBL2527	Homo sapiens	pKi		8.8
inactive	9616167	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	O=C(c1cc(Cc2n[nH]c(=O)c3c2CCCC3)ccc1F)N1CCN(c2ncccn2)CC1		CHEMBL1986530	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9616168	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	O=c1c(NCCc2ccc(Oc3ccccc3)cc2)c(Nc2ccncc2)c1=O		CHEMBL1999321	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9616169	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CNC(=O)C=Cc1cnc(N)c2c(-c3ccc4sc(C)nc4c3)csc12		CHEMBL1968590	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
active	9616170	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	COc1cc(Nc2ncnc3ccc(-c4ccc(CN5CC6C(CO)C6C5)cc4)cc23)ccc1Oc1ccccc1		CHEMBL1999749	=	Ki	nM	1258.93	CHEMBL2527	Homo sapiens	pKi		5.9
inactive	9616171	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CCC1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCCCC4)cc3OC)nc2N1C1CCCC1		CHEMBL2005375	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9616172	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Clc1ccc(-c2n[nH]cc2-c2ccncn2)cc1Cl		CHEMBL1984191	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9616173	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	COc1cc(C(=O)O)c(Cl)cc1NC(=O)Nc1cnc(C#N)cn1		CHEMBL1983006	<	Ki	nM	10000.0	CHEMBL2527	Homo sapiens	pKi		5.0
active	9616174	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CNS(=O)(=O)c1ccccc1Nc1nc(Nc2cc(N3CCN(C(C)=O)CC3)ccc2OC)ncc1Br		CHEMBL1971029	=	Ki	nM	251.19	CHEMBL2527	Homo sapiens	pKi		6.6
inactive	9616175	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CC(C)Nc1n[nH]c2ccc(N)cc12		CHEMBL1995391	<	Ki	nM	25118.86	CHEMBL2527	Homo sapiens	pKi		4.6
inactive	9616176	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)c12		CHEMBL394790	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
active	9616177	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	O=C1NCCc2[nH]c(-c3ccnc(-c4ccccc4F)c3)cc21		CHEMBL226471	=	Ki	nM	630.96	CHEMBL2527	Homo sapiens	pKi		6.2
inactive	9616178	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1nc2c(sc3c(Br)ccc(Cl)c32)c(=O)o1		CHEMBL1974702	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9616179	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CN(C)C(=O)c1c(-c2ccc3[nH]ncc3c2)nnn1Cc1ccccc1		CHEMBL1996111	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9616180	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1nccn2c(-c3ccnc(NCC4(O)CC4)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1965589	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9616181	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	O=C(NCCCCCCNC(=O)Nc1cccnc1)Nc1cccnc1		CHEMBL1998193	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
active	9616182	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)O)s3)c2cc1OC		CHEMBL474432	=	Ki	nM	1000.0	CHEMBL2527	Homo sapiens	pKi		6.0
inactive	9616183	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1nnc(-c2cc3c(Oc4ccc(C(F)(F)F)cc4)cncc3s2)o1		CHEMBL1988153	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
active	9616184	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CC(=O)N1CCN(C2CCC(n3nc(-c4ccc(NC(=O)c5cc6ccccc6n5C)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL1972584	=	Ki	nM	398.11	CHEMBL2527	Homo sapiens	pKi		6.4
inactive	9616185	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	N#Cc1ccc2[nH]c(O)c(-c3ccc(CN4CCOCC4)cn3)c2c1		CHEMBL1969664	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
active	9616186	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	NC(=O)c1cc2c(-c3ccccc3)cncc2s1		CHEMBL1999556	=	Ki	nM	125.89	CHEMBL2527	Homo sapiens	pKi		6.9
inactive	9616187	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CNC(=O)c1ccccc1Sc1ccc2c(C=Cc3ccccn3)n[nH]c2c1		CHEMBL1988437	<	Ki	nM	3981.07	CHEMBL2527	Homo sapiens	pKi		5.4
inactive	9616188	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	NC(COc1cc(C=Cc2ccncc2)cnc1Cl)Cc1c[nH]c2ccccc12		CHEMBL1968245	<	Ki	nM	10000.0	CHEMBL2527	Homo sapiens	pKi		5.0
active	9616189	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	NCCC(C(=O)Nc1ccc2[nH]ncc2c1)c1ccc(Cl)c(Cl)c1		CHEMBL1998121	=	Ki	nM	100.0	CHEMBL2527	Homo sapiens	pKi		7.0
active	9616190	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CC(C)(C)N)cnc(N)c34)cc2)c1		CHEMBL1979577	=	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9616191	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(CC4CC4)nccn23)n1		CHEMBL1991800	<	Ki	nM	5011.87	CHEMBL2527	Homo sapiens	pKi		5.3
inactive	9616192	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	COc1cc(-c2ccc3c(c2)Nc2ccc(CCOc4ccc(N5CCOCC5)cc4)cc2NC3=O)ccc1CC#N		CHEMBL1985566	<	Ki	nM	10000.0	CHEMBL2527	Homo sapiens	pKi		5.0
inactive	9616193	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CCC(CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL52387	<	Ki	nM	5011.87	CHEMBL2527	Homo sapiens	pKi		5.3
inactive	9616194	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1nn(-c2ccccc2)c2c1c(=O)c1cc(Cl)ccc1n2O		CHEMBL379835	<	Ki	nM	5011.87	CHEMBL2527	Homo sapiens	pKi		5.3
inactive	9616195	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	N#Cc1ncc2nc1OCC(O)C(O)COc1ccc(Cl)cc1NC(=O)N2		CHEMBL1980802	<	Ki	nM	10000.0	CHEMBL2527	Homo sapiens	pKi		5.0
inactive	9616196	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cn1cc(C(CN)c2cncc(C=Cc3ccncc3)c2)c2ccccc21		CHEMBL1979357	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
active	9616197	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	O=c1c(NCc2ccc(Cl)cc2Cl)c(Nc2ccc3[nH]ncc3c2)c1=O		CHEMBL1979554	=	Ki	nM	39.81	CHEMBL2527	Homo sapiens	pKi		7.4
inactive	9616198	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CCCCOc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL1996817	<	Ki	nM	3981.07	CHEMBL2527	Homo sapiens	pKi		5.4
inactive	9616199	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CCOc1nc(C(=O)NCc2ccc(S(N)(=O)=O)cc2)cc(N)c1C#N		CHEMBL2004355	<	Ki	nM	10000.0	CHEMBL2527	Homo sapiens	pKi		5.0
inactive	9616200	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9616201	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CCn1c2cc(Cl)c(F)cc2c(=O)c2c(=O)o[nH]c21		CHEMBL468280	<	Ki	nM	3981.07	CHEMBL2527	Homo sapiens	pKi		5.4
inactive	9616202	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1cc(C)c2oc(Nc3ccc(-c4cccc(C(N)=O)c4N)cc3F)nc2c1		CHEMBL1990884	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
active	9616203	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2C(=O)Nc3ccc(F)cc32)c1C		CHEMBL1990885	=	Ki	nM	31.62	CHEMBL2527	Homo sapiens	pKi		7.5
inactive	9616204	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	COc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL256835	<	Ki	nM	7943.28	CHEMBL2527	Homo sapiens	pKi		5.1
inactive	9616205	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(C(F)(F)F)cccc12		CHEMBL1980142	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9616206	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CN(C)CCCC(=O)Nc1n[nH]c2nnc(-c3cccc(F)c3F)cc12		CHEMBL41783	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9616207	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Nc1c(-c2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)ccc2nccnc12		CHEMBL2004438	<	Ki	nM	10000.0	CHEMBL2527	Homo sapiens	pKi		5.0
inactive	9616208	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	COc1cccc2c1Nc1cc(Nc3ccncc3)ccc1C(=O)N2		CHEMBL2006276	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9616209	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	COc1ccc(-c2ccc(NC(=O)Nc3cccc(Br)c3)cc2)c2c(N)noc12		CHEMBL271381	<	Ki	nM	1995.26	CHEMBL2527	Homo sapiens	pKi		5.7
inactive	9616210	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1ccc(C(=O)Nc2c(C#N)sc3ccc(Cl)c(Cl)c23)cc1		CHEMBL2006785	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9616211	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C)c5)cnc(N)c34)cc2)cc1		CHEMBL1982466	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
active	9616212	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	COc1cc(-c2ccc3c(c2)Nc2ccc([N+](=O)[O-])cc2NC3=O)ccc1O		CHEMBL1995740	=	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
active	9616213	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	O=C(O)c1cc2c(-c3ccccc3)cncc2s1		CHEMBL1996390	=	Ki	nM	501.19	CHEMBL2527	Homo sapiens	pKi		6.3
inactive	9616214	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	OC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1986943	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9616215	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CC1CCN(C(=O)CC#N)CC1N(C)c1ncnc2[nH]ccc12		CHEMBL234085	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9619772	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	COc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1995832	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
active	9619773	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1n[nH]c2sc(C(=O)NCCc3ccc(Cl)cc3)cc12		CHEMBL1998414	=	Ki	nM	316.23	CHEMBL2527	Homo sapiens	pKi		6.5
inactive	9619774	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Oc1ccc(Nc2[nH]nc(-c3ccc(O)cc3)c2-c2ccc(O)cc2)cc1		CHEMBL1969042	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
active	9619775	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	COc1cc(C=C(C#N)c2nc3cc(C)ccc3[nH]2)c(Br)cc1O		CHEMBL2000345	=	Ki	nM	199.53	CHEMBL2527	Homo sapiens	pKi		6.7
active	9619776	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	O=C(Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12)c1ccccc1		CHEMBL1999931	=	Ki	nM	12.59	CHEMBL2527	Homo sapiens	pKi		7.9
inactive	9619777	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	O=c1[nH]sc2c1c(=O)c1cc(F)c(NCc3ccccc3)c(F)c1n2C1CC1		CHEMBL1991640	<	Ki	nM	10000.0	CHEMBL2527	Homo sapiens	pKi		5.0
active	9619778	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Ki	nM	79.43	CHEMBL2527	Homo sapiens	pKi		7.1
active	9619779	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1[nH]c(C=C2C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL2007064	=	Ki	nM	50.12	CHEMBL2527	Homo sapiens	pKi		7.3
inactive	9619780	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	COC(C(=O)N1Cc2[nH]nc(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL1981047	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
active	9619781	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4ccc(Cl)c(Cl)c4)c3)cc12		CHEMBL1991063	=	Ki	nM	398.11	CHEMBL2527	Homo sapiens	pKi		6.4
active	9619782	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	COc1cccc(C(CN)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL1976240	=	Ki	nM	398.11	CHEMBL2527	Homo sapiens	pKi		6.4
inactive	9619783	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	COc1ccc(-c2ccc(NC(=O)Nc3ccc(F)c(C)c3)cc2)c2c(N)noc12		CHEMBL1979093	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9619784	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	O=c1[nH]c2sccc2c2nc(-c3ccncc3)nn12		CHEMBL1968151	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9619785	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Clc1ccc(CNc2ccc3nnc(-c4ccccc4)n3n2)cc1		CHEMBL1381197	<	Ki	nM	10000.0	CHEMBL2527	Homo sapiens	pKi		5.0
active	9619786	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	COc1cccc(CNC(=O)c2cc3c(-c4ccccc4)n[nH]c3s2)c1		CHEMBL1987009	=	Ki	nM	15.85	CHEMBL2527	Homo sapiens	pKi		7.8
active	9619787	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4ccccc4)c3)cc12		CHEMBL2002726	=	Ki	nM	1258.93	CHEMBL2527	Homo sapiens	pKi		5.9
active	9619788	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	O=C(Nc1cnccn1)Nc1ccnc2cc(C(F)(F)F)ccc12		CHEMBL2003817	=	Ki	nM	1000.0	CHEMBL2527	Homo sapiens	pKi		6.0
inactive	9619789	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ncccc2N1		CHEMBL336961	<	Ki	nM	10000.0	CHEMBL2527	Homo sapiens	pKi		5.0
inactive	9619790	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Nc1nnc(-c2cc3c(Oc4ccc(Cl)cc4)cncc3s2)o1		CHEMBL1994830	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
active	9619791	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	COCCOC1CCC(n2nc(-c3ccc(Nc4nc5cc(C)cc(Cl)c5o4)cc3)c3c(N)ncnc32)CC1		CHEMBL1987054	=	Ki	nM	7943.28	CHEMBL2527	Homo sapiens	pKi		5.1
active	9619792	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Nc1ncc(-c2ccncc2)c2scc(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL1970083	=	Ki	nM	5011.87	CHEMBL2527	Homo sapiens	pKi		5.3
active	9619793	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	O=C1NCCc2[nH]c(-c3ccnc(-c4cnc5ccccc5c4)c3)cc21		CHEMBL226403	=	Ki	nM	158.49	CHEMBL2527	Homo sapiens	pKi		6.8
active	9619794	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cc(C)ccc4F)cc3)csc12		CHEMBL2005631	=	Ki	nM	3981.07	CHEMBL2527	Homo sapiens	pKi		5.4
inactive	9619795	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Nc1ncc(C=CC(=O)NCCCn2ccnc2)c2scc(-c3ccc(Br)cc3)c12		CHEMBL1994938	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9619796	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CC(Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL1825138	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
active	9619797	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CCCC(=O)Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12		CHEMBL1977223	=	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9619798	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CC(C)(C)C(=O)Oc1ccc2c(c1)nc(NC(=O)c1cccc([N+](=O)[O-])c1)n2CCCO		CHEMBL1236126	<	Ki	nM	5011.87	CHEMBL2527	Homo sapiens	pKi		5.3
inactive	9619799	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	NCCCNS(=O)(=O)c1cccc(C(=O)Nc2ccc(-c3n[nH]c(=O)c4ccccc34)cc2)c1		CHEMBL1966279	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
active	9619800	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Clc1cc(NC2CCCCC2)nc(-c2c[nH]c3ncccc23)n1		CHEMBL1997846	=	Ki	nM	316.23	CHEMBL2527	Homo sapiens	pKi		6.5
inactive	9619801	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CC(C)Cn1c(N)nc2c(F)cc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc21		CHEMBL2004419	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
active	9619802	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CC(=NNC(=N)N)c1cc(NC(=O)NCCCCCCNC(=O)Nc2cc(C(C)=NNC(=N)N)cc(C(C)=NNC(=N)N)c2)cc(C(C)=NNC(=N)N)c1		CHEMBL1991728	=	Ki	nM	794.33	CHEMBL2527	Homo sapiens	pKi		6.1
active	9619803	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	NC(=O)c1cc2c(-c3ccc(F)cc3F)cncc2s1		CHEMBL1975787	=	Ki	nM	398.11	CHEMBL2527	Homo sapiens	pKi		6.4
inactive	9619804	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	COc1cc(C=C(C#N)c2n[nH]c(N)c2C#N)ccc1O		CHEMBL2002407	<	Ki	nM	10000.0	CHEMBL2527	Homo sapiens	pKi		5.0
inactive	9619805	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	O=C(Nc1ccc2cn[nH]c2c1)c1ccc(Cl)cc1		CHEMBL1972489	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
active	9619806	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Brc1ccc2[nH]nc(-c3ccccc3)c2c1		CHEMBL1994074	=	Ki	nM	1258.93	CHEMBL2527	Homo sapiens	pKi		5.9
inactive	9619807	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1ccc(Nc2nc3ccc([N+](=O)[O-])cc3[nH]2)nc1		CHEMBL1992937	<	Ki	nM	1258.93	CHEMBL2527	Homo sapiens	pKi		5.9
inactive	9619808	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	COc1cc(-c2ccc3c(c2)Nc2ccc(CCOc4ccc(N5CCOCC5)cc4)cc2NC3=O)ccc1CC#N		CHEMBL1985566	<	Ki	nM	10000.0	CHEMBL2527	Homo sapiens	pKi		5.0
inactive	9619809	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cc(Cl)ccc1O		CHEMBL536151	<	Ki	nM	10000.0	CHEMBL2527	Homo sapiens	pKi		5.0
inactive	9619810	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	O=C(Nc1cccc(N2CCOCC2)n1)Nc1ccnc2c(C(F)(F)F)cccc12		CHEMBL1972119	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9619811	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	COc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL95692	<	Ki	nM	5011.87	CHEMBL2527	Homo sapiens	pKi		5.3
inactive	9619812	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)c1		CHEMBL1090356	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9619813	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	O=C(Nc1cnccn1)Nc1ccnc2ccc(C(F)(F)F)cc12		CHEMBL1976455	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9619814	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(C=Cc3ccccc3)n2)n[nH]1		CHEMBL1983923	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
active	9619815	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	=	Ki	nM	630.96	CHEMBL2527	Homo sapiens	pKi		6.2
inactive	9619816	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	c1ccc(CNc2nc3ccc(-c4ccncc4)cc3s2)cc1		CHEMBL1983534	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
active	9619817	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	O=c1c(NCc2ccccc2F)c(Nc2ccncc2)c1=O		CHEMBL1982361	=	Ki	nM	794.33	CHEMBL2527	Homo sapiens	pKi		6.1
inactive	9619818	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CCOC(=O)C1=c2sc(=Cc3ccco3)c(=O)n2C(N)=C(C#N)C1c1ccco1		CHEMBL1999112	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9619819	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	OCCC(Nc1nc2ccc(-c3ccncc3)cc2s1)c1ccccc1		CHEMBL1982122	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9619820	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	O=C(Nc1ccc(-c2cccc3sncc23)cc1)Nc1ccc(F)c(C(F)(F)F)c1		CHEMBL2000801	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9619821	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	c1ccc(CNc2nc(-c3ccc4[nH]ncc4c3)cs2)cc1		CHEMBL1682546	<	Ki	nM	5011.87	CHEMBL2527	Homo sapiens	pKi		5.3
inactive	9619822	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3cnccn23)n1		CHEMBL1991395	<	Ki	nM	3981.07	CHEMBL2527	Homo sapiens	pKi		5.4
inactive	9619823	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CN1CCN(c2cccc(Nc3nccc(-c4c(C(N)=O)nc5ccccn45)n3)c2)CC1		CHEMBL1971245	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9619824	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3)nc12		CHEMBL1987648	<	Ki	nM	10000.0	CHEMBL2527	Homo sapiens	pKi		5.0
inactive	9619825	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CCOC(=O)c1cn(-c2ccc(O)cc2C)c2cc(-c3ccncc3)ccc2c1=O		CHEMBL1996780	<	Ki	nM	10000.0	CHEMBL2527	Homo sapiens	pKi		5.0
active	9619826	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	O=C(NCc1ccccc1)c1cccc(-c2cnc3[nH]ccc3c2)c1		CHEMBL1972142	=	Ki	nM	158.49	CHEMBL2527	Homo sapiens	pKi		6.8
active	9619827	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Nc1ncc(-c2ccoc2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1966514	=	Ki	nM	1000.0	CHEMBL2527	Homo sapiens	pKi		6.0
inactive	9619828	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CCCCCCCCCCCCOc1ccc(NC(=N)N)cc1NC(=N)N		CHEMBL1980715	<	Ki	nM	10000.0	CHEMBL2527	Homo sapiens	pKi		5.0
active	9619829	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	O=C(Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12)c1cccc(F)c1		CHEMBL2003638	=	Ki	nM	19.95	CHEMBL2527	Homo sapiens	pKi		7.7
active	9619830	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Ki	nM	630.96	CHEMBL2527	Homo sapiens	pKi		6.2
inactive	9619831	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	N#Cc1ccc2nc(N)n(-c3nc(-c4ccccc4)cs3)c2c1		CHEMBL1996066	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
active	9619832	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	NC(COc1cncc(-c2cc3ccncc3s2)c1)Cc1c[nH]c2ccccc12		CHEMBL1966524	=	Ki	nM	398.11	CHEMBL2527	Homo sapiens	pKi		6.4
inactive	9619833	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Nc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4cc(C(=O)O)ccc4F)cc3)c12		CHEMBL1993722	<	Ki	nM	6309.57	CHEMBL2527	Homo sapiens	pKi		5.2
inactive	9619834	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	O=c1[nH]c2sc3c(c2c2nc(-c4cccnc4)nn12)CCCC3		CHEMBL1970806	<	Ki	nM	5011.87	CHEMBL2527	Homo sapiens	pKi		5.3
inactive	9619835	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	COc1cc(CN2CCCCC2)c(Cl)cc1NC(=O)Nc1cnc(C#N)cn1		CHEMBL202635	<	Ki	nM	10000.0	CHEMBL2527	Homo sapiens	pKi		5.0
inactive	9619836	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1nc(COc2ccccc2Cl)sc1-c1ccnc(N)n1		CHEMBL1375640	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9619837	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CCCC(=O)Nc1n[nH]c2nnc(-c3cccc(F)c3F)cc12		CHEMBL1979970	<	Ki	nM	3981.07	CHEMBL2527	Homo sapiens	pKi		5.4
inactive	9619838	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	N#Cc1ccc(-c2n[nH]c3c2Cc2ccc(OCCN4CCOCC4)cc2-3)cn1		CHEMBL249282	<	Ki	nM	1258.93	CHEMBL2527	Homo sapiens	pKi		5.9
active	9619839	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CC(C)(C)NC(=O)c1ccc2nc3[nH]c4ccccc4c3nc2c1		CHEMBL1969264	=	Ki	nM	794.33	CHEMBL2527	Homo sapiens	pKi		6.1
inactive	9619840	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	N#Cc1c(O)[nH]c(=O)c2c(=N)oc3ccc(Cl)cc3c12		CHEMBL1973711	<	Ki	nM	10000.0	CHEMBL2527	Homo sapiens	pKi		5.0
inactive	9619841	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CN1CCN(CCCNc2cccc(-c3nc4c(C(N)=O)cccc4[nH]3)n2)CC1		CHEMBL2006237	<	Ki	nM	5011.87	CHEMBL2527	Homo sapiens	pKi		5.3
active	9619842	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CC(C)(C(N)=O)n1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1967720	=	Ki	nM	501.19	CHEMBL2527	Homo sapiens	pKi		6.3
inactive	9619843	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	NC1C2CN(c3nc4c(cc3F)c(=O)c(C(=O)O)cn4-c3ccc(F)cc3F)CC12		CHEMBL1624529	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9619844	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Nc1nccn2c(C3CC(CN4CCCC4)C3)nc(-c3cccc(OCc4ccccc4)c3)c12		CHEMBL1991138	<	Ki	nM	5011.87	CHEMBL2527	Homo sapiens	pKi		5.3
inactive	9619845	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	O=C(NC(CO)Cc1ccccc1)c1ccc(-c2ccncc2)cc1F		CHEMBL1969755	<	Ki	nM	5011.87	CHEMBL2527	Homo sapiens	pKi		5.3
inactive	9619846	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CCNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)csc12		CHEMBL1979516	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9619847	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CC(N)C1CCC(C(=O)Nc2ccncc2)CC1		CHEMBL1994526	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9619848	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CC(C)OC1=NNC(=O)C1=Cc1c[nH]c2ccccc12		CHEMBL1989029	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9619849	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CSc1ccccc1CNc1ncc([N+](=O)[O-])c(NCC2CCC(CN)CC2)n1		CHEMBL392642	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9619850	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	<	Ki	nM	5011.87	CHEMBL2527	Homo sapiens	pKi		5.3
inactive	9619851	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CN(C)CC(=O)Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12		CHEMBL1965631	<	Ki	nM	2511.89	CHEMBL2527	Homo sapiens	pKi		5.6
active	9619852	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1ccccc1NC(=O)Nc1ccc(NC(=O)c2csc3ncnc(N)c23)cc1		CHEMBL1980144	=	Ki	nM	3.162	CHEMBL2527	Homo sapiens	pKi		8.5
inactive	9619853	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3F)cc2OC)c1		CHEMBL1991188	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9619854	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CC(C)(CO)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)nn12		CHEMBL1972849	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9619855	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CCOc1nc(C(=O)NCc2ccccc2S(N)(=O)=O)cc(N)c1C#N		CHEMBL377408	<	Ki	nM	10000.0	CHEMBL2527	Homo sapiens	pKi		5.0
active	9619856	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	=	Ki	nM	1995.26	CHEMBL2527	Homo sapiens	pKi		5.7
inactive	9619857	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL231209	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9619858	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4cccc(Br)c4)cc3)c12		CHEMBL1976220	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9619859	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1ccc(C(=O)Nc2ccon2)cc1Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL259922	<	Ki	nM	5011.87	CHEMBL2527	Homo sapiens	pKi		5.3
active	9619860	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CN1CCN(C2CCC(n3cc(-c4ccc(Oc5ccccc5)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL1997617	=	Ki	nM	63.1	CHEMBL2527	Homo sapiens	pKi		7.2
inactive	9619861	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(CCN)nccn23)n1		CHEMBL1982383	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9619862	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CCCCn1c(NC(=O)c2cccc(C#N)c2)nc2cc(N(C)C(=O)C3CCCCC3)ccc21		CHEMBL1969301	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9619863	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CSc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17370	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9619864	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4ccccc4C(F)(F)F)cc3)c12		CHEMBL1987910	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
inactive	9619865	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	COc1ccc2c(NC(=O)Nc3cccc(Br)n3)ccnc2c1		CHEMBL1983932	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
active	9619866	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Nc1ncc(-c2cnn(CCO)c2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1980297	=	Ki	nM	79.43	CHEMBL2527	Homo sapiens	pKi		7.1
inactive	9619867	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	c1ccc2c(c1)nnn2Cc1cn(-c2ccc3[nH]ncc3c2)nn1		CHEMBL1966069	<	Ki	nM	10000.0	CHEMBL2527	Homo sapiens	pKi		5.0
inactive	9619868	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	<	Ki	nM	3162.28	CHEMBL2527	Homo sapiens	pKi		5.5
inactive	9619869	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1cc2cc(-c3csc4c(-c5cccc(S(C)(=O)=O)c5)cnc(N)c34)ccc2[nH]1		CHEMBL1997822	<	Ki	nM	5011.87	CHEMBL2527	Homo sapiens	pKi		5.3
inactive	9619870	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	Cc1cc(OCC2CCC(C(=O)O)C2)c(NC(=O)Nc2cnc(C#N)cn2)cc1Cl		CHEMBL1991285	<	Ki	nM	5011.87	CHEMBL2527	Homo sapiens	pKi		5.3
inactive	9619871	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	COc1cc(-c2ccc3c(c2)NC(=O)c2ccc(-c4ccccc4NS(C)(=O)=O)cc2N3)cc(OC)c1OC		CHEMBL1984038	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
active	9619872	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	O=C(O)c1ccccc1Nc1ccnc(Nc2cccc(O)c2)n1		CHEMBL243088	=	Ki	nM	398.11	CHEMBL2527	Homo sapiens	pKi		6.4
active	9619873	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	CNS(=O)(=O)c1ccccc1Nc1nc(Nc2cc(OC)c(OC)c(OC)c2)ncc1Cl		CHEMBL1993661	=	Ki	nM	79.43	CHEMBL2527	Homo sapiens	pKi		7.1
inactive	9619874	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	O=C(Nc1cnc2[nH]cc(-c3ccccc3)c2c1)c1cccc(F)c1F		CHEMBL1974416	<	Ki	nM	1584.89	CHEMBL2527	Homo sapiens	pKi		5.8
active	9619875	CHEMBL1963720	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2	F	COc1cc2c(cc1F)C(c1ccccc1Cl)=Nc1c(n[nH]c1C)N2		CHEMBL1980391	=	Ki	nM	125.89	CHEMBL2527	Homo sapiens	pKi		6.9
	10838675	CHEMBL2014901	Inhibition of CHK2 at 10 uM	B	COc1ccc2c3ccnc(C(F)(F)F)c3n(CCCCN)c2c1		CHEMBL2012574	=	Inhibition	%	27.0	CHEMBL2527	Homo sapiens	INH	%	27.0
	10839535	CHEMBL2015841	Inhibition of CHK2 assessed as residual activity at 1 uM relative to control	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Activity	%	3.0	CHEMBL2527	Homo sapiens	Activity	%	3.0
	10840501	CHEMBL2015933	Inhibition of CHK2 assessed as residual activity at 10 uM relative to control	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Activity	%	3.0	CHEMBL2527	Homo sapiens	Activity	%	3.0
	10843861	CHEMBL2016107	Inhibition of human CHK2 using ATP as substrate	B	CC(C)Cn1c2ccc(Nc3ncccn3)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3		CHEMBL2010872	=	IC50	nM	140.0	CHEMBL2527	Homo sapiens	IC50	nM	140.0
	10849708	CHEMBL2019667	Inhibition of CHK2	B	CSc1ccccc1Nc1nc(N2CCNCC2)nc2c(NCC3CC3)ncnc12		CHEMBL2017214	>	IC50	nM	40000.0	CHEMBL2527	Homo sapiens	IC50	uM	40.0
	10923952	CHEMBL2044292	Inhibition of CHK2 incubated for 30 mins prior to substrate addition study done at apparent ATP Km for enzyme	B	C[C@H](/C=C\C(F)(F)F)Oc1cc(-c2cc(-c3cc(CN(C)C)cs3)cnc2N)ccc1C(N)=O		CHEMBL2042135	=	IC50	nM	2000.0	CHEMBL2527	Homo sapiens	IC50	uM	2.0
	10923973	CHEMBL2044291	Inhibition of CHK2 at 1 uM incubated for 30 mins prior to substrate addition study done at apparent ATP Km for enzyme	B	C[C@H](/C=C\C(F)(F)F)Oc1cc(-c2cc(-c3cc(CN(C)C)cs3)cnc2N)ccc1C(N)=O		CHEMBL2042135	=	Inhibition	%	32.0	CHEMBL2527	Homo sapiens	INH	%	32.0
	10978480	CHEMBL2066185	Inhibition of human recombinant CHK2 expressed in insect cells using CREBtide as substrate assessed as residual activity at 1 uM after 15 mins by Cerep assay	B	N#Cc1ccc(-c2ccc(CSc3nnc(-c4ccc5c(c4)OCO5)o3)cc2)cc1		CHEMBL2064515	>	Activity	%	80.0	CHEMBL2527	Homo sapiens	Activity	%	80.0
	10980246	CHEMBL2065112	Inhibition of CHEK2 at 10 uM by FRET assay	B	CSc1ccccc1Nc1nc(N2CC3(CNC3)C2)nc2c(NCC3CC3)ncnc12		CHEMBL2017253	=	Inhibition	%	25.0	CHEMBL2527	Homo sapiens	INH	%	25.0
	10980247	CHEMBL2065112	Inhibition of CHEK2 at 10 uM by FRET assay	B	CSc1ccccc1Nc1nc(N2CCN(C3CCNCC3)CC2)nc2c(NCC3CC3)ncnc12		CHEMBL2063926	<	Inhibition	%	15.0	CHEMBL2527	Homo sapiens	INH	%	15.0
	10980298	CHEMBL2065142	Inhibition of CHEK2 by FRET assay	B	CSc1ccccc1Nc1nc(N2CCN(C3CCNCC3)CC2)nc2c(NCC3CC3)ncnc12		CHEMBL2063926	<	IC50	nM	10000.0	CHEMBL2527	Homo sapiens	IC50	uM	10.0
	10981543	CHEMBL2067603	Inhibition of human CHK2 at 1 uM	B	COc1c(Nc2ncc(Cl)c(N[C@H]3[C@@H](C(N)=O)[C@@H]4C=C[C@H]3C4)n2)ccc2c1CC[C@@H](N1CCOCC1)CC2		CHEMBL2064666	>=	Inhibition	%	90.0	CHEMBL2527	Homo sapiens	INH	%	90.0
	10981558	CHEMBL2067588	Inhibition of human CHK2	B	COc1c(Nc2ncc(Cl)c(N[C@H]3[C@@H](C(N)=O)[C@@H]4C=C[C@H]3C4)n2)ccc2c1CC[C@@H](N1CCOCC1)CC2		CHEMBL2064666	=	IC50	nM	29.0	CHEMBL2527	Homo sapiens	IC50	nM	29.0
	10995718	CHEMBL2072700	Inhibition of CHK2	B	NC(=O)Nc1cc(-c2cccc(F)c2)sc1C(=O)N[C@H]1CCCNC1		CHEMBL2041933	<	IC50	nM	10.0	CHEMBL2527	Homo sapiens	IC50	nM	10.0
	11011268	CHEMBL2092318	Inhibition of Chk2	B	NC1=NC(=O)/C(=C2\CCNC(=O)c3[nH]c(Br)cc32)N1		CHEMBL361708	=	IC50	nM	42.0	CHEMBL2527	Homo sapiens	IC50	nM	42.0
	11011271	CHEMBL2092318	Inhibition of Chk2	B	Nc1nc(C2=C3C(=Nc4ccccc43)C(=O)NCC2)c(O)[nH]1		CHEMBL332551	=	IC50	nM	8.0	CHEMBL2527	Homo sapiens	IC50	nM	8.0
	12046264	CHEMBL2156501	Inhibition of CHK2 at 1 uM	B	CC(C)(O)C1CCN(Cc2ccc3nc(-c4c(F)ccc5[nH]ccc45)nc(N4CCOCC4)c3n2)CC1		CHEMBL2152768	=	Inhibition	%	10.6	CHEMBL2527	Homo sapiens	INH	%	10.6
	12074623	CHEMBL2161020	Inhibition of CHK2 at 1 uM	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1		CHEMBL1908842	<	Inhibition	%	50.0	CHEMBL2527	Homo sapiens	INH	%	50.0
	12094370	CHEMBL2166152	Inhibition of human CHK2 by cyclex assay	B	CCOc1ccc(Nc2c(C)c(N[C@H]3CCCNC3)nc3ccnn23)cc1		CHEMBL1235213	>	IC50	nM	30000.0	CHEMBL2527	Homo sapiens	IC50	uM	30.0
Not Active	12094371	CHEMBL2166153	Inhibition of human CHK2 at 30 uM by radiometric assay	B	N[C@H]1CC[C@H](Nc2cc(Nc3ccccc3Cl)n3nccc3n2)CC1		CHEMBL2163607		Inhibition	%		CHEMBL2527	Homo sapiens	INH		
Not Active	12094372	CHEMBL2166153	Inhibition of human CHK2 at 30 uM by radiometric assay	B	CCOc1ccc(Nc2c(C)c(N[C@H]3CC[C@H](N)CC3)nc3ccnn23)cc1		CHEMBL2163981		Inhibition	%		CHEMBL2527	Homo sapiens	INH		
Not Active	12094373	CHEMBL2166153	Inhibition of human CHK2 at 30 uM by radiometric assay	B	CCc1c(N[C@H]2CC[C@H](N)CC2)nc2ccnn2c1Nc1ccc(F)c(Cl)c1		CHEMBL2163993		Inhibition	%		CHEMBL2527	Homo sapiens	INH		
	12094374	CHEMBL2166169	Inhibition of human CHK2 by radiometric assay	B	CCOc1ccc(Nc2c(C)c(N[C@H]3CCCNC3)nc3ccnn23)cc1		CHEMBL1235213	=	IC50	nM	1700.0	CHEMBL2527	Homo sapiens	IC50	uM	1.7
	12094378	CHEMBL2166156	Inhibition of human CHK2 at 10 uM	B	CCOc1ccc(Nc2c(C)c(N[C@H]3CCCNC3)nc3ccnn23)cc1		CHEMBL1235213	>	Inhibition	%	75.0	CHEMBL2527	Homo sapiens	INH	%	75.0
	12112590	CHEMBL2174415	Inhibition of CHK2 at 1 uM by 33P kinase hotspot assay	B	NC(=O)c1ccc(Nc2ncc(F)c(Nc3ccccc3Cl)n2)cc1		CHEMBL2170414	=	Inhibition	%	30.0	CHEMBL2527	Homo sapiens	INH	%	30.0
	12112591	CHEMBL2174415	Inhibition of CHK2 at 1 uM by 33P kinase hotspot assay	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Inhibition	%	4.0	CHEMBL2527	Homo sapiens	INH	%	4.0
	12166131	CHEMBL2211604	Binding affinity to CHK2 at 1 uM	B	Cc1nc(N)nc(-c2cc(Cl)cnc2Nc2cnc(Cl)c(NS(=O)(=O)N(C)C)c2)n1		CHEMBL2206921	<	Activity	%	50.0	CHEMBL2527	Homo sapiens	Activity	%	50.0
	12170831	CHEMBL2212698	Inhibition of CHK2 assessed as residual activity at 1 uM	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	89.0	CHEMBL2527	Homo sapiens	Activity	%	89.0
	12172132	CHEMBL2214387	Inhibition of CHK2 assessed as residual activity at 10 uM	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	90.0	CHEMBL2527	Homo sapiens	Activity	%	90.0
	12173688	CHEMBL2209324	Inhibition of CHEK2 assessed as residual activity at 10 uM relative to control	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	100.0	CHEMBL2527	Homo sapiens	Activity	%	100.0
	12188711	CHEMBL2216280	Inhibition of CHK2 using Biotin- KKKVSRSGLYRSPSMPENLNRPR as substrate after 30 mins by DELFIA assay in presence of ATP	B	COc1cc(Nc2cnc(C#N)c(O[C@H](C)CN(C)C)n2)ncc1-c1cnn(C)c1		CHEMBL2203843	>	IC50	nM	10000.0	CHEMBL2527	Homo sapiens	IC50	uM	10.0
	12188712	CHEMBL2216280	Inhibition of CHK2 using Biotin- KKKVSRSGLYRSPSMPENLNRPR as substrate after 30 mins by DELFIA assay in presence of ATP	B	CNc1cc(Nc2cnc(C#N)c(O[C@H](C)CN(C)C)n2)ncc1-c1cnn(C)c1		CHEMBL2204592	=	IC50	nM	3200.0	CHEMBL2527	Homo sapiens	IC50	uM	3.2
	12188713	CHEMBL2216280	Inhibition of CHK2 using Biotin- KKKVSRSGLYRSPSMPENLNRPR as substrate after 30 mins by DELFIA assay in presence of ATP	B	COC(=O)c1cnc(Nc2cnc(C#N)cn2)cc1NCC1CCNCC1		CHEMBL1928692	=	IC50	nM	9600.0	CHEMBL2527	Homo sapiens	IC50	uM	9.6
	12195432	CHEMBL2210930	Inhibition of recombinant CHK2 after 1 hr by scintillation counter analysis in presence of gamma-[33P]ATP	B	CC(C)(C)Nc1c(Nc2ccnc(Nc3ccc(-c4ccncc4)cc3)n2)c(=O)c1=O		CHEMBL2205426	=	Ki	nM	88.0	CHEMBL2527	Homo sapiens	Ki	nM	88.0
	12195623	CHEMBL2212872	Inhibition of human recombinant CHK2 expressed in insect cells using CKRREILSRRPSYRK as substrate assessed as residual activity at 1 uM after 15 mins relative to staurosporine	B	CCN(CC)CCOc1ccc(/C=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL2206008	=	Activity	%	94.0	CHEMBL2527	Homo sapiens	Activity	%	94.0
	12238636	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	96.0	CHEMBL2527	Homo sapiens	Residual Activity	%	96.0
	12238637	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	73.0	CHEMBL2527	Homo sapiens	Residual Activity	%	73.0
	12238638	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	97.0	CHEMBL2527	Homo sapiens	Residual Activity	%	97.0
	12238639	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	85.0	CHEMBL2527	Homo sapiens	Residual Activity	%	85.0
	12238640	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	97.0	CHEMBL2527	Homo sapiens	Residual Activity	%	97.0
	12238641	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	92.0	CHEMBL2527	Homo sapiens	Residual Activity	%	92.0
	12238642	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	4.0	CHEMBL2527	Homo sapiens	Residual Activity	%	4.0
	12238643	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	79.0	CHEMBL2527	Homo sapiens	Residual Activity	%	79.0
	12238644	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	86.0	CHEMBL2527	Homo sapiens	Residual Activity	%	86.0
	12238645	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	89.0	CHEMBL2527	Homo sapiens	Residual Activity	%	89.0
	12238646	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	99.0	CHEMBL2527	Homo sapiens	Residual Activity	%	99.0
	12238647	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	79.0	CHEMBL2527	Homo sapiens	Residual Activity	%	79.0
	12238648	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	95.0	CHEMBL2527	Homo sapiens	Residual Activity	%	95.0
	12238649	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	96.0	CHEMBL2527	Homo sapiens	Residual Activity	%	96.0
	12238650	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	15.0	CHEMBL2527	Homo sapiens	Residual Activity	%	15.0
	12238651	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	45.0	CHEMBL2527	Homo sapiens	Residual Activity	%	45.0
	12238652	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	92.0	CHEMBL2527	Homo sapiens	Residual Activity	%	92.0
	12238653	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	73.0	CHEMBL2527	Homo sapiens	Residual Activity	%	73.0
	12238654	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	77.0	CHEMBL2527	Homo sapiens	Residual Activity	%	77.0
	12238655	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	2.0	CHEMBL2527	Homo sapiens	Residual Activity	%	2.0
	12238656	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	93.0	CHEMBL2527	Homo sapiens	Residual Activity	%	93.0
	12238657	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	84.0	CHEMBL2527	Homo sapiens	Residual Activity	%	84.0
	12238658	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	85.0	CHEMBL2527	Homo sapiens	Residual Activity	%	85.0
	12238659	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	91.0	CHEMBL2527	Homo sapiens	Residual Activity	%	91.0
	12238660	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	92.0	CHEMBL2527	Homo sapiens	Residual Activity	%	92.0
	12238661	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	91.0	CHEMBL2527	Homo sapiens	Residual Activity	%	91.0
	12238662	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	60.0	CHEMBL2527	Homo sapiens	Residual Activity	%	60.0
	12238663	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	46.0	CHEMBL2527	Homo sapiens	Residual Activity	%	46.0
	12238664	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	96.0	CHEMBL2527	Homo sapiens	Residual Activity	%	96.0
	12238665	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	95.0	CHEMBL2527	Homo sapiens	Residual Activity	%	95.0
	12238666	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	90.0	CHEMBL2527	Homo sapiens	Residual Activity	%	90.0
	12238667	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	79.0	CHEMBL2527	Homo sapiens	Residual Activity	%	79.0
	12238668	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	95.0	CHEMBL2527	Homo sapiens	Residual Activity	%	95.0
	12238669	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	111.0	CHEMBL2527	Homo sapiens	Residual Activity	%	111.0
	12238670	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	97.0	CHEMBL2527	Homo sapiens	Residual Activity	%	97.0
	12238671	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	100.0	CHEMBL2527	Homo sapiens	Residual Activity	%	100.0
	12238672	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	82.0	CHEMBL2527	Homo sapiens	Residual Activity	%	82.0
	12238673	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	98.0	CHEMBL2527	Homo sapiens	Residual Activity	%	98.0
	12238674	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	91.0	CHEMBL2527	Homo sapiens	Residual Activity	%	91.0
	12238675	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	44.0	CHEMBL2527	Homo sapiens	Residual Activity	%	44.0
	12238676	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	94.0	CHEMBL2527	Homo sapiens	Residual Activity	%	94.0
	12238677	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	94.0	CHEMBL2527	Homo sapiens	Residual Activity	%	94.0
	12238678	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	25.0	CHEMBL2527	Homo sapiens	Residual Activity	%	25.0
	12238679	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	24.0	CHEMBL2527	Homo sapiens	Residual Activity	%	24.0
	12238680	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	48.0	CHEMBL2527	Homo sapiens	Residual Activity	%	48.0
	12238681	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	86.0	CHEMBL2527	Homo sapiens	Residual Activity	%	86.0
	12238682	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	81.0	CHEMBL2527	Homo sapiens	Residual Activity	%	81.0
	12238683	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	18.0	CHEMBL2527	Homo sapiens	Residual Activity	%	18.0
	12238684	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	85.0	CHEMBL2527	Homo sapiens	Residual Activity	%	85.0
	12238685	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	100.0	CHEMBL2527	Homo sapiens	Residual Activity	%	100.0
	12238686	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	34.0	CHEMBL2527	Homo sapiens	Residual Activity	%	34.0
	12238687	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	79.0	CHEMBL2527	Homo sapiens	Residual Activity	%	79.0
	12238688	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	50.0	CHEMBL2527	Homo sapiens	Residual Activity	%	50.0
	12238689	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	80.0	CHEMBL2527	Homo sapiens	Residual Activity	%	80.0
	12238690	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	89.0	CHEMBL2527	Homo sapiens	Residual Activity	%	89.0
	12238691	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	87.0	CHEMBL2527	Homo sapiens	Residual Activity	%	87.0
	12238692	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	34.0	CHEMBL2527	Homo sapiens	Residual Activity	%	34.0
	12238693	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	93.0	CHEMBL2527	Homo sapiens	Residual Activity	%	93.0
	12238694	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	85.0	CHEMBL2527	Homo sapiens	Residual Activity	%	85.0
	12238695	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	88.0	CHEMBL2527	Homo sapiens	Residual Activity	%	88.0
	12238696	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	76.0	CHEMBL2527	Homo sapiens	Residual Activity	%	76.0
	12238697	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	79.0	CHEMBL2527	Homo sapiens	Residual Activity	%	79.0
	12238698	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	88.0	CHEMBL2527	Homo sapiens	Residual Activity	%	88.0
	12238699	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	86.0	CHEMBL2527	Homo sapiens	Residual Activity	%	86.0
	12238700	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	95.0	CHEMBL2527	Homo sapiens	Residual Activity	%	95.0
	12238701	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	73.0	CHEMBL2527	Homo sapiens	Residual Activity	%	73.0
	12238702	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	91.0	CHEMBL2527	Homo sapiens	Residual Activity	%	91.0
	12238703	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	90.0	CHEMBL2527	Homo sapiens	Residual Activity	%	90.0
	12238704	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	78.0	CHEMBL2527	Homo sapiens	Residual Activity	%	78.0
	12238705	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	24.0	CHEMBL2527	Homo sapiens	Residual Activity	%	24.0
	12238706	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	84.0	CHEMBL2527	Homo sapiens	Residual Activity	%	84.0
	12238707	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	81.0	CHEMBL2527	Homo sapiens	Residual Activity	%	81.0
	12238708	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	52.0	CHEMBL2527	Homo sapiens	Residual Activity	%	52.0
	12238709	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	8.0	CHEMBL2527	Homo sapiens	Residual Activity	%	8.0
	12238710	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	85.0	CHEMBL2527	Homo sapiens	Residual Activity	%	85.0
	12238711	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	84.0	CHEMBL2527	Homo sapiens	Residual Activity	%	84.0
	12238712	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	93.0	CHEMBL2527	Homo sapiens	Residual Activity	%	93.0
	12238713	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	6.0	CHEMBL2527	Homo sapiens	Residual Activity	%	6.0
	12238714	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	86.0	CHEMBL2527	Homo sapiens	Residual Activity	%	86.0
	12238715	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	3.0	CHEMBL2527	Homo sapiens	Residual Activity	%	3.0
	12238716	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	92.0	CHEMBL2527	Homo sapiens	Residual Activity	%	92.0
	12238717	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	52.0	CHEMBL2527	Homo sapiens	Residual Activity	%	52.0
	12238718	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	33.0	CHEMBL2527	Homo sapiens	Residual Activity	%	33.0
	12238719	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	103.0	CHEMBL2527	Homo sapiens	Residual Activity	%	103.0
	12238720	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	35.0	CHEMBL2527	Homo sapiens	Residual Activity	%	35.0
	12238721	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	91.0	CHEMBL2527	Homo sapiens	Residual Activity	%	91.0
	12238722	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	5.0	CHEMBL2527	Homo sapiens	Residual Activity	%	5.0
	12238723	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	90.0	CHEMBL2527	Homo sapiens	Residual Activity	%	90.0
	12238724	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	106.0	CHEMBL2527	Homo sapiens	Residual Activity	%	106.0
	12238725	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	13.0	CHEMBL2527	Homo sapiens	Residual Activity	%	13.0
	12238726	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	106.0	CHEMBL2527	Homo sapiens	Residual Activity	%	106.0
	12238727	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	98.0	CHEMBL2527	Homo sapiens	Residual Activity	%	98.0
	12238728	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	22.0	CHEMBL2527	Homo sapiens	Residual Activity	%	22.0
	12238729	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	99.0	CHEMBL2527	Homo sapiens	Residual Activity	%	99.0
	12238730	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	43.0	CHEMBL2527	Homo sapiens	Residual Activity	%	43.0
	12238731	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	90.0	CHEMBL2527	Homo sapiens	Residual Activity	%	90.0
	12238732	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	103.0	CHEMBL2527	Homo sapiens	Residual Activity	%	103.0
	12238733	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	85.0	CHEMBL2527	Homo sapiens	Residual Activity	%	85.0
	12238734	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	96.0	CHEMBL2527	Homo sapiens	Residual Activity	%	96.0
	12238735	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	19.0	CHEMBL2527	Homo sapiens	Residual Activity	%	19.0
	12238736	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	23.0	CHEMBL2527	Homo sapiens	Residual Activity	%	23.0
	12238737	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	3.0	CHEMBL2527	Homo sapiens	Residual Activity	%	3.0
	12238738	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	85.0	CHEMBL2527	Homo sapiens	Residual Activity	%	85.0
	12238739	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	26.0	CHEMBL2527	Homo sapiens	Residual Activity	%	26.0
	12238740	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	3.0	CHEMBL2527	Homo sapiens	Residual Activity	%	3.0
	12238741	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	86.0	CHEMBL2527	Homo sapiens	Residual Activity	%	86.0
	12238742	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	90.0	CHEMBL2527	Homo sapiens	Residual Activity	%	90.0
	12238743	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	77.0	CHEMBL2527	Homo sapiens	Residual Activity	%	77.0
	12238744	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	89.0	CHEMBL2527	Homo sapiens	Residual Activity	%	89.0
	12238745	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	37.0	CHEMBL2527	Homo sapiens	Residual Activity	%	37.0
	12238746	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	97.0	CHEMBL2527	Homo sapiens	Residual Activity	%	97.0
	12238747	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	91.0	CHEMBL2527	Homo sapiens	Residual Activity	%	91.0
	12238748	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	4.0	CHEMBL2527	Homo sapiens	Residual Activity	%	4.0
	12238749	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	75.0	CHEMBL2527	Homo sapiens	Residual Activity	%	75.0
	12238750	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	0.0	CHEMBL2527	Homo sapiens	Residual Activity	%	0.0
	12238751	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	71.0	CHEMBL2527	Homo sapiens	Residual Activity	%	71.0
	12238752	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	34.0	CHEMBL2527	Homo sapiens	Residual Activity	%	34.0
	12238753	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	103.0	CHEMBL2527	Homo sapiens	Residual Activity	%	103.0
	12238754	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	92.0	CHEMBL2527	Homo sapiens	Residual Activity	%	92.0
	12238755	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	92.0	CHEMBL2527	Homo sapiens	Residual Activity	%	92.0
	12238756	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	31.0	CHEMBL2527	Homo sapiens	Residual Activity	%	31.0
	12238757	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	59.0	CHEMBL2527	Homo sapiens	Residual Activity	%	59.0
	12238758	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	64.0	CHEMBL2527	Homo sapiens	Residual Activity	%	64.0
	12238759	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	72.0	CHEMBL2527	Homo sapiens	Residual Activity	%	72.0
	12238760	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	26.0	CHEMBL2527	Homo sapiens	Residual Activity	%	26.0
	12238761	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	98.0	CHEMBL2527	Homo sapiens	Residual Activity	%	98.0
	12238762	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	96.0	CHEMBL2527	Homo sapiens	Residual Activity	%	96.0
	12238763	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	64.0	CHEMBL2527	Homo sapiens	Residual Activity	%	64.0
	12238764	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	44.0	CHEMBL2527	Homo sapiens	Residual Activity	%	44.0
	12238765	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	4.0	CHEMBL2527	Homo sapiens	Residual Activity	%	4.0
	12238766	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	77.0	CHEMBL2527	Homo sapiens	Residual Activity	%	77.0
	12238767	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	90.0	CHEMBL2527	Homo sapiens	Residual Activity	%	90.0
	12238768	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	29.0	CHEMBL2527	Homo sapiens	Residual Activity	%	29.0
	12238769	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	88.0	CHEMBL2527	Homo sapiens	Residual Activity	%	88.0
	12238770	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	54.0	CHEMBL2527	Homo sapiens	Residual Activity	%	54.0
	12238771	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	67.0	CHEMBL2527	Homo sapiens	Residual Activity	%	67.0
	12238772	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	82.0	CHEMBL2527	Homo sapiens	Residual Activity	%	82.0
	12238773	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	55.0	CHEMBL2527	Homo sapiens	Residual Activity	%	55.0
	12238774	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	18.0	CHEMBL2527	Homo sapiens	Residual Activity	%	18.0
	12238775	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	75.0	CHEMBL2527	Homo sapiens	Residual Activity	%	75.0
	12238776	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	94.0	CHEMBL2527	Homo sapiens	Residual Activity	%	94.0
	12238777	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	81.0	CHEMBL2527	Homo sapiens	Residual Activity	%	81.0
	12238778	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	86.0	CHEMBL2527	Homo sapiens	Residual Activity	%	86.0
	12238779	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	90.0	CHEMBL2527	Homo sapiens	Residual Activity	%	90.0
	12238780	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	92.0	CHEMBL2527	Homo sapiens	Residual Activity	%	92.0
	12238781	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	91.0	CHEMBL2527	Homo sapiens	Residual Activity	%	91.0
	12238782	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	71.0	CHEMBL2527	Homo sapiens	Residual Activity	%	71.0
	12238783	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	80.0	CHEMBL2527	Homo sapiens	Residual Activity	%	80.0
	12238784	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	73.0	CHEMBL2527	Homo sapiens	Residual Activity	%	73.0
	12238785	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	91.0	CHEMBL2527	Homo sapiens	Residual Activity	%	91.0
	12238786	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	67.0	CHEMBL2527	Homo sapiens	Residual Activity	%	67.0
	12238787	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	59.0	CHEMBL2527	Homo sapiens	Residual Activity	%	59.0
	12238788	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	91.0	CHEMBL2527	Homo sapiens	Residual Activity	%	91.0
	12238789	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	88.0	CHEMBL2527	Homo sapiens	Residual Activity	%	88.0
	12238790	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	103.0	CHEMBL2527	Homo sapiens	Residual Activity	%	103.0
	12238791	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	52.0	CHEMBL2527	Homo sapiens	Residual Activity	%	52.0
	12238792	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	89.0	CHEMBL2527	Homo sapiens	Residual Activity	%	89.0
	12238793	CHEMBL2218988	Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	49.0	CHEMBL2527	Homo sapiens	Residual Activity	%	49.0
	12238794	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	99.0	CHEMBL2527	Homo sapiens	Residual Activity	%	99.0
	12238795	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	25.0	CHEMBL2527	Homo sapiens	Residual Activity	%	25.0
	12238796	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	74.0	CHEMBL2527	Homo sapiens	Residual Activity	%	74.0
	12238797	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	104.0	CHEMBL2527	Homo sapiens	Residual Activity	%	104.0
	12238798	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	56.0	CHEMBL2527	Homo sapiens	Residual Activity	%	56.0
	12238799	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	105.0	CHEMBL2527	Homo sapiens	Residual Activity	%	105.0
	12238800	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	1.0	CHEMBL2527	Homo sapiens	Residual Activity	%	1.0
	12238801	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	42.0	CHEMBL2527	Homo sapiens	Residual Activity	%	42.0
	12238802	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	101.0	CHEMBL2527	Homo sapiens	Residual Activity	%	101.0
	12238803	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	56.0	CHEMBL2527	Homo sapiens	Residual Activity	%	56.0
	12238804	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	108.0	CHEMBL2527	Homo sapiens	Residual Activity	%	108.0
	12238805	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	67.0	CHEMBL2527	Homo sapiens	Residual Activity	%	67.0
	12238806	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	87.0	CHEMBL2527	Homo sapiens	Residual Activity	%	87.0
	12238807	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	48.0	CHEMBL2527	Homo sapiens	Residual Activity	%	48.0
	12238808	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	2.0	CHEMBL2527	Homo sapiens	Residual Activity	%	2.0
	12238809	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	34.0	CHEMBL2527	Homo sapiens	Residual Activity	%	34.0
	12238810	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	80.0	CHEMBL2527	Homo sapiens	Residual Activity	%	80.0
	12238811	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	90.0	CHEMBL2527	Homo sapiens	Residual Activity	%	90.0
	12238812	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	98.0	CHEMBL2527	Homo sapiens	Residual Activity	%	98.0
	12238813	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	1.0	CHEMBL2527	Homo sapiens	Residual Activity	%	1.0
	12238814	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	97.0	CHEMBL2527	Homo sapiens	Residual Activity	%	97.0
	12238815	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	77.0	CHEMBL2527	Homo sapiens	Residual Activity	%	77.0
	12238816	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	85.0	CHEMBL2527	Homo sapiens	Residual Activity	%	85.0
	12238817	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	89.0	CHEMBL2527	Homo sapiens	Residual Activity	%	89.0
	12238818	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	97.0	CHEMBL2527	Homo sapiens	Residual Activity	%	97.0
	12238819	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	47.0	CHEMBL2527	Homo sapiens	Residual Activity	%	47.0
	12241408	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	22.0	CHEMBL2527	Homo sapiens	Residual Activity	%	22.0
	12241409	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	11.0	CHEMBL2527	Homo sapiens	Residual Activity	%	11.0
	12241410	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	96.0	CHEMBL2527	Homo sapiens	Residual Activity	%	96.0
	12241411	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	51.0	CHEMBL2527	Homo sapiens	Residual Activity	%	51.0
	12241412	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	88.0	CHEMBL2527	Homo sapiens	Residual Activity	%	88.0
	12241413	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	30.0	CHEMBL2527	Homo sapiens	Residual Activity	%	30.0
	12241414	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	87.0	CHEMBL2527	Homo sapiens	Residual Activity	%	87.0
	12241415	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	93.0	CHEMBL2527	Homo sapiens	Residual Activity	%	93.0
	12241416	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	92.0	CHEMBL2527	Homo sapiens	Residual Activity	%	92.0
	12241417	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	72.0	CHEMBL2527	Homo sapiens	Residual Activity	%	72.0
	12241418	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	70.0	CHEMBL2527	Homo sapiens	Residual Activity	%	70.0
	12241419	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	85.0	CHEMBL2527	Homo sapiens	Residual Activity	%	85.0
	12241420	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	97.0	CHEMBL2527	Homo sapiens	Residual Activity	%	97.0
	12241421	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	42.0	CHEMBL2527	Homo sapiens	Residual Activity	%	42.0
	12241422	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	103.0	CHEMBL2527	Homo sapiens	Residual Activity	%	103.0
	12241423	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	91.0	CHEMBL2527	Homo sapiens	Residual Activity	%	91.0
	12241424	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	15.0	CHEMBL2527	Homo sapiens	Residual Activity	%	15.0
	12241425	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	4.0	CHEMBL2527	Homo sapiens	Residual Activity	%	4.0
	12241426	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	23.0	CHEMBL2527	Homo sapiens	Residual Activity	%	23.0
	12241427	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	100.0	CHEMBL2527	Homo sapiens	Residual Activity	%	100.0
	12241428	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	87.0	CHEMBL2527	Homo sapiens	Residual Activity	%	87.0
	12241429	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	3.0	CHEMBL2527	Homo sapiens	Residual Activity	%	3.0
	12241430	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	89.0	CHEMBL2527	Homo sapiens	Residual Activity	%	89.0
	12241431	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	68.0	CHEMBL2527	Homo sapiens	Residual Activity	%	68.0
	12241432	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	9.0	CHEMBL2527	Homo sapiens	Residual Activity	%	9.0
	12241433	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	24.0	CHEMBL2527	Homo sapiens	Residual Activity	%	24.0
	12241434	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	15.0	CHEMBL2527	Homo sapiens	Residual Activity	%	15.0
	12241435	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	83.0	CHEMBL2527	Homo sapiens	Residual Activity	%	83.0
	12241436	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	73.0	CHEMBL2527	Homo sapiens	Residual Activity	%	73.0
	12241437	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	112.0	CHEMBL2527	Homo sapiens	Residual Activity	%	112.0
	12241438	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	8.0	CHEMBL2527	Homo sapiens	Residual Activity	%	8.0
	12241439	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	85.0	CHEMBL2527	Homo sapiens	Residual Activity	%	85.0
	12241440	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	57.0	CHEMBL2527	Homo sapiens	Residual Activity	%	57.0
	12241441	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	87.0	CHEMBL2527	Homo sapiens	Residual Activity	%	87.0
	12241442	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	25.0	CHEMBL2527	Homo sapiens	Residual Activity	%	25.0
	12241443	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	54.0	CHEMBL2527	Homo sapiens	Residual Activity	%	54.0
	12241444	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	85.0	CHEMBL2527	Homo sapiens	Residual Activity	%	85.0
	12241445	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	105.0	CHEMBL2527	Homo sapiens	Residual Activity	%	105.0
	12241446	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	87.0	CHEMBL2527	Homo sapiens	Residual Activity	%	87.0
	12241447	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	36.0	CHEMBL2527	Homo sapiens	Residual Activity	%	36.0
	12241448	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	89.0	CHEMBL2527	Homo sapiens	Residual Activity	%	89.0
	12241449	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	91.0	CHEMBL2527	Homo sapiens	Residual Activity	%	91.0
	12241450	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	33.0	CHEMBL2527	Homo sapiens	Residual Activity	%	33.0
	12241451	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	8.0	CHEMBL2527	Homo sapiens	Residual Activity	%	8.0
	12241452	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	89.0	CHEMBL2527	Homo sapiens	Residual Activity	%	89.0
	12241453	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	48.0	CHEMBL2527	Homo sapiens	Residual Activity	%	48.0
	12241454	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	16.0	CHEMBL2527	Homo sapiens	Residual Activity	%	16.0
	12241455	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	3.0	CHEMBL2527	Homo sapiens	Residual Activity	%	3.0
	12241456	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	77.0	CHEMBL2527	Homo sapiens	Residual Activity	%	77.0
	12241457	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	61.0	CHEMBL2527	Homo sapiens	Residual Activity	%	61.0
	12241458	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	85.0	CHEMBL2527	Homo sapiens	Residual Activity	%	85.0
	12241459	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	1.0	CHEMBL2527	Homo sapiens	Residual Activity	%	1.0
	12241460	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	88.0	CHEMBL2527	Homo sapiens	Residual Activity	%	88.0
	12241461	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	1.0	CHEMBL2527	Homo sapiens	Residual Activity	%	1.0
	12241462	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	79.0	CHEMBL2527	Homo sapiens	Residual Activity	%	79.0
	12241463	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	11.0	CHEMBL2527	Homo sapiens	Residual Activity	%	11.0
	12241464	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	30.0	CHEMBL2527	Homo sapiens	Residual Activity	%	30.0
	12241465	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	97.0	CHEMBL2527	Homo sapiens	Residual Activity	%	97.0
	12241466	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	21.0	CHEMBL2527	Homo sapiens	Residual Activity	%	21.0
	12241467	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	72.0	CHEMBL2527	Homo sapiens	Residual Activity	%	72.0
	12241468	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	3.0	CHEMBL2527	Homo sapiens	Residual Activity	%	3.0
	12241469	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	90.0	CHEMBL2527	Homo sapiens	Residual Activity	%	90.0
	12241470	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	87.0	CHEMBL2527	Homo sapiens	Residual Activity	%	87.0
	12241471	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	2.0	CHEMBL2527	Homo sapiens	Residual Activity	%	2.0
	12241472	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	68.0	CHEMBL2527	Homo sapiens	Residual Activity	%	68.0
	12241473	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	78.0	CHEMBL2527	Homo sapiens	Residual Activity	%	78.0
	12241474	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	2.0	CHEMBL2527	Homo sapiens	Residual Activity	%	2.0
	12241475	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	81.0	CHEMBL2527	Homo sapiens	Residual Activity	%	81.0
	12241476	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	33.0	CHEMBL2527	Homo sapiens	Residual Activity	%	33.0
	12241477	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	54.0	CHEMBL2527	Homo sapiens	Residual Activity	%	54.0
	12241478	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	82.0	CHEMBL2527	Homo sapiens	Residual Activity	%	82.0
	12241479	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	78.0	CHEMBL2527	Homo sapiens	Residual Activity	%	78.0
	12241480	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	82.0	CHEMBL2527	Homo sapiens	Residual Activity	%	82.0
	12241481	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	11.0	CHEMBL2527	Homo sapiens	Residual Activity	%	11.0
	12241482	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	8.0	CHEMBL2527	Homo sapiens	Residual Activity	%	8.0
	12241483	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	1.0	CHEMBL2527	Homo sapiens	Residual Activity	%	1.0
	12241484	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	72.0	CHEMBL2527	Homo sapiens	Residual Activity	%	72.0
	12241485	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	24.0	CHEMBL2527	Homo sapiens	Residual Activity	%	24.0
	12241486	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	1.0	CHEMBL2527	Homo sapiens	Residual Activity	%	1.0
	12241487	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	60.0	CHEMBL2527	Homo sapiens	Residual Activity	%	60.0
	12241488	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	76.0	CHEMBL2527	Homo sapiens	Residual Activity	%	76.0
	12241489	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	75.0	CHEMBL2527	Homo sapiens	Residual Activity	%	75.0
	12241490	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	78.0	CHEMBL2527	Homo sapiens	Residual Activity	%	78.0
	12241491	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	5.0	CHEMBL2527	Homo sapiens	Residual Activity	%	5.0
	12241492	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	84.0	CHEMBL2527	Homo sapiens	Residual Activity	%	84.0
	12241493	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	72.0	CHEMBL2527	Homo sapiens	Residual Activity	%	72.0
	12241494	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	0.0	CHEMBL2527	Homo sapiens	Residual Activity	%	0.0
	12241495	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	41.0	CHEMBL2527	Homo sapiens	Residual Activity	%	41.0
	12241496	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	0.0	CHEMBL2527	Homo sapiens	Residual Activity	%	0.0
	12241497	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	67.0	CHEMBL2527	Homo sapiens	Residual Activity	%	67.0
	12241498	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	4.0	CHEMBL2527	Homo sapiens	Residual Activity	%	4.0
	12241499	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	73.0	CHEMBL2527	Homo sapiens	Residual Activity	%	73.0
	12241500	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	70.0	CHEMBL2527	Homo sapiens	Residual Activity	%	70.0
	12241501	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	88.0	CHEMBL2527	Homo sapiens	Residual Activity	%	88.0
	12241502	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	10.0	CHEMBL2527	Homo sapiens	Residual Activity	%	10.0
	12241503	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	12.0	CHEMBL2527	Homo sapiens	Residual Activity	%	12.0
	12241504	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	21.0	CHEMBL2527	Homo sapiens	Residual Activity	%	21.0
	12241505	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	65.0	CHEMBL2527	Homo sapiens	Residual Activity	%	65.0
	12241506	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	3.0	CHEMBL2527	Homo sapiens	Residual Activity	%	3.0
	12241507	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	76.0	CHEMBL2527	Homo sapiens	Residual Activity	%	76.0
	12241508	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	38.0	CHEMBL2527	Homo sapiens	Residual Activity	%	38.0
	12241509	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	40.0	CHEMBL2527	Homo sapiens	Residual Activity	%	40.0
	12241510	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	11.0	CHEMBL2527	Homo sapiens	Residual Activity	%	11.0
	12241511	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	0.0	CHEMBL2527	Homo sapiens	Residual Activity	%	0.0
	12241512	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	33.0	CHEMBL2527	Homo sapiens	Residual Activity	%	33.0
	12241513	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	77.0	CHEMBL2527	Homo sapiens	Residual Activity	%	77.0
	12241514	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	2.0	CHEMBL2527	Homo sapiens	Residual Activity	%	2.0
	12241515	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	84.0	CHEMBL2527	Homo sapiens	Residual Activity	%	84.0
	12241516	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	12.0	CHEMBL2527	Homo sapiens	Residual Activity	%	12.0
	12241517	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	30.0	CHEMBL2527	Homo sapiens	Residual Activity	%	30.0
	12241518	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	61.0	CHEMBL2527	Homo sapiens	Residual Activity	%	61.0
	12241519	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	12.0	CHEMBL2527	Homo sapiens	Residual Activity	%	12.0
	12241520	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	3.0	CHEMBL2527	Homo sapiens	Residual Activity	%	3.0
	12241521	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	40.0	CHEMBL2527	Homo sapiens	Residual Activity	%	40.0
	12241522	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	81.0	CHEMBL2527	Homo sapiens	Residual Activity	%	81.0
	12241523	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	27.0	CHEMBL2527	Homo sapiens	Residual Activity	%	27.0
	12241524	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	38.0	CHEMBL2527	Homo sapiens	Residual Activity	%	38.0
	12241525	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	62.0	CHEMBL2527	Homo sapiens	Residual Activity	%	62.0
	12241526	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	81.0	CHEMBL2527	Homo sapiens	Residual Activity	%	81.0
	12241527	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	80.0	CHEMBL2527	Homo sapiens	Residual Activity	%	80.0
	12241528	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	26.0	CHEMBL2527	Homo sapiens	Residual Activity	%	26.0
	12241529	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	48.0	CHEMBL2527	Homo sapiens	Residual Activity	%	48.0
	12241530	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	59.0	CHEMBL2527	Homo sapiens	Residual Activity	%	59.0
	12241531	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	84.0	CHEMBL2527	Homo sapiens	Residual Activity	%	84.0
	12241532	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	25.0	CHEMBL2527	Homo sapiens	Residual Activity	%	25.0
	12241533	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	33.0	CHEMBL2527	Homo sapiens	Residual Activity	%	33.0
	12241534	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	75.0	CHEMBL2527	Homo sapiens	Residual Activity	%	75.0
	12241535	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	79.0	CHEMBL2527	Homo sapiens	Residual Activity	%	79.0
	12241536	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	76.0	CHEMBL2527	Homo sapiens	Residual Activity	%	76.0
	12241537	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	17.0	CHEMBL2527	Homo sapiens	Residual Activity	%	17.0
	12241538	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	68.0	CHEMBL2527	Homo sapiens	Residual Activity	%	68.0
	12241539	CHEMBL2218989	Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	36.0	CHEMBL2527	Homo sapiens	Residual Activity	%	36.0
	12626705	CHEMBL2316982	Inhibition of CHK2 (unknown origin) at 1 uM	B	COc1cc(Nc2ncc(Cl)c(-c3cccc(CC#N)c3)n2)ccc1N1CCN(C)CC1		CHEMBL2312140	>=	Inhibition	%	80.0	CHEMBL2527	Homo sapiens	INH	%	80.0
	12628459	CHEMBL2321410	Inhibition of CHK2 (unknown origin) at 10 uM	B	N#Cc1c(N)nc2sc(C(=O)c3cccc(Cl)c3)c(N)c2c1-c1ccccc1Cl		CHEMBL2313853	>	Inhibition	%	50.0	CHEMBL2527	Homo sapiens	INH	%	50.0
	12629545	CHEMBL2319134	Inhibition of CHK2 (unknown origin)	B	O=C(NCCCN1CCOC1=O)c1cnc(NCc2cc(Cl)ccc2Cl)nc1NC1CCCC1		CHEMBL2312304	>	IC50	nM	30000.0	CHEMBL2527	Homo sapiens	IC50	uM	30.0
	12629546	CHEMBL2319134	Inhibition of CHK2 (unknown origin)	B	O=C(NCCCN1CCCC1=O)c1cnc(NCc2cc(Cl)ccc2Cl)nc1NC1CCCC1		CHEMBL2312303	>	IC50	nM	30000.0	CHEMBL2527	Homo sapiens	IC50	uM	30.0
	12629547	CHEMBL2319134	Inhibition of CHK2 (unknown origin)	B	COc1ccccc1CNc1ncc(C(=O)NCCCN2CCCC2=O)c(NC2CCCC2)n1		CHEMBL2312301	>	IC50	nM	30000.0	CHEMBL2527	Homo sapiens	IC50	uM	30.0
	12629548	CHEMBL2319134	Inhibition of CHK2 (unknown origin)	B	COc1ccc(CCNc2ncc(C(=O)NCCCN3CCCC3=O)c(NC3CCCC3)n2)cc1OC		CHEMBL2312290	>	IC50	nM	30000.0	CHEMBL2527	Homo sapiens	IC50	uM	30.0
	12631722	CHEMBL2317780	Inhibition of CHK2 (unknown origin) in presence of ATP	B	Cc1cc(-c2cnc(Nc3cc(Cl)cc(Cl)c3)nc2NC2CCC(N(C)C)CC2)on1		CHEMBL2312654	=	IC50	nM	7970.0	CHEMBL2527	Homo sapiens	IC50	uM	7.97
	12631723	CHEMBL2317780	Inhibition of CHK2 (unknown origin) in presence of ATP	B	CN1CCC(NC(=O)c2cnc(Nc3cc(Cl)cc(Cl)c3)nc2N[C@@H]2COC[C@H]2O)CC1		CHEMBL2312652	=	IC50	nM	30000.0	CHEMBL2527	Homo sapiens	IC50	uM	30.0
	12631724	CHEMBL2317780	Inhibition of CHK2 (unknown origin) in presence of ATP	B	CN1CCC(NC(=O)c2cnc(Nc3cc(Cl)cc(Cl)c3)nc2NC2CCC(N(C)C)CC2)CC1		CHEMBL2312649	=	IC50	nM	30000.0	CHEMBL2527	Homo sapiens	IC50	uM	30.0
	12631725	CHEMBL2317780	Inhibition of CHK2 (unknown origin) in presence of ATP	B	CN1CCC(NC(=O)c2cnc(NCc3cc(Cl)ccc3Cl)nc2NC2CCCC2)CC1		CHEMBL2312646	=	IC50	nM	30000.0	CHEMBL2527	Homo sapiens	IC50	uM	30.0
	12631726	CHEMBL2317780	Inhibition of CHK2 (unknown origin) in presence of ATP	B	COc1ccccc1CNc1ncc(C(=O)NC2CCN(C)CC2)c(NC2CCCC2)n1		CHEMBL2312645	=	IC50	nM	30000.0	CHEMBL2527	Homo sapiens	IC50	uM	30.0
	12647995	CHEMBL2329200	Inhibition of CHK2 (unknown origin) at 1 uM	B	CC(C)(C)[C@@H](NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C(=O)N1CC(C#N)C1		CHEMBL2325895	=	Inhibition	%	11.0	CHEMBL2527	Homo sapiens	INH	%	11.0
	12647996	CHEMBL2329200	Inhibition of CHK2 (unknown origin) at 1 uM	B	C[C@@H](NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C(=O)N1CC(C#N)C1		CHEMBL2325894	=	Inhibition	%	33.0	CHEMBL2527	Homo sapiens	INH	%	33.0
	12647997	CHEMBL2329200	Inhibition of CHK2 (unknown origin) at 1 uM	B	C[C@H](NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C(C)(C)C#N		CHEMBL2325906	=	Inhibition	%	7.0	CHEMBL2527	Homo sapiens	INH	%	7.0
	12647998	CHEMBL2329200	Inhibition of CHK2 (unknown origin) at 1 uM	B	C[C@H](NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C(C)(C)C		CHEMBL2325903	=	Inhibition	%	51.0	CHEMBL2527	Homo sapiens	INH	%	51.0
	12649657	CHEMBL2329552	Inhibition of CHK2 (unknown origin) at 10 uM	B	C[C@@H](NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C(=O)N1CC(C#N)C1		CHEMBL2325894	=	Inhibition	%	92.0	CHEMBL2527	Homo sapiens	INH	%	92.0
	12649658	CHEMBL2329552	Inhibition of CHK2 (unknown origin) at 10 uM	B	C[C@H](NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C(C)(C)O		CHEMBL2325904	=	Inhibition	%	90.0	CHEMBL2527	Homo sapiens	INH	%	90.0
	12649659	CHEMBL2329552	Inhibition of CHK2 (unknown origin) at 10 uM	B	CC(C)NC(=O)c1c[nH]c2ncc(C3CC3)nc12		CHEMBL2325901	=	Inhibition	%	90.0	CHEMBL2527	Homo sapiens	INH	%	90.0
	12656867	CHEMBL2327148	Inhibition of CHK2 (unknown origin)	B	COc1cc2c(cc1F)C(c1ccccc1Cl)=Nc1c(n[nH]c1C)N2		CHEMBL1980391	=	IC50	nM	24.0	CHEMBL2527	Homo sapiens	IC50	nM	24.0
	12657931	CHEMBL2330109	Inhibition of CHK2 (unknown origin) using [gamma33P]ATP assessed as residual activity at 1 uM after 120 mins by radiometric assay	B	O=C1c2c(O)ccc(O)c2C(=O)c2c(NCCNCCO)ccc(NCCNCCO)c21		CHEMBL58	=	Activity	%	59.7	CHEMBL2527	Homo sapiens	Activity	%	59.7
	12673027	CHEMBL2339740	Inhibition of recombinant CHK2 (unknown origin) assessed as residual activity using [gamma-33P]ATP as substrate at 1 uM	B	CC[C@@H](CO)Nc1nc(NC(=N)N)c2ncn(C(C)C)c2n1		CHEMBL2336379	=	Activity	%	42.0	CHEMBL2527	Homo sapiens	Activity	%	42.0
	12673028	CHEMBL2339740	Inhibition of recombinant CHK2 (unknown origin) assessed as residual activity using [gamma-33P]ATP as substrate at 1 uM	B	CC[C@H](CO)Nc1nc(NC(=N)N)c2ncn(C(C)C)c2n1		CHEMBL2336377	=	Activity	%	59.0	CHEMBL2527	Homo sapiens	Activity	%	59.0
	12679749	CHEMBL2346290	Inhibition of CHEK2 (unknown origin) at 1 uM	B	Cc1ccc(-c2ccc3ncc4c(c3n2)n(C2CCN(C(=O)[C@H](C)O)CC2)c(=O)n4C)cn1		CHEMBL2331664	=	Inhibition	%	1.5	CHEMBL2527	Homo sapiens	INH	%	1.5
	12693246	CHEMBL2343930	Inhibition of CHK2 (unknown origin)	B	Cc1c(C(=O)N2CCOc3ccc(-c4ccc(N)nc4)cc3C2)ccc(S(C)(=O)=O)c1F		CHEMBL2333365	>	IC50	nM	10000.0	CHEMBL2527	Homo sapiens	IC50	nM	10000.0
	12728878	CHEMBL2349960	Inhibition of CHK2 (unknown origin) assessed as remaining activity at 10 uM relative to control	B	O=c1[nH]c2ncc(-c3ccc(-c4nc[nH]n4)cc3)nc2n1CCC1CCOCC1		CHEMBL2348865	=	Activity	%	63.0	CHEMBL2527	Homo sapiens	Activity	%	63.0
	12729764	CHEMBL2349765	Inhibition of CHK2 (unknown origin) using [gamma-33P]ATP	B	CCc1ccc(-c2ccc3c(c2)-c2c(cnn2CC)S(=O)(=O)N3C)cc1		CHEMBL2333436	>	IC50	nM	10000.0	CHEMBL2527	Homo sapiens	IC50	uM	10.0
	12729765	CHEMBL2349765	Inhibition of CHK2 (unknown origin) using [gamma-33P]ATP	B	CCc1ccc(-c2ccc3c(c2)-c2[nH]ncc2S(=O)(=O)N3C)cc1		CHEMBL2333445	=	IC50	nM	3400.0	CHEMBL2527	Homo sapiens	IC50	uM	3.4
	12729787	CHEMBL2350032	Inhibition of CHK2 I157T mutant (unknown origin) using [gamma-33P]ATP assessed as residual activity at 3 uM	B	CCc1ccc(-c2ccc3c(c2)-c2[nH]ncc2S(=O)(=O)N3C)cc1		CHEMBL2333445	=	Activity	%	61.0	CHEMBL2527	Homo sapiens	Activity	%	61.0
	12730020	CHEMBL2353894	Inhibition of CHK2 (unknown origin) assessed as remaining activity at 1 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	94.0	CHEMBL2527	Homo sapiens	Activity	%	94.0
	12730268	CHEMBL2349960	Inhibition of CHK2 (unknown origin) assessed as remaining activity at 10 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	97.0	CHEMBL2527	Homo sapiens	Activity	%	97.0
	12730900	CHEMBL2349829	Inhibition of CHK2 (unknown origin) using [gamma-33P]ATP assessed as residual activity at 3 uM	B	CCc1ccc(-c2ccc3c(c2)-c2[nH]ncc2S(=O)(=O)N3C)cc1		CHEMBL2333445	=	Activity	%	50.0	CHEMBL2527	Homo sapiens	Activity	%	50.0
	13282396	CHEMBL2378495	Inhibition of CHK2 (unknown origin) at 10 uM relative to control	B	C[C@@H](NC(=O)c1c[nH]c2ncc(-c3ncn4cc(F)cc(F)c34)nc12)C(=O)N1CC(C#N)C1		CHEMBL2376158	=	Inhibition	%	80.0	CHEMBL2527	Homo sapiens	INH	%	80.0
	13282397	CHEMBL2378495	Inhibition of CHK2 (unknown origin) at 10 uM relative to control	B	Cn1nc(-c2cnc3[nH]cc(C(=O)N[C@@H](C(=O)N4CC(C#N)C4)C4CC4)c3n2)c2ccc(Cl)cc21		CHEMBL2376154	=	Inhibition	%	16.0	CHEMBL2527	Homo sapiens	INH	%	16.0
	13282398	CHEMBL2378495	Inhibition of CHK2 (unknown origin) at 10 uM relative to control	B	CC[C@@H](NC(=O)c1c[nH]c2ncc(-c3nn(C)c4cc(Cl)ccc34)nc12)C(=O)N1CC(C#N)C1		CHEMBL2376153	=	Inhibition	%	58.0	CHEMBL2527	Homo sapiens	INH	%	58.0
	13282399	CHEMBL2378495	Inhibition of CHK2 (unknown origin) at 10 uM relative to control	B	C[C@@H](NC(=O)c1c[nH]c2ncc(-c3nn(C)c4cc(Cl)cc(F)c34)nc12)C(=O)N1CC(C#N)C1		CHEMBL2376152	=	Inhibition	%	17.0	CHEMBL2527	Homo sapiens	INH	%	17.0
	13282400	CHEMBL2378495	Inhibition of CHK2 (unknown origin) at 10 uM relative to control	B	C[C@@H](NC(=O)c1c[nH]c2ncc(-c3nn(C)c4cc(Cl)ccc34)nc12)C(=O)N1CC(C#N)C1		CHEMBL2376144	=	Inhibition	%	1.0	CHEMBL2527	Homo sapiens	INH	%	1.0
	13282401	CHEMBL2378495	Inhibition of CHK2 (unknown origin) at 10 uM relative to control	B	C[C@@H](NC(=O)c1c[nH]c2ncc(-c3cn(C)c4cc(Cl)ccc34)nc12)C(=O)N1CC(C#N)C1		CHEMBL2376143	=	Inhibition	%	79.0	CHEMBL2527	Homo sapiens	INH	%	79.0
Active	13300201	CHEMBL2384449	Inhibition of human CHK2 at 1 uM	B	CC(C)CCNc1ccc(-c2cnc3ccc(NC4CCN(C)CC4)nn23)cn1		CHEMBL2380687		Inhibition	%		CHEMBL2527	Homo sapiens	INH		
	13301301	CHEMBL2382836	Inhibition of CHK2 (unknown origin)	B	O=C(Nc1ccc(Nc2ccnc3[nH]c(=O)c4ccccc4c23)cc1)c1ccc(F)cc1C(F)(F)F		CHEMBL2380834	=	IC50	nM	161.0	CHEMBL2527	Homo sapiens	IC50	nM	161.0
	13301302	CHEMBL2382836	Inhibition of CHK2 (unknown origin)	B	O=C(Nc1ccc(Nc2ccnc3[nH]c(=O)c4ccccc4c23)cc1)c1ccccc1		CHEMBL2380845	=	IC50	nM	41.0	CHEMBL2527	Homo sapiens	IC50	nM	41.0
	13327622	CHEMBL2389805	Inhibition of CHK2 (unknown origin) at 1 uM by kinase Glo assay	B	CC(C)(C)c1cc(NC(=O)NCc2ccc(-c3cc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)[nH]n3)cc2)no1		CHEMBL2386802	=	Inhibition	%	10.0	CHEMBL2527	Homo sapiens	INH	%	10.0
	13327623	CHEMBL2389805	Inhibition of CHK2 (unknown origin) at 1 uM by kinase Glo assay	B	Cc1cc(-c2cc(NC(=O)c3ccc(CN4CCN(C)CC4)cc3)[nH]n2)ccc1NC(=O)Nc1cc(C(C)(C)C)on1		CHEMBL2386796	=	Inhibition	%	68.0	CHEMBL2527	Homo sapiens	INH	%	68.0
	13327692	CHEMBL2389841	Inhibition of CHK2 (unknown origin) at 1 uM	B	Cc1cc(-c2cc(NC(=O)c3ccc(CN4CCN(C)CC4)cc3)[nH]n2)ccc1NC(=O)Nc1cc(C(C)(C)C)on1		CHEMBL2386796	=	Inhibition	%	37.0	CHEMBL2527	Homo sapiens	INH	%	37.0
Not Active	13328777	CHEMBL2388502	Inhibition of CHEK2 (unknown origin)	B	Cc1cccc2nc(Cn3cnc4ccccc43)cc(=O)n12		CHEMBL2386917		Inhibition	%		CHEMBL2527	Homo sapiens	INH		
Active	13358541	CHEMBL2400107	Inhibition of CHK2 (unknown origin) at 1 uM	B	CN(C)CCOc1ccc(-c2cc3c(NCCc4ccc(NC(=O)Nc5ccccc5)cc4)ncnc3o2)cc1		CHEMBL2398657		Inhibition	%		CHEMBL2527	Homo sapiens	INH		
	13375914	CHEMBL2405323	Inhibition of CHEK2 (unknown origin) at 10 uM relative to control	B	CC[C@@H]1C(=O)N(C)c2cnc(-n3ccnc3-c3ccc(F)cc3)nc2N1c1ccn(C)n1		CHEMBL2402081	=	Inhibition	%	3.0	CHEMBL2527	Homo sapiens	INH	%	3.0
	13415425	CHEMBL2424328	Inhibition of CHK2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Inhibition	%	82.0	CHEMBL2527	Homo sapiens	INH	%	82.0
	13415426	CHEMBL2424328	Inhibition of CHK2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=C(C1CCC2(CCN(c3ncnc4[nH]cnc34)CC2)NC1)N1CCOCC1		CHEMBL2420907	=	Inhibition	%	29.0	CHEMBL2527	Homo sapiens	INH	%	29.0
	13415427	CHEMBL2424328	Inhibition of CHK2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	CN(C)C(=O)C1CCC2(CCN(c3ncnc4[nH]cnc34)CC2)NC1		CHEMBL2420906	=	Inhibition	%	27.0	CHEMBL2527	Homo sapiens	INH	%	27.0
	13415428	CHEMBL2424328	Inhibition of CHK2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	CNC(=O)C1CCC2(CCN(c3ncnc4[nH]cnc34)CC2)NC1		CHEMBL2420905	=	Inhibition	%	34.0	CHEMBL2527	Homo sapiens	INH	%	34.0
	13415429	CHEMBL2424328	Inhibition of CHK2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	OCC1CCC2(CCN(c3ncnc4[nH]cnc34)CC2)NC1		CHEMBL2417586	=	Inhibition	%	56.0	CHEMBL2527	Homo sapiens	INH	%	56.0
	13415430	CHEMBL2424328	Inhibition of CHK2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=C(O)C1CCC2(CCN(c3ncnc4[nH]cnc34)CC2)NC1		CHEMBL2420904	=	Inhibition	%	2.0	CHEMBL2527	Homo sapiens	INH	%	2.0
	13415431	CHEMBL2424328	Inhibition of CHK2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	COC(=O)C1CCC2(CCN(c3ncnc4[nH]cnc34)CC2)NC1		CHEMBL2420903	=	Inhibition	%	16.0	CHEMBL2527	Homo sapiens	INH	%	16.0
	13415432	CHEMBL2424328	Inhibition of CHK2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1ccc(C2CCC3(CCN(c4ncnc5[nH]cnc45)CC3)NC2)cc1		CHEMBL2420902	=	Inhibition	%	44.0	CHEMBL2527	Homo sapiens	INH	%	44.0
	13415433	CHEMBL2424328	Inhibition of CHK2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1ccc(CC2CCC3(CCN(c4ncnc5[nH]cnc45)CC3)NC2)cc1		CHEMBL2420901	=	Inhibition	%	58.0	CHEMBL2527	Homo sapiens	INH	%	58.0
	13415434	CHEMBL2424328	Inhibition of CHK2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1ccc(CC2CCNC3(CCN(c4ncnc5[nH]cnc45)CC3)C2)cc1		CHEMBL2420900	=	Inhibition	%	98.0	CHEMBL2527	Homo sapiens	INH	%	98.0
	13415435	CHEMBL2424328	Inhibition of CHK2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1ccc(C2CCNC3(CCN(c4ncnc5[nH]cnc45)CC3)C2)cc1		CHEMBL2420899	=	Inhibition	%	75.0	CHEMBL2527	Homo sapiens	INH	%	75.0
	13415436	CHEMBL2424328	Inhibition of CHK2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=S(=O)(c1cccc2cnccc12)N1CCC2(CC1)CC(O)CCN2		CHEMBL2420898	=	Inhibition	%	50.0	CHEMBL2527	Homo sapiens	INH	%	50.0
	13415437	CHEMBL2424328	Inhibition of CHK2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	OC1CCNC2(CCN(c3ncnc4[nH]cnc34)CC2)C1		CHEMBL2420897	=	Inhibition	%	44.0	CHEMBL2527	Homo sapiens	INH	%	44.0
	13415438	CHEMBL2424328	Inhibition of CHK2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=S(=O)(c1cccc2cnccc12)N1CCC2(CCC(O)CN2)CC1		CHEMBL2420928	=	Inhibition	%	59.0	CHEMBL2527	Homo sapiens	INH	%	59.0
	13415439	CHEMBL2424328	Inhibition of CHK2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	OC1CCC2(CCN(c3ncnc4[nH]cnc34)CC2)NC1		CHEMBL2420927	=	Inhibition	%	53.0	CHEMBL2527	Homo sapiens	INH	%	53.0
	13415440	CHEMBL2424328	Inhibition of CHK2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1nc(N2CCC3(CCCOC3)CC2)c2nc[nH]c2n1		CHEMBL2420926	=	Inhibition	%	28.0	CHEMBL2527	Homo sapiens	INH	%	28.0
	13415441	CHEMBL2424328	Inhibition of CHK2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1nc(N2CCC3(CCCCO3)CC2)c2nc[nH]c2n1		CHEMBL2420925	=	Inhibition	%	47.0	CHEMBL2527	Homo sapiens	INH	%	47.0
	13415442	CHEMBL2424328	Inhibition of CHK2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1nc(N2CCC3(CCCCC3)CC2)c2nc[nH]c2n1		CHEMBL2420924	=	Inhibition	%	25.0	CHEMBL2527	Homo sapiens	INH	%	25.0
	13415443	CHEMBL2424328	Inhibition of CHK2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=S(=O)(c1cccc2cnccc12)N1CCCC12CCNCC2		CHEMBL2420923	=	Inhibition	%	12.0	CHEMBL2527	Homo sapiens	INH	%	12.0
	13415444	CHEMBL2424328	Inhibition of CHK2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=S(=O)(c1cccc2cnccc12)N1CCCC2(CCCNC2)C1		CHEMBL2420922	=	Inhibition	%	23.0	CHEMBL2527	Homo sapiens	INH	%	23.0
	13415445	CHEMBL2424328	Inhibition of CHK2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=S(=O)(c1cccc2cnccc12)N1CCCC2(CCNCC2)C1		CHEMBL2420921	=	Inhibition	%	13.0	CHEMBL2527	Homo sapiens	INH	%	13.0
	13415446	CHEMBL2424328	Inhibition of CHK2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=S(=O)(c1cccc2cnccc12)N1CCC2(CCNC2)CC1		CHEMBL2420920	=	Inhibition	%	59.0	CHEMBL2527	Homo sapiens	INH	%	59.0
	13415447	CHEMBL2424328	Inhibition of CHK2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=S(=O)(c1cccc2cnccc12)N1CCC2(CCCNC2)CC1		CHEMBL2420919	=	Inhibition	%	65.0	CHEMBL2527	Homo sapiens	INH	%	65.0
	13415448	CHEMBL2424328	Inhibition of CHK2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=S(=O)(c1cccc2cnccc12)N1CCC2(CCCN2)CC1		CHEMBL2420918	=	Inhibition	%	50.0	CHEMBL2527	Homo sapiens	INH	%	50.0
	13415449	CHEMBL2424328	Inhibition of CHK2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=S(=O)(c1cccc2cnccc12)N1CCC2(CCCCN2)CC1		CHEMBL2420917	=	Inhibition	%	26.0	CHEMBL2527	Homo sapiens	INH	%	26.0
	13415450	CHEMBL2424328	Inhibition of CHK2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	NC1(Cc2ccccc2)CCN(S(=O)(=O)c2cccc3cnccc23)CC1		CHEMBL2420916	=	Inhibition	%	8.0	CHEMBL2527	Homo sapiens	INH	%	8.0
	13415451	CHEMBL2424328	Inhibition of CHK2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1nc(N2CCCC23CCNCC3)c2nc[nH]c2n1		CHEMBL2420915	=	Inhibition	%	26.0	CHEMBL2527	Homo sapiens	INH	%	26.0
	13415452	CHEMBL2424328	Inhibition of CHK2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1nc(N2CCCC3(CCCNC3)C2)c2nc[nH]c2n1		CHEMBL2420914	=	Inhibition	%	26.0	CHEMBL2527	Homo sapiens	INH	%	26.0
	13415453	CHEMBL2424328	Inhibition of CHK2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1nc(N2CCCC3(CCNCC3)C2)c2nc[nH]c2n1		CHEMBL2420913	=	Inhibition	%	35.0	CHEMBL2527	Homo sapiens	INH	%	35.0
	13415454	CHEMBL2424328	Inhibition of CHK2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1nc(N2CCC3(CCNC3)CC2)c2nc[nH]c2n1		CHEMBL2420912	=	Inhibition	%	64.0	CHEMBL2527	Homo sapiens	INH	%	64.0
	13415455	CHEMBL2424328	Inhibition of CHK2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1nc(N2CCC3(CCCNC3)CC2)c2nc[nH]c2n1		CHEMBL2420911	=	Inhibition	%	72.0	CHEMBL2527	Homo sapiens	INH	%	72.0
	13415456	CHEMBL2424328	Inhibition of CHK2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1nc(N2CCC3(CCCN3)CC2)c2nc[nH]c2n1		CHEMBL2420910	=	Inhibition	%	81.0	CHEMBL2527	Homo sapiens	INH	%	81.0
	13415457	CHEMBL2424328	Inhibition of CHK2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1nc(N2CCC3(CCCCN3)CC2)c2nc[nH]c2n1		CHEMBL2420909	=	Inhibition	%	58.0	CHEMBL2527	Homo sapiens	INH	%	58.0
	13415458	CHEMBL2424328	Inhibition of CHK2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	NC1(Cc2ccccc2)CCN(c2ncnc3[nH]cnc23)CC1		CHEMBL2420908	=	Inhibition	%	74.0	CHEMBL2527	Homo sapiens	INH	%	74.0
	13420985	CHEMBL2424121	Inhibition of CHK2 (unknown origin) by microfluidic mobility shift assay	B	c1nc(N2CCC3(CCCNC3)CC2)c2nc[nH]c2n1		CHEMBL2420911	=	IC50	nM	13000.0	CHEMBL2527	Homo sapiens	IC50	uM	13.0
	13420986	CHEMBL2424121	Inhibition of CHK2 (unknown origin) by microfluidic mobility shift assay	B	c1nc(N2CCC3(CCCCN3)CC2)c2nc[nH]c2n1		CHEMBL2420909	=	IC50	nM	41000.0	CHEMBL2527	Homo sapiens	IC50	uM	41.0
	13438152	CHEMBL2422446	Inhibition of CHK2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(NC1(Cc2ccc(F)cc2)CC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420551	<	Inhibition	%	35.0	CHEMBL2527	Homo sapiens	INH	%	35.0
	13438153	CHEMBL2422446	Inhibition of CHK2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(NC1(c2ccc(F)cc2)CC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420555	<	Inhibition	%	35.0	CHEMBL2527	Homo sapiens	INH	%	35.0
	13438154	CHEMBL2422446	Inhibition of CHK2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(NC1(c2ccccc2)CCC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420573	<	Inhibition	%	35.0	CHEMBL2527	Homo sapiens	INH	%	35.0
	13438155	CHEMBL2422446	Inhibition of CHK2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(NC1(c2ccccc2)CC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420572	<	Inhibition	%	35.0	CHEMBL2527	Homo sapiens	INH	%	35.0
	13438156	CHEMBL2422446	Inhibition of CHK2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	CC(C)(NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420570	<	Inhibition	%	35.0	CHEMBL2527	Homo sapiens	INH	%	35.0
	13438157	CHEMBL2422446	Inhibition of CHK2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	CCC[C@@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420565	<	Inhibition	%	35.0	CHEMBL2527	Homo sapiens	INH	%	35.0
	13438158	CHEMBL2422446	Inhibition of CHK2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(N[C@H](CO)c1ccccc1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420564	<	Inhibition	%	35.0	CHEMBL2527	Homo sapiens	INH	%	35.0
	13438159	CHEMBL2422446	Inhibition of CHK2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	CC[C@@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420562	<	Inhibition	%	35.0	CHEMBL2527	Homo sapiens	INH	%	35.0
	13438160	CHEMBL2422446	Inhibition of CHK2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	C[C@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420560	<	Inhibition	%	35.0	CHEMBL2527	Homo sapiens	INH	%	35.0
	13438161	CHEMBL2422446	Inhibition of CHK2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	C[C@@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420556	<	Inhibition	%	35.0	CHEMBL2527	Homo sapiens	INH	%	35.0
	13438162	CHEMBL2422446	Inhibition of CHK2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420587	<	Inhibition	%	35.0	CHEMBL2527	Homo sapiens	INH	%	35.0
	13438163	CHEMBL2422446	Inhibition of CHK2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420585	<	Inhibition	%	35.0	CHEMBL2527	Homo sapiens	INH	%	35.0
	13438320	CHEMBL2422676	Inhibition of CHK2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(NC1(Cc2ccc(F)cc2)CC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420551	<	Inhibition	%	35.0	CHEMBL2527	Homo sapiens	INH	%	35.0
	13438321	CHEMBL2422676	Inhibition of CHK2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(NC1(c2ccc(F)cc2)CC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420555	<	Inhibition	%	35.0	CHEMBL2527	Homo sapiens	INH	%	35.0
	13438322	CHEMBL2422676	Inhibition of CHK2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(NC1(c2ccccc2)CCC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420573	<	Inhibition	%	35.0	CHEMBL2527	Homo sapiens	INH	%	35.0
	13438323	CHEMBL2422676	Inhibition of CHK2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(NC1(c2ccccc2)CC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420572	<	Inhibition	%	35.0	CHEMBL2527	Homo sapiens	INH	%	35.0
	13438324	CHEMBL2422676	Inhibition of CHK2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	CC(C)(NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420570	<	Inhibition	%	35.0	CHEMBL2527	Homo sapiens	INH	%	35.0
	13438325	CHEMBL2422676	Inhibition of CHK2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	CCC[C@@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420565	<	Inhibition	%	35.0	CHEMBL2527	Homo sapiens	INH	%	35.0
	13438326	CHEMBL2422676	Inhibition of CHK2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(N[C@H](CO)c1ccccc1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420564	=	Inhibition	%	45.6	CHEMBL2527	Homo sapiens	INH	%	45.6
	13438327	CHEMBL2422676	Inhibition of CHK2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	CC[C@@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420562	<	Inhibition	%	35.0	CHEMBL2527	Homo sapiens	INH	%	35.0
	13438328	CHEMBL2422676	Inhibition of CHK2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	C[C@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420560	<	Inhibition	%	35.0	CHEMBL2527	Homo sapiens	INH	%	35.0
	13438329	CHEMBL2422676	Inhibition of CHK2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	C[C@@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420556	=	Inhibition	%	36.9	CHEMBL2527	Homo sapiens	INH	%	36.9
	13438330	CHEMBL2422676	Inhibition of CHK2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420587	<	Inhibition	%	35.0	CHEMBL2527	Homo sapiens	INH	%	35.0
	13438331	CHEMBL2422676	Inhibition of CHK2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420585	=	Inhibition	%	35.0	CHEMBL2527	Homo sapiens	INH	%	35.0
	13440866	CHEMBL2429609	Inhibition of CHK2 (unknown origin) at 1 uM by [33P]-ATP filter-binding assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(-n3cnc4c(N)ncnc43)cc2)cc1	Outside typical range	CHEMBL2425144	=	Inhibition	%	-47.0	CHEMBL2527	Homo sapiens	INH	%	-47.0
	13443080	CHEMBL2427508	Inhibition of CHK2 (unknown origin) at 1 uM relative to control	B	COc1ccc(NC(=O)/C=C/CN(C)C)cc1Nc1ncc(Cl)c(-c2cnn3ccccc23)n1		CHEMBL2426288	>	Inhibition	%	75.0	CHEMBL2527	Homo sapiens	INH	%	75.0
	13453044	CHEMBL2429609	Inhibition of CHK2 (unknown origin) at 1 uM by [33P]-ATP filter-binding assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(-c3cccnc3)cc2)cc1	Outside typical range	CHEMBL2425156	=	Inhibition	%	-24.0	CHEMBL2527	Homo sapiens	INH	%	-24.0
	13453092	CHEMBL2429609	Inhibition of CHK2 (unknown origin) at 1 uM by [33P]-ATP filter-binding assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(-n3cnc(C)c3)cc2)cc1	Outside typical range	CHEMBL2425145	=	Inhibition	%	-13.0	CHEMBL2527	Homo sapiens	INH	%	-13.0
	13465478	CHEMBL2434230	Inhibition of human CHK2 assessed as residual activity at 1 uM relative to control	B	CCCC(=O)Nc1n[nH]c2ncc(-c3cccnc3)cc12		CHEMBL407002	=	Activity	%	96.0	CHEMBL2527	Homo sapiens	Activity	%	96.0
	13465504	CHEMBL2434779	Inhibition of human CHK2 assessed as residual activity at 10 uM relative to control	B	CCCC(=O)Nc1n[nH]c2ncc(-c3cccnc3)cc12		CHEMBL407002	=	Activity	%	96.0	CHEMBL2527	Homo sapiens	Activity	%	96.0
	13465528	CHEMBL2434203	Inhibition of human CHK2 assessed as residual activity at 25 uM relative to control	B	COc1cc(OC)c(C=C2C(=O)Nc3ccccc32)c(OC)c1		CHEMBL576349	=	Activity	%	76.0	CHEMBL2527	Homo sapiens	Activity	%	76.0
	13465551	CHEMBL2434779	Inhibition of human CHK2 assessed as residual activity at 10 uM relative to control	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Activity	%	92.0	CHEMBL2527	Homo sapiens	Activity	%	92.0
	13466479	CHEMBL2434230	Inhibition of human CHK2 assessed as residual activity at 1 uM relative to control	B	CC(=O)Nc1nccc(-c2c(-c3ccccc3)noc2C)n1		CHEMBL2430324	=	Activity	%	89.45	CHEMBL2527	Homo sapiens	Activity	%	89.45
	13466506	CHEMBL2434779	Inhibition of human CHK2 assessed as residual activity at 10 uM relative to control	B	CC(=O)Nc1nccc(-c2c(-c3ccccc3)noc2C)n1		CHEMBL2430324	=	Activity	%	78.79	CHEMBL2527	Homo sapiens	Activity	%	78.79
	13466533	CHEMBL2434230	Inhibition of human CHK2 assessed as residual activity at 1 uM relative to control	B	CC(=O)Nc1cccc(-c2cnc3[nH]nc(C)c3c2)c1		CHEMBL2430323	=	Activity	%	68.5	CHEMBL2527	Homo sapiens	Activity	%	68.5
	13466560	CHEMBL2434779	Inhibition of human CHK2 assessed as residual activity at 10 uM relative to control	B	CC(=O)Nc1cccc(-c2cnc3[nH]nc(C)c3c2)c1		CHEMBL2430323	=	Activity	%	28.92	CHEMBL2527	Homo sapiens	Activity	%	28.92
Active	13466849	CHEMBL2432708	Reduction in CHK2 phosphorylation at Thr68 in human PC3 cells at IC50 after 12 to 48 hrs by Western blotting analysis	B	CC1=C(CO)C(=O)O[C@H]([C@@H](C)[C@H]2CC[C@H]3[C@@H]4C[C@H]5O[C@]56[C@@H](O)C=CC(=O)[C@]6(C)[C@H]4CC[C@@]32C)C1		CHEMBL1221986		Activity			CHEMBL2527	Homo sapiens	Activity		
Active	13488452	CHEMBL2439438	Inhibition of human CHK2 at 1 uM	B	c1ccc(-n2cc(-c3cnc4ccc(NC5CCNCC5)nn34)cn2)cc1		CHEMBL2436454		Inhibition	%		CHEMBL2527	Homo sapiens	INH		
	13872184	CHEMBL3101936	Inhibition of human CHK2 assessed as residual activity at 1 uM relative to control	B	O=C1Nc2ncccc2/C1=C1/Nc2ncccc2C1=O		CHEMBL3099673	=	Activity	%	120.0	CHEMBL2527	Homo sapiens	Activity	%	120.0
	13872231	CHEMBL3102537	Inhibition of CHK2 (unknown origin) assessed as residual activity at 10 uM relative to control	B	O=C1Nc2ncccc2/C1=C1/Nc2ncccc2C1=O		CHEMBL3099673	=	Activity	%	84.0	CHEMBL2527	Homo sapiens	Activity	%	84.0
	13872261	CHEMBL3100337	Inhibition of CHK2 (unknown origin) assessed as residual activity at 1 uM relative to control	B	O=C1Nc2ncccc2/C1=C1/Nc2ncccc2C1=O		CHEMBL3099673	=	Activity	%	89.0	CHEMBL2527	Homo sapiens	Activity	%	89.0
	13966026	CHEMBL3136514	Inhibition of human full length CHK2 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 1000 uM after 90 mins by microfluidic peptide phosphorylation assay	B	c1cnc2[nH]ccc2c1		CHEMBL389685	=	Inhibition	%	74.0	CHEMBL2527	Homo sapiens	INH	%	74.0
	13973301	CHEMBL3136894	Inhibition of human full length CHK2 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.1 uM after 90 mins by microfluidic peptide phosphorylation assay	B	C[C@H](CN(C)C)Oc1nc(Nc2cc3cccc(Cl)c3cn2)cnc1C#N		CHEMBL1928705	=	Inhibition	%	0.0	CHEMBL2527	Homo sapiens	INH	%	0.0
	13974019	CHEMBL3136483	Inhibition of human full length CHK2 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.35 uM after 90 mins by microfluidic peptide phosphorylation assay	B	COC(=O)c1cnc(Nc2cnc(C#N)cn2)cc1NCC1CCNCC1		CHEMBL1928692	=	Inhibition	%	0.0	CHEMBL2527	Homo sapiens	INH	%	0.0
	13974110	CHEMBL3135621	Inhibition of human full length CHK2 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 9 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCC1CN(c2ncnc3[nH]c4cnccc4c23)CCO1		CHEMBL1928677	=	Inhibition	%	49.0	CHEMBL2527	Homo sapiens	INH	%	49.0
	13974201	CHEMBL3134733	Inhibition of human full length CHK2 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 90 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCC1CN(c2ncnc3[nH]cnc23)CCO1		CHEMBL560373	=	Inhibition	%	52.5	CHEMBL2527	Homo sapiens	INH	%	52.5
	13974292	CHEMBL3136844	Inhibition of human full length CHK2 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 420 uM after 90 mins by microfluidic peptide phosphorylation assay	B	c1nc(N2CCOCC2)c2nc[nH]c2n1		CHEMBL271138	=	Inhibition	%	85.0	CHEMBL2527	Homo sapiens	INH	%	85.0
	13975030	CHEMBL3135990	Inhibition of human full length CHK2 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.02 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NC1(C(=O)NCc2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL598194	=	Inhibition	%	0.5	CHEMBL2527	Homo sapiens	INH	%	0.5
	13975121	CHEMBL3135717	Inhibition of human full length CHK2 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.06 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NC1(Cc2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL263664	=	Inhibition	%	0.0	CHEMBL2527	Homo sapiens	INH	%	0.0
	13975212	CHEMBL3135801	Inhibition of human full length CHK2 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 2 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NC1CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL259141	=	Inhibition	%	0.0	CHEMBL2527	Homo sapiens	INH	%	0.0
	13975855	CHEMBL3135470	Inhibition of human full length CHK2 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 8 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCC1CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL261249	=	Inhibition	%	0.0	CHEMBL2527	Homo sapiens	INH	%	0.0
	13975948	CHEMBL3137002	Inhibition of human full length CHK2 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.2 uM after 90 mins by microfluidic peptide phosphorylation assay	B	Clc1ccc(C2(c3ccc(-c4ncnc5[nH]cnc45)cc3)CCNCC2)cc1		CHEMBL228133	=	Inhibition	%	59.0	CHEMBL2527	Homo sapiens	INH	%	59.0
	13976039	CHEMBL3135395	Inhibition of human full length CHK2 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 95 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCCc1ccc(-c2ncnc3[nH]cnc23)cc1		CHEMBL227727	=	Inhibition	%	74.0	CHEMBL2527	Homo sapiens	INH	%	74.0
	13976130	CHEMBL3136920	Inhibition of human full length CHK2 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 70 uM after 90 mins by microfluidic peptide phosphorylation assay	B	CNCc1ccc(-c2ncnc3[nH]cnc23)cc1		CHEMBL376388	=	Inhibition	%	57.5	CHEMBL2527	Homo sapiens	INH	%	57.5
	14582462	CHEMBL3240422	Inhibition of human CHK2 assessed as enzyme activity at 1 uM relative to control	B	CCCS(=O)(=O)Nc1cccc(Nc2ccc3ncn(C)c(=O)c3c2)c1C#N		CHEMBL3236464	=	Activity	%	100.5	CHEMBL2527	Homo sapiens	Activity	%	100.5
	14648098	CHEMBL3267006	Inhibition of human CHK2 at 1 uM relative to control	B	CC(C)CCNc1ccc(-c2cnc3ccc(NC4CCN(C)CC4)nn23)cn1		CHEMBL2380687	=	Inhibition	%	50.0	CHEMBL2527	Homo sapiens	INH	%	50.0
	14648099	CHEMBL3267006	Inhibition of human CHK2 at 1 uM relative to control	B	N[C@H]1CC[C@H](Nc2ccc3ncc(-c4cnc(Nc5ncccc5F)nc4)n3n2)CC1		CHEMBL3264059	<	Inhibition	%	50.0	CHEMBL2527	Homo sapiens	INH	%	50.0
	14666340	CHEMBL3270458	Inhibition of CHK2 (unknown origin) assessed as [33P] incorporation in substrate by TopCount microplate scintillation counting analysis	B	COc1ccc(Oc2cc(C)c(-c3csc(NC(=O)c4ccnc(F)c4)n3)c(C)c2)cc1		CHEMBL3263869	>	IC50	nM	10000.0	CHEMBL2527	Homo sapiens	IC50	uM	10.0
	14979416	CHEMBL3372982	Inhibition of CHK2 (unknown origin) in presence of 1 mM ATP	B	CN(Cc1ccccc1)C(=O)c1ccc(S(=O)(=O)Nc2ccccc2)cc1		CHEMBL3355482	>	IC50	nM	100000.0	CHEMBL2527	Homo sapiens	IC50	uM	100.0
	14984387	CHEMBL3384988	Inhibition of CHK2 (unknown origin) at 1 uM	B	CN1CCN(c2ccc(-c3cnc4[nH]c5cnc(C#N)cc5c4c3)cc2)CC1		CHEMBL3359895	=	Inhibition	%	17.0	CHEMBL2527	Homo sapiens	INH	%	17.0
	14984453	CHEMBL3381894	Inhibition of CHK2 (unknown origin) at 0.1 uM	B	CN1CCN(c2ccc(-c3cnc4[nH]c5cnc(C#N)cc5c4c3)cc2)CC1		CHEMBL3359895	=	Inhibition	%	-1.0	CHEMBL2527	Homo sapiens	INH	%	-1.0
	15007938	CHEMBL3367530	Inhibition of CHK2 (unknown origin) by FRET-based homogenous assay	B	CCc1cccc(CC)c1NC(=O)Nc1ccc2[nH]nc(-c3cccc(S(N)(=O)=O)c3)c2c1		CHEMBL3330260	=	IC50	nM	410.0	CHEMBL2527	Homo sapiens	IC50	uM	0.41
	15007939	CHEMBL3367530	Inhibition of CHK2 (unknown origin) by FRET-based homogenous assay	B	NS(=O)(=O)c1cccc(-c2n[nH]c3ccc(NC(=O)C(c4ccsc4)N4CCCC4)cc23)c1		CHEMBL3330410	=	IC50	nM	100.0	CHEMBL2527	Homo sapiens	IC50	uM	0.1
	15007940	CHEMBL3367530	Inhibition of CHK2 (unknown origin) by FRET-based homogenous assay	B	CCc1ccccc1C(C(=O)Nc1ccc2[nH]nc(-c3cccc(S(N)(=O)=O)c3)c2c1)N(C)C		CHEMBL3330409	=	IC50	nM	420.0	CHEMBL2527	Homo sapiens	IC50	uM	0.42
	15007994	CHEMBL3367993	Inhibition of human CHK2 at 1 uM by radiometric Assay	B	NS(=O)(=O)c1cccc(-c2n[nH]c3ccc(NC(=O)Cc4ccccc4)cc23)c1		CHEMBL3330255	=	Inhibition	%	98.0	CHEMBL2527	Homo sapiens	INH	%	98.0
	15007995	CHEMBL3367993	Inhibition of human CHK2 at 1 uM by radiometric Assay	B	COC(C(=O)Nc1ccc2[nH]nc(-c3cccc(S(N)(=O)=O)c3)c2c1)c1ccccc1		CHEMBL3330401	=	Inhibition	%	93.0	CHEMBL2527	Homo sapiens	INH	%	93.0
	15007996	CHEMBL3367993	Inhibition of human CHK2 at 1 uM by radiometric Assay	B	NS(=O)(=O)c1cccc(-c2n[nH]c3ccc(NC(=O)C(c4ccsc4)N4CCCC4)cc23)c1		CHEMBL3330410	=	Inhibition	%	93.0	CHEMBL2527	Homo sapiens	INH	%	93.0
	15018562	CHEMBL3361876	Inhibition of CHK2 (unknown origin) at 100 nM	B	O=C(N[C@H](CO)c1ccc(Cl)c(F)c1)N1CCc2cnc(NC3CCOCC3)nc2C1		CHEMBL3298678	=	Inhibition	%	4.3	CHEMBL2527	Homo sapiens	INH	%	4.3
	15019152	CHEMBL3364354	Inhibition of CHK2 (unknown origin) at 1 uM in presence of 100 uM ATP	B	C=CC(=O)[C@H](Cc1ccccc1)NC(=O)OC(C)(C)C		CHEMBL3298512	=	Inhibition	%	46.0	CHEMBL2527	Homo sapiens	INH	%	46.0
Not Active	15062591	CHEMBL3370525	Inhibition of human CHK2 by Off-chip mobility shift assay	B	O=C(Cc1c(F)cccc1Cl)Nc1onc(-c2ccc(F)cc2)c1-c1ccncn1		CHEMBL3310142		Inhibition	%		CHEMBL2527	Homo sapiens	INH		
	15072456	CHEMBL3380118	Inhibition of CHK2 (unknown origin) assessed as remaining enzyme activity at 10 uM by radioactive [33P]-ATP filter binding assay	B	Cc1ccc(-c2cc(C(=O)Nc3ccnc(Cl)c3)nn2-c2ccc3ccccc3n2)cc1		CHEMBL3338802	=	Activity	%	94.0	CHEMBL2527	Homo sapiens	Activity	%	94.0
	15073012	CHEMBL3389030	Inhibition of CHK2 (unknown origin) at 1 uM relative to control	B	COc1ccc(NC(=O)/C=C/CN(C)C)cc1Nc1ncc(Cl)c(-c2cnn3ccccc23)n1		CHEMBL2426288	=	Inhibition	%	90.0	CHEMBL2527	Homo sapiens	INH	%	90.0
	15091102	CHEMBL3390663	Inhibition of human recombinant CHK2 expressed insect cells using CREBtide (CKRREILSRRPSYRK) substrate assessed as remaining enzyme activity at 1 uM after 15 mins relative to control	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Br)c(O)c(Br)c1		CHEMBL2206014	=	Activity	%	87.0	CHEMBL2527	Homo sapiens	Activity	%	87.0
	15191075	CHEMBL3413717	Inhibition of CHK2 (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	N#Cc1c(-c2ccccc2)cc(-c2ccccc2)nc1NC(=S)Nc1ccccc1		CHEMBL3408381	=	Inhibition	%	33.0	CHEMBL2527	Homo sapiens	INH	%	33.0
	15191076	CHEMBL3413717	Inhibition of CHK2 (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	N#Cc1c(-c2ccccc2)cc(-c2ccccc2)nc1/N=c1\sc(-c2ccccc2)nn1-c1ccccc1		CHEMBL3408382	=	Inhibition	%	17.0	CHEMBL2527	Homo sapiens	INH	%	17.0
	15191077	CHEMBL3413717	Inhibition of CHK2 (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	CC(=O)c1nn(-c2ccccc2)/c(=N/c2nc(-c3ccccc3)cc(-c3ccccc3)c2C#N)s1		CHEMBL3408383	=	Inhibition	%	3.0	CHEMBL2527	Homo sapiens	INH	%	3.0
	15191078	CHEMBL3413717	Inhibition of CHK2 (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	CC(=O)c1nn(-c2ccc(C)cc2)/c(=N/c2nc(-c3ccccc3)cc(-c3ccccc3)c2C#N)s1		CHEMBL3408384	=	Inhibition	%	2.0	CHEMBL2527	Homo sapiens	INH	%	2.0
	15191079	CHEMBL3413717	Inhibition of CHK2 (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	COc1ccc(-n2nc(C(C)=O)s/c2=N\c2nc(-c3ccccc3)cc(-c3ccccc3)c2C#N)cc1		CHEMBL3408385	=	Inhibition	%	3.0	CHEMBL2527	Homo sapiens	INH	%	3.0
	15191080	CHEMBL3413717	Inhibition of CHK2 (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	CC(=O)c1nn(-c2ccc(Cl)cc2)/c(=N/c2nc(-c3ccccc3)cc(-c3ccccc3)c2C#N)s1		CHEMBL3408386	=	Inhibition	%	4.0	CHEMBL2527	Homo sapiens	INH	%	4.0
	15191081	CHEMBL3413717	Inhibition of CHK2 (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	CCOC(=O)c1nn(-c2ccccc2)/c(=N/c2nc(-c3ccccc3)cc(-c3ccccc3)c2C#N)s1		CHEMBL3408387	=	Inhibition	%	5.0	CHEMBL2527	Homo sapiens	INH	%	5.0
	15191082	CHEMBL3413717	Inhibition of CHK2 (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	CCOC(=O)c1nn(-c2ccc(C)cc2)/c(=N/c2nc(-c3ccccc3)cc(-c3ccccc3)c2C#N)s1		CHEMBL3408388	=	Inhibition	%	6.0	CHEMBL2527	Homo sapiens	INH	%	6.0
	15191083	CHEMBL3413717	Inhibition of CHK2 (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	CCOC(=O)c1nn(-c2ccc(Cl)cc2)/c(=N/c2nc(-c3ccccc3)cc(-c3ccccc3)c2C#N)s1		CHEMBL3408389	=	Inhibition	%	7.0	CHEMBL2527	Homo sapiens	INH	%	7.0
	15191084	CHEMBL3413717	Inhibition of CHK2 (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	N#Cc1c(-c2ccccc2)cc(-c2ccccc2)nc1/N=c1\sc(C(=O)Nc2ccccc2)nn1-c1ccccc1		CHEMBL3408390	=	Inhibition	%	8.0	CHEMBL2527	Homo sapiens	INH	%	8.0
	15191085	CHEMBL3413717	Inhibition of CHK2 (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	N#Cc1c(-c2ccccc2)cc(-c2ccccc2)nc1/N=C1\SCC(=O)N1c1ccccc1		CHEMBL3408391	=	Inhibition	%	1.0	CHEMBL2527	Homo sapiens	INH	%	1.0
	15191086	CHEMBL3413717	Inhibition of CHK2 (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	N#Cc1c(-c2ccccc2)cc(-c2ccccc2)nc1/N=c1\scc(-c2ccccc2)n1-c1ccccc1		CHEMBL3408392	=	Inhibition	%	0.0	CHEMBL2527	Homo sapiens	INH	%	0.0
	15191087	CHEMBL3413717	Inhibition of CHK2 (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	N#Cc1c(-c2ccccc2)cc(-c2ccccc2)nc1/N=C1\S/C(=C2\SC(c3ccccc3)=NN2c2ccccc2)C(=O)N1c1ccccc1		CHEMBL3408393	=	Inhibition	%	5.0	CHEMBL2527	Homo sapiens	INH	%	5.0
	15191088	CHEMBL3413717	Inhibition of CHK2 (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	CC(=O)C1=NN(c2ccccc2)/C(=C2/S/C(=N\c3nc(-c4ccccc4)cc(-c4ccccc4)c3C#N)N(c3ccccc3)C2=O)S1		CHEMBL3408394	=	Inhibition	%	1.0	CHEMBL2527	Homo sapiens	INH	%	1.0
	15191089	CHEMBL3413717	Inhibition of CHK2 (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	CCOC(=O)C1=NN(c2ccccc2)/C(=C2/S/C(=N\c3nc(-c4ccccc4)cc(-c4ccccc4)c3C#N)N(c3ccccc3)C2=O)S1		CHEMBL3408395	=	Inhibition	%	0.0	CHEMBL2527	Homo sapiens	INH	%	0.0
	15191090	CHEMBL3413717	Inhibition of CHK2 (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	N#Cc1c(-c2ccccc2)cc(-c2ccccc2)nc1/N=C1\S/C(=C2\SC(C(=O)Nc3ccccc3)=NN2c2ccccc2)C(=O)N1c1ccccc1		CHEMBL3408396	=	Inhibition	%	8.0	CHEMBL2527	Homo sapiens	INH	%	8.0
	15220928	CHEMBL3418523	Inhibition of CHK2 (unknown origin)	B	NC(=O)c1ncc(N[C@@H]2CCCC[C@@H]2N)cc1-c1nc2ccccc2[nH]1		CHEMBL3415608	=	IC50	nM	160.0	CHEMBL2527	Homo sapiens	IC50	nM	160.0
	15251875	CHEMBL3427827	Inhibition of CHK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL443738	=	Activity	%	28.0	CHEMBL2527	Homo sapiens	Activity	%	28.0
	15251922	CHEMBL3427827	Inhibition of CHK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL3427170	=	Activity	%	34.0	CHEMBL2527	Homo sapiens	Activity	%	34.0
	15252024	CHEMBL3427827	Inhibition of CHK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL3427171	=	Activity	%	32.0	CHEMBL2527	Homo sapiens	Activity	%	32.0
	15252669	CHEMBL3427827	Inhibition of CHK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL3427172	=	Activity	%	56.0	CHEMBL2527	Homo sapiens	Activity	%	56.0
	15252771	CHEMBL3427827	Inhibition of CHK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@@H](C(=O)O)CS3)sc2c1		CHEMBL3427173	=	Activity	%	60.0	CHEMBL2527	Homo sapiens	Activity	%	60.0
	15252873	CHEMBL3427827	Inhibition of CHK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@H](C(=O)O)CS3)sc2c1		CHEMBL3427174	=	Activity	%	63.0	CHEMBL2527	Homo sapiens	Activity	%	63.0
	15253547	CHEMBL3427827	Inhibition of CHK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@H]1CSC(c2nc3ccc(OC)cc3s2)=N1		CHEMBL3427175	=	Activity	%	81.0	CHEMBL2527	Homo sapiens	Activity	%	81.0
	15253649	CHEMBL3427827	Inhibition of CHK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@@H]1CSC(c2nc3ccc(OC)cc3s2)=N1		CHEMBL3427176	=	Activity	%	71.0	CHEMBL2527	Homo sapiens	Activity	%	71.0
	15253751	CHEMBL3427827	Inhibition of CHK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@@H](C(=O)O)C(C)(C)S3)sc2c1		CHEMBL3427177	=	Activity	%	55.0	CHEMBL2527	Homo sapiens	Activity	%	55.0
	15254417	CHEMBL3427827	Inhibition of CHK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@H](C(=O)O)C(C)(C)S3)sc2c1		CHEMBL3427178	=	Activity	%	37.0	CHEMBL2527	Homo sapiens	Activity	%	37.0
	15254519	CHEMBL3427827	Inhibition of CHK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	CC1(C)SC(c2nc3ccc(O)cc3s2)=N[C@H]1C(=O)O		CHEMBL3427179	=	Activity	%	81.0	CHEMBL2527	Homo sapiens	Activity	%	81.0
	15254621	CHEMBL3427827	Inhibition of CHK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	CC1(C)SC(c2nc3ccc(O)cc3s2)=N[C@@H]1C(=O)O		CHEMBL3427180	=	Activity	%	56.0	CHEMBL2527	Homo sapiens	Activity	%	56.0
	15255312	CHEMBL3427827	Inhibition of CHK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@H]1CSC(c2ccc3cc(O)ccc3n2)=N1		CHEMBL3427181	=	Activity	%	62.0	CHEMBL2527	Homo sapiens	Activity	%	62.0
	15255414	CHEMBL3427827	Inhibition of CHK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@@H]1CSC(c2ccc3cc(O)ccc3n2)=N1		CHEMBL3427182	=	Activity	%	78.0	CHEMBL2527	Homo sapiens	Activity	%	78.0
	15255517	CHEMBL3427827	Inhibition of CHK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@H]1CSC(c2ccc3cccc(O)c3n2)=N1		CHEMBL3427183	=	Activity	%	75.0	CHEMBL2527	Homo sapiens	Activity	%	75.0
	15256248	CHEMBL3427827	Inhibition of CHK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@@H]1CSC(c2ccc3cccc(O)c3n2)=N1		CHEMBL3427184	=	Activity	%	77.0	CHEMBL2527	Homo sapiens	Activity	%	77.0
	15258342	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Thermal melting change	degrees C	10.3	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	10.3
	15258402	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Thermal melting change	degrees C	0.4	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	0.4
	15258462	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Thermal melting change	degrees C	0.1	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	0.1
	15258522	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Thermal melting change	degrees C	5.7	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	5.7
	15258582	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Thermal melting change	degrees C	1.7	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	1.7
	15258642	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Thermal melting change	degrees C	3.2	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	3.2
	15258702	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Thermal melting change	degrees C	1.5	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	1.5
	15258762	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	O=C(O)Cc1ccc(O)c([N+](=O)[O-])c1		CHEMBL501822	=	Thermal melting change	degrees C	-0.8	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	-0.8
	15258822	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	NS(=O)(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL319467	=	Thermal melting change	degrees C	2.5	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	2.5
	15258882	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Thermal melting change	degrees C	6.6	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	6.6
	15258942	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	CS(=O)(=O)O.Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL1642	=	Thermal melting change	degrees C	-1.1	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	-1.1
	15259002	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Thermal melting change	degrees C	5.2	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	5.2
	15259062	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Thermal melting change	degrees C	8.2	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	8.2
	15259122	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL216543	=	Thermal melting change	degrees C	4.9	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	4.9
	15259182	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Thermal melting change	degrees C	8.6	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	8.6
	15259242	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	Cn1cc(/C=C2/C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL3430785	=	Thermal melting change	degrees C	10.6	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	10.6
	15259302	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B			CHEMBL3430786	=	Thermal melting change	degrees C	-2.0	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	-2.0
	15259362	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	CCOc1ccc(/C=C2/SC(=O)N(CCN)C2=O)cc1		CHEMBL262615	=	Thermal melting change	degrees C	0.7	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	0.7
	15259422	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	O=c1c(-c2ccc(F)cc2)c(-c2ccncc2)[nH]n1-c1ccc(Cl)cc1		CHEMBL408678	=	Thermal melting change	degrees C	0.3	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	0.3
	15259482	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Thermal melting change	degrees C	0.7	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	0.7
	15259542	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Thermal melting change	degrees C	0.1	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	0.1
	15259602	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	COc1nccc(-c2c(-c3ccc(F)cc3)ncn2[C@H]2CC[C@H](O)CC2)n1		CHEMBL97162	=	Thermal melting change	degrees C	1.2	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	1.2
	15259662	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	=	Thermal melting change	degrees C	3.5	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	3.5
	15259722	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Thermal melting change	degrees C	12.9	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	12.9
	15259782	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	CCCNC(=O)Nc1ccc(Oc2ncnc3cc(OC)c(OC)cc23)cc1Cl		CHEMBL406381	=	Thermal melting change	degrees C	2.4	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	2.4
	15259842	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Thermal melting change	degrees C	7.3	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	7.3
	15259902	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Thermal melting change	degrees C	0.1	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	0.1
	15259962	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	Cl.NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL558969	=	Thermal melting change	degrees C	6.6	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	6.6
	15260022	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)c(C)c1C(=O)N1CCN(C)CC1		CHEMBL261641	=	Thermal melting change	degrees C	2.9	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	2.9
	15260082	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Thermal melting change	degrees C	0.9	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	0.9
	15260142	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Thermal melting change	degrees C	-0.1	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	-0.1
	15260202	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B			CHEMBL3430787	=	Thermal melting change	degrees C	1.9	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	1.9
	15260262	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Thermal melting change	degrees C	2.4	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	2.4
	15260322	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	CN(c1cccnc1)c1cc2c(Nc3ccc(F)c(Cl)c3)c(C#N)cnc2cn1		CHEMBL261238	=	Thermal melting change	degrees C	5.0	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	5.0
	15260382	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Thermal melting change	degrees C	3.6	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	3.6
	15260442	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Thermal melting change	degrees C	-1.8	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	-1.8
	15260502	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	Cc1nc(N)sc1-c1ccnc(Nc2cccc([N+](=O)[O-])c2)n1		CHEMBL298445	=	Thermal melting change	degrees C	9.7	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	9.7
	15260562	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Thermal melting change	degrees C	3.8	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	3.8
	15260622	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B			CHEMBL3430788	=	Thermal melting change	degrees C	5.3	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	5.3
	15260682	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Thermal melting change	degrees C	7.5	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	7.5
	15260742	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Thermal melting change	degrees C	2.4	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	2.4
	15260802	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	CN1CCc2[nH]c(=S)c(C#N)c(-c3cccs3)c2C1		CHEMBL261211	=	Thermal melting change	degrees C	5.3	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	5.3
	15260862	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(O)c1c(F)cccc1F		CHEMBL259605	=	Thermal melting change	degrees C	5.5	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	5.5
	15260922	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Thermal melting change	degrees C	1.2	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	1.2
	15260982	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	=	Thermal melting change	degrees C	0.2	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	0.2
	15261042	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	CN1CCC(Nc2ncc3ncnc(Nc4ccc(F)c(Cl)c4)c3n2)CC1		CHEMBL258940	=	Thermal melting change	degrees C	0.2	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	0.2
	15261102	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	=	Thermal melting change	degrees C	3.1	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	3.1
	15261185	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Thermal melting change	degrees C	-0.4	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	-0.4
	15261245	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	Brc1c(Br)c(Br)c2[nH]nnc2c1Br		CHEMBL177820	=	Thermal melting change	degrees C	0.5	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	0.5
	15261305	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	Nc1cc2ncnc(Nc3cccc(Br)c3)c2cc1N		CHEMBL328216	=	Thermal melting change	degrees C	1.8	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	1.8
	15261365	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Thermal melting change	degrees C	2.6	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	2.6
	15261420	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	NC1=N/C(=C2/CCNC(=O)c3[nH]ccc32)C(=O)N1		CHEMBL255465	=	Thermal melting change	degrees C	1.7	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	1.7
	15261480	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	COc1cc(C[C@H]2C(=O)OC[C@@H]2Cc2ccc(OC)c(OC)c2)ccc1O		CHEMBL435734	=	Thermal melting change	degrees C	-0.3	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	-0.3
	15261540	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	O=C1C=C2C(=Nc3c2c2c(c4c3=NC3=C4CCC=C3)C=NC=2)CC1		CHEMBL408953	=	Thermal melting change	degrees C	7.9	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	7.9
	15261600	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC.[Cl-]		CHEMBL258893	=	Thermal melting change	degrees C	-3.9	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	-3.9
	15261673	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	COc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OC		CHEMBL29197	=	Thermal melting change	degrees C	2.0	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	2.0
	15261733	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	C[S+]([O-])c1ccc(CSc2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL111456	=	Thermal melting change	degrees C	-0.4	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	-0.4
	15261793	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	O=c1cc(-c2ccc(O)cc2)oc2cc(O)cc(O)c12		CHEMBL28	=	Thermal melting change	degrees C	2.7	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	2.7
	15261853	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	O=c1c(-c2ccc(O)cc2)coc2cc(O)cc(O)c12		CHEMBL44	=	Thermal melting change	degrees C	1.6	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	1.6
	15261909	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Thermal melting change	degrees C	-0.4	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	-0.4
	15261969	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	CC(C)c1cc(/C=C(\C#N)C(=O)NCCCc2ccccc2)cc(C(C)C)c1O		CHEMBL261508	=	Thermal melting change	degrees C	-0.1	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	-0.1
	15262029	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Thermal melting change	degrees C	-0.3	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	-0.3
	15262089	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B			CHEMBL3430782	=	Thermal melting change	degrees C	3.5	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	3.5
	15262162	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	CC(C)(C)n1nc(-c2cccc3ccccc23)c2c(N)ncnc21		CHEMBL264406	=	Thermal melting change	degrees C	0.3	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	0.3
	15262222	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	CC(C)(C)n1nc(-c2ccc(Cl)cc2)c2c(N)ncnc21		CHEMBL406845	=	Thermal melting change	degrees C	0.4	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	0.4
	15262282	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	Nc1ncnc2c1c(I)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL99203	=	Thermal melting change	degrees C	0.9	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	0.9
	15262342	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	O=C(O)c1cc(NCc2cc(O)ccc2O)ccc1O		CHEMBL319620	=	Thermal melting change	degrees C	0.0	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	0.0
	15262402	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	OC[C@H]1O[C@@H](n2cnc3cc(Cl)c(Cl)cc32)[C@H](O)[C@@H]1O		CHEMBL375530	=	Thermal melting change	degrees C	0.2	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	0.2
	15262462	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	O=C(O)c1cc(N(Cc2ccccc2O)Cc2cc(O)ccc2O)ccc1O		CHEMBL103552	=	Thermal melting change	degrees C	0.8	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	0.8
	15262522	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	O=C1Nc2ccc(I)cc2/C1=C\c1cc(Br)c(O)c(Br)c1		CHEMBL264949	=	Thermal melting change	degrees C	0.1	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	0.1
	15262582	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Thermal melting change	degrees C	0.5	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	0.5
	15262642	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	CN(C)c1ncnc2nc[nH]c12		CHEMBL407391	=	Thermal melting change	degrees C	0.5	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	0.5
	15262702	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	Cc1ccc2c(c1)C(=O)c1cc(O)cc(O)c1C2=O		CHEMBL405992	=	Thermal melting change	degrees C	0.4	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	0.4
	15262762	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	O=c1ccc2ccc(O)c(O)c2o1		CHEMBL244948	=	Thermal melting change	degrees C	-0.1	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	-0.1
	15262822	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	COc1cc(O)c2c(c1)oc(=O)c1c3cc(O)c(O)cc3oc21		CHEMBL97453	=	Thermal melting change	degrees C	1.8	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	1.8
	15262882	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Thermal melting change	degrees C	5.7	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	5.7
	15262942	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Thermal melting change	degrees C	3.9	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	3.9
	15263002	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Thermal melting change	degrees C	6.1	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	6.1
	15263062	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Thermal melting change	degrees C	7.8	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	7.8
	15263122	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	N#CC(C#N)=Cc1ccc(O)c(O)c1		CHEMBL76904	=	Thermal melting change	degrees C	0.7	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	0.7
	15263182	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Thermal melting change	degrees C	0.4	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	0.4
	15263242	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)Nc1ccccc1		CHEMBL56731	=	Thermal melting change	degrees C	0.1	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	0.1
	15263302	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	CCOc1cc(/C=C(\C#N)C(N)=O)cc(CSc2ccccc2)c1O		CHEMBL485070	=	Thermal melting change	degrees C	0.0	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	0.0
	15263362	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	C/C(O)=C(\C#N)C(=O)Nc1cc(Br)ccc1Br		CHEMBL228043	=	Thermal melting change	degrees C	0.5	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	0.5
	15263398	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Thermal melting change	degrees C	2.3	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	2.3
	15263458	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Thermal melting change	degrees C	-0.7	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	-0.7
	15263513	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	O=C1c2ccccc2-c2n[nH]c3cccc1c23		CHEMBL7064	=	Thermal melting change	degrees C	6.0	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	6.0
	15263573	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B			CHEMBL3430783	=	Thermal melting change	degrees C	0.6	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	0.6
	15263633	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	Cc1nc2sccn2c(=O)c1CCN1CCC(=C(c2ccccc2)c2ccc(F)cc2)CC1		CHEMBL259388	=	Thermal melting change	degrees C	0.4	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	0.4
	15263693	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	Cc1c2ccncc2c(C)c2c1[nH]c1ccccc12		CHEMBL123	=	Thermal melting change	degrees C	2.0	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	2.0
	15263767	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	Cc1cncc2cccc(S(=O)(=O)N3CCCNC[C@@H]3C)c12		CHEMBL406821	=	Thermal melting change	degrees C	1.5	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	1.5
	15263827	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Thermal melting change	degrees C	0.7	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	0.7
	15263887	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	CN(C)c1ccc(CC2C(=O)Nc3ccccc32)cc1		CHEMBL1373282	=	Thermal melting change	degrees C	0.7	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	0.7
	15263947	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	O=C1Nc2ccccc2/C1=C/c1cc2c([nH]1)CCC(Br)C2		CHEMBL408565	=	Thermal melting change	degrees C	0.5	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	0.5
	15264001	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	CCOC(=O)c1cnc2oc3ccc(O)cc3c2c1-c1ccccc1		CHEMBL132904	=	Thermal melting change	degrees C	0.8	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	0.8
	15264061	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21.[Cl-]		CHEMBL258765	=	Thermal melting change	degrees C	4.9	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	4.9
	15264121	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	COC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O		CHEMBL278315	=	Thermal melting change	degrees C	0.2	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	0.2
	15264181	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Thermal melting change	degrees C	0.9	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	0.9
	15264254	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	O=C1Nc2ccccc2/C1=C/c1cnc[nH]1		CHEMBL261692	=	Thermal melting change	degrees C	3.0	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	3.0
	15264314	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	O=S(=O)(c1cccc2c(Cl)cccc12)N1CCCNCC1		CHEMBL429298	=	Thermal melting change	degrees C	-0.1	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	-0.1
	15264374	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	COc1cc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(O)c(OC)c2)ccc1O		CHEMBL116438	=	Thermal melting change	degrees C	5.4	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	5.4
	15264434	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	NC1=NC(=O)/C(=C2\CCNC(=O)c3[nH]c(Br)cc32)N1		CHEMBL361708	=	Thermal melting change	degrees C	8.2	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	8.2
	15264490	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Thermal melting change	degrees C	3.1	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	3.1
	15264550	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	COC(=O)[C@]1(O)C[C@@H]2O[C@@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL416056	=	Thermal melting change	degrees C	6.0	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	6.0
	15264610	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Thermal melting change	degrees C	-0.1	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	-0.1
	15264670	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	Cl.NCCNS(=O)(=O)c1cccc2c(Cl)cccc12		CHEMBL1255867	=	Thermal melting change	degrees C	0.2	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	0.2
	15264742	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	Cc1cc(C=C2C(=O)C=CC2=O)cc(C)c1O		CHEMBL437612	=	Thermal melting change	degrees C	2.5	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	2.5
	15264802	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	CC(C)(C)c1cc(C=C2C(=O)C=CC2=O)cc(C(C)(C)C)c1O		CHEMBL258726	=	Thermal melting change	degrees C	1.8	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	1.8
	15264862	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Thermal melting change	degrees C	14.1	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	14.1
	15264922	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	CC(C)N(CCO)c1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL126254	=	Thermal melting change	degrees C	0.6	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	0.6
	15264978	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	N=C(N)NCCNS(=O)(=O)c1cccc2cnccc12		CHEMBL143054	=	Thermal melting change	degrees C	0.2	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	0.2
	15265038	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	CNC(=O)c1cc(Oc2ccc(Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL3430784	=	Thermal melting change	degrees C	-1.5	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	-1.5
	15265098	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Thermal melting change	degrees C	0.4	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	0.4
	15265158	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	CCn1cnc2c(N)nc(N(c3cccc(Cl)c3)[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL411901	=	Thermal melting change	degrees C	3.6	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	3.6
	15265231	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Thermal melting change	degrees C	1.7	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	1.7
	15265291	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	Cn1cnc2c(NCc3ccccc3)nc(NCCO)nc21		CHEMBL280074	=	Thermal melting change	degrees C	-0.6	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	-0.6
	15265351	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	CC(C)n1cnc2c(NCc3ccccc3O)nc(NCCCO)nc21		CHEMBL419931	=	Thermal melting change	degrees C	-0.4	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	-0.4
	15265411	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Thermal melting change	degrees C	0.9	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	0.9
	15265467	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Thermal melting change	degrees C	2.6	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	2.6
	15265527	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	Cc1ccc(NC(=O)c2cccc(N(C)C)c2)cc1NC(=O)c1ccc(O)cc1		CHEMBL186526	=	Thermal melting change	degrees C	0.9	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	0.9
	15265587	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Thermal melting change	degrees C	1.4	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	1.4
	15265647	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	C[C@@H]1C[C@H]2O[C@@H]2/C=C\C=C\C(=O)Cc2c(Cl)c(O)cc(O)c2C(=O)O1		CHEMBL414883	=	Thermal melting change	degrees C	1.6	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	1.6
	15265707	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Thermal melting change	degrees C	4.7	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	4.7
	15265719	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Thermal melting change	degrees C	-0.3	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	-0.3
	15265779	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	=	Thermal melting change	degrees C	0.0	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	0.0
	15265839	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	O=C(O)/C=C/c1cc(CO)ccc1CO		CHEMBL407534	=	Thermal melting change	degrees C	0.6	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	0.6
	15265899	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Thermal melting change	degrees C	-0.5	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	-0.5
	15265959	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	O=C1CC(=O)c2[nH]c3c4[nH]c5c(c4c4cn(Br)cc4c3c2C1)CCC=C5		CHEMBL264685	=	Thermal melting change	degrees C	2.6	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	2.6
	15266016	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	Oc1cc(O)cc(/C=C/c2ccc(O)c(O)c2)c1		CHEMBL69863	=	Thermal melting change	degrees C	1.9	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	1.9
	15266076	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	N#C/C(=C(/N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL261237	=	Thermal melting change	degrees C	0.3	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	0.3
	15266136	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	O=C1Nc2ccc(I)cc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL411645	=	Thermal melting change	degrees C	1.9	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	1.9
	15266196	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	O=C1Nc2ccc(S(=O)(=O)O)cc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL440411	=	Thermal melting change	degrees C	4.5	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	4.5
	15266268	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Thermal melting change	degrees C	5.6	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	5.6
	15266328	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Thermal melting change	degrees C	-0.9	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	-0.9
	15266388	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	O=C1Nc2ccccc2/C1=C\c1ccc[nH]1		CHEMBL101797	=	Thermal melting change	degrees C	4.1	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	4.1
	15266448	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12		CHEMBL50	=	Thermal melting change	degrees C	4.8	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	4.8
	15266503	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	CC(=O)O/N=C1C(=C2/C(=O)Nc3cc(Br)ccc32)/Nc2ccccc2/1		CHEMBL430226	=	Thermal melting change	degrees C	0.1	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	0.1
	15266563	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Thermal melting change	degrees C	7.1	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	7.1
	15266623	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	CC(=O)O.Cn1cc(C2=C(c3cn(CCCN)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL3430781	=	Thermal melting change	degrees C	5.9	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	5.9
	15266683	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Thermal melting change	degrees C	2.6	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	2.6
	15266756	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Thermal melting change	degrees C	-0.7	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	-0.7
	15266816	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Thermal melting change	degrees C	1.6	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	1.6
	15266876	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Thermal melting change	degrees C	1.6	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	1.6
	15266936	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Thermal melting change	degrees C	0.5	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	0.5
	15266991	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	CS(=O)(=O)O.Cn1cc(C2=C(c3cn(CCCSC(=N)N)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL1591531	=	Thermal melting change	degrees C	7.0	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	7.0
	15267051	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	Cl.Cn1cc(C2=C(c3ccc4cc5n(c4c3)CCC(CN)C5)C(=O)NC2=O)c2ccccc21		CHEMBL541401	=	Thermal melting change	degrees C	1.0	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	1.0
	15267111	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	CN(C)CC1CCn2c(c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc32)C1		CHEMBL372585	=	Thermal melting change	degrees C	0.6	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	0.6
	15267171	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	CN[C@@H]1CC2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL162	=	Thermal melting change	degrees C	16.6	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	16.6
	15267244	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Thermal melting change	degrees C	0.7	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	0.7
	15267304	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	COc1cc2ncnc(Nc3cccc(O)c3)c2cc1OC		CHEMBL127907	=	Thermal melting change	degrees C	1.8	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	1.8
	15267364	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Thermal melting change	degrees C	-0.2	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	-0.2
	15267424	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Thermal melting change	degrees C	-0.5	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	-0.5
	15267479	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	O=c1sn(Cc2ccccc2)c(=S)n1Cc1ccccc1		CHEMBL24338	=	Thermal melting change	degrees C	0.3	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	0.3
	15267539	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	C=CNC#N		CHEMBL259526	=	Thermal melting change	degrees C	0.1	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	0.1
	15267599	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	N#CC(=C(/N)Sc1ccccc1N)/C(C#N)=C(/N)Sc1ccccc1N		CHEMBL100473	=	Thermal melting change	degrees C	0.1	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	0.1
	15267659	CHEMBL3430801	Delta TM value showing the stabilisation of CHEK2 produced by compound binding	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Thermal melting change	degrees C	-0.3	CHEMBL2527	Homo sapiens	Thermal melting change	degrees C	-0.3
	15650177	CHEMBL3595497	Inhibition of human CHK2 at 0.1 uM relative to control	B	CCc1cc(NC(=O)Nc2ccc(-c3cnc(Nc4cc(N5CCN(CC)CC5)nc(C)n4)s3)cc2)no1		CHEMBL3593290	=	Inhibition	%	-3.0	CHEMBL2527	Homo sapiens	INH	%	-3.0
	15686145	CHEMBL3606971	Inhibition of CHK2 (unknown origin) at 250 nM by radioactive filter-binding assay	B	c1ccc2c(Nc3cc(C4CCC4)[nH]n3)nc(Nc3ccc4[nH]cnc4c3)nc2c1		CHEMBL3605055	>=	Inhibition	%	80.0	CHEMBL2527	Homo sapiens	INH	%	80.0
	15756060	CHEMBL3632311	Inhibition of CHK2 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CS(=O)(=O)c1cccc(Nc2nccc(-c3sc(N4CCOCC4)nc3-c3cccc(NS(=O)(=O)c4c(F)cccc4F)c3)n2)c1		CHEMBL3628627	=	Inhibition	%	51.74	CHEMBL2527	Homo sapiens	INH	%	51.74
	15757040	CHEMBL3632311	Inhibition of CHK2 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccncc3)cc2)no1		CHEMBL166031	=	Inhibition	%	11.08	CHEMBL2527	Homo sapiens	INH	%	11.08
	15758662	CHEMBL3632311	Inhibition of CHK2 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	COCCNC(=O)c1ccc2c(c1)nc(-c1cnc(-c3ccc(Cl)cc3)[nH]1)n2CCOC		CHEMBL3628628	=	Inhibition	%	-5.19	CHEMBL2527	Homo sapiens	INH	%	-5.19
	16376442	CHEMBL3734466	Inhibition of recombinant human CHK2 using fluorescein-labeled peptide as substrate by fluorescence-electrophoretic mobility shift assay	B	Cl.NCCN1C(=O)S/C(=C\CCC2CCCCC2)C1=O		CHEMBL3732044	=	Inhibition	%	8.0	CHEMBL2527	Homo sapiens	INH	%	8.0
	16388294	CHEMBL3737351	Inhibition of CHEK2 (unknown origin) at 1 uM by selectscreen kinase profiling assay in presence of ATP	B	COc1cc2c(cc1OC)CN(CC(=O)Nc1ccc3c(c1)/C(=C/c1cnc[nH]1)C(=O)N3)CC2		CHEMBL3091673	=	Inhibition	%	24.0	CHEMBL2527	Homo sapiens	INH	%	24.0
	16397463	CHEMBL3743119	Inhibition of CHK2 (unknown origin) at 30 uM by microfluidic assay relative to control	B	CC(=O)c1nn(-c2ccccc2)cc1C(=O)c1c(C)[nH]c(-c2ccccc2)c1-c1ccccc1		CHEMBL3739750	=	Inhibition	%	34.0	CHEMBL2527	Homo sapiens	INH	%	34.0
	16397464	CHEMBL3743119	Inhibition of CHK2 (unknown origin) at 30 uM by microfluidic assay relative to control	B	CC(=O)c1nn(-c2ccc(C)cc2)cc1C(=O)c1c(C)[nH]c(-c2ccccc2)c1-c1ccccc1		CHEMBL3740247	=	Inhibition	%	32.0	CHEMBL2527	Homo sapiens	INH	%	32.0
	16397465	CHEMBL3743119	Inhibition of CHK2 (unknown origin) at 30 uM by microfluidic assay relative to control	B	CC(=O)c1nn(-c2ccc(Cl)cc2)cc1C(=O)c1c(C)[nH]c(-c2ccccc2)c1-c1ccccc1		CHEMBL3739587	=	Inhibition	%	22.0	CHEMBL2527	Homo sapiens	INH	%	22.0
	16397466	CHEMBL3743119	Inhibition of CHK2 (unknown origin) at 30 uM by microfluidic assay relative to control	B	CCOC(=O)c1nn(-c2ccccc2)cc1C(=O)c1c(C)[nH]c(-c2ccccc2)c1-c1ccccc1		CHEMBL3740131	=	Inhibition	%	46.0	CHEMBL2527	Homo sapiens	INH	%	46.0
	16397467	CHEMBL3743119	Inhibition of CHK2 (unknown origin) at 30 uM by microfluidic assay relative to control	B	CCOC(=O)c1nn(-c2ccc(C)cc2)cc1C(=O)c1c(C)[nH]c(-c2ccccc2)c1-c1ccccc1		CHEMBL3742349	=	Inhibition	%	12.0	CHEMBL2527	Homo sapiens	INH	%	12.0
	16397468	CHEMBL3743119	Inhibition of CHK2 (unknown origin) at 30 uM by microfluidic assay relative to control	B	CCOC(=O)c1nn(-c2ccc(Cl)cc2)cc1C(=O)c1c(C)[nH]c(-c2ccccc2)c1-c1ccccc1		CHEMBL3741526	=	Inhibition	%	65.0	CHEMBL2527	Homo sapiens	INH	%	65.0
	16397469	CHEMBL3743119	Inhibition of CHK2 (unknown origin) at 30 uM by microfluidic assay relative to control	B	Cc1[nH]c(-c2ccccc2)c(-c2ccccc2)c1C(=O)c1cn(-c2ccccc2)nc1C(=O)Nc1ccccc1		CHEMBL3740930	=	Inhibition	%	4.0	CHEMBL2527	Homo sapiens	INH	%	4.0
	16397470	CHEMBL3743119	Inhibition of CHK2 (unknown origin) at 30 uM by microfluidic assay relative to control	B	Cc1ccc(-n2cc(C(=O)c3c(C)[nH]c(-c4ccccc4)c3-c3ccccc3)c(C(=O)Nc3ccccc3)n2)cc1		CHEMBL3740713	=	Inhibition	%	3.0	CHEMBL2527	Homo sapiens	INH	%	3.0
	16397471	CHEMBL3743119	Inhibition of CHK2 (unknown origin) at 30 uM by microfluidic assay relative to control	B	Cc1[nH]c(-c2ccccc2)c(-c2ccccc2)c1C(=O)c1cn(-c2ccc(Cl)cc2)nc1C(=O)Nc1ccccc1		CHEMBL3740385	=	Inhibition	%	32.0	CHEMBL2527	Homo sapiens	INH	%	32.0
	16397472	CHEMBL3743119	Inhibition of CHK2 (unknown origin) at 30 uM by microfluidic assay relative to control	B	Cc1[nH]c(-c2ccccc2)c(-c2ccccc2)c1C(=O)c1cn(-c2ccccc2)nc1-c1ccccc1		CHEMBL3741069	=	Inhibition	%	54.0	CHEMBL2527	Homo sapiens	INH	%	54.0
	16397473	CHEMBL3743119	Inhibition of CHK2 (unknown origin) at 30 uM by microfluidic assay relative to control	B	Cc1[nH]c(-c2ccccc2)c(-c2ccccc2)c1-c1nnc(C)c2nn(-c3ccccc3)cc12		CHEMBL3740582	=	Inhibition	%	35.0	CHEMBL2527	Homo sapiens	INH	%	35.0
	16397474	CHEMBL3743119	Inhibition of CHK2 (unknown origin) at 30 uM by microfluidic assay relative to control	B	Cc1ccc(-n2cc3c(-c4c(C)[nH]c(-c5ccccc5)c4-c4ccccc4)nnc(C)c3n2)cc1		CHEMBL3742060	=	Inhibition	%	12.0	CHEMBL2527	Homo sapiens	INH	%	12.0
	16397475	CHEMBL3743119	Inhibition of CHK2 (unknown origin) at 30 uM by microfluidic assay relative to control	B	Cc1[nH]c(-c2ccccc2)c(-c2ccccc2)c1-c1nnc(C)c2nn(-c3ccc(Cl)cc3)cc12		CHEMBL3741655	=	Inhibition	%	24.0	CHEMBL2527	Homo sapiens	INH	%	24.0
	16397476	CHEMBL3743119	Inhibition of CHK2 (unknown origin) at 30 uM by microfluidic assay relative to control	B	Oc1nnc(-c2c[nH]c(-c3ccccc3)c2-c2ccccc2)c2cn(-c3ccccc3)nc12		CHEMBL3740923	=	Inhibition	%	24.0	CHEMBL2527	Homo sapiens	INH	%	24.0
	16397477	CHEMBL3743119	Inhibition of CHK2 (unknown origin) at 30 uM by microfluidic assay relative to control	B	Cc1ccc(-n2cc3c(-c4c[nH]c(-c5ccccc5)c4-c4ccccc4)nnc(O)c3n2)cc1		CHEMBL3739586	=	Inhibition	%	23.0	CHEMBL2527	Homo sapiens	INH	%	23.0
	16397478	CHEMBL3743119	Inhibition of CHK2 (unknown origin) at 30 uM by microfluidic assay relative to control	B	Oc1nnc(-c2c[nH]c(-c3ccccc3)c2-c2ccccc2)c2cn(-c3ccc(Cl)cc3)nc12		CHEMBL3742200	=	Inhibition	%	34.0	CHEMBL2527	Homo sapiens	INH	%	34.0
	16397479	CHEMBL3743119	Inhibition of CHK2 (unknown origin) at 30 uM by microfluidic assay relative to control	B	Cc1[nH]c(-c2ccccc2)c(-c2ccccc2)c1-c1ccc(NC(=O)c2ccccc2)c(=O)o1		CHEMBL3740003	=	Inhibition	%	64.0	CHEMBL2527	Homo sapiens	INH	%	64.0
	16397480	CHEMBL3743119	Inhibition of CHK2 (unknown origin) at 30 uM by microfluidic assay relative to control	B	Cc1c(C(=O)c2coc3ccc(O)cc23)[nH]c(-c2ccccc2)c1-c1ccccc1		CHEMBL3741960	=	Inhibition	%	7.0	CHEMBL2527	Homo sapiens	INH	%	7.0
	16397481	CHEMBL3743119	Inhibition of CHK2 (unknown origin) at 30 uM by microfluidic assay relative to control	B	Cc1c(C(=O)c2coc3c2cc(O)c2ccccc23)[nH]c(-c2ccccc2)c1-c1ccccc1		CHEMBL3740492	=	Inhibition	%	55.0	CHEMBL2527	Homo sapiens	INH	%	55.0
	16413424	CHEMBL3743720	Inhibition of CHK2 (unknown origin)	B	O=C(O)C1CN(Cc2ccc(OCc3ccc(Cl)c(Cl)c3)cc2)C1		CHEMBL3741589	>	IC50	nM	10000.0	CHEMBL2527	Homo sapiens	IC50	uM	10.0
	16425389	CHEMBL3751064	Inhibition of CHK2 (unknown origin) at 1 uM	B	Cc1c(-c2cc(Nc3cc4n(n3)CCN(C)C4)c(=O)[nH]n2)ccc(F)c1NC(=O)c1cc2ccccc2s1		CHEMBL3746293	=	Inhibition	%	-3.8	CHEMBL2527	Homo sapiens	INH	%	-3.8
	16431779	CHEMBL3748671	Inhibition of human CHK2 using [KKKVSRSGLYRSPSMPENLNRPR] as substrate	B	Cn1c(=O)c(S(=O)(=O)c2ccc(F)cc2F)cc2cnc(Nc3ccc4[nH]ccc4c3)nc21		CHEMBL3745885	>	IC50	nM	10000.0	CHEMBL2527	Homo sapiens	IC50	uM	10.0
	16450786	CHEMBL3762304	Inhibition of CHK2 (unknown origin) at 100 nM	B	CC1(C)OCc2c(Nc3n[nH]c4ccccc34)nc(-c3cn[nH]c3)nc21		CHEMBL3758502	=	Inhibition	%	-1.3	CHEMBL2527	Homo sapiens	INH	%	-1.3
	16474682	CHEMBL3767168	Inhibition of CHK2 (unknown origin) at 10 uM	B	CN1CCN(CCCOc2ccc(N3C(=O)/C(=C/c4ccc(Oc5ccc(F)cc5)cc4)SC3=S)cc2)CC1		CHEMBL3765499	=	Inhibition	%	47.0	CHEMBL2527	Homo sapiens	INH	%	47.0
	16495361	CHEMBL3776911	Inhibition of N-terminal His6-tagged recombinant human CHK2 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CCOCC5)cc34)cc2)cn1		CHEMBL3774885	=	Activity	%	-1.0	CHEMBL2527	Homo sapiens	Activity	%	-1.0
	16495362	CHEMBL3776912	Inhibition of N-terminal His6-tagged recombinant human CHK2 I157T mutant expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CCOCC5)cc34)cc2)cn1		CHEMBL3774885	=	Activity	%	4.0	CHEMBL2527	Homo sapiens	Activity	%	4.0
	16495363	CHEMBL3777128	Inhibition of N-terminal His6-tagged recombinant human CHK2 R145W expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CCOCC5)cc34)cc2)cn1		CHEMBL3774885	=	Activity	%	-5.0	CHEMBL2527	Homo sapiens	Activity	%	-5.0
Not Active	16496863	CHEMBL3776411	Inhibition of human CHK2 (5 to 543 residues) at 1 uM by radioactive [33P]-ATP filter binding assay	B	O=c1[nH]cnc2c(-n3cc(CCN4CCC(c5cccc(Cl)c5)CC4)cn3)nccc12		CHEMBL3774537		Inhibition	%		CHEMBL2527	Homo sapiens	INH		
	16507364	CHEMBL3777420	Inhibition of recombinant CHK2 (unknown origin) assessed as residual activity at 1 uM relative to control	B	CC(O)CNc1nc(NCc2ccc(-c3ccccn3)cc2)c2[nH]nc(C(C)C)c2n1		CHEMBL3774632	=	Activity	%	79.0	CHEMBL2527	Homo sapiens	Activity	%	79.0
	16508130	CHEMBL3776911	Inhibition of N-terminal His6-tagged recombinant human CHK2 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	CNC(=O)c1ccc2[nH]nc(Cc3ccc4c(cnn4C)c3)c2c1		CHEMBL3775576	=	Activity	%	-1.0	CHEMBL2527	Homo sapiens	Activity	%	-1.0
	16508131	CHEMBL3776912	Inhibition of N-terminal His6-tagged recombinant human CHK2 I157T mutant expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	CNC(=O)c1ccc2[nH]nc(Cc3ccc4c(cnn4C)c3)c2c1		CHEMBL3775576	=	Activity	%	-4.0	CHEMBL2527	Homo sapiens	Activity	%	-4.0
	16508132	CHEMBL3777128	Inhibition of N-terminal His6-tagged recombinant human CHK2 R145W expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	CNC(=O)c1ccc2[nH]nc(Cc3ccc4c(cnn4C)c3)c2c1		CHEMBL3775576	=	Activity	%	9.0	CHEMBL2527	Homo sapiens	Activity	%	9.0
	16509107	CHEMBL3776911	Inhibition of N-terminal His6-tagged recombinant human CHK2 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CC[C@@H](O)C5)cc34)cc2)cn1		CHEMBL3775317	=	Activity	%	-11.0	CHEMBL2527	Homo sapiens	Activity	%	-11.0
	16509108	CHEMBL3776912	Inhibition of N-terminal His6-tagged recombinant human CHK2 I157T mutant expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CC[C@@H](O)C5)cc34)cc2)cn1		CHEMBL3775317	=	Activity	%	8.0	CHEMBL2527	Homo sapiens	Activity	%	8.0
	16509109	CHEMBL3777128	Inhibition of N-terminal His6-tagged recombinant human CHK2 R145W expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CC[C@@H](O)C5)cc34)cc2)cn1		CHEMBL3775317	=	Activity	%	5.0	CHEMBL2527	Homo sapiens	Activity	%	5.0
	16534414	CHEMBL3789286	Inhibition of human CHK2 at 1 uM after 30 mins by fluorescence assay in presence of ATP	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCC(N)C2(C)C		CHEMBL3786892	=	Inhibition	%	99.0	CHEMBL2527	Homo sapiens	INH	%	99.0
	16562713	CHEMBL3802093	Inhibition of CHK2 (unknown origin) at 1 uM	B	CSc1sc(-c2cc[nH]n2)c2c1C(=O)NCC2		CHEMBL3800053	=	Inhibition	%	45.0	CHEMBL2527	Homo sapiens	INH	%	45.0
	16562714	CHEMBL3802093	Inhibition of CHK2 (unknown origin) at 1 uM	B	CSc1sc(-c2cc[nH]n2)c2c1C(=O)N[C@@H](c1ccccc1)C2		CHEMBL3800284	=	Inhibition	%	45.0	CHEMBL2527	Homo sapiens	INH	%	45.0
	16562715	CHEMBL3802093	Inhibition of CHK2 (unknown origin) at 1 uM	B	CC1(C)CC(=O)c2c(SC3CCCC3)sc(-c3cc[nH]n3)c2C1		CHEMBL3800282	<	Inhibition	%	10.0	CHEMBL2527	Homo sapiens	INH	%	10.0
	16562718	CHEMBL3802093	Inhibition of CHK2 (unknown origin) at 1 uM	B	CSc1sc(-c2cc[nH]n2)c2c1C(=O)CCC2		CHEMBL3799347	=	Inhibition	%	45.0	CHEMBL2527	Homo sapiens	INH	%	45.0
	16593482	CHEMBL3812160	Inhibition of His-tagged human recombinant CHK2 expressed in baculovirus using Fluorescein-CREBtide as substrate at 100 nM	B	COC(=O)c1cc2cc(NCc3cc(NC(=O)c4cc(-n5cnc(C)c5)cc(C(F)(F)F)c4)ccc3C)cnc2[nH]1		CHEMBL3808884	<	Inhibition	%	40.0	CHEMBL2527	Homo sapiens	INH	%	40.0
	16611892	CHEMBL3816735	Inhibition of human CHK2 (5 to 543 residues) assessed as enzyme activity at 1 uM using 33P ATP by radioactive filter binding assay	B	CCCCc1cc(-c2c[nH]c3ncc(-c4cnn(C5CCNCC5)c4)cc23)nc(N)n1		CHEMBL3815046	=	Activity	%	-92.0	CHEMBL2527	Homo sapiens	Activity	%	-92.0
	16611893	CHEMBL3816735	Inhibition of human CHK2 (5 to 543 residues) assessed as enzyme activity at 1 uM using 33P ATP by radioactive filter binding assay	B	CCc1cc(-c2c[nH]c3ncc(-c4cnn(C5CCNCC5)c4)cc23)nc(N)n1		CHEMBL3814140	=	Activity	%	-81.0	CHEMBL2527	Homo sapiens	Activity	%	-81.0
	16611894	CHEMBL3816735	Inhibition of human CHK2 (5 to 543 residues) assessed as enzyme activity at 1 uM using 33P ATP by radioactive filter binding assay	B	CCCCc1cc(-c2c[nH]c3ncccc23)nc(N)n1		CHEMBL3814340	=	Activity	%	-44.0	CHEMBL2527	Homo sapiens	Activity	%	-44.0
	16611895	CHEMBL3816735	Inhibition of human CHK2 (5 to 543 residues) assessed as enzyme activity at 1 uM using 33P ATP by radioactive filter binding assay	B	Nc1nccc(-c2c[nH]c3ncccc23)n1		CHEMBL405665	=	Activity	%	-37.0	CHEMBL2527	Homo sapiens	Activity	%	-37.0
	16613264	CHEMBL3816079	Inhibition of Chk2 FHA (1 to 225 residues) (unknown origin) using 5-carboxyfluorescein-GHFDpTYLI-RR-OH as substrate at 40 uM incubated for 1 hr prior to addition of substrate by fluorescence polarization assay	B	COc1ccc(Br)cc1/C=c1\sc2nc(=O)c(C)nn2c1=O		CHEMBL3814269	=	Inhibition	%	35.0	CHEMBL2527	Homo sapiens	INH	%	35.0
	16614425	CHEMBL3817291	Inhibition of human CHK2 at 1 uM using [KKKVSRSGLYRSPSMPENLNRPR] as substrate	B	CNS(=O)(=O)c1ccc(N(C)C)c(Nc2ncnc3cc(OC)c(OC)cc23)c1		CHEMBL3815093	=	Inhibition	%	1.0	CHEMBL2527	Homo sapiens	INH	%	1.0
	16618263	CHEMBL3817061	Inhibition of full length recombinant human His-tagged CHK2 expressed in baculovirus expression system at 1 uM relative to control	B	CC1(C)OCCn2c1nc1c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL3813842	<	Inhibition	%	50.0	CHEMBL2527	Homo sapiens	INH	%	50.0
	16619680	CHEMBL3820248	Inhibition of recombinant human full length His-tagged CHK2 expressed in Baculovirus at 1 uM relative to control	B	Cc1nc(Nc2[nH]nc3c2CN(C(=O)N[C@H](CN(C)C)c2ccccc2)C3(C)C)c2sccc2n1		CHEMBL3128043	>	Inhibition	%	75.0	CHEMBL2527	Homo sapiens	INH	%	75.0
	16627500	CHEMBL3820219	Inhibition of recombinant human N-terminal GST-tagged C-terminal His6-tagged CHK2 (5 to 543 residues) expressed in Escherichia coli at 1 uM by radiometric assay relative to control	B	Cc1cc(-c2cnn3c(NCC4CCOCC4)nc(Oc4ccccc4)nc23)ccc1C(=O)NC1CC1		CHEMBL3819210	=	Inhibition	%	-8.0	CHEMBL2527	Homo sapiens	INH	%	-8.0
	16627501	CHEMBL3820219	Inhibition of recombinant human N-terminal GST-tagged C-terminal His6-tagged CHK2 (5 to 543 residues) expressed in Escherichia coli at 1 uM by radiometric assay relative to control	B	O=C(N[C@@H](c1ccccn1)C1CC1)c1ccc2[nH]nc(-c3ccc(N4C5CCC4CC(O)C5)cc3)c2c1		CHEMBL3818239	=	Inhibition	%	19.0	CHEMBL2527	Homo sapiens	INH	%	19.0
	16628505	CHEMBL3820621	Inhibition of human recombinant CHK2 (5 to 543 residues) expressed in Escherichia coli at 1 uM after 30 mins	B	O=C(Nc1cc(Nc2c(Cl)cnc3c2OCO3)ccn1)C1CC1		CHEMBL3818173	<	Inhibition	%	80.0	CHEMBL2527	Homo sapiens	INH	%	80.0
	16641951	CHEMBL3826398	Inhibition of His-tagged full-length human CHEK2 expressed in baculovirus system at 100 nM by Z-lyte assay	B	O=C(CNC(=O)c1cccn(Cc2ccc(F)c(F)c2)c1=O)Nc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL3824119	=	Inhibition	%	4.0	CHEMBL2527	Homo sapiens	INH	%	4.0
	16654149	CHEMBL3829174	Inhibition of human CHK2 (5 to 543 residues) assessed as remaining enzyme activity at 50 uM after 30 mins by 33P-ATP filter-binding assay	B	Cc1cc(=O)c2c(O)cc(O)c([C@H]3CCN(C)C[C@H]3O)c2o1		CHEMBL1077604	=	Activity	%	60.0	CHEMBL2527	Homo sapiens	Activity	%	60.0
Active	16751702	CHEMBL3860249	Induction of CHK2 phosphorylation at T68-residue in human MDA-MB-468 cells at 1 uM after 2 hrs by immunoblot analysis	B	C=C[C@@H]1C[C@H](C)C[C@H](C)[C@H]1c1c(O)ccn(O[C@@H]2C(C(=O)OC)=C[C@@H](O)[C@@H](O)[C@H]2O)c1=O		CHEMBL3903473		Activity			CHEMBL2527	Homo sapiens	Activity		
Active	16769091	CHEMBL3863736	Induction of CHK2 phosphorylation in human MDA-MB-231 cells at 10 uM after 6 to 24 hrs by Western blot method	B	CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](CC(=O)NO)OC(=O)c3ccccc3)[C@H]21		CHEMBL3933005		Activity			CHEMBL2527	Homo sapiens	Activity		
	16769092	CHEMBL3863736	Induction of CHK2 phosphorylation in human MDA-MB-231 cells at 10 uM after 6 to 24 hrs by Western blot method	B	CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21	Potential missing data	CHEMBL503		Activity			CHEMBL2527	Homo sapiens	Activity		
	16781882	CHEMBL3865680	Inhibition of His-tagged recombinant full length human CHK2 expressed in baculovirus	B	NC(=O)c1ncc(N[C@@H]2CCCC[C@@H]2N)nc1-c1nc2ccccc2[nH]1		CHEMBL3943181	=	IC50	nM	60.0	CHEMBL2527	Homo sapiens	IC50	nM	60.0
	16804161	CHEMBL3869752	Inhibition of human recombinant full length His-tagged CHK2 expressed in baculovirus expression system at 200 nM by Z'-LYTE assay	B	Cn1cc(-c2nc(N[C@@H]3CCCC[C@@H]3N)c(F)c3c2C(=O)NC3)cn1		CHEMBL3979920	=	Inhibition	%	63.0	CHEMBL2527	Homo sapiens	INH	%	63.0
	16815454	CHEMBL3871615	Inhibition of human recombinant full-length His-tagged CHK2 expressed in baculovirus expression system at 1 uM	B	O=C(O)/C=C\C(=O)Nc1cccc(-c2n[nH]c3ccc(NS(=O)(=O)c4ccccc4)cc23)c1		CHEMBL3986609	=	Inhibition	%	8.0	CHEMBL2527	Homo sapiens	INH	%	8.0
	16837414	CHEMBL3876085	Inhibition of human recombinant full length His-tagged CHEK2 expressed in baculovirus expression system	B	CC1(C)C(=O)N([C@H]2CCc3c(O)cccc32)c2nc(Nc3ccccc3)ncc21		CHEMBL3884319	=	IC50	nM	2174.0	CHEMBL2527	Homo sapiens	IC50	nM	2174.0
	16897397	CHEMBL3882739	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ADP after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	IC50	nM	16.0	CHEMBL2527	Homo sapiens	IC50	nM	16.0
	16897398	CHEMBL3882739	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ADP after 3 hrs by scintillation counting method	B	Cc1ccc(Oc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)cc1Cl		CHEMBL359881	=	IC50	nM	4.0	CHEMBL2527	Homo sapiens	IC50	nM	4.0
	16897399	CHEMBL3882739	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ADP after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)c(C(F)(F)F)c4)cc3)nc2c1		CHEMBL179717	=	IC50	nM	3.0	CHEMBL2527	Homo sapiens	IC50	nM	3.0
	16897400	CHEMBL3882739	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ADP after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)c(Cl)c4)cc3)nc2c1		CHEMBL175553	=	IC50	nM	5.0	CHEMBL2527	Homo sapiens	IC50	nM	5.0
	16897401	CHEMBL3882739	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ADP after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(F)c(Cl)c4)cc3)nc2c1		CHEMBL3953915	=	IC50	nM	10.0	CHEMBL2527	Homo sapiens	IC50	nM	10.0
	16897402	CHEMBL3882739	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ADP after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4cc(C(F)(F)F)ccc4F)cc3)nc2c1		CHEMBL361378	=	IC50	nM	12.0	CHEMBL2527	Homo sapiens	IC50	nM	12.0
	16897403	CHEMBL3882739	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ADP after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)c(F)c4)cc3)nc2c1		CHEMBL3916197	=	IC50	nM	6.0	CHEMBL2527	Homo sapiens	IC50	nM	6.0
	16897404	CHEMBL3882739	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ADP after 3 hrs by scintillation counting method	B	Cc1ccc(Oc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)cc1C		CHEMBL362255	=	IC50	nM	12.0	CHEMBL2527	Homo sapiens	IC50	nM	12.0
	16897405	CHEMBL3882739	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ADP after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc5ccccc5c4)cc3)nc2c1		CHEMBL369254	=	IC50	nM	12.0	CHEMBL2527	Homo sapiens	IC50	nM	12.0
	16897406	CHEMBL3882739	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ADP after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(C(F)(F)F)cc4)cc3)nc2c1		CHEMBL3942502	=	IC50	nM	14.0	CHEMBL2527	Homo sapiens	IC50	nM	14.0
	16897407	CHEMBL3882739	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ADP after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Br)cc4)cc3)nc2c1		CHEMBL3894750	=	IC50	nM	14.0	CHEMBL2527	Homo sapiens	IC50	nM	14.0
	16897408	CHEMBL3882739	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ADP after 3 hrs by scintillation counting method	B	Cc1cc(Oc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)ccc1F		CHEMBL3904466	=	IC50	nM	16.0	CHEMBL2527	Homo sapiens	IC50	nM	16.0
	16897409	CHEMBL3882739	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ADP after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4cccc(Cl)c4)cc3)nc2c1		CHEMBL178972	=	IC50	nM	17.0	CHEMBL2527	Homo sapiens	IC50	nM	17.0
	16897410	CHEMBL3882739	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ADP after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc5c(c4)CCCC5)cc3)nc2c1		CHEMBL3923429	=	IC50	nM	17.0	CHEMBL2527	Homo sapiens	IC50	nM	17.0
	16897411	CHEMBL3882739	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ADP after 3 hrs by scintillation counting method	B	Cc1ccc(Cl)cc1Oc1ccc(-c2nc3cc(C(N)=O)ccc3[nH]2)cc1		CHEMBL3906984	=	IC50	nM	18.0	CHEMBL2527	Homo sapiens	IC50	nM	18.0
	16897412	CHEMBL3882739	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ADP after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4cccc(C(F)(F)F)c4)cc3)nc2c1		CHEMBL3964555	=	IC50	nM	19.0	CHEMBL2527	Homo sapiens	IC50	nM	19.0
	16897413	CHEMBL3882739	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ADP after 3 hrs by scintillation counting method	B	COc1ccc(Oc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)cc1		CHEMBL176164	=	IC50	nM	23.0	CHEMBL2527	Homo sapiens	IC50	nM	23.0
	16897414	CHEMBL3882739	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ADP after 3 hrs by scintillation counting method	B	Cc1ccc(Oc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)cc1		CHEMBL175879	=	IC50	nM	24.0	CHEMBL2527	Homo sapiens	IC50	nM	24.0
	16897415	CHEMBL3882739	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ADP after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4cccc(C(F)(F)F)c4F)cc3)nc2c1		CHEMBL3907976	=	IC50	nM	26.0	CHEMBL2527	Homo sapiens	IC50	nM	26.0
	16897416	CHEMBL3882739	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ADP after 3 hrs by scintillation counting method	B	Cc1ccc(Oc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)c(Cl)c1		CHEMBL3891573	=	IC50	nM	26.0	CHEMBL2527	Homo sapiens	IC50	nM	26.0
	16897417	CHEMBL3882739	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ADP after 3 hrs by scintillation counting method	B	CCc1ccc(Oc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)cc1		CHEMBL3951780	=	IC50	nM	28.0	CHEMBL2527	Homo sapiens	IC50	nM	28.0
	16897418	CHEMBL3882739	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ADP after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(F)cc4)cc3)nc2c1		CHEMBL3942275	=	IC50	nM	29.0	CHEMBL2527	Homo sapiens	IC50	nM	29.0
	16897419	CHEMBL3882739	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ADP after 3 hrs by scintillation counting method	B	COc1ccc(Oc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)cc1OC		CHEMBL179267	=	IC50	nM	31.0	CHEMBL2527	Homo sapiens	IC50	nM	31.0
	16897420	CHEMBL3882739	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ADP after 3 hrs by scintillation counting method	B	NC(=O)c1ccc(Oc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)cc1		CHEMBL362677	=	IC50	nM	47.0	CHEMBL2527	Homo sapiens	IC50	nM	47.0
	16897421	CHEMBL3882739	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ADP after 3 hrs by scintillation counting method	B	CN(C)c1cccc(Oc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)c1		CHEMBL3982788	=	IC50	nM	72.0	CHEMBL2527	Homo sapiens	IC50	nM	72.0
	16897422	CHEMBL3882739	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ADP after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc([N+](=O)[O-])cc4)cc3)nc2c1		CHEMBL193397	=	IC50	nM	82.0	CHEMBL2527	Homo sapiens	IC50	nM	82.0
	16897423	CHEMBL3882739	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ADP after 3 hrs by scintillation counting method	B	N#Cc1ccc(Oc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)cc1		CHEMBL3906161	=	IC50	nM	108.0	CHEMBL2527	Homo sapiens	IC50	nM	108.0
	16897424	CHEMBL3882739	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ADP after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(CCC(=O)O)cc4)cc3)nc2c1		CHEMBL3897490	=	IC50	nM	163.0	CHEMBL2527	Homo sapiens	IC50	nM	163.0
	16897425	CHEMBL3882739	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ADP after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4cccc(C(=O)O)c4)cc3)nc2c1		CHEMBL381436	=	IC50	nM	715.0	CHEMBL2527	Homo sapiens	IC50	nM	715.0
	16897426	CHEMBL3882739	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ADP after 3 hrs by scintillation counting method	B	CCN(CC)C(=O)c1cccc(Oc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)c1		CHEMBL195678	=	IC50	nM	820.0	CHEMBL2527	Homo sapiens	IC50	nM	820.0
	16897427	CHEMBL3882739	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ADP after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4cccnc4)cc3)nc2c1		CHEMBL3932401	=	IC50	nM	633.0	CHEMBL2527	Homo sapiens	IC50	nM	633.0
	16897428	CHEMBL3882739	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ADP after 3 hrs by scintillation counting method	B	COc1ccc(Oc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2Cl)cc1OC		CHEMBL3981163	=	IC50	nM	46.0	CHEMBL2527	Homo sapiens	IC50	nM	46.0
	16897429	CHEMBL3882739	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ADP after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3Cl)nc2c1		CHEMBL3971136	=	IC50	nM	60.0	CHEMBL2527	Homo sapiens	IC50	nM	60.0
	16897430	CHEMBL3882739	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ADP after 3 hrs by scintillation counting method	B	Cc1cc(Oc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2Cl)ccc1F		CHEMBL3923496	=	IC50	nM	68.0	CHEMBL2527	Homo sapiens	IC50	nM	68.0
	16897431	CHEMBL3882739	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ADP after 3 hrs by scintillation counting method	B	COc1cc(C)ccc1Oc1ccc(-c2nc3cc(C(N)=O)ccc3[nH]2)cc1Cl		CHEMBL3923907	=	IC50	nM	68.0	CHEMBL2527	Homo sapiens	IC50	nM	68.0
	16897432	CHEMBL3882739	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ADP after 3 hrs by scintillation counting method	B	Cc1ccc(Oc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2Cl)cc1Cl		CHEMBL3921179	=	IC50	nM	71.0	CHEMBL2527	Homo sapiens	IC50	nM	71.0
	16897433	CHEMBL3882739	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ADP after 3 hrs by scintillation counting method	B	Cc1ccc(Oc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cn2)cc1		CHEMBL3961387	=	IC50	nM	191.0	CHEMBL2527	Homo sapiens	IC50	nM	191.0
	16897434	CHEMBL3882739	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ADP after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(Sc4ccc(F)c(Cl)c4)cc3)nc2c1		CHEMBL3958697	=	IC50	nM	4.0	CHEMBL2527	Homo sapiens	IC50	nM	4.0
	16897435	CHEMBL3882739	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ADP after 3 hrs by scintillation counting method	B	CCc1ccc(Sc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)cc1		CHEMBL3909532	=	IC50	nM	10.0	CHEMBL2527	Homo sapiens	IC50	nM	10.0
	16897436	CHEMBL3882739	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ADP after 3 hrs by scintillation counting method	B	COc1ccc(Sc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)cc1OC		CHEMBL3970700	=	IC50	nM	15.0	CHEMBL2527	Homo sapiens	IC50	nM	15.0
	16897437	CHEMBL3882739	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ADP after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(Sc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL191969	=	IC50	nM	7.0	CHEMBL2527	Homo sapiens	IC50	nM	7.0
	16897438	CHEMBL3882739	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ADP after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(Sc4ccc(Cl)cc4)nc3)nc2c1		CHEMBL3916678	=	IC50	nM	21.0	CHEMBL2527	Homo sapiens	IC50	nM	21.0
	16897439	CHEMBL3882739	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ADP after 3 hrs by scintillation counting method	B	Cc1ccc(Sc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cn2)cc1		CHEMBL3956950	=	IC50	nM	26.0	CHEMBL2527	Homo sapiens	IC50	nM	26.0
	16897440	CHEMBL3882739	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ADP after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(Sc4ccc(OC(F)(F)F)cc4)cc3)nc2c1		CHEMBL3954343	=	IC50	nM	67.0	CHEMBL2527	Homo sapiens	IC50	nM	67.0
	16897441	CHEMBL3882739	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ADP after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(-c4ccc(F)cc4)cc3)nc2c1		CHEMBL3897063	=	IC50	nM	53.0	CHEMBL2527	Homo sapiens	IC50	nM	53.0
	16897442	CHEMBL3882739	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ADP after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(-c4ccccc4)cc3)nc2c1		CHEMBL193476	=	IC50	nM	103.0	CHEMBL2527	Homo sapiens	IC50	nM	103.0
	16897443	CHEMBL3882739	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ADP after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(-c4ccccc4Cl)cc3)nc2c1		CHEMBL3949385	=	IC50	nM	209.0	CHEMBL2527	Homo sapiens	IC50	nM	209.0
	16897444	CHEMBL3882739	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ADP after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(-c4ccc(Cl)cc4)cc3)nc2c1		CHEMBL195599	=	IC50	nM	253.0	CHEMBL2527	Homo sapiens	IC50	nM	253.0
	16897445	CHEMBL3882739	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ADP after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(-c4ccccn4)cc3)nc2c1		CHEMBL3924197	=	IC50	nM	277.0	CHEMBL2527	Homo sapiens	IC50	nM	277.0
	16897446	CHEMBL3882739	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ADP after 3 hrs by scintillation counting method	B	O=C(O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL208463	=	IC50	nM	133.0	CHEMBL2527	Homo sapiens	IC50	nM	133.0
	16897447	CHEMBL3882739	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ADP after 3 hrs by scintillation counting method	B	COc1ccc(Oc2ccc(-c3nc4cc(C(=O)O)ccc4[nH]3)cc2)cc1		CHEMBL3961695	=	IC50	nM	276.0	CHEMBL2527	Homo sapiens	IC50	nM	276.0
	16897448	CHEMBL3882739	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ADP after 3 hrs by scintillation counting method	B	O=C(O)c1ccc2[nH]c(-c3ccc(Oc4ccc(F)cc4)cc3)nc2c1		CHEMBL3904289	=	IC50	nM	351.0	CHEMBL2527	Homo sapiens	IC50	nM	351.0
	16897449	CHEMBL3882739	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ADP after 3 hrs by scintillation counting method	B	O=C(O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3Cl)nc2c1		CHEMBL3960549	=	IC50	nM	445.0	CHEMBL2527	Homo sapiens	IC50	nM	445.0
	16897450	CHEMBL3882739	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ADP after 3 hrs by scintillation counting method	B	O=C(O)c1ccc2[nH]c(-c3ccc(Oc4ccc([N+](=O)[O-])cc4)cc3)nc2c1		CHEMBL3965716	=	IC50	nM	478.0	CHEMBL2527	Homo sapiens	IC50	nM	478.0
	16897451	CHEMBL3882739	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ADP after 3 hrs by scintillation counting method	B	O=C(O)c1ccc2[nH]c(-c3ccc(-c4ccc(Cl)cc4)cc3)nc2c1		CHEMBL3956375	=	IC50	nM	270.0	CHEMBL2527	Homo sapiens	IC50	nM	270.0
	16897452	CHEMBL3882739	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ADP after 3 hrs by scintillation counting method	B	O=C(O)c1ccc2[nH]c(-c3ccc(Oc4ccccc4)cc3)nc2c1		CHEMBL367390	=	IC50	nM	844.0	CHEMBL2527	Homo sapiens	IC50	nM	844.0
	16897453	CHEMBL3882739	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ADP after 3 hrs by scintillation counting method	B	NS(=O)(=O)c1ccc2[nH]c(-c3ccc(Oc4ccccc4)cc3)nc2c1		CHEMBL176015	=	IC50	nM	289.0	CHEMBL2527	Homo sapiens	IC50	nM	289.0
	16897454	CHEMBL3882739	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ADP after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(S(=O)(=O)Nc4ccc(Cl)c(Cl)c4)cc3)nc2c1		CHEMBL195177	=	IC50	nM	3.0	CHEMBL2527	Homo sapiens	IC50	nM	3.0
	16897455	CHEMBL3882739	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ADP after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(S(=O)(=O)Nc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL195846	=	IC50	nM	10.0	CHEMBL2527	Homo sapiens	IC50	nM	10.0
	16897456	CHEMBL3882739	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ADP after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(S(=O)(=O)Nc4ccc([N+](=O)[O-])cc4)cc3)nc2c1		CHEMBL3970129	=	IC50	nM	14.0	CHEMBL2527	Homo sapiens	IC50	nM	14.0
	16897457	CHEMBL3882739	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ADP after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(S(=O)(=O)Nc4ccc(Br)cc4)cc3)nc2c1		CHEMBL3933192	=	IC50	nM	15.0	CHEMBL2527	Homo sapiens	IC50	nM	15.0
	16897458	CHEMBL3882739	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ADP after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(S(=O)(=O)Nc4ccc(C(F)(F)F)cc4)cc3)nc2c1		CHEMBL3935552	=	IC50	nM	13.0	CHEMBL2527	Homo sapiens	IC50	nM	13.0
	16897459	CHEMBL3882739	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ADP after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(S(=O)(=O)Nc4ccc5ccccc5c4)cc3)nc2c1		CHEMBL3923712	=	IC50	nM	29.0	CHEMBL2527	Homo sapiens	IC50	nM	29.0
	16897460	CHEMBL3882739	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ADP after 3 hrs by scintillation counting method	B	COc1ccc(NS(=O)(=O)c2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)cc1		CHEMBL3892460	=	IC50	nM	69.0	CHEMBL2527	Homo sapiens	IC50	nM	69.0
	16897461	CHEMBL3882739	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ADP after 3 hrs by scintillation counting method	B	CN(c1ccc(Cl)cc1)S(=O)(=O)c1ccc(-c2nc3cc(C(N)=O)ccc3[nH]2)cc1		CHEMBL3961522	=	IC50	nM	652.0	CHEMBL2527	Homo sapiens	IC50	nM	652.0
	16897462	CHEMBL3882739	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ADP after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(S(=O)(=O)Nc4ccc(N5CCOCC5)cc4)cc3)nc2c1		CHEMBL3973311	=	IC50	nM	409.0	CHEMBL2527	Homo sapiens	IC50	nM	409.0
	16897463	CHEMBL3882739	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ADP after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(NS(=O)(=O)c4ccc(Cl)c(Cl)c4)cc3)nc2c1		CHEMBL3909679	=	IC50	nM	6.0	CHEMBL2527	Homo sapiens	IC50	nM	6.0
	16897464	CHEMBL3882739	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ADP after 3 hrs by scintillation counting method	B	NC(=O)c1cc2nc(-c3ccc(Oc4ccc(Cl)c(Cl)c4)cc3)[nH]c2cc1Cl		CHEMBL3912368	=	IC50	nM	1500.0	CHEMBL2527	Homo sapiens	IC50	nM	1500.0
	16897465	CHEMBL3882739	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ADP after 3 hrs by scintillation counting method	B	CNC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(OC)cc4)cc3)nc2c1		CHEMBL3948906	=	IC50	nM	601.0	CHEMBL2527	Homo sapiens	IC50	nM	601.0
	16897466	CHEMBL3882739	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ADP after 3 hrs by scintillation counting method	B	CNC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL3982809	=	IC50	nM	608.0	CHEMBL2527	Homo sapiens	IC50	nM	608.0
	16897467	CHEMBL3882739	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ADP after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(S(=O)(=O)c4ccc(Cl)cc4)cc3)nc2c1		CHEMBL193990	=	IC50	nM	7.0	CHEMBL2527	Homo sapiens	IC50	nM	7.0
	16897468	CHEMBL3882739	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ADP after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc([S+]([O-])c4ccc(Cl)cc4)cc3)nc2c1		CHEMBL364978	=	IC50	nM	13.0	CHEMBL2527	Homo sapiens	IC50	nM	13.0
	16897469	CHEMBL3882739	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ADP after 3 hrs by scintillation counting method	B	O=C(O)c1ccc2[nH]c(-c3ccc(S(=O)(=O)c4ccc(Cl)cc4)cc3)nc2c1		CHEMBL3921492	=	IC50	nM	147.0	CHEMBL2527	Homo sapiens	IC50	nM	147.0
	16897470	CHEMBL3882739	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ADP after 3 hrs by scintillation counting method	B	O=C(O)c1ccc2[nH]c(-c3ccc([S+]([O-])c4ccc(Cl)cc4)cc3)nc2c1		CHEMBL3980237	=	IC50	nM	348.0	CHEMBL2527	Homo sapiens	IC50	nM	348.0
	16897471	CHEMBL3882739	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ADP after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)c(Cl)c4)cc3)nc2n1		CHEMBL3924947	=	IC50	nM	35.0	CHEMBL2527	Homo sapiens	IC50	nM	35.0
	16897472	CHEMBL3882739	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ADP after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2n1		CHEMBL206609	=	IC50	nM	77.0	CHEMBL2527	Homo sapiens	IC50	nM	77.0
	16897473	CHEMBL3882739	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ADP after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(N4CCN(c5ccc(F)cc5)CC4)cc3)nc2c1		CHEMBL3929268	=	IC50	nM	34.0	CHEMBL2527	Homo sapiens	IC50	nM	34.0
	16897474	CHEMBL3882739	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ADP after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(N4CCN(c5ccccn5)CC4)cc3)nc2c1		CHEMBL3889622	=	IC50	nM	31.0	CHEMBL2527	Homo sapiens	IC50	nM	31.0
	16897475	CHEMBL3882739	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ADP after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(N4CCN(c5cccc(Cl)c5)CC4)cc3)nc2c1		CHEMBL3939390	=	IC50	nM	31.0	CHEMBL2527	Homo sapiens	IC50	nM	31.0
	16897476	CHEMBL3882739	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ADP after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(N4CCN(c5ccccc5)CC4)cc3)nc2c1		CHEMBL3942083	=	IC50	nM	46.0	CHEMBL2527	Homo sapiens	IC50	nM	46.0
	16897477	CHEMBL3882739	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ADP after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(N4CCN(c5cccc(Cl)c5Cl)CC4)cc3)nc2c1		CHEMBL3929382	=	IC50	nM	117.0	CHEMBL2527	Homo sapiens	IC50	nM	117.0
	16897478	CHEMBL3882739	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ADP after 3 hrs by scintillation counting method	B	COc1ccc(N2CCN(c3ccc(-c4nc5cc(C(N)=O)ccc5[nH]4)cc3)CC2)cc1		CHEMBL3932142	=	IC50	nM	147.0	CHEMBL2527	Homo sapiens	IC50	nM	147.0
	16897479	CHEMBL3882739	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ADP after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(N4CCN(c5ccc([N+](=O)[O-])cc5)CC4)cc3)nc2c1		CHEMBL3961938	=	IC50	nM	643.0	CHEMBL2527	Homo sapiens	IC50	nM	643.0
	16897480	CHEMBL3882739	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ADP after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc5c(c4)OCO5)cc3)nc2c1		CHEMBL3894138	=	IC50	nM	14.0	CHEMBL2527	Homo sapiens	IC50	nM	14.0
	16897481	CHEMBL3882739	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ADP after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(N)cc4)cc3)nc2c1		CHEMBL3956680	=	IC50	nM	30.0	CHEMBL2527	Homo sapiens	IC50	nM	30.0
	16897482	CHEMBL3882739	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ADP after 3 hrs by scintillation counting method	B	CS(=O)(=O)Nc1ccc(Oc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)cc1		CHEMBL363339	=	IC50	nM	46.0	CHEMBL2527	Homo sapiens	IC50	nM	46.0
	16897483	CHEMBL3882739	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ADP after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(Sc4ccc(O)cc4)cc3)nc2c1		CHEMBL195041	=	IC50	nM	2.0	CHEMBL2527	Homo sapiens	IC50	nM	2.0
	16897484	CHEMBL3882739	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ADP after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Br)c(O)c4)cc3)nc2c1		CHEMBL3894962	=	IC50	nM	4.0	CHEMBL2527	Homo sapiens	IC50	nM	4.0
	16897485	CHEMBL3882739	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ADP after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4O)cc3)nc2c1		CHEMBL3942698	=	IC50	nM	9.0	CHEMBL2527	Homo sapiens	IC50	nM	9.0
	16897486	CHEMBL3882739	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ADP after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)c(O)c4)cc3)nc2c1		CHEMBL175472	=	IC50	nM	10.0	CHEMBL2527	Homo sapiens	IC50	nM	10.0
	16897487	CHEMBL3882739	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ADP after 3 hrs by scintillation counting method	B	NS(=O)(=O)c1ccc2[nH]c(-c3ccc(Sc4ccc(F)c(Cl)c4)cc3)nc2c1		CHEMBL3952374	=	IC50	nM	33.0	CHEMBL2527	Homo sapiens	IC50	nM	33.0
	16897488	CHEMBL3882739	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ADP after 3 hrs by scintillation counting method	B	NS(=O)(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc5ccccc5c4)cc3)nc2c1		CHEMBL3949750	=	IC50	nM	46.0	CHEMBL2527	Homo sapiens	IC50	nM	46.0
	16897489	CHEMBL3882739	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ADP after 3 hrs by scintillation counting method	B	NS(=O)(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)c(C(F)(F)F)c4)cc3)nc2c1		CHEMBL3893157	=	IC50	nM	41.0	CHEMBL2527	Homo sapiens	IC50	nM	41.0
	16897490	CHEMBL3882739	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ADP after 3 hrs by scintillation counting method	B	NS(O)(O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL3918849	=	IC50	nM	55.0	CHEMBL2527	Homo sapiens	IC50	nM	55.0
	16897491	CHEMBL3882739	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ADP after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(S(=O)(=O)Nc4ccc(Cl)cc4Cl)cc3)nc2c1		CHEMBL3971843	=	IC50	nM	16.0	CHEMBL2527	Homo sapiens	IC50	nM	16.0
	16897492	CHEMBL3882739	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ADP after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4cccc(Cl)c4)c([N+](=O)[O-])c3)nc2c1		CHEMBL3924211	=	IC50	nM	11.0	CHEMBL2527	Homo sapiens	IC50	nM	11.0
	16897493	CHEMBL3882739	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ADP after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(I)cc4)cc3)nc2c1		CHEMBL3931376	=	IC50	nM	6.0	CHEMBL2527	Homo sapiens	IC50	nM	6.0
	16897494	CHEMBL3882739	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ADP after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(C(=O)Nc4ccccc4)cc3)nc2c1		CHEMBL193394	=	IC50	nM	410.0	CHEMBL2527	Homo sapiens	IC50	nM	410.0
	16897495	CHEMBL3882739	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ADP after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(C(=O)Nc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL195598	=	IC50	nM	679.0	CHEMBL2527	Homo sapiens	IC50	nM	679.0
	16897496	CHEMBL3882739	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ADP after 3 hrs by scintillation counting method	B	CN(C(=O)c1ccc(-c2nc3cc(C(N)=O)ccc3[nH]2)cc1)c1ccc(Cl)cc1		CHEMBL3979896	=	IC50	nM	896.0	CHEMBL2527	Homo sapiens	IC50	nM	896.0
	16897497	CHEMBL3882739	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ADP after 3 hrs by scintillation counting method	B	COc1ccc(Sc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)cc1		CHEMBL3917001	=	IC50	nM	5.0	CHEMBL2527	Homo sapiens	IC50	nM	5.0
	16897498	CHEMBL3882739	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ADP after 3 hrs by scintillation counting method	B	COc1cccc(Sc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)c1		CHEMBL3919738	=	IC50	nM	13.0	CHEMBL2527	Homo sapiens	IC50	nM	13.0
	16897499	CHEMBL3882739	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ADP after 3 hrs by scintillation counting method	B	COc1cc(Oc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)ccc1Br		CHEMBL3956891	=	IC50	nM	5.0	CHEMBL2527	Homo sapiens	IC50	nM	5.0
	16897515	CHEMBL3882742	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-adenosine triphosphate after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(S(=O)(=O)N4Cc5ccccc5C4)cc3)nc2c1		CHEMBL3911761	=	IC50	nM	9.0	CHEMBL2527	Homo sapiens	IC50	nM	9.0
	16897516	CHEMBL3882742	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-adenosine triphosphate after 3 hrs by scintillation counting method	B	Cc1ccccc1CNS(=O)(=O)c1ccc(-c2nc3cc(C(N)=O)ccc3[nH]2)cc1		CHEMBL3983526	=	IC50	nM	42.0	CHEMBL2527	Homo sapiens	IC50	nM	42.0
	16897517	CHEMBL3882742	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-adenosine triphosphate after 3 hrs by scintillation counting method	B	COc1ccccc1C(O)c1ccc(-c2nc3cc(C(N)=O)ccc3[nH]2)cc1		CHEMBL3947799	=	IC50	nM	272.0	CHEMBL2527	Homo sapiens	IC50	nM	272.0
	16897518	CHEMBL3882742	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-adenosine triphosphate after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(C(O)c4ccc(Cl)cc4Cl)cc3)nc2c1		CHEMBL3931377	=	IC50	nM	14.0	CHEMBL2527	Homo sapiens	IC50	nM	14.0
	16897519	CHEMBL3882742	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-adenosine triphosphate after 3 hrs by scintillation counting method	B	Cc1ccccc1Cc1ccc(-c2nc3cc(C(N)=O)ccc3[nH]2)cc1		CHEMBL3933503	=	IC50	nM	42.0	CHEMBL2527	Homo sapiens	IC50	nM	42.0
	16897520	CHEMBL3882742	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-adenosine triphosphate after 3 hrs by scintillation counting method	B	COc1ccccc1Cc1ccc(-c2nc3cc(C(N)=O)ccc3[nH]2)cc1		CHEMBL3930812	=	IC50	nM	45.0	CHEMBL2527	Homo sapiens	IC50	nM	45.0
	16897521	CHEMBL3882742	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-adenosine triphosphate after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(Cc4cc5c(cc4Cl)OCO5)cc3)nc2c1		CHEMBL3910004	=	IC50	nM	41.0	CHEMBL2527	Homo sapiens	IC50	nM	41.0
	16897522	CHEMBL3882742	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-adenosine triphosphate after 3 hrs by scintillation counting method	B	Cc1ccccc1C(O)c1ccc(-c2nc3cc(C(N)=O)ccc3[nH]2)cc1		CHEMBL3907188	=	IC50	nM	114.0	CHEMBL2527	Homo sapiens	IC50	nM	114.0
	16897523	CHEMBL3882742	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-adenosine triphosphate after 3 hrs by scintillation counting method	B	Cc1cccc(CNS(=O)(=O)c2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)c1		CHEMBL3895497	=	IC50	nM	50.0	CHEMBL2527	Homo sapiens	IC50	nM	50.0
	16897524	CHEMBL3882742	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-adenosine triphosphate after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(C(O)c4ccccc4Cl)cc3)nc2c1		CHEMBL3931050	=	IC50	nM	80.0	CHEMBL2527	Homo sapiens	IC50	nM	80.0
	16897525	CHEMBL3882742	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-adenosine triphosphate after 3 hrs by scintillation counting method	B	CC(NS(=O)(=O)c1ccc(-c2nc3cc(C(N)=O)ccc3[nH]2)cc1)c1ccccc1		CHEMBL3978421	=	IC50	nM	181.0	CHEMBL2527	Homo sapiens	IC50	nM	181.0
	16897526	CHEMBL3882742	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-adenosine triphosphate after 3 hrs by scintillation counting method	B	CCc1ccc(Cc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)cc1		CHEMBL3901442	=	IC50	nM	12.0	CHEMBL2527	Homo sapiens	IC50	nM	12.0
	16897527	CHEMBL3882742	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-adenosine triphosphate after 3 hrs by scintillation counting method	B	Cc1ccc(Cc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)cc1C		CHEMBL3904143	=	IC50	nM	5.0	CHEMBL2527	Homo sapiens	IC50	nM	5.0
	16897528	CHEMBL3882742	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-adenosine triphosphate after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(C(O)c4cnc5ccccc5c4)cc3)nc2c1		CHEMBL3897209	=	IC50	nM	9.0	CHEMBL2527	Homo sapiens	IC50	nM	9.0
	16897529	CHEMBL3882742	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-adenosine triphosphate after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(C(O)c4ccc5c(c4)OCCO5)cc3)nc2c1		CHEMBL3982061	=	IC50	nM	47.0	CHEMBL2527	Homo sapiens	IC50	nM	47.0
	16897530	CHEMBL3882742	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-adenosine triphosphate after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(C(O)c4ccc5c(c4)OCO5)cc3)nc2c1		CHEMBL3938370	=	IC50	nM	23.0	CHEMBL2527	Homo sapiens	IC50	nM	23.0
	16897531	CHEMBL3882742	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-adenosine triphosphate after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(C(=O)c4ccc(Cl)c(C(F)(F)F)c4)cc3)nc2c1		CHEMBL3926180	=	IC50	nM	11.0	CHEMBL2527	Homo sapiens	IC50	nM	11.0
	16897532	CHEMBL3882742	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-adenosine triphosphate after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(C(=O)c4ccc5ccccc5c4)cc3)nc2c1		CHEMBL3909860	=	IC50	nM	7.0	CHEMBL2527	Homo sapiens	IC50	nM	7.0
	16897533	CHEMBL3882742	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-adenosine triphosphate after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(C(=O)c4cccs4)cc3)nc2c1		CHEMBL3904920	=	IC50	nM	77.0	CHEMBL2527	Homo sapiens	IC50	nM	77.0
	16897534	CHEMBL3882742	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-adenosine triphosphate after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(C(=O)C4CCOCC4)cc3)nc2c1		CHEMBL3956671	=	IC50	nM	182.0	CHEMBL2527	Homo sapiens	IC50	nM	182.0
	16897535	CHEMBL3882742	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-adenosine triphosphate after 3 hrs by scintillation counting method	B	CCc1ccc(C(O)c2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)cc1		CHEMBL3922168	=	IC50	nM	13.0	CHEMBL2527	Homo sapiens	IC50	nM	13.0
	16897536	CHEMBL3882742	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-adenosine triphosphate after 3 hrs by scintillation counting method	B	CN(Cc1ccccc1)S(=O)(=O)c1ccc(-c2nc3cc(C(N)=O)ccc3[nH]2)cc1		CHEMBL3954095	=	IC50	nM	290.0	CHEMBL2527	Homo sapiens	IC50	nM	290.0
	16897537	CHEMBL3882742	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-adenosine triphosphate after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(Cc4ccc5ccccc5c4)cc3)nc2c1		CHEMBL3947096	=	IC50	nM	5.0	CHEMBL2527	Homo sapiens	IC50	nM	5.0
	16897538	CHEMBL3882742	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-adenosine triphosphate after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(C(=O)c4ccncc4)cc3)nc2c1		CHEMBL3896690	=	IC50	nM	240.0	CHEMBL2527	Homo sapiens	IC50	nM	240.0
	16897539	CHEMBL3882742	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-adenosine triphosphate after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(Cc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL3949796	=	IC50	nM	4.0	CHEMBL2527	Homo sapiens	IC50	nM	4.0
	16897540	CHEMBL3882742	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-adenosine triphosphate after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(S(=O)(=O)NCc4ccccc4)cc3)nc2c1		CHEMBL3964913	=	IC50	nM	56.0	CHEMBL2527	Homo sapiens	IC50	nM	56.0
	16897541	CHEMBL3882742	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-adenosine triphosphate after 3 hrs by scintillation counting method	B	CNCCN(C)C(c1ccc(Cl)cc1)c1ccc(-c2nc3cc(C(N)=O)ccc3[nH]2)cc1		CHEMBL3966673	=	IC50	nM	113.0	CHEMBL2527	Homo sapiens	IC50	nM	113.0
	16897542	CHEMBL3882742	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-adenosine triphosphate after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(S(=O)(=O)NCc4ccncc4)cc3)nc2c1		CHEMBL3960448	=	IC50	nM	134.0	CHEMBL2527	Homo sapiens	IC50	nM	134.0
	16897543	CHEMBL3882742	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-adenosine triphosphate after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(C(O)c4cccs4)cc3)nc2c1		CHEMBL3954326	=	IC50	nM	42.0	CHEMBL2527	Homo sapiens	IC50	nM	42.0
	16897544	CHEMBL3882742	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-adenosine triphosphate after 3 hrs by scintillation counting method	B	COC(c1ccccc1)c1ccc(-c2nc3cc(C(N)=O)ccc3[nH]2)cc1		CHEMBL3985497	=	IC50	nM	42.0	CHEMBL2527	Homo sapiens	IC50	nM	42.0
	16897545	CHEMBL3882742	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-adenosine triphosphate after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(S(=O)(=O)NCc4ccc(Cl)c(Cl)c4)cc3)nc2c1		CHEMBL3919154	=	IC50	nM	99.0	CHEMBL2527	Homo sapiens	IC50	nM	99.0
	16897546	CHEMBL3882742	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-adenosine triphosphate after 3 hrs by scintillation counting method	B	COc1ccc(C(=O)c2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)cc1		CHEMBL3951443	=	IC50	nM	43.0	CHEMBL2527	Homo sapiens	IC50	nM	43.0
	16897547	CHEMBL3882742	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-adenosine triphosphate after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(S(=O)(=O)NCc4cccs4)cc3)nc2c1		CHEMBL3925035	=	IC50	nM	19.0	CHEMBL2527	Homo sapiens	IC50	nM	19.0
	16897548	CHEMBL3882742	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-adenosine triphosphate after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(C(=O)c4cnc5ccccc5c4)cc3)nc2c1		CHEMBL3908369	=	IC50	nM	38.0	CHEMBL2527	Homo sapiens	IC50	nM	38.0
	16897549	CHEMBL3882742	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-adenosine triphosphate after 3 hrs by scintillation counting method	B	Cc1ccc(C(O)c2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)cc1C		CHEMBL3919437	=	IC50	nM	7.0	CHEMBL2527	Homo sapiens	IC50	nM	7.0
	16897550	CHEMBL3882742	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-adenosine triphosphate after 3 hrs by scintillation counting method	B	Cc1ccc(C(=O)c2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)cc1		CHEMBL3948826	=	IC50	nM	33.0	CHEMBL2527	Homo sapiens	IC50	nM	33.0
	16897551	CHEMBL3882742	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-adenosine triphosphate after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(C(O)c4ccc(Cl)c(Cl)c4)cc3)nc2c1		CHEMBL3968771	=	IC50	nM	8.0	CHEMBL2527	Homo sapiens	IC50	nM	8.0
	16897552	CHEMBL3882742	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-adenosine triphosphate after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(C(O)C4CCCCC4)cc3)nc2c1		CHEMBL3890448	=	IC50	nM	98.0	CHEMBL2527	Homo sapiens	IC50	nM	98.0
	16897553	CHEMBL3882742	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-adenosine triphosphate after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(C(O)c4cc5c(cc4Cl)OCO5)cc3)nc2c1		CHEMBL3970535	=	IC50	nM	40.0	CHEMBL2527	Homo sapiens	IC50	nM	40.0
	16897554	CHEMBL3882742	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-adenosine triphosphate after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(S(=O)(=O)NCc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL3916397	=	IC50	nM	66.0	CHEMBL2527	Homo sapiens	IC50	nM	66.0
	16897555	CHEMBL3882742	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-adenosine triphosphate after 3 hrs by scintillation counting method	B	COc1ccc(CNS(=O)(=O)c2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)cc1		CHEMBL3950243	=	IC50	nM	150.0	CHEMBL2527	Homo sapiens	IC50	nM	150.0
	16897556	CHEMBL3882742	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-adenosine triphosphate after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(C(=O)c4ccc(Cl)cc4)cc3)nc2c1		CHEMBL3913670	=	IC50	nM	43.0	CHEMBL2527	Homo sapiens	IC50	nM	43.0
	16897557	CHEMBL3882742	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-adenosine triphosphate after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(C(O)c4ccc5ccccc5c4)cc3)nc2c1		CHEMBL3933085	=	IC50	nM	5.0	CHEMBL2527	Homo sapiens	IC50	nM	5.0
	16897558	CHEMBL3882742	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-adenosine triphosphate after 3 hrs by scintillation counting method	B	COc1cc(C(O)c2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)cc(Br)c1OC		CHEMBL3985771	=	IC50	nM	71.0	CHEMBL2527	Homo sapiens	IC50	nM	71.0
	16897559	CHEMBL3882742	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-adenosine triphosphate after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(C(O)C4CCOCC4)cc3)nc2c1		CHEMBL3956937	=	IC50	nM	1100.0	CHEMBL2527	Homo sapiens	IC50	nM	1100.0
	16897560	CHEMBL3882742	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-adenosine triphosphate after 3 hrs by scintillation counting method	B	Cc1ccc(CNS(=O)(=O)c2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)cc1		CHEMBL3970424	=	IC50	nM	112.0	CHEMBL2527	Homo sapiens	IC50	nM	112.0
	16897561	CHEMBL3882742	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-adenosine triphosphate after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(S(=O)(=O)N4CCc5ccccc54)cc3)nc2c1		CHEMBL3941646	=	IC50	nM	18.0	CHEMBL2527	Homo sapiens	IC50	nM	18.0
	16897562	CHEMBL3882742	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-adenosine triphosphate after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(C(=O)c4ccc5c(c4)OCO5)cc3)nc2c1		CHEMBL3958455	=	IC50	nM	36.0	CHEMBL2527	Homo sapiens	IC50	nM	36.0
	16897563	CHEMBL3882742	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-adenosine triphosphate after 3 hrs by scintillation counting method	B	CC(c1ccc(Cl)cc1)c1ccc(-c2nc3cc(C(N)=O)ccc3[nH]2)cc1		CHEMBL3930129	=	IC50	nM	5.0	CHEMBL2527	Homo sapiens	IC50	nM	5.0
	16897564	CHEMBL3882742	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-adenosine triphosphate after 3 hrs by scintillation counting method	B	COc1ccc(C(O)c2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)cc1		CHEMBL3965842	=	IC50	nM	33.0	CHEMBL2527	Homo sapiens	IC50	nM	33.0
	16897565	CHEMBL3882742	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-adenosine triphosphate after 3 hrs by scintillation counting method	B	Cc1ccc(C(O)c2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)cc1		CHEMBL3968271	=	IC50	nM	16.0	CHEMBL2527	Homo sapiens	IC50	nM	16.0
	16897566	CHEMBL3882742	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-adenosine triphosphate after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(C(O)c4ccc(Cl)cc4)cc3)nc2c1		CHEMBL3943846	=	IC50	nM	9.0	CHEMBL2527	Homo sapiens	IC50	nM	9.0
	16897567	CHEMBL3882742	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-adenosine triphosphate after 3 hrs by scintillation counting method	B	Cc1ccccc1C(=O)c1ccc(-c2nc3cc(C(N)=O)ccc3[nH]2)cc1		CHEMBL3916661	=	IC50	nM	40.0	CHEMBL2527	Homo sapiens	IC50	nM	40.0
	16897568	CHEMBL3882742	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-adenosine triphosphate after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(C(=O)c4ccccc4)cc3)nc2c1		CHEMBL3896405	=	IC50	nM	64.0	CHEMBL2527	Homo sapiens	IC50	nM	64.0
	16897569	CHEMBL3882742	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-adenosine triphosphate after 3 hrs by scintillation counting method	B	COc1ccccc1C(=O)c1ccc(-c2nc3cc(C(N)=O)ccc3[nH]2)cc1		CHEMBL3919402	=	IC50	nM	170.0	CHEMBL2527	Homo sapiens	IC50	nM	170.0
	16897570	CHEMBL3882742	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-adenosine triphosphate after 3 hrs by scintillation counting method	B	CN(c1ccccc1)c1ccc(-c2nc3cc(C(N)=O)ccc3[nH]2)cc1		CHEMBL3902704	=	IC50	nM	38.0	CHEMBL2527	Homo sapiens	IC50	nM	38.0
	16897571	CHEMBL3882742	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-adenosine triphosphate after 3 hrs by scintillation counting method	B	CCc1ccc(C(=O)c2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)cc1		CHEMBL3971801	=	IC50	nM	13.0	CHEMBL2527	Homo sapiens	IC50	nM	13.0
	16897572	CHEMBL3882742	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-adenosine triphosphate after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(C(O)c4ccncc4)cc3)nc2c1		CHEMBL3899916	=	IC50	nM	164.0	CHEMBL2527	Homo sapiens	IC50	nM	164.0
	16897573	CHEMBL3882742	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-adenosine triphosphate after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(S(=O)(=O)N[C@H]4CCc5ccccc54)cc3)nc2c1		CHEMBL3904091	=	IC50	nM	10.0	CHEMBL2527	Homo sapiens	IC50	nM	10.0
	16897574	CHEMBL3882742	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-adenosine triphosphate after 3 hrs by scintillation counting method	B	Cc1ccc(C(=O)c2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)cc1C		CHEMBL3939843	=	IC50	nM	17.0	CHEMBL2527	Homo sapiens	IC50	nM	17.0
	16897575	CHEMBL3882742	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-adenosine triphosphate after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(C(c4ccc(Cl)cc4)N4CCNCC4)cc3)nc2c1		CHEMBL3961648	=	IC50	nM	264.0	CHEMBL2527	Homo sapiens	IC50	nM	264.0
	16897576	CHEMBL3882742	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-adenosine triphosphate after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(S(=O)(=O)NCc4ccco4)cc3)nc2c1		CHEMBL3923965	=	IC50	nM	37.0	CHEMBL2527	Homo sapiens	IC50	nM	37.0
	16897577	CHEMBL3882742	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-adenosine triphosphate after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(C4(c5ccc(Cl)cc5)OCCO4)cc3)nc2c1		CHEMBL3929480	=	IC50	nM	66.0	CHEMBL2527	Homo sapiens	IC50	nM	66.0
	16897578	CHEMBL3882742	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-adenosine triphosphate after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(C(=O)c4ccc5c(c4)OCCO5)cc3)nc2c1		CHEMBL3955816	=	IC50	nM	39.0	CHEMBL2527	Homo sapiens	IC50	nM	39.0
	16897579	CHEMBL3882742	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-adenosine triphosphate after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(C(O)c4ccccc4)cc3)nc2c1		CHEMBL3982891	=	IC50	nM	29.0	CHEMBL2527	Homo sapiens	IC50	nM	29.0
	16897580	CHEMBL3882742	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-adenosine triphosphate after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(C(=O)c4ccc(Cl)c(Cl)c4)cc3)nc2c1		CHEMBL3967758	=	IC50	nM	7.0	CHEMBL2527	Homo sapiens	IC50	nM	7.0
	16897581	CHEMBL3882742	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-adenosine triphosphate after 3 hrs by scintillation counting method	B	C=C(c1ccc(Cl)cc1)c1ccc(-c2nc3cc(C(N)=O)ccc3[nH]2)cc1		CHEMBL3980850	=	IC50	nM	3.0	CHEMBL2527	Homo sapiens	IC50	nM	3.0
	16897582	CHEMBL3882742	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-adenosine triphosphate after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(CC4CCCCC4)cc3)nc2c1		CHEMBL3953620	=	IC50	nM	171.0	CHEMBL2527	Homo sapiens	IC50	nM	171.0
	16897583	CHEMBL3882742	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-adenosine triphosphate after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(C(=O)c4ccc(Cl)cc4Cl)cc3)nc2c1		CHEMBL3940297	=	IC50	nM	18.0	CHEMBL2527	Homo sapiens	IC50	nM	18.0
	16897584	CHEMBL3882742	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-adenosine triphosphate after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(S(=O)(=O)NC4CCCc5ccccc54)cc3)nc2c1		CHEMBL3889698	=	IC50	nM	16.0	CHEMBL2527	Homo sapiens	IC50	nM	16.0
	16897585	CHEMBL3882742	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-adenosine triphosphate after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(C4(c5ccccc5)OCCO4)cc3)nc2c1		CHEMBL3965786	=	IC50	nM	55.0	CHEMBL2527	Homo sapiens	IC50	nM	55.0
	16897586	CHEMBL3882742	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-adenosine triphosphate after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(Cc4ccc5c(c4)OCCO5)cc3)nc2c1		CHEMBL3935525	=	IC50	nM	26.0	CHEMBL2527	Homo sapiens	IC50	nM	26.0
	16897587	CHEMBL3882742	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-adenosine triphosphate after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(C(=O)c4ccccc4Cl)cc3)nc2c1		CHEMBL3942931	=	IC50	nM	49.0	CHEMBL2527	Homo sapiens	IC50	nM	49.0
	16897588	CHEMBL3882742	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-adenosine triphosphate after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(C(=O)c4cc5c(cc4Cl)OCO5)cc3)nc2c1		CHEMBL3895207	=	IC50	nM	54.0	CHEMBL2527	Homo sapiens	IC50	nM	54.0
	16897589	CHEMBL3882742	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-adenosine triphosphate after 3 hrs by scintillation counting method	B	COc1cc(C(=O)c2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)cc(Br)c1OC		CHEMBL3962849	=	IC50	nM	34.0	CHEMBL2527	Homo sapiens	IC50	nM	34.0
	16897590	CHEMBL3882742	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-adenosine triphosphate after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(C(O)c4ccc(Cl)c(C(F)(F)F)c4)cc3)nc2c1		CHEMBL3935794	=	IC50	nM	4.0	CHEMBL2527	Homo sapiens	IC50	nM	4.0
	16897591	CHEMBL3882742	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-adenosine triphosphate after 3 hrs by scintillation counting method	B	NS(=O)(=O)c1ccc2[nH]c(-c3ccc(C(=O)c4ccc(Cl)cc4)cc3)nc2c1		CHEMBL3983794	=	IC50	nM	192.0	CHEMBL2527	Homo sapiens	IC50	nM	192.0
	16897592	CHEMBL3882742	Inhibition of recombinant human CDS1 using N-terminal biotin-labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-adenosine triphosphate after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(C(=O)C4CCCCC4)cc3)nc2c1		CHEMBL3944471	=	IC50	nM	32.0	CHEMBL2527	Homo sapiens	IC50	nM	32.0
	16897593	CHEMBL3882743	Inhibition of human CDS1 using N-terminal biotin labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ATP after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(OCCC4CCCCN4C(=O)c4ccccc4)cc3)nc2c1		CHEMBL250359	=	IC50	nM	52.0	CHEMBL2527	Homo sapiens	IC50	nM	52.0
	16897594	CHEMBL3882743	Inhibition of human CDS1 using N-terminal biotin labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ATP after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(OCC4CCCN(Cc5ccc(Cl)c(Cl)c5)C4)cc3)nc2c1		CHEMBL399933	=	IC50	nM	75.0	CHEMBL2527	Homo sapiens	IC50	nM	75.0
	16897595	CHEMBL3882743	Inhibition of human CDS1 using N-terminal biotin labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ATP after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(OCCC4CCCCN4Cc4ccc(Cl)c(Cl)c4)cc3)nc2c1		CHEMBL251155	=	IC50	nM	30.0	CHEMBL2527	Homo sapiens	IC50	nM	30.0
	16897596	CHEMBL3882743	Inhibition of human CDS1 using N-terminal biotin labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ATP after 3 hrs by scintillation counting method	B	CC(C)(C)OC(=O)N1CCC(Oc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)CC1		CHEMBL3963137	=	IC50	nM	93.0	CHEMBL2527	Homo sapiens	IC50	nM	93.0
	16897597	CHEMBL3882743	Inhibition of human CDS1 using N-terminal biotin labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ATP after 3 hrs by scintillation counting method	B	CN(C)CCCOc1cccc(-c2nc3cc(C(N)=O)ccc3[nH]2)c1		CHEMBL3910547	=	IC50	nM	836.0	CHEMBL2527	Homo sapiens	IC50	nM	836.0
	16897598	CHEMBL3882743	Inhibition of human CDS1 using N-terminal biotin labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ATP after 3 hrs by scintillation counting method	B	CC(=O)N1CCCC(COc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)C1		CHEMBL250566	=	IC50	nM	140.0	CHEMBL2527	Homo sapiens	IC50	nM	140.0
	16897599	CHEMBL3882743	Inhibition of human CDS1 using N-terminal biotin labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ATP after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(OCC4CCCN(Cc5ccc(Cl)cc5)C4)cc3)nc2c1		CHEMBL248935	=	IC50	nM	35.0	CHEMBL2527	Homo sapiens	IC50	nM	35.0
	16897600	CHEMBL3882743	Inhibition of human CDS1 using N-terminal biotin labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ATP after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(OCCC4CCCCN4Cc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL398529	=	IC50	nM	53.0	CHEMBL2527	Homo sapiens	IC50	nM	53.0
	16897601	CHEMBL3882743	Inhibition of human CDS1 using N-terminal biotin labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ATP after 3 hrs by scintillation counting method	B	CC(C)(C)OC(=O)N1CCCC(Oc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)C1		CHEMBL3975740	=	IC50	nM	65.0	CHEMBL2527	Homo sapiens	IC50	nM	65.0
	16897602	CHEMBL3882743	Inhibition of human CDS1 using N-terminal biotin labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ATP after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(OC[C@H]4CC[C@H](O)CC4)cc3)nc2c1		CHEMBL3964628	=	IC50	nM	400.0	CHEMBL2527	Homo sapiens	IC50	nM	400.0
	16897603	CHEMBL3882743	Inhibition of human CDS1 using N-terminal biotin labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ATP after 3 hrs by scintillation counting method	B	CC(=O)N1CCC(Oc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)CC1		CHEMBL3920003	=	IC50	nM	140.0	CHEMBL2527	Homo sapiens	IC50	nM	140.0
	16897604	CHEMBL3882743	Inhibition of human CDS1 using N-terminal biotin labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ATP after 3 hrs by scintillation counting method	B	Cc1ccc(CN2CCCC(COc3ccc(-c4nc5cc(C(N)=O)ccc5[nH]4)cc3)C2)cc1		CHEMBL250963	=	IC50	nM	57.0	CHEMBL2527	Homo sapiens	IC50	nM	57.0
	16897605	CHEMBL3882743	Inhibition of human CDS1 using N-terminal biotin labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ATP after 3 hrs by scintillation counting method	B	Cc1ccc(CN2CCCCC2CCOc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)cc1		CHEMBL250759	=	IC50	nM	61.0	CHEMBL2527	Homo sapiens	IC50	nM	61.0
	16897606	CHEMBL3882743	Inhibition of human CDS1 using N-terminal biotin labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ATP after 3 hrs by scintillation counting method	B	CC(C)(C)OC(=O)N1CCCCC1CCOc1ccc(-c2nc3cc(C(N)=O)ccc3[nH]2)cc1		CHEMBL3914992	=	IC50	nM	89.0	CHEMBL2527	Homo sapiens	IC50	nM	89.0
	16897607	CHEMBL3882743	Inhibition of human CDS1 using N-terminal biotin labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ATP after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(OC4CCC(O)CC4)cc3)nc2c1		CHEMBL249569	=	IC50	nM	80.0	CHEMBL2527	Homo sapiens	IC50	nM	80.0
	16897608	CHEMBL3882743	Inhibition of human CDS1 using N-terminal biotin labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ATP after 3 hrs by scintillation counting method	B	CC(=O)N1CCCC(Oc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)C1		CHEMBL250361	=	IC50	nM	100.0	CHEMBL2527	Homo sapiens	IC50	nM	100.0
	16897609	CHEMBL3882743	Inhibition of human CDS1 using N-terminal biotin labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ATP after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(OCC4CCCN(Cc5ccccc5)C4)cc3)nc2c1		CHEMBL250765	=	IC50	nM	37.0	CHEMBL2527	Homo sapiens	IC50	nM	37.0
	16897610	CHEMBL3882743	Inhibition of human CDS1 using N-terminal biotin labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ATP after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(OCC4CCCNC4)cc3)nc2c1		CHEMBL249776	=	IC50	nM	158.0	CHEMBL2527	Homo sapiens	IC50	nM	158.0
	16897611	CHEMBL3882743	Inhibition of human CDS1 using N-terminal biotin labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ATP after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(OC4CCN(Cc5ccccc5)C4)cc3)nc2c1		CHEMBL248934	=	IC50	nM	84.0	CHEMBL2527	Homo sapiens	IC50	nM	84.0
	16897612	CHEMBL3882743	Inhibition of human CDS1 using N-terminal biotin labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ATP after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(OC4CCC(O)C4)cc3)nc2c1		CHEMBL250992	=	IC50	nM	72.0	CHEMBL2527	Homo sapiens	IC50	nM	72.0
	16897613	CHEMBL3882743	Inhibition of human CDS1 using N-terminal biotin labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ATP after 3 hrs by scintillation counting method	B	CC(=O)N1CCCCC1CCOc1ccc(-c2nc3cc(C(N)=O)ccc3[nH]2)cc1		CHEMBL400980	=	IC50	nM	292.0	CHEMBL2527	Homo sapiens	IC50	nM	292.0
	16897614	CHEMBL3882743	Inhibition of human CDS1 using N-terminal biotin labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ATP after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(OCCC4CCN(Cc5ccc(Cl)c(Cl)c5)CC4)cc3)nc2c1		CHEMBL249541	=	IC50	nM	157.0	CHEMBL2527	Homo sapiens	IC50	nM	157.0
	16897615	CHEMBL3882743	Inhibition of human CDS1 using N-terminal biotin labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ATP after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(OC4CCNCC4)cc3)nc2c1		CHEMBL251368	=	IC50	nM	710.0	CHEMBL2527	Homo sapiens	IC50	nM	710.0
	16897616	CHEMBL3882743	Inhibition of human CDS1 using N-terminal biotin labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ATP after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(OC4CCCN(Cc5ccccc5)C4)cc3)nc2c1		CHEMBL3939511	=	IC50	nM	63.0	CHEMBL2527	Homo sapiens	IC50	nM	63.0
	16897617	CHEMBL3882743	Inhibition of human CDS1 using N-terminal biotin labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ATP after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(OCCCO)cc3)nc2c1		CHEMBL250796	=	IC50	nM	73.0	CHEMBL2527	Homo sapiens	IC50	nM	73.0
	16897618	CHEMBL3882743	Inhibition of human CDS1 using N-terminal biotin labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ATP after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(OCC4CCN(Cc5ccc(Cl)c(Cl)c5)CC4)cc3)nc2c1		CHEMBL251364	=	IC50	nM	110.0	CHEMBL2527	Homo sapiens	IC50	nM	110.0
	16897619	CHEMBL3882743	Inhibition of human CDS1 using N-terminal biotin labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ATP after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(OCCC4CCN(Cc5ccc(Cl)cc5)CC4)cc3)nc2c1		CHEMBL438868	=	IC50	nM	82.0	CHEMBL2527	Homo sapiens	IC50	nM	82.0
	16897620	CHEMBL3882743	Inhibition of human CDS1 using N-terminal biotin labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ATP after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(OC4CCCNC4)cc3)nc2c1		CHEMBL400287	=	IC50	nM	180.0	CHEMBL2527	Homo sapiens	IC50	nM	180.0
	16897621	CHEMBL3882743	Inhibition of human CDS1 using N-terminal biotin labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ATP after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(OC4CCN(Cc5ccccc5)CC4)cc3)nc2c1		CHEMBL3934741	=	IC50	nM	52.0	CHEMBL2527	Homo sapiens	IC50	nM	52.0
	16897622	CHEMBL3882743	Inhibition of human CDS1 using N-terminal biotin labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ATP after 3 hrs by scintillation counting method	B	COc1ccc(CN2CCC(COc3ccc(-c4nc5cc(C(N)=O)ccc5[nH]4)cc3)CC2)cc1		CHEMBL250159	=	IC50	nM	67.0	CHEMBL2527	Homo sapiens	IC50	nM	67.0
	16897623	CHEMBL3882743	Inhibition of human CDS1 using N-terminal biotin labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ATP after 3 hrs by scintillation counting method	B	Cc1ccc(CN2CCC(CCOc3ccc(-c4nc5cc(C(N)=O)ccc5[nH]4)cc3)CC2)cc1		CHEMBL249345	=	IC50	nM	90.0	CHEMBL2527	Homo sapiens	IC50	nM	90.0
	16897624	CHEMBL3882743	Inhibition of human CDS1 using N-terminal biotin labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ATP after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(OCCC4CCCCN4)cc3)nc2c1		CHEMBL3898416	=	IC50	nM	138.0	CHEMBL2527	Homo sapiens	IC50	nM	138.0
	16897625	CHEMBL3882743	Inhibition of human CDS1 using N-terminal biotin labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ATP after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(OCCN4CCCCC4)cc3)nc2c1		CHEMBL249350	=	IC50	nM	174.0	CHEMBL2527	Homo sapiens	IC50	nM	174.0
	16897626	CHEMBL3882743	Inhibition of human CDS1 using N-terminal biotin labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ATP after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(OCC4CCN(C(=O)c5ccccc5)CC4)cc3)nc2c1		CHEMBL250158	=	IC50	nM	52.0	CHEMBL2527	Homo sapiens	IC50	nM	52.0
	16897627	CHEMBL3882743	Inhibition of human CDS1 using N-terminal biotin labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ATP after 3 hrs by scintillation counting method	B	Cc1ccc(CN2CCC(COc3ccc(-c4nc5cc(C(N)=O)ccc5[nH]4)cc3)CC2)cc1		CHEMBL398467	=	IC50	nM	76.0	CHEMBL2527	Homo sapiens	IC50	nM	76.0
	16897628	CHEMBL3882743	Inhibition of human CDS1 using N-terminal biotin labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ATP after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(OCCC4CCN(Cc5ccccc5)CC4)cc3)nc2c1		CHEMBL399146	=	IC50	nM	90.0	CHEMBL2527	Homo sapiens	IC50	nM	90.0
	16897629	CHEMBL3882743	Inhibition of human CDS1 using N-terminal biotin labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ATP after 3 hrs by scintillation counting method	B	CC(C)(C)OC(=O)N1CCCC(COc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)C1		CHEMBL3901181	=	IC50	nM	84.0	CHEMBL2527	Homo sapiens	IC50	nM	84.0
	16897630	CHEMBL3882743	Inhibition of human CDS1 using N-terminal biotin labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ATP after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(OCCCN4CCCCC4)cc3)nc2c1		CHEMBL249750	=	IC50	nM	110.0	CHEMBL2527	Homo sapiens	IC50	nM	110.0
	16897631	CHEMBL3882743	Inhibition of human CDS1 using N-terminal biotin labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ATP after 3 hrs by scintillation counting method	B	CC(=O)N1CCC(COc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)CC1		CHEMBL400755	=	IC50	nM	78.0	CHEMBL2527	Homo sapiens	IC50	nM	78.0
	16897632	CHEMBL3882743	Inhibition of human CDS1 using N-terminal biotin labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ATP after 3 hrs by scintillation counting method	B	COc1ccc(CN2CCCC(COc3ccc(-c4nc5cc(C(N)=O)ccc5[nH]4)cc3)C2)cc1		CHEMBL427879	=	IC50	nM	55.0	CHEMBL2527	Homo sapiens	IC50	nM	55.0
	16897633	CHEMBL3882743	Inhibition of human CDS1 using N-terminal biotin labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ATP after 3 hrs by scintillation counting method	B	COc1ccc(CN2CCCCC2CCOc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)cc1		CHEMBL250957	=	IC50	nM	74.0	CHEMBL2527	Homo sapiens	IC50	nM	74.0
	16897634	CHEMBL3882743	Inhibition of human CDS1 using N-terminal biotin labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ATP after 3 hrs by scintillation counting method	B	CC(C)(C)OC(=O)N1CCC(CCOc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)CC1		CHEMBL3978242	=	IC50	nM	134.0	CHEMBL2527	Homo sapiens	IC50	nM	134.0
	16897635	CHEMBL3882743	Inhibition of human CDS1 using N-terminal biotin labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ATP after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(OC[C@H]4CC[C@@H](O)CC4)cc3)nc2c1		CHEMBL3922854	=	IC50	nM	54.0	CHEMBL2527	Homo sapiens	IC50	nM	54.0
	16897636	CHEMBL3882743	Inhibition of human CDS1 using N-terminal biotin labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ATP after 3 hrs by scintillation counting method	B	CC(=O)N1CCC(CCOc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)CC1		CHEMBL249566	=	IC50	nM	86.0	CHEMBL2527	Homo sapiens	IC50	nM	86.0
	16897637	CHEMBL3882743	Inhibition of human CDS1 using N-terminal biotin labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ATP after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(OC4CCCN(Cc5ccc(Cl)cc5)C4)cc3)nc2c1		CHEMBL3928245	=	IC50	nM	14.0	CHEMBL2527	Homo sapiens	IC50	nM	14.0
	16897638	CHEMBL3882743	Inhibition of human CDS1 using N-terminal biotin labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ATP after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(OCC4CCNCC4)cc3)nc2c1		CHEMBL249777	=	IC50	nM	231.0	CHEMBL2527	Homo sapiens	IC50	nM	231.0
	16897639	CHEMBL3882743	Inhibition of human CDS1 using N-terminal biotin labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ATP after 3 hrs by scintillation counting method	B	CN1CCC(Oc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)C1		CHEMBL400936	=	IC50	nM	659.0	CHEMBL2527	Homo sapiens	IC50	nM	659.0
	16897640	CHEMBL3882743	Inhibition of human CDS1 using N-terminal biotin labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ATP after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(OCCO)cc3)nc2c1		CHEMBL251585	=	IC50	nM	52.0	CHEMBL2527	Homo sapiens	IC50	nM	52.0
	16897641	CHEMBL3882743	Inhibition of human CDS1 using N-terminal biotin labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ATP after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(OCC4CCN(Cc5ccc(Cl)cc5)CC4)cc3)nc2c1		CHEMBL251170	=	IC50	nM	60.0	CHEMBL2527	Homo sapiens	IC50	nM	60.0
	16897642	CHEMBL3882743	Inhibition of human CDS1 using N-terminal biotin labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ATP after 3 hrs by scintillation counting method	B	COc1ccc(CN2CCC(CCOc3ccc(-c4nc5cc(C(N)=O)ccc5[nH]4)cc3)CC2)cc1		CHEMBL249347	=	IC50	nM	95.0	CHEMBL2527	Homo sapiens	IC50	nM	95.0
	16897643	CHEMBL3882743	Inhibition of human CDS1 using N-terminal biotin labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ATP after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(OCCC4CCNCC4)cc3)nc2c1		CHEMBL3929928	=	IC50	nM	97.0	CHEMBL2527	Homo sapiens	IC50	nM	97.0
	16897644	CHEMBL3882743	Inhibition of human CDS1 using N-terminal biotin labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ATP after 3 hrs by scintillation counting method	B	CN1CCC(Oc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)CC1		CHEMBL442282	=	IC50	nM	233.0	CHEMBL2527	Homo sapiens	IC50	nM	233.0
	16897645	CHEMBL3882743	Inhibition of human CDS1 using N-terminal biotin labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ATP after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(OCCC4CCN(C(=O)c5ccccc5)CC4)cc3)nc2c1		CHEMBL250360	=	IC50	nM	23.0	CHEMBL2527	Homo sapiens	IC50	nM	23.0
	16897646	CHEMBL3882743	Inhibition of human CDS1 using N-terminal biotin labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ATP after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(OCC4CCN(Cc5ccccc5)CC4)cc3)nc2c1		CHEMBL249959	=	IC50	nM	70.0	CHEMBL2527	Homo sapiens	IC50	nM	70.0
	16897647	CHEMBL3882743	Inhibition of human CDS1 using N-terminal biotin labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ATP after 3 hrs by scintillation counting method	B	NC(=O)c1ccc2[nH]c(-c3ccc(OCCC4CCCCN4Cc4ccccc4)cc3)nc2c1		CHEMBL250555	=	IC50	nM	45.0	CHEMBL2527	Homo sapiens	IC50	nM	45.0
	16897648	CHEMBL3882743	Inhibition of human CDS1 using N-terminal biotin labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ATP after 3 hrs by scintillation counting method	B	CC(C)(C)OC(=O)N1CCC(COc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)CC1		CHEMBL3985469	=	IC50	nM	41.0	CHEMBL2527	Homo sapiens	IC50	nM	41.0
	16897649	CHEMBL3882743	Inhibition of human CDS1 using N-terminal biotin labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ATP after 3 hrs by scintillation counting method	B	CN(C)CCCOc1ccc(-c2nc3cc(C(N)=O)ccc3[nH]2)cc1		CHEMBL249546	=	IC50	nM	122.0	CHEMBL2527	Homo sapiens	IC50	nM	122.0
	18006643	CHEMBL4003369	Inhibition of CHK2 (unknown origin) using polypeptide substrate after 40 mins in presence of [gamma-33P]ATP by scintillation counting method	B	NC1=N/C(=C2/CCNC(=O)c3[nH]ccc32)C(=O)N1		CHEMBL255465	=	IC50	nM	183.0	CHEMBL2527	Homo sapiens	IC50	nM	183.0
	18053067	CHEMBL4011914	Inhibition of CHK2 (unknown origin) at 0.1 uM pretreated for 30 mins followed by substrate addition measured after 5 hrs in presence of 1 mM ATP relative to control	B	COC(=O)C1=C(Nc2ccccc2Cl)O/C(=C\c2c[nH]c3ncccc23)C1=O		CHEMBL4089159	=	Inhibition	%	6.6	CHEMBL2527	Homo sapiens	INH	%	6.6
Active	18078264	CHEMBL4016722	Inhibition of CHK2 (unknown origin) at 1 uM	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCC(O)CO		CHEMBL1276317		Inhibition	%		CHEMBL2527	Homo sapiens	INH		
Not Active	18078265	CHEMBL4016722	Inhibition of CHK2 (unknown origin) at 1 uM	B	CN1CCN(CCO/N=C2C(=C3/C(=O)Nc4ccccc43)/Nc3ccccc3/2)CC1.Cl		CHEMBL4084775		Inhibition	%		CHEMBL2527	Homo sapiens	INH		
Active	18078266	CHEMBL4016722	Inhibition of CHK2 (unknown origin) at 1 uM	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450		Inhibition	%		CHEMBL2527	Homo sapiens	INH		
Active	18078267	CHEMBL4016722	Inhibition of CHK2 (unknown origin) at 1 uM	B	Cc1ccc2c(c1)NC(=O)/C2=C1\Nc2ccccc2\C1=N/O		CHEMBL4067175		Inhibition	%		CHEMBL2527	Homo sapiens	INH		
	18114429	CHEMBL4025065	Inhibition of wild-type human partial length CHEK2 (S253 to E574 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1		CHEMBL4077123	=	Activity	%	87.0	CHEMBL2527	Homo sapiens	Activity	%	87.0
Active	18150442	CHEMBL4033841	Induction of phosphorylation of Chk2 at Thr68 residue in human HeLa cells at IC50 after 24 hrs by Western blot analysis	B	COc1ccc2cc(NC(=O)C3=NO[C@H]4[C@H](O)C=C[C@@H](Cl)[C@@]4(O)C3)c(=O)oc2c1OC		CHEMBL259112		Activity			CHEMBL2527	Homo sapiens	Activity		
	18153115	CHEMBL4034300	Inhibition of CHK2 Lysine 2 labelling site (unknown origin) at 10 uM	B	c1cc(-c2c[nH]c3cnccc23)ccn1	Outside typical range	CHEMBL4084955	=	Inhibition	%	-19.9	CHEMBL2527	Homo sapiens	INH	%	-19.9
	18153116	CHEMBL4034299	Inhibition of CHK2 Lysine 1 labelling site (unknown origin) at 10 uM	B	c1cc(-c2c[nH]c3cnccc23)ccn1	Outside typical range	CHEMBL4084955	=	Inhibition	%	-18.3	CHEMBL2527	Homo sapiens	INH	%	-18.3
	18156007	CHEMBL4034965	Inhibition of Chk2 (unknown origin) by ELISA based spectrophotometric analysis	B	Cc1nn(-c2ccccc2)c(Oc2ccc(-c3nc4cc([N+](=O)[O-])ccc4[nH]3)cc2)c1[N+](=O)[O-]		CHEMBL4076911	=	IC50	nM	52.8	CHEMBL2527	Homo sapiens	IC50	nM	52.8
	18156008	CHEMBL4034965	Inhibition of Chk2 (unknown origin) by ELISA based spectrophotometric analysis	B	Cc1nn(-c2ccc(C#N)cc2)c(Oc2ccc(-c3nc4cc([N+](=O)[O-])ccc4[nH]3)cc2)c1[N+](=O)[O-]		CHEMBL4103039	=	IC50	nM	33.4	CHEMBL2527	Homo sapiens	IC50	nM	33.4
	18156009	CHEMBL4034965	Inhibition of Chk2 (unknown origin) by ELISA based spectrophotometric analysis	B	Cc1nn(-c2ccccc2)c(Oc2ccc(-c3nc4cc(C(=O)O)ccc4[nH]3)cc2)c1[N+](=O)[O-]		CHEMBL4083002	=	IC50	nM	48.4	CHEMBL2527	Homo sapiens	IC50	nM	48.4
	18156010	CHEMBL4034965	Inhibition of Chk2 (unknown origin) by ELISA based spectrophotometric analysis	B	Cc1nn(-c2ccc(C#N)cc2)c(Oc2ccc(-c3nc4cc(C(=O)O)ccc4[nH]3)cc2)c1[N+](=O)[O-]		CHEMBL4100980	=	IC50	nM	32.5	CHEMBL2527	Homo sapiens	IC50	nM	32.5
	18156011	CHEMBL4034965	Inhibition of Chk2 (unknown origin) by ELISA based spectrophotometric analysis	B	Cc1nn(-c2ccccc2)c(Oc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)c1[N+](=O)[O-]		CHEMBL4090789	=	IC50	nM	31.0	CHEMBL2527	Homo sapiens	IC50	nM	31.0
	18156012	CHEMBL4034965	Inhibition of Chk2 (unknown origin) by ELISA based spectrophotometric analysis	B	Cc1nn(-c2ccc(C#N)cc2)c(Oc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)c1[N+](=O)[O-]		CHEMBL4062848	=	IC50	nM	33.8	CHEMBL2527	Homo sapiens	IC50	nM	33.8
	18156013	CHEMBL4034965	Inhibition of Chk2 (unknown origin) by ELISA based spectrophotometric analysis	B	CNC(=O)c1ccc2[nH]c(-c3ccc(Oc4c([N+](=O)[O-])c(C)nn4-c4ccccc4)cc3)nc2c1		CHEMBL4063921	=	IC50	nM	14.9	CHEMBL2527	Homo sapiens	IC50	nM	14.9
	18156014	CHEMBL4034965	Inhibition of Chk2 (unknown origin) by ELISA based spectrophotometric analysis	B	Cc1nn(-c2ccccc2)c(Oc2ccc(-c3nc4cc(C(=O)NC(C)C)ccc4[nH]3)cc2)c1[N+](=O)[O-]		CHEMBL4085496	=	IC50	nM	17.9	CHEMBL2527	Homo sapiens	IC50	nM	17.9
	18156015	CHEMBL4034965	Inhibition of Chk2 (unknown origin) by ELISA based spectrophotometric analysis	B	Cc1nn(-c2ccccc2)c(Oc2ccc(-c3nc4cc(C(=O)NCc5ccccc5)ccc4[nH]3)cc2)c1[N+](=O)[O-]		CHEMBL4072515	=	IC50	nM	5.5	CHEMBL2527	Homo sapiens	IC50	nM	5.5
	18156016	CHEMBL4034965	Inhibition of Chk2 (unknown origin) by ELISA based spectrophotometric analysis	B	Cc1nn(-c2ccccc2)c(Oc2ccc(-c3nc4cc(C(=O)NC5CCCCC5)ccc4[nH]3)cc2)c1[N+](=O)[O-]		CHEMBL4093249	=	IC50	nM	6.9	CHEMBL2527	Homo sapiens	IC50	nM	6.9
	18156017	CHEMBL4034965	Inhibition of Chk2 (unknown origin) by ELISA based spectrophotometric analysis	B	NC(=O)c1ccc2[nH]c(-c3ccc(Sc4ccc(O)cc4)cc3)nc2c1		CHEMBL195041	=	IC50	nM	32.0	CHEMBL2527	Homo sapiens	IC50	nM	32.0
	18156060	CHEMBL4034972	Inhibition of Chk2 (unknown origin) at 2.5 umol/L by ELISA based spectrophotometric analysis relative to control	B	Cc1nn(-c2ccccc2)c(Oc2ccc(-c3nc4cc([N+](=O)[O-])ccc4[nH]3)cc2)c1[N+](=O)[O-]		CHEMBL4076911	=	Inhibition	%	88.8	CHEMBL2527	Homo sapiens	INH	%	88.8
	18156061	CHEMBL4034972	Inhibition of Chk2 (unknown origin) at 2.5 umol/L by ELISA based spectrophotometric analysis relative to control	B	Cc1nn(-c2ccc(C#N)cc2)c(Oc2ccc(-c3nc4cc([N+](=O)[O-])ccc4[nH]3)cc2)c1[N+](=O)[O-]		CHEMBL4103039	=	Inhibition	%	98.19	CHEMBL2527	Homo sapiens	INH	%	98.19
	18156062	CHEMBL4034972	Inhibition of Chk2 (unknown origin) at 2.5 umol/L by ELISA based spectrophotometric analysis relative to control	B	Cc1nn(-c2ccccc2)c(Oc2ccc(-c3nc4cc(C(=O)O)ccc4[nH]3)cc2)c1[N+](=O)[O-]		CHEMBL4083002	=	Inhibition	%	98.77	CHEMBL2527	Homo sapiens	INH	%	98.77
	18156063	CHEMBL4034972	Inhibition of Chk2 (unknown origin) at 2.5 umol/L by ELISA based spectrophotometric analysis relative to control	B	Cc1nn(-c2ccc(C#N)cc2)c(Oc2ccc(-c3nc4cc(C(=O)O)ccc4[nH]3)cc2)c1[N+](=O)[O-]		CHEMBL4100980	=	Inhibition	%	100.0	CHEMBL2527	Homo sapiens	INH	%	100.0
	18156064	CHEMBL4034972	Inhibition of Chk2 (unknown origin) at 2.5 umol/L by ELISA based spectrophotometric analysis relative to control	B	Cc1nn(-c2ccccc2)c(Oc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)c1[N+](=O)[O-]		CHEMBL4090789	=	Inhibition	%	100.0	CHEMBL2527	Homo sapiens	INH	%	100.0
	18156065	CHEMBL4034972	Inhibition of Chk2 (unknown origin) at 2.5 umol/L by ELISA based spectrophotometric analysis relative to control	B	Cc1nn(-c2ccc(C#N)cc2)c(Oc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)c1[N+](=O)[O-]		CHEMBL4062848	=	Inhibition	%	95.29	CHEMBL2527	Homo sapiens	INH	%	95.29
	18156066	CHEMBL4034972	Inhibition of Chk2 (unknown origin) at 2.5 umol/L by ELISA based spectrophotometric analysis relative to control	B	CNC(=O)c1ccc2[nH]c(-c3ccc(Oc4c([N+](=O)[O-])c(C)nn4-c4ccccc4)cc3)nc2c1		CHEMBL4063921	=	Inhibition	%	99.42	CHEMBL2527	Homo sapiens	INH	%	99.42
	18156067	CHEMBL4034972	Inhibition of Chk2 (unknown origin) at 2.5 umol/L by ELISA based spectrophotometric analysis relative to control	B	Cc1nn(-c2ccccc2)c(Oc2ccc(-c3nc4cc(C(=O)NC(C)C)ccc4[nH]3)cc2)c1[N+](=O)[O-]		CHEMBL4085496	=	Inhibition	%	97.79	CHEMBL2527	Homo sapiens	INH	%	97.79
	18156068	CHEMBL4034972	Inhibition of Chk2 (unknown origin) at 2.5 umol/L by ELISA based spectrophotometric analysis relative to control	B	Cc1nn(-c2ccccc2)c(Oc2ccc(-c3nc4cc(C(=O)NCc5ccccc5)ccc4[nH]3)cc2)c1[N+](=O)[O-]		CHEMBL4072515	=	Inhibition	%	100.0	CHEMBL2527	Homo sapiens	INH	%	100.0
	18156069	CHEMBL4034972	Inhibition of Chk2 (unknown origin) at 2.5 umol/L by ELISA based spectrophotometric analysis relative to control	B	Cc1nn(-c2ccccc2)c(Oc2ccc(-c3nc4cc(C(=O)NC5CCCCC5)ccc4[nH]3)cc2)c1[N+](=O)[O-]		CHEMBL4093249	=	Inhibition	%	100.0	CHEMBL2527	Homo sapiens	INH	%	100.0
	18156070	CHEMBL4034972	Inhibition of Chk2 (unknown origin) at 2.5 umol/L by ELISA based spectrophotometric analysis relative to control	B	NC(=O)c1ccc2[nH]c(-c3ccc(Sc4ccc(O)cc4)cc3)nc2c1		CHEMBL195041	=	Inhibition	%	100.0	CHEMBL2527	Homo sapiens	INH	%	100.0
	18156071	CHEMBL4034973	Inhibition of Chk2 (unknown origin) at 1.5 umol/L by ELISA based spectrophotometric analysis relative to control	B	Cc1nn(-c2ccccc2)c(Oc2ccc(-c3nc4cc([N+](=O)[O-])ccc4[nH]3)cc2)c1[N+](=O)[O-]		CHEMBL4076911	=	Inhibition	%	84.2	CHEMBL2527	Homo sapiens	INH	%	84.2
	18156072	CHEMBL4034973	Inhibition of Chk2 (unknown origin) at 1.5 umol/L by ELISA based spectrophotometric analysis relative to control	B	Cc1nn(-c2ccc(C#N)cc2)c(Oc2ccc(-c3nc4cc([N+](=O)[O-])ccc4[nH]3)cc2)c1[N+](=O)[O-]		CHEMBL4103039	=	Inhibition	%	93.26	CHEMBL2527	Homo sapiens	INH	%	93.26
	18156073	CHEMBL4034973	Inhibition of Chk2 (unknown origin) at 1.5 umol/L by ELISA based spectrophotometric analysis relative to control	B	Cc1nn(-c2ccccc2)c(Oc2ccc(-c3nc4cc(C(=O)O)ccc4[nH]3)cc2)c1[N+](=O)[O-]		CHEMBL4083002	=	Inhibition	%	94.78	CHEMBL2527	Homo sapiens	INH	%	94.78
	18156074	CHEMBL4034973	Inhibition of Chk2 (unknown origin) at 1.5 umol/L by ELISA based spectrophotometric analysis relative to control	B	Cc1nn(-c2ccc(C#N)cc2)c(Oc2ccc(-c3nc4cc(C(=O)O)ccc4[nH]3)cc2)c1[N+](=O)[O-]		CHEMBL4100980	=	Inhibition	%	96.37	CHEMBL2527	Homo sapiens	INH	%	96.37
	18156075	CHEMBL4034973	Inhibition of Chk2 (unknown origin) at 1.5 umol/L by ELISA based spectrophotometric analysis relative to control	B	Cc1nn(-c2ccccc2)c(Oc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)c1[N+](=O)[O-]		CHEMBL4090789	=	Inhibition	%	96.37	CHEMBL2527	Homo sapiens	INH	%	96.37
	18156076	CHEMBL4034973	Inhibition of Chk2 (unknown origin) at 1.5 umol/L by ELISA based spectrophotometric analysis relative to control	B	Cc1nn(-c2ccc(C#N)cc2)c(Oc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)c1[N+](=O)[O-]		CHEMBL4062848	=	Inhibition	%	90.94	CHEMBL2527	Homo sapiens	INH	%	90.94
	18156077	CHEMBL4034973	Inhibition of Chk2 (unknown origin) at 1.5 umol/L by ELISA based spectrophotometric analysis relative to control	B	CNC(=O)c1ccc2[nH]c(-c3ccc(Oc4c([N+](=O)[O-])c(C)nn4-c4ccccc4)cc3)nc2c1		CHEMBL4063921	=	Inhibition	%	96.74	CHEMBL2527	Homo sapiens	INH	%	96.74
	18156078	CHEMBL4034973	Inhibition of Chk2 (unknown origin) at 1.5 umol/L by ELISA based spectrophotometric analysis relative to control	B	Cc1nn(-c2ccccc2)c(Oc2ccc(-c3nc4cc(C(=O)NC(C)C)ccc4[nH]3)cc2)c1[N+](=O)[O-]		CHEMBL4085496	=	Inhibition	%	94.64	CHEMBL2527	Homo sapiens	INH	%	94.64
	18156079	CHEMBL4034973	Inhibition of Chk2 (unknown origin) at 1.5 umol/L by ELISA based spectrophotometric analysis relative to control	B	Cc1nn(-c2ccccc2)c(Oc2ccc(-c3nc4cc(C(=O)NCc5ccccc5)ccc4[nH]3)cc2)c1[N+](=O)[O-]		CHEMBL4072515	=	Inhibition	%	99.63	CHEMBL2527	Homo sapiens	INH	%	99.63
	18156080	CHEMBL4034973	Inhibition of Chk2 (unknown origin) at 1.5 umol/L by ELISA based spectrophotometric analysis relative to control	B	Cc1nn(-c2ccccc2)c(Oc2ccc(-c3nc4cc(C(=O)NC5CCCCC5)ccc4[nH]3)cc2)c1[N+](=O)[O-]		CHEMBL4093249	=	Inhibition	%	100.0	CHEMBL2527	Homo sapiens	INH	%	100.0
	18156081	CHEMBL4034973	Inhibition of Chk2 (unknown origin) at 1.5 umol/L by ELISA based spectrophotometric analysis relative to control	B	NC(=O)c1ccc2[nH]c(-c3ccc(Sc4ccc(O)cc4)cc3)nc2c1		CHEMBL195041	=	Inhibition	%	96.9	CHEMBL2527	Homo sapiens	INH	%	96.9
	18156082	CHEMBL4034974	Inhibition of Chk2 (unknown origin) at 0.1 umol/L by ELISA based spectrophotometric analysis relative to control	B	Cc1nn(-c2ccccc2)c(Oc2ccc(-c3nc4cc([N+](=O)[O-])ccc4[nH]3)cc2)c1[N+](=O)[O-]		CHEMBL4076911	=	Inhibition	%	75.0	CHEMBL2527	Homo sapiens	INH	%	75.0
	18156083	CHEMBL4034974	Inhibition of Chk2 (unknown origin) at 0.1 umol/L by ELISA based spectrophotometric analysis relative to control	B	Cc1nn(-c2ccc(C#N)cc2)c(Oc2ccc(-c3nc4cc([N+](=O)[O-])ccc4[nH]3)cc2)c1[N+](=O)[O-]		CHEMBL4103039	=	Inhibition	%	80.43	CHEMBL2527	Homo sapiens	INH	%	80.43
	18156084	CHEMBL4034974	Inhibition of Chk2 (unknown origin) at 0.1 umol/L by ELISA based spectrophotometric analysis relative to control	B	Cc1nn(-c2ccccc2)c(Oc2ccc(-c3nc4cc(C(=O)O)ccc4[nH]3)cc2)c1[N+](=O)[O-]		CHEMBL4083002	=	Inhibition	%	66.3	CHEMBL2527	Homo sapiens	INH	%	66.3
	18156085	CHEMBL4034974	Inhibition of Chk2 (unknown origin) at 0.1 umol/L by ELISA based spectrophotometric analysis relative to control	B	Cc1nn(-c2ccc(C#N)cc2)c(Oc2ccc(-c3nc4cc(C(=O)O)ccc4[nH]3)cc2)c1[N+](=O)[O-]		CHEMBL4100980	=	Inhibition	%	82.97	CHEMBL2527	Homo sapiens	INH	%	82.97
	18156086	CHEMBL4034974	Inhibition of Chk2 (unknown origin) at 0.1 umol/L by ELISA based spectrophotometric analysis relative to control	B	Cc1nn(-c2ccccc2)c(Oc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)c1[N+](=O)[O-]		CHEMBL4090789	=	Inhibition	%	89.49	CHEMBL2527	Homo sapiens	INH	%	89.49
	18156087	CHEMBL4034974	Inhibition of Chk2 (unknown origin) at 0.1 umol/L by ELISA based spectrophotometric analysis relative to control	B	Cc1nn(-c2ccc(C#N)cc2)c(Oc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)c1[N+](=O)[O-]		CHEMBL4062848	=	Inhibition	%	83.69	CHEMBL2527	Homo sapiens	INH	%	83.69
	18156088	CHEMBL4034974	Inhibition of Chk2 (unknown origin) at 0.1 umol/L by ELISA based spectrophotometric analysis relative to control	B	CNC(=O)c1ccc2[nH]c(-c3ccc(Oc4c([N+](=O)[O-])c(C)nn4-c4ccccc4)cc3)nc2c1		CHEMBL4063921	=	Inhibition	%	88.04	CHEMBL2527	Homo sapiens	INH	%	88.04
	18156089	CHEMBL4034974	Inhibition of Chk2 (unknown origin) at 0.1 umol/L by ELISA based spectrophotometric analysis relative to control	B	Cc1nn(-c2ccccc2)c(Oc2ccc(-c3nc4cc(C(=O)NC(C)C)ccc4[nH]3)cc2)c1[N+](=O)[O-]		CHEMBL4085496	=	Inhibition	%	93.8	CHEMBL2527	Homo sapiens	INH	%	93.8
	18156090	CHEMBL4034974	Inhibition of Chk2 (unknown origin) at 0.1 umol/L by ELISA based spectrophotometric analysis relative to control	B	Cc1nn(-c2ccccc2)c(Oc2ccc(-c3nc4cc(C(=O)NCc5ccccc5)ccc4[nH]3)cc2)c1[N+](=O)[O-]		CHEMBL4072515	=	Inhibition	%	91.3	CHEMBL2527	Homo sapiens	INH	%	91.3
	18156091	CHEMBL4034974	Inhibition of Chk2 (unknown origin) at 0.1 umol/L by ELISA based spectrophotometric analysis relative to control	B	Cc1nn(-c2ccccc2)c(Oc2ccc(-c3nc4cc(C(=O)NC5CCCCC5)ccc4[nH]3)cc2)c1[N+](=O)[O-]		CHEMBL4093249	=	Inhibition	%	99.2	CHEMBL2527	Homo sapiens	INH	%	99.2
	18156092	CHEMBL4034974	Inhibition of Chk2 (unknown origin) at 0.1 umol/L by ELISA based spectrophotometric analysis relative to control	B	NC(=O)c1ccc2[nH]c(-c3ccc(Sc4ccc(O)cc4)cc3)nc2c1		CHEMBL195041	=	Inhibition	%	88.0	CHEMBL2527	Homo sapiens	INH	%	88.0
	18156093	CHEMBL4034975	Inhibition of Chk2 (unknown origin) at 0.050 umol/L by ELISA based spectrophotometric analysis relative to control	B	Cc1nn(-c2ccccc2)c(Oc2ccc(-c3nc4cc([N+](=O)[O-])ccc4[nH]3)cc2)c1[N+](=O)[O-]		CHEMBL4076911	=	Inhibition	%	42.75	CHEMBL2527	Homo sapiens	INH	%	42.75
	18156094	CHEMBL4034975	Inhibition of Chk2 (unknown origin) at 0.050 umol/L by ELISA based spectrophotometric analysis relative to control	B	Cc1nn(-c2ccc(C#N)cc2)c(Oc2ccc(-c3nc4cc([N+](=O)[O-])ccc4[nH]3)cc2)c1[N+](=O)[O-]		CHEMBL4103039	=	Inhibition	%	77.5	CHEMBL2527	Homo sapiens	INH	%	77.5
	18156095	CHEMBL4034975	Inhibition of Chk2 (unknown origin) at 0.050 umol/L by ELISA based spectrophotometric analysis relative to control	B	Cc1nn(-c2ccccc2)c(Oc2ccc(-c3nc4cc(C(=O)O)ccc4[nH]3)cc2)c1[N+](=O)[O-]		CHEMBL4083002	=	Inhibition	%	50.36	CHEMBL2527	Homo sapiens	INH	%	50.36
	18156096	CHEMBL4034975	Inhibition of Chk2 (unknown origin) at 0.050 umol/L by ELISA based spectrophotometric analysis relative to control	B	Cc1nn(-c2ccc(C#N)cc2)c(Oc2ccc(-c3nc4cc(C(=O)O)ccc4[nH]3)cc2)c1[N+](=O)[O-]		CHEMBL4100980	=	Inhibition	%	75.72	CHEMBL2527	Homo sapiens	INH	%	75.72
	18156097	CHEMBL4034975	Inhibition of Chk2 (unknown origin) at 0.050 umol/L by ELISA based spectrophotometric analysis relative to control	B	Cc1nn(-c2ccccc2)c(Oc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)c1[N+](=O)[O-]		CHEMBL4090789	=	Inhibition	%	67.47	CHEMBL2527	Homo sapiens	INH	%	67.47
	18156098	CHEMBL4034975	Inhibition of Chk2 (unknown origin) at 0.050 umol/L by ELISA based spectrophotometric analysis relative to control	B	Cc1nn(-c2ccc(C#N)cc2)c(Oc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)c1[N+](=O)[O-]		CHEMBL4062848	=	Inhibition	%	75.72	CHEMBL2527	Homo sapiens	INH	%	75.72
	18156099	CHEMBL4034975	Inhibition of Chk2 (unknown origin) at 0.050 umol/L by ELISA based spectrophotometric analysis relative to control	B	CNC(=O)c1ccc2[nH]c(-c3ccc(Oc4c([N+](=O)[O-])c(C)nn4-c4ccccc4)cc3)nc2c1		CHEMBL4063921	=	Inhibition	%	82.97	CHEMBL2527	Homo sapiens	INH	%	82.97
	18156100	CHEMBL4034975	Inhibition of Chk2 (unknown origin) at 0.050 umol/L by ELISA based spectrophotometric analysis relative to control	B	Cc1nn(-c2ccccc2)c(Oc2ccc(-c3nc4cc(C(=O)NC(C)C)ccc4[nH]3)cc2)c1[N+](=O)[O-]		CHEMBL4085496	=	Inhibition	%	77.8	CHEMBL2527	Homo sapiens	INH	%	77.8
	18156101	CHEMBL4034975	Inhibition of Chk2 (unknown origin) at 0.050 umol/L by ELISA based spectrophotometric analysis relative to control	B	Cc1nn(-c2ccccc2)c(Oc2ccc(-c3nc4cc(C(=O)NCc5ccccc5)ccc4[nH]3)cc2)c1[N+](=O)[O-]		CHEMBL4072515	=	Inhibition	%	91.3	CHEMBL2527	Homo sapiens	INH	%	91.3
	18156102	CHEMBL4034975	Inhibition of Chk2 (unknown origin) at 0.050 umol/L by ELISA based spectrophotometric analysis relative to control	B	Cc1nn(-c2ccccc2)c(Oc2ccc(-c3nc4cc(C(=O)NC5CCCCC5)ccc4[nH]3)cc2)c1[N+](=O)[O-]		CHEMBL4093249	=	Inhibition	%	92.0	CHEMBL2527	Homo sapiens	INH	%	92.0
	18156103	CHEMBL4034975	Inhibition of Chk2 (unknown origin) at 0.050 umol/L by ELISA based spectrophotometric analysis relative to control	B	NC(=O)c1ccc2[nH]c(-c3ccc(Sc4ccc(O)cc4)cc3)nc2c1		CHEMBL195041	=	Inhibition	%	71.1	CHEMBL2527	Homo sapiens	INH	%	71.1
	18156104	CHEMBL4034976	Inhibition of Chk2 (unknown origin) at 0.025 umol/L by ELISA based spectrophotometric analysis relative to control	B	Cc1nn(-c2ccccc2)c(Oc2ccc(-c3nc4cc([N+](=O)[O-])ccc4[nH]3)cc2)c1[N+](=O)[O-]		CHEMBL4076911	=	Inhibition	%	26.45	CHEMBL2527	Homo sapiens	INH	%	26.45
	18156105	CHEMBL4034976	Inhibition of Chk2 (unknown origin) at 0.025 umol/L by ELISA based spectrophotometric analysis relative to control	B	Cc1nn(-c2ccc(C#N)cc2)c(Oc2ccc(-c3nc4cc([N+](=O)[O-])ccc4[nH]3)cc2)c1[N+](=O)[O-]		CHEMBL4103039	=	Inhibition	%	33.33	CHEMBL2527	Homo sapiens	INH	%	33.33
	18156106	CHEMBL4034976	Inhibition of Chk2 (unknown origin) at 0.025 umol/L by ELISA based spectrophotometric analysis relative to control	B	Cc1nn(-c2ccccc2)c(Oc2ccc(-c3nc4cc(C(=O)O)ccc4[nH]3)cc2)c1[N+](=O)[O-]		CHEMBL4083002	=	Inhibition	%	35.5	CHEMBL2527	Homo sapiens	INH	%	35.5
	18156107	CHEMBL4034976	Inhibition of Chk2 (unknown origin) at 0.025 umol/L by ELISA based spectrophotometric analysis relative to control	B	Cc1nn(-c2ccc(C#N)cc2)c(Oc2ccc(-c3nc4cc(C(=O)O)ccc4[nH]3)cc2)c1[N+](=O)[O-]		CHEMBL4100980	=	Inhibition	%	35.5	CHEMBL2527	Homo sapiens	INH	%	35.5
	18156108	CHEMBL4034976	Inhibition of Chk2 (unknown origin) at 0.025 umol/L by ELISA based spectrophotometric analysis relative to control	B	Cc1nn(-c2ccccc2)c(Oc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)c1[N+](=O)[O-]		CHEMBL4090789	=	Inhibition	%	42.03	CHEMBL2527	Homo sapiens	INH	%	42.03
	18156109	CHEMBL4034976	Inhibition of Chk2 (unknown origin) at 0.025 umol/L by ELISA based spectrophotometric analysis relative to control	B	Cc1nn(-c2ccc(C#N)cc2)c(Oc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)c1[N+](=O)[O-]		CHEMBL4062848	=	Inhibition	%	33.33	CHEMBL2527	Homo sapiens	INH	%	33.33
	18156110	CHEMBL4034976	Inhibition of Chk2 (unknown origin) at 0.025 umol/L by ELISA based spectrophotometric analysis relative to control	B	CNC(=O)c1ccc2[nH]c(-c3ccc(Oc4c([N+](=O)[O-])c(C)nn4-c4ccccc4)cc3)nc2c1		CHEMBL4063921	=	Inhibition	%	62.68	CHEMBL2527	Homo sapiens	INH	%	62.68
	18156111	CHEMBL4034976	Inhibition of Chk2 (unknown origin) at 0.025 umol/L by ELISA based spectrophotometric analysis relative to control	B	Cc1nn(-c2ccccc2)c(Oc2ccc(-c3nc4cc(C(=O)NC(C)C)ccc4[nH]3)cc2)c1[N+](=O)[O-]		CHEMBL4085496	=	Inhibition	%	58.3	CHEMBL2527	Homo sapiens	INH	%	58.3
	18156112	CHEMBL4034976	Inhibition of Chk2 (unknown origin) at 0.025 umol/L by ELISA based spectrophotometric analysis relative to control	B	Cc1nn(-c2ccccc2)c(Oc2ccc(-c3nc4cc(C(=O)NCc5ccccc5)ccc4[nH]3)cc2)c1[N+](=O)[O-]		CHEMBL4072515	=	Inhibition	%	81.88	CHEMBL2527	Homo sapiens	INH	%	81.88
	18156113	CHEMBL4034976	Inhibition of Chk2 (unknown origin) at 0.025 umol/L by ELISA based spectrophotometric analysis relative to control	B	Cc1nn(-c2ccccc2)c(Oc2ccc(-c3nc4cc(C(=O)NC5CCCCC5)ccc4[nH]3)cc2)c1[N+](=O)[O-]		CHEMBL4093249	=	Inhibition	%	78.2	CHEMBL2527	Homo sapiens	INH	%	78.2
	18156114	CHEMBL4034976	Inhibition of Chk2 (unknown origin) at 0.025 umol/L by ELISA based spectrophotometric analysis relative to control	B	NC(=O)c1ccc2[nH]c(-c3ccc(Sc4ccc(O)cc4)cc3)nc2c1		CHEMBL195041	=	Inhibition	%	37.9	CHEMBL2527	Homo sapiens	INH	%	37.9
	18185972	CHEMBL4040606	Inhibition of N-terminal GST and C-terminal His6 tagged recombinant human CHK2 expressed in Escherichia coli cells at 10 uM relative to control	B	N#Cc1c[nH]c2nc(N)nc(-c3ccc(S(N)(=O)=O)cc3)c12		CHEMBL4089551	>	Inhibition	%	80.0	CHEMBL2527	Homo sapiens	INH	%	80.0
	18203589	CHEMBL4043876	Inhibition of wild-type human partial length CHEK2 (S253 to E574 residues) expressed in Escherichia coli BL21 assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4092508	=	Activity	%	100.0	CHEMBL2527	Homo sapiens	Activity	%	100.0
	18211605	CHEMBL4045665	Inhibition of CHK2 labeling at conserved Lys2 (DLKPENVLLSSQEEDCLIK) in human PBMC at 1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1		CHEMBL3971067	=	Inhibition	%	-7.8	CHEMBL2527	Homo sapiens	INH	%	-7.8
	18211618	CHEMBL4045664	Inhibition of CHK2 labeling at conserved Lys1 (VAIKIISK) in human PBMC at 1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1		CHEMBL3971067	=	Inhibition	%	9.1	CHEMBL2527	Homo sapiens	INH	%	9.1
	18211811	CHEMBL4045907	Inhibition of CHK2 labeling at conserved Lys1 (VAIKIISK) in human PBMC at 0.1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1		CHEMBL3971067	=	Inhibition	%	9.7	CHEMBL2527	Homo sapiens	INH	%	9.7
	18211812	CHEMBL4045908	Inhibition of CHK2 labeling at conserved Lys2 (DLKPENVLLSSQEEDCLIK) in human PBMC at 0.1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1		CHEMBL3971067	=	Inhibition	%	-4.8	CHEMBL2527	Homo sapiens	INH	%	-4.8
	18232124	CHEMBL4050378	Inhibition of human CHK2 assessed as residual activity at 1 uM in presence of [33P]ATP by filter binding assay relative to control	B	NCCCC[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)CCCCCCCCOc1nc2cc(C(=O)O)ccc2c2cnccc12)C(=O)O		CHEMBL4077554	=	Activity	%	92.0	CHEMBL2527	Homo sapiens	Activity	%	92.0
	18248584	CHEMBL4053867	Inhibition of CHEK2 (CHK2) (unknown origin) at 1 uM relative to control	B	C=CC(=O)Nc1cc(Nc2nccc(-c3cn4c5c(cccc35)CCC4)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4104658	=	Inhibition	%	-2.0	CHEMBL2527	Homo sapiens	INH	%	-2.0
	18253765	CHEMBL4055167	Inhibition of wild-type human partial length CHK2 (S253 to E574 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)N		CHEMBL4096145	=	Activity	%	100.0	CHEMBL2527	Homo sapiens	Activity	%	100.0
	18253766	CHEMBL4055167	Inhibition of wild-type human partial length CHK2 (S253 to E574 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1		CHEMBL4080797	=	Activity	%	100.0	CHEMBL2527	Homo sapiens	Activity	%	100.0
	18265825	CHEMBL4057275	Inhibition of CHK2 (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	3.0	CHEMBL2527	Homo sapiens	INH	%	3.0
	18266085	CHEMBL4057535	Inhibition of CHK2 (unknown origin) at 0.49 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(NC(=O)C3CC3)noc2c1		CHEMBL4088455	=	Inhibition	%	8.0	CHEMBL2527	Homo sapiens	INH	%	8.0
	18266185	CHEMBL4057635	Inhibition of CHK2 (unknown origin) at 0.078 uM relative to control	B	COC(=O)Nc1noc2cc(-c3c(-c4ccccn4)n[nH]c3C)ccc12		CHEMBL4066592	=	Inhibition	%	0.7	CHEMBL2527	Homo sapiens	INH	%	0.7
	18274845	CHEMBL4118327	Inhibition of CHK2 in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled DLKPENVLLSSQEEDCLIK probe by mass-spectrometric analysis relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1Cl		CHEMBL3883384	=	Inhibition	%	8.5	CHEMBL2527	Homo sapiens	INH	%	8.5
	18274846	CHEMBL4118327	Inhibition of CHK2 in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled DLKPENVLLSSQEEDCLIK probe by mass-spectrometric analysis relative to control	B	C=CC(=O)Nc1ccccc1Oc1nc(Nc2cnn(CCOC)c2)ncc1Cl		CHEMBL3884839	=	Inhibition	%	-6.3	CHEMBL2527	Homo sapiens	INH	%	-6.3
	18274847	CHEMBL4118327	Inhibition of CHK2 in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled DLKPENVLLSSQEEDCLIK probe by mass-spectrometric analysis relative to control	B	COc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL1077979	=	Inhibition	%	12.6	CHEMBL2527	Homo sapiens	INH	%	12.6
Active	18275674	CHEMBL4118634	Binding affinity to CHEK2 in human NCI-H23 cells at 1 uM by mass spectrometry based pull down assay	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(CCOCCOCCOCCNC(=O)CCCC[C@@H]4SC[C@@H]5NC(=O)N[C@H]45)CC3)cc2)ncc1Cl		CHEMBL4129274		Activity			CHEMBL2527	Homo sapiens	Activity		
	18282024	CHEMBL4119979	Inhibition of recombinant full length His-tagged human CHK2 expressed in baculovirus expression system at 1 uM by FRET assay relative to control	B	CC(C)n1nc(-c2cnc(N)c(OC(F)(F)F)c2)cc1[C@@H]1[C@H]2CN(C3COC3)C[C@H]21		CHEMBL3719135	=	Inhibition	%	12.8	CHEMBL2527	Homo sapiens	INH	%	12.8
	18282343	CHEMBL4119979	Inhibition of recombinant full length His-tagged human CHK2 expressed in baculovirus expression system at 1 uM by FRET assay relative to control	B	Nc1ncc(-c2cc([C@@H]3[C@H]4CN(C5COC5)C[C@H]43)n(CC3CC3)n2)cc1C(F)(F)F		CHEMBL3715238	=	Inhibition	%	16.3	CHEMBL2527	Homo sapiens	INH	%	16.3
	18282675	CHEMBL4120260	Inhibition of CHK2 (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	3.0	CHEMBL2527	Homo sapiens	INH	%	3.0
	18282891	CHEMBL4120476	Inhibition of CHK2 (unknown origin) at 0.19 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(-c3ccc(N4CCN(C)CC4)nc3)n[nH]c2c1		CHEMBL4125807	=	Inhibition	%	3.0	CHEMBL2527	Homo sapiens	INH	%	3.0
	18283105	CHEMBL4120690	Inhibition of CHK2 (unknown origin) at 0.164 uM relative to control	B	COC(=O)Nc1cc(-c2c(C3CC3)n[nH]c2C)cc2[nH]ncc12		CHEMBL4129737	=	Inhibition	%	9.7	CHEMBL2527	Homo sapiens	INH	%	9.7
	18286293	CHEMBL4121528	Inhibition of recombinant full length His-tagged human CHK2 expressed in baculovirus expression system at 10 uM in presence of ATP relative to control	B	CC(C)(C)NS(=O)(=O)c1ccc(-c2sc(C(=O)N[C@H]3C[C@H](C(=O)O)C3)nc2CC2CCCCC2)c2ccccc12		CHEMBL4128926	=	Inhibition	%	-1.0	CHEMBL2527	Homo sapiens	INH	%	-1.0
Not Active	18372768	CHEMBL4143793	Induction of CHK2 phosphorylation at T68 residue in human MCF7 cells at 2 uM after 12 to 48 hrs by Western blot method	B	COc1ccc2nc3cc(Cl)ccc3c(NCCCN3C(=O)CCSC3c3cccs3)c2c1		CHEMBL4166078		Activity			CHEMBL2527	Homo sapiens	Activity		
	18379908	CHEMBL4145810	Inhibition of CHK2 (unknown origin) at 10 uM relative to control	B	COc1cc(NC(=O)Nc2cnc(Nc3ccc(N4CCOCC4)cc3)nc2Oc2ccc(C)cc2OC)cc(OC)c1		CHEMBL4159506	=	Inhibition	%	1.33	CHEMBL2527	Homo sapiens	INH	%	1.33
	18379960	CHEMBL4145861	Inhibition of CHK2 (unknown origin)	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	4.86	CHEMBL2527	Homo sapiens	IC50	nM	4.86
	18384535	CHEMBL4146617	Inhibition of Chk2 (unknown origin) by spectrophotometric analysis	B	NC(=O)c1ccc2[nH]c(-c3ccc(Sc4ccc(O)cc4)cc3)nc2c1		CHEMBL195041	=	IC50	nM	32.4	CHEMBL2527	Homo sapiens	IC50	nM	32.4
	18384536	CHEMBL4146617	Inhibition of Chk2 (unknown origin) by spectrophotometric analysis	B	Cc1nn(-c2ccccc2)c(Sc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)c1/C=N/NC(N)=O		CHEMBL4175850	=	IC50	nM	41.64	CHEMBL2527	Homo sapiens	IC50	nM	41.64
	18384537	CHEMBL4146617	Inhibition of Chk2 (unknown origin) by spectrophotometric analysis	B	CC(=O)N/N=C/c1c(C)nn(-c2ccccc2)c1Oc1ccc(-c2nc3cc(C(N)=O)ccc3[nH]2)cc1		CHEMBL4168756	=	IC50	nM	48.72	CHEMBL2527	Homo sapiens	IC50	nM	48.72
	18384538	CHEMBL4146617	Inhibition of Chk2 (unknown origin) by spectrophotometric analysis	B	Cc1nn(-c2ccccc2)c(Oc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)c1/C=N/NC(N)=S		CHEMBL4160826	=	IC50	nM	31.55	CHEMBL2527	Homo sapiens	IC50	nM	31.55
	18384539	CHEMBL4146617	Inhibition of Chk2 (unknown origin) by spectrophotometric analysis	B	Cc1nn(-c2ccccc2)c(Oc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)c1/C=N/NC(N)=O		CHEMBL4170221	=	IC50	nM	11.13	CHEMBL2527	Homo sapiens	IC50	nM	11.13
	18384540	CHEMBL4146617	Inhibition of Chk2 (unknown origin) by spectrophotometric analysis	B	Cc1nn(-c2ccccc2)c(Oc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)c1/C=N/Nc1ccc([N+](=O)[O-])cc1		CHEMBL4162300	=	IC50	nM	29.2	CHEMBL2527	Homo sapiens	IC50	nM	29.2
	18384541	CHEMBL4146617	Inhibition of Chk2 (unknown origin) by spectrophotometric analysis	B	COc1ccc(N/N=C/c2c(C)nn(-c3ccccc3)c2Oc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)cc1		CHEMBL4166813	=	IC50	nM	53.2	CHEMBL2527	Homo sapiens	IC50	nM	53.2
	18384542	CHEMBL4146617	Inhibition of Chk2 (unknown origin) by spectrophotometric analysis	B	Cc1nn(-c2ccccc2)c(Oc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)c1/C=N/Nc1ccccc1		CHEMBL4177437	=	IC50	nM	28.08	CHEMBL2527	Homo sapiens	IC50	nM	28.08
	18384543	CHEMBL4146617	Inhibition of Chk2 (unknown origin) by spectrophotometric analysis	B	Cc1nn(-c2ccccc2)c(Sc2ccc(-c3nc4cc(C(=O)O)ccc4[nH]3)cc2)c1/C=N/NC(N)=O		CHEMBL4177025	=	IC50	nM	27.91	CHEMBL2527	Homo sapiens	IC50	nM	27.91
	18384544	CHEMBL4146617	Inhibition of Chk2 (unknown origin) by spectrophotometric analysis	B	CC(=O)N/N=C/c1c(C)nn(-c2ccccc2)c1Oc1ccc(-c2nc3cc(C(=O)O)ccc3[nH]2)cc1		CHEMBL4169171	=	IC50	nM	46.29	CHEMBL2527	Homo sapiens	IC50	nM	46.29
	18384545	CHEMBL4146617	Inhibition of Chk2 (unknown origin) by spectrophotometric analysis	B	Cc1nn(-c2ccccc2)c(Oc2ccc(-c3nc4cc(C(=O)O)ccc4[nH]3)cc2)c1/C=N/NC(N)=S		CHEMBL4173655	=	IC50	nM	12.9	CHEMBL2527	Homo sapiens	IC50	nM	12.9
	18384546	CHEMBL4146617	Inhibition of Chk2 (unknown origin) by spectrophotometric analysis	B	Cc1nn(-c2ccccc2)c(Oc2ccc(-c3nc4cc(C(=O)O)ccc4[nH]3)cc2)c1/C=N/NC(N)=O		CHEMBL4165737	=	IC50	nM	25.84	CHEMBL2527	Homo sapiens	IC50	nM	25.84
	18384547	CHEMBL4146617	Inhibition of Chk2 (unknown origin) by spectrophotometric analysis	B	Cc1nn(-c2ccccc2)c(Oc2ccc(-c3nc4cc(C(=O)O)ccc4[nH]3)cc2)c1/C=N/Nc1ccc([N+](=O)[O-])cc1		CHEMBL4176212	=	IC50	nM	40.22	CHEMBL2527	Homo sapiens	IC50	nM	40.22
	18384548	CHEMBL4146617	Inhibition of Chk2 (unknown origin) by spectrophotometric analysis	B	COc1ccc(N/N=C/c2c(C)nn(-c3ccccc3)c2Oc2ccc(-c3nc4cc(C(=O)O)ccc4[nH]3)cc2)cc1		CHEMBL4165600	=	IC50	nM	9.95	CHEMBL2527	Homo sapiens	IC50	nM	9.95
	18384549	CHEMBL4146617	Inhibition of Chk2 (unknown origin) by spectrophotometric analysis	B	Cc1nn(-c2ccccc2)c(Oc2ccc(-c3nc4cc(C(=O)O)ccc4[nH]3)cc2)c1/C=N/Nc1ccccc1		CHEMBL4166017	=	IC50	nM	65.07	CHEMBL2527	Homo sapiens	IC50	nM	65.07
	18384550	CHEMBL4146617	Inhibition of Chk2 (unknown origin) by spectrophotometric analysis	B	Cc1nn(-c2ccccc2)c(Sc2ccc(-c3nc4cc([N+](=O)[O-])ccc4[nH]3)cc2)c1/C=N/NC(N)=O		CHEMBL4173942	=	IC50	nM	34.57	CHEMBL2527	Homo sapiens	IC50	nM	34.57
	18384551	CHEMBL4146617	Inhibition of Chk2 (unknown origin) by spectrophotometric analysis	B	CC(=O)N/N=C/c1c(C)nn(-c2ccccc2)c1Oc1ccc(-c2nc3cc([N+](=O)[O-])ccc3[nH]2)cc1		CHEMBL4169439	=	IC50	nM	43.82	CHEMBL2527	Homo sapiens	IC50	nM	43.82
	18384552	CHEMBL4146617	Inhibition of Chk2 (unknown origin) by spectrophotometric analysis	B	Cc1nn(-c2ccccc2)c(Oc2ccc(-c3nc4cc([N+](=O)[O-])ccc4[nH]3)cc2)c1/C=N/NC(N)=S		CHEMBL4177291	=	IC50	nM	11.49	CHEMBL2527	Homo sapiens	IC50	nM	11.49
	18384553	CHEMBL4146617	Inhibition of Chk2 (unknown origin) by spectrophotometric analysis	B	Cc1nn(-c2ccccc2)c(Oc2ccc(-c3nc4cc([N+](=O)[O-])ccc4[nH]3)cc2)c1/C=N/NC(N)=O		CHEMBL4159185	=	IC50	nM	41.64	CHEMBL2527	Homo sapiens	IC50	nM	41.64
	18384554	CHEMBL4146617	Inhibition of Chk2 (unknown origin) by spectrophotometric analysis	B	Cc1nn(-c2ccccc2)c(Oc2ccc(-c3nc4cc([N+](=O)[O-])ccc4[nH]3)cc2)c1/C=N/Nc1ccc([N+](=O)[O-])cc1		CHEMBL4167099	=	IC50	nM	31.82	CHEMBL2527	Homo sapiens	IC50	nM	31.82
	18384555	CHEMBL4146617	Inhibition of Chk2 (unknown origin) by spectrophotometric analysis	B	COc1ccc(N/N=C/c2c(C)nn(-c3ccccc3)c2Oc2ccc(-c3nc4cc([N+](=O)[O-])ccc4[nH]3)cc2)cc1		CHEMBL4162573	=	IC50	nM	35.91	CHEMBL2527	Homo sapiens	IC50	nM	35.91
	18384556	CHEMBL4146617	Inhibition of Chk2 (unknown origin) by spectrophotometric analysis	B	Cc1nn(-c2ccccc2)c(Oc2ccc(-c3nc4cc([N+](=O)[O-])ccc4[nH]3)cc2)c1/C=N/Nc1ccccc1		CHEMBL4170505	=	IC50	nM	11.73	CHEMBL2527	Homo sapiens	IC50	nM	11.73
	18384597	CHEMBL4146640	Inhibition of Chk2 (unknown origin) at 2.5 umol/L by spectrophotometric analysis relative to control	B	Cc1nn(-c2ccccc2)c(Oc2ccc(-c3nc4cc([N+](=O)[O-])ccc4[nH]3)cc2)c1/C=N/Nc1ccccc1		CHEMBL4170505	=	Inhibition	%	100.0	CHEMBL2527	Homo sapiens	INH	%	100.0
	18384598	CHEMBL4146640	Inhibition of Chk2 (unknown origin) at 2.5 umol/L by spectrophotometric analysis relative to control	B	COc1ccc(N/N=C/c2c(C)nn(-c3ccccc3)c2Oc2ccc(-c3nc4cc([N+](=O)[O-])ccc4[nH]3)cc2)cc1		CHEMBL4162573	=	Inhibition	%	97.46	CHEMBL2527	Homo sapiens	INH	%	97.46
	18384599	CHEMBL4146640	Inhibition of Chk2 (unknown origin) at 2.5 umol/L by spectrophotometric analysis relative to control	B	Cc1nn(-c2ccccc2)c(Oc2ccc(-c3nc4cc([N+](=O)[O-])ccc4[nH]3)cc2)c1/C=N/Nc1ccc([N+](=O)[O-])cc1		CHEMBL4167099	=	Inhibition	%	99.64	CHEMBL2527	Homo sapiens	INH	%	99.64
	18384600	CHEMBL4146640	Inhibition of Chk2 (unknown origin) at 2.5 umol/L by spectrophotometric analysis relative to control	B	Cc1nn(-c2ccccc2)c(Oc2ccc(-c3nc4cc([N+](=O)[O-])ccc4[nH]3)cc2)c1/C=N/NC(N)=O		CHEMBL4159185	=	Inhibition	%	100.0	CHEMBL2527	Homo sapiens	INH	%	100.0
	18384601	CHEMBL4146640	Inhibition of Chk2 (unknown origin) at 2.5 umol/L by spectrophotometric analysis relative to control	B	Cc1nn(-c2ccccc2)c(Oc2ccc(-c3nc4cc([N+](=O)[O-])ccc4[nH]3)cc2)c1/C=N/NC(N)=S		CHEMBL4177291	=	Inhibition	%	98.55	CHEMBL2527	Homo sapiens	INH	%	98.55
	18384602	CHEMBL4146640	Inhibition of Chk2 (unknown origin) at 2.5 umol/L by spectrophotometric analysis relative to control	B	CC(=O)N/N=C/c1c(C)nn(-c2ccccc2)c1Oc1ccc(-c2nc3cc([N+](=O)[O-])ccc3[nH]2)cc1		CHEMBL4169439	=	Inhibition	%	98.55	CHEMBL2527	Homo sapiens	INH	%	98.55
	18384603	CHEMBL4146640	Inhibition of Chk2 (unknown origin) at 2.5 umol/L by spectrophotometric analysis relative to control	B	Cc1nn(-c2ccccc2)c(Sc2ccc(-c3nc4cc([N+](=O)[O-])ccc4[nH]3)cc2)c1/C=N/NC(N)=O		CHEMBL4173942	=	Inhibition	%	92.32	CHEMBL2527	Homo sapiens	INH	%	92.32
	18384604	CHEMBL4146640	Inhibition of Chk2 (unknown origin) at 2.5 umol/L by spectrophotometric analysis relative to control	B	Cc1nn(-c2ccccc2)c(Oc2ccc(-c3nc4cc(C(=O)O)ccc4[nH]3)cc2)c1/C=N/Nc1ccccc1		CHEMBL4166017	=	Inhibition	%	94.92	CHEMBL2527	Homo sapiens	INH	%	94.92
	18384605	CHEMBL4146640	Inhibition of Chk2 (unknown origin) at 2.5 umol/L by spectrophotometric analysis relative to control	B	COc1ccc(N/N=C/c2c(C)nn(-c3ccccc3)c2Oc2ccc(-c3nc4cc(C(=O)O)ccc4[nH]3)cc2)cc1		CHEMBL4165600	=	Inhibition	%	99.35	CHEMBL2527	Homo sapiens	INH	%	99.35
	18384606	CHEMBL4146640	Inhibition of Chk2 (unknown origin) at 2.5 umol/L by spectrophotometric analysis relative to control	B	Cc1nn(-c2ccccc2)c(Oc2ccc(-c3nc4cc(C(=O)O)ccc4[nH]3)cc2)c1/C=N/Nc1ccc([N+](=O)[O-])cc1		CHEMBL4176212	=	Inhibition	%	95.29	CHEMBL2527	Homo sapiens	INH	%	95.29
	18384607	CHEMBL4146640	Inhibition of Chk2 (unknown origin) at 2.5 umol/L by spectrophotometric analysis relative to control	B	Cc1nn(-c2ccccc2)c(Oc2ccc(-c3nc4cc(C(=O)O)ccc4[nH]3)cc2)c1/C=N/NC(N)=O		CHEMBL4165737	=	Inhibition	%	98.55	CHEMBL2527	Homo sapiens	INH	%	98.55
	18384608	CHEMBL4146640	Inhibition of Chk2 (unknown origin) at 2.5 umol/L by spectrophotometric analysis relative to control	B	Cc1nn(-c2ccccc2)c(Oc2ccc(-c3nc4cc(C(=O)O)ccc4[nH]3)cc2)c1/C=N/NC(N)=S		CHEMBL4173655	=	Inhibition	%	92.75	CHEMBL2527	Homo sapiens	INH	%	92.75
	18384609	CHEMBL4146640	Inhibition of Chk2 (unknown origin) at 2.5 umol/L by spectrophotometric analysis relative to control	B	CC(=O)N/N=C/c1c(C)nn(-c2ccccc2)c1Oc1ccc(-c2nc3cc(C(=O)O)ccc3[nH]2)cc1		CHEMBL4169171	=	Inhibition	%	100.0	CHEMBL2527	Homo sapiens	INH	%	100.0
	18384610	CHEMBL4146640	Inhibition of Chk2 (unknown origin) at 2.5 umol/L by spectrophotometric analysis relative to control	B	Cc1nn(-c2ccccc2)c(Sc2ccc(-c3nc4cc(C(=O)O)ccc4[nH]3)cc2)c1/C=N/NC(N)=O		CHEMBL4177025	=	Inhibition	%	97.39	CHEMBL2527	Homo sapiens	INH	%	97.39
	18384611	CHEMBL4146640	Inhibition of Chk2 (unknown origin) at 2.5 umol/L by spectrophotometric analysis relative to control	B	Cc1nn(-c2ccccc2)c(Oc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)c1/C=N/Nc1ccccc1		CHEMBL4177437	=	Inhibition	%	96.37	CHEMBL2527	Homo sapiens	INH	%	96.37
	18384612	CHEMBL4146640	Inhibition of Chk2 (unknown origin) at 2.5 umol/L by spectrophotometric analysis relative to control	B	COc1ccc(N/N=C/c2c(C)nn(-c3ccccc3)c2Oc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)cc1		CHEMBL4166813	=	Inhibition	%	98.55	CHEMBL2527	Homo sapiens	INH	%	98.55
	18384613	CHEMBL4146640	Inhibition of Chk2 (unknown origin) at 2.5 umol/L by spectrophotometric analysis relative to control	B	Cc1nn(-c2ccccc2)c(Oc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)c1/C=N/Nc1ccc([N+](=O)[O-])cc1		CHEMBL4162300	=	Inhibition	%	93.11	CHEMBL2527	Homo sapiens	INH	%	93.11
	18384614	CHEMBL4146640	Inhibition of Chk2 (unknown origin) at 2.5 umol/L by spectrophotometric analysis relative to control	B	Cc1nn(-c2ccccc2)c(Oc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)c1/C=N/NC(N)=O		CHEMBL4170221	=	Inhibition	%	95.29	CHEMBL2527	Homo sapiens	INH	%	95.29
	18384615	CHEMBL4146640	Inhibition of Chk2 (unknown origin) at 2.5 umol/L by spectrophotometric analysis relative to control	B	Cc1nn(-c2ccccc2)c(Oc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)c1/C=N/NC(N)=S		CHEMBL4160826	=	Inhibition	%	100.0	CHEMBL2527	Homo sapiens	INH	%	100.0
	18384616	CHEMBL4146640	Inhibition of Chk2 (unknown origin) at 2.5 umol/L by spectrophotometric analysis relative to control	B	CC(=O)N/N=C/c1c(C)nn(-c2ccccc2)c1Oc1ccc(-c2nc3cc(C(N)=O)ccc3[nH]2)cc1		CHEMBL4168756	=	Inhibition	%	99.56	CHEMBL2527	Homo sapiens	INH	%	99.56
	18384617	CHEMBL4146640	Inhibition of Chk2 (unknown origin) at 2.5 umol/L by spectrophotometric analysis relative to control	B	Cc1nn(-c2ccccc2)c(Sc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)c1/C=N/NC(N)=O		CHEMBL4175850	=	Inhibition	%	98.55	CHEMBL2527	Homo sapiens	INH	%	98.55
	18384618	CHEMBL4146641	Inhibition of Chk2 (unknown origin) at 1.5 umol/L by spectrophotometric analysis relative to control	B	Cc1nn(-c2ccccc2)c(Oc2ccc(-c3nc4cc([N+](=O)[O-])ccc4[nH]3)cc2)c1/C=N/Nc1ccccc1		CHEMBL4170505	=	Inhibition	%	99.63	CHEMBL2527	Homo sapiens	INH	%	99.63
	18384619	CHEMBL4146641	Inhibition of Chk2 (unknown origin) at 1.5 umol/L by spectrophotometric analysis relative to control	B	COc1ccc(N/N=C/c2c(C)nn(-c3ccccc3)c2Oc2ccc(-c3nc4cc([N+](=O)[O-])ccc4[nH]3)cc2)cc1		CHEMBL4162573	=	Inhibition	%	83.48	CHEMBL2527	Homo sapiens	INH	%	83.48
	18384620	CHEMBL4146641	Inhibition of Chk2 (unknown origin) at 1.5 umol/L by spectrophotometric analysis relative to control	B	Cc1nn(-c2ccccc2)c(Oc2ccc(-c3nc4cc([N+](=O)[O-])ccc4[nH]3)cc2)c1/C=N/Nc1ccc([N+](=O)[O-])cc1		CHEMBL4167099	=	Inhibition	%	97.1	CHEMBL2527	Homo sapiens	INH	%	97.1
	18384621	CHEMBL4146641	Inhibition of Chk2 (unknown origin) at 1.5 umol/L by spectrophotometric analysis relative to control	B	Cc1nn(-c2ccccc2)c(Oc2ccc(-c3nc4cc([N+](=O)[O-])ccc4[nH]3)cc2)c1/C=N/NC(N)=O		CHEMBL4159185	=	Inhibition	%	86.95	CHEMBL2527	Homo sapiens	INH	%	86.95
	18384622	CHEMBL4146641	Inhibition of Chk2 (unknown origin) at 1.5 umol/L by spectrophotometric analysis relative to control	B	Cc1nn(-c2ccccc2)c(Oc2ccc(-c3nc4cc([N+](=O)[O-])ccc4[nH]3)cc2)c1/C=N/NC(N)=S		CHEMBL4177291	=	Inhibition	%	97.46	CHEMBL2527	Homo sapiens	INH	%	97.46
	18384623	CHEMBL4146641	Inhibition of Chk2 (unknown origin) at 1.5 umol/L by spectrophotometric analysis relative to control	B	CC(=O)N/N=C/c1c(C)nn(-c2ccccc2)c1Oc1ccc(-c2nc3cc([N+](=O)[O-])ccc3[nH]2)cc1		CHEMBL4169439	=	Inhibition	%	94.2	CHEMBL2527	Homo sapiens	INH	%	94.2
	18384624	CHEMBL4146641	Inhibition of Chk2 (unknown origin) at 1.5 umol/L by spectrophotometric analysis relative to control	B	Cc1nn(-c2ccccc2)c(Sc2ccc(-c3nc4cc([N+](=O)[O-])ccc4[nH]3)cc2)c1/C=N/NC(N)=O		CHEMBL4173942	=	Inhibition	%	83.69	CHEMBL2527	Homo sapiens	INH	%	83.69
	18384625	CHEMBL4146641	Inhibition of Chk2 (unknown origin) at 1.5 umol/L by spectrophotometric analysis relative to control	B	Cc1nn(-c2ccccc2)c(Oc2ccc(-c3nc4cc(C(=O)O)ccc4[nH]3)cc2)c1/C=N/Nc1ccccc1		CHEMBL4166017	=	Inhibition	%	94.56	CHEMBL2527	Homo sapiens	INH	%	94.56
	18384626	CHEMBL4146641	Inhibition of Chk2 (unknown origin) at 1.5 umol/L by spectrophotometric analysis relative to control	B	COc1ccc(N/N=C/c2c(C)nn(-c3ccccc3)c2Oc2ccc(-c3nc4cc(C(=O)O)ccc4[nH]3)cc2)cc1		CHEMBL4165600	=	Inhibition	%	95.65	CHEMBL2527	Homo sapiens	INH	%	95.65
	18384627	CHEMBL4146641	Inhibition of Chk2 (unknown origin) at 1.5 umol/L by spectrophotometric analysis relative to control	B	Cc1nn(-c2ccccc2)c(Oc2ccc(-c3nc4cc(C(=O)O)ccc4[nH]3)cc2)c1/C=N/Nc1ccc([N+](=O)[O-])cc1		CHEMBL4176212	=	Inhibition	%	83.69	CHEMBL2527	Homo sapiens	INH	%	83.69
	18384628	CHEMBL4146641	Inhibition of Chk2 (unknown origin) at 1.5 umol/L by spectrophotometric analysis relative to control	B	Cc1nn(-c2ccccc2)c(Oc2ccc(-c3nc4cc(C(=O)O)ccc4[nH]3)cc2)c1/C=N/NC(N)=O		CHEMBL4165737	=	Inhibition	%	87.3	CHEMBL2527	Homo sapiens	INH	%	87.3
	18384629	CHEMBL4146641	Inhibition of Chk2 (unknown origin) at 1.5 umol/L by spectrophotometric analysis relative to control	B	Cc1nn(-c2ccccc2)c(Oc2ccc(-c3nc4cc(C(=O)O)ccc4[nH]3)cc2)c1/C=N/NC(N)=S		CHEMBL4173655	=	Inhibition	%	91.3	CHEMBL2527	Homo sapiens	INH	%	91.3
	18384630	CHEMBL4146641	Inhibition of Chk2 (unknown origin) at 1.5 umol/L by spectrophotometric analysis relative to control	B	CC(=O)N/N=C/c1c(C)nn(-c2ccccc2)c1Oc1ccc(-c2nc3cc(C(=O)O)ccc3[nH]2)cc1		CHEMBL4169171	=	Inhibition	%	99.27	CHEMBL2527	Homo sapiens	INH	%	99.27
	18384631	CHEMBL4146641	Inhibition of Chk2 (unknown origin) at 1.5 umol/L by spectrophotometric analysis relative to control	B	Cc1nn(-c2ccccc2)c(Sc2ccc(-c3nc4cc(C(=O)O)ccc4[nH]3)cc2)c1/C=N/NC(N)=O		CHEMBL4177025	=	Inhibition	%	96.37	CHEMBL2527	Homo sapiens	INH	%	96.37
	18384632	CHEMBL4146641	Inhibition of Chk2 (unknown origin) at 1.5 umol/L by spectrophotometric analysis relative to control	B	Cc1nn(-c2ccccc2)c(Oc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)c1/C=N/Nc1ccccc1		CHEMBL4177437	=	Inhibition	%	82.97	CHEMBL2527	Homo sapiens	INH	%	82.97
	18384633	CHEMBL4146641	Inhibition of Chk2 (unknown origin) at 1.5 umol/L by spectrophotometric analysis relative to control	B	COc1ccc(N/N=C/c2c(C)nn(-c3ccccc3)c2Oc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)cc1		CHEMBL4166813	=	Inhibition	%	94.35	CHEMBL2527	Homo sapiens	INH	%	94.35
	18384634	CHEMBL4146641	Inhibition of Chk2 (unknown origin) at 1.5 umol/L by spectrophotometric analysis relative to control	B	Cc1nn(-c2ccccc2)c(Oc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)c1/C=N/Nc1ccc([N+](=O)[O-])cc1		CHEMBL4162300	=	Inhibition	%	89.67	CHEMBL2527	Homo sapiens	INH	%	89.67
	18384635	CHEMBL4146641	Inhibition of Chk2 (unknown origin) at 1.5 umol/L by spectrophotometric analysis relative to control	B	Cc1nn(-c2ccccc2)c(Oc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)c1/C=N/NC(N)=O		CHEMBL4170221	=	Inhibition	%	94.93	CHEMBL2527	Homo sapiens	INH	%	94.93
	18384636	CHEMBL4146641	Inhibition of Chk2 (unknown origin) at 1.5 umol/L by spectrophotometric analysis relative to control	B	Cc1nn(-c2ccccc2)c(Oc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)c1/C=N/NC(N)=S		CHEMBL4160826	=	Inhibition	%	98.55	CHEMBL2527	Homo sapiens	INH	%	98.55
	18384637	CHEMBL4146641	Inhibition of Chk2 (unknown origin) at 1.5 umol/L by spectrophotometric analysis relative to control	B	CC(=O)N/N=C/c1c(C)nn(-c2ccccc2)c1Oc1ccc(-c2nc3cc(C(N)=O)ccc3[nH]2)cc1		CHEMBL4168756	=	Inhibition	%	84.43	CHEMBL2527	Homo sapiens	INH	%	84.43
	18384638	CHEMBL4146641	Inhibition of Chk2 (unknown origin) at 1.5 umol/L by spectrophotometric analysis relative to control	B	Cc1nn(-c2ccccc2)c(Sc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)c1/C=N/NC(N)=O		CHEMBL4175850	=	Inhibition	%	94.2	CHEMBL2527	Homo sapiens	INH	%	94.2
	18384639	CHEMBL4146642	Inhibition of Chk2 (unknown origin) at 0.1 umol/L by spectrophotometric analysis relative to control	B	Cc1nn(-c2ccccc2)c(Oc2ccc(-c3nc4cc([N+](=O)[O-])ccc4[nH]3)cc2)c1/C=N/Nc1ccccc1		CHEMBL4170505	=	Inhibition	%	97.46	CHEMBL2527	Homo sapiens	INH	%	97.46
	18384640	CHEMBL4146642	Inhibition of Chk2 (unknown origin) at 0.1 umol/L by spectrophotometric analysis relative to control	B	COc1ccc(N/N=C/c2c(C)nn(-c3ccccc3)c2Oc2ccc(-c3nc4cc([N+](=O)[O-])ccc4[nH]3)cc2)cc1		CHEMBL4162573	=	Inhibition	%	77.53	CHEMBL2527	Homo sapiens	INH	%	77.53
	18384641	CHEMBL4146642	Inhibition of Chk2 (unknown origin) at 0.1 umol/L by spectrophotometric analysis relative to control	B	Cc1nn(-c2ccccc2)c(Oc2ccc(-c3nc4cc([N+](=O)[O-])ccc4[nH]3)cc2)c1/C=N/Nc1ccc([N+](=O)[O-])cc1		CHEMBL4167099	=	Inhibition	%	88.04	CHEMBL2527	Homo sapiens	INH	%	88.04
	18384642	CHEMBL4146642	Inhibition of Chk2 (unknown origin) at 0.1 umol/L by spectrophotometric analysis relative to control	B	Cc1nn(-c2ccccc2)c(Oc2ccc(-c3nc4cc([N+](=O)[O-])ccc4[nH]3)cc2)c1/C=N/NC(N)=O		CHEMBL4159185	=	Inhibition	%	78.26	CHEMBL2527	Homo sapiens	INH	%	78.26
	18384643	CHEMBL4146642	Inhibition of Chk2 (unknown origin) at 0.1 umol/L by spectrophotometric analysis relative to control	B	Cc1nn(-c2ccccc2)c(Oc2ccc(-c3nc4cc([N+](=O)[O-])ccc4[nH]3)cc2)c1/C=N/NC(N)=S		CHEMBL4177291	=	Inhibition	%	81.52	CHEMBL2527	Homo sapiens	INH	%	81.52
	18384644	CHEMBL4146642	Inhibition of Chk2 (unknown origin) at 0.1 umol/L by spectrophotometric analysis relative to control	B	CC(=O)N/N=C/c1c(C)nn(-c2ccccc2)c1Oc1ccc(-c2nc3cc([N+](=O)[O-])ccc3[nH]2)cc1		CHEMBL4169439	=	Inhibition	%	75.7	CHEMBL2527	Homo sapiens	INH	%	75.7
	18384645	CHEMBL4146642	Inhibition of Chk2 (unknown origin) at 0.1 umol/L by spectrophotometric analysis relative to control	B	Cc1nn(-c2ccccc2)c(Sc2ccc(-c3nc4cc([N+](=O)[O-])ccc4[nH]3)cc2)c1/C=N/NC(N)=O		CHEMBL4173942	=	Inhibition	%	76.45	CHEMBL2527	Homo sapiens	INH	%	76.45
	18384646	CHEMBL4146642	Inhibition of Chk2 (unknown origin) at 0.1 umol/L by spectrophotometric analysis relative to control	B	Cc1nn(-c2ccccc2)c(Oc2ccc(-c3nc4cc(C(=O)O)ccc4[nH]3)cc2)c1/C=N/Nc1ccccc1		CHEMBL4166017	=	Inhibition	%	69.2	CHEMBL2527	Homo sapiens	INH	%	69.2
	18384647	CHEMBL4146642	Inhibition of Chk2 (unknown origin) at 0.1 umol/L by spectrophotometric analysis relative to control	B	COc1ccc(N/N=C/c2c(C)nn(-c3ccccc3)c2Oc2ccc(-c3nc4cc(C(=O)O)ccc4[nH]3)cc2)cc1		CHEMBL4165600	=	Inhibition	%	91.3	CHEMBL2527	Homo sapiens	INH	%	91.3
	18384648	CHEMBL4146642	Inhibition of Chk2 (unknown origin) at 0.1 umol/L by spectrophotometric analysis relative to control	B	Cc1nn(-c2ccccc2)c(Oc2ccc(-c3nc4cc(C(=O)O)ccc4[nH]3)cc2)c1/C=N/Nc1ccc([N+](=O)[O-])cc1		CHEMBL4176212	=	Inhibition	%	74.63	CHEMBL2527	Homo sapiens	INH	%	74.63
	18384649	CHEMBL4146642	Inhibition of Chk2 (unknown origin) at 0.1 umol/L by spectrophotometric analysis relative to control	B	Cc1nn(-c2ccccc2)c(Oc2ccc(-c3nc4cc(C(=O)O)ccc4[nH]3)cc2)c1/C=N/NC(N)=O		CHEMBL4165737	=	Inhibition	%	71.74	CHEMBL2527	Homo sapiens	INH	%	71.74
	18384650	CHEMBL4146642	Inhibition of Chk2 (unknown origin) at 0.1 umol/L by spectrophotometric analysis relative to control	B	Cc1nn(-c2ccccc2)c(Oc2ccc(-c3nc4cc(C(=O)O)ccc4[nH]3)cc2)c1/C=N/NC(N)=S		CHEMBL4173655	=	Inhibition	%	89.49	CHEMBL2527	Homo sapiens	INH	%	89.49
	18384651	CHEMBL4146642	Inhibition of Chk2 (unknown origin) at 0.1 umol/L by spectrophotometric analysis relative to control	B	CC(=O)N/N=C/c1c(C)nn(-c2ccccc2)c1Oc1ccc(-c2nc3cc(C(=O)O)ccc3[nH]2)cc1		CHEMBL4169171	=	Inhibition	%	98.77	CHEMBL2527	Homo sapiens	INH	%	98.77
	18384652	CHEMBL4146642	Inhibition of Chk2 (unknown origin) at 0.1 umol/L by spectrophotometric analysis relative to control	B	Cc1nn(-c2ccccc2)c(Sc2ccc(-c3nc4cc(C(=O)O)ccc4[nH]3)cc2)c1/C=N/NC(N)=O		CHEMBL4177025	=	Inhibition	%	83.33	CHEMBL2527	Homo sapiens	INH	%	83.33
	18384653	CHEMBL4146642	Inhibition of Chk2 (unknown origin) at 0.1 umol/L by spectrophotometric analysis relative to control	B	Cc1nn(-c2ccccc2)c(Oc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)c1/C=N/Nc1ccccc1		CHEMBL4177437	=	Inhibition	%	68.47	CHEMBL2527	Homo sapiens	INH	%	68.47
	18384654	CHEMBL4146642	Inhibition of Chk2 (unknown origin) at 0.1 umol/L by spectrophotometric analysis relative to control	B	COc1ccc(N/N=C/c2c(C)nn(-c3ccccc3)c2Oc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)cc1		CHEMBL4166813	=	Inhibition	%	78.62	CHEMBL2527	Homo sapiens	INH	%	78.62
	18384655	CHEMBL4146642	Inhibition of Chk2 (unknown origin) at 0.1 umol/L by spectrophotometric analysis relative to control	B	Cc1nn(-c2ccccc2)c(Oc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)c1/C=N/Nc1ccc([N+](=O)[O-])cc1		CHEMBL4162300	=	Inhibition	%	69.56	CHEMBL2527	Homo sapiens	INH	%	69.56
	18384656	CHEMBL4146642	Inhibition of Chk2 (unknown origin) at 0.1 umol/L by spectrophotometric analysis relative to control	B	Cc1nn(-c2ccccc2)c(Oc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)c1/C=N/NC(N)=O		CHEMBL4170221	=	Inhibition	%	77.53	CHEMBL2527	Homo sapiens	INH	%	77.53
	18384657	CHEMBL4146642	Inhibition of Chk2 (unknown origin) at 0.1 umol/L by spectrophotometric analysis relative to control	B	Cc1nn(-c2ccccc2)c(Oc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)c1/C=N/NC(N)=S		CHEMBL4160826	=	Inhibition	%	86.59	CHEMBL2527	Homo sapiens	INH	%	86.59
	18384658	CHEMBL4146642	Inhibition of Chk2 (unknown origin) at 0.1 umol/L by spectrophotometric analysis relative to control	B	CC(=O)N/N=C/c1c(C)nn(-c2ccccc2)c1Oc1ccc(-c2nc3cc(C(N)=O)ccc3[nH]2)cc1		CHEMBL4168756	=	Inhibition	%	65.21	CHEMBL2527	Homo sapiens	INH	%	65.21
	18384659	CHEMBL4146642	Inhibition of Chk2 (unknown origin) at 0.1 umol/L by spectrophotometric analysis relative to control	B	Cc1nn(-c2ccccc2)c(Sc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)c1/C=N/NC(N)=O		CHEMBL4175850	=	Inhibition	%	81.16	CHEMBL2527	Homo sapiens	INH	%	81.16
	18384660	CHEMBL4146643	Inhibition of Chk2 (unknown origin) at 0.050 umol/L by spectrophotometric analysis relative to control	B	Cc1nn(-c2ccccc2)c(Oc2ccc(-c3nc4cc([N+](=O)[O-])ccc4[nH]3)cc2)c1/C=N/Nc1ccccc1		CHEMBL4170505	=	Inhibition	%	96.16	CHEMBL2527	Homo sapiens	INH	%	96.16
	18384661	CHEMBL4146643	Inhibition of Chk2 (unknown origin) at 0.050 umol/L by spectrophotometric analysis relative to control	B	COc1ccc(N/N=C/c2c(C)nn(-c3ccccc3)c2Oc2ccc(-c3nc4cc([N+](=O)[O-])ccc4[nH]3)cc2)cc1		CHEMBL4162573	=	Inhibition	%	65.21	CHEMBL2527	Homo sapiens	INH	%	65.21
	18384662	CHEMBL4146643	Inhibition of Chk2 (unknown origin) at 0.050 umol/L by spectrophotometric analysis relative to control	B	Cc1nn(-c2ccccc2)c(Oc2ccc(-c3nc4cc([N+](=O)[O-])ccc4[nH]3)cc2)c1/C=N/Nc1ccc([N+](=O)[O-])cc1		CHEMBL4167099	=	Inhibition	%	71.3	CHEMBL2527	Homo sapiens	INH	%	71.3
	18384663	CHEMBL4146643	Inhibition of Chk2 (unknown origin) at 0.050 umol/L by spectrophotometric analysis relative to control	B	Cc1nn(-c2ccccc2)c(Oc2ccc(-c3nc4cc([N+](=O)[O-])ccc4[nH]3)cc2)c1/C=N/NC(N)=O		CHEMBL4159185	=	Inhibition	%	58.37	CHEMBL2527	Homo sapiens	INH	%	58.37
	18384664	CHEMBL4146643	Inhibition of Chk2 (unknown origin) at 0.050 umol/L by spectrophotometric analysis relative to control	B	Cc1nn(-c2ccccc2)c(Oc2ccc(-c3nc4cc([N+](=O)[O-])ccc4[nH]3)cc2)c1/C=N/NC(N)=S		CHEMBL4177291	=	Inhibition	%	89.31	CHEMBL2527	Homo sapiens	INH	%	89.31
	18384665	CHEMBL4146643	Inhibition of Chk2 (unknown origin) at 0.050 umol/L by spectrophotometric analysis relative to control	B	CC(=O)N/N=C/c1c(C)nn(-c2ccccc2)c1Oc1ccc(-c2nc3cc([N+](=O)[O-])ccc3[nH]2)cc1		CHEMBL4169439	=	Inhibition	%	53.62	CHEMBL2527	Homo sapiens	INH	%	53.62
	18384666	CHEMBL4146643	Inhibition of Chk2 (unknown origin) at 0.050 umol/L by spectrophotometric analysis relative to control	B	Cc1nn(-c2ccccc2)c(Sc2ccc(-c3nc4cc([N+](=O)[O-])ccc4[nH]3)cc2)c1/C=N/NC(N)=O		CHEMBL4173942	=	Inhibition	%	65.63	CHEMBL2527	Homo sapiens	INH	%	65.63
	18384667	CHEMBL4146643	Inhibition of Chk2 (unknown origin) at 0.050 umol/L by spectrophotometric analysis relative to control	B	Cc1nn(-c2ccccc2)c(Oc2ccc(-c3nc4cc(C(=O)O)ccc4[nH]3)cc2)c1/C=N/Nc1ccccc1		CHEMBL4166017	=	Inhibition	%	38.4	CHEMBL2527	Homo sapiens	INH	%	38.4
	18384668	CHEMBL4146643	Inhibition of Chk2 (unknown origin) at 0.050 umol/L by spectrophotometric analysis relative to control	B	COc1ccc(N/N=C/c2c(C)nn(-c3ccccc3)c2Oc2ccc(-c3nc4cc(C(=O)O)ccc4[nH]3)cc2)cc1		CHEMBL4165600	=	Inhibition	%	88.87	CHEMBL2527	Homo sapiens	INH	%	88.87
	18384669	CHEMBL4146643	Inhibition of Chk2 (unknown origin) at 0.050 umol/L by spectrophotometric analysis relative to control	B	Cc1nn(-c2ccccc2)c(Oc2ccc(-c3nc4cc(C(=O)O)ccc4[nH]3)cc2)c1/C=N/Nc1ccc([N+](=O)[O-])cc1		CHEMBL4176212	=	Inhibition	%	59.42	CHEMBL2527	Homo sapiens	INH	%	59.42
	18384670	CHEMBL4146643	Inhibition of Chk2 (unknown origin) at 0.050 umol/L by spectrophotometric analysis relative to control	B	Cc1nn(-c2ccccc2)c(Oc2ccc(-c3nc4cc(C(=O)O)ccc4[nH]3)cc2)c1/C=N/NC(N)=O		CHEMBL4165737	=	Inhibition	%	53.98	CHEMBL2527	Homo sapiens	INH	%	53.98
	18384671	CHEMBL4146643	Inhibition of Chk2 (unknown origin) at 0.050 umol/L by spectrophotometric analysis relative to control	B	Cc1nn(-c2ccccc2)c(Oc2ccc(-c3nc4cc(C(=O)O)ccc4[nH]3)cc2)c1/C=N/NC(N)=S		CHEMBL4173655	=	Inhibition	%	86.59	CHEMBL2527	Homo sapiens	INH	%	86.59
	18384672	CHEMBL4146643	Inhibition of Chk2 (unknown origin) at 0.050 umol/L by spectrophotometric analysis relative to control	B	CC(=O)N/N=C/c1c(C)nn(-c2ccccc2)c1Oc1ccc(-c2nc3cc(C(=O)O)ccc3[nH]2)cc1		CHEMBL4169171	=	Inhibition	%	94.2	CHEMBL2527	Homo sapiens	INH	%	94.2
	18384673	CHEMBL4146643	Inhibition of Chk2 (unknown origin) at 0.050 umol/L by spectrophotometric analysis relative to control	B	Cc1nn(-c2ccccc2)c(Sc2ccc(-c3nc4cc(C(=O)O)ccc4[nH]3)cc2)c1/C=N/NC(N)=O		CHEMBL4177025	=	Inhibition	%	73.55	CHEMBL2527	Homo sapiens	INH	%	73.55
	18384674	CHEMBL4146643	Inhibition of Chk2 (unknown origin) at 0.050 umol/L by spectrophotometric analysis relative to control	B	Cc1nn(-c2ccccc2)c(Oc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)c1/C=N/Nc1ccccc1		CHEMBL4177437	=	Inhibition	%	60.5	CHEMBL2527	Homo sapiens	INH	%	60.5
	18384675	CHEMBL4146643	Inhibition of Chk2 (unknown origin) at 0.050 umol/L by spectrophotometric analysis relative to control	B	COc1ccc(N/N=C/c2c(C)nn(-c3ccccc3)c2Oc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)cc1		CHEMBL4166813	=	Inhibition	%	43.8	CHEMBL2527	Homo sapiens	INH	%	43.8
	18384676	CHEMBL4146643	Inhibition of Chk2 (unknown origin) at 0.050 umol/L by spectrophotometric analysis relative to control	B	Cc1nn(-c2ccccc2)c(Oc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)c1/C=N/Nc1ccc([N+](=O)[O-])cc1		CHEMBL4162300	=	Inhibition	%	64.13	CHEMBL2527	Homo sapiens	INH	%	64.13
	18384677	CHEMBL4146643	Inhibition of Chk2 (unknown origin) at 0.050 umol/L by spectrophotometric analysis relative to control	B	Cc1nn(-c2ccccc2)c(Oc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)c1/C=N/NC(N)=O		CHEMBL4170221	=	Inhibition	%	71.01	CHEMBL2527	Homo sapiens	INH	%	71.01
	18384678	CHEMBL4146643	Inhibition of Chk2 (unknown origin) at 0.050 umol/L by spectrophotometric analysis relative to control	B	Cc1nn(-c2ccccc2)c(Oc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)c1/C=N/NC(N)=S		CHEMBL4160826	=	Inhibition	%	56.52	CHEMBL2527	Homo sapiens	INH	%	56.52
	18384679	CHEMBL4146643	Inhibition of Chk2 (unknown origin) at 0.050 umol/L by spectrophotometric analysis relative to control	B	CC(=O)N/N=C/c1c(C)nn(-c2ccccc2)c1Oc1ccc(-c2nc3cc(C(N)=O)ccc3[nH]2)cc1		CHEMBL4168756	=	Inhibition	%	46.05	CHEMBL2527	Homo sapiens	INH	%	46.05
	18384680	CHEMBL4146643	Inhibition of Chk2 (unknown origin) at 0.050 umol/L by spectrophotometric analysis relative to control	B	Cc1nn(-c2ccccc2)c(Sc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)c1/C=N/NC(N)=O		CHEMBL4175850	=	Inhibition	%	51.44	CHEMBL2527	Homo sapiens	INH	%	51.44
	18384681	CHEMBL4146644	Inhibition of Chk2 (unknown origin) at 0.025 umol/L by spectrophotometric analysis relative to control	B	Cc1nn(-c2ccccc2)c(Oc2ccc(-c3nc4cc([N+](=O)[O-])ccc4[nH]3)cc2)c1/C=N/Nc1ccccc1		CHEMBL4170505	=	Inhibition	%	68.04	CHEMBL2527	Homo sapiens	INH	%	68.04
	18384682	CHEMBL4146644	Inhibition of Chk2 (unknown origin) at 0.025 umol/L by spectrophotometric analysis relative to control	B	COc1ccc(N/N=C/c2c(C)nn(-c3ccccc3)c2Oc2ccc(-c3nc4cc([N+](=O)[O-])ccc4[nH]3)cc2)cc1		CHEMBL4162573	=	Inhibition	%	36.59	CHEMBL2527	Homo sapiens	INH	%	36.59
	18384683	CHEMBL4146644	Inhibition of Chk2 (unknown origin) at 0.025 umol/L by spectrophotometric analysis relative to control	B	Cc1nn(-c2ccccc2)c(Oc2ccc(-c3nc4cc([N+](=O)[O-])ccc4[nH]3)cc2)c1/C=N/Nc1ccc([N+](=O)[O-])cc1		CHEMBL4167099	=	Inhibition	%	38.77	CHEMBL2527	Homo sapiens	INH	%	38.77
	18384684	CHEMBL4146644	Inhibition of Chk2 (unknown origin) at 0.025 umol/L by spectrophotometric analysis relative to control	B	Cc1nn(-c2ccccc2)c(Oc2ccc(-c3nc4cc([N+](=O)[O-])ccc4[nH]3)cc2)c1/C=N/NC(N)=O		CHEMBL4159185	=	Inhibition	%	31.88	CHEMBL2527	Homo sapiens	INH	%	31.88
	18384685	CHEMBL4146644	Inhibition of Chk2 (unknown origin) at 0.025 umol/L by spectrophotometric analysis relative to control	B	Cc1nn(-c2ccccc2)c(Oc2ccc(-c3nc4cc([N+](=O)[O-])ccc4[nH]3)cc2)c1/C=N/NC(N)=S		CHEMBL4177291	=	Inhibition	%	68.55	CHEMBL2527	Homo sapiens	INH	%	68.55
	18384686	CHEMBL4146644	Inhibition of Chk2 (unknown origin) at 0.025 umol/L by spectrophotometric analysis relative to control	B	CC(=O)N/N=C/c1c(C)nn(-c2ccccc2)c1Oc1ccc(-c2nc3cc([N+](=O)[O-])ccc3[nH]2)cc1		CHEMBL4169439	=	Inhibition	%	32.97	CHEMBL2527	Homo sapiens	INH	%	32.97
	18384687	CHEMBL4146644	Inhibition of Chk2 (unknown origin) at 0.025 umol/L by spectrophotometric analysis relative to control	B	Cc1nn(-c2ccccc2)c(Sc2ccc(-c3nc4cc([N+](=O)[O-])ccc4[nH]3)cc2)c1/C=N/NC(N)=O		CHEMBL4173942	=	Inhibition	%	38.4	CHEMBL2527	Homo sapiens	INH	%	38.4
	18384688	CHEMBL4146644	Inhibition of Chk2 (unknown origin) at 0.025 umol/L by spectrophotometric analysis relative to control	B	Cc1nn(-c2ccccc2)c(Oc2ccc(-c3nc4cc(C(=O)O)ccc4[nH]3)cc2)c1/C=N/Nc1ccccc1		CHEMBL4166017	=	Inhibition	%	7.24	CHEMBL2527	Homo sapiens	INH	%	7.24
	18384689	CHEMBL4146644	Inhibition of Chk2 (unknown origin) at 0.025 umol/L by spectrophotometric analysis relative to control	B	COc1ccc(N/N=C/c2c(C)nn(-c3ccccc3)c2Oc2ccc(-c3nc4cc(C(=O)O)ccc4[nH]3)cc2)cc1		CHEMBL4165600	=	Inhibition	%	71.52	CHEMBL2527	Homo sapiens	INH	%	71.52
	18384690	CHEMBL4146644	Inhibition of Chk2 (unknown origin) at 0.025 umol/L by spectrophotometric analysis relative to control	B	Cc1nn(-c2ccccc2)c(Oc2ccc(-c3nc4cc(C(=O)O)ccc4[nH]3)cc2)c1/C=N/Nc1ccc([N+](=O)[O-])cc1		CHEMBL4176212	=	Inhibition	%	34.78	CHEMBL2527	Homo sapiens	INH	%	34.78
	18384691	CHEMBL4146644	Inhibition of Chk2 (unknown origin) at 0.025 umol/L by spectrophotometric analysis relative to control	B	Cc1nn(-c2ccccc2)c(Oc2ccc(-c3nc4cc(C(=O)O)ccc4[nH]3)cc2)c1/C=N/NC(N)=O		CHEMBL4165737	=	Inhibition	%	31.15	CHEMBL2527	Homo sapiens	INH	%	31.15
	18384692	CHEMBL4146644	Inhibition of Chk2 (unknown origin) at 0.025 umol/L by spectrophotometric analysis relative to control	B	Cc1nn(-c2ccccc2)c(Oc2ccc(-c3nc4cc(C(=O)O)ccc4[nH]3)cc2)c1/C=N/NC(N)=S		CHEMBL4173655	=	Inhibition	%	42.02	CHEMBL2527	Homo sapiens	INH	%	42.02
	18384693	CHEMBL4146644	Inhibition of Chk2 (unknown origin) at 0.025 umol/L by spectrophotometric analysis relative to control	B	CC(=O)N/N=C/c1c(C)nn(-c2ccccc2)c1Oc1ccc(-c2nc3cc(C(=O)O)ccc3[nH]2)cc1		CHEMBL4169171	=	Inhibition	%	65.94	CHEMBL2527	Homo sapiens	INH	%	65.94
	18384694	CHEMBL4146644	Inhibition of Chk2 (unknown origin) at 0.025 umol/L by spectrophotometric analysis relative to control	B	Cc1nn(-c2ccccc2)c(Sc2ccc(-c3nc4cc(C(=O)O)ccc4[nH]3)cc2)c1/C=N/NC(N)=O		CHEMBL4177025	=	Inhibition	%	43.49	CHEMBL2527	Homo sapiens	INH	%	43.49
	18384695	CHEMBL4146644	Inhibition of Chk2 (unknown origin) at 0.025 umol/L by spectrophotometric analysis relative to control	B	Cc1nn(-c2ccccc2)c(Oc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)c1/C=N/Nc1ccccc1		CHEMBL4177437	=	Inhibition	%	47.46	CHEMBL2527	Homo sapiens	INH	%	47.46
	18384696	CHEMBL4146644	Inhibition of Chk2 (unknown origin) at 0.025 umol/L by spectrophotometric analysis relative to control	B	COc1ccc(N/N=C/c2c(C)nn(-c3ccccc3)c2Oc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)cc1		CHEMBL4166813	=	Inhibition	%	19.56	CHEMBL2527	Homo sapiens	INH	%	19.56
	18384697	CHEMBL4146644	Inhibition of Chk2 (unknown origin) at 0.025 umol/L by spectrophotometric analysis relative to control	B	Cc1nn(-c2ccccc2)c(Oc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)c1/C=N/Nc1ccc([N+](=O)[O-])cc1		CHEMBL4162300	=	Inhibition	%	44.93	CHEMBL2527	Homo sapiens	INH	%	44.93
	18384698	CHEMBL4146644	Inhibition of Chk2 (unknown origin) at 0.025 umol/L by spectrophotometric analysis relative to control	B	Cc1nn(-c2ccccc2)c(Oc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)c1/C=N/NC(N)=O		CHEMBL4170221	=	Inhibition	%	69.2	CHEMBL2527	Homo sapiens	INH	%	69.2
	18384699	CHEMBL4146644	Inhibition of Chk2 (unknown origin) at 0.025 umol/L by spectrophotometric analysis relative to control	B	Cc1nn(-c2ccccc2)c(Oc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)c1/C=N/NC(N)=S		CHEMBL4160826	=	Inhibition	%	46.74	CHEMBL2527	Homo sapiens	INH	%	46.74
	18384700	CHEMBL4146644	Inhibition of Chk2 (unknown origin) at 0.025 umol/L by spectrophotometric analysis relative to control	B	CC(=O)N/N=C/c1c(C)nn(-c2ccccc2)c1Oc1ccc(-c2nc3cc(C(N)=O)ccc3[nH]2)cc1		CHEMBL4168756	=	Inhibition	%	40.2	CHEMBL2527	Homo sapiens	INH	%	40.2
	18384701	CHEMBL4146644	Inhibition of Chk2 (unknown origin) at 0.025 umol/L by spectrophotometric analysis relative to control	B	Cc1nn(-c2ccccc2)c(Sc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)c1/C=N/NC(N)=O		CHEMBL4175850	=	Inhibition	%	35.5	CHEMBL2527	Homo sapiens	INH	%	35.5
	18384721	CHEMBL4146640	Inhibition of Chk2 (unknown origin) at 2.5 umol/L by spectrophotometric analysis relative to control	B	NC(=O)c1ccc2[nH]c(-c3ccc(Sc4ccc(O)cc4)cc3)nc2c1		CHEMBL195041	=	Inhibition	%	100.0	CHEMBL2527	Homo sapiens	INH	%	100.0
	18384722	CHEMBL4146641	Inhibition of Chk2 (unknown origin) at 1.5 umol/L by spectrophotometric analysis relative to control	B	NC(=O)c1ccc2[nH]c(-c3ccc(Sc4ccc(O)cc4)cc3)nc2c1		CHEMBL195041	=	Inhibition	%	96.9	CHEMBL2527	Homo sapiens	INH	%	96.9
	18384723	CHEMBL4146642	Inhibition of Chk2 (unknown origin) at 0.1 umol/L by spectrophotometric analysis relative to control	B	NC(=O)c1ccc2[nH]c(-c3ccc(Sc4ccc(O)cc4)cc3)nc2c1		CHEMBL195041	=	Inhibition	%	88.0	CHEMBL2527	Homo sapiens	INH	%	88.0
	18384724	CHEMBL4146643	Inhibition of Chk2 (unknown origin) at 0.050 umol/L by spectrophotometric analysis relative to control	B	NC(=O)c1ccc2[nH]c(-c3ccc(Sc4ccc(O)cc4)cc3)nc2c1		CHEMBL195041	=	Inhibition	%	71.1	CHEMBL2527	Homo sapiens	INH	%	71.1
	18384725	CHEMBL4146644	Inhibition of Chk2 (unknown origin) at 0.025 umol/L by spectrophotometric analysis relative to control	B	NC(=O)c1ccc2[nH]c(-c3ccc(Sc4ccc(O)cc4)cc3)nc2c1		CHEMBL195041	=	Inhibition	%	37.9	CHEMBL2527	Homo sapiens	INH	%	37.9
	18392090	CHEMBL4148177	Inhibition of Chk2 (unknown origin) assessed as decrease in Cdc25C phosphorylation at Ser216 by ELISA based spectrophotometric analysis	B	N#Cc1c(Oc2ccc(-c3nc4cc(C(=O)O)ccc4[nH]3)cc2)nc(S)nc1-c1ccccc1		CHEMBL4167715	=	IC50	nM	15.35	CHEMBL2527	Homo sapiens	IC50	nM	15.35
	18392091	CHEMBL4148177	Inhibition of Chk2 (unknown origin) assessed as decrease in Cdc25C phosphorylation at Ser216 by ELISA based spectrophotometric analysis	B	CCOC(=O)CSc1nc(Oc2ccc(-c3nc4cc(C(=O)O)ccc4[nH]3)cc2)c(C#N)c(-c2ccc(F)cc2)n1		CHEMBL4159805	=	IC50	nM	5.56	CHEMBL2527	Homo sapiens	IC50	nM	5.56
	18392092	CHEMBL4148177	Inhibition of Chk2 (unknown origin) assessed as decrease in Cdc25C phosphorylation at Ser216 by ELISA based spectrophotometric analysis	B	N#Cc1c(Oc2ccc(-c3nc4cc(C(=O)O)ccc4[nH]3)cc2)nc(S)nc1-c1ccc(Cl)cc1		CHEMBL4165274	=	IC50	nM	27.88	CHEMBL2527	Homo sapiens	IC50	nM	27.88
	18392093	CHEMBL4148177	Inhibition of Chk2 (unknown origin) assessed as decrease in Cdc25C phosphorylation at Ser216 by ELISA based spectrophotometric analysis	B	N#Cc1c(Oc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)nc(S)nc1-c1ccccc1		CHEMBL4175894	=	IC50	nM	31.0	CHEMBL2527	Homo sapiens	IC50	nM	31.0
	18392094	CHEMBL4148177	Inhibition of Chk2 (unknown origin) assessed as decrease in Cdc25C phosphorylation at Ser216 by ELISA based spectrophotometric analysis	B	CCOC(=O)CSc1nc(Oc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)c(C#N)c(-c2ccc(F)cc2)n1		CHEMBL4161839	=	IC50	nM	32.4	CHEMBL2527	Homo sapiens	IC50	nM	32.4
	18392095	CHEMBL4148177	Inhibition of Chk2 (unknown origin) assessed as decrease in Cdc25C phosphorylation at Ser216 by ELISA based spectrophotometric analysis	B	N#Cc1c(Oc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)nc(S)nc1-c1ccc(Cl)cc1		CHEMBL4172486	=	IC50	nM	33.8	CHEMBL2527	Homo sapiens	IC50	nM	33.8
	18392096	CHEMBL4148177	Inhibition of Chk2 (unknown origin) assessed as decrease in Cdc25C phosphorylation at Ser216 by ELISA based spectrophotometric analysis	B	NC(=O)c1ccc2[nH]c(-c3ccc(Sc4ccc(O)cc4)cc3)nc2c1		CHEMBL195041	=	IC50	nM	32.4	CHEMBL2527	Homo sapiens	IC50	nM	32.4
	18392097	CHEMBL4148177	Inhibition of Chk2 (unknown origin) assessed as decrease in Cdc25C phosphorylation at Ser216 by ELISA based spectrophotometric analysis	B	N#Cc1c(Nc2ccc(-c3nc4cc(C(=O)O)ccc4[nH]3)cc2)nc(=S)[nH]c1-c1ccc([N+](=O)[O-])cc1		CHEMBL4164161	=	IC50	nM	25.8	CHEMBL2527	Homo sapiens	IC50	nM	25.8
	18392098	CHEMBL4148177	Inhibition of Chk2 (unknown origin) assessed as decrease in Cdc25C phosphorylation at Ser216 by ELISA based spectrophotometric analysis	B	COc1ccc(-c2[nH]c(=S)nc(Nc3ccc(-c4nc5cc(C(=O)O)ccc5[nH]4)cc3)c2C#N)cc1		CHEMBL4168692	=	IC50	nM	33.4	CHEMBL2527	Homo sapiens	IC50	nM	33.4
	18392099	CHEMBL4148177	Inhibition of Chk2 (unknown origin) assessed as decrease in Cdc25C phosphorylation at Ser216 by ELISA based spectrophotometric analysis	B	COc1ccc(-c2nc(S)nc(Sc3ccc(-c4nc5cc(C(N)=O)ccc5[nH]4)cc3)c2C#N)cc1		CHEMBL4160772	=	IC50	nM	28.0	CHEMBL2527	Homo sapiens	IC50	nM	28.0
	18392100	CHEMBL4148177	Inhibition of Chk2 (unknown origin) assessed as decrease in Cdc25C phosphorylation at Ser216 by ELISA based spectrophotometric analysis	B	Cc1ccc(-c2nc(S)nc(Sc3ccc(-c4nc5cc(C(N)=O)ccc5[nH]4)cc3)c2C#N)cc1		CHEMBL4160383	=	IC50	nM	35.9	CHEMBL2527	Homo sapiens	IC50	nM	35.9
	18392101	CHEMBL4148177	Inhibition of Chk2 (unknown origin) assessed as decrease in Cdc25C phosphorylation at Ser216 by ELISA based spectrophotometric analysis	B	N#Cc1c(Sc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)nc(S)nc1-c1ccc(Cl)cc1		CHEMBL4170989	=	IC50	nM	46.2	CHEMBL2527	Homo sapiens	IC50	nM	46.2
	18392102	CHEMBL4148177	Inhibition of Chk2 (unknown origin) assessed as decrease in Cdc25C phosphorylation at Ser216 by ELISA based spectrophotometric analysis	B	CCOC(=O)CSc1nc(Sc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)c(C#N)c(-c2ccc(Cl)cc2)n1		CHEMBL4171617	=	IC50	nM	5.55	CHEMBL2527	Homo sapiens	IC50	nM	5.55
	18392103	CHEMBL4148178	Inhibition of Chk2 (unknown origin) assessed as decrease in Cdc25C phosphorylation at Ser216 at 2.5 umol/L by ELISA based spectrophotometric analysis relative to control	B	N#Cc1c(Oc2ccc(-c3nc4cc(C(=O)O)ccc4[nH]3)cc2)nc(S)nc1-c1ccccc1		CHEMBL4167715	=	Inhibition	%	99.42	CHEMBL2527	Homo sapiens	INH	%	99.42
	18392104	CHEMBL4148178	Inhibition of Chk2 (unknown origin) assessed as decrease in Cdc25C phosphorylation at Ser216 at 2.5 umol/L by ELISA based spectrophotometric analysis relative to control	B	CCOC(=O)CSc1nc(Oc2ccc(-c3nc4cc(C(=O)O)ccc4[nH]3)cc2)c(C#N)c(-c2ccc(F)cc2)n1		CHEMBL4159805	=	Inhibition	%	100.0	CHEMBL2527	Homo sapiens	INH	%	100.0
	18392105	CHEMBL4148178	Inhibition of Chk2 (unknown origin) assessed as decrease in Cdc25C phosphorylation at Ser216 at 2.5 umol/L by ELISA based spectrophotometric analysis relative to control	B	N#Cc1c(Oc2ccc(-c3nc4cc(C(=O)O)ccc4[nH]3)cc2)nc(S)nc1-c1ccc(Cl)cc1		CHEMBL4165274	=	Inhibition	%	100.0	CHEMBL2527	Homo sapiens	INH	%	100.0
	18392106	CHEMBL4148178	Inhibition of Chk2 (unknown origin) assessed as decrease in Cdc25C phosphorylation at Ser216 at 2.5 umol/L by ELISA based spectrophotometric analysis relative to control	B	N#Cc1c(Oc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)nc(S)nc1-c1ccccc1		CHEMBL4175894	=	Inhibition	%	100.0	CHEMBL2527	Homo sapiens	INH	%	100.0
	18392107	CHEMBL4148178	Inhibition of Chk2 (unknown origin) assessed as decrease in Cdc25C phosphorylation at Ser216 at 2.5 umol/L by ELISA based spectrophotometric analysis relative to control	B	CCOC(=O)CSc1nc(Oc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)c(C#N)c(-c2ccc(F)cc2)n1		CHEMBL4161839	=	Inhibition	%	94.93	CHEMBL2527	Homo sapiens	INH	%	94.93
	18392108	CHEMBL4148178	Inhibition of Chk2 (unknown origin) assessed as decrease in Cdc25C phosphorylation at Ser216 at 2.5 umol/L by ELISA based spectrophotometric analysis relative to control	B	N#Cc1c(Oc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)nc(S)nc1-c1ccc(Cl)cc1		CHEMBL4172486	=	Inhibition	%	95.29	CHEMBL2527	Homo sapiens	INH	%	95.29
	18392109	CHEMBL4148178	Inhibition of Chk2 (unknown origin) assessed as decrease in Cdc25C phosphorylation at Ser216 at 2.5 umol/L by ELISA based spectrophotometric analysis relative to control	B	NC(=O)c1ccc2[nH]c(-c3ccc(Sc4ccc(O)cc4)cc3)nc2c1		CHEMBL195041	=	Inhibition	%	100.0	CHEMBL2527	Homo sapiens	INH	%	100.0
	18392110	CHEMBL4148178	Inhibition of Chk2 (unknown origin) assessed as decrease in Cdc25C phosphorylation at Ser216 at 2.5 umol/L by ELISA based spectrophotometric analysis relative to control	B	N#Cc1c(Nc2ccc(-c3nc4cc(C(=O)O)ccc4[nH]3)cc2)nc(=S)[nH]c1-c1ccc([N+](=O)[O-])cc1		CHEMBL4164161	=	Inhibition	%	92.76	CHEMBL2527	Homo sapiens	INH	%	92.76
	18392111	CHEMBL4148178	Inhibition of Chk2 (unknown origin) assessed as decrease in Cdc25C phosphorylation at Ser216 at 2.5 umol/L by ELISA based spectrophotometric analysis relative to control	B	COc1ccc(-c2[nH]c(=S)nc(Nc3ccc(-c4nc5cc(C(=O)O)ccc5[nH]4)cc3)c2C#N)cc1		CHEMBL4168692	=	Inhibition	%	95.29	CHEMBL2527	Homo sapiens	INH	%	95.29
	18392112	CHEMBL4148178	Inhibition of Chk2 (unknown origin) assessed as decrease in Cdc25C phosphorylation at Ser216 at 2.5 umol/L by ELISA based spectrophotometric analysis relative to control	B	COc1ccc(-c2nc(S)nc(Sc3ccc(-c4nc5cc(C(N)=O)ccc5[nH]4)cc3)c2C#N)cc1		CHEMBL4160772	=	Inhibition	%	96.37	CHEMBL2527	Homo sapiens	INH	%	96.37
	18392113	CHEMBL4148178	Inhibition of Chk2 (unknown origin) assessed as decrease in Cdc25C phosphorylation at Ser216 at 2.5 umol/L by ELISA based spectrophotometric analysis relative to control	B	Cc1ccc(-c2nc(S)nc(Sc3ccc(-c4nc5cc(C(N)=O)ccc5[nH]4)cc3)c2C#N)cc1		CHEMBL4160383	=	Inhibition	%	97.46	CHEMBL2527	Homo sapiens	INH	%	97.46
	18392114	CHEMBL4148178	Inhibition of Chk2 (unknown origin) assessed as decrease in Cdc25C phosphorylation at Ser216 at 2.5 umol/L by ELISA based spectrophotometric analysis relative to control	B	N#Cc1c(Sc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)nc(S)nc1-c1ccc(Cl)cc1		CHEMBL4170989	=	Inhibition	%	96.4	CHEMBL2527	Homo sapiens	INH	%	96.4
	18392115	CHEMBL4148178	Inhibition of Chk2 (unknown origin) assessed as decrease in Cdc25C phosphorylation at Ser216 at 2.5 umol/L by ELISA based spectrophotometric analysis relative to control	B	CCOC(=O)CSc1nc(Sc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)c(C#N)c(-c2ccc(Cl)cc2)n1		CHEMBL4171617	=	Inhibition	%	99.38	CHEMBL2527	Homo sapiens	INH	%	99.38
	18392116	CHEMBL4148179	Inhibition of Chk2 (unknown origin) assessed as decrease in Cdc25C phosphorylation at Ser216 at 1.5 umol/L by ELISA based spectrophotometric analysis relative to control	B	N#Cc1c(Oc2ccc(-c3nc4cc(C(=O)O)ccc4[nH]3)cc2)nc(S)nc1-c1ccccc1		CHEMBL4167715	=	Inhibition	%	96.74	CHEMBL2527	Homo sapiens	INH	%	96.74
	18392117	CHEMBL4148179	Inhibition of Chk2 (unknown origin) assessed as decrease in Cdc25C phosphorylation at Ser216 at 1.5 umol/L by ELISA based spectrophotometric analysis relative to control	B	CCOC(=O)CSc1nc(Oc2ccc(-c3nc4cc(C(=O)O)ccc4[nH]3)cc2)c(C#N)c(-c2ccc(F)cc2)n1		CHEMBL4159805	=	Inhibition	%	95.25	CHEMBL2527	Homo sapiens	INH	%	95.25
	18392118	CHEMBL4148179	Inhibition of Chk2 (unknown origin) assessed as decrease in Cdc25C phosphorylation at Ser216 at 1.5 umol/L by ELISA based spectrophotometric analysis relative to control	B	N#Cc1c(Oc2ccc(-c3nc4cc(C(=O)O)ccc4[nH]3)cc2)nc(S)nc1-c1ccc(Cl)cc1		CHEMBL4165274	=	Inhibition	%	100.0	CHEMBL2527	Homo sapiens	INH	%	100.0
	18392119	CHEMBL4148179	Inhibition of Chk2 (unknown origin) assessed as decrease in Cdc25C phosphorylation at Ser216 at 1.5 umol/L by ELISA based spectrophotometric analysis relative to control	B	N#Cc1c(Oc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)nc(S)nc1-c1ccccc1		CHEMBL4175894	=	Inhibition	%	96.36	CHEMBL2527	Homo sapiens	INH	%	96.36
	18392120	CHEMBL4148179	Inhibition of Chk2 (unknown origin) assessed as decrease in Cdc25C phosphorylation at Ser216 at 1.5 umol/L by ELISA based spectrophotometric analysis relative to control	B	CCOC(=O)CSc1nc(Oc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)c(C#N)c(-c2ccc(F)cc2)n1		CHEMBL4161839	=	Inhibition	%	91.05	CHEMBL2527	Homo sapiens	INH	%	91.05
	18392121	CHEMBL4148179	Inhibition of Chk2 (unknown origin) assessed as decrease in Cdc25C phosphorylation at Ser216 at 1.5 umol/L by ELISA based spectrophotometric analysis relative to control	B	N#Cc1c(Oc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)nc(S)nc1-c1ccc(Cl)cc1		CHEMBL4172486	=	Inhibition	%	90.94	CHEMBL2527	Homo sapiens	INH	%	90.94
	18392122	CHEMBL4148179	Inhibition of Chk2 (unknown origin) assessed as decrease in Cdc25C phosphorylation at Ser216 at 1.5 umol/L by ELISA based spectrophotometric analysis relative to control	B	NC(=O)c1ccc2[nH]c(-c3ccc(Sc4ccc(O)cc4)cc3)nc2c1		CHEMBL195041	=	Inhibition	%	96.9	CHEMBL2527	Homo sapiens	INH	%	96.9
	18392123	CHEMBL4148179	Inhibition of Chk2 (unknown origin) assessed as decrease in Cdc25C phosphorylation at Ser216 at 1.5 umol/L by ELISA based spectrophotometric analysis relative to control	B	N#Cc1c(Nc2ccc(-c3nc4cc(C(=O)O)ccc4[nH]3)cc2)nc(=S)[nH]c1-c1ccc([N+](=O)[O-])cc1		CHEMBL4164161	=	Inhibition	%	91.3	CHEMBL2527	Homo sapiens	INH	%	91.3
	18392124	CHEMBL4148179	Inhibition of Chk2 (unknown origin) assessed as decrease in Cdc25C phosphorylation at Ser216 at 1.5 umol/L by ELISA based spectrophotometric analysis relative to control	B	COc1ccc(-c2[nH]c(=S)nc(Nc3ccc(-c4nc5cc(C(=O)O)ccc5[nH]4)cc3)c2C#N)cc1		CHEMBL4168692	=	Inhibition	%	90.94	CHEMBL2527	Homo sapiens	INH	%	90.94
	18392125	CHEMBL4148179	Inhibition of Chk2 (unknown origin) assessed as decrease in Cdc25C phosphorylation at Ser216 at 1.5 umol/L by ELISA based spectrophotometric analysis relative to control	B	COc1ccc(-c2nc(S)nc(Sc3ccc(-c4nc5cc(C(N)=O)ccc5[nH]4)cc3)c2C#N)cc1		CHEMBL4160772	=	Inhibition	%	82.97	CHEMBL2527	Homo sapiens	INH	%	82.97
	18392126	CHEMBL4148179	Inhibition of Chk2 (unknown origin) assessed as decrease in Cdc25C phosphorylation at Ser216 at 1.5 umol/L by ELISA based spectrophotometric analysis relative to control	B	Cc1ccc(-c2nc(S)nc(Sc3ccc(-c4nc5cc(C(N)=O)ccc5[nH]4)cc3)c2C#N)cc1		CHEMBL4160383	=	Inhibition	%	83.48	CHEMBL2527	Homo sapiens	INH	%	83.48
	18392127	CHEMBL4148179	Inhibition of Chk2 (unknown origin) assessed as decrease in Cdc25C phosphorylation at Ser216 at 1.5 umol/L by ELISA based spectrophotometric analysis relative to control	B	N#Cc1c(Sc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)nc(S)nc1-c1ccc(Cl)cc1		CHEMBL4170989	=	Inhibition	%	83.0	CHEMBL2527	Homo sapiens	INH	%	83.0
	18392128	CHEMBL4148179	Inhibition of Chk2 (unknown origin) assessed as decrease in Cdc25C phosphorylation at Ser216 at 1.5 umol/L by ELISA based spectrophotometric analysis relative to control	B	CCOC(=O)CSc1nc(Sc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)c(C#N)c(-c2ccc(Cl)cc2)n1		CHEMBL4171617	=	Inhibition	%	95.64	CHEMBL2527	Homo sapiens	INH	%	95.64
	18392129	CHEMBL4148180	Inhibition of Chk2 (unknown origin) assessed as decrease in Cdc25C phosphorylation at Ser216 at 0.1 umol/L by ELISA based spectrophotometric analysis relative to control	B	N#Cc1c(Oc2ccc(-c3nc4cc(C(=O)O)ccc4[nH]3)cc2)nc(S)nc1-c1ccccc1		CHEMBL4167715	=	Inhibition	%	88.04	CHEMBL2527	Homo sapiens	INH	%	88.04
	18392130	CHEMBL4148180	Inhibition of Chk2 (unknown origin) assessed as decrease in Cdc25C phosphorylation at Ser216 at 0.1 umol/L by ELISA based spectrophotometric analysis relative to control	B	CCOC(=O)CSc1nc(Oc2ccc(-c3nc4cc(C(=O)O)ccc4[nH]3)cc2)c(C#N)c(-c2ccc(F)cc2)n1		CHEMBL4159805	=	Inhibition	%	96.01	CHEMBL2527	Homo sapiens	INH	%	96.01
	18392131	CHEMBL4148180	Inhibition of Chk2 (unknown origin) assessed as decrease in Cdc25C phosphorylation at Ser216 at 0.1 umol/L by ELISA based spectrophotometric analysis relative to control	B	N#Cc1c(Oc2ccc(-c3nc4cc(C(=O)O)ccc4[nH]3)cc2)nc(S)nc1-c1ccc(Cl)cc1		CHEMBL4165274	=	Inhibition	%	99.2	CHEMBL2527	Homo sapiens	INH	%	99.2
	18392132	CHEMBL4148180	Inhibition of Chk2 (unknown origin) assessed as decrease in Cdc25C phosphorylation at Ser216 at 0.1 umol/L by ELISA based spectrophotometric analysis relative to control	B	N#Cc1c(Oc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)nc(S)nc1-c1ccccc1		CHEMBL4175894	=	Inhibition	%	89.5	CHEMBL2527	Homo sapiens	INH	%	89.5
	18392133	CHEMBL4148180	Inhibition of Chk2 (unknown origin) assessed as decrease in Cdc25C phosphorylation at Ser216 at 0.1 umol/L by ELISA based spectrophotometric analysis relative to control	B	CCOC(=O)CSc1nc(Oc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)c(C#N)c(-c2ccc(F)cc2)n1		CHEMBL4161839	=	Inhibition	%	90.9	CHEMBL2527	Homo sapiens	INH	%	90.9
	18392134	CHEMBL4148180	Inhibition of Chk2 (unknown origin) assessed as decrease in Cdc25C phosphorylation at Ser216 at 0.1 umol/L by ELISA based spectrophotometric analysis relative to control	B	N#Cc1c(Oc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)nc(S)nc1-c1ccc(Cl)cc1		CHEMBL4172486	=	Inhibition	%	83.69	CHEMBL2527	Homo sapiens	INH	%	83.69
	18392135	CHEMBL4148180	Inhibition of Chk2 (unknown origin) assessed as decrease in Cdc25C phosphorylation at Ser216 at 0.1 umol/L by ELISA based spectrophotometric analysis relative to control	B	NC(=O)c1ccc2[nH]c(-c3ccc(Sc4ccc(O)cc4)cc3)nc2c1		CHEMBL195041	=	Inhibition	%	88.0	CHEMBL2527	Homo sapiens	INH	%	88.0
	18392136	CHEMBL4148180	Inhibition of Chk2 (unknown origin) assessed as decrease in Cdc25C phosphorylation at Ser216 at 0.1 umol/L by ELISA based spectrophotometric analysis relative to control	B	N#Cc1c(Nc2ccc(-c3nc4cc(C(=O)O)ccc4[nH]3)cc2)nc(=S)[nH]c1-c1ccc([N+](=O)[O-])cc1		CHEMBL4164161	=	Inhibition	%	89.49	CHEMBL2527	Homo sapiens	INH	%	89.49
	18392137	CHEMBL4148180	Inhibition of Chk2 (unknown origin) assessed as decrease in Cdc25C phosphorylation at Ser216 at 0.1 umol/L by ELISA based spectrophotometric analysis relative to control	B	COc1ccc(-c2[nH]c(=S)nc(Nc3ccc(-c4nc5cc(C(=O)O)ccc5[nH]4)cc3)c2C#N)cc1		CHEMBL4168692	=	Inhibition	%	83.69	CHEMBL2527	Homo sapiens	INH	%	83.69
	18392138	CHEMBL4148180	Inhibition of Chk2 (unknown origin) assessed as decrease in Cdc25C phosphorylation at Ser216 at 0.1 umol/L by ELISA based spectrophotometric analysis relative to control	B	COc1ccc(-c2nc(S)nc(Sc3ccc(-c4nc5cc(C(N)=O)ccc5[nH]4)cc3)c2C#N)cc1		CHEMBL4160772	=	Inhibition	%	68.47	CHEMBL2527	Homo sapiens	INH	%	68.47
	18392139	CHEMBL4148180	Inhibition of Chk2 (unknown origin) assessed as decrease in Cdc25C phosphorylation at Ser216 at 0.1 umol/L by ELISA based spectrophotometric analysis relative to control	B	Cc1ccc(-c2nc(S)nc(Sc3ccc(-c4nc5cc(C(N)=O)ccc5[nH]4)cc3)c2C#N)cc1		CHEMBL4160383	=	Inhibition	%	77.53	CHEMBL2527	Homo sapiens	INH	%	77.53
	18392140	CHEMBL4148180	Inhibition of Chk2 (unknown origin) assessed as decrease in Cdc25C phosphorylation at Ser216 at 0.1 umol/L by ELISA based spectrophotometric analysis relative to control	B	N#Cc1c(Sc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)nc(S)nc1-c1ccc(Cl)cc1		CHEMBL4170989	=	Inhibition	%	68.45	CHEMBL2527	Homo sapiens	INH	%	68.45
	18392141	CHEMBL4148180	Inhibition of Chk2 (unknown origin) assessed as decrease in Cdc25C phosphorylation at Ser216 at 0.1 umol/L by ELISA based spectrophotometric analysis relative to control	B	CCOC(=O)CSc1nc(Sc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)c(C#N)c(-c2ccc(Cl)cc2)n1		CHEMBL4171617	=	Inhibition	%	91.34	CHEMBL2527	Homo sapiens	INH	%	91.34
	18392142	CHEMBL4148181	Inhibition of Chk2 (unknown origin) assessed as decrease in Cdc25C phosphorylation at Ser216 at 0.050 umol/L by ELISA based spectrophotometric analysis relative to control	B	N#Cc1c(Oc2ccc(-c3nc4cc(C(=O)O)ccc4[nH]3)cc2)nc(S)nc1-c1ccccc1		CHEMBL4167715	=	Inhibition	%	82.97	CHEMBL2527	Homo sapiens	INH	%	82.97
	18392143	CHEMBL4148181	Inhibition of Chk2 (unknown origin) assessed as decrease in Cdc25C phosphorylation at Ser216 at 0.050 umol/L by ELISA based spectrophotometric analysis relative to control	B	CCOC(=O)CSc1nc(Oc2ccc(-c3nc4cc(C(=O)O)ccc4[nH]3)cc2)c(C#N)c(-c2ccc(F)cc2)n1		CHEMBL4159805	=	Inhibition	%	95.65	CHEMBL2527	Homo sapiens	INH	%	95.65
	18392144	CHEMBL4148181	Inhibition of Chk2 (unknown origin) assessed as decrease in Cdc25C phosphorylation at Ser216 at 0.050 umol/L by ELISA based spectrophotometric analysis relative to control	B	N#Cc1c(Oc2ccc(-c3nc4cc(C(=O)O)ccc4[nH]3)cc2)nc(S)nc1-c1ccc(Cl)cc1		CHEMBL4165274	=	Inhibition	%	92.0	CHEMBL2527	Homo sapiens	INH	%	92.0
	18392145	CHEMBL4148181	Inhibition of Chk2 (unknown origin) assessed as decrease in Cdc25C phosphorylation at Ser216 at 0.050 umol/L by ELISA based spectrophotometric analysis relative to control	B	N#Cc1c(Oc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)nc(S)nc1-c1ccccc1		CHEMBL4175894	=	Inhibition	%	67.45	CHEMBL2527	Homo sapiens	INH	%	67.45
	18392146	CHEMBL4148181	Inhibition of Chk2 (unknown origin) assessed as decrease in Cdc25C phosphorylation at Ser216 at 0.050 umol/L by ELISA based spectrophotometric analysis relative to control	B	CCOC(=O)CSc1nc(Oc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)c(C#N)c(-c2ccc(F)cc2)n1		CHEMBL4161839	=	Inhibition	%	83.4	CHEMBL2527	Homo sapiens	INH	%	83.4
	18392147	CHEMBL4148181	Inhibition of Chk2 (unknown origin) assessed as decrease in Cdc25C phosphorylation at Ser216 at 0.050 umol/L by ELISA based spectrophotometric analysis relative to control	B	N#Cc1c(Oc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)nc(S)nc1-c1ccc(Cl)cc1		CHEMBL4172486	=	Inhibition	%	75.72	CHEMBL2527	Homo sapiens	INH	%	75.72
	18392148	CHEMBL4148181	Inhibition of Chk2 (unknown origin) assessed as decrease in Cdc25C phosphorylation at Ser216 at 0.050 umol/L by ELISA based spectrophotometric analysis relative to control	B	NC(=O)c1ccc2[nH]c(-c3ccc(Sc4ccc(O)cc4)cc3)nc2c1		CHEMBL195041	=	Inhibition	%	71.1	CHEMBL2527	Homo sapiens	INH	%	71.1
	18392149	CHEMBL4148181	Inhibition of Chk2 (unknown origin) assessed as decrease in Cdc25C phosphorylation at Ser216 at 0.050 umol/L by ELISA based spectrophotometric analysis relative to control	B	N#Cc1c(Nc2ccc(-c3nc4cc(C(=O)O)ccc4[nH]3)cc2)nc(=S)[nH]c1-c1ccc([N+](=O)[O-])cc1		CHEMBL4164161	=	Inhibition	%	86.59	CHEMBL2527	Homo sapiens	INH	%	86.59
	18392150	CHEMBL4148181	Inhibition of Chk2 (unknown origin) assessed as decrease in Cdc25C phosphorylation at Ser216 at 0.050 umol/L by ELISA based spectrophotometric analysis relative to control	B	COc1ccc(-c2[nH]c(=S)nc(Nc3ccc(-c4nc5cc(C(=O)O)ccc5[nH]4)cc3)c2C#N)cc1		CHEMBL4168692	=	Inhibition	%	75.72	CHEMBL2527	Homo sapiens	INH	%	75.72
	18392151	CHEMBL4148181	Inhibition of Chk2 (unknown origin) assessed as decrease in Cdc25C phosphorylation at Ser216 at 0.050 umol/L by ELISA based spectrophotometric analysis relative to control	B	COc1ccc(-c2nc(S)nc(Sc3ccc(-c4nc5cc(C(N)=O)ccc5[nH]4)cc3)c2C#N)cc1		CHEMBL4160772	=	Inhibition	%	60.5	CHEMBL2527	Homo sapiens	INH	%	60.5
	18392152	CHEMBL4148181	Inhibition of Chk2 (unknown origin) assessed as decrease in Cdc25C phosphorylation at Ser216 at 0.050 umol/L by ELISA based spectrophotometric analysis relative to control	B	Cc1ccc(-c2nc(S)nc(Sc3ccc(-c4nc5cc(C(N)=O)ccc5[nH]4)cc3)c2C#N)cc1		CHEMBL4160383	=	Inhibition	%	65.21	CHEMBL2527	Homo sapiens	INH	%	65.21
	18392153	CHEMBL4148181	Inhibition of Chk2 (unknown origin) assessed as decrease in Cdc25C phosphorylation at Ser216 at 0.050 umol/L by ELISA based spectrophotometric analysis relative to control	B	N#Cc1c(Sc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)nc(S)nc1-c1ccc(Cl)cc1		CHEMBL4170989	=	Inhibition	%	60.51	CHEMBL2527	Homo sapiens	INH	%	60.51
	18392154	CHEMBL4148181	Inhibition of Chk2 (unknown origin) assessed as decrease in Cdc25C phosphorylation at Ser216 at 0.050 umol/L by ELISA based spectrophotometric analysis relative to control	B	CCOC(=O)CSc1nc(Sc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)c(C#N)c(-c2ccc(Cl)cc2)n1		CHEMBL4171617	=	Inhibition	%	88.85	CHEMBL2527	Homo sapiens	INH	%	88.85
	18392155	CHEMBL4148182	Inhibition of Chk2 (unknown origin) assessed as decrease in Cdc25C phosphorylation at Ser216 at 0.025 umol/L by ELISA based spectrophotometric analysis relative to control	B	N#Cc1c(Oc2ccc(-c3nc4cc(C(=O)O)ccc4[nH]3)cc2)nc(S)nc1-c1ccccc1		CHEMBL4167715	=	Inhibition	%	61.68	CHEMBL2527	Homo sapiens	INH	%	61.68
	18392156	CHEMBL4148182	Inhibition of Chk2 (unknown origin) assessed as decrease in Cdc25C phosphorylation at Ser216 at 0.025 umol/L by ELISA based spectrophotometric analysis relative to control	B	CCOC(=O)CSc1nc(Oc2ccc(-c3nc4cc(C(=O)O)ccc4[nH]3)cc2)c(C#N)c(-c2ccc(F)cc2)n1		CHEMBL4159805	=	Inhibition	%	81.8	CHEMBL2527	Homo sapiens	INH	%	81.8
	18392157	CHEMBL4148182	Inhibition of Chk2 (unknown origin) assessed as decrease in Cdc25C phosphorylation at Ser216 at 0.025 umol/L by ELISA based spectrophotometric analysis relative to control	B	N#Cc1c(Oc2ccc(-c3nc4cc(C(=O)O)ccc4[nH]3)cc2)nc(S)nc1-c1ccc(Cl)cc1		CHEMBL4165274	=	Inhibition	%	78.2	CHEMBL2527	Homo sapiens	INH	%	78.2
	18392158	CHEMBL4148182	Inhibition of Chk2 (unknown origin) assessed as decrease in Cdc25C phosphorylation at Ser216 at 0.025 umol/L by ELISA based spectrophotometric analysis relative to control	B	N#Cc1c(Oc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)nc(S)nc1-c1ccccc1		CHEMBL4175894	=	Inhibition	%	42.11	CHEMBL2527	Homo sapiens	INH	%	42.11
	18392159	CHEMBL4148182	Inhibition of Chk2 (unknown origin) assessed as decrease in Cdc25C phosphorylation at Ser216 at 0.025 umol/L by ELISA based spectrophotometric analysis relative to control	B	CCOC(=O)CSc1nc(Oc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)c(C#N)c(-c2ccc(F)cc2)n1		CHEMBL4161839	=	Inhibition	%	44.9	CHEMBL2527	Homo sapiens	INH	%	44.9
	18392160	CHEMBL4148182	Inhibition of Chk2 (unknown origin) assessed as decrease in Cdc25C phosphorylation at Ser216 at 0.025 umol/L by ELISA based spectrophotometric analysis relative to control	B	N#Cc1c(Oc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)nc(S)nc1-c1ccc(Cl)cc1		CHEMBL4172486	=	Inhibition	%	33.33	CHEMBL2527	Homo sapiens	INH	%	33.33
	18392161	CHEMBL4148182	Inhibition of Chk2 (unknown origin) assessed as decrease in Cdc25C phosphorylation at Ser216 at 0.025 umol/L by ELISA based spectrophotometric analysis relative to control	B	NC(=O)c1ccc2[nH]c(-c3ccc(Sc4ccc(O)cc4)cc3)nc2c1		CHEMBL195041	=	Inhibition	%	37.9	CHEMBL2527	Homo sapiens	INH	%	37.9
	18392162	CHEMBL4148182	Inhibition of Chk2 (unknown origin) assessed as decrease in Cdc25C phosphorylation at Ser216 at 0.025 umol/L by ELISA based spectrophotometric analysis relative to control	B	N#Cc1c(Nc2ccc(-c3nc4cc(C(=O)O)ccc4[nH]3)cc2)nc(=S)[nH]c1-c1ccc([N+](=O)[O-])cc1		CHEMBL4164161	=	Inhibition	%	42.02	CHEMBL2527	Homo sapiens	INH	%	42.02
	18392163	CHEMBL4148182	Inhibition of Chk2 (unknown origin) assessed as decrease in Cdc25C phosphorylation at Ser216 at 0.025 umol/L by ELISA based spectrophotometric analysis relative to control	B	COc1ccc(-c2[nH]c(=S)nc(Nc3ccc(-c4nc5cc(C(=O)O)ccc5[nH]4)cc3)c2C#N)cc1		CHEMBL4168692	=	Inhibition	%	33.33	CHEMBL2527	Homo sapiens	INH	%	33.33
	18392164	CHEMBL4148182	Inhibition of Chk2 (unknown origin) assessed as decrease in Cdc25C phosphorylation at Ser216 at 0.025 umol/L by ELISA based spectrophotometric analysis relative to control	B	COc1ccc(-c2nc(S)nc(Sc3ccc(-c4nc5cc(C(N)=O)ccc5[nH]4)cc3)c2C#N)cc1		CHEMBL4160772	=	Inhibition	%	47.46	CHEMBL2527	Homo sapiens	INH	%	47.46
	18392165	CHEMBL4148182	Inhibition of Chk2 (unknown origin) assessed as decrease in Cdc25C phosphorylation at Ser216 at 0.025 umol/L by ELISA based spectrophotometric analysis relative to control	B	Cc1ccc(-c2nc(S)nc(Sc3ccc(-c4nc5cc(C(N)=O)ccc5[nH]4)cc3)c2C#N)cc1		CHEMBL4160383	=	Inhibition	%	36.59	CHEMBL2527	Homo sapiens	INH	%	36.59
	18392166	CHEMBL4148182	Inhibition of Chk2 (unknown origin) assessed as decrease in Cdc25C phosphorylation at Ser216 at 0.025 umol/L by ELISA based spectrophotometric analysis relative to control	B	N#Cc1c(Sc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)nc(S)nc1-c1ccc(Cl)cc1		CHEMBL4170989	=	Inhibition	%	47.44	CHEMBL2527	Homo sapiens	INH	%	47.44
	18392167	CHEMBL4148182	Inhibition of Chk2 (unknown origin) assessed as decrease in Cdc25C phosphorylation at Ser216 at 0.025 umol/L by ELISA based spectrophotometric analysis relative to control	B	CCOC(=O)CSc1nc(Sc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)c(C#N)c(-c2ccc(Cl)cc2)n1		CHEMBL4171617	=	Inhibition	%	81.21	CHEMBL2527	Homo sapiens	INH	%	81.21
Active	18392168	CHEMBL4148183	Inhibition of phosphorylation of Chk2 at Thr68 residue in human MCF7 cells at GI50 by Western blot analysis	B	CCOC(=O)CSc1nc(Oc2ccc(-c3nc4cc(C(=O)O)ccc4[nH]3)cc2)c(C#N)c(-c2ccc(F)cc2)n1		CHEMBL4159805		Inhibition	%		CHEMBL2527	Homo sapiens	INH		
Active	18392169	CHEMBL4148183	Inhibition of phosphorylation of Chk2 at Thr68 residue in human MCF7 cells at GI50 by Western blot analysis	B	CCOC(=O)CSc1nc(Oc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)c(C#N)c(-c2ccc(F)cc2)n1		CHEMBL4161839		Inhibition	%		CHEMBL2527	Homo sapiens	INH		
Not Active	18392170	CHEMBL4148184	Inhibition of phosphorylation of Chk2 at Thr68 residue in human MCF7 cells at 0.1 uM cotreated with cisplatin by Western blot analysis	B	CCOC(=O)CSc1nc(Oc2ccc(-c3nc4cc(C(=O)O)ccc4[nH]3)cc2)c(C#N)c(-c2ccc(F)cc2)n1		CHEMBL4159805		Inhibition	%		CHEMBL2527	Homo sapiens	INH		
Active	18392171	CHEMBL4148184	Inhibition of phosphorylation of Chk2 at Thr68 residue in human MCF7 cells at 0.1 uM cotreated with cisplatin by Western blot analysis	B	CCOC(=O)CSc1nc(Oc2ccc(-c3nc4cc(C(N)=O)ccc4[nH]3)cc2)c(C#N)c(-c2ccc(F)cc2)n1		CHEMBL4161839		Inhibition	%		CHEMBL2527	Homo sapiens	INH		
	18420978	CHEMBL4153927	Inhibition of DNA-tagged CHK2 (unknown origin) expressed in HEK293 cells at 10 uM after 1 hr by real-time fluorescent quantitative PCR analysis	B	Fc1ccc(Nc2nc(N3CCOCC3)c3nc[nH]c3n2)cc1		CHEMBL4175978	=	Inhibition	%	72.0	CHEMBL2527	Homo sapiens	INH	%	72.0
	18440131	CHEMBL4156955	Binding affinity to wild-type human partial length CHEK2 (S253 to E574 residues) expressed in bacterial expression system assessed as residual binding at 1 uM by Kinomescan method relative to control	B	Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1		CHEMBL4174988	=	Activity	%	100.0	CHEMBL2527	Homo sapiens	Activity	%	100.0
	18443315	CHEMBL4157927	Inhibition of human CHK2 assessed as enzyme residual activity at 100 nM by radiometric filter binding assay relative to control	B	NCCCC[C@@H](NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CC(=O)O)NC(=O)CCCCCNC(=O)CCC(=O)Nc1ncc(-c2ccc(C(=O)O)cc2)s1)C(=O)O		CHEMBL4177303	=	Activity	%	96.0	CHEMBL2527	Homo sapiens	Activity	%	96.0
	18449889	CHEMBL4178123	Inhibition of human CHK2 (5 to 543 residues) assessed as residual activity at 500 nM in presence of 33P-ATP by filter binding assay relative to control	B	Cc1cccc(-c2nc(N)sc2-c2ccc3ncccc3n2)c1		CHEMBL4209540	=	Activity	%	101.0	CHEMBL2527	Homo sapiens	Activity	%	101.0
	18457546	CHEMBL4179642	Inhibition of CHK2 (unknown origin) at 1 uM relative to control	B	CS(=O)(=O)N1CCN(Cc2cc3c(N4CCOCC4)nc(-c4cnc(N)nc4)cn3n2)CC1		CHEMBL4212439	<	Inhibition	%	25.0	CHEMBL2527	Homo sapiens	INH	%	25.0
	18457547	CHEMBL4179642	Inhibition of CHK2 (unknown origin) at 1 uM relative to control	B	CS(=O)(=O)N1CCN(Cc2nc3c(N4CCOCC4)nc(-c4cnc(N)nc4)cn3n2)CC1		CHEMBL4217392	<	Inhibition	%	25.0	CHEMBL2527	Homo sapiens	INH	%	25.0
	18457548	CHEMBL4179642	Inhibition of CHK2 (unknown origin) at 1 uM relative to control	B	CS(=O)(=O)N1CCN(Cc2cn3nc(-c4cnc(N)nc4)nc(N4CCOCC4)c3n2)CC1		CHEMBL4208064	<	Inhibition	%	25.0	CHEMBL2527	Homo sapiens	INH	%	25.0
	18457549	CHEMBL4179642	Inhibition of CHK2 (unknown origin) at 1 uM relative to control	B	CS(=O)(=O)N1CCN(Cc2nc3c(N4CCOCC4)nc(-c4cnc(N)nc4)c(Cl)n3n2)CC1		CHEMBL4205584	<	Inhibition	%	25.0	CHEMBL2527	Homo sapiens	INH	%	25.0
	18462171	CHEMBL4180858	Inhibition of recombinant human full length GST-tagged CHK2 (5 to 543 residues) expressed in Escherichia coli assessed as residual activity at 1 uM after 30 mins in presence of [gamma-33P]ATP relative to control	B	CC(C)=CCC/C(C)=C/Cn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@H]3CC[C@H](N)CC3)nc21		CHEMBL4203120	=	Activity	%	99.0	CHEMBL2527	Homo sapiens	Activity	%	99.0
	18463736	CHEMBL4181152	Inhibition of recombinant human N-terminal GST-tagged CHK2 (5 to 543 residues) expressed in Escherichia coli cells at 10 uM by filter binding radioactive ATP transferase assay relative to control	B	C=C(C)n1c(=O)n(C(C)=O)c2cc(Br)cnc21		CHEMBL4212680	=	Inhibition	%	4.0	CHEMBL2527	Homo sapiens	INH	%	4.0
	18484571	CHEMBL4185734	Binding affinity to wild-type human partial length CHEK2 (S253 to E574 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL4206831	=	Activity	%	95.0	CHEMBL2527	Homo sapiens	Activity	%	95.0
	18485050	CHEMBL4185734	Binding affinity to wild-type human partial length CHEK2 (S253 to E574 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL3969370	=	Activity	%	97.0	CHEMBL2527	Homo sapiens	Activity	%	97.0
	18507850	CHEMBL4190912	Inhibition of recombinant human CHK2 R145W mutant (5 to end residues) at 1 uM using KKKVSRSGLYRSPSMPENLNRPR as substrate after 40 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CS(=O)(=O)c1ccc(-n2nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc32)cc1		CHEMBL4207014	=	Inhibition	%	4.0	CHEMBL2527	Homo sapiens	INH	%	4.0
	18507851	CHEMBL4190911	Inhibition of recombinant human CHK2 I157T mutant (5 to end residues) at 1 uM using KKKVSRSGLYRSPSMPENLNRPR as substrate after 40 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CS(=O)(=O)c1ccc(-n2nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc32)cc1		CHEMBL4207014	=	Inhibition	%	-2.0	CHEMBL2527	Homo sapiens	INH	%	-2.0
	18507852	CHEMBL4190910	Inhibition of recombinant human CHK2 (5 to end residues) at 1 uM using KKKVSRSGLYRSPSMPENLNRPR as substrate after 40 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CS(=O)(=O)c1ccc(-n2nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc32)cc1		CHEMBL4207014	=	Inhibition	%	-3.0	CHEMBL2527	Homo sapiens	INH	%	-3.0
	18653709	CHEMBL4230049	Inhibition of CHEK2 (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc(NC(=O)c3cccc(C(F)(F)F)c3)c2)c2c(N)ncnc21		CHEMBL3736320	=	Inhibition	%	3.0	CHEMBL2527	Homo sapiens	INH	%	3.0
	18653710	CHEMBL4230049	Inhibition of CHEK2 (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc3cc(-c4cccc(C(F)(F)F)c4)ncc23)c2c(N)ncnc21		CHEMBL4247506	=	Inhibition	%	-4.0	CHEMBL2527	Homo sapiens	INH	%	-4.0
	18655601	CHEMBL4230634	Binding affinity to wild-type human partial length CHEK2 (S253 to E574 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298	=	Activity	%	95.0	CHEMBL2527	Homo sapiens	Activity	%	95.0
	18665550	CHEMBL4233302	Inhibition of CHK2 (unknown origin)	B	O=C(Cc1cccc(OCCCN2CCNCC2)c1)Nc1nc(-c2ccncc2)cs1		CHEMBL4245507	>	IC50	nM	10000.0	CHEMBL2527	Homo sapiens	IC50	nM	10000.0
	18674598	CHEMBL4235333	Inhibition of CheK2 (unknown origin)	B	CS(=O)(=O)Nc1cccc(CC(=O)Nc2nc(-c3c[nH]c4ncccc34)cs2)c1		CHEMBL4249925	>	Ki	nM	2000.0	CHEMBL2527	Homo sapiens	Ki	nM	2000.0
	18674599	CHEMBL4235333	Inhibition of CheK2 (unknown origin)	B	O=C(Cc1cccc(OCCCC2CCNCC2)c1)Nc1nc(-c2c[nH]c3ncccc23)cs1		CHEMBL4245242	>	Ki	nM	2000.0	CHEMBL2527	Homo sapiens	Ki	nM	2000.0
Not Determined	18674600	CHEMBL4235333	Inhibition of CheK2 (unknown origin)	B	CN1CCN(CCCOc2cccc(CC(=O)Nc3nc(-c4c[nH]c5ncccc45)cs3)c2)CC1		CHEMBL4248525		Ki			CHEMBL2527	Homo sapiens	Ki		
	18693970	CHEMBL4253423	Inhibition of recombinant full length human His-tagged CHEK2 expressed in baculovirus expression system at 0.1 uM by Z'-Lyte assay relative to control	B	CC1=Nc2c(F)cc(-c3nc(Nc4ccc(C5CCN(C)CC5)cn4)ncc3F)cc2C12CCCC2		CHEMBL4277900	=	Inhibition	%	-2.0	CHEMBL2527	Homo sapiens	INH	%	-2.0
	18694052	CHEMBL4253505	Inhibition of recombinant full length human His-tagged CHEK2 expressed in baculovirus expression system at 1 uM by Z'-Lyte assay relative to control	B	CC1=Nc2c(F)cc(-c3nc(Nc4ccc(C5CCN(C)CC5)cn4)ncc3F)cc2C12CCCC2		CHEMBL4277900	=	Inhibition	%	6.0	CHEMBL2527	Homo sapiens	INH	%	6.0
	18702501	CHEMBL4255106	Inhibition of recombinant full length human His-tagged CHEK2 expressed in baculovirus expression system at 1 uM relative to control	B	COc1ccc(S(N)(=O)=O)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1		CHEMBL4278211	=	Inhibition	%	73.0	CHEMBL2527	Homo sapiens	INH	%	73.0
	18702538	CHEMBL4255106	Inhibition of recombinant full length human His-tagged CHEK2 expressed in baculovirus expression system at 1 uM relative to control	B	COc1ccc(C(N)=O)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1		CHEMBL4282644	=	Inhibition	%	45.0	CHEMBL2527	Homo sapiens	INH	%	45.0
	18702582	CHEMBL4255106	Inhibition of recombinant full length human His-tagged CHEK2 expressed in baculovirus expression system at 1 uM relative to control	B	COc1ccc(S(C)(=O)=O)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1		CHEMBL4287097	=	Inhibition	%	48.0	CHEMBL2527	Homo sapiens	INH	%	48.0
	18702634	CHEMBL4255106	Inhibition of recombinant full length human His-tagged CHEK2 expressed in baculovirus expression system at 1 uM relative to control	B	COc1cc(C)c(S(N)(=O)=O)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1		CHEMBL4283739	=	Inhibition	%	87.0	CHEMBL2527	Homo sapiens	INH	%	87.0
	18702678	CHEMBL4255106	Inhibition of recombinant full length human His-tagged CHEK2 expressed in baculovirus expression system at 1 uM relative to control	B	COc1cc(C)c(C(N)=O)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1		CHEMBL4294318	=	Inhibition	%	76.0	CHEMBL2527	Homo sapiens	INH	%	76.0
	18702721	CHEMBL4255106	Inhibition of recombinant full length human His-tagged CHEK2 expressed in baculovirus expression system at 1 uM relative to control	B	COc1cc(C)c(S(C)(=O)=O)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1		CHEMBL4289040	=	Inhibition	%	76.0	CHEMBL2527	Homo sapiens	INH	%	76.0
	18708946	CHEMBL4256666	Inhibition of CHK2 (unknown origin) at 100 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	Nc1ccc[nH]c1=O		CHEMBL4286709	=	Inhibition	%	49.0	CHEMBL2527	Homo sapiens	INH	%	49.0
	18708959	CHEMBL4256666	Inhibition of CHK2 (unknown origin) at 100 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	Cn1cc(-c2c[nH]c(=O)c(N)c2)cn1		CHEMBL4288628	=	Inhibition	%	99.0	CHEMBL2527	Homo sapiens	INH	%	99.0
	18709004	CHEMBL4256666	Inhibition of CHK2 (unknown origin) at 100 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	Nc1cc(-c2ccncc2)c[nH]c1=O		CHEMBL12856	=	Inhibition	%	0.0	CHEMBL2527	Homo sapiens	INH	%	0.0
	18709036	CHEMBL4256666	Inhibition of CHK2 (unknown origin) at 100 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	COc1ncc(-c2ccncc2)cc1N		CHEMBL4291350	=	Inhibition	%	36.0	CHEMBL2527	Homo sapiens	INH	%	36.0
	18709065	CHEMBL4256666	Inhibition of CHK2 (unknown origin) at 100 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	Nc1cc(-c2ccnc3ccccc23)c[nH]c1=O		CHEMBL4280308	=	Inhibition	%	57.0	CHEMBL2527	Homo sapiens	INH	%	57.0
	18709094	CHEMBL4256666	Inhibition of CHK2 (unknown origin) at 100 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	CNc1nccc(-c2c[nH]c(=O)c(N)c2)n1		CHEMBL4292538	=	Inhibition	%	98.0	CHEMBL2527	Homo sapiens	INH	%	98.0
	18709123	CHEMBL4256666	Inhibition of CHK2 (unknown origin) at 100 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	Nc1cc(-c2ccnc(NC3CC3)n2)c[nH]c1=O		CHEMBL4282263	=	Inhibition	%	61.0	CHEMBL2527	Homo sapiens	INH	%	61.0
	18709170	CHEMBL4256666	Inhibition of CHK2 (unknown origin) at 100 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	Cc1nc(O)c(N)cc1-c1ccncc1		CHEMBL302219	=	Inhibition	%	42.0	CHEMBL2527	Homo sapiens	INH	%	42.0
	18709200	CHEMBL4256692	Inhibition of CHK2 (unknown origin) at 30 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	O=C(Nc1cc(-c2ccncc2)c[nH]c1=O)c1ccccc1		CHEMBL1738828	=	Inhibition	%	29.0	CHEMBL2527	Homo sapiens	INH	%	29.0
	18709229	CHEMBL4256666	Inhibition of CHK2 (unknown origin) at 100 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	COc1cccc(C(=O)Nc2cc(-c3ccncc3)c[nH]c2=O)c1		CHEMBL4285109	=	Inhibition	%	58.0	CHEMBL2527	Homo sapiens	INH	%	58.0
	18709271	CHEMBL4256692	Inhibition of CHK2 (unknown origin) at 30 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	CN1CCN(c2ccc(C(=O)Nc3cc(-c4ccncc4)c[nH]c3=O)cc2)CC1		CHEMBL4286130	=	Inhibition	%	33.0	CHEMBL2527	Homo sapiens	INH	%	33.0
	18709304	CHEMBL4256692	Inhibition of CHK2 (unknown origin) at 30 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	O=C(Nc1cc(-c2ccnc(NC3CC3)n2)c[nH]c1=O)c1ccccc1		CHEMBL4291472	=	Inhibition	%	71.0	CHEMBL2527	Homo sapiens	INH	%	71.0
	18725374	CHEMBL4259071	Inhibition of CHK2 (unknown origin)	B	CC(=O)n1nc(C)c(-c2ccc(Cl)c(Cl)c2)c1N		CHEMBL4276946	>	IC50	nM	100000.0	CHEMBL2527	Homo sapiens	IC50	uM	100.0
	18737160	CHEMBL4261259	Binding affinity to CHK2 (unknown origin) assessed as remaining unbound target protein level at 10 uM relative to control	B	COc1cc2c(=O)n(CCCN(C)C)c3c4cc[nH]c4ncc3c2cc1OC		CHEMBL4280783	=	Activity	%	5.2	CHEMBL2527	Homo sapiens	Activity	%	5.2
	18751149	CHEMBL4263765	Inhibition of CHEK2 (unknown origin) at 1 uM relative to control	B	NC1(c2ccc(-c3cnc4c(-c5ccc(S(N)(=O)=O)c6ccccc56)cnn4c3)cc2)CCC1		CHEMBL4278763	=	Inhibition	%	8.0	CHEMBL2527	Homo sapiens	INH	%	8.0
	18751680	CHEMBL4264223	Binding affinity to wild-type human partial length CHEK2 (S253 to E574 residues) expressed in bacterial expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control	B	COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1		CHEMBL4281048	=	Activity	%	90.0	CHEMBL2527	Homo sapiens	Activity	%	90.0
	18757968	CHEMBL4265582	Inhibition of recombinant human CHEK2 (253 to 574 residues) expressed in bacterial expression system at 1 uM in presence of 1 mM ATP by kinomescan assay relative to control	B	N#CN[C@H]1C[C@@H](O)c2ccc(-c3ncnc4[nH]ccc34)cc21		CHEMBL4294868	=	Inhibition	%	52.0	CHEMBL2527	Homo sapiens	INH	%	52.0
	18764515	CHEMBL4267074	Inhibition of human CHK2 at 100 nM	B	CN1CCC(c2nc(-c3ccc(F)cc3)c(-c3ccnc(Nc4ccc(N5CCNCC5)cc4)n3)s2)CC1		CHEMBL4288103	<	Inhibition	%	70.0	CHEMBL2527	Homo sapiens	INH	%	70.0
	18764516	CHEMBL4267074	Inhibition of human CHK2 at 100 nM	B	CN1CCC(c2nc(-c3cccc(S(C)(=O)=O)c3)c(-c3ccnc(Nc4ccc(N5CCNCC5)cc4)n3)s2)CC1		CHEMBL4286880	<	Inhibition	%	70.0	CHEMBL2527	Homo sapiens	INH	%	70.0
	18764517	CHEMBL4267074	Inhibition of human CHK2 at 100 nM	B	CN1CCC(c2nc(-c3ccc(F)c(NS(C)(=O)=O)c3)c(-c3ccnc(NCC4CC4)n3)s2)CC1		CHEMBL4286841	<	Inhibition	%	70.0	CHEMBL2527	Homo sapiens	INH	%	70.0
	18782840	CHEMBL4270706	Inhibition of CHK2 (unknown origin) assessed as residual enzyme activity at 1 uM relative to untreated control	B	Cc1cccc(-c2nn3c(c2-c2ccc(O)cc2)C(C)C(C)(C)C3)n1		CHEMBL4277021	>	Activity	%	80.0	CHEMBL2527	Homo sapiens	Activity	%	80.0
	18786941	CHEMBL4271856	Inhibition of CHK2 (unknown origin) at 30 uM relative to control	B	O=c1cc(-c2ccc(-c3ccccc3)cc2)c2ccc(N3CCC(NCCc4ccccc4)CC3)cc2o1		CHEMBL4276817	=	Inhibition	%	9.44	CHEMBL2527	Homo sapiens	INH	%	9.44
	18849491	CHEMBL4305557	Inhibition of recombinant N-terminal GST-fusion protein tagged human full length CHK2 (1 to 543 residues) expressed in baculovirus expression system assessed as decrease in fluorescence labelled CHKtide phosphorylation at 200 nM by off-chip mobility shift assay relative to control	B	Cc1cccc(Nc2nc(N[C@@H]3CCCC[C@@H]3N)c(C#N)c3cn[nH]c(=O)c23)c1		CHEMBL4461851	>	Inhibition	%	90.0	CHEMBL2527	Homo sapiens	INH	%	90.0
	18851347	CHEMBL4305839	Inhibition of CHK2 (unknown origin)	B	Cc1nc2c(F)cc(-c3nc(Nc4ccc5c(n4)CCN(CCN(C)C)C5)ncc3F)cc2n1C(C)C		CHEMBL4448494	=	IC50	nM	978.0	CHEMBL2527	Homo sapiens	IC50	nM	978.0
	18857892	CHEMBL4307738	Binding affinity to wild-type human partial length CHEK2 (S253 to E574 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	CC(C)N1C(=O)C(NCCCN(C)C)=C(c2cn(C)c3ccccc23)C1=O.Cl		CHEMBL4533018	=	Activity	%	80.0	CHEMBL2527	Homo sapiens	Activity	%	80.0
	18892839	CHEMBL4314805	Inhibition of recombinant human CHK2 (5 to end residues) assessed as residual activity at 10 uM using KKKVSRSGLYRSPSMPENLNRPR as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	Cc1cc(C)c(CNc2nc(Cl)nc3c2ncn3C2CCCC2)c(=O)[nH]1		CHEMBL4557538	=	Activity	%	105.0	CHEMBL2527	Homo sapiens	Activity	%	105.0
	18892840	CHEMBL4314806	Inhibition of recombinant human CHK2 I157T mutant (5 to end residues) assessed as residual activity at 10 uM using KKKVSRSGLYRSPSMPENLNRPR as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	Cc1cc(C)c(CNc2nc(Cl)nc3c2ncn3C2CCCC2)c(=O)[nH]1		CHEMBL4557538	=	Activity	%	103.0	CHEMBL2527	Homo sapiens	Activity	%	103.0
	18892841	CHEMBL4314807	Inhibition of recombinant human CHK2 R145W mutant (5 to end residues) assessed as residual activity at 10 uM using KKKVSRSGLYRSPSMPENLNRPR as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	Cc1cc(C)c(CNc2nc(Cl)nc3c2ncn3C2CCCC2)c(=O)[nH]1		CHEMBL4557538	=	Activity	%	103.0	CHEMBL2527	Homo sapiens	Activity	%	103.0
Active	18907919	CHEMBL4320502	Inhibition of Chk2 phosphorylation in human SUM159 cells at 0.1 to 0.2 uM measured after 48 hrs by Western blot analysis	B	C=C1C(=O)O[C@H]2[C@H]1CC/C(COC(=O)/C=C/c1c(OC)cccc1OC)=C\CC[C@@]1(C)O[C@@H]21		CHEMBL4463727		Inhibition	%		CHEMBL2527	Homo sapiens	INH		
	18919357	CHEMBL4322731	Binding affinity to recombinant full-length N-terminal His-FLAG-GST-tagged CHEK2 (unknown origin) expressed in baculovirus infected Sf9 insect cells incubated for 1 hr by TR-FRET assay	B	CO[C@@H]1[C@H](NCCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4465866	=	Kd	nM	147.0	CHEMBL2527	Homo sapiens	Kd	nM	147.0
Not Determined	18919371	CHEMBL4322731	Binding affinity to recombinant full-length N-terminal His-FLAG-GST-tagged CHEK2 (unknown origin) expressed in baculovirus infected Sf9 insect cells incubated for 1 hr by TR-FRET assay	B	CO[C@@H]1[C@H](N(C)CCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4576489		Kd			CHEMBL2527	Homo sapiens	Kd		
	18937817	CHEMBL4327640	Inhibition of human CHK2 assessed as residual activity at 1 uM using KKKVSRSGLYRSPSMPENLNRPR as substrate by [gamma-33P]-ATP assay relative to control	B	ClC/C=C/C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4438024	=	Activity	%	99.48	CHEMBL2527	Homo sapiens	Activity	%	99.48
	18937818	CHEMBL4327640	Inhibition of human CHK2 assessed as residual activity at 1 uM using KKKVSRSGLYRSPSMPENLNRPR as substrate by [gamma-33P]-ATP assay relative to control	B	C(=C/c1ccccc1)\C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4446405	=	Activity	%	99.79	CHEMBL2527	Homo sapiens	Activity	%	99.79
	18938479	CHEMBL4327999	Inhibition of human CHK2 assessed as residual activity at 100 uM using KKKVSRSGLYRSPSMPENLNRPR as substrate by [gamma-33P]-ATP assay relative to control	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	<	Activity	%	65.0	CHEMBL2527	Homo sapiens	Activity	%	65.0
	18938852	CHEMBL4328363	Inhibition of human CHK2 using KKKVSRSGLYRSPSMPENLNRPR as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	9.21	CHEMBL2527	Homo sapiens	IC50	10'-9M	9.21
	18953704	CHEMBL4331913	Inhibition of CHK2 (unknown origin) at 10 uM relative to control	B	Cc1n[nH]c2ccnc(NC3CCCCC3)c12		CHEMBL4440433	=	Inhibition	%	37.0	CHEMBL2527	Homo sapiens	INH	%	37.0
	18953770	CHEMBL4331913	Inhibition of CHK2 (unknown origin) at 10 uM relative to control	B	Cc1n[nH]c2ccnc(Nc3ccccc3F)c12		CHEMBL4449552	=	Inhibition	%	26.0	CHEMBL2527	Homo sapiens	INH	%	26.0
	18953827	CHEMBL4331913	Inhibition of CHK2 (unknown origin) at 10 uM relative to control	B	Cc1n[nH]c2ccnc(OC3CCCCC3)c12		CHEMBL4524629	=	Inhibition	%	63.0	CHEMBL2527	Homo sapiens	INH	%	63.0
	18953919	CHEMBL4331972	Inhibition of CHK2 (unknown origin) at 1 uM relative to control	B	CC(C)n1cc(-c2n[nH]c3ccnc(OC4CCOCC4)c23)cn1		CHEMBL4589022	=	Inhibition	%	29.0	CHEMBL2527	Homo sapiens	INH	%	29.0
	18953983	CHEMBL4331972	Inhibition of CHK2 (unknown origin) at 1 uM relative to control	B	c1cc(-c2n[nH]c3ccnc(OC4CCOCC4)c23)cc(N2CCOCC2)n1		CHEMBL4460272	=	Inhibition	%	0.0	CHEMBL2527	Homo sapiens	INH	%	0.0
	18954050	CHEMBL4331913	Inhibition of CHK2 (unknown origin) at 10 uM relative to control	B	Cc1n[nH]c2ccnc(Nc3ccc4ncsc4c3)c12		CHEMBL4588446	=	Inhibition	%	36.0	CHEMBL2527	Homo sapiens	INH	%	36.0
	18958810	CHEMBL4333329	Binding affinity to wild-type human partial length CHEK2 (S253 to E574 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	CC(C)Nc1sc(C(=O)c2ccc(Cl)s2)c(N)c1C#N		CHEMBL4563315	=	Activity	%	84.0	CHEMBL2527	Homo sapiens	Activity	%	84.0
	18964169	CHEMBL4335020	Inhibition of recombinant human CHK2 (5 to end residues) assessed as residual activity at 1 uM using KKKVSRSGLYRSPSMPENLNRPR as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	N=C1NC(=O)/C(=C\c2ccc(-c3cccc([N+](=O)[O-])c3)o2)S1		CHEMBL4455512	=	Activity	%	94.0	CHEMBL2527	Homo sapiens	Activity	%	94.0
	18964170	CHEMBL4335020	Inhibition of recombinant human CHK2 (5 to end residues) assessed as residual activity at 1 uM using KKKVSRSGLYRSPSMPENLNRPR as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	C=CCOC(=O)c1cc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)ccc1Cl		CHEMBL4568120	=	Activity	%	92.0	CHEMBL2527	Homo sapiens	Activity	%	92.0
	18964171	CHEMBL4335021	Inhibition of recombinant human CHK2 I157T mutant (5 to end residues) assessed as residual activity at 1 uM using KKKVSRSGLYRSPSMPENLNRPR as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	N=C1NC(=O)/C(=C\c2ccc(-c3cccc([N+](=O)[O-])c3)o2)S1		CHEMBL4455512	=	Activity	%	85.0	CHEMBL2527	Homo sapiens	Activity	%	85.0
	18964172	CHEMBL4335021	Inhibition of recombinant human CHK2 I157T mutant (5 to end residues) assessed as residual activity at 1 uM using KKKVSRSGLYRSPSMPENLNRPR as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	C=CCOC(=O)c1cc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)ccc1Cl		CHEMBL4568120	=	Activity	%	91.0	CHEMBL2527	Homo sapiens	Activity	%	91.0
	18964173	CHEMBL4335022	Inhibition of recombinant human CHK2 R145W mutant (5 to end residues) assessed as residual activity at 1 uM using KKKVSRSGLYRSPSMPENLNRPR as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	N=C1NC(=O)/C(=C\c2ccc(-c3cccc([N+](=O)[O-])c3)o2)S1		CHEMBL4455512	=	Activity	%	99.0	CHEMBL2527	Homo sapiens	Activity	%	99.0
	18964174	CHEMBL4335022	Inhibition of recombinant human CHK2 R145W mutant (5 to end residues) assessed as residual activity at 1 uM using KKKVSRSGLYRSPSMPENLNRPR as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	C=CCOC(=O)c1cc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)ccc1Cl		CHEMBL4568120	=	Activity	%	91.0	CHEMBL2527	Homo sapiens	Activity	%	91.0
	18971838	CHEMBL4336848	Inhibition of recombinant human CHK2 (5 to end residues) assessed as residual activity at 10 uM using KKKVSRSGLYRSPSMPENLNRPR as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	C[C@@H](c1ccccc1)n1nnc2cnc3ccc(-c4cnc5[nH]ccc5c4)cc3c21		CHEMBL4472294	=	Activity	%	57.0	CHEMBL2527	Homo sapiens	Activity	%	57.0
	18971839	CHEMBL4336849	Inhibition of recombinant human CHK2 I157T mutant (5 to end residues) assessed as residual activity at 10 uM using KKKVSRSGLYRSPSMPENLNRPR as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	C[C@@H](c1ccccc1)n1nnc2cnc3ccc(-c4cnc5[nH]ccc5c4)cc3c21		CHEMBL4472294	=	Activity	%	59.0	CHEMBL2527	Homo sapiens	Activity	%	59.0
	18971840	CHEMBL4336850	Inhibition of recombinant human CHK2 R145W mutant (5 to end residues) assessed as residual activity at 10 uM using KKKVSRSGLYRSPSMPENLNRPR as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	C[C@@H](c1ccccc1)n1nnc2cnc3ccc(-c4cnc5[nH]ccc5c4)cc3c21		CHEMBL4472294	=	Activity	%	81.0	CHEMBL2527	Homo sapiens	Activity	%	81.0
	18989205	CHEMBL4340747	Inhibition of recombinant human CHK2 measured after 60 mins in presence of [gamma-33P]-ATP by scintillation counting method	B	CN(CCc1ccc(-c2ccccc2)cc1)Cc1cn(C)c2ccc(C(=O)Nc3ccc(F)cc3)cc12		CHEMBL4446681	=	IC50	nM	79000.0	CHEMBL2527	Homo sapiens	IC50	uM	79.0
	19030028	CHEMBL4349167	Inhibition of recombinant full length human His-tagged CHEK2 expressed in baculovirus expression system assessed as enzyme residual activity at 0.4 uM using fluorophore-labeled serine/threonine-07 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control	B	C=CC(=O)N1CCC(Oc2nc(Nc3ccc(N4CCOCC4)cc3)nc3[nH]cc(-c4cncc(NC)n4)c23)CC1		CHEMBL4443805	=	Activity	%	78.7	CHEMBL2527	Homo sapiens	Activity	%	78.7
	19032183	CHEMBL4349777	Inhibition of CHK2 (unknown origin) at 20 nM using phosphatidylserine as substrate incubated for 60 mins in presence of [33P]-ATP by scintillation counting method	B	Cn1cc(-c2n[nH]c3ccc(NCc4cc(F)ccc4S(C)(=O)=O)cc23)cn1		CHEMBL4555442	=	Inhibition	%	-1.0	CHEMBL2527	Homo sapiens	INH	%	-1.0
	19035295	CHEMBL4350391	Inhibition of human CHK2 assessed as residual activity at 10 uM using KKKVSRSGLYRSPSMPENLNRPR as substrate by [gamma-33P]-ATP assay	B	O=C1NC2(CCCCC2)n2c1c(Cl)cc(Nc1ccncn1)c2=O		CHEMBL4439094	=	Activity	%	100.0	CHEMBL2527	Homo sapiens	Activity	%	100.0
Not Active	19039841	CHEMBL4351803	Inhibition of recombinant human CHK2 R145W mutant (5 to end residues) at 10 uM using KKKVSRSGLYRSPSMPENLNRPR as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	CN1C[C@H](Nc2nc3cc[nH]c3c(=O)n2C)C[C@H](c2ccc3c(c2)OCCO3)C1		CHEMBL4574669		Inhibition	%		CHEMBL2527	Homo sapiens	INH		
Not Active	19039842	CHEMBL4351802	Inhibition of recombinant human CHK2 I157T mutant (5 to end residues) at 10 uM using KKKVSRSGLYRSPSMPENLNRPR as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	CN1C[C@H](Nc2nc3cc[nH]c3c(=O)n2C)C[C@H](c2ccc3c(c2)OCCO3)C1		CHEMBL4574669		Inhibition	%		CHEMBL2527	Homo sapiens	INH		
Not Active	19039843	CHEMBL4351801	Inhibition of recombinant human CHK2 (5 to end residues) at 10 uM using KKKVSRSGLYRSPSMPENLNRPR as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	CN1C[C@H](Nc2nc3cc[nH]c3c(=O)n2C)C[C@H](c2ccc3c(c2)OCCO3)C1		CHEMBL4574669		Inhibition	%		CHEMBL2527	Homo sapiens	INH		
Active	19041059	CHEMBL4352320	Inhibition of human CHK2 at 10 uM using KKKVSRSGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ATP	B	CC(C)(C)C(=O)N1N=CC[C@H]1c1ccccc1		CHEMBL4521353		Inhibition	%		CHEMBL2527	Homo sapiens	INH		
	19059511	CHEMBL4357812	Binding affinity to wild-type human partial length CHEK2 (S253 to E574 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441	=	Activity	%	90.0	CHEMBL2527	Homo sapiens	Activity	%	90.0
	19072938	CHEMBL4362113	Effect on CHK2 at T68 phosphorylation level in human NCI-H1975 incubated for 12 hrs by human phosphokinase proteome profiler array relative to control	B	CCOc1ccc(-c2nc(C(=O)NO)c3[nH]c(=O)n(-c4ccccc4OC)c3n2)cc1		CHEMBL4443725	=	FC		0.87	CHEMBL2527	Homo sapiens	FC		0.87
	19072977	CHEMBL4362152	Effect on CHK2 at T68 phosphorylation level in human NCI-H1975 incubated for 12 hrs by human phosphokinase proteome profiler array relative to beta-catenin	B	CCOc1ccc(-c2nc(C(=O)NO)c3[nH]c(=O)n(-c4ccccc4OC)c3n2)cc1		CHEMBL4443725	=	FC		0.97	CHEMBL2527	Homo sapiens	FC		0.97
	19073016	CHEMBL4362113	Effect on CHK2 at T68 phosphorylation level in human NCI-H1975 incubated for 12 hrs by human phosphokinase proteome profiler array relative to control	B	CCOc1ccc(-c2nc(C(=O)NO)c3[nH]c(=O)n(-c4ccccc4OC)c3n2)cc1		CHEMBL4443725	=	log2FC		-0.2	CHEMBL2527	Homo sapiens	log2FC		-0.2
	19073055	CHEMBL4362152	Effect on CHK2 at T68 phosphorylation level in human NCI-H1975 incubated for 12 hrs by human phosphokinase proteome profiler array relative to beta-catenin	B	CCOc1ccc(-c2nc(C(=O)NO)c3[nH]c(=O)n(-c4ccccc4OC)c3n2)cc1		CHEMBL4443725	=	log2FC		-0.04	CHEMBL2527	Homo sapiens	log2FC		-0.04
	19073117	CHEMBL4362113	Effect on CHK2 at T68 phosphorylation level in human NCI-H1975 incubated for 12 hrs by human phosphokinase proteome profiler array relative to control	B	CCOc1ccc(-c2nc(/C(N)=N/O)c3[nH]c(=O)n(-c4ccccc4OC)c3n2)cc1		CHEMBL4515196	=	FC		0.73	CHEMBL2527	Homo sapiens	FC		0.73
	19073156	CHEMBL4362152	Effect on CHK2 at T68 phosphorylation level in human NCI-H1975 incubated for 12 hrs by human phosphokinase proteome profiler array relative to beta-catenin	B	CCOc1ccc(-c2nc(/C(N)=N/O)c3[nH]c(=O)n(-c4ccccc4OC)c3n2)cc1		CHEMBL4515196	=	FC		0.86	CHEMBL2527	Homo sapiens	FC		0.86
	19073195	CHEMBL4362113	Effect on CHK2 at T68 phosphorylation level in human NCI-H1975 incubated for 12 hrs by human phosphokinase proteome profiler array relative to control	B	CCOc1ccc(-c2nc(/C(N)=N/O)c3[nH]c(=O)n(-c4ccccc4OC)c3n2)cc1		CHEMBL4515196	=	log2FC		-0.44	CHEMBL2527	Homo sapiens	log2FC		-0.44
	19073234	CHEMBL4362152	Effect on CHK2 at T68 phosphorylation level in human NCI-H1975 incubated for 12 hrs by human phosphokinase proteome profiler array relative to beta-catenin	B	CCOc1ccc(-c2nc(/C(N)=N/O)c3[nH]c(=O)n(-c4ccccc4OC)c3n2)cc1		CHEMBL4515196	=	log2FC		-0.22	CHEMBL2527	Homo sapiens	log2FC		-0.22
	19090082	CHEMBL4365656	Inhibition of wild-type human partial length CHEK2 (S253 to E574 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1		CHEMBL4436895	=	Activity	%	100.0	CHEMBL2527	Homo sapiens	Activity	%	100.0
	19091872	CHEMBL4366346	Inhibition of human CHK2 at 100 nM using KKKVSRSGLYRSPSMPENLNRPR as substrate by [gamma-33P]-ATP assay	B	COc1ccc(N2C(=O)COc3ccc(-c4cnc(OC)c(NS(=O)(=O)c5ccc(F)cc5)c4)cc32)cc1		CHEMBL4528675	=	Inhibition	%	6.04	CHEMBL2527	Homo sapiens	INH	%	6.04
	19112646	CHEMBL4370775	Inhibition of CHK2 (unknown origin)	B	CCCCNc1ncnc2c1sc1nc3ccccc3cc12		CHEMBL4449599	=	IC50	nM	1700.0	CHEMBL2527	Homo sapiens	IC50	umol/L	1.7
	19144701	CHEMBL4377717	Inhibition of recombinant human CHK2 (5 to end residues) at 1 uM using KKKVSRSGLYRSPSMPENLNRPR as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(NC(=O)CCCCCCCN=C=S)cc3)nc2n1C1CCCC1		CHEMBL4548580	=	Inhibition	%	32.0	CHEMBL2527	Homo sapiens	INH	%	32.0
	19144702	CHEMBL4377718	Inhibition of recombinant human CHK2 I157T mutant (5 to end residues) at 1 uM using KKKVSRSGLYRSPSMPENLNRPR as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(NC(=O)CCCCCCCN=C=S)cc3)nc2n1C1CCCC1		CHEMBL4548580	=	Inhibition	%	43.0	CHEMBL2527	Homo sapiens	INH	%	43.0
	19144703	CHEMBL4377719	Inhibition of recombinant human CHK2 R145W mutant (5 to end residues) at 1 uM using KKKVSRSGLYRSPSMPENLNRPR as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(NC(=O)CCCCCCCN=C=S)cc3)nc2n1C1CCCC1		CHEMBL4548580	=	Inhibition	%	52.0	CHEMBL2527	Homo sapiens	INH	%	52.0
	19146873	CHEMBL4378919	Inhibition of recombinant human CHK2 (5 to end residues) at 10 uM using KKKVSRSGLYRSPSMPENLNRPR as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	C=CS(=O)(=O)Nc1ccc(Cc2ccc3ccccc3c2)cc1		CHEMBL4459587	=	Inhibition	%	-7.0	CHEMBL2527	Homo sapiens	INH	%	-7.0
	19147792	CHEMBL4379188	Inhibition of recombinant human CHK2 (5 to end residues) using KKKVSRSGLYRSP as substrate incubated for 40 mins in presence of [gamma-33ATP] by radiometric scintillation counting analysis	B	CN(C)c1ccc(C(=O)Nc2cccc(NC(=O)COc3ccc4c(=O)ccoc4c3)c2)cc1		CHEMBL4438748	>	IC50	nM	10000.0	CHEMBL2527	Homo sapiens	IC50	uM	10.0
	19147793	CHEMBL4379189	Inhibition of recombinant human CHK2 I157T mutant (5 to end residues) using KKKVSRSGLYRSP as substrate incubated for 40 mins in presence of [gamma-33ATP] by radiometric scintillation counting analysis	B	CN(C)c1ccc(C(=O)Nc2cccc(NC(=O)COc3ccc4c(=O)ccoc4c3)c2)cc1		CHEMBL4438748	>	IC50	nM	10000.0	CHEMBL2527	Homo sapiens	IC50	uM	10.0
	19147794	CHEMBL4379190	Inhibition of recombinant human CHK2 R145W mutant (5 to end residues) using KKKVSRSGLYRSP as substrate incubated for 40 mins in presence of [gamma-33ATP] by radiometric scintillation counting analysis	B	CN(C)c1ccc(C(=O)Nc2cccc(NC(=O)COc3ccc4c(=O)ccoc4c3)c2)cc1		CHEMBL4438748	>	IC50	nM	10000.0	CHEMBL2527	Homo sapiens	IC50	uM	10.0
	19159339	CHEMBL4382443	Binding affinity to wild-type human partial length CHEK2 (S253 to E574 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4473365	=	Activity	%	0.35	CHEMBL2527	Homo sapiens	Activity	%	0.35
	19176689	CHEMBL4386153	Inhibition of CHK2 (unknown origin) assessed as residual activity at 1 uM relative to control	B	CC(C)c1n[nH]c2c(NCc3ccc(-c4ccccn4)cc3)nc(SCCN)nc12		CHEMBL4540226	=	Activity	%	18.0	CHEMBL2527	Homo sapiens	Activity	%	18.0
	19176691	CHEMBL4386155	Inhibition of CHK2 (unknown origin)	B	CC(C)c1n[nH]c2c(NCc3ccc(-c4ccccn4)cc3)nc(SCCN)nc12		CHEMBL4540226	=	IC50	nM	525.0	CHEMBL2527	Homo sapiens	IC50	uM	0.525
	19180991	CHEMBL4387202	Inhibition of recombinant full length human His-tagged CHK2 expressed in baculovirus expression system at 0.1 uM using serine/threonine-07 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	=	Inhibition	%	0.5	CHEMBL2527	Homo sapiens	INH	%	0.5
	19181217	CHEMBL4387202	Inhibition of recombinant full length human His-tagged CHK2 expressed in baculovirus expression system at 0.1 uM using serine/threonine-07 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control	B	CCN1CC2(C1)CN(c1ccc(Nc3ncc(F)c(-c4cnn5c4[C@H](C)CCCC5)n3)nc1)C2		CHEMBL4545456	=	Inhibition	%	22.5	CHEMBL2527	Homo sapiens	INH	%	22.5
	19191668	CHEMBL4389162	Inhibition of wild-type human partial length CHEK2 (S253 to E574 residues) expressed in bacterial expression system at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1		CHEMBL4555459	=	Inhibition	%	47.0	CHEMBL2527	Homo sapiens	INH	%	47.0
	19191825	CHEMBL4389639	Inhibition of wild-type human partial length CHEK2 (S253 to E574 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1		CHEMBL4564973	=	Inhibition	%	69.0	CHEMBL2527	Homo sapiens	INH	%	69.0
	19199957	CHEMBL4391265	Binding affinity to wild-type human partial length CHEK2 (S253 to E574 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O		CHEMBL4559936	=	Activity	%	90.0	CHEMBL2527	Homo sapiens	Activity	%	90.0
	19219393	CHEMBL4394698	Inhibition of recombinant human N-terminal GST-tagged CHK2 (M1 to L543 residues) expressed in baculovirus infected insect cells using biotin-labelled STK substrate-1 as substrate incubated for 60 mins by HTRF assay	B	CC(=O)O.CNc1nc(Nc2cnc(C#N)c(O[C@@H]3CCCNC3)c2)ncc1-c1cnn(C)c1		CHEMBL4577258	=	IC50	nM	1729.0	CHEMBL2527	Homo sapiens	IC50	nM	1729.0
	19219483	CHEMBL4394698	Inhibition of recombinant human N-terminal GST-tagged CHK2 (M1 to L543 residues) expressed in baculovirus infected insect cells using biotin-labelled STK substrate-1 as substrate incubated for 60 mins by HTRF assay	B	COc1cccc(OCCCN)c1-c1cc(Nc2cnc(C#N)cn2)n[nH]1		CHEMBL3544911	=	IC50	nM	32.57	CHEMBL2527	Homo sapiens	IC50	nM	32.57
	19225456	CHEMBL4395876	Inhibition of human recombinant CHK2 at 1 uM using CREBtide as substrate incubated for 15 mins in presence of ATP by LANCE assay relative to control	B	CCc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)C3CC3)c2)[nH]1		CHEMBL4536012	=	Inhibition	%	-9.7	CHEMBL2527	Homo sapiens	INH	%	-9.7
	19266368	CHEMBL4405318	Inhibition of wild-type human partial length CHEK2 (S253 to E574 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	CC[C@H](Nc1nc(N)nc(C)c1C#N)c1nc2cccc(NCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4455923	<	Inhibition	%	50.0	CHEMBL2527	Homo sapiens	INH	%	50.0
	19274904	CHEMBL4407583	Inhibition of recombinant human full-length His-tagged CHEK2 expressed in baculovirus expression system at 25 uM using FRET-labeled Ser/Thr 07 peptide as substrate measured after 1 hr by Z'-lyte assay relative to control	A	Nc1ncc2cc(-c3c(Br)cccc3Br)c(N)nc2n1		CHEMBL57531	=	Inhibition	%	13.0	CHEMBL2527	Homo sapiens	INH	%	13.0
	19274905	CHEMBL4407583	Inhibition of recombinant human full-length His-tagged CHEK2 expressed in baculovirus expression system at 25 uM using FRET-labeled Ser/Thr 07 peptide as substrate measured after 1 hr by Z'-lyte assay relative to control	A	Nc1ncc2cc(-c3c(Cl)cccc3-c3cccnc3)c(N3C[C@H]4[C@H](N)[C@H]4C3)nc2n1		CHEMBL4453148	=	Inhibition	%	20.0	CHEMBL2527	Homo sapiens	INH	%	20.0
	19274906	CHEMBL4407583	Inhibition of recombinant human full-length His-tagged CHEK2 expressed in baculovirus expression system at 25 uM using FRET-labeled Ser/Thr 07 peptide as substrate measured after 1 hr by Z'-lyte assay relative to control	A	CC(C)COc1cccc(Cl)c1-c1cc2cnc(N)nc2nc1N1C[C@H]2[C@H](N)[C@H]2C1		CHEMBL4546703	=	Inhibition	%	67.0	CHEMBL2527	Homo sapiens	INH	%	67.0
	19275954	CHEMBL4407957	Inhibition of recombinant human CHK2 (5 to end residues) at 1 uM using KKKVSRSGLYRSP as substrate incubated for 40 mins in presence of [gamma-33P]-ATP by scintillation counting method relative to control	B	Cc1ccc(NC(=O)C2(C(=O)Nc3ccc(Nc4ncc(F)c(-c5cc(F)c6nc(C)n(C(C)C)c6c5)n4)cc3)CC2)cc1		CHEMBL4445335	=	Inhibition	%	22.0	CHEMBL2527	Homo sapiens	INH	%	22.0
	19275955	CHEMBL4407958	Inhibition of recombinant human CHK2 I157T mutant (5 to end residues) at 1 uM using KKKVSRSGLYRSP as substrate incubated for 40 mins in presence of [gamma-33P]-ATP by scintillation counting method relative to control	B	Cc1ccc(NC(=O)C2(C(=O)Nc3ccc(Nc4ncc(F)c(-c5cc(F)c6nc(C)n(C(C)C)c6c5)n4)cc3)CC2)cc1		CHEMBL4445335	=	Inhibition	%	24.0	CHEMBL2527	Homo sapiens	INH	%	24.0
	19275956	CHEMBL4407959	Inhibition of recombinant human CHK2 R145W mutant (5 to end residues) at 1 uM using KKKVSRSGLYRSP as substrate incubated for 40 mins in presence of [gamma-33P]-ATP by scintillation counting method relative to control	B	Cc1ccc(NC(=O)C2(C(=O)Nc3ccc(Nc4ncc(F)c(-c5cc(F)c6nc(C)n(C(C)C)c6c5)n4)cc3)CC2)cc1		CHEMBL4445335	=	Inhibition	%	28.0	CHEMBL2527	Homo sapiens	INH	%	28.0
Not Active	19296706	CHEMBL4412642	Inhibition of CHK2 (unknown origin) at 10 uM after 60 mins by ADP-Glo luminescence assay	B	COc1ccc(Cn2cc(C(=O)N/N=C3/C(=O)Nc4c(C)cccc43)nn2)cc1		CHEMBL4529234		Inhibition	%		CHEMBL2527	Homo sapiens	INH		
	19303740	CHEMBL4414171	Inhibition of recombinant full length human His-tagged CHK2 expressed in baculovirus expression system assessed as reduction in enzyme activity at 5 uM in presence of ATP relative to control	B	O=C(O)c1ccc(Nc2nc(-c3ccc4ccccc4c3)cs2)cc1O		CHEMBL4520531	=	Inhibition	%	20.0	CHEMBL2527	Homo sapiens	INH	%	20.0
	19303777	CHEMBL4414229	Inhibition of CHK2 (unknown origin) assessed as residual activity at 50 uM relative to control	B	O=C(O)c1ccc(Nc2nc(-c3cccc([N+](=O)[O-])c3)cs2)cc1		CHEMBL4462082	=	Activity	%	89.0	CHEMBL2527	Homo sapiens	Activity	%	89.0
	19303828	CHEMBL4414229	Inhibition of CHK2 (unknown origin) assessed as residual activity at 50 uM relative to control	B	O=C(O)c1ccc(Nc2nc(-c3cccc(Br)c3)cs2)cc1		CHEMBL4458300	=	Activity	%	72.0	CHEMBL2527	Homo sapiens	Activity	%	72.0
Active	19364798	CHEMBL4423697	Induction of CHK2 phosphorylation at T68 in human MCF7 cells at 10 uM pretreated for 30 mins followed by 10 J/m'2 irradiation and measured after 1 hr by Western blot analysis	B	COC(=O)/C=C/C1(O)C=CC(=O)C=C1		CHEMBL1981072		Activity			CHEMBL2527	Homo sapiens	Activity		
Not Active	19364814	CHEMBL4423681	Inhibition of CHK2 phosphorylation at T68 in human MCF7 cells at 10 uM pretreated for 30 mins followed by 10 J/m'2 irradiation and measured after 1 hr by Western blot analysis	B	COC(=O)/C=C/c1ccc(O)cc1		CHEMBL146816		Inhibition	%		CHEMBL2527	Homo sapiens	INH		
	19411479	CHEMBL4427686	Inhibition of CHK2 (unknown origin)	B	Cc1cnc(-c2cc(Cl)ccc2F)cc1-n1c(=O)n(CC(N)=O)c2cnccc21		CHEMBL4564126	>=	IC50	nM	5000.0	CHEMBL2527	Homo sapiens	IC50	uM	5.0
	19411535	CHEMBL4427630	Inhibition of CHK2 (unknown origin) at 1 uM relative to control	B	Cc1cnc(-c2cc(Cl)ccc2F)cc1-n1c(=O)n(CC(N)=O)c2cnccc21		CHEMBL4564126	<=	Inhibition	%	16.0	CHEMBL2527	Homo sapiens	INH	%	16.0
	19476560	CHEMBL4479708	Inhibition of full-length recombinant human His-tagged CHEK2 expressed in baculovirus expression system by Z'-LYTE assay	B	O=C(NCC(F)(F)F)c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)cs1		CHEMBL4569508	=	IC50	nM	450.0	CHEMBL2527	Homo sapiens	IC50	nM	450.0
	19476660	CHEMBL4479708	Inhibition of full-length recombinant human His-tagged CHEK2 expressed in baculovirus expression system by Z'-LYTE assay	B	Cn1cc(-c2cnc3c(-c4csc(C(=O)NCC(F)(F)F)c4)cnn3c2)cn1		CHEMBL4550702	=	IC50	nM	420.0	CHEMBL2527	Homo sapiens	IC50	nM	420.0
	19476760	CHEMBL4479708	Inhibition of full-length recombinant human His-tagged CHEK2 expressed in baculovirus expression system by Z'-LYTE assay	B	Cn1cc(-c2cnc3c(-c4csc(C(=O)N[C@@H]5CCCC[C@@H]5N)c4)cnn3c2)cn1		CHEMBL4568087	=	IC50	nM	24.0	CHEMBL2527	Homo sapiens	IC50	nM	24.0
	19476860	CHEMBL4479708	Inhibition of full-length recombinant human His-tagged CHEK2 expressed in baculovirus expression system by Z'-LYTE assay	B	Cc1sc(C(=O)N[C@@H]2[C@H](N)CCCC2(F)F)cc1-c1cnn2cc(Cl)cnc12		CHEMBL4552628	=	IC50	nM	390.0	CHEMBL2527	Homo sapiens	IC50	nM	390.0
	20600488	CHEMBL4603440	Inhibition of recombinant human full-length His-tagged CHEK2 expressed in baculovirus expression system using FRET-labeled Ser/Thr 07 peptide as substrate measured after 1 hr in presence of ATP by Z'-lyte assay	B	C[C@@H]1C[C@H]1C(=O)N1CCN(c2cnc(C#N)c(-c3cnn(C)c3)n2)C[C@H]1C		CHEMBL4634634	>	IC50	nM	100000.0	CHEMBL2527	Homo sapiens	IC50	uM	100.0
	20601665	CHEMBL4603797	Inhibition of recombinant human His-tagged full length CHEK2 expressed in baculovirus expression system using Ser/Thr07 peptide as substrate at 0.6 uM incubated for 1 hr by Z'lyte assay relative to control	B	C=CC(=O)NCCOc1cc(Cc2ccccc2)cc2[nH]c(-c3n[nH]c4cc(C(F)F)ccc34)cc12		CHEMBL4646281	=	Inhibition	%	9.0	CHEMBL2527	Homo sapiens	INH	%	9.0
	22392018	CHEMBL4667113	Inhibition of recombinant human His-tagged full length CHK2 expressed in baculovirus expression system using Ser/Thr 07 as substrate at 10 uM incubated for 60 mins by Z'-Lyte assay relative to control	B	CN1C(=O)[C@@H](NC(=O)c2n[nH]c3ncc(C(F)(F)C(F)(F)F)cc23)COc2ccccc21		CHEMBL4785812	=	Inhibition	%	0.5	CHEMBL2527	Homo sapiens	INH	%	0.5
	22423727	CHEMBL4674439	Inhibition of human CHK2 using KKKVSRSGLYRSPSMPENLNRPR as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OC1CCCCC1		CHEMBL4785602	=	Activity	%	89.53	CHEMBL2527	Homo sapiens	Activity	%	89.53
	22423728	CHEMBL4674439	Inhibition of human CHK2 using KKKVSRSGLYRSPSMPENLNRPR as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OCc1ccncc1		CHEMBL4749141	=	Activity	%	65.24	CHEMBL2527	Homo sapiens	Activity	%	65.24
	22752703	CHEMBL4700174	Inhibition of human ChK2 by kinase-profiling analysis	B	C#Cc1nc(Nc2ccccc2)nc2[nH]cnc12		CHEMBL4094562	=	IC50	nM	4400.0	CHEMBL2527	Homo sapiens	IC50	uM	4.4
	22752704	CHEMBL4700174	Inhibition of human ChK2 by kinase-profiling analysis	B	C#Cc1nc(Nc2ccc(S(N)(=O)=O)cc2)nc2[nH]cnc12		CHEMBL4074015	=	IC50	nM	2600.0	CHEMBL2527	Homo sapiens	IC50	uM	2.6
Active	22775211	CHEMBL4705416	Binding affinity to human CHK2 at 1 uM by KINOMEscan binding assay	B	CC[C@@H](c1nc2cccc(F)c2c(=O)n1C1CC1)n1nc(-c2ccc(OC)c(F)c2)c2c(N)ncnc21		CHEMBL4781849		Activity			CHEMBL2527	Homo sapiens	Activity		
	22779644	CHEMBL4706922	Inhibition of CHK2 (unknown origin) using Biotin-KKKVSRSGLYRSPSMPENLNRPR peptide as substrate incubated for 30 mins in presence of ATP by dissociation-enhanced lanthanide fluorescent immunoassay	B	COC(=O)c1cnc(Nc2cnc(C#N)cn2)cc1NCC1CCNCC1		CHEMBL1928692	=	IC50	nM	9600.0	CHEMBL2527	Homo sapiens	IC50	uM	9.6
	22779645	CHEMBL4706922	Inhibition of CHK2 (unknown origin) using Biotin-KKKVSRSGLYRSPSMPENLNRPR peptide as substrate incubated for 30 mins in presence of ATP by dissociation-enhanced lanthanide fluorescent immunoassay	B	COC(=O)c1cnc(Nc2cnc(C#N)cn2)cc1NCCC1CCNCC1		CHEMBL4797888	=	IC50	nM	9800.0	CHEMBL2527	Homo sapiens	IC50	uM	9.8
	22779646	CHEMBL4706922	Inhibition of CHK2 (unknown origin) using Biotin-KKKVSRSGLYRSPSMPENLNRPR peptide as substrate incubated for 30 mins in presence of ATP by dissociation-enhanced lanthanide fluorescent immunoassay	B	COC(=O)c1cnc(Nc2cnc(C#N)cn2)cc1NC1CCN(C)CC1		CHEMBL4784549	=	IC50	nM	14000.0	CHEMBL2527	Homo sapiens	IC50	uM	14.0
	22779647	CHEMBL4706922	Inhibition of CHK2 (unknown origin) using Biotin-KKKVSRSGLYRSPSMPENLNRPR peptide as substrate incubated for 30 mins in presence of ATP by dissociation-enhanced lanthanide fluorescent immunoassay	B	COC(=O)c1cnc(Nc2cnc(C#N)cn2)cc1N[C@@H]1C[C@@H]2CC[C@H](C1)N2		CHEMBL4789854	=	IC50	nM	11000.0	CHEMBL2527	Homo sapiens	IC50	uM	11.0
	22779648	CHEMBL4706922	Inhibition of CHK2 (unknown origin) using Biotin-KKKVSRSGLYRSPSMPENLNRPR peptide as substrate incubated for 30 mins in presence of ATP by dissociation-enhanced lanthanide fluorescent immunoassay	B	COC(=O)c1cnc(Nc2cnc(C#N)cn2)cc1NC1C[C@@H]2CC[C@H](C1)N2C		CHEMBL4753307	=	IC50	nM	2200.0	CHEMBL2527	Homo sapiens	IC50	uM	2.2
	22779649	CHEMBL4706922	Inhibition of CHK2 (unknown origin) using Biotin-KKKVSRSGLYRSPSMPENLNRPR peptide as substrate incubated for 30 mins in presence of ATP by dissociation-enhanced lanthanide fluorescent immunoassay	B	COC(=O)c1cnc(Nc2cnc(C#N)cn2)cc1NCC1CNCCO1		CHEMBL4782664	=	IC50	nM	5000.0	CHEMBL2527	Homo sapiens	IC50	uM	5.0
	22820450	CHEMBL4716227	Inhibition of human CHK2 assessed as residual activity at 1 uM relative to control	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	=	Activity	%	9.0	CHEMBL2527	Homo sapiens	Activity	%	9.0
	22820451	CHEMBL4716227	Inhibition of human CHK2 assessed as residual activity at 1 uM relative to control	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCNC2		CHEMBL4782674	=	Activity	%	1.0	CHEMBL2527	Homo sapiens	Activity	%	1.0
	22843446	CHEMBL4720443	Inhibition of human CHK2 assessed as residual activity using KKKVSRSGLYRSPSMPENLNRPR as substrate at 1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1)c1cc([N+](=O)[O-])ccc1F		CHEMBL4750196	=	Activity	%	97.9	CHEMBL2527	Homo sapiens	Activity	%	97.9
	22843796	CHEMBL4720782	Inhibition of human CHK2 using KKKVSRSGLYRSPSMPENLNRPR as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	5.72	CHEMBL2527	Homo sapiens	IC50	10^-9M	5.72
	22844663	CHEMBL4721338	Inhibition of CHK2 (unknown origin) assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCOc1nc(Nc2ccc(C(=O)N3CCOCC3)cc2OC)nc2[nH]ccc12		CHEMBL4794578	=	Activity	%	16.79	CHEMBL2527	Homo sapiens	Activity	%	16.79
	22949060	CHEMBL4765737	Inhibition of human CHK2 assessed as residual activity at 0.1 uM relative to control	B	CNS(=O)(=O)c1ccc2c(c1)/C(=C/c1cn(C)c3ccc(OC)cc13)C(=O)N2		CHEMBL104519	=	Activity	%	93.0	CHEMBL2527	Homo sapiens	Activity	%	93.0
	22949061	CHEMBL4765737	Inhibition of human CHK2 assessed as residual activity at 0.1 uM relative to control	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cn(C)c3ccc(O)cc13)C(=O)N2		CHEMBL4798255	=	Activity	%	94.0	CHEMBL2527	Homo sapiens	Activity	%	94.0
	22949062	CHEMBL4765737	Inhibition of human CHK2 assessed as residual activity at 0.1 uM relative to control	B	COc1ccc2c(c1)c(/C=C1\C(=O)Nc3ccc(S(=O)(=O)N(C)C)cc31)cn2C		CHEMBL322153	=	Activity	%	100.0	CHEMBL2527	Homo sapiens	Activity	%	100.0
	22949063	CHEMBL4765737	Inhibition of human CHK2 assessed as residual activity at 0.1 uM relative to control	B	COc1ccc2[nH]cc(/C=C3\C(=O)Nc4ccc(S(N)(=O)=O)cc43)c2c1		CHEMBL106226	=	Activity	%	59.0	CHEMBL2527	Homo sapiens	Activity	%	59.0
	22949064	CHEMBL4765737	Inhibition of human CHK2 assessed as residual activity at 0.1 uM relative to control	B	COc1ccc2c(c1)c(/C=C1\C(=O)Nc3ccc(S(N)(=O)=O)cc31)cn2C		CHEMBL104333	=	Activity	%	35.0	CHEMBL2527	Homo sapiens	Activity	%	35.0
	22949065	CHEMBL4765737	Inhibition of human CHK2 assessed as residual activity at 0.1 uM relative to control	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Activity	%	9.0	CHEMBL2527	Homo sapiens	Activity	%	9.0
	22949066	CHEMBL4765738	Inhibition of human CHK2 assessed as residual activity at 1 uM relative to control	B	CNS(=O)(=O)c1ccc2c(c1)/C(=C/c1cn(C)c3ccc(OC)cc13)C(=O)N2		CHEMBL104519	=	Activity	%	75.0	CHEMBL2527	Homo sapiens	Activity	%	75.0
	22949067	CHEMBL4765738	Inhibition of human CHK2 assessed as residual activity at 1 uM relative to control	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cn(C)c3ccc(O)cc13)C(=O)N2		CHEMBL4798255	=	Activity	%	92.0	CHEMBL2527	Homo sapiens	Activity	%	92.0
	22949068	CHEMBL4765738	Inhibition of human CHK2 assessed as residual activity at 1 uM relative to control	B	COc1ccc2c(c1)c(/C=C1\C(=O)Nc3ccc(S(=O)(=O)N(C)C)cc31)cn2C		CHEMBL322153	=	Activity	%	99.0	CHEMBL2527	Homo sapiens	Activity	%	99.0
	22949069	CHEMBL4765738	Inhibition of human CHK2 assessed as residual activity at 1 uM relative to control	B	COc1ccc2[nH]cc(/C=C3\C(=O)Nc4ccc(S(N)(=O)=O)cc43)c2c1		CHEMBL106226	=	Activity	%	12.0	CHEMBL2527	Homo sapiens	Activity	%	12.0
	22949070	CHEMBL4765738	Inhibition of human CHK2 assessed as residual activity at 1 uM relative to control	B	COc1ccc2c(c1)c(/C=C1\C(=O)Nc3ccc(S(N)(=O)=O)cc31)cn2C		CHEMBL104333	=	Activity	%	39.0	CHEMBL2527	Homo sapiens	Activity	%	39.0
	22949071	CHEMBL4765738	Inhibition of human CHK2 assessed as residual activity at 1 uM relative to control	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Activity	%	5.0	CHEMBL2527	Homo sapiens	Activity	%	5.0
	22952791	CHEMBL4766728	Inhibition of recombinant human CHK2 (5 to end residues) assessed as residual activity at 10 uM using KKKVSRSGLYRSPSMPENLNRPR as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1		CHEMBL4793380	=	Activity	%	23.0	CHEMBL2527	Homo sapiens	Activity	%	23.0
	23120298	CHEMBL4804364	Inhibition of CHK2 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2cccc3ncsc23)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855542	=	IC50	nM	19700.0	CHEMBL2527	Homo sapiens	IC50	uM	19.7
	23120299	CHEMBL4804364	Inhibition of CHK2 in human NCI-H929 cells by mass spectroscopic analysis	B	CN(C1CC1)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc4c(c3)CCNC4=O)c2)c(F)c1		CHEMBL4860979	=	IC50	nM	6800.0	CHEMBL2527	Homo sapiens	IC50	uM	6.8
	23120300	CHEMBL4804364	Inhibition of CHK2 in human NCI-H929 cells by mass spectroscopic analysis	B	COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1		CHEMBL4867931	=	IC50	nM	19300.0	CHEMBL2527	Homo sapiens	IC50	uM	19.3
	23120301	CHEMBL4804364	Inhibition of CHK2 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855730	=	IC50	nM	14100.0	CHEMBL2527	Homo sapiens	IC50	uM	14.1
	23120302	CHEMBL4804364	Inhibition of CHK2 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4868141	=	IC50	nM	11200.0	CHEMBL2527	Homo sapiens	IC50	uM	11.2
	23120303	CHEMBL4804364	Inhibition of CHK2 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2cccc([N+](=O)[O-])c2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4859660	=	IC50	nM	80900.0	CHEMBL2527	Homo sapiens	IC50	uM	80.9
	23121340	CHEMBL4804546	Inhibition of CHK2 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2cccc3ncsc23)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855542	=	Inhibition	%	0.0	CHEMBL2527	Homo sapiens	INH	%	0.0
	23121341	CHEMBL4804546	Inhibition of CHK2 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	CN(C1CC1)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc4c(c3)CCNC4=O)c2)c(F)c1		CHEMBL4860979	=	Inhibition	%	0.0	CHEMBL2527	Homo sapiens	INH	%	0.0
	23121342	CHEMBL4804546	Inhibition of CHK2 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1		CHEMBL4867931	=	Inhibition	%	0.0	CHEMBL2527	Homo sapiens	INH	%	0.0
	23121343	CHEMBL4804546	Inhibition of CHK2 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855730	=	Inhibition	%	0.0	CHEMBL2527	Homo sapiens	INH	%	0.0
	23121344	CHEMBL4804546	Inhibition of CHK2 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4868141	=	Inhibition	%	0.0	CHEMBL2527	Homo sapiens	INH	%	0.0
	23121345	CHEMBL4804546	Inhibition of CHK2 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2cccc([N+](=O)[O-])c2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4859660	=	Inhibition	%	75.0	CHEMBL2527	Homo sapiens	INH	%	75.0
	23122497	CHEMBL4804848	Inhibition of human CHEK2 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1		CHEMBL4878072	=	Activity	%	98.0	CHEMBL2527	Homo sapiens	Activity	%	98.0
	23123192	CHEMBL4805436	Inhibition of human CHEK2 assessed as percent of control at 1000 nM by KINOMEscan assay relative to control	B	COc1cc2nc(NC3CC3)nc(NC3CCN(C(C)C)CC3)c2cc1OC.O=C(O)C(F)(F)F		CHEMBL4870304	=	Activity	%	100.0	CHEMBL2527	Homo sapiens	Activity	%	100.0
	23123698	CHEMBL4805942	Inhibition of DNA-tagged human CHEK2 assessed as percent of control at 50000 nM by qPCR analysis relative to control	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Activity	%	100.0	CHEMBL2527	Homo sapiens	Activity	%	100.0
	23124474	CHEMBL4806453	Inhibition of human CHEK2 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	92.0	CHEMBL2527	Homo sapiens	Activity	%	92.0
	23124475	CHEMBL4806453	Inhibition of human CHEK2 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	92.0	CHEMBL2527	Homo sapiens	Activity	%	92.0
	23127948	CHEMBL4807791	Inhibition of CHK2 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)csc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL4867844	>	Activity	%	75.0	CHEMBL2527	Homo sapiens	Activity	%	75.0
	23127949	CHEMBL4807791	Inhibition of CHK2 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(Cl)ccnc3C)s2)cc(NN2CCN(CCO)CC2)n1		CHEMBL4855726	>	Activity	%	75.0	CHEMBL2527	Homo sapiens	Activity	%	75.0
	23127950	CHEMBL4807791	Inhibition of CHK2 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Activity	%	75.0	CHEMBL2527	Homo sapiens	Activity	%	75.0
	23150934	CHEMBL4810427	Inhibition of recombinant human CHK2 (5 to end residues) at 1 uM using KKKVSRSGLYRSPSMPENLNRPR as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	CCc1cc(Nc2nc(NCc3ccc(Cl)cc3OC)nc3cccc(OC)c23)n[nH]1		CHEMBL4877302	>	Inhibition	%	50.0	CHEMBL2527	Homo sapiens	INH	%	50.0
	23150937	CHEMBL4810430	Inhibition of recombinant human CHK2 (5 to end residues) using KKKVSRSGLYRSPSMPENLNRPR as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay	B	CCc1cc(Nc2nc(NCc3ccc(Cl)cc3OC)nc3cccc(OC)c23)n[nH]1		CHEMBL4877302	=	IC50	nM	820.0	CHEMBL2527	Homo sapiens	IC50	nM	820.0
	23297806	CHEMBL4841286	Inhibition of CHK2 (unknown origin)	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3Cl)cc12		CHEMBL4876497	>	IC50	nM	1000.0	CHEMBL2527	Homo sapiens	IC50	nM	1000.0
	23299288	CHEMBL4841744	Inhibition of CHK2 (unknown origin) at 1000 nM relative to control	B	Nc1c(-c2nc3cc(N4CCN(C(=O)CCCCCNc5cccc6c5C(=O)N(C5CCC(=O)NC5=O)C6=O)CC4)ccc3[nH]2)c(=O)[nH]c2cccc(F)c12		CHEMBL4860038	=	Inhibition	%	0.0	CHEMBL2527	Homo sapiens	INH	%	0.0
	23299289	CHEMBL4841744	Inhibition of CHK2 (unknown origin) at 1000 nM relative to control	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Inhibition	%	25.0	CHEMBL2527	Homo sapiens	INH	%	25.0
Not Active	23317332	CHEMBL4879638	KinomeScan assay: inhibition of CHEK2	B	CCC(=N\O)/C(C)=C/c1ccc(F)cc1		CHEMBL3697701		% Control	%	85.0	CHEMBL2527	Homo sapiens	% Control	%	85.0
Not Active	23317800	CHEMBL4879638	KinomeScan assay: inhibition of CHEK2	B	CCC(=N\O)/C(C)=C/c1ccc(F)c(C)c1		CHEMBL3701197		% Control	%	90.0	CHEMBL2527	Homo sapiens	% Control	%	90.0
Not Active	23318470	CHEMBL4879638	KinomeScan assay: inhibition of CHEK2	B	Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4586794		% Control	%	100.0	CHEMBL2527	Homo sapiens	% Control	%	100.0
Not Active	23318950	CHEMBL4879638	KinomeScan assay: inhibition of CHEK2	B	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4526341		% Control	%	96.0	CHEMBL2527	Homo sapiens	% Control	%	96.0
Not Active	23319589	CHEMBL4879638	KinomeScan assay: inhibition of CHEK2	B	CCCCN(CCCC)C(=O)CN1C[C@H](c2cc(OC)c3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1CC(C)(C)CCC		CHEMBL111612		% Control	%	100.0	CHEMBL2527	Homo sapiens	% Control	%	100.0
Not Active	23320062	CHEMBL4879638	KinomeScan assay: inhibition of CHEK2	B	CCCCN(CCCC)C(=O)CN1C[C@@H](c2cc(OC)c3c(c2)OCO3)[C@H](C(=O)O)[C@H]1CC(C)(C)CCC		CHEMBL4513786		% Control	%	87.8	CHEMBL2527	Homo sapiens	% Control	%	87.8
Not Active	23320740	CHEMBL4879638	KinomeScan assay: inhibition of CHEK2	B	c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1		CHEMBL440687		% Control	%	100.0	CHEMBL2527	Homo sapiens	% Control	%	100.0
Not Active	23321208	CHEMBL4879638	KinomeScan assay: inhibition of CHEK2	B	CSc1cccnc1N1CCN(Cc2nc3ccccc3[nH]2)CC1		CHEMBL4630641		% Control	%	96.0	CHEMBL2527	Homo sapiens	% Control	%	96.0
Not Active	23321838	CHEMBL4879638	KinomeScan assay: inhibition of CHEK2	B	CCCOc1ccc([C@H]2[C@H](C(=O)O)[C@@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL332794		% Control	%	88.0	CHEMBL2527	Homo sapiens	% Control	%	88.0
Not Active	23322306	CHEMBL4879638	KinomeScan assay: inhibition of CHEK2	B	CCCOc1ccc([C@@H]2[C@@H](C(=O)O)[C@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL4533479		% Control	%	98.0	CHEMBL2527	Homo sapiens	% Control	%	98.0
Not Active	23322995	CHEMBL4879638	KinomeScan assay: inhibition of CHEK2	B	COc1ccc2c(c1)O[C@@H](c1ccc(OC)c(OC)c1)C[C@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4093612		% Control	%	84.0	CHEMBL2527	Homo sapiens	% Control	%	84.0
Not Active	23323463	CHEMBL4879638	KinomeScan assay: inhibition of CHEK2	B	COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4066040		% Control	%	100.0	CHEMBL2527	Homo sapiens	% Control	%	100.0
Not Active	23323973	CHEMBL4880592	CHK2 (h) Millipore kinase activity assay	B	CC1=C(C#N)C(c2ccc3[nH]nc(C)c3c2)C(C#N)=C(C)N1		CHEMBL4593677		Inhibition	%	4.0	CHEMBL2527	Homo sapiens	% inhibition	%	4.0
Not Active	23324317	CHEMBL4879638	KinomeScan assay: inhibition of CHEK2	B	CC1=C(C#N)[C@@H](c2ccc3[nH]nc(C)c3c2)C(C#N)=C(c2ccc(Cl)cc2)N1		CHEMBL4522773		% Control	%	100.0	CHEMBL2527	Homo sapiens	% Control	%	100.0
Not Active	23324952	CHEMBL4879638	KinomeScan assay: inhibition of CHEK2	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@H]1CC[C@@H](Cn2nnc3ccccc3c2=O)[C@@H]1C(=O)O		CHEMBL4585243		% Control	%	100.0	CHEMBL2527	Homo sapiens	% Control	%	100.0
Not Active	23325420	CHEMBL4879638	KinomeScan assay: inhibition of CHEK2	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@@H]1CC[C@H](Cn2nnc3ccccc3c2=O)[C@H]1C(=O)O		CHEMBL4539943		% Control	%	100.0	CHEMBL2527	Homo sapiens	% Control	%	100.0
Not Active	23326067	CHEMBL4879638	KinomeScan assay: inhibition of CHEK2	B	NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1		CHEMBL4521594		% Control	%	81.0	CHEMBL2527	Homo sapiens	% Control	%	81.0
Not Active	23326535	CHEMBL4879638	KinomeScan assay: inhibition of CHEK2	B	NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1		CHEMBL4516843		% Control	%	100.0	CHEMBL2527	Homo sapiens	% Control	%	100.0
Not Active	23327235	CHEMBL4879638	KinomeScan assay: inhibition of CHEK2	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4537788		% Control	%	100.0	CHEMBL2527	Homo sapiens	% Control	%	100.0
Not Active	23327703	CHEMBL4879638	KinomeScan assay: inhibition of CHEK2	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4564312		% Control	%	97.0	CHEMBL2527	Homo sapiens	% Control	%	97.0
Not Active	23328290	CHEMBL4879638	KinomeScan assay: inhibition of CHEK2	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1		CHEMBL4448899		% Control	%	73.0	CHEMBL2527	Homo sapiens	% Control	%	73.0
Not Active	23328758	CHEMBL4879638	KinomeScan assay: inhibition of CHEK2	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C(C)(C)C)cc1		CHEMBL4552180		% Control	%	99.0	CHEMBL2527	Homo sapiens	% Control	%	99.0
Not Active	23329295	CHEMBL4881002	CHK2(h) Eurofins Kinase panel	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% residual kinase activity	%	92.0	CHEMBL2527	Homo sapiens	% residual kinase activity	%	92.0
Not Active	23329704	CHEMBL4879638	KinomeScan assay: inhibition of CHEK2	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% Control	%	100.0	CHEMBL2527	Homo sapiens	% Control	%	100.0
Not Active	23330172	CHEMBL4879638	KinomeScan assay: inhibition of CHEK2	B	Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1		CHEMBL4455582		% Control	%	100.0	CHEMBL2527	Homo sapiens	% Control	%	100.0
Not Active	23330928	CHEMBL4879638	KinomeScan assay: inhibition of CHEK2	B	O=C(N1CCS(=O)(=O)CC1)N1C[C@H](c2ccc(OC(F)(F)F)cc2)C[C@H](c2nc(C3CC3)no2)C1		CHEMBL4630644		% Control	%	100.0	CHEMBL2527	Homo sapiens	% Control	%	100.0
Not Active	23331396	CHEMBL4879638	KinomeScan assay: inhibition of CHEK2	B	Cc1noc([C@H]2C[C@@H](c3ccc(C(F)(F)F)cc3)CN(C(=O)N3CCS(=O)(=O)C3)C2)n1		CHEMBL4630643		% Control	%	100.0	CHEMBL2527	Homo sapiens	% Control	%	100.0
Not Active	23331983	CHEMBL4879638	KinomeScan assay: inhibition of CHEK2	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1		CHEMBL3907057		% Control	%	100.0	CHEMBL2527	Homo sapiens	% Control	%	100.0
Not Active	23332451	CHEMBL4879638	KinomeScan assay: inhibition of CHEK2	B	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1		CHEMBL4526351		% Control	%	100.0	CHEMBL2527	Homo sapiens	% Control	%	100.0
Not Active	23333167	CHEMBL4879638	KinomeScan assay: inhibition of CHEK2	B	CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1		CHEMBL3617968		% Control	%	85.6	CHEMBL2527	Homo sapiens	% Control	%	85.6
Not Active	23333655	CHEMBL4881458	CHK2(h) Eurofins Kinase panel	B	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4535474		% residual kinase activity	%	80.0	CHEMBL2527	Homo sapiens	% residual kinase activity	%	80.0
Not Active	23333806	CHEMBL4879638	KinomeScan assay: inhibition of CHEK2	B	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4535474		% Control	%	76.0	CHEMBL2527	Homo sapiens	% Control	%	76.0
Not Active	23334274	CHEMBL4879638	KinomeScan assay: inhibition of CHEK2	B	CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4520788		% Control	%	87.0	CHEMBL2527	Homo sapiens	% Control	%	87.0
Not Active	23334881	CHEMBL4881505	CHK2 (h) Upstate kinase activity assay	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		Inhibition	%	64.0	CHEMBL2527	Homo sapiens	% inhibition	%	64.0
Not Active	23335253	CHEMBL4879638	KinomeScan assay: inhibition of CHEK2	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		% Control	%	89.0	CHEMBL2527	Homo sapiens	% Control	%	89.0
Not Active	23335721	CHEMBL4879638	KinomeScan assay: inhibition of CHEK2	B	Cn1cc(Cl)c2c(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)ccnc21		CHEMBL4546802		% Control	%	94.0	CHEMBL2527	Homo sapiens	% Control	%	94.0
Not Active	23336348	CHEMBL4879638	KinomeScan assay: inhibition of CHEK2	B	O=C(NC[C@H]1[C@@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@H]12)c1ccc2[nH]nnc2c1		CHEMBL4165749		% Control	%	86.0	CHEMBL2527	Homo sapiens	% Control	%	86.0
Not Active	23336816	CHEMBL4879638	KinomeScan assay: inhibition of CHEK2	B	Cc1nccc(COC(=O)N2C[C@H]3[C@H](CNC(=O)c4ccc5[nH]nnc5c4)[C@H]3C2)n1		CHEMBL4552354		% Control	%	100.0	CHEMBL2527	Homo sapiens	% Control	%	100.0
Not Active	23337546	CHEMBL4881917	CHEK2 Invitrogen selectivity data (BI)	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Ctrl	%	99.0	CHEMBL2527	Homo sapiens	% Ctrl	%	99.0
Not Active	23337897	CHEMBL4879638	KinomeScan assay: inhibition of CHEK2	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Control	%	100.0	CHEMBL2527	Homo sapiens	% Control	%	100.0
Not Active	23338365	CHEMBL4879638	KinomeScan assay: inhibition of CHEK2	B	CN(C)C(=O)Cn1cc(-c2nc(C3(c4ccc(-c5cnc(N)nc5)cc4)CC3)no2)cn1		CHEMBL4560241		% Control	%	100.0	CHEMBL2527	Homo sapiens	% Control	%	100.0
Not Active	23338977	CHEMBL4879638	KinomeScan assay: inhibition of CHEK2	B	CCS(=O)(=O)c1cc2cc(C[C@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL3358954		% Control	%	92.0	CHEMBL2527	Homo sapiens	% Control	%	92.0
Not Active	23339445	CHEMBL4879638	KinomeScan assay: inhibition of CHEK2	B	CCS(=O)(=O)c1cc2cc(C[C@@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL4531220		% Control	%	84.0	CHEMBL2527	Homo sapiens	% Control	%	84.0
Not Active	23340082	CHEMBL4879638	KinomeScan assay: inhibition of CHEK2	B	CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1		CHEMBL4456123		% Control	%	100.0	CHEMBL2527	Homo sapiens	% Control	%	100.0
Not Active	23340550	CHEMBL4879638	KinomeScan assay: inhibition of CHEK2	B	CS(=O)(=O)NCC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1ccnc(S(C)(=O)=O)c1		CHEMBL4539555		% Control	%	77.0	CHEMBL2527	Homo sapiens	% Control	%	77.0
Not Active	23341207	CHEMBL4879638	KinomeScan assay: inhibition of CHEK2	B	CC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1		CHEMBL2170610		% Control	%	100.0	CHEMBL2527	Homo sapiens	% Control	%	100.0
Not Active	23341675	CHEMBL4879638	KinomeScan assay: inhibition of CHEK2	B	CC(=O)N1CCC(c2ccc(C(=O)NC3=NCCN3)cc2C(F)(F)F)CC1		CHEMBL4540759		% Control	%	100.0	CHEMBL2527	Homo sapiens	% Control	%	100.0
Not Active	23342291	CHEMBL4879638	KinomeScan assay: inhibition of CHEK2	B	CCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834184		% Control	%	100.0	CHEMBL2527	Homo sapiens	% Control	%	100.0
Not Active	23342759	CHEMBL4879638	KinomeScan assay: inhibition of CHEK2	B	CCC(=O)N[C@@H]1CC[C@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834199		% Control	%	100.0	CHEMBL2527	Homo sapiens	% Control	%	100.0
Not Active	23343389	CHEMBL4879638	KinomeScan assay: inhibition of CHEK2	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Control	%	100.0	CHEMBL2527	Homo sapiens	% Control	%	100.0
Not Active	23343857	CHEMBL4879638	KinomeScan assay: inhibition of CHEK2	B	Cn1nc(C(=O)NCc2ccc(C(=O)O)cc2)cc1-c1ccc2[nH]ccc2c1		CHEMBL1939880		% Control	%	100.0	CHEMBL2527	Homo sapiens	% Control	%	100.0
Active	23344495	CHEMBL4879638	KinomeScan assay: inhibition of CHEK2	B	CCOCCn1cc(C(=O)Nc2ccc(-n3nc(-c4cccnc4)cc3C(F)(F)F)cn2)ccc1=O		CHEMBL4516982		% Control	%	0.0	CHEMBL2527	Homo sapiens	% Control	%	0.0
Not Active	23345068	CHEMBL4879638	KinomeScan assay: inhibition of CHEK2	B	COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)CC5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(=O)C(C)C)n3)nc2c1C		CHEMBL4588900		% Control	%	94.0	CHEMBL2527	Homo sapiens	% Control	%	94.0
Not Active	23345536	CHEMBL4879638	KinomeScan assay: inhibition of CHEK2	B	O=C(N[C@H]1CCCCC/C=C\C2C[C@@]2(C(=O)O)NC(=O)[C@@H]2C[C@@H](Oc3ccncc3)CN2C1=O)OC1CCCC1		CHEMBL4516471		% Control	%	100.0	CHEMBL2527	Homo sapiens	% Control	%	100.0
Not Active	23346113	CHEMBL4879638	KinomeScan assay: inhibition of CHEK2	B	Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1		CHEMBL3685796		% Control	%	100.0	CHEMBL2527	Homo sapiens	% Control	%	100.0
Not Active	23346582	CHEMBL4879638	KinomeScan assay: inhibition of CHEK2	B	Cc1ccc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)cc1Nc1cccc(C(F)(F)F)n1		CHEMBL4530401		% Control	%	100.0	CHEMBL2527	Homo sapiens	% Control	%	100.0
Not Active	23347191	CHEMBL4879638	KinomeScan assay: inhibition of CHEK2	B	C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1		CHEMBL4538174		% Control	%	100.0	CHEMBL2527	Homo sapiens	% Control	%	100.0
Not Active	23347673	CHEMBL4879638	KinomeScan assay: inhibition of CHEK2	B	C[C@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccn1		CHEMBL4557026		% Control	%	95.9	CHEMBL2527	Homo sapiens	% Control	%	95.9
Not Active	23348252	CHEMBL4879638	KinomeScan assay: inhibition of CHEK2	B	CC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12		CHEMBL204232		% Control	%	100.0	CHEMBL2527	Homo sapiens	% Control	%	100.0
Not Active	23348720	CHEMBL4879638	KinomeScan assay: inhibition of CHEK2	B	CC(=O)c1c(NS(C)(=O)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O		CHEMBL4578164		% Control	%	100.0	CHEMBL2527	Homo sapiens	% Control	%	100.0
Not Active	23349307	CHEMBL4879638	KinomeScan assay: inhibition of CHEK2	B	O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F		CHEMBL1091513		% Control	%	100.0	CHEMBL2527	Homo sapiens	% Control	%	100.0
Not Active	23349925	CHEMBL4879638	KinomeScan assay: inhibition of CHEK2	B	COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1		CHEMBL3609637		% Control	%	100.0	CHEMBL2527	Homo sapiens	% Control	%	100.0
Not Active	23350393	CHEMBL4879638	KinomeScan assay: inhibition of CHEK2	B	COc1cc(-c2cn(C3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1		CHEMBL4534005		% Control	%	100.0	CHEMBL2527	Homo sapiens	% Control	%	100.0
Not Active	23350998	CHEMBL4879638	KinomeScan assay: inhibition of CHEK2	B	CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL561132		% Control	%	100.0	CHEMBL2527	Homo sapiens	% Control	%	100.0
Not Active	23351466	CHEMBL4879638	KinomeScan assay: inhibition of CHEK2	B	CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL1643772		% Control	%	100.0	CHEMBL2527	Homo sapiens	% Control	%	100.0
Not Active	23351995	CHEMBL4882688	CHEK2 (CHK2) Kinase screen	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		Inhibition	%	14.93	CHEMBL2527	Homo sapiens	% Inhibition	%	14.926
Not Active	23352490	CHEMBL4879638	KinomeScan assay: inhibition of CHEK2	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		% Control	%	68.0	CHEMBL2527	Homo sapiens	% Control	%	68.0
Not Active	23352958	CHEMBL4879638	KinomeScan assay: inhibition of CHEK2	B	C[C@H]1CN(c2cc(-c3nn(C)c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4560589		% Control	%	97.0	CHEMBL2527	Homo sapiens	% Control	%	97.0
Not Active	23353840	CHEMBL4879638	KinomeScan assay: inhibition of CHEK2	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1		CHEMBL1800685		% Control	%	100.0	CHEMBL2527	Homo sapiens	% Control	%	100.0
Not Active	23354308	CHEMBL4879638	KinomeScan assay: inhibition of CHEK2	B	Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12		CHEMBL4566600		% Control	%	100.0	CHEMBL2527	Homo sapiens	% Control	%	100.0
Not Active	23355040	CHEMBL4879638	KinomeScan assay: inhibition of CHEK2	B	COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2		CHEMBL2204538		% Control	%	100.0	CHEMBL2527	Homo sapiens	% Control	%	100.0
Not Active	23355508	CHEMBL4879638	KinomeScan assay: inhibition of CHEK2	B	CC(C)CC(=O)N1CCc2nc(-c3ccc(Br)cc3)nc(N(C)Cc3ccccc3)c2C1		CHEMBL4518342		% Control	%	100.0	CHEMBL2527	Homo sapiens	% Control	%	100.0
Not Active	23356144	CHEMBL4879638	KinomeScan assay: inhibition of CHEK2	B	CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1		CHEMBL3582478		% Control	%	100.0	CHEMBL2527	Homo sapiens	% Control	%	100.0
Not Active	23356612	CHEMBL4879638	KinomeScan assay: inhibition of CHEK2	B	FC(F)(F)c1ccc2c(c1)nc(-c1cccnc1)n2C1CC1		CHEMBL3582461		% Control	%	100.0	CHEMBL2527	Homo sapiens	% Control	%	100.0
Not Active	23357221	CHEMBL4879638	KinomeScan assay: inhibition of CHEK2	B	C[C@H](c1ccc(F)cc1)N(Cc1cccc(C(=O)O)c1)C(=O)c1cnc2ccccc2c1		CHEMBL3577885		% Control	%	91.0	CHEMBL2527	Homo sapiens	% Control	%	91.0
Not Active	23357868	CHEMBL4879638	KinomeScan assay: inhibition of CHEK2	B	O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1		CHEMBL1651534		% Control	%	94.0	CHEMBL2527	Homo sapiens	% Control	%	94.0
Not Active	23358336	CHEMBL4879638	KinomeScan assay: inhibition of CHEK2	B	O=C(Nc1cccnn1)N1CC(C/C=C/c2cncc(Oc3ccc(C(F)(F)F)cn3)n2)C1		CHEMBL4780458		% Control	%	100.0	CHEMBL2527	Homo sapiens	% Control	%	100.0
Not Active	23358922	CHEMBL4879638	KinomeScan assay: inhibition of CHEK2	B	COc1cccc(CNC(=O)c2nc3scc(COCc4ccc(C(=O)O)cc4)c3c(=O)[nH]2)c1		CHEMBL3337894		% Control	%	92.0	CHEMBL2527	Homo sapiens	% Control	%	92.0
Not Active	23359520	CHEMBL4879638	KinomeScan assay: inhibition of CHEK2	B	C[C@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3799292		% Control	%	100.0	CHEMBL2527	Homo sapiens	% Control	%	100.0
Not Active	23359988	CHEMBL4879638	KinomeScan assay: inhibition of CHEK2	B	C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3797887		% Control	%	100.0	CHEMBL2527	Homo sapiens	% Control	%	100.0
Not Active	23360573	CHEMBL4879638	KinomeScan assay: inhibition of CHEK2	B	Cn1nc(C(F)(F)F)cc1-c1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4455357		% Control	%	100.0	CHEMBL2527	Homo sapiens	% Control	%	100.0
Not Active	23361041	CHEMBL4879638	KinomeScan assay: inhibition of CHEK2	B	Nc1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4585920		% Control	%	92.0	CHEMBL2527	Homo sapiens	% Control	%	92.0
Not Active	23361614	CHEMBL4879638	KinomeScan assay: inhibition of CHEK2	B	Cc1nc(N2CC[C@@H](O)C2)ncc1-c1cc(C(F)(F)F)cc2[nH]ncc12		CHEMBL3799512		% Control	%	96.0	CHEMBL2527	Homo sapiens	% Control	%	96.0
Not Active	23362150	CHEMBL4879638	KinomeScan assay: inhibition of CHEK2	B	Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O		CHEMBL4082756		% Control	%	100.0	CHEMBL2527	Homo sapiens	% Control	%	100.0
Not Active	23362618	CHEMBL4879638	KinomeScan assay: inhibition of CHEK2	B	Cc1nc(Cc2cccc(C(F)(F)F)c2)sc1-c1ccc(C(N)=O)nc1		CHEMBL4100408		% Control	%	100.0	CHEMBL2527	Homo sapiens	% Control	%	100.0
Not Active	23363230	CHEMBL4883231	CHEK2 (CHK2) Kinase activity screen	B	CN1CCN(C(=O)C(C)(C)c2ccc(C(=O)Nc3cn4cc(-c5ccncc5)ccc4n3)cc2)CC1		CHEMBL4531334		Inhibition	%	24.25	CHEMBL2527	Homo sapiens	% inhibition	%	24.2456
Not Active	23363231	CHEMBL4883231	CHEK2 (CHK2) Kinase activity screen	B	CN1CCN(C(=O)C(C)(C)c2ccc(C(=O)Nc3cn4cc(-c5ccncc5)ccc4n3)cc2)CC1		CHEMBL4531334		Inhibition	%	21.89	CHEMBL2527	Homo sapiens	% inhibition	%	21.8889
Not Active	23364260	CHEMBL4879638	KinomeScan assay: inhibition of CHEK2	B	CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1		CHEMBL4228713		% Control	%	89.0	CHEMBL2527	Homo sapiens	% Control	%	89.0
Not Active	23364728	CHEMBL4879638	KinomeScan assay: inhibition of CHEK2	B	O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccc(C(F)(F)F)cc3-c3ccc(Cl)cc3)CC2)cc1Oc1cnc2[nH]ccc2c1		CHEMBL4551344		% Control	%	95.0	CHEMBL2527	Homo sapiens	% Control	%	95.0
Not Active	23365467	CHEMBL4879638	KinomeScan assay: inhibition of CHEK2	B	CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1		CHEMBL3342332		% Control	%	100.0	CHEMBL2527	Homo sapiens	% Control	%	100.0
Not Active	23366010	CHEMBL4879638	KinomeScan assay: inhibition of CHEK2	B	Cc1c(Oc2c(F)cccc2F)c(OC(C)C)nn1-c1ncc(C2CC2)cc1F		CHEMBL3589752		% Control	%	100.0	CHEMBL2527	Homo sapiens	% Control	%	100.0
Not Active	23366600	CHEMBL4879638	KinomeScan assay: inhibition of CHEK2	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748		% Control	%	88.0	CHEMBL2527	Homo sapiens	% Control	%	88.0
Not Active	23367068	CHEMBL4879638	KinomeScan assay: inhibition of CHEK2	B	O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4531775		% Control	%	100.0	CHEMBL2527	Homo sapiens	% Control	%	100.0
Not Active	23367511	CHEMBL4883864	CHK2 ProQinase selectivity panel	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC[C@H](O)CO)cc21		CHEMBL2152944		% Residual activity with Skepinone-L	%	89.0	CHEMBL2527	Homo sapiens	% Residual activity with Skepinone-L	%	89.0
Not Active	23367946	CHEMBL4879638	KinomeScan assay: inhibition of CHEK2	B	O=C(Nc1cnc(Oc2ccc(F)cc2)nc1)N1CCc2ncccc2[C@@H]1c1ccc(F)cc1		CHEMBL4458424		% Control	%	92.0	CHEMBL2527	Homo sapiens	% Control	%	92.0
Not Active	23368414	CHEMBL4879638	KinomeScan assay: inhibition of CHEK2	B	O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2[C@H]1c1ccc(F)cc1		CHEMBL4592872		% Control	%	94.0	CHEMBL2527	Homo sapiens	% Control	%	94.0
Not Active	23369013	CHEMBL4879638	KinomeScan assay: inhibition of CHEK2	B	C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1		CHEMBL4537673		% Control	%	84.0	CHEMBL2527	Homo sapiens	% Control	%	84.0
Not Active	23369481	CHEMBL4879638	KinomeScan assay: inhibition of CHEK2	B	CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl		CHEMBL4538591		% Control	%	100.0	CHEMBL2527	Homo sapiens	% Control	%	100.0
Not Active	23370017	CHEMBL4884261	CHK2(h) Eurofins kinase panel	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% residual kinase activity	%	100.0	CHEMBL2527	Homo sapiens	% residual kinase activity	%	100.0
Not Active	23370449	CHEMBL4879638	KinomeScan assay: inhibition of CHEK2	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% Control	%	70.0	CHEMBL2527	Homo sapiens	% Control	%	70.0
Not Active	23370917	CHEMBL4879638	KinomeScan assay: inhibition of CHEK2	B	CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1		CHEMBL4630642		% Control	%	74.0	CHEMBL2527	Homo sapiens	% Control	%	74.0
Slightly Active	23371636	CHEMBL4884597	NanoBRET (SGC-Frankfurt) (CHEK2)	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1	Non standard unit for type	CHEMBL4591082	>	IC50	µM	25.0	CHEMBL2527	Homo sapiens	IC50	µM	25.0
Slightly Active	23371726	CHEMBL4879638	KinomeScan assay: inhibition of CHEK2	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1		CHEMBL4591082		% Control	%	37.0	CHEMBL2527	Homo sapiens	% Control	%	37.0
Not Active	23372194	CHEMBL4879638	KinomeScan assay: inhibition of CHEK2	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNc3ncnc4c3nnn4-c3ccccc3)cc2)C1		CHEMBL4568183		% Control	%	100.0	CHEMBL2527	Homo sapiens	% Control	%	100.0
	23372698	CHEMBL4884663	CHK2(CHE2LGY1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(Cc4ccccc4)nc3C2=O)COc2ccccc21		CHEMBL4088216		IC50	nM	1000.0	CHEMBL2527	Homo sapiens	pIC50		6.0
	23373107	CHEMBL4884954	CHK2(CHE2LGY1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3c(nn(Cc4ccccc4)c3Br)C2=O)COc2ccccc21		CHEMBL4549667		IC50	nM	1000.0	CHEMBL2527	Homo sapiens	pIC50		6.0
	23373468	CHEMBL4885245	CHK2(CHE2LGY1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(CC4CCS(=O)(=O)CC4)nc3C2=O)COc2ccccc21		CHEMBL4097778		IC50	nM	1000.0	CHEMBL2527	Homo sapiens	pIC50		6.0
Not Active	23374937	CHEMBL4885931	CHK2 Kinase panel	B	CC(C)(O)[C@H](F)CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCOCC3)cc2C1=O		CHEMBL4475494		Inhibition	%	13.0	CHEMBL2527	Homo sapiens	% Inhibition	%	13.0
Not Active	23375621	CHEMBL4879638	KinomeScan assay: inhibition of CHEK2	B	O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1		CHEMBL4075278		% Control	%	69.0	CHEMBL2527	Homo sapiens	% Control	%	69.0
Not Active	23376089	CHEMBL4879638	KinomeScan assay: inhibition of CHEK2	B	N#Cc1ccc(Nc2ccc3[nH]c(=O)[nH]c3c2)c(Cl)c1		CHEMBL4063249		% Control	%	100.0	CHEMBL2527	Homo sapiens	% Control	%	100.0
Not Active	23376666	CHEMBL4879638	KinomeScan assay: inhibition of CHEK2	B	O=c1nc(-c2ccccn2)sc2ccccc12		CHEMBL4516611		% Control	%	100.0	CHEMBL2527	Homo sapiens	% Control	%	100.0
Not Active	23377136	CHEMBL4879638	KinomeScan assay: inhibition of CHEK2	B	O=C1NC(c2ccccn2)Sc2ccccc21		CHEMBL4561806		% Control	%	100.0	CHEMBL2527	Homo sapiens	% Control	%	100.0
Not Active	23377994	CHEMBL4879638	KinomeScan assay: inhibition of CHEK2	B	CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4282264		% Control	%	100.0	CHEMBL2527	Homo sapiens	% Control	%	100.0
Not Active	23378462	CHEMBL4879638	KinomeScan assay: inhibition of CHEK2	B	CNC(=O)Nc1ccc2c(c1)[C@@]1(CC2)OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4536197		% Control	%	100.0	CHEMBL2527	Homo sapiens	% Control	%	100.0
Not Active	23379629	CHEMBL4879638	KinomeScan assay: inhibition of CHEK2	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1		CHEMBL1800285		% Control	%	87.0	CHEMBL2527	Homo sapiens	% Control	%	87.0
Not Active	23380097	CHEMBL4879638	KinomeScan assay: inhibition of CHEK2	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)N3CCCC3)c(=O)n3ccccc23)CC1		CHEMBL2204283		% Control	%	92.0	CHEMBL2527	Homo sapiens	% Control	%	92.0
Not Active	23380791	CHEMBL4879638	KinomeScan assay: inhibition of CHEK2	B	COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1		CHEMBL3286797		% Control	%	93.0	CHEMBL2527	Homo sapiens	% Control	%	93.0
Not Active	23381439	CHEMBL4879638	KinomeScan assay: inhibition of CHEK2	B	C[C@H](NC(=O)c1cnc2n1[C@](C)(Cc1ccc(C#N)cc1)C(=O)N2c1cc(Cl)c(F)c(Cl)c1)C(=O)NC1(c2ccccn2)CC1		CHEMBL4530740		% Control	%	100.0	CHEMBL2527	Homo sapiens	% Control	%	100.0
Not Active	23381907	CHEMBL4879638	KinomeScan assay: inhibition of CHEK2	B	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21		CHEMBL4577237		% Control	%	100.0	CHEMBL2527	Homo sapiens	% Control	%	100.0
Not Active	23382395	CHEMBL4887115	CHK2 Invitrogen kinase activity assay	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		Inhibition	%	28.0	CHEMBL2527	Homo sapiens	% inhibition	%	28.0
Not Active	23382531	CHEMBL4879638	KinomeScan assay: inhibition of CHEK2	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		% Control	%	100.0	CHEMBL2527	Homo sapiens	% Control	%	100.0
Active	23382999	CHEMBL4879638	KinomeScan assay: inhibition of CHEK2	B	CN(c1ccnc(CNc2nc(Nc3ccc4c(c3)CC(=O)N4)ncc2C(F)(F)F)n1)S(C)(=O)=O		CHEMBL4518706		% Control	%	0.0	CHEMBL2527	Homo sapiens	% Control	%	0.0
Not Active	23383736	CHEMBL4887383	CHEK2 Invitrogen Lab (UK) kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	79.0	CHEMBL2527	Homo sapiens	% Ctrl	%	79.0
Slightly Active	23384032	CHEMBL4887630	CHK2 DUNDEE kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	49.7	CHEMBL2527	Homo sapiens	% Ctrl	%	49.7
Not Active	23384221	CHEMBL4887816	CHK2(h) Millipore kinase panel	B	CC[C@@H](Nc1c(C#N)c(-c2ccc(-c3cccc(C)c3F)cc2)nc2cnccc12)C(=O)O		CHEMBL4802045		Inhibition	%	5.38	CHEMBL2527	Homo sapiens	% inhibition	%	5.38
Not Active	23384645	CHEMBL4888171	CHEK2 (CHK2) SelectScreen Kinase panel (LifeTechnologies)	B	C=CC(=O)Nc1ccc2[nH]c(=O)n(C3CCN(Cc4ccc(-c5nc6cc[nH]c(=O)c6cc5-c5ccccc5)cc4)CC3)c2c1		CHEMBL4795065		Inhibition	%	4.0	CHEMBL2527	Homo sapiens	% Inhibition	%	4.0
Not Active	23384914	CHEMBL4879638	KinomeScan assay: inhibition of CHEK2	B	CO[C@@H](C)c1c(Nc2ccc([C@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4568735		% Control	%	90.0	CHEMBL2527	Homo sapiens	% Control	%	90.0
Not Active	23385381	CHEMBL4879638	KinomeScan assay: inhibition of CHEK2	B	CO[C@@H](C)c1c(Nc2ccc([C@@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4584981		% Control	%	100.0	CHEMBL2527	Homo sapiens	% Control	%	100.0
Not Active	23385871	CHEMBL4888344	CHK2 Invitrogen kinase panel	B	COc1nc2ccc([C@@](O)(c3ccccc3)C3CCN(C(C)=O)CC3)cc2c(Cl)c1Cc1ccc(-n2cccn2)cc1		CHEMBL4802042		Inhibition	%	6.0	CHEMBL2527	Homo sapiens	% inhibition	%	6.0
